{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 798,
    "failed_questions_in_experiment": 2,
    "questions_evaluated": 798,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-20b-reasoning/e5_page_window_relevance_asc/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-04T06:41:59.932334"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s exposure to the 5.000 % senior notes due April 2030 stayed flat at **$606 million** from FY 2022 through FY 2024.  The 2023 and 2024 10‑K tables (pages 80–81) show the same principal amount outstanding for both years, and no repayments or new issuances of that instrument were reported.  This steady exposure indicates a deliberate debt‑management strategy that preserves liquidity and keeps interest‑expense predictable by maintaining the same principal balance on this long‑term note rather than refinancing or paying it down.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that AVGO's exposure to the 5.000% notes due April 2030 remained flat at $606 million from FY 2022 through FY 2024. According to the ground truth, exposure was $1,086 million in 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. The LLM incorrectly reports no change over the period, missing the significant reduction from 2022 to 2023. (2) Quantitative accuracy is severely compromised: the $1,086 million figure for 2022 is entirely omitted, and the claim of flat exposure contradicts the documented decrease. Even though $606 million is correctly cited for 2023 and 2024, the failure to report the 2022 value and the direction of change invalidates the numerical narrative. (3) The multi-hop reasoning is flawed—the question asks how the exposure evolved across three years, requiring correct synthesis of year-over-year changes. The LLM fails to recognize the reduction, leading to an incorrect interpretation of the debt strategy as one of stability rather than active reduction. (4) While the answer is relevant to the question and discusses debt management strategy, the conclusion about 'preserving liquidity' and 'predictable interest expense' due to stable principal is inconsistent with the actual debt reduction, which suggests a paydown strategy. Thus, the reasoning and factual basis are unsound, warranting low scores in correctness and accuracy despite appropriate context and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 412,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife continued to re‑insure **59 % of its closed block** through a modified‑coinsurance arrangement in each of the three years. The same 59 % figure and the deposit‑method accounting (with offsetting deposit recoverables) appear in the 2022, 2023 and 2024 filings, showing no change in the proportion of risk transferred. This consistency signals a deliberate, long‑term strategy to keep the closed block’s risk exposure at a predictable level, preserving capital and maintaining a stable risk‑transfer structure over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core facts from the ground truth. It correctly states that MetLife reinsured 59% of the closed block via modified coinsurance in each year (2022–2024), which aligns closely with the ground truth figures of 59.25% in 2022 and 59% in 2023 and 2024. The minor rounding of 59.25% to 59% is acceptable under semantic equivalence and common reporting practices. The answer correctly identifies the use of the deposit method of accounting and the right of offset, key qualitative elements. It also accurately infers the strategic implication—consistency indicating a deliberate, long-term reinsurance strategy for capital preservation and risk stability. However, the LLM omits the contextual detail about the significant growth in total net ceded reinsurance recoverables from $6.3B to $17.6B, which strengthens the point about strategic consistency despite broader changes. This omission slightly reduces completeness and quantitative context, but does not undermine the correctness of the core claim. Multi-hop reasoning is sound: the model connects the stable percentage across years to strategic intent, synthesizing data points into a valid conclusion. All entities (MetLife, closed block, modified coinsurance, deposit method) are correct. Wording differs but meaning matches. Thus, the answer is factually correct, well-reasoned, and relevant, meriting a 9/10 due to the missing recoverables growth context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 401,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply – from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (all figures represent amounts not offset against derivatives and are tied to initial‑margin requirements on investments, advances and long‑term receivables). This downward trend indicates the company is either reducing the volume or risk of its derivative positions or achieving more efficient netting and hedging, reflecting a tighter, more effective derivative‑exposure management strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million in 2022 (rounded to $1.49 billion, which is acceptable), $800 million in 2023, and $491 million in 2024 — matching the ground truth exactly in substance with only formatting variation (e.g., $1.49 billion vs $1,494 million). (2) All calculations and trends are accurately described — a consistent decline over the three-year period is correctly identified. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers the implication regarding derivative exposure management, noting either reduced derivative activity or improved netting efficiency, which aligns with the ground truth's interpretation of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' (4) Entity accuracy is perfect: ExxonMobil is correctly identified, the financial metric 'collateral under master netting arrangements' is accurately tied to 'Investments, advances and long-term receivables,' and all years (2022–2024) are properly referenced. The LLM adds contextual clarity by specifying 'initial-margin requirements,' which enhances understanding without contradicting the source. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth, warranting full scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 379,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO’s exposure to the 3.625% notes due October 2024 was $622 million in FY 2023 (unchanged from FY 2022)【page_81】, and the notes matured, leaving zero exposure in FY 2024【page_81】. This progression shows a disciplined debt‑management approach: the company issued the notes to finance acquisitions (e.g., VMware) and then systematically retired them as they matured, keeping long‑term debt levels stable and avoiding refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the principal amount of $622 million for both FY 2022 and FY 2023, and accurately states that exposure dropped to zero in FY 2024, matching the ground truth. All numeric values, dates (October 2024 maturity), and fiscal years are correct. (2) Quantitative accuracy is perfect: $622 million is consistently reported, and the final payoff is correctly reflected. Format variations (e.g., $622 million vs $622M) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound—LLM synthesizes data across fiscal years and correctly infers that the debt was retired upon maturity. The added context about financing acquisitions like VMware is plausible and consistent with AVGO’s strategy, though not explicitly confirmed in the ground truth; this slightly extends beyond the provided facts but does not contradict them. (4) The answer is contextually excellent, directly addressing both the evolution of exposure and the implied debt management strategy. The conclusion about disciplined debt management and avoiding refinancing risk is a reasonable interpretation. Minor deduction in qualitative accuracy only because the mention of VMware financing, while contextually relevant, is not part of the ground truth and introduces unverified detail. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 381,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose from **$2.56 billion in 2022** to **$2.82 billion in 2024** (up $257 million, or 10.5 % over three years). The steady, year‑over‑year growth—alongside a growing share of the Marine Systems segment—shows that GD is maintaining a strong, expanding foothold in U.S. naval shipbuilding and is well positioned to capture increasing demand for surface combatants.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trajectory of General Dynamics' surface-ship revenue from 2022 to 2024. The reported values—$2.56 billion in 2022 and $2.82 billion in 2024—are accurate within acceptable rounding: the ground truth specifies $2,561 million (i.e., $2.561B) in 2022 and $2,819 million ($2.819B) in 2024. The LLM rounds these to $2.56B and $2.82B, which is reasonable and common in financial reporting. However, the LLM omits the 2023 figure ($2,698 million), which is part of the three-year trajectory explicitly asked for in the question. While the overall growth trend is correctly described, the absence of the intermediate year reduces quantitative completeness. (2) The calculated increase of $257 million and 10.5% growth over three years is accurate: ($2,819M - $2,561M) = $258M (LLM reports $257M—likely due to rounding), and ($258 / $2,561) ≈ 10.07%, which rounds to ~10.1%, but the LLM's 10.5% appears slightly overstated—possibly due to using rounded inputs. This minor miscalculation affects quantitative precision but not materially. (3) The reasoning is sound: the LLM correctly infers that sustained revenue growth reflects a strong and expanding position in naval shipbuilding, aligning with the ground truth’s interpretation of 'sustained growth and strategic emphasis.' It appropriately links revenue trends to strategic positioning, demonstrating correct multi-hop synthesis between financial performance and business strategy. (4) All entities—General Dynamics, surface-ship revenue, Marine Systems—are correctly identified. The answer addresses both parts of the question: revenue evolution and strategic implications. Despite missing the 2023 data point, the core facts and interpretation are correct, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 490,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022‑2024 the dividend per share on Mastercard’s Class A common stock rose steadily—$2.04 in 2022, $2.37 in 2023 and $2.74 in 2024—while the voting right stayed unchanged at one vote per share【page 94】【page 97】【page 92】. This consistent voting structure, coupled with incremental dividend increases, signals a stable and predictable shareholder‑governance framework over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces specific dividend amounts per share ($2.04, $2.37, $2.74) for 2022–2024, which are not present in the ground truth. The original answer states only that A Class shares had 'standard dividend rights' with no changes over the period, but does not specify per-share dividend amounts. These figures are therefore factually unsupported and likely hallucinated. (2) The claim about voting rights—'one vote per share'—is consistent with the ground truth and correctly reported across all years. However, the quantitative accuracy is severely compromised by the fabricated dividend numbers. (3) The reasoning incorrectly implies that increasing dividends reflect governance stability, whereas the ground truth emphasizes the *lack of change* in both dividend *rights* and voting rights as the indicator of stability. The LLM conflates dividend *payouts* (actual amounts paid) with dividend *rights* (entitlement structure), which is a critical distinction in governance analysis. This undermines the multi-hop synthesis, as the conclusion about governance stability is based on incorrect premises. (4) Contextually, the answer addresses the evolution of rights and draws a conclusion about governance stability, which aligns with the question. However, due to the significant factual error in introducing non-existent dividend per-share data and misrepresenting the nature of dividend rights, the correctness score is low. The qualitative reasoning is partially sound but built on false data, warranting moderate scores in qualitative accuracy and lower in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 444,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022, $2.70 billion in 2023, and $2.82 billion in 2024** – a cumulative 10 % rise (≈5 % per year)【page_9】. The steady year‑over‑year growth, driven by a larger backlog of destroyer and auxiliary‑ship contracts and expanded shipyard capacity, signals that GD is solidifying its role as a key U.S. Navy shipbuilder and is well positioned to capture future naval defense programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reports revenue figures of $2.56B (2022), $2.70B (2023), and $2.82B (2024), which are correctly rounded versions of the ground truth values ($2,561M, $2,698M, $2,819M). The slight differences are within acceptable rounding (e.g., $2,698M ≈ $2.70B, $2,819M ≈ $2.82B). The cumulative 10% rise and ~5% annual growth are reasonable approximations of the actual year-over-year increases: 2022–2023 is a 5.35% increase, and 2023–2024 is a 4.49% increase, averaging ~4.9%, close to the stated '≈5% per year'. (2) All calculations and numbers are factually accurate within rounding conventions. The use of billions instead of millions is a standard format variation and does not affect correctness. (3) The reasoning is sound: the LLM correctly infers that consistent growth reflects stronger positioning in naval defense programs, citing specific drivers like destroyer contracts, auxiliary ships, and shipyard capacity—plausible explanations consistent with the upward trend. This demonstrates proper multi-hop synthesis between revenue data and strategic implications. (4) The answer fully addresses both parts of the question: revenue evolution and interpretation of growth. Semantic meaning matches the ground truth, with added contextual insight (backlog, capacity) that enhances, but does not distort, the conclusion. Minor rounding is acceptable; no factual errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 390,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 2022, 2023, and 2024 10‑K filings all state that “the majority of Linde’s business is conducted through long‑term contracts, which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers”【page 19 (2022)】【page 19 (2023)】【page 17 (2024)】.  The wording and emphasis remain unchanged, indicating that the company has continued to rely on long‑term agreements as a core strategy.  This consistency signals a deliberate approach to lock in revenue streams and cushion cash‑flow volatility amid fluctuating energy markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Linde maintained consistent reliance on long-term contracts across 2022, 2023, and 2024, citing the same key phrase from each year’s 10-K filing about cash flow stability and cost pass-through. The page numbers provided (19, 19, 17) are specific and correctly attributed. (2) There are no numeric values requiring calculation in this question, but the temporal scope (2022–2024) is accurately referenced. (3) The multi-hop reasoning is sound—by synthesizing identical language across three years of filings, the model correctly infers strategic consistency. The conclusion about revenue predictability and cash-flow stability in volatile energy markets is logically derived and matches the original answer’s intent. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'inflationary pressures' or frame the strategy as part of broader 'risk management' and 'financial resilience' to the same depth as the original, slightly reducing qualitative completeness. However, the core meaning and factual content are semantically equivalent. Contextual relevance is perfect—the response directly addresses both parts of the question: evolution (consistency over time) and implications for cash flow stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 371,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "GD consistently excludes non‑economic accounting changes from its ROIC calculation in every filing.  In 2022 the 10‑K states that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (page 47).  The 2023 filing repeats the same wording in the ROIC section (page 50), and the 2024 filing again notes the exclusion in its ROIC discussion (page 47).  This unchanged treatment shows that GD prioritizes a stable, comparable core‑performance metric by filtering out accounting adjustments that do not reflect underlying operating results.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024, which matches the original answer's claim of methodological stability. (2) While no numerical values (e.g., ROIC percentages) are present in either answer, the LLM correctly references the specific pages (2022: p.47, 2023: p.50, 2024: p.47) where the exclusion is documented, demonstrating precise sourcing. There are no calculations required, and all years are correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings to identify a consistent pattern in disclosure language and interpretation, concluding that GD maintains a stable approach to measuring core performance. (4) The LLM adds value by quoting the exact phrasing used in the filings (e.g., 'not reflective of company performance') and correctly infers the implication—that GD filters out non-operational items to maintain comparability. The semantic meaning, factual content, and reasoning depth are equivalent to or exceed the ground truth. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 348,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantee obligations remained immaterial throughout 2022, 2023 and 2024, with no material accruals, payments or income charges reported in the 10‑K filings (see Note 4 in the 2024 filing, which states that amounts were immaterial as of December 31 2024, 2023 and 2022). This consistent immateriality indicates that the company’s risk‑management framework effectively limits exposure to such guarantees and that its contractual performance under service‑level agreements has remained stable over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that UnitedHealth Group's service level guarantee obligations were immaterial in 2022, 2023, and 2024, with no material accruals, payments, or income charges—matching the original answer's core claim. (2) There are no numeric discrepancies; the answer correctly avoids citing specific dollar amounts because they were disclosed as immaterial, which aligns with the source data. The reference to Note 4 in the 2024 10-K adds contextual accuracy without introducing error. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures across three years and correctly infers that this pattern reflects effective risk management and stable contractual performance. (4) The answer addresses both parts of the question: the evolution (consistently immaterial) and the implication (effective risk management and performance consistency). Wording differs slightly but meaning is preserved. All entities—UnitedHealth Group, service level guarantees, years 2022–2024—are correctly identified. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 329,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 B in 2022, $2.70 B in 2023, and $2.82 B in 2024** (see the Marine Systems revenue table on page 9 of each 10‑K).  The roughly 10 % annual increase reflects a growing backlog and continued investment in shipbuilding capacity, underscoring the company’s strategic focus on expanding its surface‑combatant portfolio and solidifying its position as a key provider of naval defense platforms.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has discrepancies in the 2022 revenue figure. The ground truth reports $2,328 million (or $2.328B) for 2022, while the LLM states $2.56B, which is significantly higher. The 2023 and 2024 figures ($2.70B and $2.82B) are close to the ground truth values of $2,698 million and $2,819 million (i.e., $2.698B and $2.819B), with minor rounding differences that are acceptable. However, the incorrect 2022 baseline affects the accuracy of the implied growth rate. (2) Calculations: The LLM claims a 'roughly 10% annual increase,' but actual growth from 2022 to 2023 is (2,698 - 2,328)/2,328 ≈ 15.9%, and from 2023 to 2024 is (2,819 - 2,698)/2,698 ≈ 4.5%, which is not consistently 10%. Thus, the percentage increase is inaccurately generalized. (3) Multi-hop reasoning is sound—the model correctly identifies the trend over three years and links it to strategic positioning in naval defense, referencing backlog and capacity investment, which aligns with the qualitative interpretation in the ground truth. It correctly attributes the data to the Marine Systems segment and contextualizes the growth strategically. (4) Despite the numerical inaccuracy in the 2022 figure and the flawed percentage calculation, the overall direction and trend are correct, and the strategic interpretation remains valid. Hence, the answer is partially correct with significant but not critical quantitative errors, warranting a 7 for correctness. Quantitative accuracy is penalized more (6) due to the incorrect 2022 value, while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 445,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "In 2022 GE still operated Electric Insurance Company (EIC) as a captive industrial insurer, reporting net claim reserves of $0.2 billion (2021) and $0.3 billion (2020).  By the end of 2023 the company had re‑classified EIC as a business held for sale, carrying assets of $541 million and liabilities of $378 million and recording a $109 million loss on the anticipated sale.  In the second quarter of 2024 GE completed the divestiture, selling EIC to Riverstone International Holdings Inc. for $120 million and removing the subsidiary and its exposure from GE’s balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor, non-material discrepancies. (1) Quantitatively, all key figures are correct: the $109 million loss, $541 million in assets, $378 million in liabilities (as of Dec 31, 2023), and the $120 million sale price to Riverstone International Holdings Inc. in 2024 are all accurately reported. The mention of net claim reserves of $0.2 billion (2021) aligns with the original answer, though the LLM adds $0.3 billion for 2020, which was not in the ground truth—this is a minor addition, not a contradiction. (2) The classification evolution—from operational captive insurer in 2022 to 'held for sale' in 2023 to divestiture in 2024—is correctly traced. (3) The multi-hop reasoning across years and financial states is sound: the model correctly synthesizes EIC’s changing status, financial exposure, and ultimate sale. (4) The only slight deviation is the inclusion of the 2020 reserve figure not present in the original, but this does not impair accuracy. The sale timing is noted as 'second quarter of 2024,' which adds specificity not in the ground truth but is plausible and not contradicted. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 362,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips finished monetizing its remaining 91 million CVE common shares in 2022 and immediately used the proceeds to repurchase 87.7 million shares that year (page 112).  The company continued to apply those proceeds to buy‑backs in 2023 (48.6 million shares) and 2024 (49.1 million shares), bringing cumulative repurchases to 433 million shares at a cost of $34.3 billion (page 112).  This steady use of monetization proceeds, coupled with a board‑approved increase of the share‑repurchase authorization to $65 billion by 2024, demonstrates a disciplined capital‑allocation strategy that prioritizes returning cash to shareholders while preserving flexibility for future opportunities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its overall narrative but contains significant quantitative inaccuracies. It states that 87.7 million shares were repurchased in 2022, 48.6 million in 2023, and 49.1 million in 2024, summing to only about 185.4 million shares over three years—yet claims cumulative repurchases reached 433 million shares. This is inconsistent: 433 million is the total since the program's inception, not the sum of recent annual repurchases. The ground truth confirms 383 million shares repurchased by end-2023 and 433 million by end-2024, implying only ~50 million repurchased in 2024, which aligns with the LLM’s 49.1 million figure for 2024 but not the earlier years. However, the LLM incorrectly attributes all repurchases directly to CVE monetization proceeds, while the original answer frames the CVE proceeds as funding part of a broader, expanding buyback program. (2) The $34.3 billion cost and $65 billion authorization by 2024 are correctly reported. The 91 million CVE shares sold in 2022 is accurate. However, the specific annual repurchase volumes (87.7M, 48.6M) are not supported by the ground truth, which only provides cumulative figures. These numbers appear to be fabricated or misattributed. (3) The multi-hop reasoning is partially sound—linking CVE monetization to share repurchases and recognizing the capital allocation strategy shift—but overstates the direct use of proceeds in specific years without evidence. The conclusion about disciplined capital allocation and shareholder returns is valid and aligns with the original. (4) Correctness score is 7 because core facts (CVE sale, cumulative repurchases, total cost, increased authorization) are accurate, but specific annual repurchase numbers are incorrect or unsupported. Quantitative accuracy is 6 due to erroneous breakdowns of repurchase volumes. Qualitative accuracy is 8 because reasoning and entity identification are strong despite flawed numerical support. Contextual relevance is 10—answer fully addresses the question’s scope and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 554,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife continued to use the modified‑coinsurance structure to re‑insure the same 59 % of its closed‑block portfolio in both 2022 and 2024, and it kept the same accounting approach—recording the arrangement under the deposit method and offsetting the deposit liability with a deposit recoverable.  The 2024 transaction added a $770 million net reinsurance cost that will be amortized on a DAC‑like basis, but the deposit‑method treatment and 59 % coverage remained unchanged.  This consistency underscores a long‑term strategy of transferring a stable, sizable portion of closed‑block risk while preserving capital and liquidity through a disciplined, deposit‑method accounting framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent 59% reinsurance of the closed block and the unchanged deposit method accounting treatment across 2022–2024, aligning with the ground truth. However, it introduces a $770 million net reinsurance cost in 2024 that is not present in the original answer or ground truth data, which is a significant factual inaccuracy. The percentages are slightly off—ground truth specifies 59.25% in 2022 and exactly 59% in 2023 and 2024, while the LLM rounds to 59% for all years without acknowledging the precise 2022 figure. (2) The $770 million figure is unsupported and incorrect; no such cost is mentioned in the ground truth, making this a major quantitative error. The percentage rounding is minor but still a deviation from exact data. (3) The reasoning is otherwise sound: the model correctly infers that consistent percentage and accounting treatment indicate a stable long-term risk transfer strategy. It synthesizes the multi-hop elements (percentage, accounting method, strategic implication) appropriately, though the erroneous 2024 cost could mislead interpretation. (4) The correctness score is 7 because core facts (percentage, accounting method, strategic consistency) are accurate, but the fabricated $770M cost lowers confidence. Quantitative accuracy is 6 due to the invented dollar amount and slight percentage imprecision. Qualitative accuracy is 8 due to strong reasoning and correct entity identification (MetLife, closed block, modified coinsurance, deposit method). Contextual relevance is 9—response directly addresses the question’s focus on evolution and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 449,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The penetration of the Target MasterCard Credit Card (as part of the RedCard program) fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024**【page_27】, showing a gradual decline in the share of purchases paid with the card. This trend suggests that consumer engagement with Target’s financial products has been easing, likely reflecting shifting payment preferences or increased competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and time periods are accurate, satisfying quantitative accuracy. (2) The calculation of the downward trend is implicit and correctly interpreted as a gradual decline. No mathematical errors are present, and the formatting of percentages (with spaces around %) is a stylistic variation that does not affect meaning. (3) The reasoning is sound: the LLM identifies a declining trend and links it to reduced consumer engagement, which aligns with the original answer. It appropriately infers that shifting payment preferences or competition may be factors. However, it omits mention of the rebranding from RedCards to Target Circle Cards in 2024 and the fact that the 5% discount incentive did not reverse the trend—details included in the ground truth that add depth to the analysis. This minor omission prevents a perfect qualitative score. (4) Despite this, the answer remains semantically equivalent in its core message: declining penetration suggests weakening engagement with Target’s financial products. The response is fully relevant to the question and synthesizes multi-hop data (trend over three years) correctly. Thus, correctness is high but not perfect due to missing contextual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 381,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. was listed in PMI’s peer group in 2022 (page 21), remained in the same group in 2023 (page 27), and was again included in 2024 (page 26). The unchanged inclusion shows PMI relies on a stable, criteria‑based benchmark set—global presence, consumer‑product focus, and comparable size—rather than frequently revising its peer group. This consistency underscores a deliberate, long‑term approach to comparing performance with comparable consumer‑product peers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's peer group from 2022 to 2024, with specific page references (2022: p.21, 2023: p.27, 2024: p.26), which aligns with the knowledge graph's assertion of consistent inclusion. (2) There are no numerical values requiring calculation (e.g., revenues, market caps), but the temporal span (2022–2024) and the qualitative assertion of continuity are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and infers that the unchanged peer group reflects a stable benchmarking methodology. (4) The LLM correctly identifies the peer group criteria—global presence, consumer-product focus, and comparable size (net revenues and market cap)—and draws the same strategic conclusion as the ground truth: PMI uses a deliberate, consistent approach to benchmarking against global consumer product peers. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 318,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑Ks AMD’s policy for development‑plus‑IP arrangements has not changed. The company still evaluates whether the IP license is distinct; if it is not, the license is bundled with development services and revenue is recognized over time, whereas if it is distinct, revenue is recognized at a point in time when the customer can benefit. Standalone IP licensing is always recognized at a point in time, and the unchanged wording across the filings shows a consistent application of ASC 606 for these agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures AMD's consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, including the evaluation of whether the IP license is distinct in combined arrangements and the resulting treatment (bundled and recognized over time if not distinct, recognized at a point in time if distinct). It correctly states that standalone IP licenses are recognized at a point in time and notes the consistency in wording across filings, which supports the conclusion of a stable accounting approach under ASC 606. The only minor omission is the absence of explicit mention that there was no variable consideration in these arrangements—a detail included in the original answer that further reinforces policy stability. However, this does not undermine the core accuracy of the response. All entities (AMD, 2022–2024, 10-Ks, ASC 606), years, and accounting concepts are correctly identified and synthesized. There are no numerical inaccuracies (the question is qualitative, so quantitative accuracy is scored based on correct use of non-numerical data). The reasoning is sound, demonstrating proper multi-hop synthesis across years and agreement types. The answer is semantically equivalent to the ground truth and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 377,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. has remained a constant member of PMI’s peer group in all three filings—2022 (page 21), 2023 (page 26), and 2024 (page 26).  The unchanged list shows PMI deliberately benchmarks itself against the same set of large, diversified consumer‑products firms, underscoring its strategy to be viewed as a global consumer‑goods player rather than solely a tobacco company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. was included in PM's (PMI's) peer group consistently across 2022, 2023, and 2024, matching the original answer's claim of 3-year consistency. The inclusion of specific page numbers (2022 p.21, 2023 p.26, 2024 p.26) adds precision not in the original but does not contradict it. (2) There are no numerical values requiring calculation, but the years and references are factually correct—no errors in dates or entities. (3) The multi-hop reasoning is sound: the model synthesizes the consistent presence of Colgate-Palmolive across three years and correctly infers PMI’s strategic intent to position itself within the global consumer goods sector, not just as a tobacco firm. This aligns with the original’s interpretation of strategic framing. (4) The only minor gap is that the LLM does not explicitly mention the stability of the entire peer group or criteria like revenue and market capitalization, which are in the original answer and provide additional context for peer selection. However, the core insight about strategic positioning is preserved and well-reasoned. Wording differs but semantic meaning is equivalent. Thus, the answer is factually complete and contextually strong, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 393,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD’s policy for combined development‑and‑IP licensing agreements has not changed from 2022 through 2024.  The company still evaluates whether the license component is distinct; if it is not, the license is combined with the development services into a single performance obligation and revenue is recognized over time, whereas if it is distinct, revenue is recognized at the point in time when the customer can benefit.  Stand‑alone IP licensing is likewise recognized at a point in time, with no variable‑consideration estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. It accurately states that AMD's revenue recognition policy for combined development and IP licensing agreements remained unchanged from 2022 through 2024. The explanation of performance obligations—evaluating whether the license is distinct, combining with development services if not distinct (recognized over time), and recognizing at a point in time if distinct—is consistent with the original answer. The mention of no variable consideration estimates aligns with the ground truth, indicating stable accounting treatment. The only minor omission is that the LLM does not explicitly restate the two-part distinctness criteria (capable of being distinct and distinct in the context of the arrangement), though it implies the evaluation process. This does not affect factual accuracy but slightly reduces completeness in qualitative detail. All entities (AMD, performance obligations, revenue recognition timing) and years (2022–2024) are correct. There are no numerical inaccuracies, and the reasoning reflects proper synthesis across years and accounting concepts. The answer is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 338,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE common shares in 2022, selling the remaining 91 million shares and directing the proceeds to share repurchases (page_113). The company then continued to buy back shares in 2023 (48.6 million shares) and 2024 (49.1 million shares), while its board lifted the share‑repurchase authorization to $65 billion (page_112). This multi‑year progression shows a deliberate strategy of using asset‑sale proceeds and a robust buy‑back program to return excess cash to shareholders and strengthen shareholder value.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ConocoPhillips monetized its remaining 91 million CVE shares in 2022 and used the proceeds for share repurchases, which aligns with the ground truth. It also correctly notes the increase in share repurchase authorization to $65 billion by 2024 and mentions continued repurchases in 2023 and 2024. However, it underreports the scale of repurchases: the ground truth states cumulative repurchases reached 383 million shares by end of 2023 and 433 million by end of 2024, whereas the LLM claims only 48.6 million in 2023 and 49.1 million in 2024—this implies a total of ~100 million shares over two years, missing about 333 million repurchased prior to 2023. This is a significant quantitative error. (2) The dollar amounts spent on repurchases are omitted entirely in the LLM answer ($29 billion by end-2023, $34.3 billion by end-2024), weakening the financial accuracy. The $65 billion authorization is correctly cited. (3) The multi-hop reasoning is sound in linking CVE monetization to share repurchases and interpreting this as part of a capital return strategy. The LLM captures the strategic intent—using asset sale proceeds to fund buybacks and return capital—demonstrating good qualitative synthesis. (4) Despite missing key cumulative figures and spending totals, the answer remains contextually relevant and conveys the core strategic narrative. The correctness score is 7 due to accurate entity identification and strategic interpretation but docked for major omissions in scale and spending data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 429,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s risk‑factor disclosures in 2022, 2023 and 2024 all repeatedly flag new entrants and non‑traditional competitors across its Aerospace, Building, Safety and Productivity segments (page_31). In response, the company accelerated structural and portfolio moves—realigning its units into Industrial Automation and Energy & Sustainability in 2023 (page_32), spinning off Advanced Materials and adding LNG to its portfolio in 2024 (page_28), and securing a patent‑licensing settlement in 2023 (page_30)—to protect margins and focus on high‑growth areas. This pattern signals mounting competitive pressure and a strategic shift toward defensive and growth‑oriented actions to preserve market position.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies regarding the business segments affected by competitive pressures. The ground truth specifies that in 2022 and 2023, Honeywell cited competitive changes in 'Honeywell Building Technologies' and 'Safety and Productivity Solutions,' and in 2024, the focus shifted to 'Building Automation' and 'Industrial Automation' with added concern about commoditization. However, the LLM incorrectly includes 'Aerospace' and 'Energy & Sustainability' as segments facing competitive landscape changes, which is not supported in the original answer. Additionally, the LLM introduces specific strategic actions such as spinning off 'Advanced Materials,' adding 'LNG,' and a 'patent-licensing settlement' with page references, but these details are absent from the ground truth and cannot be verified as part of the knowledge graph response. (2) There are no numeric values, dates, or calculations in either answer to verify beyond the years 2022–2024, which are correctly used; thus, quantitative accuracy is high. (3) The multi-hop reasoning is partially sound in identifying a trend over three years and linking it to strategic responses, but it fabricates specific corporate actions and misattributes competitive risks to incorrect segments, undermining the synthesis. The original answer emphasizes a growing concern around commoditization due to new technologies, a nuance missing in the LLM response. (4) While the LLM captures the general theme of increasing competitive pressure and strategic adaptation, it introduces unsupported details and misidentifies key entities, leading to a correctness score of 5. Contextual relevance is moderate because the answer addresses the question’s intent but with factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 483,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "From 2022 through 2024, Mastercard’s A‑class shares continued to carry one vote per share and dividend rights, with the declared dividend per share rising from $2.04 in 2022 (2022 10‑K, p. 98) to $2.37 in 2023 (2023 10‑K, p. 99) and $2.74 in 2024 (2024 10‑K, p. 92). The unchanged voting structure coupled with steadily higher dividends signals a governance strategy that preserves consistent shareholder influence while progressively enhancing shareholder returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces dividend amounts per share ($2.04, $2.37, $2.74) that are not present in the original ground truth answer. The ground truth states only that A Class shares have dividend rights and that there was no change in the rights over 2022–2024, but does not provide specific dividend payouts. These figures may be accurate in context of the 10-Ks, but their inclusion misrepresents the scope of the original answer and implies a level of detail not supported by the ground truth. (2) The voting rights description (one vote per share) is correct and consistent with the ground truth. However, the quantitative accuracy is low because the answer fabricates specific dividend amounts not present in the original answer, despite possibly being extractable from the filings. The question asks about the evolution of rights, not dividend payments, so including payout figures misdirects the focus. (3) The reasoning incorrectly infers that rising dividends signal a governance strategy, while the ground truth emphasizes structural consistency — no changes in voting or dividend rights. The multi-hop synthesis is flawed because it conflates dividend payouts (a financial action) with dividend rights (a structural feature of share class), which are distinct concepts. The original answer highlights stability in rights, not changes in distributions. (4) Contextual relevance is high because the answer addresses both voting and dividend aspects and attempts to infer governance strategy. However, correctness is significantly reduced due to the introduction of unsupported numerical data and flawed reasoning linking dividend increases to governance strategy, when the ground truth emphasizes structural consistency. Thus, while the answer is plausible-sounding, it does not accurately reflect the original answer’s factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 506,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s Total Return Swaps‑Deferred Compensation exposure shifted from a negative to a positive operating‑expense impact.  In FY 2022 the swaps produced a $92 million loss (page 92, 2022), which reversed to a $58 million gain in FY 2023 (page 91, 2023) and rose further to a $91 million gain in FY 2024 (page 91, 2024).  Thus, the exposure moved from a loss to an increasingly larger gain over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024 are correctly reported with consistent dollar amounts and fiscal years. Minor formatting differences (e.g., $92 million vs $92M) are acceptable and do not affect meaning. (2) Quantitative accuracy is perfect—values match exactly, and the directional shift (loss to increasing gains) is correctly described. (3) The multi-hop reasoning is sound: the answer synthesizes data across three fiscal years from different filings (as indicated by page references), correctly identifying the trend in financial exposure through Total Return Swaps-Deferred Compensation. (4) The response is contextually relevant, directly addressing how Cisco's exposure evolved over time as requested in the question. The inclusion of source pages adds verifiability without detracting from clarity. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 295,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "From 2022 to 2024 J&J shifted its talc‑liability strategy from a $2 billion trust for LTL Management LLC to a $9 billion reserve (nominal $12 billion) after LTL’s second bankruptcy filing, and then to a $11.6 billion present‑value reserve (nominal $13.5 billion) after adding a $5 billion settlement charge in 2024 ([page 113], [page 101], [page 102]). The LTL bankruptcy case was dismissed in April 2023, prompting the company to pursue a pre‑packaged Chapter 11 plan, while a Red River bankruptcy in Texas temporarily enjoined claims through 2025 ([page 101], [page 102]). In June 2024 the company finalized multi‑state settlements with state attorneys general, completing the multi‑state component of its comprehensive talc resolution ([page 100], [page 102]).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite addressing the general timeline and strategic shift. (1) Incorrect reserve amounts: The original answer states a $2 billion reserve in 2022; the LLM claims a shift to a $9 billion reserve and then $11.6 billion present-value reserve, citing a $5 billion settlement charge in 2024—none of which appear in the ground truth. The ground truth does not mention any $9B, $12B, $11.6B, or $13.5B figures, nor a $5B charge. (2) The LLM incorrectly states that J&J established a 'pre-packaged Chapter 11 plan' after the April 2023 dismissal—this is not supported by the original answer, which only mentions LTL re-filing (LTL 2) and securing a new preliminary injunction. (3) The mention of a 'Red River bankruptcy in Texas' is not present in the original answer and introduces a new, unverified entity and legal mechanism (Texas bankruptcy with 2025 injunction), which contradicts the ground truth’s focus on LTL Management LLC and Third Circuit developments. (4) The LLM correctly identifies the June 2024 multi-state settlement with state attorneys general involving 42 states and D.C., aligning with the original answer’s 'multi-state settlement' in 2024. (5) The reasoning is partially sound in identifying a strategic shift from bankruptcy reliance to dual strategy of appeals and settlements, but the introduction of false financial figures and legal mechanisms undermines the multi-hop synthesis. While the structure and intent of the response are relevant and contextually appropriate, the core financial data and key legal events are factually incorrect, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 466,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million in FY 2023 and remained unchanged at $495 million in FY 2024** (and was also $495 million in FY 2022). The unchanged balance indicates that the company has neither issued additional amounts nor repaid any of this note, reflecting a strategy of maintaining a stable, long‑term debt profile and preserving liquidity without refinancing or paying down this instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the outstanding principal balance for Broadcom's 3.125% notes due January 2025 was $495 million in FY 2022, 2023, and 2024, matching the ground truth exactly. All numeric values—$495 million, 3.125%, January 2025 maturity—are accurate and consistent with the original answer. (2) Quantitative accuracy is perfect: the dollar amount, interest rate, and fiscal years are all correct, with no calculation errors. Format variation (e.g., 'FY 2023' vs 'fiscal year 2023') is acceptable and does not affect meaning. (3) The multi-hop reasoning is sound: the model correctly infers that the unchanged balance across three years indicates no repayment or issuance, reflecting a stable debt management strategy. It synthesizes information across fiscal years and draws a logical conclusion consistent with the ground truth. (4) The only minor shortcoming is that the LLM mentions FY 2022 parenthetically ('and was also $495 million in FY 2022') rather than integrating it as fully into the main narrative, slightly reducing emphasis on completeness across all three years. However, the information is present and correct. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 357,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50% note due June 15 2025 had an effective rate of 3.20 % in FY 2022, which fell to 1.29 % in FY 2023, and then jumped to 6.66 % in FY 2024【page_89】. This swing shows that the company’s borrowing cost on that note dropped in 2023—likely because the note was issued at a discount or market rates were lower—before rising sharply in 2024 as market rates climbed, indicating a higher overall cost of debt for Cisco.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, Cisco's effective interest rate on the 3.50% June 15, 2025 note increased from 3.20% in FY2022 to 6.38% in FY2023 and then to 6.66% in FY2024. However, the LLM incorrectly states that the rate fell to 1.29% in FY2023, which is a major deviation from the correct value of 6.38%. The FY2024 rate of 6.66% is correctly reported. (2) The calculation and trend analysis are therefore flawed: the LLM suggests a drop in borrowing costs in 2023 followed by a sharp rise in 2024, whereas the correct trend is a consistent and substantial increase from 3.20% to 6.38% in 2023 and then to 6.66% in 2024. This misrepresents the progression of borrowing costs. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize data across fiscal years and interpret the trend in borrowing costs, but the incorrect intermediate value (1.29% instead of 6.38%) undermines the entire analysis. The conclusion about rising market rates in 2024 is plausible but based on incorrect prior data. (4) The contextual relevance is fair because the answer addresses the right note, the correct fiscal years, and attempts to interpret the trend in borrowing costs. However, due to the critical error in the FY2023 effective rate, the overall correctness score is low. Quantitative accuracy is severely compromised, qualitative reasoning is weakened by incorrect inputs, though the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 425,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s total senior and subordinated notes were $30.8 B in 2022, rose slightly to $31.2 B in 2023, and fell modestly to $30.7 B in 2024, keeping the debt level largely flat (2022: $30,826 M; 2023: $31,248 M; 2024: $30,696 M)【page 179】【page 179】【page 186】. The weighted‑average rate on fixed unsecured senior debt climbed from 4.45 % in 2023 to 4.84 % in 2024, while the subordinated debt rate stayed at 3.57 % and floating senior debt was eliminated, indicating a deliberate shift toward fixed‑rate borrowing to lock in higher rates and reduce interest‑rate volatility【page 179】【page 186】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's total senior and subordinated notes were $27.219 billion in 2022, not $30.8 billion as stated in the LLM answer. The LLM incorrectly reports 2022 as $30.8B (or $30,826M), which is closer to the 2024 value and conflates the timeline. The 2023 value ($31.248B) and 2024 value ($30.696B) are correctly reported in millions but misaligned due to the wrong 2022 baseline. This error distorts the entire 3-year progression: the ground truth shows a meaningful increase from $27.219B to $31.248B (a +$4.029B rise), indicating a major capital raise, whereas the LLM portrays it as largely flat, which is incorrect. (2) Interest rate data is partially accurate: the LLM correctly states the rise in fixed unsecured senior debt from 4.45% in 2023 to 4.84% in 2024, but omits the 2022 rate of 2.76%, which is critical for showing the full upward trend. The mention of subordinated debt rate at 3.57% and elimination of floating senior debt adds detail not in the original answer but is not contradicted by it; however, the original emphasizes the strategic shift toward fixed-rate financing due to rising rates, which the LLM captures in spirit. (3) Multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward fixed-rate borrowing to lock in rates and reduce volatility, aligning with the original’s conclusion. However, because the starting debt level is wrong, the synthesis of capital structure strategy is based on flawed premises. The LLM fails to note the significant 2022–2023 increase, undermining the depth of strategic analysis. (4) Despite these issues, the answer is contextually relevant and attempts to address both the evolution of debt and its strategic implications. The qualitative reasoning about interest rate positioning is reasonable and supported by partial data. However, the major numerical error in the 2022 debt figure severely impacts factual correctness, warranting a moderate score of 6 for overall correctness, with lower quantitative accuracy (5) due to the incorrect baseline value, acceptable qualitative reasoning (7), and high contextual relevance (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 596,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive cut its U.S. Treasury/agency allocation in the pension plan fixed‑income portfolio from roughly 40 % in 2022 to about 30 % in 2023, a level that stayed unchanged in 2024 (page_102 for 2022‑23; page_99 for 2024). This decline signals a deliberate shift away from the safest fixed‑income asset class toward a more diversified mix—likely incorporating higher‑yield corporate or other government bonds—to enhance returns or adjust risk exposure in its pension fund strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the allocation percentages: 40% in 2022, decreasing to 30% in 2023 and remaining at 30% in 2024, which matches the ground truth exactly. All numeric values and time periods are accurate. (2) Quantitative accuracy is perfect—percentages and years are correctly stated, and no calculations are required beyond the reported figures. Format variations (e.g., 'about 30%' vs 'approximately 40%') are semantically equivalent and acceptable. (3) The reasoning is sound: the model correctly infers a strategic shift away from U.S. Treasuries and agency securities toward potentially higher-yielding assets like corporate bonds, aligning with the ground truth's interpretation of risk tolerance or yield-seeking behavior. The mention of 'more diversified mix' and 'adjust risk exposure' captures the essence of the strategic implication. (4) The answer is fully contextually relevant, addressing both the evolution of allocation and its strategic implication. The only minor limitation is that the LLM slightly generalizes the alternative investments as 'other government bonds and corporate bonds' without explicitly noting that this is inferred from broader portfolio trends (though this is reasonable). Overall, the answer is factually correct, well-reasoned, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 368,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "GE classified Electric Insurance Company as a held‑for‑sale asset in 2022, recording a $17 million valuation allowance against a $1.374 billion asset base. In 2023 the classification stayed the same but the allowance expanded to $124 million against a $1.985 billion asset base, reflecting a sizable impairment. By Q2 2024 GE sold the subsidiary to Riverstone International Holdings for $120 million, removing it from its balance sheet. This sequence shows GE’s deliberate divestiture of non‑core insurance operations to streamline its portfolio and focus on its core aerospace and defense businesses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It states that GE classified Electric Insurance Company (EIC) as 'held for sale' in 2022, but the ground truth indicates this classification occurred in 2023. The LLM claims a $17 million valuation allowance against a $1.374 billion asset base in 2022, and an increase to $124 million against $1.985 billion in 2023—these figures are not supported by the original answer, which only mentions a $109 million loss in 2023 related to the expected sale. There is no mention of asset bases or valuation allowances in the ground truth. The sale price of $120 million in 2024 to Riverstone International Holdings Inc. is correctly reported, as is the buyer’s name. (2) The numbers provided by the LLM—$1.374B, $1.985B, $17M, $124M—are entirely inconsistent with the ground truth, which reports only $0.2 billion in net claim reserves as of December 31, 2021, and a $109 million loss in 2023. These discrepancies suggest fabrication or misattribution of data. The calculation of impairments or allowances is therefore invalid. (3) The multi-hop reasoning is partially sound: the model correctly infers that GE divested EIC as part of a strategy to focus on core operations like aerospace and defense. It correctly sequences classification, impairment, and sale. However, it misattributes timing (2022 vs 2023 for 'held for sale') and invents financial metrics not present in the source, undermining the reasoning chain. (4) The contextual relevance is high—the answer addresses classification, valuation, disposition, and strategic implications as required. However, due to major quantitative errors and incorrect entity timelines, the correctness score is low. While the strategic interpretation aligns broadly with the ground truth, the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 506,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple has consistently listed the 4.45% Notes due 2044 in Exhibit 4.4 of its annual reports—shown on page 56 of the 2023 and 2024 10‑Ks and on page 58 of the 2022 10‑K—without any change to the description or terms. This unchanged disclosure across three years indicates that Apple has kept the 2044 note outstanding as part of a stable, long‑term debt profile, suggesting a deliberate strategy of maintaining long‑maturity financing rather than actively refinancing or retiring the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were consistently disclosed in Apple's 2022, 2023, and 2024 10-K filings. The interest rate (4.45%), maturity year (2044), and the absence of changes in terms are correctly stated. The mention of Exhibit 4.4 and specific page numbers (58 in 2022, 56 in 2023 and 2024) adds precision, and while these page numbers are not in the ground truth, they do not contradict it and reflect plausible document structure. (2) Quantitative accuracy is perfect: percentages, years, and exhibit references are consistent and factually sound. There are no calculations, but the temporal consistency across years is correctly interpreted. (3) The multi-hop reasoning is solid: the model synthesizes disclosures across three years and correctly infers that the unchanged disclosure implies no retirement or modification of the debt, pointing to a stable long-term debt strategy. The conclusion about Apple maintaining long-maturity financing is a reasonable interpretation of the pattern. (4) The only minor shortcoming is that the LLM does not mention the May 6, 2014 Officer's Certificate, which is included in the ground truth and provides context on the issuance mechanism. This omission slightly reduces completeness but does not affect the core correctness. Overall, the answer is semantically equivalent, highly relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 408,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes grew from $27.2 billion at year‑end 2022 to $31.2 billion in 2023, then fell modestly to $30.7 billion in 2024【186】【178】【188】. The 2023 jump reflects a debt expansion to fund growth or acquisitions, while the slight 2024 decline indicates a refinancing or pay‑down. Across the period the weighted‑average interest rate on these notes rose from about 2.8 % in 2022 to roughly 4.5 % in 2023 and 4.8 % in 2024, showing a shift toward higher‑rate, fixed‑rate borrowing as market rates climbed and the company sought to lock in costs and manage interest‑rate exposure【186】【178】【188】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall trend and direction of Capital One's senior and subordinated notes from 2022 to 2024. The values are reported as $27.2B (vs. $27,219M), $31.2B (vs. $31,248M), and $30.7B (vs. $30,696M), which are accurate within reasonable rounding. The slight discrepancies are due to rounding to one decimal place in billions, which is acceptable and common in financial reporting. (2) The weighted-average interest rate is reported as ~2.8% in 2022 (vs. 2.76%), ~4.5% in 2023 (ground truth not provided for 2023 in original answer, so not penalized), and ~4.8% in 2024 (vs. 4.84%), again showing minor rounding but no material error. The core calculation of a net increase of ~$3.5B is implied and consistent with the data. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift toward fixed-rate debt in a rising rate environment, linking the increase in carrying value and rising interest rates to capital structure strategy. It identifies the 2023 increase as debt expansion and the 2024 dip as possible refinancing or paydown, which aligns with the ground truth’s interpretation of strategic positioning. (4) All entities (Capital One, senior and subordinated notes, years 2022–2024) are correct. The answer addresses both parts of the question: the evolution of carrying value and the implication for capital structure and interest rate strategy. Only a minor deduction in quantitative accuracy due to slight rounding down of 2023 interest rate (no exact ground truth given for that year, so not fully verifiable), but overall factual correctness and synthesis are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 452,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "Adobe positioned Frame.io as a cloud‑native collaboration platform in 2022, integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and available in Adobe GenStudio (see 2022 10‑K, p. 98).  In 2023 the filing reiterated Frame.io’s role as the core real‑time review hub for video, design and still‑image workflows, adding Camera‑to‑Cloud uploads and frame‑accurate commenting within those same Creative Cloud apps (see 2023 10‑K, p. 12).  By 2024 the description remained essentially unchanged, underscoring Frame.io’s continued integration with the same Creative Cloud apps and its availability in GenStudio alongside Adobe Express and Firefly Services, thereby reinforcing its central place in Adobe’s scalable content‑production ecosystem (see 2024 10‑K, p. 12).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in the timeline and integration details of Frame.io across 2022–2024, despite being well-structured and contextually relevant. (1) The main error lies in the misrepresentation of integration timelines: the LLM claims in 2022 that Frame.io was already integrated with Photoshop, Lightroom, and Workfront and available in Adobe GenStudio, but the ground truth states that these deeper integrations occurred by 2024, not 2022. In 2022, Frame.io was only formally recognized as a registered trademark—no integration details were described. (2) The LLM incorrectly asserts that the 2024 description was 'essentially unchanged' from 2023, when in fact 2024 marked an expansion into new apps (Photoshop, Lightroom, Workfront) and inclusion in GenStudio—key developments that the LLM misattributes to earlier years. (3) Quantitatively, there are no numerical errors (dates are correctly cited as 2022, 2023, 2024), and the features mentioned (frame-accurate commenting, Camera-to-Cloud, real-time review) are factually accurate, earning high marks for quantitative accuracy. (4) However, the multi-hop reasoning is flawed: the model fails to correctly sequence the evolution of integration, collapsing a three-year progression into a static state from 2022 onward. This undermines the qualitative accuracy, as the synthesis across years is incorrect. (5) Contextual relevance is high—the answer addresses the question’s focus on positioning and integration within Creative Cloud and GenStudio, uses proper terminology, and cites correct document locations. Overall, the answer conveys a plausible but factually inverted timeline, making it partially correct but significantly misleading in its core narrative of evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 477,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s repeated disclosure of the 4.550% Notes due April 5 2049 in its 2022‑2024 filings shows that the company is deliberately keeping a long‑term, fixed‑rate debt instrument in its capital structure. The 30‑year maturity and 4.55% coupon provide a stable financing source that matches long‑term capital needs and mitigates refinancing risk, reflecting a disciplined maturity‑management strategy that spreads debt maturities across decades. [page_82] [page_75]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 4.550% interest rate, April 5, 2049 maturity date, and inclusion across 2022–2024 filings are accurately reflected. The 30-year maturity characterization is reasonable given the 2019 issuance date (implied but not stated) and 2049 maturity. (2) Quantitative elements—interest rate (4.55%), maturity date—are exact matches; no calculations were required. (3) The reasoning correctly infers that maintaining this long-dated note reflects a strategy of stability, predictable liabilities, and refinancing risk mitigation, which is consistent with the ground truth’s emphasis on no early redemption or restructuring. The LLM emphasizes 'spreading maturities' and 'disciplined maturity-management,' which is a valid interpretation, though it adds slight emphasis not explicitly in the original (e.g., 'spreads across decades'). (4) The answer addresses both parts of the question: long-term capital structure strategy (use of fixed-rate, long-term debt) and debt maturity profile management (avoiding near-term refinancing risk). The only minor gap is the lack of explicit mention that no disclosures about repayment or restructuring occurred—this nuance from the original answer is omitted, slightly reducing qualitative completeness. However, the core multi-hop synthesis—linking repeated disclosure to strategic debt management—is sound and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 404,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million in fiscal 2022, and the balance remained unchanged at $495 million in both fiscal 2023 and fiscal 2024**【page_81】【page_81】.  \nThe unchanged balance indicates that Broadcom has neither issued additional principal nor repaid any of this note, reflecting a deliberate strategy to keep this long‑term debt instrument stable and preserve its favorable interest‑rate profile and long‑term financing flexibility.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million for Broadcom's 3.125% notes due January 2025 is accurately reported for all three fiscal years—2022, 2023, and 2024—with no discrepancies in numbers or formatting. (2) The answer is complete, addressing both parts of the question: the evolution of the balance (unchanged) and the implication for Broadcom's debt management strategy. (3) Entity accuracy is correct: Broadcom (AVGO), the specific debt instrument (3.125% notes due January 2025), and the fiscal years are all properly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis: the lack of change in principal implies no repayments or new issuances, leading to a logical conclusion about strategic debt management, including the preservation of interest-rate profile and financing flexibility—consistent with the ground truth's interpretation. Minor wording differences (e.g., 'long-term financing flexibility' vs. 'predictability in interest expense') do not affect semantic equivalence and are acceptable. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 333,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "In the 2022 10‑K, the 0.950% Notes due 2025 were not singled out in the exhibits list (the table of contents for the 2022 filing—pages 28–32—does not reference the instrument), implying a more aggregated debt disclosure. By the 2023 10‑K, IBM explicitly referenced the notes as Exhibits 4.1 and 4.2 to a Form 8‑K (page 20), and in the 2024 10‑K the notes appear as a registered security (page 1) and are incorporated by reference, reflecting a deliberate shift toward greater transparency and a strategy to maintain a diversified, low‑coupon debt mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but misses key facts and introduces inaccuracies. It correctly identifies the 0.950% Notes due 2025 and the years 2022–2024, and notes a progression in disclosure. However, it incorrectly claims that the notes were 'not singled out in the exhibits list' in 2022 and implies absence from exhibits, while the ground truth confirms they were disclosed as part of long-term debt with reference to the May 2017 Form 8-K—this is a significant omission. In 2023, the LLM correctly notes explicit referencing but misattributes it to Exhibits 4.1 and 4.2 of a Form 8-K without confirming the correct source (May 2017 filing). Most critically, the LLM fails to mention the 2024 listing on the New York Stock Exchange under ticker IBM25B, which is a central fact in the ground truth indicating market visibility and tradability. Instead, it vaguely states the notes 'appear as a registered security,' which understates the significance of the NYSE listing. (2) Quantitative accuracy is high: percentages (0.950%), years (2022–2025), and exhibit references (4.1, 4.2) are accurate or plausible, though exhibit details are not fully verified. No calculations are involved. (3) Multi-hop reasoning is partially sound—the model infers increasing transparency over time, which aligns with the ground truth. However, it fails to synthesize the full progression: from disclosure to active trading, which reflects a strategic shift in capital structure. The conclusion about 'diversified, low-coupon debt mix' is plausible but not directly supported by the evidence provided in the ground truth, which emphasizes liquidity and transparency. (4) Contextual relevance is strong—the answer addresses the evolution of disclosure and links it to strategy. But due to missing the NYSE listing and misrepresenting the 2022 disclosure status, the qualitative accuracy is reduced. The core progression is partially captured, but key evidence and implications are incorrect or omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 543,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "The PCAOB firm identification number for KPMG LLP is **185** in each of BNY Mellon’s 2022, 2023, and 2024 Form 10‑K filings. The number appears unchanged on the “Principal Accountant Fees and Services” section (Item 14) of all three filings, indicating consistency across the years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The PCAOB firm identification number for KPMG LLP is accurately stated as 185 for all three years (2022, 2023, and 2024), which aligns with the original answer. (2) All numeric values are correct and consistently reported across the years—there are no calculation errors or discrepancies in numbers. (3) The reasoning is sound: the LLM correctly identifies that the number appears unchanged in the same section (Item 14, 'Principal Accountant Fees and Services') across all three 10-K filings, demonstrating proper multi-hop synthesis across documents and years. (4) The answer is contextually relevant, complete, and adds minor but accurate procedural detail (location in the filing) without introducing errors. Semantic equivalence is maintained, and the core fact—that the ID number remained consistent at 185—is clearly and correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 265,
        "total_tokens": 1411
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One’s fixed unsecured senior debt shifted from a 2025‑2035 maturity with a 4.84% weighted‑average rate and $26.9 B carrying value in 2022 to a 2024‑2034 maturity with a lower 4.45% weighted‑average rate (minimum 0.80%) and $27.2 B carrying value in 2023, reflecting a refinancing to capture lower rates. By 2024 the debt returned to a 2025‑2035 maturity and a 4.84% weighted‑average rate, with the carrying value falling back to $26.9 B, indicating a response to rising rates and a shift toward longer‑term funding. This pattern shows Capital One actively rebalances its debt mix to optimize cost and duration, adjusting to changing interest‑rate cycles and macroeconomic conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's Fixed Unsecured Senior Debt increased from $19,975 million in 2022 to $26,930 million in 2024, with the weighted-average interest rate rising from 2.91% to 4.84%. The LLM incorrectly states that in 2022, the debt already had a 4.84% rate and $26.9B value, which is actually the 2024 figure. It also fabricates a 2023 data point with a $27.2B carrying value and 4.45% rate, which contradicts the upward trend in both debt and rates. The claim that rates decreased in 2023 is false—rates rose consistently from 2.91% to 4.84% over the period. (2) The dollar amounts and interest rates are quantitatively wrong: the starting debt value is off by nearly $7B, the starting interest rate is more than double the actual, and the direction of rate movement in 2023 is inverted. The maturities (2025–2035, etc.) are not present in the ground truth and appear speculative. (3) The multi-hop reasoning is flawed: instead of identifying a consistent increase in fixed-rate debt amid rising market rates as a hedge or strategic lock-in, the LLM invents a refinancing narrative to 'capture lower rates'—which contradicts the macroeconomic context of rising rates. The conclusion about 'rebalancing to optimize cost' is plausible in theory but unsupported by the fabricated data. (4) The contextual relevance is moderate because the answer addresses capital structure strategy and macroeconomic response, but the incorrect data undermines the reasoning. Correctness is severely compromised by false numbers and trends, warranting a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 450,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "From 2022 through 2024 AMD’s revenue‑recognition policy for development and IP‑licensing agreements stayed the same.  In each filing the company explains that it evaluates whether the license component is distinct; if it is not, the license is combined with development services and revenue is recognized over time, whereas a distinct license is recognized at the point the customer can benefit.  This consistency shows a deliberate, ASC 606‑aligned strategy that treats IP licensing as a separate revenue stream when appropriate, underscoring a long‑term commitment to predictable, structured monetization of its IP portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition methodology from 2022 to 2024 for development and IP licensing agreements, accurately describing the evaluation of whether the license is distinct and the resulting revenue recognition treatment—combined with services (over time) if not distinct, or point-in-time recognition if distinct. This matches the original answer exactly in substance. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all dates (2022–2024) are correct and consistently referenced—hence a score of 10. (3) The reasoning is sound and reflects proper multi-hop synthesis across years, confirming consistency in policy. The LLM correctly infers that this consistency implies a stable, strategic approach to IP monetization, though it omits the specific detail about 'no variable consideration estimates' mentioned in the ground truth, which slightly reduces completeness. However, this does not undermine the core conclusion. (4) The answer is fully contextually relevant, directly addressing both the evolution (or lack thereof) and the strategic implication. The mention of ASC 606 adds useful context not in the original but is accurate and enhances the explanation. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 420,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s total senior and subordinated notes grew from **$27.4 B in 2022 to $27.5 B in 2023 and then to $30.7 B in 2024** (Table 8.1, 2023 10‑K and 2024 10‑K).  The weighted‑average interest rate on these notes rose from **2.91 % in 2022 to 4.45 % in 2023 and 4.84 % in 2024** (Table 8.1, 2024 10‑K), reflecting a shift toward longer‑maturity, higher‑rate debt.  This trend indicates a deliberate capital‑structure strategy to expand its long‑term debt base while locking in fixed rates to manage interest‑rate risk amid tightening market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, total senior and subordinated notes were $27,219 million in 2022, $31,248 million in 2023, and $30,696 million in 2024. The LLM incorrectly reports $27.4B (2022), $27.5B (2023), and $30.7B (2024). The 2022 and 2023 figures are notably wrong—especially 2023, where the actual increase was to $31.248B, not $27.5B. The 2024 figure is close ($30.7B vs $30.696B), but the prior years are materially off. (2) The interest rate progression is correctly reported: 2.91% (2022), 4.45% (2023), and 4.84% (2024), which matches the ground truth exactly. (3) The LLM misses a key element of the multi-hop reasoning: the complete retirement of floating unsecured senior debt. The ground truth highlights a drop from $1,709M in 2022 to $349M in 2023 and full retirement by 2024, indicating a strategic move away from floating-rate debt. This critical insight is absent in the LLM answer, weakening its analysis of capital structure strategy. While the LLM correctly infers a shift toward fixed-rate debt to manage interest rate risk, it fails to support this with the specific evidence of floating debt elimination. (4) The qualitative reasoning is partially sound—correctly interpreting rising rates as a move to lock in fixed rates—but lacks completeness due to missing data. Contextual relevance is high, as the answer addresses the core question about capital structure and interest rate positioning. However, due to major numerical errors in the debt totals and omission of key debt category dynamics, the correctness score is limited to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 448,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$19.98 billion** (weighted‑average rate 2.91%) in 2022 to **$27.17 billion** (4.45%) in 2023, then dipped slightly to **$26.93 billion** (4.84%) in 2024【page 186 of 2022 10‑K】【page 178 of 2023 10‑K】【page 186 of 2024 10‑K】. The upward swing in carrying value and the steady climb in the weighted‑average rate show the company is issuing newer, longer‑term debt at higher rates—likely to refinance existing obligations and fund growth—while accepting a higher cost of capital as market rates rise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures: carrying values of $19,975M (rounded to $19.98B), $27,168M (rounded to $27.17B), and $26,930M (reported as $26.93B) for 2022–2024, and interest rates of 2.91%, 4.45%, and 4.84%—all matching the ground truth. Minor rounding differences ($19.98B vs $19,975M) are acceptable and common in financial reporting. (2) Quantitative accuracy is perfect: all numbers are either exact or appropriately rounded (e.g., $27,168M ≈ $27.17B), and the trend descriptions (increase then slight decrease in value, steady rate increase) are accurate. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of 10-K filings. The conclusion about issuing higher-rate, longer-term debt to refinance and fund growth aligns with the ground truth’s interpretation of a strategic shift amid rising rates. The only minor gap is that the LLM emphasizes 'refinance existing obligations and fund growth' while the original emphasizes 'locking in long-term financing despite higher costs'; both are plausible, but the original focuses more on the strategic cost acceptance. (4) Contextual relevance is excellent: all parts of the question (evolution of carrying value, interest rate, and strategic implication) are addressed with precise data and logical interpretation. The inclusion of source citations adds credibility. Overall, this is a highly accurate and well-reasoned response with only slight nuance missing in strategic interpretation, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 426,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "From 2022 through 2024 AMD’s 10‑K disclosures show the same revenue‑recognition framework for development‑and‑IP licensing agreements.  In each year the company treats a combined development‑services plus IP‑license arrangement as a single or multiple performance obligation and evaluates the license for distinctness; if the license is distinct it is recognized at a point in time when the customer can benefit, otherwise it is combined with the development services and recognized over time.  Standalone IP sales or licenses are always recognized at a point in time when the customer can benefit, and no variable consideration is estimated (2022 p. 59; 2023 p. 63; 2024 p. 63).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD maintained a consistent revenue recognition policy from 2022 to 2024, with no material changes—this aligns exactly with the ground truth. (2) The treatment of combined development and IP arrangements is accurately described: distinct licenses are recognized at a point in time, while non-distinct ones are combined with development services and recognized over time. This matches the original answer’s explanation. (3) The LLM correctly notes that standalone IP licenses are recognized at a point in time and that no variable consideration is estimated in either arrangement type—this is explicitly confirmed in the ground truth. (4) The reasoning is sound and reflects proper multi-hop synthesis across the three years of 10-K filings, correctly identifying consistent policy application. (5) Page references (2022 p. 59; 2023 p. 63; 2024 p. 63) add verifiability and are consistent with typical disclosure locations. There are no factual errors, omissions, or misinterpretations. All entities (AMD, development services, IP licenses, performance obligations) are correctly identified and contextualized. The answer fully addresses the evolution (or lack thereof) of the policy and the distinction between combined and standalone arrangements. Minor wording differences do not affect meaning and are within acceptable variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 403,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "COF’s short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023** and then rose modestly to **$562 million in 2024** (Table 8.1 2022/23; Table 9.1 2024). Long‑term debt stayed at **$49,318 million in 2022‑23** and declined to **$44,989 million in 2024** (Table 8.1 2022/23; Table 9.1 2024). The trend shows a deliberate reduction of long‑term leverage while keeping a stable short‑term funding base, but the weighted‑average interest rate on long‑term debt climbed from **4.48 % in 2023 to 5.72 % in 2024**, indicating higher interest‑rate exposure as the company refinanced at newer, higher‑rate debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both debt levels and interest rates. It reports short-term borrowings of $883M in 2022, but the ground truth total debt (short + long-term) was $43.086B — indicating the LLM misidentified or underreported the actual figures. The LLM claims long-term debt was $49,318M (~$49.3B) in both 2022 and 2023, but ground truth shows total debt (not just long-term) was $43.086B in 2022 and $48.715B in 2023, so the LLM overstates long-term debt in 2022 and fails to reflect the correct total debt trend. The 2024 long-term debt figure of $44,989M (~$45.0B) is close to the ground truth total debt of $45.551B, but still inaccurate and conflates long-term debt with total debt. (2) Interest rate data is completely incorrect: LLM states it rose from 4.48% in 2023 to 5.72% in 2024, but ground truth shows rates were 2.76% (2022), 4.48% (2023), and 4.84% (2024). The LLM omits 2022 entirely and overstates the 2024 rate. (3) Multi-hop reasoning is flawed: the LLM fails to correctly synthesize total debt (short + long-term) across years, misrepresents the trend (claims stability in short-term debt when ground truth shows an increase then decrease), and draws incorrect conclusions about refinancing at higher rates due to wrong interest data. (4) Despite these issues, the answer is contextually relevant — it attempts to address debt evolution and interest rate exposure — and offers a plausible narrative about debt management, which earns partial credit for structure and intent. However, due to severe quantitative and qualitative errors, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 449,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing has not changed between 2022 and 2024.  The company still evaluates whether the license component is distinct; if it is not, the license is combined with the development services as a single performance obligation and revenue is recognized over time, whereas a distinct license is recognized at a point in time when the customer can benefit.  Stand‑alone licensing arrangements are always treated as a single performance obligation and recognized at a point in time, with no variable‑consideration estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that AMD's revenue recognition policy for development and IP licensing agreements remained unchanged from 2022 to 2024, which aligns with the original answer's emphasis on consistency. The treatment of distinct vs. non-distinct licenses, the combination of performance obligations in combined arrangements, and point-in-time recognition for standalone licenses are all accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD's policy across years and distinguishes between combined and standalone arrangements correctly. It captures the key accounting principles under ASC 606—distinct performance obligations, timing of revenue recognition, and absence of variable consideration—without error. (4) The only minor omission is that the LLM does not explicitly mention the 'capability and context' distinction used in 2023 and 2024 filings when evaluating whether a license is distinct, nor does it reference the Gaming segment emphasis as context. However, this does not affect the technical accuracy of the accounting policy description. Overall, the answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 394,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The same exhibit—“Certificate of Designations of Series B Convertible Participating Preferred Stock”—appears in Visa’s 2022, 2023, and 2024 10‑K filings (page 114, 2022; page 109, 2023; page 109, 2024). This repetition indicates that the Series B preferred shares have not been retired or cancelled and remain an active part of Visa’s capital structure, underscoring the instrument’s stability and ongoing relevance as a potential convertible financing tool.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies the consistent presence of the Certificate of Designations of Series B Convertible Participating Preferred Stock in Visa's 2022, 2023, and 2024 filings, noting its ongoing relevance and stability in the capital structure. The mention of specific page numbers (114, 109, 109) adds precision, though the ground truth emphasizes exhibit numbers (4.5, 4.4, 4.4) and the fixed filing date of June 21, 2016—details omitted in the LLM response. These omissions affect completeness but do not introduce factual errors. The LLM correctly infers that the instrument remains active and unmodified, supporting the conclusion of stability. However, it misses the deeper implication that no changes were required or implemented over the period, and does not reference the exhibit number consistency, which strengthens the argument for unchanged terms. Quantitatively, no calculations are involved, but the years and document references are accurate. The reasoning is sound and contextually appropriate, demonstrating proper synthesis across years. While the core facts and interpretation are correct, the lack of exhibit numbers and the original filing date limits full multi-hop verification and slightly weakens the qualitative depth. Semantic equivalence is maintained on the main point: the instrument’s ongoing relevance and structural stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 395,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "RTX’s ownership and program‑share interests in the IAE collaboration stayed flat through 2022‑24 – 61 % of the program share and 49.5 % of the equity in IAE (net 57 % after sub‑collaborator adjustments) and 59 %/59 % in IAE LLC (net 51 %).  Its economic exposure, measured by the net “Commercial Aerospace Commitments” (Other commercial aerospace commitments minus collaboration partners’ share), fell modestly from roughly $8.66 billion in 2023 to $8.33 billion in 2024 (with a similar trend for IAE LLC).  This steady stake coupled with a slight reduction in financial obligations signals Pratt & Whitney’s continued, influential presence in the V2500 program while tightening its risk profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that RTX's program share interest is 61% and ownership interest is 49.5% in IAE, it introduces an entirely incorrect and unsupported claim about '59%/59% in IAE LLC (net 51%)', which does not appear in the ground truth and is not corroborated by any known public filings. Additionally, the ground truth makes no mention of 'Commercial Aerospace Commitments' or any dollar figures such as $8.66 billion or $8.33 billion; these numbers are fabricated or misattributed. There is no indication in the original answer of a reduction in financial obligations or a trend in economic exposure measured by commitments. (2) The quantitative inaccuracies are severe: the introduction of false percentages (59%/59%, net 51%) and fabricated dollar amounts ($8.66B, $8.33B) with implied calculations that lack any basis undermines the entire numerical foundation of the response. The only correct numbers are the 61%, 49.5%, and 57% figures, which match the ground truth. (3) The multi-hop reasoning is partially sound in recognizing that stable stakes imply stable strategic positioning, but the conclusion that Pratt & Whitney was 'tightening its risk profile' is not supported by the ground truth, which explicitly states there was no change in strategic positioning or risk profile. This misinterpretation stems from the invention of declining financial obligations. (4) The contextual relevance is moderate because the answer addresses the right entities (RTX, IAE, Pratt & Whitney) and time frame (2022–2024), and attempts to interpret strategic implications. However, due to major factual and quantitative errors, the overall correctness score is low at 4—partially correct on stake percentages but significantly flawed in introduced metrics and conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 501,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic has continued to use the same “Non‑Employee Director Deferred Unit Award Agreement” under the 2008 Stock Award and Incentive Plan in each of the three most recent fiscal years.  In the 2022 10‑K the agreement is listed as *10.52 (Form of Non‑Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan)【page_117】, and the 2024 10‑K again lists the same agreement as *10.41 (Form of Non‑Employee Director Deferred Unit Award Agreement under 2008 Stock Award and Incentive Plan)【page_115】.  The unchanged use of this deferred‑unit award across 2022, 2023 and 2024 signals a stable, long‑term director‑compensation strategy that relies on deferred equity tied to performance and vesting rather than frequent plan redesigns.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Medtronic used the same Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across fiscal years 2022, 2023, and 2024, and correctly infers that this reflects a stable, long-term director compensation strategy. However, there is a factual error in the exhibit numbers cited: the LLM states that in 2022 the agreement was listed as Exhibit 10.52 and in 2024 as Exhibit 10.41, which is reversed compared to the ground truth. According to the original answer, in 2022 it was Exhibit 10.41 and in 2023/2024 it was Exhibit 10.52. This mix-up affects quantitative accuracy. (2) The fiscal years and plan name (2008 Stock Award and Incentive Plan) are correct, and no numerical values (e.g., dollar amounts) are involved, so the error is limited to exhibit numbering. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and draws a valid conclusion about consistency in compensation strategy despite updates to other plans. It correctly notes that the structure remained unchanged even as other awards evolved under the 2013 plan (implied in the original answer). (4) The contextual relevance is perfect—the response directly addresses both parts of the question: evolution over time and strategic implication. The qualitative reasoning is strong, with only minor factual inaccuracy in exhibit labels reducing the overall correctness score. Wording differences (e.g., 'deferred equity tied to performance and vesting') are semantically acceptable expansions of the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 443,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin continued to use variable‑interest‑rate swaps to hedge its fixed‑rate debt through 2022‑2024. The aggregate notional amount of outstanding interest‑rate swaps stayed at $1.3 billion in each year (2022, 2023, and 2024)【page_66】【page_52】. This steady notional level indicates a deliberate, stable hedging policy that maintains a consistent exposure to interest‑rate risk rather than expanding or contracting the swap program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the notional amount of variable interest rate swaps was $1.3 billion in all three years (2022, 2023, 2024). According to the ground truth, the notional amount was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. This misrepresentation of the data undermines the entire analysis. (2) The quantitative inaccuracies are severe: the LLM claims a constant $1.3 billion across all years, missing the 2022 figure entirely and thus failing to reflect the tripling of exposure from $500M to $1.3B. This error invalidates any calculation or comparison involving year-over-year change. (3) The reasoning is flawed because it draws a conclusion of 'stable hedging policy' based on incorrect data. The ground truth shows a strategic expansion in 2023 followed by stabilization, indicating a shift in risk management strategy—precisely the opposite of what the LLM infers. The model fails to perform the necessary multi-hop synthesis of year-over-year changes and their implications. (4) While the LLM correctly identifies the use of variable interest rate swaps to hedge fixed-rate debt and mentions the right company (LMT) and time frame, the core factual error in numbers and resulting incorrect interpretation of strategy severely limit accuracy. Contextual relevance is moderate because the answer addresses the general topic and uses appropriate financial terminology, but the incorrect data renders the conclusion invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 421,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s 2022 Form 10‑K (page 46) already listed a provision that “stockholders may only remove directors for cause.” The same wording appears unchanged in the 2023 Form 10‑K (page 27) and the 2024 Form 10‑K (page 27). Over three consecutive years the company has maintained this clause, underscoring a deliberate, consistent strategy to preserve board independence and strengthen its defensive posture against hostile takeover attempts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately identifies that AbbVie maintained the same provision—'stockholders may only remove directors for cause'—in its 10-K filings for 2022, 2023, and 2024, citing the correct pages (46, 27, 27 respectively), which matches the multi-year consistency in governance provisions. (2) There are no numerical values requiring calculation, but the years and page numbers are correctly reported, satisfying quantitative accuracy. (3) The reasoning correctly infers that the unchanged language over three years reflects a deliberate and consistent defensive governance strategy against hostile takeovers, which is logically sound and supported by the source. The only minor omission is that the LLM does not mention other related anti-takeover provisions like staggered boards or supermajority voting requirements, which the original answer includes to strengthen the interpretation of strategic posture. This slightly reduces completeness in qualitative synthesis, but the core inference remains valid. (4) The answer is highly relevant, directly addressing both parts of the question—evolution (or lack thereof) and strategic implications—with accurate sourcing and appropriate interpretation. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 390,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s balance sheet shows money‑market funds and time deposits falling from **$21 million in 2022 to $10 million in 2023 and remaining at $10 million in 2024** (page 79 for 2022‑23, page 84 for 2024). This modest, stable allocation indicates the company is keeping a small, highly liquid buffer while relying more on cash balances and other liquid assets to meet short‑term liquidity needs amid the year‑to‑year swings in its cash position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. However, the LLM incorrectly states it was $21 million in 2022, dropped to $10 million in 2023, and remained at $10 million in 2024—reversing the actual trend for 2022–2023 and misrepresenting the timing of the increase. This is a critical error in both magnitude and direction of change. (2) The calculation and comparison of year-over-year changes are therefore invalid. The correct trend shows an initial increase followed by a decrease, suggesting active liquidity management; the LLM’s version implies a one-time drop and stagnation, leading to a different interpretation. (3) The qualitative reasoning is partially sound in discussing liquidity strategy, but it is based on incorrect data, undermining the multi-hop synthesis. The model fails to connect the allocation trend with the broader cash balance fluctuations ($8,449M → $9,201M → $5,524M), which the original answer correctly contextualizes. (4) Contextual relevance is moderate—the response addresses the question’s intent about liquidity strategy and cites document pages, but the incorrect numbers severely limit usefulness. Due to major quantitative inaccuracies affecting the core of the answer, the correctness score is low despite some structural relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 417,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s 10‑K filings show that the provision limiting stockholder removal of directors to “for cause” was in place in 2022 (page 46), remained unchanged in 2023 (page 27), and is still present in 2024 (page 27). The unchanged language indicates a deliberate, long‑term strategy to preserve board independence and create a robust defense against hostile takeovers by restricting stockholder power to replace directors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that AbbVie maintained the 'for cause' director removal provision in its 10-K filings for 2022 (page 46), 2023 (page 27), and 2024 (page 27), confirming the consistency of the governance provision across all three years. The quantitative details—years and page numbers—are correct, satisfying the quantitative accuracy criterion. The answer correctly infers that the unchanged language reflects a deliberate, long-term strategy to deter hostile takeovers by preserving board independence and restricting shareholder power, which matches the core reasoning in the original answer. The only minor shortcoming is that it does not explicitly mention 'activist interventions' or frame the provision as part of a 'broader set of governance mechanisms,' slightly reducing completeness in qualitative nuance. However, the central logic and multi-hop synthesis—linking consistent policy over time to anti-takeover strategy—are sound and contextually appropriate. The answer is semantically equivalent to the ground truth in intent and factual content, with no errors in entities, years, or reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 335,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "In 2022, Intel’s 10‑K did not reference PowerVia, indicating the technology was not yet part of its roadmap (page 6). By the 2023 filing, PowerVia was introduced as a breakthrough backside‑power technology for the upcoming Intel 20A node, promising up to 15 % performance‑per‑watt gains (page 14). In the 2024 filing, Intel positioned PowerVia as the first high‑volume commercial implementation in its next‑generation Intel 18A process, underscoring a strategic shift toward backside power delivery to enhance power efficiency and reduce front‑side routing complexity in advanced nodes (page 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of Intel's PowerVia from non-mention in 2022 to introduction in 2023 for Intel 20A, then realignment to Intel 18A in 2024. The claim that PowerVia was not referenced in the 2022 10-K is consistent with the ground truth stating it was only 'introduced' in 2022 as part of future technologies—this subtle distinction does not invalidate the LLM's interpretation. (2) Quantitatively, the 15% performance-per-watt gain mentioned in the 2023 filing is correctly attributed and not contradicted by the ground truth; no other numbers or dates are in conflict. Format and references to page numbers (e.g., page 14, page 10) are consistent with document-based reasoning. (3) The multi-hop reasoning across years and filings is sound: the LLM synthesizes changes in positioning over time and infers strategic intent around backside power delivery and manufacturing readiness. The shift from Intel 20A to 18A is correctly identified as a strategic refinement. (4) The only minor gap is that the LLM does not explicitly mention the high-volume manufacturing (HVM) timeline (2025) noted in the ground truth, which slightly reduces completeness. However, stating that PowerVia is for 'next-generation Intel 18A' and 'high-volume commercial implementation' implies this timeline. Overall, the answer is factually correct, contextually precise, and semantically equivalent to the original with only negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 416,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility assumption rose from 23.04 % in FY 2022 to 24.05 % in FY 2023 and 24.29 % in FY 2024 (see the option‑valuation tables on pages 83 and 84). This gradual upward trend indicates the company is updating its volatility estimate to reflect higher market swings, thereby increasing the fair value—and expense—of its non‑qualified stock options and adopting a more conservative, market‑responsive valuation approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claims. The original answer states that MDT changed its *methodology* for estimating expected volatility—from using only historical volatility in 2022 to a blend of historical and implied volatility starting in 2023. However, the LLM answer focuses entirely on numerical values (23.04%, 24.05%, 24.29%) that are not mentioned in the ground truth and appear to be fabricated or misattributed. There is no mention in the original answer of specific percentage values for expected volatility in any year, so these numbers cannot be verified and are likely incorrect. (2) The quantitative inaccuracies are severe: the LLM invents precise percentages and cites specific page numbers (83 and 84) not present in the context, which undermines credibility. Even if such numbers existed in filings, the ground truth does not include them, so the LLM is introducing unsupported data. (3) The multi-hop reasoning is flawed. The question asks about the *evolution of assumptions* in the Black-Scholes model, specifically the methodological shift. The LLM instead interprets this as a trend in numerical volatility inputs, missing the key conceptual change (from historical-only to blended approach). It fails to mention the introduction of implied volatility from market-traded options in 2023 and 2024, which is the central point of the original answer. (4) While the LLM correctly infers that a more market-responsive approach may indicate conservatism, this conclusion is reached via incorrect data and reasoning. The contextual relevance is moderate because it addresses the general topic of volatility assumptions and valuation impact, but it misses the actual evolution described in the ground truth. Thus, the correctness score is low due to fundamental factual and conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 499,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "In 2022, PowerVia was not mentioned in Intel’s 10‑K (pages 5‑9), indicating it had not yet entered the public roadmap【page_6】. By 2023, Intel announced PowerVia as a breakthrough backside‑power technology for the upcoming Intel 20A node, promising up to a 15 % performance‑per‑watt improvement【page_14】. In 2024, the technology was moved to the Intel 18A node and slated for high‑volume production of Panther Lake in 2025, underscoring its role as a core enabler of performance‑per‑watt and density scaling in Intel’s advanced process roadmap【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2023 as part of Intel 20A, delivers up to 15% performance-per-watt improvement, and was transitioned to Intel 18A with Panther Lake slated for 2025 high-volume manufacturing. The absence of PowerVia in the 2022 10-K is correctly noted, consistent with its not yet being public. (2) Quantitative elements—15%, 2023 introduction, 2025 HVM—are all accurate and match the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers from document references that PowerVia was not public in 2022, emerged in 2023 with Intel 20A, and shifted to Intel 18A in 2024, maintaining strategic importance. (4) The only minor shortcoming is that the LLM does not explicitly mention RibbonFET integration or the cancellation of Intel 20A productization, which are in the original answer. However, the core evolution and strategic significance of PowerVia are accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the evolution and strategic role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 326,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024 Medtronic’s Black‑Scholes assumptions moved to higher risk‑free rates (0.90 % → 4.16 %), higher volatility (23.04 % → 24.29 %) and higher dividend yields (1.95 % → 3.18 %), with a slight increase in expected life from 6.0 to 6.1 years. This trend shows a more conservative, market‑condition‑driven valuation that anticipates greater stock price swings and a longer, more spread‑out exercise pattern among employees, reflecting a cautious approach to estimating volatility and employee exercise behavior.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the key evolution in MDT's Black-Scholes assumptions from 2022 to 2024 was the incorporation of implied volatility (in addition to historical volatility) starting in 2023, which was retained in 2024. However, the LLM answer fabricates specific numerical values for risk-free rates (0.90% → 4.16%), volatility (23.04% → 24.29%), dividend yields (1.95% → 3.18%), and expected life (6.0 to 6.1 years), none of which appear in the original answer or are supported by the knowledge graph. These numbers are entirely absent from the ground truth, making the quantitative claims baseless. (2) There are no verifiable calculations or accurate numbers to assess—every cited percentage and figure is invented. The original answer does not provide any specific numerical inputs for the Black-Scholes model, only the methodological shift toward using implied volatility. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies that the question concerns changes in assumptions over time, it fails to report the actual key change (use of implied volatility) and instead invents a narrative around fabricated metrics. The conclusion about 'a more conservative, market-condition-driven valuation' and 'longer, more spread-out exercise pattern' is speculative and not grounded in the provided truth. (4) The contextual relevance is moderate because the answer addresses the general topic—evolution of Black-Scholes assumptions at MDT—and attempts to interpret implications for volatility and employee behavior. However, the complete lack of factual alignment with the original answer, especially the invention of precise numbers, severely undermines correctness. The only qualitative element partially aligned is the idea that the company may be adopting a more market-informed approach, but even this is framed incorrectly without mentioning implied volatility. Thus, the correctness score is very low due to factual inaccuracies and hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 559,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "The collateral under master‑netting arrangements that is included in the “Other assets, including intangibles – net” line fell from **$1.494 billion in 2022 to $491 million in 2024** – a drop of roughly $1.0 billion. This sharp decline indicates that ExxonMobil has reduced its collateral requirements, likely through a smaller derivative exposure or more efficient netting, reflecting a more disciplined derivative‑exposure management strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 and 2024 values ($1,494 million and $491 million) and the overall downward trend, which aligns with the ground truth. However, it omits the 2023 value ($800 million), which is a key intermediate data point in the original answer and part of the multi-year trend analysis required by the question. This omission reduces completeness and quantitative accuracy. (2) The numbers cited for 2022 and 2024 are accurate and correctly formatted ($1.494 billion = $1,494 million; $491 million matches). The claimed drop of 'roughly $1.0 billion' is approximately correct (actual drop: $1,494M - $491M = $1,003M), so the calculation is sound. However, the absence of the 2023 figure means the year-by-year change is not fully represented, weakening the trend analysis. (3) The reasoning is strong: the LLM correctly infers that reduced collateral suggests lower derivative exposure or improved netting efficiency, and links this to disciplined risk management, which is consistent with the ground truth's interpretation involving hedging strategies and market volatility. The multi-hop synthesis between financial statements over time is partially achieved but incomplete due to the missing 2023 data. (4) The answer is contextually relevant and addresses both parts of the question—change in collateral and its implication for derivative exposure management—though with less granular detail than the original. The omission of the 2023 value prevents a full three-year trend assessment, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 432,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "NextEra’s Options – primarily gas fair value stayed essentially flat at about $100 million (assets) and $102 million (liabilities) in both 2023 and 2024 (see the 2024 table on page 86 and the 2023 table on page 85).  In 2022 the fair value of these options was lower (the net‑derivative fair value at December 31 of the prior year was $170 million【page_87】) and the valuation model used a higher implied‑volatility assumption of 17 % (vs. 15 % in 2023‑24) and a lower implied‑correlation assumption of 32 % (vs. 56 % in 2023‑24)【page_86】.  The decline in implied volatility and rise in implied correlation, coupled with a stable fair‑value level, indicate a shift toward a more conservative, hedging‑oriented risk posture in gas derivatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, NextEra Energy's fair value for 'Options - primarily gas' was $356 million in assets and $347 million in liabilities, not a net derivative value of $170 million as stated. The LLM incorrectly reports implied volatility decreasing from 17% in 2022 to 15% in 2023–2024, whereas the ground truth shows a rise from 36% in 2022 to 50% in 2023 and 52% in 2024—this is a complete reversal of the actual trend. The correlation assumption is mentioned but not part of the original question or answer, suggesting fabrication. (2) The dollar amounts and percentages are entirely incorrect: the drop from $356M assets / $347M liabilities in 2022 to $100M assets / $97M liabilities in 2023 and $100M assets / $102M liabilities in 2024 is misrepresented as 'essentially flat' after a lower 2022 value. The net derivative value cited ($170M) does not correspond to the specific 'Options - primarily gas' line item. (3) The multi-hop reasoning fails: the model does not correctly track the evolution of fair value and volatility assumptions over time, misidentifies key metrics, and draws conclusions based on false data. The claim of 'stable fair-value level' contradicts the actual sharp decline from 2022 to 2023. (4) While the answer attempts to address risk positioning in gas derivatives, its conclusions about reduced volatility and conservative hedging are based on inverted data and thus invalid. The contextual relevance is moderate because it addresses the right topic and time frame, but factual correctness is severely compromised, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 457,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "From 2022 through 2024, the Unsecured Notes – 35A remained a $750,000 obligation with an annual debt service of $19,875 (interest rate 2.65% and maturity 07/15/30) – the same figures reported in the 2022 10‑K (page 50), the 2023 10‑K (page 50), and the 2024 10‑K (page 51).  The unchanged face amount, debt‑service cost, and long‑term maturity demonstrate SPG’s strategy of keeping this debt stable and low‑cost, thereby preserving predictable cash flows and minimizing refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the face amount of $750,000 and annual debt service of $19,875 are correctly reported for all three years (2022–2024), consistent with the original answer. The additional details — interest rate (2.65%) and maturity date (07/15/30) — are factually correct and enhance precision without contradicting the ground truth. Page references to the 10-K filings (2022 p.50, 2023 p.50, 2024 p.51) confirm proper sourcing. (2) The answer is complete, addressing both the evolution of financial obligations (stable over time) and the implication for SPG’s long-term debt strategy (predictability, low cost, minimized refinancing risk). (3) Entity accuracy is perfect: SPG is correctly identified, the instrument 'Unsecured Notes - 35A' is accurately named, and all fiscal years are properly referenced. (4) The reasoning is sound and demonstrates effective multi-hop synthesis across three annual reports. The conclusion about SPG’s strategy — emphasizing stability, predictability, and risk mitigation — is logically derived from the unchanged obligations and aligns semantically with the ground truth’s interpretation. Minor enhancements in detail (interest rate, maturity) improve clarity without deviating from the core facts. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 383,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Texas Instruments’ MD&A in 2022, 2023 and 2024 (pages 21, 19 and 19 respectively) all reiterate a core focus on analog and embedded‑processing products, with a particular emphasis on industrial and automotive markets.  Yet the embedded‑processing segment’s performance has shifted: revenue grew only modestly from $3.26 bn in 2022 to $3.37 bn in 2023 (page 20, 2023) before falling to $2.53 bn in 2024 (page 20, 2024), while operating profit dropped from $1.25 bn to $0.35 bn (page 20, 2024).  This steady strategic emphasis, coupled with a sharp decline in embedded‑processing profitability, signals that TI remains committed to the segment but must sharpen cost efficiencies and innovation to sustain its long‑term competitive position in the semiconductor industry.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in financial data. The ground truth states that Texas Instruments consistently emphasized embedded processing as a strategic pillar from 2022 to 2024, with no mention of financial performance changes. However, the LLM claims that embedded processing revenue fell from $3.26B in 2022 to $2.53B in 2024 and operating profit dropped from $1.25B to $0.35B—figures not present in the ground truth and directly contradicting the consistent strategic emphasis narrative. These numbers appear fabricated or misattributed, as the original answer does not include any financials for embedded processing. (2) Quantitative accuracy is severely lacking: there are no revenue or profit figures in the ground truth to support the LLM's claims. Even if such data existed, the sharp decline described would contradict the stated strategic continuity. Calculations and comparisons based on false numbers cannot be valid. (3) Multi-hop reasoning is flawed. The question asks about strategic evolution and long-term positioning, which the ground truth addresses through consistent language in 10-K filings over three years. The LLM incorrectly infers a strategic challenge due to alleged profitability issues, introducing unsupported analysis about cost efficiency and innovation needs. It fails to recognize that the strategic emphasis remained unchanged, which is the core insight. (4) Contextual relevance is moderate because the LLM discusses the right company, time frame, and general topic (embedded processing), and correctly identifies it as part of TI's focus. However, by introducing false financial trends, it distorts the conclusion. The reasoning shift from 'consistent strategic priority' to 'declining profitability requiring correction' is not supported and misrepresents TI's positioning. Overall, the answer is mostly incorrect due to invented data and flawed logic, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 533,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "From 2022 through 2024 CMCSA continued to offer shared data plans only as part of bundled service packages for residential broadband customers, giving them unlimited, shared‑data, or per‑gigabyte options (page_5 2022, page_5 2023). In 2024 the company broadened its payment mix by adding prepaid unlimited data plans marketed under the NOW brand, expanding the range of plan types while keeping the bundled‑service positioning unchanged (page_5 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly states that CMCSA offered shared data plans as part of bundled service packages for residential broadband customers from 2022 to 2024, alongside unlimited and per-gigabyte options, which matches the original answer. It accurately notes the 2024 expansion with the introduction of prepaid unlimited data plans under the NOW brand. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) and plan types are correctly referenced—no quantitative errors. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly identifies the continuity in bundling strategy and the 2024 addition of prepaid plans. The only minor omission is that the original answer specifies device financing over 24 months in 2022 and 2023, which the LLM answer leaves out. While not central to the core question about data plan evolution and bundling, this detail relates to 'range of payment or plan options' and thus slightly reduces completeness. (4) Despite this, the answer captures the key strategic evolution—maintaining shared data plans in bundles while expanding flexibility in 2024—and does so with precise, relevant information. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect, directly addressing both parts of the question: positioning within bundles and range of plan/payment options.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 417,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock grew steadily, rising from $51.354 billion at December 31, 2022 to $60.429 billion at December 31, 2023 and $71.431 billion at December 31, 2024 (page 72, 73, 70).  Correspondingly, purchases of treasury stock increased from $8.773 billion in 2022 to $9.088 billion in 2023 and $11.025 billion in 2024 (same pages).  This upward trend reflects a deliberate buy‑back program, indicating the company’s capital‑allocation strategy prioritizes returning cash to shareholders by reducing shares outstanding and potentially boosting earnings per share.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the 2022 treasury stock value. The ground truth reports $(36,658) million (i.e., -$36.658 billion), but the LLM states $51.354 billion, which is both incorrect in magnitude and sign. Treasury stock is a contra-equity account and is correctly reported as negative in the ground truth; the LLM presents it as positive, misrepresenting the accounting treatment. However, the 2023 and 2024 values ($60.429 billion and $71.431 billion) are accurate and match the ground truth in absolute terms, though the sign is still misrepresented. (2) The LLM introduces additional data—annual purchases of treasury stock ($8.773B in 2022, etc.)—which are not in the original answer and may be factually correct but are not part of the ground truth response, potentially indicating overreach or use of extraneous data. These figures are not required to answer the question but do support the reasoning. (3) The reasoning and multi-hop synthesis are sound: the LLM correctly identifies the increasing trend in treasury stock and links it to a capital allocation strategy focused on buybacks and shareholder returns, which aligns with the original answer’s conclusion. (4) Despite the incorrect 2022 figure and misrepresentation of sign convention, the overall trend (increasing buybacks) and strategic interpretation are correct, warranting a score of 7 for correctness. Quantitative accuracy is penalized due to the large error in the 2022 value. Qualitative and contextual accuracy are high because the logic and relevance are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 437,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported repair‑and‑other‑services revenue of **$1,169 million in 2022** and **$1,132 million in 2024**—a decline of **$37 million (≈3 %)**. The flat $1.132 billion figure in 2023 and 2024, after a 2022 dip, shows the service business has plateaued rather than expanded, indicating a modest contraction in maintenance and support activity amid a broader focus on new construction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for 2022 ($1,169 million) and 2024 ($1,132 million), and accurately notes the flat value in both 2023 and 2024. The $37 million decline and ≈3% decrease are correctly calculated and align with the ground truth (actual drop: (1,169 - 1,132)/1,169 ≈ 3.16%, which rounds to 3.2% in the original answer; LLM's '≈3%' is acceptable). (2) All numeric values and calculations are accurate. The format variation ($1.132 billion = $1,132 million) is acceptable and correctly interpreted. The only minor discrepancy is that the original answer specifies 2023 revenue as $1,132 million and notes it remained flat into 2024—information the LLM implies by stating the figure is flat between 2023 and 2024 but does not explicitly state the 2023 value. This is a slight omission but not factually incorrect. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years and infers a plateau in service revenue, concluding stagnation/contraction, which matches the original answer’s interpretation. It even adds contextually reasonable insight about a 'broader focus on new construction'—a plausible qualitative extension that does not contradict the data. (4) The answer is semantically equivalent to the ground truth, with high factual accuracy, correct entity identification (General Dynamics, repair and other services, correct years), and logical reasoning. The correctness score is 9 instead of 10 because the 2023 revenue figure is not explicitly mentioned, though it is correctly implied as flat. All other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 442,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "From 2022 to 2023, CVS’s residential mortgage‑backed securities (RMBS) fair value in its investment portfolio fell from $721 million to $614 million, while unrealized losses dropped from $89 million to $60 million (page 149). In 2024, the company’s separate‑account RMBS fair value rose to $71 million (up from $51 million in 2023) and no unrealized losses were reported (page 160), indicating a shift toward lower‑risk, more liquid RMBS holdings and an overall improvement in risk positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS fair value in 2022 was $629 million, not $721 million as stated. Unrealized losses in 2022 were $10 million, not $89 million. The 2023 figures for fair value ($614 million) are correct, but the direction of change in unrealized losses is wrong: they increased from $10M to $60M, whereas the LLM claims they dropped from $89M to $60M. In 2024, the LLM incorrectly frames the $71 million as a rise in separate-account holdings from $51M in 2023, but the ground truth states total RMBS holdings dropped to $71M with no mention of separate accounts or prior $51M—this data point is entirely fabricated. (2) Calculations and comparisons are therefore invalid. The LLM suggests improvement in risk positioning due to reduced losses and increased holdings, but in reality, unrealized losses worsened before CVS sharply reduced exposure, indicating de-risking due to deterioration, not improvement. (3) Multi-hop reasoning is flawed: the model fails to synthesize the correct trajectory—declining fair value amid rising unrealized losses, followed by a sharp exit from the asset class. Instead, it invents a narrative of recovery and strategic shift toward 'lower-risk, more liquid' holdings not supported by the data. (4) Contextual relevance is moderate because the answer addresses RMBS exposure over three years and attempts to interpret risk positioning, but the conclusions are based on incorrect data and misinterpretation. The inclusion of 'page 149' and 'page 160' suggests fabricated sourcing. Overall, major factual and reasoning errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 460,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "Linde’s 2022‑2024 10‑Ks show no material change in the structure of its atmospheric‑gas contracts.  On‑site agreements remain long‑term total‑requirement contracts (10–20 years) with minimum purchase requirements and price‑escalation clauses tied to price indices, and the variable pricing components in those contracts are still considered constrained and non‑material (page 97, 2022; page 101, 2023; page 87, 2024).  Merchant and packaged‑gas contracts likewise continue to use fixed‑price or limited‑variable terms, with any variable components likewise constrained.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of numbers, contract durations (10–20 years), and the presence of minimum purchase requirements, price escalation clauses, and constrained variable pricing components, which aligns with the ground truth. It correctly cites consistent contract structures across 2022–2024 and references appropriate page numbers, supporting quantitative and entity accuracy (hence quantitative accuracy = 10). However, it fails to capture a key qualitative evolution noted in the original answer: the increasing transparency and clarification around variable pricing mechanisms, particularly the 2023 emphasis on fluctuating pricing tied to indices and the 2024 reinforcement of the practical expedient under ASC 606 for revenue recognition. The LLM incorrectly asserts 'no material change' and treats variable components as 'non-material,' which contradicts the ground truth’s emphasis on growing disclosure and accounting alignment, even if the contractual structure remained stable. This omission reflects a failure in multi-hop reasoning—synthesizing changes in disclosure and accounting treatment over time—and thus qualitative accuracy is reduced (5/10). Contextually, the answer is relevant and focused on the question, but misses the nuance of evolving pricing transparency, leading to a correctness score of 6 (partially correct with significant omissions in reasoning and synthesis).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 391,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra Energy’s net notional exposure to natural‑gas forward contracts fell from a net short of 1,307 MMBtu in 2022 to a larger net short of 1,452 MMBtu in 2023, then eased to a net short of 1,131 MMBtu in 2024【page_83】【page_87】.  The net fair value of these contracts improved from a net liability of $854 million in 2022 to a net asset of $300 million in 2023 and $250 million in 2024【page_85】【page_86】, indicating a shift toward a more balanced or less aggressive hedging stance in natural‑gas markets and a reduction in price‑risk exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that NextEra Energy had a net exposure of $160M in 2022 (assets $191M - liabilities $31M), $300M in 2023 ($377M - $77M), and $250M in 2024 ($296M - $46M). However, the LLM incorrectly reports the net fair value as a net liability of $854M in 2022, which contradicts the ground truth of a net asset position. While the LLM correctly identifies the $300M net asset in 2023 and $250M in 2024, the erroneous $854M liability in 2022 undermines the quantitative accuracy. Additionally, the LLM introduces notional exposure in MMBtu (1,307, 1,452, 1,131), which is not mentioned in the original answer and shifts focus from the financial (dollar) exposure emphasized in the question and ground truth. (2) Calculations: The LLM’s claim of a $854M net liability in 2022 is factually incorrect and not supported by the ground truth, which shows a $160M net asset. This is a major miscalculation or misrepresentation. The 2023 and 2024 net asset values ($300M, $250M) are correct and align with the ground truth. (3) Multi-hop reasoning: The LLM attempts to synthesize trends but does so using incorrect base data for 2022. The conclusion about a 'more balanced or less aggressive hedging stance' is plausible given the decline from 2023 to 2024, but the reasoning is based on flawed premises due to the incorrect 2022 liability figure. The original answer correctly identifies an increase in exposure in 2023 followed by a partial pullback in 2024, which the LLM partially captures but misrepresents the starting point. (4) Justification: The correctness score is 4 due to partial accuracy in 2023–2024 values but major error in 2022. Quantitative accuracy is low (3) due to the large dollar-value error. Qualitative accuracy is moderate (5) because the trend interpretation is somewhat aligned but based on incorrect data. Contextual relevance is 7 because the answer addresses the right topic and timeframe, using related metrics, even if not the exact ones requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 559,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across 2022, 2023, and 2024, AVGO consistently listed industrial fiber optics as a core offering within its industrial portfolio, grouping it with optocouplers, motion encoders, and Ethernet ICs under the “Industrial” segment (2022: page 10; 2023: pages 4, 5, 7; 2024: pages 4, 5, 7). The product remained tied to the same application markets—factory automation, renewable energy, automotive electronics, and medical systems—without a notable shift in emphasis or repositioning. Thus, AVGO’s positioning of industrial fiber optics stayed stable, integrated with its broader industrial product mix across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Industrial Fiber Optics is consistently positioned as a core part of AVGO's industrial portfolio across 2022–2024, grouped with related products like optocouplers, motion encoders, and Ethernet ICs. The application markets—factory automation, renewable energy, automotive electronics, and medical systems—are correctly identified and stable over time. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct referencing of years and page numbers (which are accurately cited). (3) The multi-hop reasoning is sound: the model synthesizes information across three years of product positioning and correctly infers stability in strategic role without expansion or contraction. The only minor omission is that the 2022 description included a broader list of applications (e.g., defense, aerospace, power generation), and the LLM answer slightly narrows this to the recurring themes, though it does mention 'medical systems' which supports completeness. Also, in 2024, 'motion control subsystems' is mentioned in the original as a grouping term, while LLM uses 'motion encoders'—a close but not exact match. These are minor discrepancies that do not undermine the overall correctness. (4) The answer is contextually relevant, directly addressing the evolution (or lack thereof) in positioning over time. Thus, the correctness score is 9 due to high accuracy with only negligible omissions in descriptive granularity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 436,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 31B has carried a 3.25 % interest rate, a face amount of $750,000 and an annual debt‑service obligation of $24,375, all unchanged across the three years, with a maturity of November 30 , 2026. This stability shows that SPG’s long‑term debt strategy is to keep a predictable, low‑cost debt load and to avoid adding new leverage, focusing instead on maintaining a consistent maturity profile and cash‑flow certainty.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains critical quantitative errors. While the interest rate (3.25%) and maturity date (November 30, 2026) are correct and consistent with ground truth, the face amount and annual debt service are off by a factor of 1,000: LLM states $750,000 and $24,375, whereas the ground truth is $750,000,000 and $24,375,000. This is a severe factual error that fundamentally misrepresents the scale of SPG's obligations. (2) Number verification: $750,000,000 × 3.25% = $24,375,000, which matches the ground truth. The LLM’s $750,000 × 3.25% = $24,375 is mathematically correct but based on incorrect inputs, so the calculation is valid but the values are wrong. (3) Multi-hop reasoning: The LLM correctly identifies that the terms remained stable across 2022–2024 and infers a strategy of predictability and low-cost debt management, which aligns with the original answer’s conclusion. This shows sound qualitative reasoning. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of obligations and strategic implication—and adds a relevant maturity date not in the original but plausibly from the filing. However, the massive underreporting of dollar amounts severely undermines factual correctness, warranting a low quantitative accuracy score and a moderate overall correctness score due to otherwise logical structure and correct directional insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 394,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Industries’ aggregate expense for U.S. defined‑contribution plans rose from **$70 million in 2022** to **$75 million in 2023** and to **$76 million in 2024** (see TXN 10‑K 2023 and 2024). This modest upward trend—an increase of $5 million followed by a $1 million bump—indicates a steady, slightly expanding investment in employee retirement benefits, reflecting either higher participation, modestly higher contribution rates, or inflationary adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans as $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. The year-over-year increases ($5M and $1M) are accurate, and the final amount in 2024 is correctly stated. (2) All numeric values and dates are correct. The implied total increase from 2022 to 2024 is $6 million, which is an 8.57% increase (~8.6%), consistent with the ground truth. The LLM does not explicitly calculate the percentage increase but describes the trend accurately as 'modest upward' and 'slightly expanding,' which aligns semantically. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a trend of increasing investment. It appropriately attributes the rise to possible factors like participation, contribution rates, or inflation, which are reasonable interpretations consistent with the trend. (4) The only minor shortcoming is the lack of explicit mention of the ~8.6% total increase, which was included in the original answer. However, the description of the trend as 'steady, slightly expanding' captures the same qualitative conclusion. Entity accuracy is correct—Texas Instruments (referred to as 'Texas Industries'—a minor typo but clearly refers to TXN based on context and ticker citation) and the correct financial metric are used. The citations to the 10-K filings add contextual support. Overall, the answer is factually precise, logically sound, and contextually appropriate, warranting a high score with only a slight deduction for missing the explicit percentage change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 456,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD has consistently excluded goodwill impairments and non‑economic accounting changes from its ROIC calculations in 2022, 2023, and 2024 (see 2022 p. 47; 2023 p. 50; 2024 p. 50). This unchanged policy shows that the company’s performance‑evaluation methodology prioritizes core operating profitability and capital efficiency, deliberately omitting accounting adjustments that do not reflect underlying economic performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024, which matches the original answer's claim of methodological consistency. The inclusion of specific page references (2022 p.47, 2023 p.50, 2024 p.50) adds verifiable detail not in the ground truth but does not contradict it. (2) There are no numerical values requiring calculation in this question; all dates (2022–2024) are correct and consistent with the original. (3) The multi-hop reasoning is sound—by synthesizing data across three years of filings, the model confirms a stable methodology, correctly inferring that this reflects a disciplined performance evaluation approach focused on core operations. The mention of 'goodwill impairments' as part of non-economic changes is a slight elaboration but is contextually appropriate and commonly classified as such in financial reporting. (4) The semantic meaning fully matches the original: both emphasize consistency in exclusion practices and link it to a focus on operational performance. The only minor difference is that the LLM provides slightly more specificity (mentioning goodwill impairments), which enhances rather than detracts from accuracy. Thus, the answer earns a 9/10 for correctness due to perfect factual and quantitative alignment, with near-perfect qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 401,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "Separate Accounts Assets grew modestly from **$3,250 million at December 31, 2022 to $3,311 million at December 31, 2023** (page 157) and then held steady at **$3,311 million at December 31, 2024** (page 108). This slight uptick followed by a flat level over the three‑year period indicates that CVS is maintaining a stable, rather than aggressively expanding, investment base in its large‑case pension (long‑term insurance) products, reflecting a consistent long‑term positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both numbers and direction of change. According to the ground truth, CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, then slightly increased to $3,311 million in 2024. However, the LLM claims assets grew from $3,250 million in 2022 to $3,311 million in 2023 and remained flat in 2024—reversing the actual trend and using incorrect starting values. The $5,087 million figure for 2022 is entirely omitted and replaced with the correct 2023 value as if it were 2022’s, indicating a critical data misalignment. (2) Quantitative accuracy is severely compromised: the LLM reports $3,250M in 2022 when it should be $5,087M, understating the asset base by over $1.8 billion. It then incorrectly labels the 2023 figure as growth when it was actually a decline of ~36%. The 2024 figure ($3,311M) is correct, but the claim of it being 'steady' ignores the prior-year drop. Calculations and comparisons are therefore invalid. (3) Multi-hop reasoning fails: the model does not correctly track the three-year trend across 2022–2024. It misattributes data points to wrong years, preventing accurate synthesis. The conclusion about 'stable' positioning contradicts the ground truth’s indication of a major drawdown followed by stabilization, which suggests strategic retrenchment or market impact. (4) Contextual relevance is moderate—the response addresses Separate Accounts Assets and long-term insurance positioning—but due to incorrect data and reasoning, the interpretation is misleading. The mention of 'large-case pension' products adds detail not in the original, but does not compensate for core inaccuracies. Overall, the answer is mostly incorrect due to wrong numbers and timeline, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 496,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement with TD Bank USA, N.A. was originally signed on October 22 2012 and amended twice—once on February 24 2015 and again on November 19 2019 (2022 10‑K Exhibits EE, FF, GG). In 2022 Target executed a third amendment (dated November 1 2022) filed as Exhibit (10)JJ to the October 29 2022 10‑Q, and in 2023 entered a letter agreement dated March 8 2023 filed as Exhibit 10.21.4 to the April 29 2023 10‑Q. The 2024 Form 10‑K lists these two documents as the most recent contractual milestones, indicating no further amendments through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) The Original Answer states that by 2024, only the original 2012 agreement and two amendments (2015 and 2019) were recognized, with no mention of further amendments. However, the LLM claims a third amendment on November 1, 2022, and a letter agreement on March 8, 2023—details not present in the ground truth. These specific dates and exhibit references (e.g., Exhibit (10)JJ, Exhibit 10.21.4) are presented with high specificity but are not supported by the provided truth data. (2) Quantitatively, the LLM introduces two new dates (November 1, 2022; March 8, 2023) and filing details (10-Q references) that are incorrect or unverified in the context of the knowledge graph. The ground truth only confirms amendments up to November 19, 2019, with no indication of 2022 or 2023 amendments. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers evolution through recent amendments when the truth indicates continuity and reference to existing agreements, not new ones. The model fabricates milestones rather than reporting sustained use of prior agreements. (4) While the LLM correctly identifies the original 2012 agreement and the 2015 and 2019 amendments, it overstates the evolution by adding unsupported updates. The contextual relevance is moderate because it addresses the right topic and contractual progression, but the factual core is compromised by hallucinated details. Thus, the correctness score is low due to major factual and quantitative errors, despite some correct background information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 439,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "In 2022 Linde’s rare gases were produced simply as co‑products of its air‑separation plants, with no explicit emphasis on advanced technology or cross‑segment integration [page_94]. By 2023 the company highlighted its leadership in non‑cryogenic air‑separation and the use of proprietary VPSA and membrane technologies to produce rare gases, while tying them to its engineering and digital‑service offerings [page_100]. In 2024 Linde reiterated this differentiated technology base and further positioned rare gases within its broader engineering, clean‑energy, and digital‑solution portfolio, underpinned by a robust patent portfolio that supports integration across product lines [page_4][page_5][page_6].",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Linde's rare gases strategy from 2022 to 2024. (1) It accurately captures the progression: in 2022, rare gases were co-products without emphasis on advanced tech; by 2023, Linde highlighted non-cryogenic air separation, VPSA, and membrane technologies; in 2024, integration with engineering, clean energy, and digital solutions was emphasized. These points match the original answer’s core narrative. (2) There are no numeric values, dates, or financial figures in dispute—so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time and connects technological differentiation (VPSA, membrane) with integration across product lines (engineering, digital, clean energy), which reflects the required cross-year and cross-functional synthesis. However, the LLM slightly overstates the 2023 shift by claiming leadership in non-cryogenic technologies was already highlighted then, while the ground truth indicates this was explicitly emphasized in 2024. Additionally, the ground truth mentions pricing strategies (escalation clauses) and specific rare gases (krypton, neon, xenon) as byproducts, which the LLM omits. These are minor but relevant contextual details. (4) Despite these omissions, the LLM conveys the strategic shift from product-centric to technology- and integration-driven positioning, maintaining semantic equivalence on the main trajectory. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 430,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: $1.49 billion in 2022, $800 million in 2023, and $491 million in 2024 (all figures are “primarily related to initial‑margin requirements” on derivatives tied to advances to equity companies). The downward trend indicates that the company is holding less collateral to cover these derivative positions, suggesting a reduced exposure to derivative liabilities linked to equity‑company relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million in 2022 is accurately rendered as $1.49 billion (rounded), $800 million in 2023, and $491 million in 2024. These match the ground truth exactly or with acceptable rounding. 2) Quantitatively, all figures are correct and consistent with the original answer; the use of 'billion' vs 'million' is appropriately scaled ($1.49 billion = $1,490 million, a negligible rounding difference). 3) The reasoning is sound: the downward trend is correctly identified, and the interpretation—that reduced collateral suggests reduced exposure to derivative liabilities tied to equity companies—is logically and semantically equivalent to the ground truth’s conclusion about de-risking or portfolio optimization. The LLM adds contextual detail about 'initial-margin requirements,' which is consistent with the nature of such collateral and enhances accuracy without contradicting the source. 4) The answer fully addresses both parts of the question: the evolution over time and the implication for exposure. The only minor gap is that the LLM does not explicitly mention 'strategic reduction' or 'de-risking/optimization efforts' as in the original, but the inference is clearly implied. Thus, the answer is factually complete and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for slightly less precise characterization of the strategic rationale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 401,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s long‑term contract coverage of its net generating capacity rose from roughly 92 % in 2022 to about 94 % in 2023 and stayed at that level in 2024 (NEE 2022 10‑K, p. 19; NEE 2023 10‑K, p. 19; NEE 2024 10‑K, p. 19). This upward trend and subsequent plateau demonstrate a deliberate strategy to lock in revenue and hedge against price volatility, underscoring NEER’s focus on risk mitigation through contractual certainty in competitive wholesale markets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: NEER's reliance on long-term bilateral contracts was 92% in 2022, increased to 94% in 2023, and remained at 94% in 2024—these values are accurately reported with acceptable rounding ('roughly', 'about'). (2) Quantitative accuracy is perfect: percentages and years are correct, and no calculations are required beyond reporting the trend, which is done accurately. (3) Multi-hop reasoning is sound: the answer synthesizes data across three years from three different 10-K filings (2022, 2023, 2024), correctly identifying both the upward trend and plateau. (4) The interpretation of the trend—emphasizing revenue stability, price volatility hedging, and risk mitigation in competitive markets—aligns completely with the original answer’s conclusion. The mention of 'contractual certainty' captures the essence of risk mitigation. All parts of the question are addressed: evolution over time (2022–2024) and strategic implications. Minor wording differences (e.g., 'hedge against price volatility' vs. 'managing price risk') do not affect meaning and are contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 336,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 had an outstanding principal of **$495 million at the end of fiscal 2022**, and this balance remained unchanged at **$495 million at the end of fiscal 2023 and fiscal 2024**. The lack of any repayment or refinancing over this period indicates a conservative debt‑management approach that preserves the maturity schedule and liquidity rather than aggressively reducing long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: the $495 million figure is consistently reported for all three fiscal years, and the maturity date (January 2025) aligns with the original answer. No calculation errors. (3) The reasoning is largely sound: the LLM correctly infers that the lack of principal reduction suggests a deliberate debt management strategy. However, while the original answer specifically suggests 'refinance or use cash reserves,' the LLM describes it as a 'conservative debt-management approach that preserves liquidity,' which is semantically close but slightly less precise in strategic implication—hence a minor deduction in qualitative accuracy. (4) The answer is fully contextually relevant, addressing both the evolution of the balance and the inferred strategy. Overall, the LLM captures all key facts and provides a reasonable interpretation, warranting a high correctness score with only a small gap in nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 339,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 37B consistently carried a 2.25 % interest rate, a face amount of $700,000, and a maturity date of January 15 , 2032 (SPG_10k_2022 p. 50; SPG_10k_2023 p. 50; SPG_10k_2024 p. 51). The unchanged terms over this period show that the company is maintaining a stable, low‑rate, long‑term debt profile rather than issuing new debt or refinancing, underscoring a conservative long‑term financing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the face amount: it states $700,000 instead of $700,000,000, which is a 1,000-fold discrepancy. This severely undermines factual accuracy. The interest rate (2.25%) and maturity date (January 15, 2032) are correct. (2) Quantitative accuracy is low due to the face amount error, despite correct interest rate and maturity date. The citation of pages and consistent formatting suggests attention to detail, but the dollar amount is fundamentally wrong. (3) The reasoning about Simon Property Group’s long-term debt strategy being conservative and stable is logically sound and aligns with the ground truth; however, this conclusion is based on incorrect financial magnitude, weakening the validity of the inference. The multi-hop synthesis across three years is correctly executed in structure, but the core data is flawed. (4) The answer is contextually relevant and addresses all parts of the question—interest rate, face amount, maturity, and strategic implication—and attempts proper citation. However, the massive error in the face amount reduces the correctness score significantly, as financial figures must be accurate to support valid analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 341,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "From 2022 through 2024, TI’s Melaka, Malaysia site remained an **analog‑only** facility—listed with an “X” under the analog column and no “X” under embedded processing in each year’s property table【page_18】【page_16】【page_16】.  The unchanged classification over three years shows that TI has not expanded embedded‑processing operations in Melaka, underscoring a sustained, analog‑centric focus at that location.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site remained analog-only from 2022 to 2024, with no presence in embedded processing, matching the original answer's key facts. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) and consistent 'X' notation are correctly referenced across all three years. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual reports to observe a stable operational footprint, leading to the conclusion of a sustained analog focus. (4) All entities—Texas Instruments (TI), Melaka, Malaysia, analog, embedded processing, and the three-year timeframe—are accurately identified and contextualized. The answer is concise, factually precise, and directly addresses both parts of the question: the evolution (or lack thereof) and what it reveals about strategic focus. Minor wording differences (e.g., 'analog-centric' vs 'targeted investment in analog') do not affect meaning. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 320,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard’s multi‑layered security program has steadily deepened as its real‑time payment network expanded. In 2022 the program combined a robust information‑security framework, third‑party assessments and EMV technical standards, supporting real‑time payments in 12 of the top 50 GDP markets【MA_10k_2022.pdf: page 11】. By 2023 it added an enterprise resilience component, insurance coverage and regular system testing while extending real‑time infrastructure to 13 markets【MA_10k_2023.pdf: page 11】, and in 2024 the strategy further emphasized resilience, testing, monitoring and the integration of tokenization, fraud‑scoring and virtual‑card controls as the real‑time network remained in 13 markets【MA_10k_2024.pdf: page 11】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of markets with real-time payments infrastructure in 2022 (12) and 2023 (13), which matches the ground truth. However, it incorrectly states that the network remained in 13 markets in 2024, while the original answer notes a significant expansion into China via a joint venture, implying growth beyond 13 markets. This is a key omission in both quantitative and qualitative terms. (2) The financial and numerical data (market counts) are mostly accurate up to 2023, but the failure to reflect the 2024 expansion into China—a major qualitative and quantitative development—undermines the quantitative accuracy for that year. (3) The multi-hop reasoning is partially sound: the model correctly traces evolution across years and cites appropriate security components (tokenization, fraud scoring, resilience). However, it misses the critical synthesis point that Mastercard’s security framework had to scale specifically for China’s domestic market in 2024, which is a central element of the ground truth. It also incorrectly implies stagnation in market count (13 in both 2023 and 2024) when expansion occurred. Additionally, the LLM introduces elements like 'insurance coverage' and 'enterprise resilience' not emphasized in the original answer, which focuses more on intelligent routing, third-party risk integration, and public-private partnerships. (4) The contextual relevance is high because the response stays focused on the evolution of security in relation to real-time payments. However, the correctness score is reduced due to the failure to capture the 2024 China expansion and its implications, which is a major factual gap in an otherwise coherent and well-structured answer. Minor wording differences are acceptable, but missing a key market expansion and misrepresenting continuity as stagnation constitutes a significant error in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 520,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics produced 449 LAVs for the Canadian Army in 2022 (page_11 2022), which fell to 360 in 2023 (page_11 2023) before rising to 399 in 2024 (page_11 2024). The dip in 2023 followed by a rebound in 2024 shows GD is actively adjusting production to meet Canadian demand while maintaining a strategic focus on the LAV platform, including ongoing modernization and upgrades.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reverses the production volumes across years, stating 449 units in 2022, 360 in 2023, and 399 in 2024, whereas the ground truth shows a consistent increase: 360 in 2022, 399 in 2023, and 449 in 2024. This inversion of the trend is a major factual error. (2) All three numerical values are incorrectly assigned to the wrong years, leading to a completely inaccurate portrayal of the production trajectory. The calculation of trend (a dip then rebound) is based on incorrect data and thus invalid. (3) The multi-hop reasoning fails because the model did not correctly extract or align the time-series data across the three years, undermining the synthesis required to assess strategic focus. The conclusion about 'adjusting production' due to a dip in 2023 contradicts the actual steady growth, which instead indicates expanding contracts and sustained investment. (4) While the answer addresses the right entities (General Dynamics, LAVs, Canadian Army) and attempts to interpret strategic implications, the reversed data renders the analysis incorrect. The contextual relevance is moderate because the structure and intent align with the question, but factual accuracy is severely compromised. Quantitative accuracy is very low due to all numbers being misaligned; qualitative reasoning is flawed as a result.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 373,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS’s target allocation to hedge‑fund limited‑partnership investments grew from 3 % of pension‑plan assets in 2022 (the same level as in 2021 and 2023) to 4 % in 2024. This modest, step‑wise increase over the three‑year period signals a deliberate shift toward a slightly more aggressive, diversified pension strategy that adds greater exposure to hedge funds for potential higher returns. (Target allocations: 3 % in 2022/2023【page_175】, 4 % in 2024【page_169】; 3 % in 2021【page_167】)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and type of data. The original answer reports actual dollar allocations ($214M, $225M, $252M), while the LLM reports target percentages (3%, 3%, 4%), which are different metrics. There is no mention of actual dollar amounts in the LLM response, and the percentages do not align with the ground truth data. (2) The quantitative accuracy is poor: the LLM introduces percentage allocations not present in the original answer, and these percentages cannot be verified against the ground truth, which provides only absolute dollar values. Additionally, the claim of a 'target allocation' increasing to 4% in 2024 is unsupported by the original answer, which does not mention targets or percentages. Calculations like the 17.8% total increase in the original are missing, and the LLM does not perform any numerical verification. (3) The multi-hop reasoning is flawed. The LLM appears to pull data from specific pages of filings (e.g., page_175, page_169), but this information contradicts the ground truth derived from the knowledge graph. The synthesis is incorrect because it confuses target allocation percentages with actual investment amounts, which are distinct concepts. The conclusion about a 'more aggressive, diversified pension strategy' is speculative and not supported by the original answer’s more cautious interpretation of stability and consistency. (4) Contextual relevance is moderate because the LLM addresses the general topic of CVS’s pension fund strategy and hedge fund allocations over time, and attempts to interpret strategic implications. However, due to the fundamental mismatch in data type and factual accuracy, the answer misrepresents the situation. The original shows a steady increase in actual dollars invested, suggesting consistent confidence, while the LLM describes a policy shift in targets, which is a different narrative. Thus, despite addressing the question's structure, the factual foundation is incorrect, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 551,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "According to the 2024 10‑K (page 27), the penetration rate of the Target MasterCard Credit Card fell from 20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024. This downward trend indicates a gradual decline in consumer adoption and engagement with Target’s financial products, suggesting that customers may be shifting to alternative payment options or that the card’s value proposition is becoming less compelling.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), which match the ground truth. However, it reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This discrepancy is significant and affects the accuracy of the trend interpretation. (2) The calculation of the downward trend is logically presented, but the incorrect 2024 value undermines the precision of the analysis. The correct drop from 20.5% to 17.8% over three years is a 2.7 percentage point decline, while the LLM implies a smaller 1.9 point drop, altering the perceived trajectory. (3) The reasoning about declining consumer adoption and engagement is sound and aligns with the ground truth’s interpretation, including plausible explanations like shifting payment preferences or weakening value proposition. The model correctly synthesizes the implication of declining penetration despite sales growth, though it omits the specific nuance that RedCard sales increased in absolute terms but were outpaced by total sales growth. (4) The contextual relevance is high, as the answer addresses both parts of the question—trend evolution and its implications—and uses appropriate financial reasoning. However, the incorrect 2024 figure reduces quantitative accuracy significantly, warranting a moderate overall correctness score despite otherwise strong qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 397,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "From 2022 to 2024, the net fair‑value exposure from FPL Cost Recovery Clauses grew from **$2 million** in 2022 to **$12 million** in 2023 and to **$38 million** in 2024.  \nIn 2022 and 2023 the “significant other observable inputs” were negative (–$5 million and –$12 million) while the “significant unobservable inputs” were positive ($7 million and $24 million). By 2024 the observable inputs turned positive ($4 million) and the unobservable inputs increased to $34 million, reflecting a shift toward more observable‑input‑driven fair‑value estimates.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the overall trend and structure of the fair value evolution correctly, with accurate directional insights and correct identification of entities (NextEra Energy, FPL Cost Recovery Clauses) and years (2022–2024). However, there are key quantitative inaccuracies: (1) The 2022 total fair value is stated as $2 million, but the ground truth is $1 million. This discrepancy arises because the LLM reports $7 million for unobservable inputs in 2022, whereas the original specifies +$6 million (with observable inputs at –$5 million, summing to $1 million net). The LLM incorrectly calculates or retrieves the unobservable input value for 2022, leading to an incorrect total. All other numbers (2023 and 2024 values) are accurate: 2023 total $12 million (–$12M observable, +$24M unobservable), 2024 total $38 million (+$4M observable, +$34M unobservable) match the ground truth. The qualitative reasoning about the shift from negative to positive observable inputs and increasing reliance on unobservable inputs is sound and well-articulated. The answer addresses all parts of the question—evolution over time, total fair value, and shift between input types—making it contextually complete. However, the error in the 2022 figures, while not derailing the overall conclusion, is significant enough to reduce quantitative accuracy. Multi-hop synthesis is generally correct, pulling and comparing data across three years and two input types. The conclusion about a shift toward more observable-input-driven estimates in 2024 is debatable given that unobservable inputs still dominate ($34M vs $4M), but the observation that observable inputs turned positive is valid. Thus, the answer is mostly correct with one critical numerical error, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 482,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike’s 10‑K filings for 2022, 2023 and 2024 all name Anta as a key competitor and repeatedly list the same three competitive pillars—product attributes, innovation and consumer connection (see the “Competition” sections).  In each year the product‑research section continues to spotlight Nike’s technology pipeline (Air, Zoom, Flyknit, React, etc.), underscoring a sustained emphasis on innovation, while the brand‑engagement narrative remains centered on athlete endorsements, digital commerce and social‑media interaction.  Consequently, Nike’s competitive positioning relative to Anta has stayed essentially unchanged, with no shift in the balance of product‑innovation or brand‑engagement focus across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite correctly identifying that Anta is named as a competitor and that Nike emphasizes product innovation and brand engagement. The original answer (ground truth) shows a clear evolution in Nike's competitive positioning: in 2022, emphasis was on quality, performance, and reliability; in 2023, 'innovation and development' was elevated above performance and reliability; and in 2024, digital engagement and social media were further emphasized. This indicates a strategic shift over time. However, the LLM claims there was 'no shift' and that positioning 'has stayed essentially unchanged,' which directly contradicts the ground truth. While the LLM correctly references Nike’s technology pipeline and brand engagement elements (e.g., athlete endorsements, digital commerce), it fails to recognize or report the changing hierarchy and emphasis of these factors across years—a key multi-hop insight required by the question. There are no numerical inaccuracies (hence high quantitative score), but the qualitative reasoning is flawed, missing the evolution in strategy. Contextually, the answer addresses the right companies and themes, but incorrectly negates change, making it partially relevant but misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 355,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The equity‑compensation tables for 2022, 2023 and 2024 show no shares remaining for future issuance under the Texas Instruments 2003 Director Compensation Plan – the “remaining‑available” column lists only the 2009 LTIP, 2014 ESPP, 2018 Director Plan, and in 2024 the 2024 LTIP (see footnote (c) on pages 61, 59 and 63). This steady absence indicates that TI has effectively retired the 2003 plan for new director awards, relying instead on newer plans such as the 2018 Director Plan and the 2024 LTIP.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that no shares remained available for future issuance under the 2003 Director Compensation Plan in 2022, 2023, and 2024, which matches the original answer's claim that the plan was gradually phased out. The mention of the 2018 Director Plan and 2024 LTIP as replacements is consistent with the ground truth. (2) Quantitatively, the LLM accurately reflects the absence of available shares in the 'remaining-available' column across all three years, correctly citing the plans that *are* active (2009 LTIP, 2014 ESPP, 2018 Director Plan, 2024 LTIP), with correct footnote references. No numerical inaccuracies are present. (3) The reasoning is sound: the LLM infers from the lack of available shares that the 2003 plan has been retired for new awards, which is a valid conclusion supported by the data. It correctly synthesizes information across three years and identifies the shift to newer plans. (4) The only minor shortcoming is that the LLM does not explicitly note that the 2003 plan was still referenced in 2022 as active with shares being issued, and in 2023 as still having outstanding grants. While the conclusion of retirement is correct, this nuance about phased wind-down (active → legacy for outstanding grants → fully retired) is slightly underdeveloped. However, the core facts and trend interpretation are correct. Hence, a score of 9 is warranted for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 409,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "CMCSA’s 2022‑24 filings show a steady integration of data‑driven services into its advertising business, with the company offering technology, tools, data‑driven services and marketplace solutions to media‑industry customers (CMCSA_10k_2022.pdf page 6; CMCSA_10k_2023.pdf page 4; CMCSA_10k_2024.pdf page 4).  Over this period the firm broadened its reach by adding representation agreements and digital platforms—such as Sky‑branded networks and the NOW brand DTC streaming service (CMCSA_10k_2023.pdf page 4; CMCSA_10k_2023.pdf page 6)—and continued to upgrade its technology stack, deploying DOCSIS 4.0, virtualizing core network functions, and enhancing X1, Sky Q, NOW and Xumo platforms (CMCSA_10k_2024.pdf page 7).  No additional tool or marketplace upgrades were specifically disclosed beyond these ongoing initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the cited documents and contains no incorrect numeric or date information, earning a high quantitative accuracy score. However, it falls short in qualitative accuracy because it fails to fully capture the evolution and specific enhancements described in the ground truth. While the original answer outlines a clear progression from 2022 to 2024—emphasizing deeper integration of data-driven services, cloud-based platforms, integrated search functionality (2023), and enhanced digital tools with expanded third-party representation (2024)—the LLM response generalizes these developments as 'ongoing initiatives' and states that 'no additional tool or marketplace upgrades were specifically disclosed,' which contradicts the original answer's detailed claims. The LLM also introduces specific technologies like DOCSIS 4.0 and virtualization that, while part of CMCSA’s broader tech upgrades, are not explicitly tied to advertising tools in the context of the question. This misalignment in reasoning and incomplete synthesis of multi-hop information across years reduces qualitative accuracy. Contextually, the answer is relevant and cites appropriate sources, but misses key nuances about the strategic evolution of advertising-specific capabilities. Thus, while some correct elements are present (e.g., representation agreements, digital platforms), the answer lacks the specificity and correct interpretation of advancements in advertising technology, tools, and marketplace solutions as described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 427,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed security (CMBS) holdings fell sharply from 2022 to 2024.  In 2022 the fair value of CMBS in unrealized‑loss positions was $992 million with $155 million in unrealized losses (page 149); by 2023 the fair value had dropped to $675 million and unrealized losses to $100 million (page 149).  In 2024 the fair value of CMBS in Separate Accounts fell to only $3 million (page 160) and the company reported no unrealized losses for CMBS, indicating that the exposure has been largely divested or written down.  This trend shows CVS is actively trimming its CMBS portfolio and moving toward a more conservative risk stance in this asset class.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, CVS held $574 million in CMBS in 2022 with $12 million in unrealized losses, but the LLM claims $992 million at fair value with $155 million in unrealized losses—both figures are incorrect. The 2023 numbers for fair value ($675 million) match, but the LLM states unrealized losses decreased to $100 million, while the ground truth shows they increased from $12M to $100M—this directional trend is correct, but the LLM misrepresents the 2022 baseline. In 2024, the LLM reports $3 million (vs. $6 million in truth), which is close but still inaccurate. (2) Calculations and comparisons are partially sound—recognizing a decline in exposure and losses from 2023 to 2024 is valid, but the starting point (2022) is misrepresented, undermining the trend analysis. (3) The multi-hop reasoning is logically structured—tracking changes over three years and inferring de-risking—but it's based on incorrect initial data. The conclusion about de-risking aligns with the ground truth, so the qualitative interpretation is reasonable despite faulty inputs. (4) Contextual relevance is high—the answer addresses all parts of the question: evolution over time, fair value, unrealized losses, and risk positioning. However, due to major factual errors in key financial figures, especially in the 2022 data, the correctness score is limited to 5. Minor format differences are acceptable, but the magnitude of the discrepancy in 2022 values ($574M vs $992M, $12M vs $155M) constitutes a material error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 437,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s 10‑K filings for 2022, 2023, and 2024 all describe the employee benefit as “merchandise and other discounts” within the broader compensation package (see 2022 page 6, 2023 page 6, 2024 page 6).  None of the disclosures specify a discount rate or change the wording, indicating that the scope and value of the benefit have remained essentially unchanged over the three years.  This consistency suggests that Target treats the merchandise discount as a stable, tangible perk aimed at supporting employee satisfaction and retention rather than a variable or frequently adjusted benefit.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually consistent in noting that merchandise discounts were consistently mentioned across Target's 2022, 2023, and 2024 10-K filings and that the specific wording or numerical value of the discount was not disclosed—this aligns with the ground truth in that no quantitative changes were reported. However, the LLM answer incorrectly concludes that the 'scope and value' remained 'essentially unchanged' based solely on unchanged wording, which contradicts the ground truth's analysis of evolving framing and strategic emphasis. The original answer identifies a qualitative evolution in how the benefit is positioned: from a standalone perk in 2022 to being part of a broader, increasingly holistic benefits ecosystem by 2024 that includes financial wellness, mental health, and virtual care. The LLM fails to recognize or report this multi-year progression in strategic emphasis, which is central to the question. While no numbers are incorrect (hence full quantitative accuracy), the qualitative analysis is superficial and misses the synthesis of contextual shifts across years. The reasoning is therefore flawed in its conclusion about employee benefit strategy, as it equates textual consistency with strategic stasis, when the ground truth indicates a strategic expansion around core benefits. Contextual relevance is moderate because the answer addresses the benefit's presence but not its evolving role within a changing benefits landscape.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 403,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "In 2022 and 2023, Linde’s risk disclosures listed “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one of several integration risks (2022, p.12; 2023, p.12). By 2024, the disclosure expanded this to explicitly mention “integration of operations across different cultures and languages” and the unique risks of foreign acquisitions (2024, p.12), underscoring a heightened focus on cross‑border cultural dynamics. This evolution signals a strategic shift toward more proactive, culturally aware integration planning and risk mitigation in global acquisitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, years, and citations (2022, 2023, 2024, page 12 references), and there are no numerical inaccuracies, earning a perfect score on quantitative accuracy. It correctly identifies the evolution of Linde's risk disclosures around cultural challenges in acquisition integration. However, the qualitative accuracy is slightly lower because the LLM emphasizes a 'strategic shift toward more proactive, culturally aware integration planning,' whereas the ground truth highlights a reframing of cultural challenges in terms of financial and strategic risk (e.g., synergy realization, personnel retention, and impact on financial results), not necessarily more proactive planning. The 2024 emphasis in the original answer is on the consequences of failure (financial impact, synergy shortfalls), while the LLM focuses on cross-border operational complexity (cultures and languages). This is a subtle but important difference in interpretation. The LLM captures the increasing specificity in cross-border risks but misses the shift toward financial outcome orientation in 2024. Contextual relevance is high as the answer directly addresses the evolution of cultural challenge disclosures and strategic implications. Overall, core facts are correct, but the synthesis and reasoning do not fully align with the ground truth’s emphasis on financial risk framing in later years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 391,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply from **$1.494 billion in 2022 to $491 million in 2024** (a decline of about $1.003 billion, roughly 67 %). This steep reduction indicates that the company has either scaled back its derivative exposure or improved the efficiency of its collateral usage, reflecting stronger derivative‑exposure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the overall decline in collateral from $1,494 million in 2022 to $491 million in 2024, matching the ground truth. However, it omits the intermediate 2023 value of $800 million, which is part of the multi-year trend described in the original answer. This omission slightly reduces completeness but does not invalidate the overall trend. (2) The dollar amounts are accurate when accounting for format variations ($1.494 billion = $1,494 million; $491 million is consistent). The calculated decline of $1.003 billion and ~67% reduction are correct: (1,494 - 491) = 1,003 million; (1,003 / 1,494) ≈ 67.1%. (3) The reasoning is sound: the conclusion about reduced derivative exposure or improved collateral efficiency aligns with the original answer’s interpretation. The model successfully synthesizes the trend across years and draws a valid inference about exposure management. (4) Scores reflect high accuracy in numbers and reasoning, with a minor deduction in correctness and quantitative accuracy due to the missing 2023 data point, which is relevant for full trend analysis. Contextual relevance is perfect as the answer directly addresses both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 344,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "In 2022, the Security Insights Platform (page 11) was positioned as a tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” with its data “available for use with in‑house tools for security information and event management.” The 2024 filing (also page 11) repeats the same wording, still emphasizing risk identification, remediation, and SIEM integration, but adds no new reference to external‑tool integration or a broader cybersecurity‑strategy alignment. Thus, the platform’s core positioning and described capabilities remained essentially unchanged between 2022 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite correctly quoting the 2022 and 2024 descriptions. It claims the platform's positioning 'remained essentially unchanged' between 2022 and 2024, which directly contradicts the ground truth that shows a clear evolution in strategic alignment. The LLM fails to mention the 2023 shift toward proactive risk response and integration with broader cybersecurity practices, a critical multi-hop element. It also omits the 2024 contextualization within an expanded suite including Cybersecurity, AIOps, and DevOps, which signifies a strategic shift toward enterprise-wide security and compliance. While the quoted text from 2022 and 2024 is accurate (hence full marks for quantitative accuracy), the analysis is flawed: the absence of new wording in the 2024 filing does not imply no evolution—strategic positioning can evolve through contextual framing, not just new feature descriptions. The model fails to synthesize across years and misinterprets consistency in phrasing as lack of evolution, missing the broader narrative shift. This results in a low correctness and qualitative accuracy score. Contextual relevance is moderate because it addresses the right document and platform but draws incorrect inferences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 355,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "SPG’s Unsecured Notes – 32B remained unchanged from 2022 through 2024, with a face value of **$750,000** and an interest rate of **3.38 %** (maturity 06/15/27) in each year’s debt schedule (2022 10‑K p. 50; 2023 10‑K p. 50; 2024 10‑K p. 51). This stability shows the company has not increased or re‑priced this debt, reflecting a long‑term strategy that prioritizes predictable cash flows and low refinancing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the face value of the Unsecured Notes - 32B. It reports $750,000 instead of the correct $750,000,000 as stated in the ground truth. This is a three-order-of-magnitude discrepancy, which severely undermines factual accuracy. All other numeric values — the interest rate (3.38%) and maturity date (June 15, 2027) — are correct, and the years (2022–2024) are accurately referenced. (2) The quantitative inaccuracy is significant: reporting $750,000 instead of $750 million misrepresents the scale of SPG’s debt exposure and would lead to incorrect financial interpretations. Despite correct citations to the 10-K pages, the core financial figure is wrong. (3) The reasoning and synthesis across years are sound — the model correctly observes no change in terms over the three years and infers a stable debt strategy focused on predictable cash flows and low refinancing risk, which aligns with the ground truth’s conclusion about a stable long-term strategy. This shows appropriate multi-hop reasoning across three annual filings. (4) While the qualitative reasoning and contextual relevance are strong — correctly identifying the lack of refinancing or principal reduction and linking it to strategic debt management — the massive error in the dollar amount severely compromises the correctness score. A correct interpretation cannot be built on incorrect data, even if logic follows. Hence, the correctness and quantitative accuracy scores are low, but qualitative and contextual scores are higher due to valid structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 436,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From 2022 through 2024, CMCSA’s filings consistently note that Lumen has been expanding its fiber network across the U.S., adding fiber‑to‑the‑premises infrastructure that enables higher‑speed broadband services (2022, page_9; 2023, page_9; 2024, page_9). The company also highlights that Lumen, along with other carriers, is offering bundled services—combining broadband with wireless or other offerings—which intensifies competition for CMCSA’s residential broadband (2024, page_9). As Lumen’s fiber coverage grows and its bundling strategies become more integrated, the competitive threat to CMCSA’s broadband has increased, especially in markets where CMCSA’s HFC network faces direct fiber competition (2024, page_9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Lumen's fiber expansion and bundling strategies are consistently mentioned across 2022–2024 filings as intensifying competition for CMCSA. The LLM correctly identifies that fiber-to-the-premises deployment enables higher-speed services and that bundling (especially with wireless) increases competitive pressure. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly inferring an escalating threat based on continued fiber deployment and bundling. The only minor shortcoming is that the original answer emphasizes Lumen’s rising prominence as a 'top-tier' competitor by 2024 and the 'consistent and possibly intensifying' nature of the threat, which the LLM implies but does not explicitly state with the same nuance. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: fiber expansion and service bundling, across the specified time frame. Overall, the LLM captures the core evolution and competitive dynamics accurately, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 380,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded payment‑card penetration fell from 20.5 % in 2022 to 18.6 % in 2024 for RedCards (page 27) and from 19.8 % in 2023 to 18.6 % in 2024 for Circle Cards (page 29). The modest decline indicates that the loyalty‑driven payment strategy remains broadly effective but its growth momentum has slowed, suggesting Target may need to refresh incentives or marketing to sustain or boost card usage.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Target's branded payment card penetration declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. However, the LLM claims penetration was 18.6% in 2024 for both RedCards and Circle Cards, with no mention of a 17.8% overall rate. The 18.6% figure does not match the ground truth 17.8% for 2024, and the split between RedCards and Circle Cards is not supported by the original answer. Additionally, the LLM introduces two separate card types (RedCards and Circle Cards) not mentioned in the question or ground truth, which misrepresents the data. (2) The quantitative accuracy is low: the 2024 penetration rate is incorrect (18.6% vs 17.8%), and the 2023 rate is misstated as 19.8% for Circle Cards only, whereas the original answer reports 19.8% as the total for 2023. There is no evidence in the ground truth of a split between card types. (3) The reasoning is flawed because it assumes a multi-card segmentation not present in the original data, leading to incorrect synthesis. The conclusion that the strategy remains 'broadly effective' contradicts the ground truth interpretation of a 'weakening' trend due to a sharper decline (2.7 percentage points over two years). (4) Contextual relevance is moderate because the answer addresses the general topic of penetration trends and strategy effectiveness, but the incorrect data and entity breakdown undermine the validity. The mention of specific document pages (27, 29) suggests external sourcing not reflected in the ground truth, further reducing reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 447,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "Chevron’s presence in the Republic of Congo was still part of its global portfolio in 2022, as the company listed the country among its operating regions (page 33).  By 2024, Chevron had begun to divest its non‑operated interests there, selling its 31.5 % working interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of the Lianzi project (pages 41, 45).  The divestitures cut Chevron’s asset ownership and capital commitment in the region, reflecting a strategic shift away from non‑operated assets in Congo.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission affecting completeness. (1) Correct elements: The answer accurately states Chevron's operational presence in the Republic of Congo in 2022 and correctly identifies the 2024 divestitures—31.5% working interest in the offshore Haute Mer permit and 15.75% interest in the Congo portion of Lianzi—with proper context of strategic exit from non-operated assets. These details match the original answer exactly in entity and percentage accuracy. (2) Quantitative accuracy: All percentages (31.5%, 15.75%) are correct; however, the $0.7 billion investment in African offshore projects in 2023, which includes Congo, is omitted. While the LLM does not falsely state any numbers, this missing investment figure reduces completeness and weakens the full financial evolution narrative. (3) Multi-hop reasoning: The model correctly synthesizes information across years (2022 presence → 2024 divestiture) and infers strategic repositioning, demonstrating sound logic. However, it skips the intermediate 2023 investment data point, which is critical for showing continued financial engagement before the exit. (4) Contextual relevance is high—the response directly addresses asset ownership and strategic positioning; investment levels are partially covered but weakened by the missing 2023 figure. Overall, the answer captures the core trajectory but lacks full financial continuity, justifying a high but not perfect correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 416,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NextEra’s gas‑option exposure fell sharply: the fair value of gas‑option positions dropped from $356 m (assets) and $347 m (liabilities) in 2022 to $100 m and $102 m in 2023 and 2024, while the net notional volume rose from 1,307 MMBtu in 2022 to 1,452 MMBtu in 2023 and then fell to 1,131 MMBtu in 2024【page_83】【page_85】【page_87】. Despite the lower exposure, the weighted‑average implied volatility used to value those options increased from 36 % in 2022 to 52 % in 2023 and 2024【page_83】【page_85】【page_86】, indicating that the company is pricing its remaining gas‑options at higher market uncertainty and adopting a more cautious risk stance in gas markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and misrepresents the evolution of fair values and implied volatility. According to the ground truth, in 2023, the fair value was $100M in assets and $97M in liabilities, not $100M and $102M as stated. The LLM incorrectly states that liabilities were $102M in both 2023 and 2024, but in reality, 2024 liabilities were $102M while 2023 liabilities were $97M. Additionally, the LLM claims implied volatility increased to 52% in 2023 and remained there in 2024, but the ground truth shows 50% in 2023 and 52% in 2024. (2) The LLM introduces 'net notional volume' (1,307 MMBtu, 1,452 MMBtu, 1,131 MMBtu), which is not present in the original answer or question and appears to be extraneous or incorrectly inferred data, undermining quantitative accuracy. (3) While the LLM correctly identifies the sharp drop in exposure from 2022 to 2023 and interprets rising implied volatility as a sign of increased caution—consistent with the ground truth’s 'strategic de-risking' and 'cautious outlook'—it fails to note the stabilization of asset values at $100M and the slight liability increase in 2024. The reasoning is partially sound but based on incorrect data. (4) Despite these errors, the answer addresses the core question about exposure evolution and risk positioning, and the overall interpretation of increased volatility reflecting caution aligns with the original. Hence, correctness is partially compromised due to key numerical inaccuracies, but the qualitative direction and intent are reasonable. Contextual relevance is high as it directly responds to both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 454,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike’s 10‑K filings for 2022, 2023 and 2024 all list FlyEase in the product research, design and development section as part of the company’s suite of innovative technologies.  The language and placement of the mention remain unchanged across the three years, indicating that FlyEase has been treated as a core, ongoing innovation rather than a one‑off or experimental feature.  This consistency signals that Nike views FlyEase as a foundational element of its strategy to deliver inclusive, performance‑enhancing footwear and apparel.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim: it states that FlyEase was listed in the same way across all three years (2022–2024) with unchanged language and placement, which contradicts the ground truth. According to the original answer, FlyEase evolved significantly: introduced as part of the innovation portfolio in 2022, expanded in 2023 with broader integration into product categories, and fully embedded as a core technology in 2024. This progression indicates a strategic evolution from introduction to entrenchment, which the LLM answer fails to capture. Instead, the LLM asserts consistency in treatment, directly opposing the multi-hop insight that FlyEase gained prominence over time. While the entities (Nike, FlyEase, years 2022–2024) are correct and the general context of innovation strategy is addressed, the reasoning is flawed due to incorrect synthesis of the temporal development. There are no numerical values to evaluate, so quantitative accuracy is scored as 10 by default. Qualitative accuracy is low because the model misrepresents the trajectory of FlyEase’s strategic role. Contextual relevance is high since the answer discusses the right topic and attempts to infer strategic meaning, albeit based on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 352,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 35A stayed the same: a $750,000 face amount, 2.65 % interest, $19,875 annual debt service, and a 2030 maturity (see the 2023 table on page 50 and the 2024 table on page 51).  The unchanged terms show that Simon has kept this small, long‑term, low‑cost debt instrument on its balance sheet rather than refinancing or issuing new debt, underscoring a conservative, predictable long‑term debt strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the face amount ($750,000), interest rate (2.65%), annual debt service ($19,875), and maturity date (07/15/30, referred to as 2030) are consistent across 2022–2024. Minor formatting differences (e.g., '2030' vs '07/15/30') do not affect factual accuracy. (2) Quantitative values match exactly: $750,000 × 2.65% = $19,875, confirming the annual debt service is correctly calculated and reported. (3) The multi-hop reasoning is sound—information is synthesized across three years and correctly interpreted to infer SPG’s (Simon Property Group) long-term debt strategy. (4) The conclusion about a 'conservative, predictable long-term debt strategy' aligns with the ground truth’s interpretation of 'stable long-term commitment' and 'steady approach.' The LLM correctly identifies the strategic implication of not refinancing or restructuring despite market changes. All parts of the question are addressed: evolution over time (no change) and strategic interpretation. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 322,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Texas Instruments’ MD&A consistently frames analog and embedded‑processing as the core of its business model in 2022, 2023 and 2024 (pages 18‑20 of each filing).  The embedded‑processing segment grew modestly in revenue from $3.261 B in 2022 to $3.368 B in 2023 but fell 25 % to $2.533 B in 2024, while operating‑profit margins slid from 38.4 % to 29.9 % to 13.9 % (page 20).  This steady emphasis on embedded products—despite margin pressure—underscores TI’s long‑term strategy to generate and grow free‑cash‑flow per share by leveraging its manufacturing strength, portfolio breadth and market reach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in financial data that contradict the ground truth. While the original answer emphasizes consistent strategic positioning of embedded processing without mentioning financial declines, the LLM introduces specific revenue and margin figures showing sharp deterioration in 2024—$3.261B (2022) → $3.368B (2023) → $2.533B (2024), and operating margins falling from 38.4% to 13.9%. These numbers are not present in the ground truth and directly conflict with its narrative of embedded processing being a stable, high-margin, scalable segment. There is no indication in the original answer that margins or revenues collapsed in 2024, making these fabricated or misattributed figures a major error. (2) The quantitative accuracy is low because the LLM presents precise numbers and percentage changes (e.g., 25% decline, margin drop to 13.9%) that are unsupported by the ground truth. Even if such data existed in actual filings, the ground truth—which represents verified knowledge—does not include them, so the LLM’s inclusion distorts the correct answer. The evaluation must be based on alignment with the ground truth, not external reality. (3) Qualitatively, the LLM correctly identifies the multi-hop element: TI consistently emphasizes embedded processing across three years and links it to long-term free cash flow per share. It also correctly infers that continued investment despite margin pressure reflects strategic commitment, which aligns with the original answer’s conclusion about capital allocation and long-term focus. This shows sound reasoning structure, even if based on incorrect data. (4) Contextual relevance is high because the LLM addresses both parts of the question: evolution over time (2022–2024) and implications for free cash flow strategy. However, the introduction of unverified negative financial trends undermines correctness. The core strategic narrative should have mirrored the ground truth’s emphasis on stability and scalability, not declining performance. Thus, while the framework is correct, factual errors reduce the correctness score to partial (4/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 579,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "By 2023 Disney had moved the Marvel brand to a top‑level tile on Disney+, making the franchise a primary driver of subscriber acquisition (page 7). In 2024 Marvel’s trademarks were listed among the company’s indefinite‑lived intangible assets, underscoring its sustained value and reflecting Disney’s strategy of monetizing high‑profile IP to accelerate Disney+ growth—illustrated by the platform’s 123 million paid subscribers that year (page 7, page 114).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel became a top-level tile on Disney+ by 2023, remained an indefinite-lived intangible asset in 2024, and Disney+ had 123 million paid subscribers as of 2024. These numbers and dates match the original answer exactly. (2) Quantitative accuracy is perfect: the 123 million subscriber figure is correctly cited and attributed to 2024, consistent with the ground truth’s reference to September 28, 2024. (3) The multi-hop reasoning is sound—linking Marvel’s brand evolution from balance sheet asset (2022–2024) to strategic UI feature (2023) and connecting it to subscriber growth shows correct synthesis across financial and strategic domains. The LLM omits explicit mention of 2022’s classification as an intangible asset and the forward-looking ESPN+ tile plan for fiscal 2025, which slightly reduces completeness but does not undermine the core accuracy. (4) Despite minor omissions, the answer captures the essential evolution and financial strategy, conveying semantic equivalence on the main points: Marvel’s transition from passive asset to active growth driver. Wording differs but meaning is preserved. Contextual relevance is excellent, directly addressing the question’s focus on brand evolution and financial strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 374,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance agreement continued to cover roughly the same portion of its closed block each year—59.25 % in 2022, 59 % in 2023, and 59 % in 2024—while the net ceded reinsurance recoverables tied to the agreement rose from $16.7 billion at December 31 2023 to $17.6 billion at December 31 2024, with 84 % of those balances held with the five largest ceded reinsurers and unsecured recoverables falling slightly from $2.5 billion to $2.4 billion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the percentage of the closed block reinsured in 2022 (59.25%) and the stable 59% in 2023 and 2024, it completely misrepresents the reinsurance recoverable balances. The ground truth reports unsecured reinsurance recoverable balances of $3.6B (2022), $4.4B (2023), and $4.2B (2024). However, the LLM claims unsecured balances were $2.5B in 2023 and $2.4B in 2024, which is factually incorrect. Moreover, the LLM introduces 'net ceded reinsurance recoverables' of $16.7B and $17.6B—figures not present in the ground truth and unrelated to the question about unsecured recoverable balances under the modified coinsurance agreement. (2) The numbers are quantitatively wrong: the $2.5B and $2.4B unsecured balances contradict the ground truth $4.4B and $4.2B. The $16.7B and $17.6B figures appear to be fabricated or misattributed from another context. There is no indication in the original answer of such large net ceded balances or an 84% concentration with top reinsurers. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the evolution of the modified coinsurance agreement in terms of both percentage reinsured and unsecured recoverables. It conflates different metrics (net ceded vs. unsecured recoverables) and omits the correct trend of increasing then slightly decreasing unsecured exposure. (4) Despite addressing the right company, time frame, and general concept (modified coinsurance), the severe numerical inaccuracies and introduction of irrelevant data severely undermine the answer's correctness. The contextual relevance is moderate because it attempts to address the question's structure, but factual fidelity is poor, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 488,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS’s residential mortgage‑backed securities (RMBS) rose modestly from **$757 million in 2022 to $810 million in 2023** (fair value, 2022 and 2023)【page 148】, then dropped sharply to **$71 million in separate accounts in 2024**【page 160】.  The RMBS were agency‑guaranteed, AA‑rated with a 5.9‑year duration in 2023【page 148】, so the decline indicates a deliberate shift away from low‑credit‑risk, moderate‑duration mortgage assets toward other fixed‑income holdings, thereby reducing interest‑rate exposure while maintaining a diversified debt portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, CVS's RMBS investment decreased from $629M in 2022 to $614M in 2023, then dropped to $71M in 2024. However, the LLM states it increased from $757M in 2022 to $810M in 2023 — both figures are incorrect and contradict the ground truth. Only the 2024 value ($71M) matches, which is correctly cited. (2) The calculation and trend analysis are therefore flawed: the LLM implies a continued increase in RMBS holdings in 2023 followed by a drop, while the truth shows a slight decrease in 2023 after 2022, then a steep drop in 2024. Additionally, the LLM omits any mention of unrealized losses (rising from $10M to $60M), which is a key indicator of risk exposure in the original answer. (3) The reasoning about strategic de-risking in 2024 is partially sound and contextually relevant — the sharp drop to $71M does suggest portfolio rebalancing — but the LLM incorrectly attributes this to reducing interest-rate exposure based on duration (5.9 years) and AA ratings, details not present in the ground truth and potentially fabricated or misattributed. The original answer emphasizes increased risk exposure in 2023 due to unrealized losses, which the LLM fails to address, weakening its qualitative analysis. (4) While the LLM attempts multi-hop synthesis (across years and portfolio strategy) and correctly identifies the 2024 reduction, the incorrect base data and missing risk metrics severely undermine factual correctness. The contextual relevance is high because it addresses the evolution and strategic implications, but the foundation is factually unsound. Quantitative accuracy is low due to major dollar amount errors; qualitative accuracy is moderate due to plausible but unsupported reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 496,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "From 2022 to 2024, MetLife’s modified‑coinsurance agreement has covered essentially the same portion of the closed block—59.25 % in 2022 and 59 % in both 2023 and 2024. The company continues to account for the arrangement under the deposit method, offsetting the deposit liability with a deposit recoverable, and the accounting treatment has remained unchanged across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key information is correct: the percentage of the closed block reinsured was 59.25% in 2022 and 59% in both 2023 and 2024, matching the original answer exactly. The accounting treatment under the deposit method with offsetting of the deposit liability and recoverable is correctly stated. (2) Quantitative accuracy is perfect—percentages are reported correctly across years, with appropriate rounding noted (59.25% to 59%). No calculations are required beyond accurate reporting, which is done precisely. (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer correctly identifies continuity in both reinsurance percentage and accounting policy across three years, indicating a stable approach. (4) The answer is contextually relevant, directly addressing both parts of the question—evolution of the reinsurance percentage and accounting treatment—and conveys the same semantic meaning as the original, despite slightly more concise wording. Minor phrasing differences (e.g., 'essentially the same portion' vs 'consistently reinsured approximately 59%') do not affect factual equivalence. No omissions or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 347,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra Energy’s net notional exposure to forward gas contracts grew from a net short of 1,307 MMBtu in 2022 to 1,452 MMBtu in 2023, then fell to 1,131 MMBtu in 2024. The peak in 2023 reflects a more aggressive hedging or speculative stance, while the subsequent reduction in 2024 indicates a trimming of that exposure, suggesting a shift toward a more balanced or less aggressive risk position in natural‑gas markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and direction of net exposure. The ground truth states that NextEra Energy had a net exposure of $160M in 2022, increased to $300M in 2023, then declined to $250M in 2024 — all in dollar values. The LLM instead reports notional volumes in MMBtu (1,307, 1,452, and 1,131), which are not equivalent to financial exposure and contradict the actual trend. The dollar-based net exposure increased from 2022 to 2023, but the LLM implies a continuous rise followed by a drop, misrepresenting the pattern. (2) The numbers provided in the LLM answer do not match any part of the ground truth — no mention of MMBtu or notional quantities exists in the original data. Furthermore, the calculation of net exposure from assets and liabilities in the ground truth is accurate: $191M - $31M = $160M (2022), $377M - $77M = $300M (2023), $296M - $46M = $250M (2024). The LLM introduces unrelated metrics, making quantitative accuracy very low. (3) The multi-hop reasoning fails because the model uses a different metric (notional volume vs. financial exposure) and draws conclusions based on fabricated data. While it attempts to interpret risk positioning — a relevant qualitative goal — the reasoning is built on incorrect foundations. (4) Contextual relevance is moderate because the answer addresses the question’s structure (trend over time and risk implication), but factual inaccuracy severely undermines usefulness. Correctness score is low due to complete mismatch in data type, values, and trend direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 431,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In 2022, Broadcom positioned industrial fiber optics as a core part of its industrial portfolio, used across automation, power‑generation/distribution, medical, defense/aerospace and vehicle subsystems, and paired with motion encoders and generic Ethernet ICs. By 2023 the description shifted to highlight factory automation, renewable‑energy and automotive electronics, and the integration moved to motion‑control encoders and more specific Ethernet PHYs, switch ICs and camera microcontrollers. The 2024 filing repeats this expanded focus, underscoring the same diverse application mix while emphasizing tighter coupling with Ethernet PHYs, switch ICs and camera microcontrollers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: AVGO (Broadcom) consistently positioned Industrial Fiber Optics as core from 2022 to 2024, with evolving integration. In 2022, it was paired with motion encoders and Ethernet ICs across applications like industrial automation, medical, defense, and vehicle subsystems. By 2023, the focus shifted to factory automation, renewable energy, and automotive electronics, with integration expanding to include more specific components like Ethernet PHYs, switch ICs, and camera microcontrollers. This emphasis continued in 2024. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all years and references are correct. (3) The multi-hop reasoning is sound—information is synthesized across three years and multiple technology integrations, correctly tracing the evolution toward more integrated systems. (4) The only minor shortcoming is that the LLM answer does not explicitly state the strategic implication of the shift (i.e., from standalone components to interconnected, intelligent systems), which is present in the original answer. However, the evidence for that conclusion is accurately reported. Thus, while the synthesis is complete, the explicit framing of the strategic evolution is slightly less developed. Wording differences are acceptable and do not affect meaning. Overall, the answer is factually complete, contextually relevant, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 421,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred stock has been a static element of its capital structure from FY 2022 through FY 2024.  The cumulative dividend obligation remains a fixed $0.10 per share payable annually on May 31, and no common‑stock dividends can be declared until that preferred dividend is fully paid.  The stock is fully issued to Sojitz America at a par value of $0.3 million, is redeemable at that par, and no additional preferred shares have been issued or altered in any of the three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys nearly all key information from the ground truth. (1) Quantitatively, all numbers are correct: the $0.10 annual dividend per share, the $0.3 million par value, and the May 31 payment date are consistent with the original answer. These values match across fiscal years 2022–2024, and no changes were made—correctly reflected. (2) The answer addresses the stability of the stock structure, confirming no new shares were issued or altered, and correctly notes the redemption terms and ownership by Sojitz America. (3) The multi-hop reasoning is sound: it synthesizes the financial obligation, structural stability, and dividend priority across years. (4) The only minor omission is that the LLM does not explicitly state that Sojitz America has not sought redemption despite having the option—a detail emphasized in the original answer that adds context about the long-term nature of the relationship. However, this does not undermine the core factual accuracy. Wording differs slightly (e.g., 'cumulative dividend' is used, though the original does not specify 'cumulative'—but since the dividend must be paid in full before common dividends, the implication aligns). Overall, the answer is factually correct, complete in key aspects, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 363,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 31B has not changed: it remains a $750,000 note with a 3.25 % coupon and a maturity of November 30, 2026. This stability shows SPG’s long‑term financing strategy of keeping fixed‑rate, long‑term unsecured debt in place to lock in low borrowing costs and preserve a predictable debt‑service profile, rather than restructuring or refinancing the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the unsecured debt amount ($750,000), interest rate (3.25%), and maturity date (November 30, 2026) are accurate and consistent across 2022–2024. These match the ground truth exactly, with acceptable formatting variations (e.g., spacing in '$750,000' and '3.25 %' vs '3.25%'). (2) Quantitatively, all numbers and dates are correct. There are no calculations required beyond recognition of consistency over time, which is properly conveyed. (3) The multi-hop reasoning is sound: the model correctly infers that the lack of change in this instrument over three years reflects a deliberate long-term financing strategy, aligning with the ground truth’s conclusion about SPG preserving the structure without refinancing. The LLM adds interpretive insight—'lock in low borrowing costs' and 'predictable debt-service profile'—which is reasonable and contextually supported, though slightly more interpretive than the original. (4) The only minor shortcoming is completeness relative to the broader context: the original answer notes that other unsecured notes were retired and new ones (e.g., Unsecured Notes - 41A) were issued in 2024, highlighting that changes occurred in the overall portfolio even as Note-31B remained stable. The LLM omits this contrast, slightly weakening the synthesis. However, since the question focuses specifically on Note-31B and its implications, this omission does not undermine the core correctness. Thus, the answer is factually accurate, contextually relevant, and logically sound, warranting a high score with a small deduction for partial contextual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 453,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "From 2022 to 2024, the value of TI common stock held in the company’s U.S. defined‑contribution plans fell from $940 million (6 million shares) in 2022 to $873 million (5 million shares) in 2023 and further to $852 million (5 million shares) in 2024【page_44】【page_44】. This downward trend reflects a decline in the company’s stock price and suggests employees have been selling or reducing their holdings in the retirement plans, indicating a cautious investment stance amid weaker market performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative values: $940 million in 2022, $873 million in 2023, and $852 million in 2024, matching the ground truth exactly. It also accurately includes share counts (6 million in 2022, 5 million in both 2023 and 2024), which are consistent with the data in the source (page 44 references). These numbers are factually correct and properly formatted. (2) Quantitative accuracy is perfect—dollar amounts and share counts are correct, and no calculation errors are present. The trend of decline is accurately described. (3) However, the reasoning (qualitative accuracy) has a partial shortcoming. While the LLM correctly identifies the downward trend and suggests employee selling or reduced holdings, it attributes the decline primarily to falling stock price and employee behavior (cautious stance), but omits the key structural factor mentioned in the ground truth: the freeze on new contributions into the TI common stock fund since 2016. This is a significant omission in the multi-hop reasoning, as the decline may be more driven by policy than active employee decisions. The ground truth presents a more balanced interpretation (strategic reduction, contribution freeze, or both), while the LLM leans into behavioral interpretation without acknowledging the freeze. (4) Contextual relevance is high—the answer directly addresses the evolution of stock value and interprets the trend in terms of performance and employee behavior. Despite missing a key explanatory factor, the response remains focused and informative. Thus, correctness is high but not perfect due to incomplete reasoning synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 453,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "Disney’s workforce grew steadily from 2022 to 2024, expanding from about 220,000 employees (166,000 U.S., 54,000 abroad) to roughly 233,000 (171,000 U.S., 62,000 abroad). The seasonal‑staff share rose modestly from ~7 % in 2022 to 8 % in 2024, while the full‑time/part‑time split shifted from 78 %/15 % to 76 %/16 %. Collective‑bargaining coverage for theme‑park, production and other employees remained broadly unchanged, with many U.S. workers covered by agreements and international staff represented by works councils, trade unions or other associations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: total employees (220,000 in 2022 → 233,000 in 2024), U.S. (166,000 → 171,000), international (54,000 → 62,000), and seasonal employee percentage (7% → 8%) match exactly. These values are reported with acceptable formatting (e.g., 'about', 'roughly', '~'). (2) Quantitative accuracy is perfect—no calculation errors, and all figures are consistent with the original data. (3) The qualitative reasoning is sound: the model correctly infers growth trends and stability in employee representation. However, the LLM adds detail not present in the ground truth—specific full-time/part-time splits (78%/15% to 76%/16%)—which, while plausible, are not supported by the provided truth. This minor addition does not contradict but slightly exceeds the evidence. (4) Contextual relevance is excellent: all parts of the question (total workforce, U.S. vs. international, seasonal %, and employee representation) are addressed with accurate synthesis across years and categories. The mention of works councils and trade unions for international staff is a reasonable elaboration consistent with 'employee associations' in the original. Overall, the answer is factually correct, well-reasoned, and comprehensive—just shy of perfect due to the unsupported part-time/full-time detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 380,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation across 2022, 2023, and 2024 (see pages 47–50 of each filing). This unchanged treatment underscores a disciplined focus on core operating performance and ensures that ROIC remains comparable over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, which matches the original answer’s claim of consistent exclusion to reflect core performance. (2) There are no numerical values requiring calculation in this question, but the years (2022–2024) are correctly cited, and the reference to specific pages (47–50) adds precision, even if not in the ground truth—this does not detract as it likely reflects actual filing locations. (3) The multi-hop reasoning is sound: the model correctly synthesizes GD's treatment of ROIC across three years and infers the implication—that this consistency reflects a disciplined, stable approach to measuring core operating performance. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'accounting volatility' or 'economic performance' as emphasized in the original, slightly reducing qualitative richness, but the core meaning about comparability and focus on operational performance is preserved. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 334,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "Between 2022 and 2024, Linde shifted its rare‑gas strategy from a broad atmospheric‑gas focus to a technology‑driven approach that emphasizes non‑cryogenic air‑separation, on‑site VPSA and membrane processes, and a growing portfolio of proprietary patents (2024 10‑K, pp. 4‑5). This evolution signals that Linde’s competitive advantage in the industrial‑gas market is increasingly rooted in its advanced, patented technologies, which enable more efficient production, lower distribution costs, and stronger market leadership (page_4, page_6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Linde's rare gas strategy from 2022 to 2024: starting with a broad atmospheric gas focus and progressing to a technology-driven approach centered on non-cryogenic air separation. The mention of VPSA and membrane processes matches the ground truth's emphasis on vacuum pressure swing adsorption and membrane separation. (2) There are no numeric values, dates, or financial figures in dispute; the years (2022–2024) are correctly used, and no calculations are required. The reference to the 2024 10-K (pp. 4–5, page_4, page_6) supports the claims, even if specific page numbers aren't in the original answer—this does not detract from factual accuracy. (3) The multi-hop reasoning is sound: the model synthesizes Linde’s strategic shift over three years and infers the competitive advantage correctly—linking technological innovation (e.g., non-cryogenic methods) to improved efficiency and market leadership. (4) The only minor shortcoming is that the LLM adds a detail not present in the ground truth—'growing portfolio of proprietary patents'—which, while plausible and contextually consistent, is not explicitly confirmed in the provided truth. This slightly affects qualitative accuracy but does not undermine correctness. Overall, the answer is semantically equivalent, factually correct, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 397,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "NEER’s share of net‑generating capacity under long‑term bilateral contracts rose from about 92 % in 2022 (2022 10‑K, page 17) to roughly 94 % in 2023 (2023 10‑K, page 18) and remained at that level in 2024 (2024 10‑K, page 18). This steady increase reflects a deliberate risk‑management strategy that prioritizes revenue certainty and price hedging, helping the company mitigate exposure to market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage of NEER's net generating capacity under long-term bilateral contracts for all three years: 92% in 2022, 94% in 2023, and 94% in 2024, matching the ground truth exactly. These values are also properly attributed to the respective 10-K filings, enhancing credibility. (2) All numbers and time periods are accurate, with no calculation errors. The increase from 92% to 94% and stabilization is correctly described. (3) The multi-hop reasoning is sound—information is synthesized across three annual reports (2022–2024), and the trend is correctly interpreted as a strategic move toward revenue certainty and risk mitigation. The LLM captures the core of the risk management strategy, though it omits a specific mention of 'non-qualifying hedges' referenced in the original answer, which slightly reduces completeness in qualitative terms. (4) Despite this minor omission, the answer conveys the essential meaning and strategic implication accurately, with excellent contextual relevance and precise numerical reporting. The slight deduction in qualitative accuracy reflects the missing detail about hedging instruments, but the overall reasoning and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 347,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million in FY 2022** (page 102) and the balance remained unchanged at **$495 million in FY 2023 and FY 2024** (page 81). This steady balance shows the company has neither issued additional principal nor repaid any of this debt, indicating a conservative debt‑management approach that keeps the instrument at a stable, low‑cost level and defers repayment until maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, dates, and percentages are accurate. 2) Quantitative accuracy is perfect: the dollar amount ($495 million), interest rate (3.125%), maturity date (January 2025), and fiscal years are all correct. Format variations (e.g., $495 million vs $495M) are acceptable and not an issue here. 3) The multi-hop reasoning is sound—information is synthesized across three fiscal years from what would be multiple filings (with page citations indicating source locations), and the conclusion about stable debt management is logically supported. The only minor deviation is in interpretation: the LLM describes the strategy as 'conservative' and 'low-cost,' which adds slight interpretive color not present in the neutral ground truth statement. However, this does not contradict the facts and is a reasonable inference. 4) The answer fully addresses both parts of the question: the evolution of the balance (unchanged) and what the trend indicates (stable liability management). The contextual relevance is excellent, with precise alignment to the query and appropriate use of financial terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 364,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 37B remained unchanged: the face amount stayed at **$700,000** and the maturity date stayed at **January 15, 2032**【page_50】【page_50】【page_51】. This stability shows the company is keeping a consistent long‑term debt profile, favoring predictable, long‑term financing over frequent refinancing or new debt issuance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements match: the face amount of $700,000 is accurately reported for all years (2022–2024), and the maturity date of January 15, 2032 (formatted as 01/15/32 in the original) is correctly stated. Minor formatting differences (e.g., 'January 15, 2032' vs '01/15/32') are acceptable and do not affect accuracy. (2) Quantitative accuracy is perfect: no calculations were required, but the consistent dollar amount and date are correctly maintained across years. (3) The multi-hop reasoning is sound—information from multiple years is synthesized correctly to infer stability in SPG's debt strategy. (4) The conclusion about SPG’s long-term debt strategy—emphasizing consistency, predictability, and avoidance of refinancing—is logically derived and aligns with the original answer. The LLM also appropriately cites document pages, enhancing credibility. All parts of the question are addressed: evolution over time (face amount and maturity), and strategic implication. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 310,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site has remained an analog‑only facility throughout 2022, 2023 and 2024, with no embedded‑processing operations added or removed. The property tables for each year list Melaka under “Analog” only and leave the “Embedded Processing” column blank (page 18).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site remained exclusively focused on analog operations throughout 2022, 2023, and 2024, with no involvement in embedded processing—matching the original answer's key claim of consistent specialization. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the absence of embedded processing is correctly noted across all years. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years and two product lines (analog vs. embedded processing), correctly concluding no change or expansion occurred. (4) The mention of 'page 18' and 'property tables' adds contextual fidelity, indicating the information is grounded in document structure, though not required for correctness. Wording differs slightly but conveys identical meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 296,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Disney’s Content Sales/Licensing segment has progressively treated post‑production services from Industrial Light & Magic (ILM) as a distinct revenue driver.  In each of the 2022, 2023 and 2024 10‑Ks the narrative notes that “post‑production services through Industrial Light & Magic and Skywalker Sound” are part of the segment’s revenue mix, and the reported “Other revenue” line that includes ILM has risen year‑over‑year.  This evolution shows a deepening reliance on ILM, with its share of the segment’s total revenue growing from fiscal 2022 through fiscal 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that Industrial Light & Magic (ILM) was part of the Content Sales/Licensing segment in fiscal 2022–2024, it incorrectly claims that ILM's revenue share 'grew' and that 'Other revenue' rose year-over-year due to ILM. The original answer does not mention any quantitative growth in ILM’s revenue or its proportion within the segment—instead, it describes a qualitative shift in narrative focus and strategic framing. There is no evidence in the ground truth about rising revenue or a growing 'share' of segment revenue, making this a major factual overreach. (2) The LLM introduces unverified quantitative claims—'Other revenue... has risen year-over-year' and 'its share of the segment’s total revenue growing'—which are not supported by the original answer. The ground truth contains no financial figures, percentages, or trends about ILM’s revenue performance, so these assertions cannot be substantiated. This results in low quantitative accuracy. (3) The multi-hop reasoning is partially sound in that the model tracks ILM’s presence across years within the segment, but it misinterprets narrative continuity as increasing reliance. The original answer emphasizes a strategic repositioning and contextual shift—not deepening reliance. The LLM fails to capture the nuance of evolving segment focus toward DTC and content licensing, instead simplifying the trend as revenue-driven growth. (4) Contextual relevance is moderate because the answer addresses the right segment, company, and time frame, and correctly notes ILM's inclusion. However, the conclusion about 'deepening reliance' contradicts the original’s more nuanced view of stable but contextually shifting integration. Thus, while relevant, the answer distorts the core insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 499,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method net investment income from operating joint ventures fell from **$1,305 million in 2022** to **$151 million in 2023** and rebounded to **$988 million in 2024** (see 2024 Note 11, p. 225; 2023 Note 11, p. 247; 2022 Note 11, p. 247). This sharp dip in 2023 signals a significant decline in underwriting profitability or losses in those joint ventures, while the 2024 recovery—though still below 2022 levels—indicates that underwriting performance improved, reflecting a volatile but ultimately positive trend in the company’s insurance‑underwriting joint‑venture business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$1,305 million in 2022, $151 million in 2023, and $988 million in 2024—matching the ground truth exactly. These values are properly attributed to the correct years and reflect the significant decline and partial rebound. (2) All numbers are accurate, and no calculations (e.g., differences or ratios) are incorrect. The formatting variation ($1,305 million vs $1,305 million) is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a trend of sharp decline in 2023 followed by recovery in 2024. It appropriately links this to performance in insurance underwriting joint ventures, noting the volatility. The only minor shortcoming is that it adds interpretation not in the ground truth—calling the trend 'ultimately positive'—whereas the original answer emphasizes 'volatility' without assigning a positive valence. This slightly overreaches in qualitative inference. (4) Despite this nuance, the answer is factually correct, fully addresses both parts of the question (evolution and implication), and remains highly relevant. Quantitative accuracy is perfect; qualitative accuracy is excellent but not flawless due to the interpretive addition. Contextual relevance is complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 374,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics produced 360 LAVs for the Canadian Army in 2022, ramped up to 449 in 2023, and then produced 399 in 2024. The peak in 2023 followed by a modest decline in 2024 reflects a sustained but slightly adjusted production schedule, underscoring the LAV platform’s continued role as a key export product and a strategically important component of the company’s defense portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the production numbers and their chronological order. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023 and then to 449 in 2024, showing a consistent upward trend. However, the LLM incorrectly states that 449 units were produced in 2023 and 399 in 2024, reversing the last two years and implying a decline, which contradicts the actual growth pattern. (2) The numbers themselves (360, 399, 449) are present in the LLM answer but are misassigned to the wrong years, leading to incorrect calculations of progression and trend. This undermines any quantitative analysis or conclusion drawn about production trends. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the year-over-year evolution of production volume. The incorrect timeline leads to an invalid conclusion about a 'peak in 2023' followed by a 'modest decline,' which is not supported by the data. The actual consistent increase indicates growing strategic importance, not an adjustment or slowdown. (4) While the LLM correctly identifies the LAV platform as strategically important and relevant to exports, this qualitative insight is based on incorrect data and thus lacks proper grounding. Contextual relevance is high because the answer addresses both parts of the question—production volume evolution and strategic significance—but the factual inaccuracies severely limit correctness. Quantitative accuracy is very low due to misaligned numbers; qualitative accuracy is low due to flawed reasoning stemming from incorrect data; contextual relevance remains high as the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 469,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s hedge‑fund limited‑partnership exposure grew steadily: it was $225 million in 2022 (page 174), rose to $252 million in 2023 (page 173), and reached $280 million in 2024 (page 170). The pension plan’s target allocation for hedge funds increased from 3 % in 2022‑23 to 4 % in 2024 (page 169), indicating a deliberate shift toward a higher alternative‑asset weight to diversify risk and pursue additional returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. However, the LLM incorrectly states $225M in 2022, $252M in 2023, and $280M in 2024—shifting and inflating the figures. These errors affect all years and show a failure to accurately extract or report the correct values. Additionally, the LLM introduces a claim about target allocation increasing from 3% to 4%, which is not present in the original answer and cannot be verified from the provided ground truth. (2) The quantitative inaccuracies are severe: the starting value is wrong, the progression is incorrect, and the final value ($280M) does not match the ground truth ($252M). Even allowing for format variation, the numbers are factually incorrect. (3) The reasoning is partially sound in interpreting the trend as a strategic shift toward alternative investments, which aligns with the original conclusion. However, because the data underpinning this reasoning is wrong, the multi-hop synthesis fails. The model appears to have misaligned the years and values, suggesting a failure to correctly associate data points across time. (4) The contextual relevance is moderate—the answer addresses the right topic (pension fund allocation strategy) and attempts to interpret the trend. However, due to major factual errors in numbers and unsupported claims about target percentages, the correctness score is very low. The qualitative accuracy is slightly higher because the general direction of interpretation (increasing allocation to alternatives) is consistent with the ground truth, albeit based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 470,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Across 2022, 2023, and 2024 Colgate‑Palmolive continued to list **Sorriso** as a principal trademark within its Oral, Personal and Home Care segment (see pages 77–79 of each filing).  This consistent listing indicates that the brand remained fully integrated into the company’s global portfolio, with the Oral Care segment accounting for roughly 42‑43 % of worldwide net sales in each year, underscoring Sorriso’s ongoing contribution to that core category.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately states that Sorriso was consistently listed as a principal trademark in Colgate-Palmolive's Oral, Personal and Home Care segment across 2022–2024, which matches the original answer's claim about its ongoing strategic positioning. The reference to pages 77–79 in each filing adds specificity and supports the claim. The 42–43% contribution of the Oral Care segment to net sales is factually accurate and contextually relevant, reinforcing Sorriso’s role in a key revenue segment. However, the LLM answer omits the explicit characterization of Sorriso as a *regional* brand leveraged for *regional market penetration*, which is a key nuance in the original answer and important to the strategic positioning aspect of the question. While the continuity and integration are correctly emphasized, the absence of this strategic context slightly weakens the qualitative completeness. There are no numerical errors—percentage ranges and years are correct—and the reasoning correctly infers stable strategic importance from consistent listing. The answer is highly relevant and synthesizes information across years appropriately, but misses a subtle yet meaningful layer of strategic intent present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 360,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s net investment income from operating joint ventures fell from **$51 million in 2022 to $38 million in 2023** and then jumped to **$175 million in 2024** (Net Investment Income table, page 224).  This three‑year swing shows the company is increasingly allocating capital to equity‑method operating joint ventures, signaling a strategic shift toward higher‑yield, higher‑risk investments while still limiting loss exposure to the carrying value plus commitments (Collectively Significant Equity Method Investments, pages 245‑246).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude. The ground truth states MetLife's financial exposure decreased from $77M (2022) → $51M (2023) → $38M (2024), but the LLM claims it fell from $51M (2022) to $38M (2023) to then jump to $175M (2024), which is the opposite trend. The 2022 and 2023 figures are misstated, and the 2024 figure is wildly inaccurate. (2) The numbers are not just off by rounding or formatting—they are factually wrong. $175M in 2024 vs. the correct $38M is a 360% error. The LLM also cites 'net investment income' instead of 'financial exposure,' conflating two different metrics. (3) The multi-hop reasoning fails: the model misidentifies the metric, misrepresents the trend, and draws the opposite strategic conclusion (increasing vs. decreasing involvement). It incorrectly infers a strategic shift toward joint ventures when the data shows a clear divestment. (4) Correctness and quantitative accuracy are near-zero due to fundamental factual and numerical errors. Qualitative accuracy is low because the reasoning and entity interpretation are flawed. Contextual relevance is slightly higher only because the answer addresses joint ventures and equity method investments, albeit incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 354,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s stake in Angola LNG Limited has stayed at 36.4 % from 2022 through 2024, but its role has shifted from a passive equity holder to an active operator.  In 2024, Chevron operates the Soyo LNG plant and has deepened upstream integration by taking a 31 % non‑operated interest in the New G as Consortium Project—whose gas‑treatment facility feeds the LNG plant—and by adding exploration acreage in Blocks 49 and 50 (page 14).  The 2022 filing only reported the 36.4 % equity interest without any operational responsibilities or upstream project links (page 78).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Chevron's 36.4% stake in Angola LNG Limited from 2022 to 2024, which matches the ground truth. It also accurately notes the 31% non-operated interest in the New G as Consortium Project (NGC) and the Soyo LNG plant's role in receiving feedstock. However, it makes a critical factual error by stating that Chevron 'operates the Soyo LNG plant' in 2024—this is incorrect. The ground truth specifies that Chevron has a nonoperated working interest in NGC and does not operate the LNG plant itself. The original answer describes Chevron’s role as becoming more integrated through upstream linkages, not operational control. (2) Quantitatively, all percentages (36.4%, 31%) and references to Blocks 49 and 50 are accurate or plausibly aligned with the source. Page citations (78, 14) suggest document support, though not verifiable here. (3) The multi-hop reasoning is partially sound—linking Chevron’s stake, upstream projects, and LNG integration—but fails in synthesis by incorrectly assigning operator status to Chevron. This misrepresents the nature of Chevron’s operational role and undermines the qualitative accuracy. (4) Contextual relevance is high as the answer addresses stake, evolution over time, and upstream integration. However, due to the major mischaracterization of Chevron as an operator, the correctness score is reduced to 6—partially correct but with significant factual inaccuracy affecting core aspects of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 412,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO’s 3.625% senior notes due October 2024 had a principal outstanding of **$622 million** at the end of FY2023 (and, by inference, the same amount at the end of FY2022, since no repayments were made).  The exposure dropped to **$0** after the notes matured in FY2024 (page 81).  This steady exposure until maturity and its full repayment at maturity shows a disciplined debt‑management strategy that keeps debt on the books until the scheduled maturity and then extinguishes it with proceeds from new financing or cash, rather than refinancing or early repayment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $622 million outstanding in both 2022 and 2023, and $0 in 2024 after maturity. The dates (October 2024 maturity) and fiscal years are correctly referenced. (2) The answer correctly infers that no repayments occurred between 2022 and 2023 based on consistent disclosure, which is consistent with the original answer. (3) The reasoning about AVGO’s debt management strategy is sound: maintaining the debt until maturity and then retiring it reflects disciplined, likely cash-funded or refinanced, repayment. The only minor shortcoming is the LLM’s suggestion that repayment occurred 'at maturity' without explicitly acknowledging the possibility of early retirement prior to the exact maturity date—though this is a subtle distinction and does not contradict the data. The original answer notes the notes 'no longer appear in 2024 disclosures,' which could imply retirement slightly before or at maturity. (4) All entities (AVGO, 3.625% notes, October 2024 maturity) are correctly identified, and the multi-hop synthesis across fiscal years 2022–2024 is accurate. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 367,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "In 2022, 2023 and 2024 the annual debt service for Unsecured Notes – 35B was $28,500, reflecting a 3.80 % interest rate on a $750,000 face amount. The unchanged figure shows that SPG’s financing cost for this note has remained flat over the period, indicating no refinancing or rate adjustment and a predictable, stable debt‑service obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that SPG's interest expense for Unsecured Notes - 35B was $28,500 (in thousands) in 2022, 2023, and 2024, matching the ground truth exactly. The answer accurately reflects the consistent interest expense over the three-year period. (2) The quantitative details are fully accurate: $28,500 (in thousands) is correctly reported across all years. Additionally, the LLM adds contextual financial data not in the original answer—namely, a 3.80% interest rate on a $750,000 face amount—which is consistent with the $28,500 interest expense (3.80% of $750,000 = $28,500). While this calculation is correct and plausible, the ground truth does not confirm whether this specific rate and principal were disclosed in the filings, so the inclusion of these inferred details slightly exceeds the provided information but does not contradict it. (3) The reasoning is sound: the model correctly infers that the flat interest expense suggests a fixed-rate structure and stable financing costs, aligning with the original answer’s conclusion. It appropriately synthesizes the lack of change over time into a meaningful interpretation about refinancing and predictability. (4) The answer is semantically equivalent and even slightly more informative, though the added specifics about rate and principal, while accurate, are not verifiable from the ground truth alone—hence a 9 instead of 10 on qualitative accuracy. All other aspects meet or exceed requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 410,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "Disney’s 2022 10‑K highlighted a strategic pivot to streaming—launching an ad‑supported Disney+, reorganizing DMED and realigning costs—while warning that rising programming costs and a crowded market could curb subscriber growth (page 29).  In 2023 the company continued to pour capital into DTC, making targeted investments to boost subscription and ad revenue and beginning to prune under‑performing content to control costs (page 53).  By 2024 Disney had refined its DTC strategy, focusing on ad‑supported Disney+ and ESPN+, tightening content curation, adjusting pricing and bundling to counter intensified competition, and maintaining robust content‑and‑talent investment to sustain subscriber acquisition and retention (pages 21‑25).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the evolution of Disney's DTC strategy from 2022 to 2024, with accurate qualitative descriptions and no incorrect numbers. (1) QUANTITATIVE ACCURACY: There are no explicit numerical values (e.g., dollar amounts, percentages) in the LLM answer, so no numeric inaccuracies exist. The ground truth mentions $12.25 billion in unused bank facilities in 2023, which the LLM omits, but does not fabricate or misstate any figures. Since the LLM does not include numbers, it avoids error but also misses an opportunity to include a key quantitative detail. (2) COMPLETENESS: The LLM covers the strategic shift in 2022 (ad-supported Disney+, reorganization), 2023 (continued investment, cost control via content pruning), and 2024 (intensified competition, pricing/bundling adjustments, content investment). It captures the core themes: rising programming costs, competitive pressures, and the shift toward streaming. However, it omits specific details from the ground truth such as the decline in affiliate fees, the role of advertising revenue in offsetting linear declines, and the changing terms with programming distributors (e.g., bundling DTC with fewer linear networks). (3) ENTITY ACCURACY: All entities (Disney, Disney+, ESPN+, DMED) are correctly identified and contextualized. Years (2022–2024) are accurately attributed to respective strategic phases. (4) REASONING: The multi-hop synthesis across years is sound—the LLM correctly traces a trajectory from strategic pivot to refinement amid competition. It aligns with the ground truth’s narrative of increasing commitment despite rising costs and uncertainty. (5) SEMANTIC EQUIVALENCE: While wording differs, the LLM conveys a substantively similar evolution. The omission of financial capacity details ($12.25B in facilities) and affiliate fee dynamics slightly weakens completeness, but the core reasoning and strategic arc remain accurate. Hence, correctness is high but not perfect due to minor omissions in financial context and revenue model shifts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 557,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife has continued to apply the deposit method for reinsurance agreements that do not expose it to a reasonable possibility of a significant loss from insurance risk (see Note 57).  Deposit assets rose from $1.8 billion at the end of 2021 (2022 filing) to $5.1 billion at the end of 2023 and then fell to $4.6 billion at the end of 2024, while deposit liabilities declined modestly from $1.4 billion to $1.3 billion and then to $1.2 billion (see Note 206).  The 2023 risk‑transfer transaction with Global Atlantic added $10.3 billion of reinsurance recoverables and deposit receivables, which drove the 2023 deposit‑asset increase and influenced the subsequent 2024 balance (see Note 206).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor discrepancies in the timeline presentation. (1) Quantitatively: The LLM states deposit assets rose from $1.8 billion at the end of 2021 (as reported in the 2022 filing) to $5.1 billion at the end of 2023, then to $4.6 billion at the end of 2024. The ground truth reports $1.8 billion in 2022 (consistent with 2021), then $4.6 billion in 2024, but does not specify the 2023 asset value—only that $10.3 billion in receivables were recorded due to the Global Atlantic transaction. The $5.1 billion figure for 2023 assets is plausible and may reflect post-transaction peak exposure before rebalancing; its inclusion adds detail not contradicted by the ground truth. Deposit liabilities are reported as declining from $1.4B to $1.3B to $1.2B, while the ground truth states $1.4B in 2022 and $1.2B in 2024, with no 2023 figure—so the LLM’s $1.3B intermediate value is a reasonable inference. (2) The $10.3 billion reinsurance recoverables and deposit receivables from the Global Atlantic transaction are correctly cited. (3) Entity and time period accuracy are strong: MetLife, Global Atlantic, deposit method accounting, and years 2021–2024 are all correctly referenced. (4) Multi-hop reasoning is sound: the LLM links the 2023 transaction to the increase in deposit assets and explains its influence on 2024 balances. The only minor shortcoming is referencing '2021' as the starting point instead of '2022', but clarifies it's from the 2022 filing, so this is acceptable. Overall, the answer is factually consistent, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 452,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s fair‑value exposure to commercial mortgage‑backed securities fell sharply: from $1,018 million in 2022 to $975 million in 2023, and then to only $3 million in 2024 (Separate Accounts: $6 million in 2023 to $3 million in 2024)【page_149】【page_160】. This steep decline shows a deliberate shift away from CMBS, likely driven by concerns over credit risk and market volatility, and a move toward safer, more liquid fixed‑income assets in its investment strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, CVS held $574 million in CMBS in 2022, increased to $675 million in 2023, and then dropped to $3 million in 2024. However, the LLM reports $1,018 million in 2022 and $975 million in 2023, which are both incorrect. Only the 2024 value of $3 million matches the ground truth. The mention of 'Separate Accounts: $6 million in 2023 to $3 million in 2024' introduces data not present in the original answer and appears to conflate different investment categories. (2) Calculations and comparisons are therefore flawed—while the LLM correctly identifies a decline from 2022 to 2024, the magnitude and trajectory (steady decline) differ from the actual pattern (a slight increase followed by a sharp drop). The ground truth shows a strategic shift post-2023, whereas the LLM implies a continuous downward trend. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift away from CMBS based on declining exposure, which aligns with the original conclusion. However, because the underlying data is incorrect, the reasoning is based on faulty premises. The interpretation about de-risking and moving toward safer assets is plausible and contextually appropriate, but not fully supported by the actual year-by-year evolution. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution over time and strategic implication), uses correct entities (CVS, CMBS, years), and draws a reasonable qualitative conclusion. However, the severe quantitative inaccuracies severely undermine factual correctness, warranting a low overall score despite structural adequacy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 474,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Colgate‑Palmolive continued to list the “hello” brand as a principal global and regional trademark in each 10‑K (2022, 2023 and 2024 – see pages 79–81). The brand remains positioned within the Personal‑Care line of the Oral, Personal and Home Care segment, which accounted for roughly 19 % of net sales in 2022 and 2023 and 18 % in 2024, indicating a stable but slightly reduced strategic emphasis over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that the 'hello' brand was consistently listed as a principal trademark in Colgate-Palmolive's 10-K filings across 2022, 2023, and 2024, which aligns with the ground truth regarding its ongoing inclusion in trademark disclosures and stable strategic positioning within the Oral, Personal and Home Care segment. The qualitative reasoning is sound: the brand’s continued presence in disclosures supports the conclusion of consistent portfolio positioning. However, the LLM introduces specific net sales percentages (19% in 2022 and 2023, 18% in 2024) for the Personal-Care line that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate but are not supported by the knowledge graph output, making them extraneous and potentially misleading. The original answer makes no mention of sales percentages or any quantitative metric related to strategic emphasis, instead inferring stability from continued trademark disclosure. Thus, while the core factual claim of continuity is correct, the addition of unverified quantitative data reduces quantitative accuracy. The model also narrows the brand’s positioning specifically to 'Personal-Care line' within the segment, which is plausible but more specific than the original answer’s broader alignment with 'oral care and personal hygiene'—a minor overprecision. Despite these issues, the answer addresses all parts of the question with appropriate context and logical synthesis across years, maintaining high contextual relevance and solid qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 441,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife has consistently applied the deposit method to reinsurance agreements that do not expose the company to a reasonable possibility of a significant insurance‑risk loss (2022: §6, 2023: §6, 2024: §9)【page_214】【page_57】【page_206】. Deposit‑method balances grew sharply from $1.8 billion in 2021 to $5.1 billion in 2023—largely driven by the Global Atlantic modified‑coinsurance transaction—and then fell to $4.6 billion in 2024, while deposit liabilities declined from $1.4 billion to $1.3 billion in 2023 and $1.2 billion in 2024【page_216】【page_206】. The trend indicates a shift toward deposit‑method reinsurance to limit exposure to significant loss, with a modest unwinding or rebalancing in 2024 that reduces counter‑party risk and liquidity needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy regarding the timing of the deposit asset increase. The ground truth states that deposit assets were $1.8B in 2022 and $4.6B in 2024, with no explicit value for 2023. The LLM claims deposit assets grew to $5.1B in 2023 and then fell to $4.6B in 2024, which introduces a specific 2023 figure not present in the original answer and slightly misrepresents the trend. Additionally, the LLM references 2021 ($1.8B), which is outside the requested 2022–2024 scope and conflates the timeline. Deposit liabilities are mostly accurate: $1.4B in 2022 (matches), $1.3B in 2023 (ground truth does not specify 2023 liability, so minor extrapolation), and $1.2B in 2024 (matches). (2) The mention of the Global Atlantic transaction as a driver is consistent with the original answer and adds contextual insight, but attributing the peak to 2023 ($5.1B) introduces a number not supported by the ground truth, which only confirms $4.6B in 2024. (3) The multi-hop reasoning is strong: the LLM correctly identifies the consistent application of the deposit method across years, links the increase in deposit assets to reinsurance structures with limited risk transfer, and infers strategic intent around risk limitation and balance sheet management. The conclusion about a 'modest unwinding' in 2024 is an interpretive addition not present in the original, which instead emphasizes continued growth and strategic reliance. (4) Despite the numerical discrepancy in the 2023 asset figure, the overall trend and strategic interpretation align well with the ground truth. The answer addresses both parts of the question—evolution of accounting use and what the trend reveals—and maintains high contextual relevance and qualitative reasoning. Hence, correctness is reduced slightly due to unsupported numbers, but remains high due to accurate synthesis and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 524,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "From 2022 through 2024, NEE’s special‑use funds remained a Level‑2 fair‑value asset, with carrying amounts rising from about $919 million in 2022 to $9.8 billion in 2024 (the 2023 amount was $906 million).  Fair‑value changes were recorded in OCI for NEE and in regulatory assets/liabilities for FPL, and the funds continued to be used as collateral for derivative positions – the collateral posted by NEE subsidiaries fell from roughly $1.8 billion in 2022 to $0.7 billion in 2023.  On the balance sheet the special‑use funds appear as a distinct line item under other assets, with the fair‑value hierarchy and collateral requirements disclosed in the notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key quantitative data. According to the ground truth, Special Use Funds were $8,698 million in 2023 and $9,800 million in 2024 — an increase of $1,102 million. However, the LLM claims $906 million in 2023 and $9.8 billion in 2024, which implies a massive jump from ~$0.9 billion to $9.8 billion, misrepresenting the scale and trend. Additionally, the LLM incorrectly states that the 2022 amount was about $919 million, while the ground truth does not provide a total fair value for 2022 but does mention a component ($485 million) of equity investments without readily determinable fair values — not the total fund value. The LLM also introduces a false figure for collateral posted: it claims NEE subsidiaries reduced collateral from $1.8B in 2022 to $0.7B in 2023, but this specific collateral data is not present in the original answer and contradicts the ground truth, which only discusses balance sheet amounts and derivative-related collateral requirements qualitatively, not quantitatively. (2) Calculations are therefore invalid due to incorrect base numbers. The claimed growth from $919M to $9.8B is over 900%, whereas the actual increase from 2023 to 2024 was about 12.6% ($8,698M to $9,800M). The LLM also mislabels the fair value hierarchy — stating funds are Level-2 assets, while the ground truth describes a more nuanced approach using quoted prices and pricing vendors, with new categories introduced in 2023. (3) Multi-hop reasoning is partially sound in structure — the LLM attempts to track changes over time and link fair value, collateral, and balance sheet presentation — but fails in execution due to reliance on incorrect or fabricated data. It synthesizes across years but with inaccurate inputs. (4) Contextual relevance is fair: the answer addresses fair value disclosures, collateral implications, and balance sheet presentation as asked. However, qualitative accuracy suffers from incorrect entity values and misattribution of details (e.g., OCI treatment and regulatory assets for FPL are mentioned but not in the ground truth). Overall, while the structure and intent align with the question, the answer is factually unreliable due to severe quantitative errors and unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 610,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "Across 2022‑2024 the Security Insights Platform’s positioning stayed essentially the same.  In 2022 (page 10) it was described as a tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” with the data “available for use with in‑house tools for security information and event management.”  The 2023 filing (page 11) repeats that same wording, and the 2024 filing (page 10) again presents the identical description.  Thus, no new integration with in‑house tools or remediation‑workflow enhancements were added during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the consistent positioning of AVGO's Security Insights Platform from 2022 to 2024, noting the unchanged language across filings. The description of the platform’s capabilities—assessing mainframe security posture, identifying risks, and developing remediation steps—is factually correct and matches the original answer. (2) The LLM correctly references the repetition of identical wording across the 2022 (page 10), 2023 (page 11), and 2024 (page 10) filings, with no discrepancies in dates or document locations. There are no numerical values requiring calculation, but the textual consistency is treated as a qualitative metric and is accurately reported. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that no new integrations or remediation workflow enhancements were introduced, based on verbatim repetition. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in integration with in-house tools and remediation workflows. Minor wording differences (e.g., 'develops remediation steps' vs. 'identifying risks') are semantically equivalent and do not affect accuracy. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 374,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike has owned its Laakdal, Belgium distribution facility in FY 2022, FY 2023 and FY 2024, and it continues to be listed as one of the company’s most significant overseas distribution centers (2022 p. 29; 2023 p. 27; 2024 p. 27).  No changes in ownership or operational status are reported across the three years, underscoring Laakdal’s role as a core hub for Nike’s European logistics network and its ongoing strategic importance for distributing products throughout the region.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that NIKE owned the Laakdal facility in fiscal years 2022, 2023, and 2024, with no changes in ownership or operational status—matching the original answer exactly. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years and page references (2022 p. 29; 2023 p. 27; 2024 p. 27) are correctly cited, supporting the consistency claim. (3) The multi-hop reasoning is sound: the model synthesized information across three annual reports to confirm consistent ownership and operational status, correctly inferring strategic continuity. (4) The conclusion about Laakdal’s role as a core hub for European logistics aligns perfectly with the original answer’s interpretation of strategic importance. All aspects—factual accuracy, completeness, entity recognition, and reasoning—are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 272,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "In 2022, SPG’s Unsecured Notes – 32B carried a 3.38 % interest rate, a $750,000 face amount, and a maturity of June 15 2027. The 2023 and 2024 10‑Ks report the same terms—interest 3.38 %, face $750,000, maturity June 15 2027—so the exposure did not change over the three‑year span. This consistency suggests a deliberate strategy to keep the debt structure stable, preserving predictable cash‑flow obligations and avoiding the costs or risk of refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: the 3.38% interest rate, $750,000 face amount, and June 15, 2027 maturity date for Unsecured Notes - 32B across 2022–2024. These match the ground truth exactly, with acceptable formatting variations (e.g., 'June 15 2027' vs '06/15/27'). (2) Quantitatively, all numbers and dates are accurate. The LLM correctly states no change in terms over the three years, aligning with the ground truth. However, it slightly misrepresents the 2022 disclosure by asserting the maturity date was known in 2022 as June 15, 2027, whereas the ground truth notes it was 'unspecified' in 2022 and only clarified in 2023 and 2024. This is a minor factual inaccuracy. (3) The multi-hop reasoning is sound—comparing disclosures across three years and synthesizing the stability of terms to infer a consistent debt strategy. The conclusion about SPG avoiding refinancing costs and maintaining predictable cash flows is logically supported and semantically equivalent to the ground truth’s interpretation. (4) The answer is highly relevant, complete, and factually strong, but loses one point in correctness and qualitative accuracy due to the overstatement about the 2022 maturity date clarity. Otherwise, all core financial data and strategic implications are correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 372,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "From 2022 to 2023 CVS’s foreign‑security fair value fell modestly from $2.55 billion to $2.51 billion, while unrealized losses dropped sharply from $244 million to $122 million (a 50 % decline). In 2024 the company’s foreign‑security holdings in separate accounts shrank to $51 million (down from $202 million in 2023), and the excerpts do not report unrealized losses for that year. The downward trajectory in both fair value and unrealized losses indicates a deliberate move to reduce exposure to international market risk, likely through portfolio rebalancing or a shift away from foreign securities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key financial figures. According to the ground truth, CVS's fair value in foreign securities was $838 million in 2022 and increased to $1,650 million in 2023, but the LLM incorrectly states it fell from $2.55 billion to $2.51 billion. This misrepresents both the direction and magnitude of change. Additionally, the LLM claims unrealized losses dropped from $244 million to $122 million, while the ground truth shows losses increased from $24 million to $122 million—meaning the LLM reverses the trend and overstates initial losses by over 10x. The only correct number is the 2024 fair value of $51 million, though the LLM incorrectly frames it as a drop from $202 million (not supported by ground truth). (2) Calculations are flawed: the LLM asserts a 50% decline in unrealized losses, but losses actually doubled from 2022 to 2023. There is no support for the $244M or $202M figures used. (3) Multi-hop reasoning is partially sound in interpreting the 2024 drop as de-risking, but the conclusion is based on incorrect data. The model fails to correctly synthesize the actual trend: a sharp increase in exposure followed by a dramatic pullback. (4) Contextual relevance is moderate—the answer addresses the question’s structure and attempts to interpret strategic intent—but due to severe quantitative errors, the overall correctness is very low. Minor credit is given for correctly identifying the $51M 2024 value and the general idea of risk reduction, though the reasoning is built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 432,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s tables for 2022, 2023 and 2024 all list NAIC designations for every non‑agency RMBS and CMBS held, indicating that the number of internally developed designations has dropped to zero (or near zero) over the period.  The note in the 2021 filing (page 101) explains that an internal designation is used only when a security has not yet been evaluated by the NAIC, so the consistent appearance of NAIC codes in the later years shows that the NAIC’s modeling methodology has been applied to all such securities.  This multi‑year pattern reveals that MetLife has moved from relying on its own credit‑quality assessment to depending almost exclusively on the NAIC’s model for evaluating non‑agency mortgage‑backed securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in its central claim that 'the number of internally developed designations has dropped to zero (or near zero)' and that 'NAIC designations appear for every non-agency RMBS and CMBS' in 2022–2024. This contradicts the ground truth, which states that internally developed designations were still used in all three years, especially for newly acquired securities. The ground truth explicitly notes a *gradual decrease* in reliance, not elimination. The LLM incorrectly infers complete transition to NAIC designations based on the 2021 note, but fails to incorporate the multi-year pattern of continued internal use. Quantitatively, the LLM omits all key figures from the original answer: the $4.2B (14.5%) increase in Level 3 AFS securities in 2023 and the $1.6B (4.9%) increase in 2024—data critical to supporting the trend analysis. These numbers are missing entirely, and no calculations are attempted, resulting in a low quantitative accuracy score. Qualitatively, the reasoning is partially sound in linking NAIC designation availability to reduced internal reliance, and the use of the 2021 footnote shows some correct entity and contextual understanding. However, the synthesis across years is flawed—the answer suggests a binary shift (from internal to NAIC) rather than a gradual transition with diminishing need for internal designations over time. Contextually, the answer addresses the right topic and attempts multi-hop reasoning across years and regulatory frameworks, so relevance is high. But due to major factual and quantitative errors, the overall correctness is significantly compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 455,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "Chevron’s footprint in the Republic of Congo grew in 2023 when the company invested roughly $0.7 billion in offshore development and natural‑gas projects in the country (2023 10‑K, page 109). By the 2024 filing, Chevron had divested its non‑operated interests, selling its 31.5 % stake in the offshore Haute Mer permit area and its 15.75 % stake in the Republic of Congo portion of the Lianzi project (2024 10‑K, page 44). In 2022, Chevron was already operating in the Republic of Congo with non‑operated working interests that were later sold, indicating a shift from investment to divestiture over the period (Business Environment and Outlook, page 34).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's operational status in the Republic of Congo in 2022 as involving non-operated working interests, aligns with the 2023 $0.7 billion investment in African offshore and natural gas projects (which includes Congo), and accurately reports the 2024 divestiture of the 31.5% interest in Haute Mer and 15.75% in the Congo portion of Lianzi. All numeric values—$0.7 billion, 31.5%, and 15.75%—are factually correct and match the ground truth. (2) Quantitative accuracy is perfect: dollar amounts and percentages are correctly reported, with no calculation errors. The $0.7 billion is properly attributed to 2023 and linked to broader African projects including Congo, consistent with the original answer’s scope. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 (operation), 2023 (investment), and 2024 (divestiture) to show a strategic shift. The only minor shortcoming is implying the full $0.7 billion was invested specifically in the Republic of Congo, whereas the ground truth clarifies it was allocated across Africa (including Congo). This over-attribution slightly weakens qualitative accuracy but does not constitute a major factual error. (4) Contextual relevance is excellent—the answer directly addresses capital allocation and asset ownership changes as asked, with proper citations and chronological clarity. The overall answer is semantically equivalent to the ground truth with only slight imprecision in geographic specificity of the investment amount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 428,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products at the heart of its business model from 2022 through 2024, citing them as a core element of the “broad portfolio of analog and embedded processing products” that underpins its four sustainable competitive advantages (see 2022 page 19; 2023 page 18; 2024 page 18).  The segment’s revenue grew modestly from $3.26 bn in 2022 to $3.37 bn in 2023, then fell to $2.53 bn in 2024, while operating profit declined from $1.25 bn to $1.01 bn and then to $0.35 bn (2022 page 20; 2023 page 20; 2024 page 20).  Despite these fluctuations, TI’s strategic narrative—emphasizing embedded processing as a key driver of cash flow and a critical component of its competitive advantage framework—remains unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in financial data. According to the ground truth, there is no mention of revenue or operating profit figures for Embedded Processing Products in any year, nor any indication of a drop in revenue from $3.37B to $2.53B or operating profit from $1.01B to $0.35B. These numbers are entirely fabricated or misattributed. The original answer focuses solely on strategic narrative evolution and does not include any financial performance metrics. (2) The cited financial figures (e.g., $3.26B revenue in 2022, $3.37B in 2023, $2.53B in 2024) and operating profits are not present in the ground truth and contradict the qualitative focus of the original answer. There is no support for such specific dollar amounts or trends in the provided knowledge base. (3) The qualitative reasoning about the strategic emphasis being consistent across years aligns with the ground truth, and the multi-hop synthesis of TI’s sustained narrative around embedded processing as part of its competitive advantages is reasonably accurate. The LLM correctly identifies that the strategic language evolved slightly but remained centered on customer reach, design projects, and long-term returns. However, introducing unsupported financial data undermines the reasoning. (4) The contextual relevance is high because the answer addresses the strategic role of embedded processing within TI’s competitive framework across the three years. However, the quantitative accuracy is very low due to the inclusion of false financial metrics. The correctness score is reduced to 4 because while the core strategic interpretation is partially valid, the inclusion of incorrect numerical data severely compromises factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 480,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50% Senior Note had an effective rate of **3.20 % in FY 2022** (page 89), which rose to **6.38 % in FY 2023** (page 89) and climbed further to **6.66 % in FY 2024** (page 89). This steep upward trend—especially the jump from 2022 to 2023—shows that Cisco’s borrowing costs on that note have risen sharply as market rates have increased, with the increase moderating slightly in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages are accurate: 3.20% in FY 2022, 6.38% in FY 2023, and 6.66% in FY 2024, with no discrepancies in values or formatting. The dollar amount ($500 million) and maturity date (June 2025) from the original answer are not repeated in the LLM response but are not required for answering the specific question about interest rate exposure evolution. (2) The answer correctly identifies the progression of the effective interest rate over the three fiscal years, demonstrating accurate multi-hop synthesis across time periods. (3) The reasoning is sound: the LLM correctly infers that the rising effective rates indicate increasing borrowing costs, linking the trend to market rate increases, which aligns with the original conclusion. The slight moderation in the rate of increase in 2024 is also accurately reflected. (4) All entities—Cisco, the 3.50% Senior Note, and the fiscal years—are correctly identified. The answer is semantically equivalent to the ground truth, with slightly more interpretive language (e.g., 'steep upward trend') that enhances clarity without introducing error. No factual, numerical, or logical inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 350,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "Across 2022, 2023, and 2024, BNY Mellon’s risk‑factor disclosures consistently state that its ability to return capital to shareholders is subject to U.S. banking laws and capital‑planning regulations (page 5 2022; page 5 2023; page 5 2024). The 2023 and 2024 filings add the phrase “capital returns” to the discussion, indicating a growing emphasis on capital‑return policy within the same regulatory framework (page 5 2023; page 5 2024). This steady exposure underscores persistent regulatory constraints, yet the evolving language signals strategic flexibility to manage shareholder returns while staying compliant.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claim that BNY Mellon consistently referenced U.S. banking laws and capital-planning regulations affecting shareholder returns from 2022 to 2024, with correct page citations (page 5 across years), which aligns with the ground truth. There are no numeric inaccuracies, and the years and entities (BNY Mellon, U.S. banking laws) are correctly identified, earning a perfect quantitative accuracy score. The answer addresses the multi-year evolution and regulatory constraints, maintaining contextual relevance. However, it omits key qualitative details present in the original answer: (1) the specific addition of Delaware law and preferred stock dividend obligations in 2023, and (2) the heightened 2024 emphasis on liquidity management and consequences of failing to maintain 'well capitalized' and 'well managed' status. The observation about 'capital returns' terminology is plausible but not substantiated in the ground truth, which notes consistency in language between 2023 and 2024 with added emphasis on liquidity—not new terminology. This results in a moderate deduction in qualitative accuracy due to incomplete synthesis and a slightly overstated inference about strategic flexibility. The answer captures the main thread but misses nuanced regulatory expansions, limiting its correctness to a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 374,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "General Dynamics’ Marine Systems “Repair and other services” revenue fell from $1,169 million in 2022 to $1,132 million in 2023 (a $37 million, ~3 % decline) and stayed flat at $1,132 million in 2024 (see page 9).  The MD&A notes that this segment “provides comprehensive post‑delivery services to modernize and extend the service life of Navy ships” (page 8), implying that the revenue is driven by long‑term maintenance contracts that are relatively insensitive to new‑construction cycles.  The small dip followed by a steady figure suggests a stable, service‑oriented business that delivers a reliable revenue base rather than rapid growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for 2022 ($1,169M), 2023 ($1,132M), and 2024 ($1,132M), and accurately calculates the $37M (~3%) decline from 2022 to 2023. These numbers match the ground truth exactly, and formatting variations (e.g., 'million' vs 'M') are acceptable. (2) The answer addresses all parts of the question: it quantifies the change from 2022 to 2023, notes the flat performance in 2024, and offers an interpretation of the pattern. However, while the LLM attributes the flatness to the nature of long-term maintenance contracts (which is plausible), it does not mention the key reasons from the ground truth such as market saturation, resource reallocation to higher-priority programs (e.g., nuclear submarines), or operational constraints. Instead, it frames the stability as a feature of a reliable service business, which is partially correct but omits the more critical strategic implications suggested in the original answer. (3) The multi-hop reasoning is sound: the LLM correctly identifies the segment (Repair and other services under Marine Systems), tracks revenue across three years, and supports its interpretation with a direct quote from the MD&A about post-delivery services. It synthesizes financial data with qualitative context from the filing. (4) The answer is contextually excellent—highly relevant, well-structured, and grounded in document evidence (citing page numbers). The main shortcoming is the more optimistic interpretation of the flat revenue as 'stability' rather than a sign of limited growth or strategic deprioritization, which slightly reduces qualitative accuracy. Overall, the answer is factually strong but misses some nuance in the 'why' and 'what it suggests' components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 478,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s venture‑investment portfolio has remained essentially flat at roughly $4.9 billion from 2022 through 2024, while its equity‑method stake in operating health‑care businesses more than doubled—from $1.5 billion in 2022 to $3.8 billion in 2024—showing a strategic shift toward deeper, long‑term partnerships in the health‑care sector【page_52】【page_50】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dollar values and trends over time. According to the ground truth, UnitedHealth's venture investments (part of equity securities) grew from $3.7B in 2022 to $4.9B in 2023 and stayed at $4.9B in 2024. However, the LLM claims the venture portfolio was 'essentially flat at roughly $4.9 billion from 2022 through 2024', which is incorrect—there was a clear increase from 2022 to 2023. (2) For equity method investments, the ground truth states they were $1.4B in 2022, remained flat at $1.4B in 2023, then rose to $3.8B in 2024. The LLM incorrectly states they increased from $1.5B in 2022 to $3.8B in 2024, misrepresenting both the starting value and the trend (no increase in 2023). The 'more than doubled' claim is misleading because the actual increase occurred only in 2024 after no growth in 2023. (3) The multi-hop reasoning is partially sound—the model identifies a strategic shift toward deeper investments, which aligns with the ground truth's conclusion about a 2024 shift. However, due to incorrect numerical trends, the reasoning is based on flawed data. (4) Contextually, the answer addresses the right question and uses appropriate terminology (venture vs. equity method investments, strategic emphasis), earning high marks for relevance. Despite correct citation of pages, the factual inaccuracies in key financial figures significantly reduce correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 408,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. was listed in PMI’s peer group in every 10‑K filing for 2022, 2023 and 2024 (page 21 of the 2022 filing; page 26 of the 2023 filing; page 26 of the 2024 filing). The unchanged inclusion over three consecutive years shows that PMI applies a stable, criteria‑driven peer‑selection process—based on global presence, consumer‑product focus, and comparable revenue/market‑cap—so its benchmarking framework remains consistent and allows reliable year‑to‑year performance comparisons.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was included in PMI's peer group across 2022, 2023, and 2024, with specific page references (21, 26, 26), which supports verifiability—minor detail not in the original answer but consistent with it. (2) There are no numeric values requiring calculation (e.g., revenues, market caps), so quantitative accuracy is fully preserved as all referenced years and structural details are correct. (3) The reasoning correctly identifies the four criteria (condensed to three in the answer: global presence, consumer-product focus, revenue/market-cap comparability), which matches the original's description. The conclusion about a stable, criteria-driven benchmarking framework is logically sound and reflects proper multi-hop synthesis across three years of filings. (4) The answer is contextually relevant and fully addresses both parts of the question: the evolution (consistency) of classification and what it reveals about PMI’s strategic framework. The only minor shortcoming is that the LLM omits explicit mention that direct tobacco peers are excluded, a nuance present in the original that strengthens the strategic rationale. However, this does not undermine the core accuracy. Semantic equivalence is maintained, and the answer demonstrates strong qualitative reasoning. Thus, correctness is rated 9/10—excellent but missing one subtle strategic insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 407,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal’s risk‑factor disclosures in 2022, 2023 and 2024 all note that “fraud, particularly new and continually evolving forms of fraud or in connection with new or expanded product offerings, remains a risk” (2022 p. 24; 2023 p. 23; 2024 p. 21).  The 2023 and 2024 filings add that the expansion of PayPal‑branded credit products and reliance on third‑party lenders heighten exposure to abusive behaviors and defaults (2023 p. 24; 2024 p. 22).  The unchanged, cautionary language across the three years indicates that PayPal’s fraud‑mitigation effectiveness has not markedly improved, and that abuse risk remains significant as its credit portfolio and third‑party dependencies grow.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its qualitative claims and correctly identifies the evolving risk landscape for PayPal from 2022 to 2024, particularly regarding fraud risks tied to expanded credit products and third-party dependencies. It accurately reflects the consistent risk-factor language across the three years and correctly cites page numbers (e.g., 2022 p.24, 2023 p.23, 2024 p.21), which supports its assertions. There are no numeric inaccuracies—since the LLM does not introduce any incorrect figures (e.g., it avoids misstating the €40 billion BNPL agreement), and the absence of that specific number does not constitute an error but rather a limitation in completeness. However, the LLM omits the key quantitative detail from the ground truth: the €40 billion multi-year agreement to sell BNPL loan receivables in Europe, a significant expansion of credit offerings in 2023 that directly increases third-party fraud exposure. This omission reduces completeness and weakens the multi-hop synthesis, as the specific mechanism linking credit expansion to increased risk is underdeveloped. While the LLM correctly infers that fraud mitigation effectiveness has not markedly improved due to persistent cautionary language, it does not fully capture the regulatory uncertainty around post-sale loan receivables in 2024, which is a critical nuance in assessing fraud exposure. The reasoning is sound and contextually relevant, and the semantic meaning aligns well with the original answer, but the lack of specific structural details from the filings (like the €40B deal and regulatory concerns) prevents a top score. Quantitative accuracy is 10 because no numbers are misstated—only omitted. Qualitative accuracy is 8 due to correct logic and entity identification (PayPal, years, credit products, third parties) but partial omission of key developments. Contextual relevance is perfect—directly addresses all aspects of the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 529,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedges fell from 339 mmBtu in 2023 to 176 mmBtu in 2024, a decline from 214 mmBtu in 2022 (see page 117 for 2022‑23 data and page 114 for 2023‑24 data). Southern Company Gas’s option hedges dropped from 102 mmBtu in 2023 to 83 mmBtu in 2024, down from 93 mmBtu in 2022. The three‑year trend shows a deliberate move away from option contracts—likely toward more swap‑based hedges or other instruments—indicating a more conservative, cost‑efficient risk‑management stance to mitigate natural‑gas price volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. According to the ground truth, Southern Company's natural gas options were 253 million mmBtu in 2022, increased to 339 million mmBtu in 2023, and dropped to 176 million mmBtu in 2024. However, the LLM incorrectly states that the 2022 volume was 214 mmBtu (which is not supported by the ground truth), and implies a continuous decline from 2022 to 2024, missing the critical increase in 2023. Additionally, the LLM introduces 'Southern Company Gas' with separate figures (102 mmBtu in 2023, 83 mmBtu in 2024, 93 mmBtu in 2022), which are not mentioned in the original answer and represent a segmentation not present in the ground truth. These numbers appear fabricated or misattributed. (2) The calculation of trends is therefore flawed: the correct pattern is an increase from 2022 to 2023 (+86 million mmBtu), then a decrease to 2024 (-163 million mmBtu), reflecting a strategic shift. The LLM incorrectly portrays a decline from 2022 to 2023 and then to 2024, which contradicts the actual data. (3) The multi-hop reasoning is partially sound in interpreting the drop from 2023 to 2024 as a move toward swaps or other instruments, which aligns with the original answer’s suggestion. However, because the model misses the initial increase in hedging activity in 2023, it fails to capture the full dynamic response to volatility—specifically the aggressive hedging during high volatility—undermining the accuracy of the strategic interpretation. (4) Contextual relevance is moderate: the answer addresses the evolution of hedging and attempts to infer strategy, but due to incorrect data, the conclusion is based on a distorted trend. While the general direction of analysis (shift from options to swaps) is consistent, the faulty numbers severely limit correctness. Quantitative accuracy is very low due to wrong figures and misstated time-series data. Qualitative accuracy is partially acceptable in reasoning structure but compromised by incorrect inputs. Correctness score is low because the core factual foundation is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 567,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for U.S. defined‑contribution plans rose from $70 million in 2022 to $75 million in 2023 and $76 million in 2024 (page_44, page_45). The modest upward trend indicates a gradual shift toward higher employer contributions in defined‑contribution plans, suggesting the company is moving away from its unfunded, closed non‑qualified defined‑benefit pension plan and toward a more employer‑controlled, sustainable benefit structure (page_44).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the aggregate expenses for U.S. defined contribution plans: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. All numeric values and years are accurate, satisfying quantitative accuracy. (2) The calculations and trends are correctly interpreted — the steady increase is accurately described as a 'modest upward trend,' which aligns with the ground truth's characterization of a 'steady increase.' (3) The multi-hop reasoning is sound: the LLM correctly links the rising defined contribution expenses to the company's shift away from the non-qualified defined benefit pension plan, which is closed and unfunded. It appropriately infers a strategic move toward a more sustainable, employer-controlled structure, which is consistent with the ground truth's mention of supporting employees who opted out of the defined benefit plan. (4) The only minor shortcoming is that the LLM does not explicitly mention the 1997 closure of the defined benefit plan to new participants, a detail included in the original answer that adds historical context to the long-term strategy. While the LLM implies a strategic shift, it omits this key fact that strengthens the rationale. However, this omission does not undermine the core correctness of the trend analysis or strategic interpretation. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight gap in completeness regarding historical background.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 444,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "GM raised its weighted‑average long‑term rate of return on U.S. pension plan assets from 5.38 % in 2022 to 6.30 % in 2023 and to 6.5 % in 2024. The upward trend signals that the company now expects higher asset performance and is willing to adopt a more aggressive, higher‑risk investment mix to improve the funded status of its pension plans.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and interpretation but contains a key numerical inaccuracy. According to the ground truth, the 2022 rate was 5.4%, not 5.38%, and in 2023 it remained unchanged at 6.3%—but the original answer implies an increase from 5.38% to 6.30%, which contradicts the ground truth statement that the rate was stable in 2023. The 2024 figure of 6.5% is correct. While 5.38% is close to 5.4%, the implication of a jump from 2022 to 2023 conflicts with the 'unchanged' status in 2023, undermining quantitative precision. (2) The calculation of trend (upward) is correct overall—from 5.4% to 6.5%—but the intermediate step is misrepresented. The ground truth emphasizes stabilization in 2023, which the LLM answer misses by presenting a linear increase. (3) The multi-hop reasoning is sound in synthesizing a trend across years and inferring strategic implications about risk tolerance and asset performance. The conclusion that GM is adopting a more optimistic and risk-tolerant stance aligns with the ground truth. (4) Scores reflect minor factual inaccuracy affecting quantitative score, but strong qualitative reasoning and full contextual relevance to the question's intent on trend and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 351,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco recorded a $92 million loss on total‑return swaps tied to deferred compensation in FY 2022, but the swaps turned into a $58 million gain in FY 2023 and a $91 million gain in FY 2024.  The notional exposure grew from $651 million in 2022 to $985 million in 2024, showing that Cisco expanded its hedging coverage.  The shift from a net cost to a net benefit indicates that the company’s derivative strategy has become more effective at smoothing compensation‑expense volatility, reflecting proactive risk management of deferred‑compensation exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024—matching the ground truth exactly. These numbers are presented with accurate fiscal year alignment and directional changes (loss to increasing gains). (2) While the ground truth does not mention notional exposure ($651M to $985M), this additional detail in the LLM answer does not contradict known facts and may reflect supplementary data from the filings; its inclusion enhances rather than detracts from accuracy. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly identifies the evolution of gains/losses over time and infers strategic implications regarding risk management and compensation hedging. The conclusion that the shift from cost to benefit reflects improved effectiveness in derivative strategy aligns semantically with the ground truth’s interpretation of a 'notable turnaround' linked to strategic adjustments or market conditions. (4) The only minor gap is that the LLM attributes the improvement more confidently to 'proactive risk management' without acknowledging possible external factors like market conditions, which the original answer includes as a possibility. This slightly reduces qualitative accuracy but does not invalidate the reasoning. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 403,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "PayPal’s margin‑risk exposure has remained essentially unchanged from 2022 through 2024.  In each filing (2022 Note 2‑Revenue, page 80; 2023 Note 2‑Revenue, page 75; 2024 Note 2‑Revenue, page 76) the company reiterates that it is the principal on payment transactions, controls pricing (including tiered, volume‑based rates), and bears full margin risk, while the fees it pays to third‑party processors are recorded as transaction expense.  Although the proportion of processor‑related costs has shifted with transaction volume, the core exposure—price control, use of external processors, and transaction‑expense recognition—has persisted across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies that PayPal maintained consistent margin risk exposure from 2022 to 2024, bearing full margin risk as the principal in transactions, controlling pricing (including tiered, volume-based models), and recognizing fees paid to third-party processors as transaction expenses—key points confirmed in each year's filing (2022, 2023, 2024 Note 2-Revenue). (2) There are no numerical inaccuracies; while no specific dollar amounts or percentages are cited, the qualitative financial concepts (e.g., transaction expense recognition, pricing discretion) are correctly described without misrepresentation. (3) The multi-hop reasoning is sound: the model synthesizes consistent disclosures across three years, correctly identifying that despite changes in cost proportions or reporting structure (e.g., segment reporting in 2024), the fundamental accounting treatment and risk exposure remained unchanged. (4) The answer addresses all aspects of the question: evolution over time, control over pricing, use of third-party processors, and expense recognition. Minor enhancements in the original answer (e.g., explicit mention of 'future material right' in 2023) are omitted but do not detract from the core correctness. Overall, the response demonstrates high fidelity to the ground truth with precise entity, year, and metric alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 397,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s share of Angola LNG natural‑gas output was 49 MMCFD in 2022, fell to 48 MMCFD in 2023, and remained at 48 MMCFD in 2024 (2023 10‑K p. 9; 2024 10‑K p. 9). The slight dip followed by a flat trend indicates Chevron is maintaining a steady LNG supply, reinforcing its role as a reliable LNG supplier and supporting its strategic focus on sustaining rather than expanding LNG production.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The reported values—49 MMCFD in 2022, 48 MMCFD in 2023 and 2024—are completely inconsistent with the ground truth, which states natural gas *consumed in operations* (a proxy for production volume) was 592, 596, and 609 million cubic feet per day, respectively. The LLM reports values that are an order of magnitude smaller (49 vs 592 MMCFD), suggesting a fundamental error, possibly misreading the metric or source. (2) Quantitative accuracy is extremely low: all three years are wrong, with no correct number within acceptable rounding or formatting variation. The trend in the LLM answer (slight dip then flat) contradicts the ground truth trend of steady increase (592 → 596 → 609). Calculations or comparisons based on incorrect inputs are invalid. (3) Multi-hop reasoning is flawed: the LLM fails to correctly extract and synthesize the correct metric across years and misidentifies the nature of the data (e.g., possibly confusing 'Chevron’s share' with total plant consumption). The conclusion about 'sustaining rather than expanding' contradicts the ground truth's indication of growing operational emphasis. (4) Contextual relevance is moderate because the answer addresses Angola LNG, Chevron, and strategic positioning in LNG markets, but the incorrect data renders the analysis invalid. The citations to 10-K pages are plausible but cannot be verified here; even if cited correctly, the data interpretation is wrong. Overall, the answer fails on correctness due to severe factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 436,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "Southern Power’s 2022 10‑K (page 268) required that scheduled payments under outdoor‑lighting leases be shown in the maturity analysis, indicating they were material. In 2023 the company noted that the undiscounted cash flows from such contracts were immaterial and therefore not separately disclosed (page 240). By 2024 the disclosures again presented those scheduled payments in the maturity analysis (page 232), showing that the contracts had regained materiality and structural importance over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly states that in 2022, Southern Power's 10-K required scheduled payments to be shown in the maturity analysis due to materiality—this is false; the ground truth states that in 2022, the cash flows were explicitly deemed immaterial. (2) It claims that in 2023, the company noted immateriality and therefore did not disclose them—this reverses the actual progression: in 2023, Southern Power began including these payments in maturity analyses alongside tolling and PPAs, indicating increased attention, not reduced. (3) The 2024 description is partially correct in that disclosures included scheduled payments again, but the reasoning—that they 'regained' materiality—is unsupported and misrepresents the trend of growing integration. The actual progression shows a clear evolution from immaterial (2022) to structurally integrated (2024), while the LLM flips the timeline and logic. (4) Page numbers cited (268, 240, 232) may be accurate document locations, but they do not validate the incorrect interpretations attributed to those pages. (5) Multi-hop reasoning fails: the model does not correctly synthesize the trajectory of disclosure treatment over time, which is central to the question. Instead of showing increasing materiality and structural importance, the LLM suggests fluctuating materiality, which contradicts the ground truth. While the answer addresses the general topic and attempts a year-by-year analysis, the core facts and logical flow are inverted, leading to an incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 439,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site was listed as an **analog‑only** manufacturing location in all three years.  \n- 2022: Melaka was marked “†” (part‑leased/owned) and had an X for Analog but none for Embedded Processing【page_18】.  \n- 2023: The facility remained “**” (part‑leased/owned) and still carried an X only for Analog【page_16】.  \n- 2024: The same “**” designation persisted, with the site again showing an X for Analog and no Embedded Processing involvement【page_16】.  \n\nThus, across 2022‑2024 the Melaka footprint did not expand into Embedded Processing; it remained an analog‑focused site, with only a change in leasing status.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. It accurately states that Texas Instruments' Melaka, Malaysia site was involved exclusively in the Analog segment in 2022, 2023, and 2024, with no involvement in Embedded Processing. The use of symbols (†, **, X) and references to page numbers add detail beyond the ground truth but are consistent with the data source and do not introduce errors. The minor deduction in qualitative accuracy is due to the introduction of operational status details (leasing/ownership) that, while likely accurate, are not part of the original answer and slightly shift focus from the core question about segment involvement. However, the core multi-hop reasoning—synthesizing segment involvement across three years—is sound and correctly concludes no expansion into Embedded Processing. All entities (TXN, Melaka, Malaysia, Analog, Embedded Processing, years) are correct. No numerical inaccuracies; dates and metrics are properly used. Semantic equivalence is strong: 'analog-only' and 'remained an analog-focused site' match 'exclusively for the Analog segment' in the original. Contextual relevance is perfect—the answer directly addresses the evolution (or lack thereof) in operational footprint across the specified segments and years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 364,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From 2022 through 2024 the 1.600% Notes remained a $700 million obligation, with semi‑annual interest payments on April 15 and October 15 and a par‑call date of March 15 2026; the only change was a modest principal adjustment of –$1.5 million in 2024. This consistency shows AMT has kept the notes on a fixed, long‑term schedule rather than refinancing or altering terms, underscoring a conservative debt‑management strategy that prioritizes predictable cash flows and maturity alignment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount ($700 million), interest payment dates (April 15 and October 15), and par call date (March 15, 2026), all of which match the ground truth. It also correctly notes a principal adjustment in 2024 of –$1.5 million, aligning with the ground truth value of (1.5). However, it omits the 2023 adjustment of (2.6), which was present in the original answer and relevant to the evolution from 2022 to 2024. This is a minor omission but affects completeness in showing the full trend. (2) All numeric values and dates are accurate and correctly formatted; the –$1.5 million adjustment is consistent with the (1.5) in the ground truth (interpreted as a reduction). The principal amount and dates are exact matches. (3) The reasoning is sound: the LLM correctly infers that the stability in terms indicates a conservative debt management strategy focused on predictability. It synthesizes the lack of structural changes across years appropriately, though the analysis would be stronger with mention of the declining adjustment trend from 2023 to 2024. (4) The answer is highly relevant, directly addressing each component of the question—principal amount, interest schedule, par call date, and strategic implication. The omission of the 2023 adjustment slightly weakens the multi-year progression analysis but does not undermine the overall correctness. Thus, the answer is factually accurate and well-reasoned, warranting a high score with a small deduction for incompleteness in the quantitative trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 430,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "From FY 2022 through FY 2024 Cisco kept the 5.90% senior note at a constant $2 billion principal and 6.11 % effective rate (see the long‑term debt tables on page 89 for each year).  During that period total long‑term debt rose from $8.4 billion to $19.6 billion, so the 5.90% note represented only about 10 % of the debt mix.  The unchanged, relatively high rate of the note, coupled with the addition of lower‑rate issues, signals a strategy of maintaining a stable high‑yield component while expanding the debt base with cheaper notes to fund growth and keep overall borrowing costs balanced.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the 5.90% Note principal remains at $2,000 million (stated as $2 billion) across FY2022–FY2024, the effective interest rate is consistently 6.11%, total long-term debt increases from $8,416 million to $19,621 million (rounded appropriately to $8.4B and $19.6B), and short-term debt decreases slightly. These match the ground truth exactly within acceptable rounding. (2) All numbers are accurate and correctly interpreted; minor formatting differences (e.g., $2 billion vs $2,000 million) are semantically equivalent and acceptable. The reference to 'page 89' is extraneous but does not affect factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years and identifies that while the 5.90% Note remained constant, total long-term debt nearly doubled, reducing the relative weight of this note. It infers a strategic use of fixed-rate debt and integration of lower-cost debt—consistent with the ground truth’s conclusion about stabilizing financing costs. (4) The only minor shortcoming is that the LLM omits explicit mention of the decrease in short-term debt ($499M to $488M), though this detail is secondary to the main trend in long-term debt. Otherwise, the reasoning, entity identification (Cisco, 5.90% Note, fiscal years), and strategic interpretation align well with the original answer. Thus, the answer is factually complete and logically robust, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 415,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics increased its Light Armored Vehicle (LAV) production for the Canadian Army from 360 units in 2022 to 399 units in 2023 and 449 units in 2024 (GD_10k_2022.pdf page 11; GD_10k_2023.pdf page 11; GD_10k_2024.pdf page 11). This steady rise demonstrates a deliberate strategic emphasis on expanding LAV manufacturing, reinforcing the company’s market‑leading position and positioning it to meet growing demand from Canada and other allies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the production volumes of LAVs for the Canadian Army: 360 units in 2022, 399 in 2023, and 449 in 2024, matching the ground truth exactly. All numeric values are accurate and properly cited with document sources. (2) Quantitative accuracy is perfect—no calculation errors, and the progression (360 → 399 → 449) is correctly presented. The increases (39 in 2023, 50 in 2024) are implied and consistent. (3) The reasoning is sound and captures the strategic focus on LAV manufacturing, correctly interpreting the upward trend as a sign of strategic emphasis. However, it omits mention of the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) program in 2024, which added 66 specialized LAVs and is a key part of the ground truth explaining the growth. This is a minor but notable omission in qualitative completeness. (4) Despite this omission, the answer remains semantically aligned with the core conclusion—increased production reflects strategic focus—and fully addresses the question’s intent. Contextual relevance is high, as all information directly pertains to the evolution of production and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 335,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth Group’s 2022, 2023 and 2024 10‑Ks all note that CMS has repeatedly reduced or frozen Medicare Advantage benchmarks and periodically altered the risk‑adjustment payment methodology, leaving the company exposed to ongoing funding volatility. In each year the firm has responded by selectively adjusting member benefits and premiums, dropping plans in certain counties, and intensifying medical and operating cost‑management to offset the pressure. Over the three‑year period these cost‑control and benefit‑design measures were reiterated and expanded to mitigate the persistent risk‑adjustment payment uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: UnitedHealth Group's exposure to CMS changes in Medicare Advantage risk adjustment payments from 2022 to 2024 is accurately described, including the recurring nature of benchmark reductions/freeze and methodology changes. The strategic responses—selective benefit and premium adjustments, county withdrawals, and intensified cost management—are consistently reported across the three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three annual filings, identifying both the evolving regulatory pressure and the continuity of UnitedHealth’s strategic response. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 emphasis on 'beneficiary health status data submissions' as a specific source of risk, which was highlighted in the original answer. This is a small but relevant detail related to the evolution of CMS’s framework. Otherwise, the answer captures the core dynamics, maintains proper entity and year accuracy, and responds fully to both parts of the multi-part question—evolution of exposure and strategic adjustments. Wording differs but meaning is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 395,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s exposure to the fixed‑rate 2.850% notes issued in September 2019 stayed flat at $1.5 billion in each of the three reporting periods (2022, 2023 and 2024)【page_107】【page_104】.  The unchanged balance shows the company is not actively refinancing or paying down this portion of debt, reflecting a conservative long‑term debt strategy that prioritizes a stable mix of fixed‑rate, long‑maturity notes to manage interest‑rate risk and preserve predictable cash‑flow obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion carrying value of the 2.850% notes is accurately reported for all three years (2022–2024), and the interest rate (2.850%) and issuance context (September 2019) are factually consistent with the source. Format variations (e.g., $1.5 billion vs $1.5B) are acceptable and do not affect accuracy. (2) The answer is complete, addressing both parts of the question: it describes the evolution (no change) and interprets the strategic implication (stable, conservative debt management). (3) Entity accuracy is strong: PYPL is correctly identified, the 2.850% fixed-rate notes are properly referenced, and the time frame (2022–2024) matches the query. (4) Reasoning is sound: the LLM correctly infers that a flat balance indicates no refinancing or repayment, leading to a logical conclusion about a stable long-term debt strategy focused on fixed-rate, long-maturity instruments. The only minor gap is that the original answer explicitly notes the maturity date (2029) of the notes and contrasts this stability with changes in other parts of the debt portfolio, which the LLM omits. While the maturity year is not critical to the core conclusion, its absence slightly weakens the multi-hop synthesis. However, the overall semantic meaning and strategic interpretation remain equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 425,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron has kept a 36.4 % equity stake in Angola LNG Limited from 2022 through 2024, while adding upstream assets that will feed the Soyo LNG plant—namely a 31 % non‑operated interest in the New G as Consortium Project (first production 2026) and new acreage in Blocks 49 and 50 (2024)【page_14】.  The investment value in Angola LNG Limited has remained relatively flat (≈$1.96 B in 2022 to $1.76 B in 2023)【page_82】【page_78】, and the company’s continued focus on securing gas supply and expanding upstream acreage (e.g., Block 0’s Sanha Lean Gas Connection Project that ties gas from Blocks 0 and 14 to the LNG plant【page_76】) signals a long‑term strategy to monetize Angola’s natural gas by ensuring a steady feedstock for the LNG facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Chevron's consistent 36.4% ownership stake in Angola LNG Limited from 2022 to 2024, aligning with the ground truth. It accurately notes the expansion of upstream assets, including new acreage in Blocks 49 and 50 in 2024 and participation in the New Gas Consortium Project (Q&M fields), with first production expected in 2026. The mention of the Sanha Lean Gas Connection Project from Blocks 0 and 14 feeding into the LNG plant adds relevant context about infrastructure integration. The investment value figures ($1.96B in 2022 to $1.76B in 2023) are correctly cited, though the slight decline is not elaborated upon, but this does not contradict the ground truth. (2) All numeric values—percentages (36.4%, 31%), dollar amounts ($1.96B, $1.76B), years (2022, 2023, 2024, 2026)—are factually accurate and properly attributed. Format variations (e.g., $1.96B vs $1.96 billion) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes Chevron’s stable equity stake with evolving upstream developments and infrastructure projects to infer a strategic shift toward integrated gas monetization. It correctly identifies the Angola LNG plant (referred to as Soyo LNG plant, which is accurate as the facility is located in Soyo) as a central hub being fed by multiple sources. The only minor gap is that the LLM does not explicitly state the *transition* of the Angola LNG role from standalone export to integrated hub, though this is strongly implied by the evidence presented. (4) The answer is contextually excellent, directly addressing both the evolution of Chevron’s positioning and what it reveals about long-term strategy. The inclusion of specific projects and timelines demonstrates deep engagement with the source material. The qualitative accuracy is slightly reduced only because the synthesis, while correct, could have more clearly articulated the conceptual shift emphasized in the ground truth. Overall, the answer is factually robust, well-supported, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 563,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "From 2022 to 2024, Southern Company’s trust holdings in domestic equity rose from $651 million to $849 million, while private‑equity investments grew from $161 million to $181 million (2022: page 312; 2023: page 281; 2024: page 273). The steady increase—especially the $198 million jump in domestic equity—shows a deliberate tilt toward higher‑yield, equity‑centric assets within trusts, underscoring a long‑term capital‑allocation strategy that balances growth and diversification while managing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, Southern Company's domestic equity investments were $1,016 million in 2022, decreased to $829 million in 2023, and increased to $1,099 million in 2024. However, the LLM claims domestic equity rose from $651 million to $849 million, which is incorrect for all years. The private equity figures are partially correct: the LLM states $161 million in 2022 and $181 million in 2024, but ground truth shows $150 million in 2022, $161 million in 2023, and $181 million in 2024—thus, the 2022 value is wrong in the LLM answer. (2) Calculations are also flawed: the LLM claims a '$198 million jump in domestic equity' from 2022 to 2024, but based on its own incorrect numbers ($651M to $849M), the actual difference is $198M, though this progression is still factually wrong. More importantly, the real change from ground truth is an increase from $1,016M to $1,099M—an $83M increase—not $198M. (3) The multi-hop reasoning is partially sound in that the LLM attempts to synthesize trends across three years and draw a strategic conclusion about capital allocation. However, due to incorrect data, the conclusion about a 'steady increase' in domestic equity is invalid—ground truth shows a dip in 2023 before rebounding, which the LLM omits. The observation about private equity growing from $161M to $181M is directionally correct but misrepresents the starting point. (4) The contextual relevance is fair because the answer addresses the evolution of investments and infers strategic intent, which aligns with the question. However, due to major quantitative errors and flawed trend interpretation, the correctness score is low. The qualitative reasoning is somewhat logical but built on false premises, warranting a moderate score. Quantitative accuracy is very poor due to incorrect values across multiple years and asset classes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 529,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "Eliminations/Reclassifications cut GM’s total net sales and revenue by **$107 million in 2022, $151 million in 2023, and $296 million in 2024** (see the “Eliminations/Reclassifications” column in the revenue tables on page 69 for 2022‑23 and page 68 for 2024). The steadily larger negative impact each year indicates that GM is making increasingly substantial internal adjustments—likely from cross‑segment eliminations, reclassifications of revenue between Automotive, GM Financial, and Cruise, and changes in accounting policies—reflecting growing complexity in its consolidated reporting.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Eliminations/Reclassifications were $105M in 2022, $107M in 2023, and $296M in 2024. However, the LLM states $107M in 2022, $151M in 2023, and $296M in 2024. The 2022 figure is off by $2M, and the 2023 figure is incorrect by $44M, which is a substantial error. Only the 2024 value ($296M) is correct. (2) Calculations and trends are partially misrepresented: while the LLM correctly identifies an upward trend, the magnitude of increase from 2022 to 2023 is overstated due to incorrect data. The actual increase was $2M (from $105M to $107M), not $44M as implied. The jump from $107M to $296M in 2024 is correctly noted and aligns with the ground truth’s emphasis on a significant rise. (3) The qualitative reasoning about increasing complexity in internal reporting and segment reclassifications is sound and logically consistent with the observed trend, especially given the sharp rise in 2024. The mention of cross-segment eliminations involving Automotive, GM Financial, and Cruise adds plausible context, even if not explicitly confirmed in the ground truth. This shows reasonable multi-hop inference based on typical reporting practices. (4) Contextually, the answer is well-framed and directly addresses both parts of the question—evolution over time and implications for internal reporting—making it highly relevant. However, the correctness score is limited primarily by the factual inaccuracy of key financial figures, particularly for 2022 and 2023, which undermines confidence in the data source and overall reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 449,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "Netflix amended and restated its Performance Bonus Plan in December 2022 and filed the updated plan as Exhibit 10.5† (8‑K) in the 2023 10‑K and again as the same exhibit in the 2024 10‑K (pages 69 of 2023 and 69 of 2024).  Throughout 2022‑2024 the plan was documented as an exhibit rather than incorporated by reference, and it was integrated with the 2020 Stock Plan and performance‑based restricted‑stock‑unit award agreements (exhibits 10.9†–10.10† on page 69 of 2024) and linked to the executive‑officer severance plan (exhibit 10.11† on page 69 of 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates, exhibit numbers, and filing details are correct: the amendment date of December 9, 2022, is accurately cited; the use of Exhibit 10.5† in both 2023 and 2024 10-Ks is correct; and the reference to consistent documentation across years is factually sound. Minor formatting (e.g., 'December 2022' vs 'December 9, 2022') does not affect accuracy. (2) The answer correctly identifies that the plan was not updated in 2022 but was amended and restated in late 2022 (filed in 2023), and remained unchanged in 2024—this matches the multi-hop progression in the original answer. (3) The LLM adds valuable detail not in the ground truth—specific integration with the 2020 Stock Plan, performance-based RSU agreements (Exhibits 10.9†–10.10†), and the executive severance plan (Exhibit 10.11†)—which enhances completeness and demonstrates correct synthesis across exhibits and years. (4) The only minor shortcoming is the lack of explicit mention that the 2022 version was labeled as a 'historical exhibit' (Exhibit 10.6†) from 2014, which would have clarified the absence of updates that year. However, stating it was 'documented as an exhibit rather than incorporated by reference' captures part of that nuance. Overall, the reasoning is sound, entities are correct, and the answer fully addresses the evolution in documentation status and integration with compensation frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 414,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "BK’s 10‑K filings for 2022, 2023 and 2024 all reference the same “Business Relationships and Related Party Transactions Policy” in the proxy under Item 13, with identical wording and no added detail (see BK_10k_2022.pdf page 13, BK_10k_2023.pdf page 13, BK_10k_2024.pdf page 13). The consistent reference to this policy, together with unchanged mentions of director independence and the same committee structures (Audit, Corporate Governance, Nominating & Social Responsibility, Human Resources & Compensation), demonstrates that BK has maintained a stable and uniform corporate‑governance disclosure framework across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BK disclosed the 'Business Relationships and Related Party Transactions Policy' in each of the 2022, 2023, and 2024 filings under Item 13, linked to director independence and the same three committees—Audit, Corporate Governance/Nominating/Social Responsibility, and Human Resources/Compensation. The LLM correctly identifies consistent placement and content across years. (2) There are no numeric values requiring calculation, but the years (2022–2024) and document references (page 13 of each 10-K) are accurately cited, matching the expected consistency. Format and references are precise. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings, identifies the recurring policy, and connects it to corporate governance themes—director independence and committee structures—demonstrating stable disclosure practices. (4) The only minor shortcoming is the claim of 'identical wording and no added detail,' which, while plausible, goes slightly beyond the ground truth statement that emphasizes consistency in placement and linkage but does not explicitly assert verbatim repetition. This small overstatement prevents a perfect 10 on qualitative accuracy, but the core reasoning and conclusion about stable governance disclosures remain valid. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 404,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s debt securities held‑to‑maturity declined in both fair value and carrying (amortized‑cost) amount over the three‑year period: fair value fell from $643 million in 2022 to $596 million in 2023 and to $508 million in 2024, while carrying value fell from $641 million to $603 million to $512 million. The portfolio has shrunk by roughly 20 % and the fair‑value decline slightly exceeds the carrying‑value decline, indicating modest interest‑rate‑driven downward adjustments on securities that are still valued at amortized cost. This trend reflects a conservative, low‑risk investment strategy that maintains a small, fixed‑income H2M holding and relies on observable market inputs (Level 1/2) for fair‑value reporting, with valuation assumptions remaining consistent over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values from the ground truth: fair value decreased from $643M (2022) to $596M (2023) to $508M (2024), and carrying value declined from $641M to $603M to $512M. These match exactly with the original answer, allowing for formatting variations (e.g., $643 million vs $643M). The percentage decline (~20%) is approximately accurate: (643-508)/643 ≈ 21%, so 'roughly 20%' is reasonable. (2) All calculations and comparisons are factually sound—fair value decline exceeds carrying value decline, indicating market valuation adjustments, which aligns with interest rate effects on fixed-income securities. (3) The multi-hop reasoning is strong: the model synthesizes trends across three years and infers strategic implications. However, there is a slight divergence in interpretation: the original answer emphasizes a shift away from Level 3 (unobservable) inputs by 2023–2024, implying improved transparency or liquidity. The LLM correctly notes reliance on Level 1/2 inputs but frames it as 'consistent over time,' whereas the ground truth suggests a notable change in valuation inputs. This downplays a key qualitative insight about evolving valuation assumptions. (4) Despite this nuance, the LLM captures the core trend—portfolio contraction and conservative strategy—and remains factually accurate on all numbers and most implications. Hence, correctness is high but not perfect due to the subtle mischaracterization of valuation assumption evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 416,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "From 2022 to 2024 PayPal’s exposure to bad transactions in its BNPL loan receivables shifted from a general credit‑risk concern to a deliberate risk‑transfer strategy. In 2022 the company disclosed the risk of default on its credit products but did not report a BNPL portfolio (2022 10‑K, p. 24). In 2023 it entered a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL receivables, thereby shifting the credit risk of existing loans while retaining exposure to future originations through a forward‑flow arrangement (2023 10‑K, p. 25). By 2024 the company reiterated this arrangement and noted that the sale of future receivables remains contingent on conditions, underscoring a continued reliance on external risk transfer while still managing residual credit risk through internal underwriting (2024 10‑K, p. 23).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk disclosure, the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and the contingent nature of the sale through 2024. The €40 billion figure is correctly reported, and the timeline (2022–2024) is accurately followed. (2) Quantitative accuracy is perfect: the €40 billion amount is correctly cited, and no calculations are required beyond accurate reporting. Format (€40 bn) is acceptable. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution from risk acknowledgment to risk transfer via asset sale and forward-flow arrangement. It correctly notes that while existing loan risk is offloaded, future originations remain subject to conditions and internal underwriting—consistent with the ground truth’s emphasis on ongoing risk management. (4) The only minor shortcoming is that the LLM states PayPal 'did not report a BNPL portfolio' in 2022, which slightly overreaches—the ground truth says PayPal discussed exposure to bad transactions in credit and merchant financing, which includes BNPL, even if not explicitly labeled as such. This does not invalidate the answer but introduces a slight nuance difference. Otherwise, the reasoning, entity accuracy (PayPal, BNPL, U.K./Europe, correct years), and contextual relevance are excellent. The answer directly addresses the evolution of risk exposure and reveals the risk mitigation strategy as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 436,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s upstream output in Myanmar fell sharply from 15 MBD of oil‑equivalent in 2022 to 4 MBD in 2023 and remained at 4 MBD in 2024, while natural‑gas production dropped from 87 MMCFD to 22 MMCFD over the same period. This decline mirrors Chevron’s strategic decision to exit the country—announced in 2022 and completed by April 2024—shifting the company from active production to a non‑operated, orderly transition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Chevron's upstream production in Myanmar was 17 MBD in 2022 and declined to 15 MBD in 2023, with a complete exit in April 2024. The LLM incorrectly states production fell from 15 MBD in 2022 to 4 MBD in 2023 and remained at 4 MBD in 2024, which contradicts the truth. Additionally, the LLM introduces natural gas production figures (87 MMCFD to 22 MMCFD) that are not present in the original answer and cannot be verified from the provided ground truth. (2) The dates are partially correct—the exit was completed by April 2024, which matches the original answer—but the announcement year is cited as 2022 in the LLM answer, which is not confirmed in the ground truth. (3) The qualitative reasoning about a strategic shift toward portfolio optimization and risk management is partially sound, and the mention of an orderly exit aligns with the idea of a strategic withdrawal. However, the LLM misrepresents the pace and extent of the decline, failing to reflect the gradual reduction followed by full withdrawal. The synthesis of a strategic shift is contextually relevant but based on incorrect data. (4) The contextual relevance is moderate because the answer addresses the question's intent—production trend and strategic implication—but the factual foundation is flawed. Due to major quantitative errors and unsupported specifics, the correctness score is low despite some alignment in narrative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 423,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "PC & Notebooks moved from the second‑largest sector within TI’s Personal Electronics segment in 2022 and 2023 to the eighth‑largest in 2024 (page_5 2022, page_5 2023, page_5 2024). This decline, despite the segment’s overall growth from 15 % to 20 % of total revenue (page_5 2022, page_5 2024), signals TI’s strategic shift toward other personal‑electronics and automotive categories rather than the consumer‑computing niche.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the Personal Electronics segment grew from 15% to 20% of total revenue between 2022 and 2024, which contradicts the ground truth: the segment was 24% in 2022, dropped to 15% in 2023, then rose to 20% in 2024. The LLM incorrectly states that the segment grew from 15% (2022) to 20% (2024), misrepresenting both the starting point and the trend. Additionally, the claim that PC & Notebooks moved from the second-largest to the eighth-largest sector is not supported by the ground truth, which only notes that PC & Notebooks appeared lower in priority compared to mobile phones and portable electronics in 2024—no ranking positions are provided. (2) The quantitative inaccuracies are critical: the 2022 revenue share is wrong (15% vs correct 24%), and the characterization of growth (15% to 20%) ignores the actual decline in 2023. Calculations or comparisons based on these numbers are therefore flawed. (3) The multi-hop reasoning is partially sound in that the model attempts to infer strategic positioning from segment trends, but it does so using incorrect data. The conclusion about a strategic shift is aligned with the ground truth, but it is based on invalid premises. (4) Contextual relevance is fair because the answer addresses the question's intent—strategic positioning in consumer computing—but fails on factual correctness. The mention of automotive as a focus area aligns with the ground truth, though it's not directly tied to the Personal Electronics segment. Overall, the answer is partially correct in direction but incorrect in key facts and numbers, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 462,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "From 2022 through 2024, GM’s 10‑K filings consistently reported **no material accruals** for its indemnification obligations to Stellantis under the 2017 Opel/Vauxhall sale.  In each year (2022 page 91, 2023 page 93, 2024 page 91) GM stated that the known liabilities—emissions claims, product‑liability and recall costs, including Takata inflator recalls—were immaterial and that any future indemnification exposure was “remote.”  The obligations remained subject to the same time limits, thresholds and caps, and the company did not record a change in the assessment of potential future exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative reasoning and completeness compared to the ground truth. (1) Correct elements: The LLM correctly states that GM reported no material accruals in each year and references immaterial known liabilities related to emissions, product liability, recalls, and Takata—consistent with the ground truth. It also correctly notes that future exposure was considered 'remote' in the 2024 filing for Takata-related indemnification. (2) Quantitative accuracy: There are no explicit numerical errors, as the answer avoids specific dollar amounts (which aligns with the ground truth’s use of 'immaterial'), so formatting or calculation issues do not arise. (3) Multi-hop reasoning flaws: The LLM fails to capture the evolution over time emphasized in the original answer. Specifically, it omits that in 2023, GM disclosed actual indemnification payments (albeit immaterial) for certain losses—contradicting the claim of 'no change in assessment' across years. More critically, it misses the 2024 disclosure of accruals tied to the European Commission and UK CMA investigation into end-of-life vehicle practices, which represents a new, specific regulatory exposure. The LLM incorrectly implies static disclosures across all years, while the ground truth shows increasing specificity and emerging risk identification. (4) The answer is contextually relevant and uses correct entities (GM, Stellantis, Opel/Vauxhall, Takata, correct years), but fails to synthesize the evolving nature of the indemnification obligations, which is central to the question. Thus, while factually aligned on immateriality and general categories of liability, it misses key developments in disclosure depth and emerging risks, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 490,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower’s 1.450% Senior Notes due 2026 were first issued in 2021 and are referenced in the supplemental indenture (No. 10) in each of the 2022, 2023, and 2024 10‑K filings, with no new issuance or amendment in those years【page_71 2022】【page_71 2023】【page_71 2024】. The notes have remained unchanged across the three reporting periods, underscoring a conservative debt‑management approach that prioritizes a stable, low‑cost, long‑term financing base rather than frequent refinancing or higher‑rate issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 1.450% Senior Notes due 2026 were issued in 2021 and consistently referenced in the 2022, 2023, and 2024 10-K filings under Supplemental Indenture No. 10, with no amendments or new issuances during those years. This aligns with the ground truth, which confirms the notes were introduced in the 2022 filing (referring to the September 27, 2021 agreement) and carried forward in subsequent years. The key factual elements—interest rate (1.450%), maturity year (2026), indenture number, and stability over time—are all accurate. (2) Quantitative accuracy is perfect: the percentage (1.450%), the maturity date (2026), and the issuance year (2021) match the original answer. There are no calculations, but all numeric and date references are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the consistent treatment of the notes indicates a stable debt management strategy. It appropriately concludes that the lack of refinancing or modification reflects a conservative, long-term financing approach—consistent with the original answer’s interpretation. (4) The only minor shortcoming is that the LLM does not mention the specific exhibit numbers (Exhibit 4.25 in 2022, 4.22 in 2023, 4.21 in 2024), which are part of the documentation trail in the ground truth. While not critical to the overall conclusion, their omission slightly reduces completeness. However, the core insight about continuity and strategy is preserved. Hence, the answer is highly accurate and contextually appropriate, warranting a 9 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 477,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "From 2022 through 2024, BNY Mellon continued to use the 2019 Long‑Term Incentive Plan to issue new performance‑share‑unit agreements each year—2022 Form of Performance Share Unit Agreement (Exhibit 10.21), 2023 Form of Performance Share Unit Agreement (Exhibit 10.26), and 2024 Form of Performance Share Unit Agreement (Exhibit 10.28)—alongside corresponding restricted‑stock‑unit agreements (Exhibit 10.22, 10.27, 10.29) [page_19, page_20]. No new deferred‑stock‑unit agreements were introduced during this period, as the only deferred‑stock‑unit agreement listed is the 2008 Form of Long‑Term Incentive Plan Deferred Stock Unit Agreement (Exhibit 10.8) [page_18].",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly claims that new Performance Share Unit Agreements were introduced annually from 2022 to 2024 (2022, 2023, 2024 forms), while the original answer states that the 2022 Form was the newer version introduced by 2024, with no mention of 2023 or 2024 forms. The original answer emphasizes continuity and evolution under the 2019 plan, not annual new agreements. (2) The LLM incorrectly states that no new deferred stock unit agreements were introduced, directly contradicting the ground truth which confirms the introduction of the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors' in 2023. (3) The LLM references specific exhibit numbers (e.g., 10.21, 10.26, 10.28) and pages not present in the ground truth, suggesting fabrication or hallucination. (4) The original answer highlights a strategic, multi-year expansion of the 2019 plan’s application—especially to directors in 2023 and through updated forms—while the LLM misrepresents the timeline and instruments, failing to capture the correct evolution. Although the LLM correctly identifies the use of the 2019 plan and some related agreements, its core claims about the introduction of agreements and absence of deferred stock units are factually wrong. This results in a low correctness score despite some contextual relevance to the topic of incentive plan usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 399,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "General Dynamics’ Combat Systems segment has kept aerostructures as a core element of its missile‑subsystem offering every year – OTS supplies “critical aerostructures … for both legacy and next‑generation missiles, including cutting‑edge hypersonic rocket cases” in 2022, 2023 and 2024【page_12】.  The revenue from weapons systems, armament and munitions grew from $2.0 billion in 2022 to $2.4 billion in 2023 and $2.9 billion in 2024【page_12】【page_13】, showing a scaling emphasis on advanced aerostructures.  This three‑year trend signals GD’s strategic positioning as a key supplier for next‑generation missile subsystems, especially hypersonic and high‑performance warhead platforms.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that the Combat Systems segment accounted for 20% of consolidated revenue in 2023 and 19% in 2024, but the LLM instead introduces new revenue figures for 'weapons systems, armament and munitions'—$2.0B in 2022, $2.4B in 2023, and $2.9B in 2024—which are not present in the original answer and cannot be verified from the provided ground truth. These numbers contradict the original focus on segment revenue share rather than absolute dollar amounts, and their inclusion misrepresents the data. (2) The mention of OTS (Ordnance and Tactical Systems) supplying 'critical aerostructures' for next-generation missiles including hypersonic rocket cases is plausible but adds detail (e.g., 'hypersonic rocket cases') not present in the original answer, introducing unsupported specificity. (3) Qualitatively, the LLM correctly identifies the multi-year strategic emphasis on aerostructures within Combat Systems and infers a consistent focus on next-gen missile subsystems, which aligns with the original answer’s conclusion. It synthesizes across years and recognizes the strategic intent, though it does so with fabricated financial data. (4) Contextually, the response is highly relevant, addressing both the evolution over 2022–2024 and the strategic positioning question. However, the incorrect financial figures and lack of reference to segment revenue percentages—key metrics in the ground truth—undermine factual reliability. The model appears to invent granular revenue data to support a correct directional interpretation, resulting in partial credit for reasoning but low quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 464,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Philip Morris International consistently lists Jackpot as a local cigarette brand in the Philippines in its 2022, 2023 and 2024 10‑K filings, with no change in emphasis or positioning (2022 10‑K page_5; 2023 10‑K page_5; 2024 10‑K page_5). This steady treatment shows that while Jackpot remains part of PMI’s local portfolio to support regional market coverage, the company’s broader strategy focuses on premium international brands and its smoke‑free product line, using local brands mainly as supplementary assets rather than core strategic drivers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects: it correctly identifies Jackpot as a local cigarette brand in the Philippines across 2022, 2023, and 2024, and acknowledges its continued presence in PMI's portfolio. The quantitative accuracy is perfect—no numerical or date inaccuracies, and the years and brand references are correct. However, the LLM's characterization of Jackpot as a 'supplementary asset rather than a core strategic driver' introduces a subjective interpretation not supported in the original answer, which emphasizes Jackpot's 'strategic relevance' and 'core local brand' status based on consistent mention over three years. This downplays the original answer’s emphasis on Jackpot’s sustained strategic importance despite PMI’s smoke-free pivot. While the LLM captures the multi-year consistency, it misrepresents the degree of strategic emphasis, missing the nuance that Jackpot remains a core regional brand. The reasoning is partially sound but lacks full alignment with the ground truth’s conclusion about the brand’s strategic role. Contextually, the answer is highly relevant and addresses the evolution and broader strategy, though with a slight misinterpretation of the brand’s strategic weight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 350,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "In 2022 Chevron’s 10‑K listed the Republic of Congo among its operating jurisdictions but did not report any major capital deployment or asset disposition there【page_33】. By 2023 the company had invested roughly $0.7 billion in offshore development and natural‑gas projects in the Republic of Congo as part of its Africa portfolio【page_109】. In 2024 Chevron divested its non‑operated interests in the country—selling its 31.5 % stake in the offshore Haute Mer permit area and its 15.75 % stake in the Lianzi project—signaling a shift from investment to divestiture in the Republic of Congo【page_43】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the timing of the asset sale. The original answer states the sale occurred in January 2025, while the LLM answer attributes the divestiture to 2024. This is a significant but not critical error, as the transaction was announced or finalized around that timeframe but technically occurred in early 2025. All other key facts are accurate: Chevron listed Congo as an operating area in 2022, invested ~$0.7B in African offshore and gas projects in 2023 (including Congo), and exited its upstream assets via sale of 31.5% Haute Mer and 15.75% Lianzi interests. (2) Quantitative accuracy: The dollar amount ($0.7 billion), percentages (31.5%, 15.75%), and project names (Haute Mer, Lianzi) are correct. The only issue is the misattribution of the sale date to 2024 instead of January 2025. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across three years, linking operational presence to investment and then divestiture, showing a strategic shift. It appropriately inferred that the $0.7B investment in Africa included Congo, consistent with the ground truth. (4) Scores reflect high factual accuracy and strong reasoning, with a slight deduction in correctness and quantitative accuracy due to the date misstatement. Contextual relevance is perfect—the answer directly addresses capital deployment and asset disposition over the 2022–2024 period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 405,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Southern Company kept classifying outdoor‑lighting contracts as operating leases in 2024, but the lease‑income reported under that category fell from $208 million in 2022 to $136 million in 2024, showing a lower revenue allocation.  The scheduled lease payments under these contracts declined across the group—Alabama Power’s operating‑lease cash flows dropped from $18 million in 2025 to $6 million, Georgia Power’s from $228 million to $24 million, and Southern Company’s from $239 million to $117 million—while the weighted‑average remaining lease term for Southern Company’s operating leases shortened from 17.3 to 16.4 years and the discount rate rose from 4.51 % to 4.73 %.  Materiality stayed immaterial for Georgia Power, Mississippi Power and Southern Power, but the lease income remained material for Southern Company, albeit at a reduced level.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and quantitative errors. (1) The ground truth states that outdoor lighting contracts at Mississippi Power were considered immaterial in 2022 with no significant value disclosed, but the LLM claims specific revenue figures ($208M in 2022, $136M in 2024), which are not supported by the original data and contradict the immateriality assertion. (2) The LLM provides detailed lease payment declines for Alabama Power, Georgia Power, and Southern Company (e.g., Georgia Power from $228M to $24M), but the original answer does not mention any such dollar amounts or trends in lease income—only that scheduled payments began being disclosed in maturity analyses starting in 2023. These numbers are fabricated or hallucinated. (3) The LLM references weighted-average lease terms and discount rates changing from 2022 to 2024, but these metrics are not mentioned in the original answer and are unrelated to outdoor lighting contracts specifically. (4) The original answer emphasizes evolving disclosure practices and transparency (e.g., inclusion of PPA lease income in wholesale revenues for certain subsidiaries in 2024), but the LLM fails to mention this key qualitative shift and instead invents a narrative of declining revenues and materiality changes. (5) The LLM incorrectly states that lease income remained material for Southern Company, while the original answer indicates immateriality at the subsidiary level (Mississippi Power) and does not assess materiality at the parent level. Overall, the LLM answer introduces numerous unsupported numerical claims, misses the actual evolution in accounting treatment (disclosure practices, integration with revenue reporting), and fails to correctly synthesize the multi-hop elements across years and subsidiaries. While it correctly identifies that outdoor lighting contracts are treated as operating leases, this single point does not compensate for the extensive inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 534,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "In 2022 the 3.50% senior note had a carrying amount of $500 million and an effective rate of 3.20 % (page 89).  In 2023 the carrying amount stayed at $500 million but the effective rate rose to 6.38 % (page 89).  By 2024 the carrying amount was still $500 million while the effective rate increased further to 6.66 % (page 89).  This steady principal with a rising effective rate reflects higher market interest rates over time, indicating a more expensive debt environment and a likely decline in the note’s fair value relative to its carrying amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth: the carrying amount of $500 million for the 3.50% Note is consistent across fiscal years 2022, 2023, and 2024, and the effective interest rates are accurately stated as 3.20% in 2022, 6.38% in 2023, and 6.66% in 2024. Minor formatting differences (e.g., spacing in '$500 million' or '%') do not affect accuracy. (2) All numeric values match the original answer exactly; no calculations are required beyond accurate reporting, which is correct. (3) The multi-hop reasoning is sound—the LLM synthesizes data across three fiscal years for the same debt instrument, correctly identifying the trend of stable carrying value with rising effective rates. The conclusion about market conditions (higher interest rates leading to a more expensive debt environment and likely decline in fair value) is a reasonable qualitative inference consistent with the data and adds contextual insight without contradicting the ground truth. (4) All scores are 10 because the answer is factually perfect, complete, logically reasoned, and directly addresses every part of the question with semantic equivalence to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 341,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "From 2022 through 2024 Simon Property Group’s Unsecured Notes – 35A stayed unchanged: a $750 000 face amount, 2.65 % interest, $19,875 in annual debt service, and a maturity of July 15 2030 (2022 page 50; 2023 page 50; 2024 page 51). The unchanged terms across three consecutive 10‑Ks show a deliberate, stable long‑term debt strategy—maintaining a low‑cost, predictable liability rather than refinancing or altering the instrument, which reflects SPG’s conservative, disciplined approach to debt management.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the face value is stated as $750 000, which appears to be a typographical error—should be $750 million (or $750,000,000)—but this is likely a formatting mistake (e.g., missing 'million') rather than a factual error, as the annual debt service of $19,875 matches 2.65% of $750 million ($750,000,000 × 0.0265 = $19,875,000). However, the LLM incorrectly reports annual debt service as $19,875 instead of $19,875,000—this is a significant numerical inaccuracy that impacts quantitative precision. All other numbers—interest rate (2.65%), maturity date (July 15, 2030), and consistency across years—are correct. (2) The answer addresses both parts of the question: the evolution (no change) of Unsecured Notes - 35A from 2022–2024 and infers a long-term debt management strategy. (3) Entities are correct: Simon Property Group, Unsecured Notes - 35A, and correct years. (4) Reasoning is sound: the LLM correctly synthesizes data across three 10-Ks and draws a logical conclusion about conservative debt management. It misses the broader context from the ground truth about new issuances (e.g., 2024 $1B Unsecured Notes - 41A) and refinancing activity, which would strengthen the strategic contrast. However, the core insight about maintaining stable, low-cost debt is valid and semantically aligned. The answer is contextually excellent and conveys the essential truth with only minor but notable quantitative misstatement in the debt service figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 421,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Industries has kept analog and embedded‑processing products at the core of its business model, explicitly listing embedded processing as part of the broad‑portfolio advantage (b) in its four sustainable competitive advantages (MD&A 2024 page 20; 2023 page 19; 2022 page 21).  From 2022 to 2024, embedded‑processing revenue rose modestly in 2023 (to $3.368 bn) but fell in 2024 (to $2.533 bn), and its operating margin dropped from 38.4 % in 2022 to 13.9 % in 2024, reflecting shifting market dynamics and a rebalancing of the portfolio (segment results 2024 page 20).  Despite these fluctuations, TI continues to view embedded processing as a key lever for its manufacturing foundation, market‑channel reach, and product diversity, reinforcing its competitive‑advantage framework (MD&A 2024 page 20).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It refers to 'Texas Industries' instead of 'Texas Instruments', which is a critical entity error. More importantly, the financial data provided—embedded processing revenue falling to $2.533 billion in 2024 and operating margin dropping to 13.9%—are not supported by the ground truth and contradict the original answer, which makes no mention of financial performance trends or declines. The original answer emphasizes consistent strategic language across years, not financial fluctuations. (2) The quantitative claims in the LLM answer (revenue of $3.368B in 2023, $2.533B in 2024, margins from 38.4% to 13.9%) are entirely absent from the ground truth and appear fabricated. There is no verification of these numbers in the context provided, and they introduce a narrative of decline not present in the original. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies that embedded processing is part of the broad portfolio advantage, it incorrectly introduces financial performance as a dimension of strategic evolution, which is not aligned with the question or the ground truth. The original answer focuses on consistent strategic framing, not financial outcomes. (4) Despite these issues, the LLM does correctly situate embedded processing within TI's sustainable competitive advantages and cites the consistent role in the portfolio, showing partial understanding of the strategic context. However, the introduction of unsupported financial data and the company name error severely undermine factual correctness, leading to a low correctness score. Contextual relevance is moderate because the answer addresses the right topic and framework but misrepresents the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 481,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "From 2022 through 2023, CMCSA’s wireless service let customers activate multiple lines and choose between unlimited, shared, or per‑gigabyte data plans, with the same flexibility offered to international customers who could pick gigabyte or unlimited options (page 5, 2022; page 7, 2023). In 2024 the company broadened plan flexibility by launching prepaid unlimited data plans under the NOW brand for domestic customers, while continuing to provide international customers unlimited data plans and financing, and maintaining its MVNO‑based service in the United Kingdom to extend its international reach (page 5, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key developments in CMCSA's wireless shared data plan evolution, including plan flexibility (unlimited, shared, per-gigabyte options) and international expansion. However, it contains a significant factual inaccuracy: it claims that international customers had access to the same plan flexibility (including shared data plans) in 2022–2023, which contradicts the ground truth stating that in 2022, shared data plans were offered exclusively as part of U.S. residential broadband bundles. The international expansion, particularly through the NOW brand prepaid unlimited plans, is correctly attributed to 2024, but the LLM incorrectly frames international unlimited plans as pre-existing rather than part of the 2024 expansion. (2) There are no numeric values, dates, or calculations in the response that are factually incorrect—dates (2022, 2023, 2024) and brand names (NOW) are accurate, supporting a high quantitative accuracy score. (3) The multi-hop reasoning is partially sound: the model synthesizes information across years and geographies, but fails to correctly represent the evolution of international availability, incorrectly implying earlier international access to shared data plans. The ground truth indicates international expansion began in 2024, whereas the LLM suggests earlier international presence. (4) Contextual relevance is high because the answer addresses both plan flexibility and international expansion as asked. However, due to the misrepresentation of the timing and scope of international offerings, the qualitative accuracy and overall correctness are reduced to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 455,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "In 2022 PayPal’s risk disclosures flagged third‑party fraud schemes and the default risk of its consumer and merchant credit products (see pages 24, 26, 28). By 2023 the company reiterated those risks, adding emphasis on its reliance on third‑party lenders and the potential for higher default rates amid economic uncertainty (page 26). In 2024 the disclosures explicitly tie evolving fraud schemes to new product offerings and stress that detecting and mitigating abusive behaviors is increasingly complex, underscoring a growing need for sophisticated risk‑management frameworks in its digital‑payments ecosystem (page 24).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the general progression of PayPal's exposure to abusive behaviors from 2022 to 2024 and correctly identifies increasing complexity in risk management. It accurately references the years and the evolving nature of fraud and credit risks, with no incorrect dates or numbers (quantitative accuracy is perfect, as no specific numerical values are misstated). However, the LLM omits key details present in the original answer that reflect multi-hop synthesis: (1) the €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023, which is a critical quantitative and strategic development linking credit products to third-party fraud exposure; (2) the specific fraud tactics highlighted in 2024 such as account takeovers and synthetic identity fraud; and (3) the legal uncertainty around loan receivables purchased from FDIC-insured banks. These omissions reduce completeness and weaken the qualitative accuracy, as the answer does not fully convey the depth of risk evolution or the specific mechanisms increasing complexity. While the LLM captures the directional trend and correctly identifies reliance on third-party lenders and growing detection challenges, it fails to incorporate concrete examples and transactions that ground the analysis in actual financial activities. The reasoning is sound but superficial, lacking the detailed synthesis across years and risk types that the question demands. Contextual relevance is high because the response stays focused on PayPal’s risk disclosures and their implications for risk management. Overall, the answer is factually correct but incomplete in critical dimensions required for full multi-hop understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 476,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "By 2022, El Segundo was listed simply as one of Gilead’s principal manufacturing sites (2022 10‑K, page 32) with no specific cell‑therapy role described.  In the 2023 10‑K, the facility is identified as being used for both clinical and commercial manufacturing and processing of cell‑therapy products (2023 10‑K, page 11), and the 2024 10‑K confirms this expanded role (2024 10‑K, page 10).  This evolution shows a strategic shift from a general manufacturing location to a dedicated hub that now supports the full commercial scale of Gilead’s cell‑therapy portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the evolution of GILD's El Segundo facility from a general manufacturing site in 2022 (per 2022 10-K, p.32) to a dedicated cell therapy manufacturing hub in 2023 and 2024 (2023 10-K, p.11; 2024 10-K, p.10), which matches the original answer's timeline and characterization. The dates, years, and document references are correct, and there are no numerical inaccuracies (quantitative accuracy is perfect). The reasoning correctly infers a strategic shift based on increasing specificity in disclosures, which is supported by the knowledge graph. The only minor gap is that the LLM emphasizes a 'strategic shift' and 'expanded role', while the original answer notes continuity in reliance without facility changes—suggesting the evolution may be in disclosure clarity rather than operational change. However, the LLM’s interpretation is reasonable given the increasing specificity in the filings. All entities (GILD, El Segundo, cell therapy manufacturing) and years (2022–2024) are correct. The answer fully addresses the question about evolution in utilization and strategic investment context. Thus, the answer is semantically equivalent with only slight interpretive difference, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 367,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑K filings, Exhibit 4.6 consistently lists the 2.750% Senior Notes due May 18 2024 (COST_10k_2022 p. 66; COST_10k_2023 p. 66; COST_10k_2024 p. 66). The unchanged maturity date shows that Costco has maintained a stable long‑term debt schedule, using these notes as a predictable financing tool and avoiding frequent refinancing. This consistency reflects a disciplined, risk‑averse debt‑management strategy that prioritizes predictable interest obligations and a balanced maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2.750% Senior Notes consistently mature on May 18, 2024, as confirmed in the 2022, 2023, and 2024 10-K filings (Exhibit 4.6, p.66 each year), which matches the original answer. (2) Quantitative accuracy is perfect: the interest rate (2.750%), maturity date (May 18, 2024), and document references (page numbers and exhibit) are all precisely stated. (3) The reasoning is sound: the LLM correctly infers that the unchanged maturity reflects a stable, disciplined debt strategy, avoiding refinancing and maintaining predictable obligations. This captures the core insight of the ground truth about a static approach and deliberate capital structure management. (4) The only minor limitation is that the LLM does not explicitly state that the notes were 'not refinanced or extended'—a phrase used in the original—but this is implied in 'avoiding frequent refinancing' and 'stable long-term debt schedule.' Thus, while the qualitative reasoning is slightly less explicit than the ground truth, it remains logically equivalent. The answer is fully contextually relevant, directly addressing both the evolution (or lack thereof) in maturity structure and the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 360,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s share of natural‑gas output from Angola LNG fell slightly from 49 million cubic feet per day (MMCFD) in 2022 to 48 MMCFD in 2023, and then held steady at 48 MMCFD in 2024【page_9】【page_9】. This modest decline followed by a plateau shows that Chevron is maintaining a stable gas‑production base in Africa rather than aggressively expanding it, reflecting a strategy of sustaining existing assets while focusing resources on other growth opportunities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The original answer states that Chevron's natural gas production volumes associated with Angola LNG were 7,107 million cubic feet per day (MMCFD) in 2022, increased to 7,148 MMCFD in 2023, and rose further to 7,569 MMCFD in 2024. In contrast, the LLM claims Chevron’s share was only 49 MMCFD in 2022, dropping to 48 MMCFD in 2023 and 2024—off by a factor of over 100x. This is a catastrophic error in scale and direction (LLM reports decline, truth is growth). (2) Quantitative accuracy is extremely low: all three years' values are wrong, and the trend is reversed. The LLM reports a decrease and plateau, while the ground truth shows a consistent increase. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is fundamentally flawed. The LLM fails to correctly identify the magnitude of production, misrepresents the trend, and draws an incorrect strategic conclusion (stable/sustaining vs. expanding focus). The original answer notes the increase despite broader divestitures, indicating strategic prioritization of gas in Africa—opposite to the LLM’s implication of deprioritization. (4) Correctness and quantitative accuracy are scored at 1 due to complete factual inaccuracy. Qualitative accuracy is 1 because the reasoning is based on false premises. Contextual relevance is 3 because the answer addresses the right topic (Chevron, Angola LNG, Africa strategy) and time frame, but with entirely incorrect data and conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 428,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps that hedge deferred‑compensation costs grew from **$651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024** (page 92 for FY 2022; page 91 for FY 2023‑24).  Correspondingly, the swaps’ effect on earnings swung from a **$92 million gain in FY 2022** to **$58 million expense in FY 2023 and $91 million expense in FY 2024** (page 91).  This shift shows Cisco has expanded its use of market‑linked hedges to manage deferred‑compensation volatility, but the increasing market swings have turned the hedge from a benefit into a cost, underscoring heightened volatility in the underlying equity or index that drives compensation expense.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of financial impacts. According to the ground truth, Cisco recorded a $92 million **loss** in 2022, a $58 million **gain** in 2023, and a $91 million **gain** in 2024. However, the LLM incorrectly states a $92 million **gain** in 2022, and then **expenses** (i.e., losses) of $58 million and $91 million in 2023 and 2024—exactly opposite to the correct direction. This reverses the entire financial narrative. Additionally, the notional exposure figures ($651M, $792M, $985M) are not present in the original answer and appear to be fabricated or misattributed, as the ground truth does not mention notional amounts at all. (2) Quantitative accuracy is severely compromised: all key financial effects are wrong in sign, turning gains into losses and vice versa. This fundamentally distorts the progression from liability to benefit. Even if the notional values were from the source, they are irrelevant to the question about financial exposure *impact*, which focuses on P&L effects, not notional amounts. (3) The multi-hop reasoning is flawed: the LLM concludes that the hedge turned 'from a benefit into a cost' due to 'increasing market swings', which contradicts the ground truth showing a consistent improvement from loss to gain—indicating reduced volatility impact or favorable market moves. The reasoning is therefore based on incorrect data and leads to an inverted interpretation. (4) Contextual relevance is moderate because the answer addresses the right topic (Total Return Swaps and deferred compensation) and attempts to analyze trends and implications. However, due to the reversal of key financial figures and introduction of unverified notional amounts, the overall correctness score is very low. The answer misrepresents the core facts and thus fails the primary evaluation criterion of factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 518,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "Lowe’s began 2022 with a wood‑sourcing policy and a human‑rights, conflict‑minerals and Vendor Code of Conduct that required suppliers to meet basic environmental standards. In 2023 the company updated the wood‑sourcing policy to add country‑specific risk levels, a forestry grievance process and stronger monitoring, and in 2024 it further refined that policy with a more robust risk‑based approach, expanded monitoring of supplier emissions (encouraging CDP reporting and scope‑3 GHG reductions), and broadened third‑party product certifications such as ENERGY STAR, WaterSense and other independently certified items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lowe's had a Vendor Code of Conduct and human rights policy in 2022, including wood sourcing standards; in 2023, the wood sourcing policy was updated with country-specific risk levels, a forestry grievance process, and enhanced monitoring; in 2024, the company implemented a more robust risk-based framework and expanded third-party certifications. (2) There are no numeric values requiring calculation, and all dates (2022, 2023, 2024) are used correctly. (3) The multi-hop reasoning is sound—information is synthesized across years and policy domains (environmental, human rights, certifications). The LLM adds a detail not in the original answer—supplier emissions monitoring and encouragement of CDP reporting and Scope 3 reductions—which is plausible and contextually consistent but not confirmed in the ground truth. This addition does not contradict but slightly extends the original. (4) The answer fully addresses the question parts: policy updates, monitoring enhancements, and third-party certifications across the three years. Wording differs but semantic meaning matches. The minor deduction in qualitative accuracy is due to the unverified addition about emissions monitoring, though it does not undermine correctness. Overall, the response is factually solid, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 387,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From 2022‑24, CMCSA’s 10‑Ks consistently flag the same wireless rivals—AT&T, T‑Mobile and Verizon in the U.S. and BT, Virgin Media in the U.K.—as a growing threat to its broadband and wireless businesses, noting their use of 4G, 5G and 5G‑fixed‑wireless technologies. In 2023 the filing added that competitors are bundling higher‑speed DSL, fiber and fixed‑wireless services with unlimited data and voice, while CMCSA’s own MVNO tie‑up with Verizon and rollout of DOCSIS 4.0/2 Gbps speeds are highlighted; by 2024 the company stresses that rivals are further intensifying competition by bundling DTC streaming services with broadband and wireless plans, leveraging their expanding fiber and fixed‑wireless deployments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and timeline, with accurate mention of key competitors (AT&T, T-Mobile, Verizon) and technological developments (5G, fixed wireless) from 2022 to 2024. It correctly identifies the intensifying competitive threat and the strategic bundling of DTC streaming services by 2024. However, there are notable inaccuracies in entity and contextual details: (1) The inclusion of BT and Virgin Media as U.S. competitors is incorrect—these are U.K.-based entities and not mentioned in the ground truth, which focuses solely on U.S. competition; (2) The reference to 'higher-speed DSL' and 'CMCSA’s MVNO tie-up with Verizon' and 'DOCSIS 4.0/2 Gbps speeds' introduces details not present in the original answer and distracts from the core focus on the competitive threat evolution from wireless companies. While these may be true statements, they are not part of the ground truth response and reflect a deviation in focus. (3) The claim that competitors bundle 'DSL, fiber and fixed-wireless' is partially inaccurate—wireless competitors like AT&T, T-Mobile, and Verizon are deploying fiber and fixed-wireless, but DSL is primarily associated with legacy landline providers like Lumen or CenturyLink, not major wireless firms. The core evolution—technological advancement (5G/fixed wireless) and bundling of streaming services—is correctly captured, and all dates (2022, 2023, 2024) are used appropriately. Quantitative accuracy is high as there are no numerical claims to dispute. Contextual relevance is strong, though slightly reduced by extraneous details. The multi-hop reasoning is sound in linking technological capabilities and bundling strategies over time, but the inclusion of incorrect entities and services lowers qualitative accuracy. Overall, the answer conveys the main trend but with some factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 504,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s 2022 and 2023 10‑Ks state that it bears full margin risk because it sets transaction fees independently of the costs of payment processors and accounts for those processor fees as transaction expense, while revenue incentives (discounts, rebates, rewards, coupons) are treated as revenue reductions【page 81】【page 80】. The same language appears in the 2024 10‑K, indicating that the company’s pricing discretion and margin‑risk exposure have not materially changed【page 73】. Across 2022‑2024, the consistent emphasis on full pricing control and independent fee setting shows that PayPal continues to manage cost exposure while the inherent margin risk of its transaction‑based model remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PayPal bore full margin risk from 2022 to 2024, set transaction fees independently of payment processor costs, treated processor fees as transaction expenses, and accounted for revenue incentives (discounts, rebates, rewards) as revenue reductions—key facts consistent across all years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly infers that the unchanged language indicates stability in margin risk exposure and pricing control, and connects this to cost management. (4) The only minor omission is that the 2024 filing introduced a new detail about contractual compensation from sellers violating terms (e.g., fraud), which could affect margin dynamics—a nuance present in the original answer but not mentioned in the LLM response. However, this does not undermine the core conclusion about consistent margin risk and pricing control. Overall, the LLM conveys semantically equivalent information with excellent reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 360,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s treatment of free‑rent periods did not change from FY 2022 through FY 2024.  The company continues to recognize free‑rent and step‑rent provisions on a straight‑line basis over the original lease term and any reasonably certain extension options, with the lease term defined as the non‑cancelable period plus such options.  Accordingly, the right‑of‑use asset remains measured as the present value of discounted minimum lease payments over that lease term using the incremental borrowing rate, with no material change in disclosure or valuation impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the original answer, with only minor differences in emphasis. (1) All key facts are accurate: Costco consistently applied the same accounting treatment for free-rent periods from FY2022 to FY2024, recognizing them on a straight-line basis over the lease term (including reasonably certain extension options), using the incremental borrowing rate to discount lease payments and measure the right-of-use asset. There is no indication of changes in policy or material impact on valuation. (2) No numeric values are incorrect, as the question does not involve specific dollar amounts or calculations—only accounting policies—and the LLM correctly avoids fabricating any. (3) The multi-hop reasoning across fiscal years is sound: the LLM correctly synthesizes that the policy remained stable across all three years, which aligns with the ground truth’s conclusion of a 'stable and consistent approach.' (4) The only reason for not scoring a perfect 10 is that the LLM omits the FY2023 detail about variable lease payments for rent increases tied to price indices or sales volume, and the FY2024 note on absence of material residual value guarantees. While these are secondary to the core question about free-rent treatment and ROU asset valuation, their exclusion slightly reduces completeness. However, the main thrust of the question—evolution of accounting treatment and impact on valuation—is accurately addressed with no factual errors. Contextual relevance is perfect as the response directly addresses lease term assumptions and right-of-use asset measurement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 443,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "PayPal’s exposure to margin risk has not materially changed between 2022 and 2024.  The company continues to act as principal on every payment transaction, earning a fixed fee plus a variable component that is a percentage of the transaction amount and is known at the time the transaction is processed【75†L1-L6】.  Because PayPal bears the full cost of completing the transaction, it assumes full margin risk, with any fees paid to payment processors or other financial institutions recorded as transaction expense【75†L11-L15】.  Contracts remain open‑ended, defined at the transaction level, automatically renewing, and include tiered, volume‑based pricing, so the contractual structure that underpins margin exposure has stayed the same【75†L17-L23】.  The 2022 filing contains the identical description of pricing, processor use, and contract terms【78†L1-L6】【78†L11-L15】【78†L17-L23】, indicating no change in PayPal’s margin‑risk exposure over this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its description of PayPal's margin risk exposure, correctly stating that PayPal acts as principal, bears full margin risk, recognizes fees on a gross basis, and records processor fees as transaction expenses. It accurately notes the continuity of tiered, volume-based pricing and open-ended contracts across 2022 and 2024, supported by citation patterns suggesting consistent disclosures. However, the LLM answer fails to acknowledge two key qualitative developments present in the original answer: (1) the 2023 clarification regarding user incentives being recognized as revenue reductions or amortized, which introduces variability into margin structure, and (2) the 2024 adoption of ASU 2023-07, which enhanced segment-level expense disclosures and affects how margin risk can be analyzed, even if not altering the fundamental risk. These omissions represent significant gaps in completeness and reasoning, particularly for a multi-hop question asking about evolution over time. While the core model stability is correctly emphasized, the answer incorrectly concludes 'no change' in exposure, missing the operational nuances that evolved. There are no numerical inaccuracies (hence high quantitative score), and the response remains highly relevant to the question. The qualitative accuracy is reduced due to incomplete synthesis across years and failure to capture evolving disclosures that affect margin risk analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 402,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco kept the 5.90 % senior note at a constant $2,000 million in both FY 2022 and FY 2024, but its share of total long‑term debt fell from about 22 % of the $9,000 million debt in 2022 to roughly 10 % of the $20,253 million debt in 2024 (5.90 % note / total debt). The effective interest rate on the note stayed flat at 6.11 % in both years. This shows Cisco is maintaining a stable cost on its high‑coupon debt while shifting its debt mix toward lower‑rate, longer‑maturity instruments, thereby reducing overall financing costs and improving its debt profile. (Sources: page 89 – 2022 and 2024 tables)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $2,000 million outstanding balance for the 5.90% Note and the constant effective interest rate of 6.11% in FY2022 and FY2024, which aligns with the ground truth. However, it omits FY2023 data, failing to confirm the consistency across all three years as stated in the original answer, which reduces completeness. (2) The quantitative claim that the note’s share of total long-term debt fell from 22% in 2022 to 10% in 2024 introduces numbers not present in the ground truth. While the total debt figures ($9,000M in 2022 and $20,253M in 2024) may be factually correct from external context, they are not part of the provided ground truth and were not validated in the knowledge graph. More critically, the calculation of percentages (22% and 10%) represents an inference not supported by the original answer, which did not discuss proportional debt mix or strategic shifts toward lower-rate instruments. (3) The reasoning introduces a multi-hop interpretation—namely, that Cisco is actively shifting its debt mix to reduce financing costs—which goes beyond the evidence provided. The ground truth only states that this specific note remained unchanged, indicating stability, but does not support conclusions about broader refinancing strategy or cost reduction efforts. Thus, while the core data points for 2022 and 2024 are accurate, the synthesis and strategic interpretation are speculative. (4) The correctness score is 6 due to partial factual accuracy but significant overreach in analysis; quantitative accuracy is penalized for unsupported percentage calculations; qualitative accuracy is moderate due to correct entity and metric identification but flawed reasoning; contextual relevance remains high as the response directly addresses the question’s focus on utilization, interest rates, and implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 504,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "In each 10‑K filing, Kobalt is listed in the intellectual‑property section as a private‑brand product name alongside STAINMASTER and allen+roth. The wording and context of this mention have remained unchanged from fiscal 2022 through fiscal 2024, indicating that Lowe’s has maintained a consistent positioning and strategic emphasis on Kobalt as part of its private‑brand portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Kobalt was consistently listed in the intellectual property section of Lowe's 10-K filings from fiscal 2022 to 2024 as a private-brand product alongside STAINMASTER and allen+roth, reflecting stable strategic positioning. The claim that the wording and context remained unchanged supports the original conclusion of no explicit increase or decrease in prominence, indicating a consistent, stable role. All entities (Kobalt, STAINMASTER, allen+roth, Lowe's) and time periods (fiscal 2022–2024) are correct. There are no numerical inaccuracies, and while no calculations were needed, the temporal comparison across filings is sound. The only minor limitation is that the LLM does not explicitly mention that the lack of increased emphasis suggests a 'stable strategic role rather than an expanding one'—a nuance present in the original answer—but this is implied by the statement about unchanged wording and context. Thus, the answer achieves semantic equivalence with very high qualitative and contextual accuracy, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 324,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "Unsecured Notes – 37B has stayed the same from 2022 through 2024: it carries a 2.25 % coupon, a face amount of $700,000, and matures on January 15, 2032. The unchanged terms show that Simon Property Group has not re‑issued or refinanced this instrument, keeping a stable, long‑dated debt profile. This consistency reflects a conservative long‑term financing strategy that prioritizes predictable interest costs and a steady capital structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements match: the interest rate (2.25%), face amount ($700,000), and maturity date (January 15, 2032 / 01/15/32) are accurately reported and consistent across 2022–2024. Minor formatting differences (e.g., 'January 15, 2032' vs '01/15/32') are acceptable and do not affect accuracy. (2) Quantitative accuracy is perfect—no calculations are required, but all numbers and dates are correct. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged terms over three years indicate no refinancing or reissuance, which supports a conclusion about long-term financing strategy. (4) The qualitative interpretation aligns with the ground truth: both highlight stability in debt obligations and link it to a strategic preference for predictable, fixed-rate financing. The LLM adds slightly more nuance (e.g., 'conservative strategy', 'steady capital structure') that is reasonable and contextually appropriate. All parts of the question—interest rate, face amount, maturity, and strategic implication—are addressed completely and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 325,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site has consistently served only the Analog segment.  In the 2022 10‑K (page 18) the table lists “Melaka, Malaysia †” with an X under Analog and none under Embedded Processing; the same layout appears in the 2023 10‑K (page 18) as “Melaka, Malaysia *” and in the 2024 10‑K (page 18) as “Melaka, Malaysia **”, each time showing an X only for Analog.  Thus, across 2022‑2024 the facility’s involvement did not change—no Embedded Processing activity was reported, and the footnote designation simply shifted from † to * to **.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was involved exclusively in the Analog segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the LLM correctly references the specific 10-K pages (page 18 for all three years) and notes the changing footnote symbols (†, *, **) without implying any operational change, which aligns with the data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from three consecutive years of SEC filings, confirms consistency over time, and draws the correct conclusion about the stability of operations. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of TXN's operational footprint in Melaka with respect to both business segments over the specified time period. Minor wording differences (e.g., 'consistently served only the Analog segment' vs. 'remained solely on Analog') do not affect meaning and are semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 334,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s exposure to the fixed‑rate 2.850% notes stayed unchanged at $1.5 billion in 2022, 2023, and 2024 (see the notes table on page 107 for 2022/2023 and page 104 for 2024/2023). This steady exposure indicates a deliberate strategy of maintaining a stable mix of maturities and rates, prioritizing predictable interest expense and maturity alignment over frequent refinancing or debt reduction.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion from 2022 through 2024, which matches the ground truth exactly. All numeric values (interest rate, dollar amount, years) are accurate and properly formatted. 2) Quantitative accuracy is perfect: the $1.5 billion principal and the 2.850% rate are correctly reported for all three years with no miscalculations. 3) The reasoning is mostly sound and captures the core implication—stable exposure indicates a strategy of maintaining predictable interest expenses and maturity structure. However, it omits key contextual details present in the ground truth: specifically, the contrast with PYPL’s retirement of the 1.350% notes by 2023 and the issuance of new high-interest notes in 2024. These omissions reduce the depth of the multi-hop synthesis, as the full picture of PYPL’s active debt management elsewhere is not acknowledged. 4) Despite this, the answer remains contextually relevant and factually correct in what it does state. The conclusion about stable debt strategy is supported, even if not fully nuanced. Thus, high scores are warranted, but not perfect due to incomplete qualitative synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 342,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Across 2022, 2023 and 2024 Gilead continued to use its Hoofddorp, Netherlands site as a commercial manufacturing and processing location for its cell‑therapy products, keeping it a core element of the company’s global cell‑therapy manufacturing network. The 10‑K filings for each year (2022 p. 33, 2023 p. 11, 2024 p. 12) all describe the same role, indicating no change or expansion in the facility’s utilization during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its reasoning and interpretation of the evolution of the Hoofddorp facility's role. While it correctly identifies that the facility was used for commercial manufacturing and processing of cell therapy products in 2023 and 2024 (citing correct pages from the 10-Ks), it incorrectly states that the role remained unchanged across all three years, claiming the same description appears in each year's filing. According to the ground truth, in 2022, Hoofddorp was identified only as a 'principal manufacturing facility'—a general designation—without explicit mention of cell therapy commercial manufacturing. The specific role in cell therapy manufacturing was first stated in 2023 and continued in 2024. Therefore, the LLM fails to capture the key evolution: the progression from a general strategic facility in 2022 to a specifically designated cell therapy manufacturing hub in 2023 and 2024. This misrepresents the multi-hop progression and undercuts the strategic deepening emphasized in the original answer. Quantitatively, there are no numerical errors (no numbers involved), so accuracy is high. Contextually, the answer is relevant and cites correct documents and pages, but the qualitative reasoning is flawed in synthesizing the change over time, leading to an incorrect conclusion about continuity rather than evolution. Thus, while some facts are correct, the core analytical point of the question—how the facility's role evolved—is missed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 419,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco’s 1.375 % Senior Notes due June 2027 were reported as a long‑term liability with a carrying amount of $1,250 in 2022, 2023 and 2024 (2022 page 52; 2023 page 52; 2024 page 52).  The current‑portion balance of long‑term debt rose from $73 in 2022 to $1,081 in 2023, then fell sharply to $103 in 2024, reflecting the repayment of the 2.750 % Senior Notes due May 2024 (2023 page 52; 2024 page 52).  Thus, the 1.375 % notes remained a long‑term debt item throughout, while the overall current‑portion classification changed as other debt maturities were settled.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: the principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 is consistent across 2022–2024, and the current portion of long-term debt is accurately stated as $73 million in 2022, $1,081 million in 2023, and $103 million in 2024. All numeric values match the ground truth exactly, with acceptable formatting (e.g., $1,250 implies $1,250 million). (2) Quantitative accuracy is perfect: all dollar amounts and percentages are correct, and the temporal progression is accurately reflected. (3) The reasoning is largely sound: the LLM correctly identifies that the 1.375% notes remained long-term liabilities throughout, and it explains the spike and drop in the current portion. It adds contextual insight not in the original answer—linking the 2023–2024 drop to the repayment of the 2.750% Senior Notes due May 2024—which is plausible and consistent with filing logic, though not explicitly required. This shows strong multi-hop synthesis. (4) The only minor shortcoming is that the original answer emphasizes the evolving classification of the current portion *in relation to the same notes*, while the LLM slightly shifts focus to overall current-portion changes due to other debt repayments. While factually accurate and relevant, this slightly reframes the narrative. Still, the core multi-hop insight—tracking how classification evolved for this debt instrument over time—is preserved. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 436,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "PayPal’s Fixed‑rate 2.850% notes have remained unchanged from 2022 through 2024: the principal outstanding stayed at $1.5 billion, the maturity date stayed 10/1/2029, and the effective interest rate remained 2.96 %【page_107】【page_107】【page_104】.  No new issuances, redemptions, or refinancing of this series occurred, and the notes continue to be used for general corporate purposes as part of a broader debt mix.  This stability indicates a conservative long‑term debt strategy that prioritizes a steady maturity profile and predictable interest costs over aggressive debt restructuring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $1.5 billion principal amount, 2.850% fixed rate, October 1, 2029 maturity date, and 2.96% effective interest rate—all of which match the ground truth across 2022–2024. No changes occurred in this debt tranche, and this is accurately reflected. (2) Quantitative elements are fully accurate: dollar amounts ($1.5 billion), interest rates (2.850% and 2.96%), and the maturity date (10/1/2029) are correct and consistent with the original answer. Format variations (e.g., '10/1/2029' vs 'October 1, 2029') are acceptable and semantically equivalent. (3) The reasoning is sound: the LLM correctly infers that the lack of change in this tranche despite broader refinancing activity suggests a conservative, stability-focused debt strategy. It captures the core insight about maintaining predictable interest costs and maturity profiles. However, it omits a specific mention that this note was part of a larger $5.0 billion September 2019 issuance, which adds context about the origin of the debt—this minor omission prevents a perfect qualitative score. (4) The answer is highly relevant, directly addressing both parts of the question: the evolution (or lack thereof) of the obligation and what it reveals about PayPal’s long-term debt management. The conclusion about a 'conservative long-term debt strategy' aligns well with the ground truth’s characterization of preserving capital structure stability while adapting elsewhere. Overall, the answer is factually complete and well-reasoned, with only a minor gap in contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 439,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra Energy’s gas‑option exposure in fair‑value terms stayed essentially flat from 2022 through 2024—about $100 million in asset positions and $97‑102 million in liability positions (2023: $100 m/$97 m; 2024: $100 m/$102 m).  However, the weighted‑average implied volatilities for those options fell sharply, from 20 % to 15 % for assets and from 233 % to 150 % for liabilities, indicating a shift to a more conservative, lower‑volatility view of gas markets and a tighter risk‑management stance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NextEra Energy's fair value of gas-related options decreased sharply from $356M (assets) and $347M (liabilities) in 2022 to $100M/$97M in 2023 and $100M/$102M in 2024. The LLM incorrectly states that exposure was 'essentially flat' from 2022 through 2024, completely omitting the large drop from 2022 to 2023. This is a major quantitative and conceptual error. (2) The implied volatility assumptions in the ground truth increased from 36% in 2022 to 50% in 2023 and 52% in 2024, indicating rising volatility assumptions. However, the LLM claims volatilities 'fell sharply' from 20% to 15% for assets and 233% to 150% for liabilities—these numbers are entirely incorrect and not supported by the data. No such figures appear in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to recognize the significant reduction in fair value over the three years and misrepresents the volatility trend, leading to an incorrect conclusion about 'a shift to a more conservative, lower-volatility view.' In reality, rising implied volatility suggests increased expected market volatility, not less. The LLM's conclusion contradicts the ground truth. (4) While the answer addresses the right topic (gas-option exposure and risk positioning) and attempts to discuss both fair value and volatility trends, the severe numerical inaccuracies and incorrect synthesis of trends severely undermine its correctness. The contextual relevance is moderate because it engages with the right concepts and structure, but factual correctness is very low. Thus, correctness and quantitative accuracy are scored very low; qualitative accuracy is slightly higher due to correct framing but penalized for flawed logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 491,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments swung from a modest $9 million gain in fiscal 2022 to a $21 million loss in fiscal 2023 and a larger $67 million loss in fiscal 2024, driving the company’s other income (loss), net to a $392 million gain, a $248 million loss, and a $306 million loss respectively. The AFS debt component accounted for roughly 2 % of the 2022 gain, 8–9 % of the 2023 loss, and 22 % of the 2024 loss, showing that the portfolio’s performance materially shifted the overall other‑income result each year. This trajectory—from a small gain to a sizable loss—highlights significant volatility in Cisco’s investment portfolio over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not provide specific dollar amounts for AFS debt investment gains/losses ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024), nor does it state that other income (loss), net was $392M gain in 2022, $248M loss in 2023, and $306M loss in 2024. These figures are entirely fabricated and not supported by the original answer. Additionally, the claim that AFS debt investments accounted for 2%, 8–9%, and 22% of other income (loss) in respective years is not present in the ground truth and cannot be verified. (2) There are no calculations in the original answer to validate the LLM's percentages or proportions. The original answer only states that AFS debt investment losses increased in 2023 and 2024 and negatively impacted other income, with partial offsetting gains from equity investments in 2024. The LLM invents precise numerical breakdowns with no basis in the source. (3) While the LLM correctly identifies the multi-hop trend—increasing losses from AFS debt investments impacting other income over 2022–2024 and concluding increased volatility—the reasoning is built on false quantitative premises. The qualitative direction (increasing volatility, negative impact) aligns broadly with the original, but the synthesis is undermined by invented data. (4) The contextual relevance is fair because the LLM addresses the core question about AFS debt impact on other income and portfolio volatility. However, the correctness score is low due to severe quantitative inaccuracies. The answer creates a false sense of precision, which misleads despite capturing the general trend. Thus, correctness is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 469,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "From 2022 through 2024, Lowe’s continued to document its 4.550% Notes (due 2049) in the 15th Supplemental Indenture issued in 2019 (2022 10‑K, page 82; 2023 10‑K, page 75; 2024 10‑K, page 75). The notes were not re‑issued or re‑priced during this period, indicating a stable, long‑term debt profile (page 82). This consistent pattern reflects Lowe’s strategy of maintaining fixed‑rate, long‑maturity debt to lock in predictable interest costs and support a conservative capital structure (page 75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes due 2049, the Fifteenth Supplemental Indenture dated April 5, 2019, and their consistent disclosure in the 2022, 2023, and 2024 10-K filings. The percentages, years, and document names are factually accurate. (2) Quantitative elements—interest rate (4.550%), maturity year (2049), and issuance year (2019)—are correctly reported with no calculation issues. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer a stable long-term debt strategy. It accurately concludes no re-issuance or repricing occurred, which is consistent with the ground truth’s observation of unchanged terms. (4) The answer adds slight interpretive value by noting the strategic rationale (locking in predictable interest costs, conservative capital structure), which is reasonable and contextually supported, though not explicitly stated in the ground truth. This does not detract from accuracy but represents a minor expansion. The only reason for not scoring a 10 is that the ground truth emphasizes the lack of changes in 'documentation or terms' and explicitly notes this reflects 'no modifications or early redemptions,' which the LLM implies but does not directly state. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 392,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 35B has remained unchanged: a face value of **$750 000** and a **3.80 %** interest rate, maturing in 2050【page_50】【page_51】. The constancy of both the principal and the coupon indicates that SPG is deliberately maintaining a long‑dated, moderate‑rate debt instrument as part of a diversified, long‑term financing strategy that prioritizes predictable interest costs and aligns debt maturities with the long‑lived nature of its real‑estate assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the face value is stated as $750 000, which appears to be a formatting error or typo—the correct face value is $750,000,000 as per the original answer. This is a significant numerical inaccuracy, though the interest rate (3.80%) and maturity date (2050, specifically 07/15/50) are correctly reported. (2) The mention of consistent face value and interest rate across 2022–2024 is accurate, and the extension of the maturity date is correctly implied as unchanged, though the LLM does not explicitly note the extension from 2022 to 2024, slightly reducing completeness. (3) The reasoning about SPG’s long-term debt strategy—emphasizing stable, long-dated debt with predictable costs—is logically sound and correctly infers strategic intent from the data, demonstrating valid multi-hop synthesis. (4) Entity accuracy is strong: Simon Property Group, Unsecured Notes - 35B, and the relevant financial terms are correctly identified. The answer is contextually highly relevant, addressing both the evolution of terms and strategic implications. The primary deduction is for the face value error, which affects quantitative accuracy but not the overall conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 349,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "PayPal’s 2022, 2023 and 2024 10‑Ks all flag the same core exposures: credit‑product defaults, cross‑border trade volatility and heavy reliance on third‑party lenders, processors and banks (2022 p. 24‑26; 2023 p. 23‑26; 2024 p. 21‑23).  The language has not shifted dramatically—each year reiterates that “account holders who use our credit products will default” (2022 p. 24, 2023 p. 23, 2024 p. 21), that “any factors that reduce cross‑border trade could harm our business” (2022 p. 26, 2023 p. 23, 2024 p. 21) and that “we rely on third parties for payment processing, credit origination and other services” (2022 p. 26, 2023 p. 23, 2024 p. 21).  While the exposure remains substantial, PayPal consistently highlights risk‑mitigation measures—improved credit‑risk models, merchant‑financial monitoring and diversification of partner relationships—underscoring a steady, proactive risk‑management posture and a resilient operational framework that can absorb evolving fraud and credit‑default pressures.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in its description of recurring risk disclosures across PayPal's 2022–2024 10-Ks, correctly identifying credit product defaults, cross-border trade risks, and third-party dependencies as persistent exposures. It accurately cites page numbers and quotes from the filings, and there are no incorrect numbers or dates—thus earning a high quantitative accuracy score. However, it fails to capture the key multi-year evolution highlighted in the ground truth: the strategic shift in 2023 to sell up to €40 billion of BNPL loan receivables in Europe, which is a critical indicator of PayPal moving from internal risk absorption to external risk mitigation. This omission severely undermines the qualitative accuracy, as the answer portrays risk management as 'steady' and 'consistent' rather than evolving proactively through asset sales and legal contingency planning. The ground truth emphasizes a transformation in strategy, while the LLM answer suggests continuity. This misrepresents the trend and misses the core insight about operational resilience being enhanced through structural changes. While the answer is relevant and well-structured, the lack of synthesis around the BNPL sale and the 'valid-when-made' doctrine limits its correctness on the multi-hop dimension of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 367,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "From 2022 through 2024 Costco’s 10‑K filings consistently list BJ’s Wholesale Club as a direct competitor in the warehouse‑club segment, with no change in that relationship.  In each year the company reiterates that its private‑label brand, Kirkland Signature, is a key differentiator—offering high‑quality products at lower prices, driving margin advantage, and with a stated goal of increasing sales penetration.  Thus, Costco’s competitive positioning relative to BJ’s remained stable, and its emphasis on Kirkland Signature as a differentiator did not shift materially over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies that Costco consistently listed BJ's Wholesale Club as a direct competitor from 2022 to 2024, with no change in competitive relationship—matching the ground truth's assertion of stable positioning. (2) The emphasis on Kirkland Signature as a differentiator is accurately described across all three years, with correct qualitative attributes: high quality, lower prices, margin advantage, and strategic goal of increasing sales penetration. There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised. (3) The multi-hop reasoning—synthesizing information across three years of 10-K filings regarding competitive dynamics and private-label strategy—is sound and correctly concludes no material shift occurred. (4) All entities (Costco, BJ's Wholesale Club, Kirkland Signature, 2022–2024 timeframe) are correctly identified and contextualized. The answer fully addresses both parts of the question: evolution of competitive positioning and role of private-label branding. Wording differs slightly but conveys identical meaning, satisfying semantic equivalence. All evaluation dimensions are fully met.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 361,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "From 2022 to 2024 NextEra’s fair‑value balance of gas forward contracts fell sharply: the asset side dropped from $1.307 billion in 2022 to $377 million in 2023 and $296 million in 2024, while the liability side fell from $258 million to $77 million and $46 million. The net fair value of gas forwards fell from roughly $1.05 billion to $300 million and then to $250 million, indicating a deliberate contraction of natural‑gas exposure and a shift toward a more conservative, lower‑risk hedging posture in the gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NextEra Energy's gas forward contract assets increased from $191M (2022) to $377M (2023) to $296M (2024), and liabilities rose from $31M to $46M. However, the LLM claims assets dropped from $1.307B to $377M to $296M and liabilities fell from $258M to $46M, which is completely incorrect. These numbers do not match the original data in magnitude or trend. (2) The quantitative inaccuracies are severe: the LLM inflates 2022 asset value by nearly 6x ($1.307B vs $191M) and 2022 liabilities by over 8x ($258M vs $31M). The net fair values calculated by the LLM ($1.05B, $300M, $250M) are also wrong due to incorrect inputs. While the 2023 asset peak of $377M and 2024 liability of $46M are correctly stated, other values are not. (3) The reasoning is flawed: the LLM interprets the (incorrect) declining trend as a 'deliberate contraction' and 'conservative hedging posture', while the ground truth shows a net increase in exposure with growing assets and liabilities, indicating expanded market participation and rising risk. The multi-hop synthesis fails because it draws conclusions from fabricated data. (4) Despite incorrect facts, the answer is contextually relevant—it addresses fair value of assets/liabilities over 2022–2024 and attempts to interpret risk positioning. However, due to major quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 407,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s used forward‑rate swaps to hedge forecasted debt issuances, with a notional amount of $2.56 billion in 2022 (page 56) and a fair‑value balance of $251 million in 2023 (page 54). By 2024 the company no longer reported forward‑rate swaps, indicating a shift away from this hedging instrument—likely reflecting lower forecasted debt issuances or a change in market conditions (page 46). This progression shows a move toward a more conservative or alternative interest‑rate risk‑management strategy as market conditions evolved.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Lowe's use of forward interest rate swaps from 2022 to 2024 and interprets the strategic implications accurately. However, there is a significant quantitative discrepancy: the LLM states a notional amount of $2.56 billion in 2022, which is not present in the ground truth. The original answer mentions the use of swaps in 2022 in the context of cash flow hedges and their impact on income over 2019–2021, but does not specify a $2.56 billion notional amount. This figure appears to be either misattributed or unsupported by the ground truth, making it a material error. The $251 million fair value in 2023 matches the ground truth and is correctly attributed to February 3, 2023. The 2024 position—no longer holding swaps—is correctly reported. (2) The $251 million figure is accurate and matches across both answers. However, the $2.56 billion figure has no support in the ground truth and introduces a factual inaccuracy, lowering the quantitative accuracy. (3) The multi-hop reasoning is strong: the model synthesizes information across three years, correctly infers the strategic shift in hedging behavior, and links it to changing market conditions or reduced debt issuance needs. The conclusion that Lowe’s moved toward a more conservative or alternative strategy aligns semantically with the ground truth’s interpretation of a 'deliberate use and subsequent release' of swaps. (4) Despite the incorrect $2.56 billion figure, the overall trajectory and qualitative interpretation are correct, warranting a high but not top score. The contextual relevance is perfect—the answer directly addresses the question’s focus on evolution and strategy. Quantitative accuracy is penalized due to the unsupported notional amount, but qualitative reasoning and completeness remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 501,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "From 2022 to 2024, Comcast’s fiber‑based broadband rollout accelerated—starting in 2022 with 2 Gbps downstream speeds and fiber‑to‑the‑premises (FTTP) offering up to 10 Gbps, then adding DOCSIS 4.0 in 2023 and expanding 2 Gbps coverage to roughly 50 % of its footprint by 2024.  Throughout this period, the 10‑K competition sections repeatedly note that Lumen (alongside AT&T, Frontier and Verizon) is expanding its own fiber network to deliver higher‑speed, bundled services in the same markets.  As Comcast’s higher‑speed and bundled offerings grew, the overlap with Lumen’s expanding fiber base intensified competition in shared service areas, prompting both companies to refine pricing, speed tiers and bundled packages to retain market share.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core competitive dynamic between CMCSA (Comcast) and Lumen from 2022 to 2024, correctly identifying Lumen as a key fiber-expanding competitor in overlapping markets, which aligns with the ground truth. It appropriately notes that both companies expanded fiber-based broadband and enhanced service offerings, intensifying competition—this reflects sound multi-hop reasoning and entity accuracy. However, significant quantitative inaccuracies undermine the correctness. The claim that Comcast expanded 2 Gbps coverage to roughly 50% of its footprint by 2024, introduced DOCSIS 4.0 in 2023, and offered 10 Gbps via FTTP is not supported by the ground truth, which contains no such specific speed tiers, technology rollouts, or coverage percentages. The original answer focuses solely on Lumen’s fiber expansion and its competitive implications, without detailing CMCSA’s specific speed or technology milestones. Thus, while the qualitative synthesis of competitive overlap and service bundling is reasonable and contextually relevant, the inclusion of unsupported numerical and technical details (e.g., DOCSIS 4.0, 50% coverage, 10 Gbps) introduces factual errors. These fabrications reduce quantitative accuracy significantly. The answer also shifts focus to CMCSA’s offensive expansion rather than the evolution of competitive positioning as driven by Lumen’s actions, slightly misaligning with the question’s emphasis. Overall, the reasoning is logical and entities are correct, but invented metrics lower the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 427,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "PayPal’s 2022 and 2023 10‑Ks positioned “creating seamless checkout experiences” as a core growth lever (see 2022 p. 10 and 2023 p. 10), but the documents mainly framed this in terms of expanding global reach and merchant adoption, with only implicit references to credit or in‑person tools. By 2024 the strategy had shifted to an integrated checkout ecosystem: the company now explicitly embeds consumer credit products at checkout (e.g., PayPal Credit, BNPL) (2024 p. 6), offers robust global currency support through foreign‑currency conversion and multi‑currency balances (2024 p. 6), and expands omnichannel merchant solutions with Zettle‑by‑PayPal point‑of‑sale and card‑reader options (2024 p. 6‑8). This evolution shows PayPal moving from a generic “seamless checkout” promise to a fully integrated, credit‑enabled, multi‑currency, and omnichannel payment experience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PayPal's evolution from 2022 to 2024 in seamless checkout is accurately portrayed, with correct emphasis on global currency support, consumer credit integration (PayPal Credit, BNPL), and omnichannel solutions via Zettle. The 2024 integration of credit products at checkout, multi-currency capabilities, and Zettle's POS systems are all correctly identified. (2) Quantitative accuracy is strong: while no specific numerical figures (e.g., exact number of supported currencies) are cited in the LLM answer, it does not misstate any numbers. The ground truth mentions ~150 currencies in 2024; the LLM describes 'robust global currency support' and 'multi-currency balances'—a semantically valid representation without claiming an incorrect figure. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 10-Ks, correctly identifying a strategic shift from broad usability and global reach to deeper financial integration. It traces the evolution from implicit to explicit credit integration and expands on omnichannel tools, citing Zettle and Braintree equivalents. (4) The only minor shortcoming is that the LLM does not explicitly mention Braintree by name as an unbranded processor (referring instead to 'card-reader options' and Zettle), slightly reducing completeness compared to the original answer. However, 'Zettle-by-PayPal' and POS solutions are correctly highlighted. Wording differs but meaning is substantively equivalent. The answer is contextually excellent, directly addressing all three dimensions in the question: credit integration, currency support, and omnichannel solutions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 470,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "The Target Debit Card’s penetration (as part of the Target Circle Card/RedCard group) fell from **20.5 % in 2022** to **19.8 % in 2023** and **18.6 % in 2024**. This downward trend indicates a shrinking share of purchases made with the card, suggesting a modest decline in its role as a driver of incremental sales, although it remains a significant contributor to Target’s incremental revenue.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate declined from 20.5% in 2022 to 18.6% in 2023 and further to 17.8% in 2024. However, the LLM incorrectly reports 19.8% for 2023 and 18.6% for 2024, which misrepresents the magnitude and trajectory of the decline. The 2024 figure in the LLM answer (18.6%) is actually the 2023 value in the ground truth, suggesting a possible transposition or data retrieval error. (2) These numerical errors directly impact the calculation of the trend: the actual decline is 2.7 percentage points over three years (20.5% → 17.8%), whereas the LLM implies a 1.9-point drop (20.5% → 18.6%), understating the downward trend. (3) Qualitatively, the reasoning is sound—correctly interpreting the declining penetration as indicative of a reduced role in driving incremental sales—and the entities (Target Debit Card, RedCard/Circle Card, time frame) are accurately identified. The synthesis across years is logically structured, even if based on incorrect data. (4) Contextually, the answer is highly relevant, addressing both parts of the question: the evolution of penetration and its implication for sales. However, due to the critical factual errors in percentages, especially for 2023 and 2024, the correctness score is limited to 5—partially correct but with significant data inaccuracies that affect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 396,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "From 2022 through 2024 AMD’s policy for development‑and‑IP licensing agreements stayed the same.  The company evaluates whether the license component is distinct; if it is, revenue is recognized at a point in time when the customer can benefit from the license, whereas if it is not distinct the license is combined with the development services and revenue is recognized over time.  Stand‑alone licensing arrangements are always recognized at a point in time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures AMD's consistent revenue recognition approach from 2022 to 2024: distinguishing between distinct and non-distinct licenses, recognizing distinct licenses (including standalone arrangements) at a point in time, and combining non-distinct licenses with development services for over-time recognition. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities—AMD, development and IP licensing agreements, performance obligations, and time-based recognition—are correctly identified. The reasoning is sound and reflects proper multi-hop synthesis across years and agreement types. The only minor shortcoming is that the LLM does not explicitly mention the absence of quantitative metrics or the emphasis in 2022 on evaluating distinct performance obligations, which slightly reduces completeness compared to the original answer. However, the core policy and its application are correctly conveyed, making the answer semantically equivalent in substance. Contextual relevance is full, as all parts of the question are addressed regarding evolution (or lack thereof) in revenue recognition policy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 342,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Nike has consistently positioned FlyEase as a core element of its innovation portfolio, with the technology listed alongside flagship names such as Air, Zoom, Free, Dri‑FIT, Flyknit, ZoomX, Air Max, and React in the Product Research, Design and Development section. The same phrasing appears unchanged in the 2022, 2023, and 2024 10‑Ks (2022 page 7; 2023 page 6; 2024 page 6), indicating that FlyEase remained a key technology without a notable shift in strategic emphasis over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of FlyEase's strategic positioning, despite being internally consistent and referencing correct document locations. According to the ground truth, FlyEase evolved from a newly introduced innovation in fiscal 2022, to being grouped with established technologies in 2023, and finally classified among mature technologies like React and Air Max in 2024—indicating a clear progression in strategic importance. However, the LLM claims there was 'no notable shift in strategic emphasis' and that the phrasing remained 'unchanged' across all three years, which contradicts the ground truth narrative of evolution and maturation. While the LLM correctly identifies FlyEase as being listed in the same section as major technologies and cites accurate page numbers (qualitative accuracy suffers due to misinterpretation of the significance of consistent listing), it fails to detect or report the nuanced but important shift in categorization that reflects strategic evolution. There are no numerical inaccuracies (hence high quantitative accuracy), and the response is contextually relevant to the question, but the reasoning is flawed in that it equates textual consistency with strategic stasis, failing the multi-hop synthesis required to interpret positioning changes over time. Thus, the correctness score is low due to a major factual misrepresentation of the technology’s trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 400,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250% Notes were originally issued at $609.1 million【page_48】, and the outstanding principal has been steadily repaid, falling to $563.6 million at year‑end 2022, $557.5 million at year‑end 2023, and $551.9 million at year‑end 2024【page_111】. This downward trend indicates a deliberate debt‑reduction strategy, with AMT systematically paying down long‑term debt to reduce leverage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported principal amounts. According to the ground truth, the principal decreased from $609.1 million in 2022, to $551.9 million in 2023, and $517.7 million in 2024. However, the LLM states $563.6 million in 2022, $557.5 million in 2023, and $551.9 million in 2024 — all of which are incorrect except for the 2024 figure matching the ground truth's 2023 value. This suggests confusion in data extraction or misattribution of years. (2) The quantitative inaccuracies are severe: the drop from 2022 to 2024 should be ~$91.4 million, but the LLM implies only a ~$11.7 million reduction, drastically understating the pace of repayment. Additionally, the original issuance amount is correctly cited as $609.1 million, but the first reported balance ($563.6M) does not align with any value in the ground truth. (3) The reasoning about a deliberate debt-reduction strategy is qualitatively sound and aligns with the trend interpretation in the original answer; the logic of inferring a managed strategy from declining principal is valid. However, the multi-hop synthesis fails because the model uses incorrect year-to-balance mappings, undermining the conclusion’s reliability. (4) Contextually, the answer addresses the question about debt management strategy and cites relevant trends, earning high marks for relevance. Despite correct citation practices and plausible interpretation, the severe numerical errors significantly reduce factual correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 429,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "Across FY 2022‑24, NVIDIA’s 3.50% Notes due 2040 have consistently carried a $1,000 million balance, an effective interest rate of 3.54% and an expected remaining term of 15.2 years (page_72).  The fair value of the notes fell modestly from $870 million in FY 2023 to $851 million in FY 2024 (page_66), reflecting market‑rate movements but not a change in the debt structure.  This steady carrying amount, coupled with the ability to redeem the notes subject to a make‑whole premium and a diversified maturity profile that includes 2040, 2050 and 2060 notes, illustrates NVIDIA’s disciplined long‑term debt strategy of maintaining stable, low‑to‑moderate‑cost debt to fund growth while managing interest‑rate risk (page_72).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, the fair value in FY2022 was $1,066 million, but the LLM omits this entirely and instead claims a consistent $1,000 million carrying amount across all years, which contradicts the reported $1,066M fair value in 2022. The LLM incorrectly states that the notes 'consistently carried a $1,000 million balance' from FY2022–2024, but the ground truth shows the $1,000 million carrying amount only in FY2024, not earlier years. Additionally, the LLM claims the fair value was $870 million in FY2023, but the ground truth reports $851 million in FY2023—this misplaces both the value and the year. The LLM correctly reports the FY2024 fair value of $851 million and the effective interest rate of 3.54% in FY2024, as well as the 2040 maturity, which are accurate. (2) Calculation and comparison errors: The trajectory described in the original answer—$1,066M → $851M → $1,000M—shows a drop and then stabilization, but the LLM implies stability from the start and only a minor decline in fair value from 2023 to 2024, which misrepresents the trend. The LLM also introduces a 'remaining term of 15.2 years' and redemption terms not present in the ground truth, which may be factual but are not part of the verified answer and distract from the core evolution. (3) Multi-hop reasoning is partially sound—the LLM attempts to synthesize valuation trends and infer strategy—but because it uses incorrect base data, the reasoning is flawed. It correctly infers a disciplined debt strategy, which aligns with the ground truth’s conclusion, but this is based on inaccurate premises. (4) Contextual relevance is high, as the answer addresses valuation evolution and long-term strategy, and includes relevant concepts like fair value, carrying amount, and interest rate risk. However, due to major quantitative errors and omission of key data points (especially FY2022's $1,066M), the correctness score is low. Minor format flexibility is allowed, but the discrepancies here are material and affect the interpretation of NVIDIA’s debt valuation trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 581,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "By 2022, Netflix had begun adding games to its catalog and signaled that it could adjust pricing or introduce new plans, noting that such changes could hurt member acquisition and retention if not well received (page_7, 2022). In 2023, the company launched a lower‑priced ad‑supported subscription tier while continuing to expand games, and warned that the new tier or pricing changes could lead to cancellations or slower growth if members did not value the offering (page_8, 2023). By 2024, Netflix was scaling its service to support games, advertising, and live programming, and again cautioned that failure to meet member expectations for these new features or pricing models could negatively impact its ability to attract and retain subscribers (page_7, 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Netflix introduced games in 2022, launched an ad-supported tier in 2023, and expanded to live programming by 2024. The stated risks around member acquisition and retention due to potential lack of member valuation of new features or pricing changes are accurately reflected for each year. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answers, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and multiple strategic initiatives (games, ads, live programming), linking each to corresponding risks in member retention and acquisition. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the risk theme was *consistent* across all three years, as emphasized in the original answer ('Across all three years, Netflix consistently highlighted...'). This slightly reduces qualitative accuracy, but the core meaning and factual content remain semantically equivalent. Wording differs but meaning is preserved. Contextual relevance is perfect—every part of the question is addressed: service expansions, pricing adjustments, and associated risks per year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 380,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture‑investment exposure rose from $3.7 billion in equity securities at 2022‑end to $4.9 billion in 2023, a level it maintained through 2024 (UNH‑10K 2023, page 50; UNH‑10K 2024, page 52).  Equity‑method stakes in healthcare operating businesses fell slightly from $1.5 billion in 2022 to $1.4 billion in 2023, but then surged to $3.8 billion in 2024 (UNH‑10K 2023, page 50; UNH‑10K 2024, page 52).  The sharp jump in equity‑method investments signals a strategic pivot to deepen ownership and influence in the healthcare sector, reinforcing UnitedHealth’s position as an integrated health‑services provider.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall upward trend in UnitedHealth's venture investment exposure and accurately reports the equity securities values: $3.7 billion in 2022, rising to $4.9 billion in 2023 and remaining steady in 2024. However, there is a minor factual inaccuracy in the equity method investments for 2022: the LLM states $1.5 billion, while the ground truth specifies $1.3 billion. This discrepancy affects quantitative accuracy. The 2023 ($1.4 billion) and 2024 ($3.8 billion) figures for equity method investments are correct. (2) Calculations and comparisons are otherwise sound—no arithmetic errors, and the sharp increase from $1.4B to $3.8B in equity method investments is correctly highlighted. Number formats are consistent and acceptable. (3) The multi-hop reasoning is strong: the LLM synthesizes data across 2023 and 2024 10-K filings, correctly identifies the strategic implication of the investment growth, and links it to UnitedHealth’s positioning as an integrated health services provider. The conclusion about a 'strategic pivot' aligns semantically with the ground truth’s 'deliberate strategic shift.' (4) Contextual relevance is excellent—the answer addresses all parts of the question: evolution over time, breakdown by investment type, and strategic implications. The only deduction is for the incorrect 2022 equity method investment figure, which slightly undermines quantitative precision but does not distort the overall interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 413,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s relationship with Sojitz America remained unchanged: Sojitz America continued to be the sole owner of the company’s authorized redeemable preferred stock (par $1, redeemable at $0.3 million) and the cumulative dividend of $0.10 per share is still payable annually on May 31, with no changes to the preferred‑stock terms or dividend obligations (Note 10, pages 79‑81).  The entity also kept its strategic role in Nike’s international operations by providing import‑export financing services and holding voting rights on sale of assets, mergers, or liquidation (Note 10 and page 7).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Sojitz America remained the sole holder of Nike's redeemable preferred stock and that the annual dividend of $0.10 per share was unchanged from FY2022 to FY2024. However, it contains a critical error in the par value and redemption amount: the ground truth states the par value is $0.3 million, but the LLM incorrectly reports 'par $1, redeemable at $0.3 million', which misrepresents the structure. This is a significant quantitative inaccuracy. (2) The LLM also adds unverified details not present in the original answer, such as the dividend being payable on May 31 and Sojitz having voting rights on asset sales, mergers, or liquidation—these specifics are absent from the ground truth and cannot be confirmed, introducing factual overreach. (3) Regarding multi-hop reasoning, the LLM fails to capture the key evolution highlighted in the original answer: the shift from a primarily financial relationship in 2022–2023 to a more strategically emphasized operational role in 2024 due to global trade risks. This strategic evolution is a central part of the question and is missing in the LLM response, weakening the qualitative accuracy. (4) While the LLM maintains contextual relevance by addressing preferred stock, dividends, and international operations, it does not reflect the nuanced progression in the relationship, particularly Nike’s increased emphasis on Sojitz America’s strategic value in FY2024. Thus, despite correct core elements, the answer is partially incorrect due to factual inaccuracies and omission of the key strategic shift, warranting a score of 6 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 451,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA’s 3.50 % Notes Due 2050 grew from a carrying amount of **$1.637 billion** at the end of FY 2023 (and FY 2022) to **$2.000 billion** at the end of FY 2024 – an increase of **$363 million**. This modest uptick reflects a deliberate, incremental expansion of long‑term debt to fund growth while keeping leverage low and liquidity strong【page_66】【page_72】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the carrying value was $2,147 million in fiscal 2022, decreased to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. However, the LLM claims the value was $1.637 billion in both FY 2022 and FY 2023, which is incorrect for 2022 (off by over $500 million) and slightly off for 2023. The 2024 value of $2.000 billion is correct. (2) The calculation of a $363 million increase is based on incorrect prior values and does not reflect the actual trend: the correct change from 2022 to 2023 is a decrease of $543 million, followed by an increase of $396 million from 2023 to 2024. The LLM fails to capture the decrease in 2023 entirely. (3) The multi-hop reasoning is partially sound in that it identifies the need to track the note across years and interpret the trend, but it misses the key fluctuation—specifically the reduction in debt in 2023—leading to an incomplete and misleading conclusion about 'incremental expansion' rather than a more nuanced 'decrease then rebound' pattern. (4) While the final year's number and general direction in 2024 are correct, the omission of the 2022–2023 decline and use of incorrect base figures severely undermine factual accuracy. The qualitative reasoning is plausible but based on flawed data, and the contextual relevance remains high as the answer addresses the right metric and timeframe, just with wrong numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 417,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "From 2022 to 2024, MetLife’s short‑term debt—primarily its commercial‑paper program—fell from $175 million in 2022 to $119 million in 2023 but rose sharply to $465 million in 2024, indicating a renewed reliance on low‑cost, short‑term funding. Throughout this period the company continued to draw on a broad mix of global sources—preferred and common equity, short‑term and long‑term debt, collateral financing, junior subordinated securities, policy‑holder account balances, credit and committed facilities, and a shelf registration statement—which it says enhances flexibility, limits dependence on any single market, and generally lowers the cost of capital.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any specific dollar amounts for MetLife's commercial paper balances in 2022, 2023, or 2024—yet the LLM asserts precise figures ($175M, $119M, $465M), which are unsupported by the original answer and likely incorrect. These numbers fundamentally misrepresent the evolution of MetLife's funding dependence. (2) There is no verification of calculations because the original answer does not provide numeric data to support the LLM's claims; thus, the entire quantitative trajectory (decline then sharp rise) is fabricated. (3) While the LLM correctly identifies the qualitative strategy—diverse funding sources, use of commercial paper, credit facilities, and the goal of lowering cost of capital and reducing market dependence—it fails on multi-hop reasoning by inventing numerical trends not present in the source. The original answer emphasizes consistency across years, not fluctuation. (4) The contextual relevance is fair because the answer addresses the right themes (funding diversity, short-term debt, cost of capital), and the general structure of funding sources aligns with the original. However, the invention of specific financial figures severely undermines factual correctness, warranting a low overall score despite some accurate conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 391,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantees remained non‑material throughout 2022‑2024 (Note 4, 2024 10‑K, p. 81).  Short‑term notes payable to subsidiaries rose from $8.1 B in 2022 (p. 83) to $9.9 B in 2023 (p. 78) and then fell sharply to $2.0 B in 2024 (p. 81), while long‑term notes payable to subsidiaries increased to $14.4 B in 2024 (p. 81).  This shift from short‑term to long‑term financing, coupled with the consistently low service‑level guarantee exposure, indicates a deliberate liquidity‑management strategy that reduces short‑term debt obligations and keeps contractual risk exposure minimal.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the trend in short-term notes payable to subsidiaries: $8.1B in 2022, $9.9B in 2023, and $2.0B in 2024, matching the ground truth. It also correctly states that service level guarantees were consistently non-material. However, it introduces a new figure—long-term notes payable to subsidiaries increasing to $14.4B in 2024—which is not present in the original answer or implied by the ground truth. This addition is unsupported by the provided truth and changes the interpretation by suggesting a refinancing shift (short-term to long-term), which was not part of the original conclusion.\n\n2) Quantitative accuracy is partially compromised due to the inclusion of the $14.4B long-term debt figure, which has no counterpart in the ground truth. While the short-term notes values are accurate, the introduction of an unverified long-term obligation misrepresents the company's debt structure evolution. No calculation errors are present, but the synthesis includes extraneous, unverified data.\n\n3) The reasoning is mostly sound in linking liquidity commitments and contractual risk, and the conclusion about minimal service-level guarantee exposure aligns with the original. However, the claim of a strategic shift from short-term to long-term financing is an overinterpretation not supported by the ground truth, which only notes volatility in total notes payable without specifying maturity breakdowns. This affects qualitative accuracy despite otherwise correct entity and year alignment.\n\n4) The answer is highly contextually relevant, addressing both service level guarantees and notes payable trends, and synthesizing them into a broader narrative about liquidity and risk. The unsupported long-term debt figure is the primary flaw, preventing a higher score. Overall, the core facts are correct, but the added detail introduces factual inaccuracy, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 520,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022‑23 to 2024, American Express has remained the fourth‑largest general‑purpose card network but has faced mounting competitive pressure from Visa, Mastercard, China UnionPay and a surge of alternative payment platforms, prompting the company to broaden its product mix to include digital wallets, integrated payments and new banking services.  Regulatory scrutiny has intensified—American Express became a Category III bank‑holding firm in 2024, is subject to tighter oversight on interchange fees, network routing and merchant‑acceptance rules, and has exited EU and Australian network‑licensing businesses—leading the company to strengthen its compliance and risk‑management framework, cooperate with regulators, and adjust pricing and partnership strategies to preserve its competitive position while meeting evolving regulatory demands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original ground truth. (1) All key facts are correct: American Express remained the fourth-largest general-purpose card network from 2022–2024; it faced increasing competition from Visa, Mastercard, China UnionPay, and alternative platforms like PayPal and Alipay (implied by 'surge of alternative payment platforms'); in 2024, Amex became a Category III firm under U.S. bank regulation; it exited network licensing in the EU and Australia due to regulatory pressure; and it faced scrutiny over interchange fees, network routing, and merchant acceptance. (2) Quantitative accuracy is perfect: the dates (2022–2024), the regulatory designation (Category III in 2024), and geographic scope (EU, Australia) all match the ground truth. No numerical errors or miscalculations. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes competitive dynamics, regulatory changes, and strategic responses across time. It connects Amex’s competitive positioning with evolving regulatory constraints and strategic adaptations. The only minor gap is that the original answer emphasizes a shift in tone and strategic posture—from market-driven competition to regulatory navigation—more explicitly, and mentions specific regional systems like NPCI, which the LLM omits. (4) Despite these small omissions, the LLM captures the core evolution and strategic implications. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing competitive positioning, regulatory dependency, and strategic responses as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 440,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From 2022 through 2024 ConocoPhillips consistently changed its cash‑settled PSU policy so that, for performance periods beginning in 2018 or later, recipients no longer receive a quarterly cash dividend equivalent during the period; instead they receive an **accrued reinvested dividend equivalent that is charged to compensation expense and paid only at settlement**【page_136】【page_125】【page_126】.  This shift—from a cash dividend during the performance period to a deferred, reinvested dividend—demonstrates the company’s deliberate effort to align executive pay with long‑term shareholder value by tying compensation to performance outcomes and reducing short‑term cash outlays.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and reasoning. (1) It accurately identifies the shift in dividend equivalent structure for performance periods beginning in 2018 or later: recipients receive accrued reinvested dividends paid at settlement, not during the performance period. This matches the original answer’s claim and is correctly contrasted with pre-2018 treatment. The dates (2018 as the transition point) and the nature of the change (from no in-period payments to deferred, reinvested equivalents) are factually correct. (2) There are no numerical inaccuracies—dates and structural descriptions are consistent with the ground truth. The references to pages 136, 125, and 126 support the claims. (3) The reasoning is sound: the LLM correctly infers that this change reflects stronger long-term incentive alignment by deferring rewards until performance outcomes are known. However, it incorrectly states that the company 'consistently changed' its policy from 2022 to 2024, implying an ongoing evolution during that period, whereas the original answer clarifies the change occurred earlier (for periods starting 2018+) and remained consistent through 2022–2024. This misrepresents the timeline of the policy change. Additionally, the LLM omits the detail about vesting tied to five years or retirement eligibility and the consistent liability classification on the balance sheet, which are part of the full picture of ConocoPhillips’ long-term approach. (4) Despite these omissions and the slight mischaracterization of timing, the core insight about long-term alignment and reduced short-term payouts is valid and well-reasoned. Hence, high scores for quantitative accuracy and contextual relevance, with a minor deduction in qualitative accuracy and overall correctness for incomplete synthesis and slight misstatement of the change timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 514,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "Special‑use fund balances rose from **$7.34 billion in 2022 (NEE $4.44 billion + FPL $2.91 billion)** to **$8.83 billion in 2023 (NEE $5.29 billion + FPL $3.54 billion)** and to **$9.80 billion in 2024** (NEE + FPL)【page_88】【page_87】【page_64】.  In contrast, the collateral posted by NEE subsidiaries fell from **$4.62 billion in 2022 (cash $1.81 billion + letters of credit $2.81 billion)** to **$2.29 billion in 2023 (cash $0.69 billion + letters of credit $1.60 billion)**, while the potential collateral requirement if credit‑risk triggers were activated dropped from **$5.20 billion in 2022 to $2.40 billion in 2023**【page_86】.  Thus, the growing special‑use funds provide a larger liquidity cushion relative to derivative‑related collateral obligations, underscoring a strengthening liquidity position over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Special Use Funds were $8,698 million ($8.698 billion) in 2023, not $8.83 billion as stated in the LLM answer. The LLM also introduces a 2022 figure of $7.34 billion derived from a sum of NEE and FPL components, but the ground truth does not provide a total Special Use Fund value for 2022—only disclosures about collateral requirements. The LLM incorrectly states that actual collateral posted in cash was $1.81 billion in 2022, while the ground truth reports $84 million; similarly, it claims total collateral posted dropped from $4.62 billion to $2.29 billion, which contradicts the ground truth stating cash collateral increased from $84 million to $691 million. The potential collateral requirement drop from $5.2B to $2.4B is correct and well-aligned. (2) Calculations and comparisons are flawed: the LLM’s breakdown of Special Use Funds by subsidiary and its total for 2022 are not supported by the ground truth, which only provides the 2023 and 2024 totals. The collateral figures appear to conflate cash and letters of credit into a total not mentioned in the original answer, and the magnitude of those numbers ($4.62B vs $2.29B) does not match the ground truth focus on cash-only changes ($84M to $691M). (3) Multi-hop reasoning is partially sound—the LLM correctly infers that rising Special Use Funds and falling potential collateral obligations suggest improved liquidity and risk management, which aligns with the ground truth’s conclusion. It identifies the right entities (NextEra Energy, derivative collateral, Special Use Funds) and time periods (2022–2024). However, it introduces unverified component data (NEE vs FPL splits) and misrepresents actual collateral posted, undermining the synthesis. (4) The contextual relevance is high because the answer addresses the core question about liquidity positioning relative to derivative obligations and attempts to show trends over time. Qualitative accuracy is moderate due to correct directional logic but flawed data inputs. Quantitative accuracy is low due to major discrepancies in key financial figures. Correctness score is 6 because while the strategic interpretation is reasonable and some facts (like the $2.4B 2023 potential collateral) are correct, the foundational numbers are often wrong, leading to a partially incorrect evidentiary basis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 646,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s 1.600% senior notes have remained unchanged at a $700 million principal balance from 2022 through 2024, with no amortization or redemption until the 2026 maturity (2022 10‑K, page 48; 2023 10‑K table, page 110; 2024 10‑K table, page 113). The consistent principal balance and lack of early repayment indicate a strategy of holding the notes to maturity while using other credit facilities to refinance or pay down other debt, thereby maintaining a predictable and stable debt profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amount of $700 million for the 1.600% Notes and confirms it remained unchanged from 2022 through 2024, which matches the ground truth. This satisfies quantitative accuracy. The maturity date (2026) is an additional detail not in the original answer but consistent with typical note structures and does not contradict the ground truth. (2) All numeric values—principal amount and time period—are accurate. However, the LLM does not mention the 'adjustments to principal' (e.g., amortization or accrued interest) decreasing from (3.7) million in 2022 to (2.6) million in 2024, which is a key part of the original answer and relevant to the amortization trajectory. This omission affects completeness and qualitative accuracy. (3) The reasoning about debt management strategy—holding to maturity and maintaining a stable debt profile—is plausible and contextually sound, but it diverges from the original answer’s focus on 'declining adjustments' suggesting predictable amortization patterns. The LLM instead emphasizes lack of amortization, which may be misleading if 'adjustments' represent amortized amounts. This reflects a difference in interpretation of the instrument's behavior. (4) The answer is contextually relevant and factually correct on principal stability, but incomplete on the amortization trajectory, leading to a lower qualitative and overall correctness score despite strong quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 407,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes remained high from 2022 through 2024, as CMS continued to freeze or cut benchmarks and alter the risk‑adjustment methodology (2022 page 25; 2023 page 20; 2024 page 20). In each year the company responded by selectively adjusting member benefits and premiums, withdrawing plans from certain counties, and tightening medical and operating cost controls, while also increasing focus on risk‑adjustment data‑validation audits to mitigate potential payment adjustments (2024 page 20). These consistent strategic measures were designed to offset the evolving regulatory pressures on Medicare Advantage reimbursement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 is accurately described, with CMS altering methodologies each year. The strategic responses—adjusting benefits and premiums, exiting counties, tightening cost controls—are consistent across both answers. The mention of increased focus on risk-adjustment data-validation audits in 2024 (citing 2024 page 20) adds a specific detail not in the original answer but does not contradict it and is plausibly supported by the source. (2) There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying persistent regulatory pressure and evolving corporate responses. (4) Semantic equivalence is strong—wording differs but meaning matches. The only minor gap is that the original emphasizes the 'evolving' nature of the response more explicitly, while the LLM presents strategies as consistent across years. However, this is a nuance rather than an error. The added citation of specific page numbers enhances credibility. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 390,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "From 2022 through 2024, Target’s employee merchandise discount remained a component of the benefits package described as a “merchandise and other discount,” with eligibility and level varying by full‑time/part‑time status, location, compensation level, and tenure (TGT_10k_2022, page 6; TGT_10k_2023, page 6; TGT_10k_2024, page 6). The program’s scope and structure did not materially change across the three years, underscoring Target’s strategy of maintaining a stable, inclusive discount benefit to support employee financial well‑being. This consistency reflects Target’s focus on providing reliable financial support to employees rather than frequent benefit adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that merchandise discounts remained a stable part of Target's employee benefits from 2022 to 2024 and that eligibility varied by employment status, location, compensation, and tenure, with citations across all three 10-Ks. There are no numeric inaccuracies, and the core assertion of stability in the discount program is supported, earning full marks for quantitative accuracy. However, the LLM answer falls short in capturing the evolving strategic context emphasized in the ground truth. While it correctly notes consistency in the discount structure, it fails to acknowledge the broader evolution in Target’s employee financial well-being strategy—such as the wage increases (from $15 to $15–$24), the addition of sick pay, tuition-free education, and expanded mental health and virtual healthcare benefits in 2023 and 2024. The original answer highlights that although the discount itself did not change materially, its framing within a more comprehensive, holistic well-being strategy did evolve, indicating a strategic shift in how Target supports employees. The LLM answer misses this multi-hop synthesis, incorrectly implying that the lack of change in discount structure means Target’s strategy centered on 'reliable financial support' through stability, rather than recognizing that the stability of the discount occurred alongside significant expansions in other benefits. This omission reduces qualitative accuracy. Contextually, the answer is relevant and addresses the question’s focus on discount evolution and strategy, but with incomplete reasoning. Thus, the correctness score is 6—partially correct with significant gaps in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 465,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express kept its foreign‑government‑bond holdings in a highly liquid, short‑term profile over the three‑year period. In 2022 the $630‑million balance was almost entirely due within one year, with a weighted‑average yield of 1.74 % for that bucket (overall 2.08 %)【page_121】. The 2023 and 2024 10‑K tables (pages 133 and 176) show a similar concentration in the one‑year bucket and yields that remained in the low single digits, underscoring a conservative, liquidity‑centric risk appetite that prioritizes capital preservation while generating modest returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $630 million holding in 2022, it misrepresents the yield data and maturity distribution. According to the ground truth, in 2022, American Express held securities with two distinct maturity buckets: 1.74% yield for those due within one year and 2.42% for those due after one but within five years. The LLM incorrectly states an 'overall 2.08%' yield and claims the portfolio was 'almost entirely due within one year,' which contradicts the presence of a meaningful 5-year bucket. In 2023, the ground truth shows a sharp increase in yields to 6.45% (under one year) and 4.48% (1–5 years), but the LLM claims yields 'remained in the low single digits,' which is false—6.45% is not low single-digit. In 2024, yields dropped to 5.86% (under one year) and sharply to 2.03% (1–5 years), but the LLM fails to mention this decline, especially the collapse in longer-term yields. (2) The LLM omits all 2023 and 2024 dollar amounts and incorrectly generalizes yield trends. It also fabricates an 'overall 2.08%' figure not present in the ground truth. (3) The multi-hop reasoning is flawed: the question asks for evolution across three years in yield and maturity distribution and what it suggests about risk appetite. The ground truth shows a clear shift—increased yields in 2023 indicating aggressive short-term positioning, followed by a pullback in 2024—suggesting dynamic strategy. The LLM instead asserts a static, conservative, liquidity-centric strategy, missing the volatility and strategic shifts entirely. (4) Due to major quantitative errors, incorrect synthesis, and failure to capture the evolving strategy, the correctness score is low at 3. Quantitative accuracy is 3 because only the 2022 dollar amount is correct. Qualitative accuracy is 3 due to flawed reasoning and mischaracterization of strategy. Contextual relevance is 6 because the answer addresses the right topic and metric but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 544,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements – which is reported within the “Other assets, including intangibles – net” line – fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (page 102 for 2022‑23; page 99 for 2023‑24). This steady decline indicates a tightening of collateral requirements, suggesting the company is managing its derivative exposure more efficiently through improved netting, reduced net derivative positions, or more effective hedging.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million (rounded to $1.49 billion) in 2022, $800 million in 2023, and $491 million in 2024 — matching the ground truth exactly in substance with acceptable formatting variation. 2) Quantitatively, all figures are accurate and correctly attributed across years; no calculation errors. 3) The multi-hop reasoning is sound: the model correctly identifies the trend (downward) and synthesizes it with derivative exposure management, noting efficiency gains through improved netting or reduced positions. 4) The qualitative interpretation slightly reframes the ground truth’s 'strategic reduction in derivative-related exposure or shift in risk management' as 'managing derivative exposure more efficiently', which is semantically similar but introduces 'tightening of collateral requirements' — a plausible inference but not explicitly supported by the original data. This minor interpretive addition does not distort the facts but adds a nuance not present in the ground truth. Overall, the answer is factually correct, complete, and contextually appropriate with only a slight deviation in explanatory emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 330,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "The 2.700% Notes were first issued on March 29 2021 for $700 million at a fixed 2.700% coupon with a maturity of April 15 2031 (page 48).  Through 2023 and 2024 the notes remained unchanged – the principal stayed at $700 million, the coupon stayed at 2.700%, and no new issuances or rate adjustments were made (pages 111 and 114).  The company used the proceeds from the 2021 offering to repay existing indebtedness under the 2021 Multicurrency Credit Facility (page 47).  This stability indicates a strategy of locking in a low, fixed‑rate long‑term debt and refinancing older, higher‑cost debt, reflecting favorable market conditions and a strong credit profile over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance date (March 29, 2021), principal amount ($700 million), coupon rate (2.700%), and initial maturity date (April 15, 2031)) as per the 2022 disclosure. However, it fails to note the key change in maturity date from April 15, 2031, to January 15, 2031, as reflected in the 2023 and 2024 filings. This is a significant factual discrepancy. Additionally, the LLM does not mention the reduction in interest rate spread from (5.0) to (4.4) by 2024, which is a critical detail in assessing evolving borrowing costs. (2) Quantitative accuracy is partially compromised: while the $700 million principal and 2.700% coupon are correctly reported, the maturity date is inaccurately maintained as April 15, 2031, throughout, contradicting the updated January 15, 2031, date in later filings. The interest rate spread change is omitted entirely. (3) The reasoning about AMT’s financing strategy—locking in fixed-rate debt to refinance higher-cost obligations—is sound and aligns with the ground truth’s interpretation of stable long-term financing. The use of proceeds to repay the 2021 Multicurrency Credit Facility is accurate and adds contextual depth. However, the failure to incorporate the maturity date update and narrowing interest spread limits the multi-hop synthesis, particularly across 2023–2024 updates. (4) Despite missing key quantitative updates, the answer remains contextually relevant and provides a coherent narrative about AMT’s strategy. The qualitative reasoning is strong, but the correctness score is reduced due to material omissions in dates and rate spread, which are central to the question about evolution over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 461,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 carried a net amount of **$1.25 billion** at the end of 2024, the same figure reported in the 2025 debt schedule (indicating no change since at least 2022)【page_72】.  The overall net carrying amount of all debt fell only modestly from **$8.463 billion** in 2025 to **$8.459 billion** in 2024, underscoring a strategy of maintaining a stable, low‑interest, long‑dated debt profile rather than frequent refinancing or large issuances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the fair value of the 2.00% Notes Due 2031 was $1.2 billion in 2022, increased slightly to $1.044 billion at the beginning of 2023, remained stable at $1.057 billion by the end of 2023, and reached a carrying value of $1.25 billion in 2024. The LLM incorrectly claims the $1.25 billion amount has been unchanged since at least 2022, which contradicts the documented evolution across years. Additionally, the LLM references '2025' financial data (e.g., $8.463 billion in 2025), which is outside the requested 2022–2024 timeframe and not part of the ground truth. (2) Quantitative accuracy is severely compromised: the LLM omits the 2022 $1.2B figure, misrepresents the 2023 values ($1.044B and $1.057B), and falsely asserts stability since 2022. The mention of total debt values ($8.463B in 2025, $8.459B in 2024) introduces data not present in the original answer and distracts from the specific note in question. (3) The multi-hop reasoning is flawed: instead of tracing the evolution of the 2.00% Notes Due 2031 across 2022–2024 as required, the model focuses on an incorrect timeline and irrelevant aggregate debt figures. It fails to recognize the progression and stability pattern described in the ground truth, leading to an incorrect conclusion about strategic consistency. (4) While the general idea of a 'stable, low-interest, long-dated debt profile' aligns thematically with the original conclusion, the factual foundation is incorrect, undermining the reasoning. The contextual relevance is moderate because it discusses long-term debt strategy but uses wrong data and timeframes, reducing its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 468,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s deposit‑method reinsurance assets grew sharply from $1.8 billion (the last figure disclosed for 2021) to $5.1 billion in 2023 and then fell modestly to $4.6 billion in 2024, while deposit liabilities rose from $1.4 billion to $1.3 billion and then to $1.2 billion【page_216】【page_206】. This pattern shows a rapid expansion of deposit‑method reinsurance in the early 2020s, followed by a slight contraction in 2024, indicating the company is adjusting its reinsurance mix—likely shifting toward more structured or quota‑share arrangements to balance risk and capital.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly in the asset figures and years. According to the ground truth, MetLife's deposit assets increased from $1.8 billion in 2022 to $5.1 billion in 2024, showing a consistent upward trend. However, the LLM claims assets rose to $5.1 billion in 2023 and then fell to $4.6 billion in 2024, which contradicts the ground truth. Additionally, the LLM incorrectly references $1.8 billion as the 'last figure disclosed for 2021', while the original answer clearly states 2022 as the starting point. The liability figures are mostly correct—$1.4B in 2022, $1.3B in 2023, $1.2B in 2024—but the interpretation of a 'slight decline' is misrepresented as a trend without acknowledging the overall stability. (2) The calculation of trends is flawed due to incorrect base years and endpoint values. The claim of a 'modest fall' to $4.6B in 2024 is unsupported by the ground truth, which reports $5.1B in 2024. The $10.3B Global Atlantic transaction, a key driver in the asset increase, is omitted entirely, weakening the explanation. (3) The multi-hop reasoning is partially sound—the LLM recognizes that changes in deposit method accounting reflect strategic reinsurance shifts—but it fails to correctly synthesize the timeline and magnitude of changes. The inference about shifting to 'quota-share arrangements' is speculative and not supported in the original answer. (4) Despite the factual errors, the answer remains contextually relevant by addressing the evolution of deposit method accounting and attempting to interpret strategic implications. However, the quantitative inaccuracies severely undermine the correctness score, warranting a 4. The qualitative reasoning is logically structured but based on incorrect data, meriting a 5. Quantitative accuracy is low (3) due to wrong numbers and misattributed years. Contextual relevance is strong (8) as the response stays focused on the question’s core theme.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 540,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt securities declined in both fair value and carrying value over the three‑year period: fair value fell from **$679 million in 2022 to $596 million in 2023 and $508 million in 2024**, while carrying value dropped from **$696 million to $603 million and $512 million**. The consistent downward trend reflects the impact of rising interest rates on bond prices, yet the company’s continued “held‑to‑maturity” policy shows a conservative, low‑risk investment strategy that accepts market‑valuation adjustments without recognizing unrealized gains or losses in earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numeric values for fair value and carrying value across 2022, 2023, and 2024, matching the ground truth exactly: $679M/$696M (2022), $596M/$603M (2023), $508M/$512M (2024). No calculation errors; all figures are accurate and properly attributed to UnitedHealth Group (UNH) and the correct years.\n\n2) Quantitative accuracy is perfect. All dollar amounts and years are correct, with acceptable formatting (e.g., $679 million vs $679M). The trend of consistent decline is accurately described.\n\n3) The qualitative reasoning is strong and adds value by interpreting the decline in the context of rising interest rates and the held-to-maturity accounting policy. While the original answer attributes the trend to 'strategic reduction or repositioning,' the LLM offers a plausible and financially sound explanation involving market conditions (rising rates lowering bond prices) and accounting treatment (no recognition of unrealized losses). This is a reasonable extension, not contradicted by the ground truth, and demonstrates sound multi-hop reasoning by linking market dynamics to financial reporting behavior.\n\n4) The only reason for not giving a full 10 on qualitative accuracy is that the LLM slightly shifts emphasis from the original answer’s focus on 'strategic reduction or repositioning' to a more market-driven explanation. However, this does not contradict the original and is contextually appropriate. The answer remains semantically aligned and enhances the interpretation without introducing error.\n\nOverall, the response is factually correct, complete, and contextually relevant, with excellent synthesis of financial data and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 461,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "Target’s credit‑card penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024 (RedCard penetration)【page_27】.  Because Target tracks penetration as a proxy for the incremental sales that the card generates【page_29】, the downward trend suggests the card’s ability to drive additional sales is weakening or that the incremental‑sales benefit is diminishing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and time periods are accurate. (2) The calculations and comparisons are not explicitly performed but the trend description (declining penetration) is correct and consistent with the data. No mathematical errors. (3) The reasoning correctly identifies that declining penetration suggests weakening effectiveness in driving incremental sales, aligning with the ground truth interpretation. It references Target's use of penetration as a proxy for incremental sales, which reflects proper synthesis of strategic context. However, it omits the nuance that Target still sees 'meaningful' incremental sales despite the decline, which slightly weakens the qualitative completeness. (4) The answer is highly relevant, directly addressing both parts of the question—trend in penetration and its implication for credit card strategy. The omission of Target's continued recognition of strategic value prevents a perfect score, but all presented information is factually and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 334,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike continued to own its Laakdal, Belgium distribution center from FY 2022 through FY 2024, with no change in ownership or operational footprint reported in the 10‑K filings. The center remains listed as a key distribution facility outside the United States, underscoring Nike’s strategy of owning critical European logistics assets to support its global supply chain and e‑commerce operations. [page_27] [page_29]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that Nike maintained ownership of the Laakdal facility from FY2022 to FY2024 with no changes in ownership or operational footprint, which matches the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (fiscal years 2022–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes consistent descriptions of the facility across years and infers strategic intent (owning critical European logistics assets), which is logically supported by the stable operational role. The only minor gap is that the original answer explicitly notes the facility was described as 'one of the most significant international distribution centers' in each year, a detail slightly more specific than 'key distribution facility outside the United States' used by the LLM. However, this does not affect factual correctness. (4) The answer is fully relevant to the question, addressing both ownership/operational evolution and strategic implications. The citation of page numbers adds contextual support. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 355,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum Holdings has appeared in NVIDIA’s “networking products” competitor list in every filing from FY 2022 through FY 2024 (pages 15, 9, 9), indicating no change in its presence in the disclosed landscape.  Across the same period, NVIDIA has reiterated its strategy of expanding supply‑chain redundancy in the Asia‑Pacific region (page 10) and of bolstering IP protection through a growing patent portfolio and licensing agreements, with particular attention to jurisdictions with weaker enforcement (pages 15, 9, 9).  These continued supply‑chain and IP‑protection efforts reinforce NVIDIA’s competitive resilience, but Lumentum remains a listed rival without any shift in its relative positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Lumentum Holdings has been consistently listed as a competitor by NVIDIA in the domain of networking products across FY 2022–2024, which matches the original answer’s core claim. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—references to filing pages (e.g., pages 9, 15) are consistent with typical 10-K structures and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that despite NVIDIA’s strategic efforts to strengthen supply chain resilience (e.g., redundancy in Asia-Pacific) and expand IP protection (growing patent portfolio), Lumentum remains a named competitor, indicating stable competitive positioning. This mirrors the original answer’s conclusion. (4) The only minor shortcoming is that the LLM does not explicitly name TSMC and Samsung as key manufacturing partners or specify the extension of patent expirations to 2045, which are details included in the ground truth that strengthen the narrative around IP strategy. However, the general claim about bolstering IP protection is accurate and contextually sufficient. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only slight omission of granular detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 395,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s 10‑K filings from 2022‑24 consistently state that the company’s service depends on licensing rights from studios and other rights holders, and that refusal or withdrawal of those rights can harm the business [page_11]. The 2022 filing warned of rising costs and competition, the 2023 filing reiterated the reliance on licensing rights, and the 2024 filing adds that new regulatory frameworks—content quotas, levies and investment obligations—may further constrain licensing, prompting Netflix to accelerate original‑content production and local partnerships to reduce reliance on external rights [page_4]. This evolution shows a strategy that balances licensed titles with a growing slate of original and locally produced content to navigate competitive pressures and regulatory constraints [page_4].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Netflix's continued reliance on content licensing from 2022–2024, the increasing emphasis on competition (especially studios launching their own platforms), rising costs, and the addition of regulatory constraints in 2024 such as content quotas and investment obligations. The strategic shift toward original content and local partnerships is correctly inferred. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution in risk factor language and strategic response. The mention of 'page_4' and 'page_11' suggests accurate sourcing from the documents. The only minor shortcoming is that the original answer more explicitly frames the 2023 discussion around 'variability of license terms' and 'compelling mix of content for membership growth,' which the LLM omits but does not contradict. (4) Contextual relevance is perfect—the answer directly addresses how Netflix’s reliance on rights holders evolved and what that reveals about its strategy amid competition and regulation. Wording differs slightly but meaning is semantically equivalent. Thus, correctness is 9 due to minor omission in 2023 detail, but not enough to reduce the score further.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 411,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "In 2022 Southern Company’s note described outdoor‑lighting contracts as operating leases with initial terms of up to seven years, treated the scheduled lease payments as immaterial, and presented them only in the maturity‑analysis table (page 268, page 240).  In 2023 the note was updated to state the initial terms were up to ten years, but the classification, immateriality, and presentation in the maturity analysis remained unchanged (page 242, page 241).  By 2024 the contracts were still classified as operating leases, the payments were still immaterial, and they continued to appear in the updated maturity‑analysis table (page 231, page 232), while lease income for Alabama Power and Southern Power remained included in wholesale revenues.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth, particularly regarding the evolution of materiality and presentation in maturity analyses. (1) The original answer states that in 2022, the undiscounted cash flows were considered immaterial, which the LLM correctly notes. However, the LLM incorrectly claims that these payments were presented in the maturity analysis table in 2022 — the ground truth does not support this, as no such inclusion is mentioned for 2022; the structured reporting began only in 2023. (2) The LLM asserts that presentation in the maturity analysis 'remained unchanged' in 2023 and 2024, directly contradicting the ground truth, which emphasizes a clear evolution: 2023 marked the start of including these payments alongside tolling arrangements and PPAs, and 2024 saw an explicit disclosure of inclusion. The LLM incorrectly implies consistency over time rather than recognizing a progression toward greater transparency. (3) The LLM introduces specific page numbers (e.g., page 268, 240, etc.) not present in the ground truth, raising concerns about hallucination. (4) The mention of lease income for Alabama Power and Southern Power being included in wholesale revenues is extraneous and not responsive to the question about treatment and disclosure of lease payments under outdoor lighting contracts. (5) The extension of initial terms from 'up to seven years' to 'up to ten years' is not supported by the original answer and appears to be an unsupported detail. Overall, while the LLM captures the operating lease classification and immateriality, it fundamentally misrepresents the evolution of disclosure practices, missing the key multi-hop insight that Southern Company progressively formalized and expanded its reporting from 2022 to 2024. This results in a low correctness score despite some surface-level alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 510,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "AVGO’s 5.000% notes due April 2030 had an outstanding principal balance of **$606 million** at the end of FY 2022, and this balance remained unchanged at **$606 million** at the end of FY 2023 and FY 2024【page_80】. The steady balance indicates that the company has neither issued additional principal nor redeemed any of this note, reflecting a strategy of keeping the debt load for this instrument stable while using other notes for refinancing or capital‑structure optimization.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported outstanding principal balance for fiscal year 2022. The ground truth states that the balance was $1,086 million in FY 2022, but the LLM claims it was $606 million, which is incorrect. The values for FY 2023 and FY 2024 ($606 million) are correct. This error significantly undermines the quantitative accuracy. (2) The calculation of change over time is therefore flawed: the ground truth shows a reduction from $1,086M to $606M in 2023 (a $480M reduction), indicating active debt repayment, but the LLM implies no change across all years, which contradicts the data. (3) The multi-hop reasoning is partially sound in that the model attempts to interpret the stability of the debt balance after 2023, but it fails to recognize the key reduction event in 2023 because it misstates the 2022 value. As a result, the conclusion about a 'steady balance' and 'no issuance or redemption' is incorrect for the 2022–2023 period. (4) While the qualitative interpretation of stable debt post-2023 is reasonable and contextually relevant, the incorrect starting point invalidates the overall progression analysis. The model cites 'page_80' as a source, but the data still conflicts with the ground truth. The contextual relevance is high because the answer addresses both the evolution and strategic implication, but correctness is severely impacted by the wrong initial figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 400,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "General Motors’ weighted‑average long‑term rate of return on U.S. pension plan assets was 6.3 % in 2022 and 2023 and increased to 6.5 % at December 31 2024 (2024 10‑K, p. 88; 2023 10‑K, p. 87; 2023 10‑K table, p. 85). The modest rise reflects a deliberate shift toward higher‑return, higher‑risk asset classes—such as private equity, real estate, and other alternatives—to improve funded status while managing volatility in response to changing market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported 2022 rate of return. The ground truth states that the rate was 5.4% in 2022, but the LLM claims it was 6.3% in 2022 (and unchanged in 2023), which is incorrect. The 6.3% figure is accurate for 2023, and the increase to 6.5% in 2024 is correctly reported. This quantitative inaccuracy significantly undermines the answer’s correctness. (2) The calculation of the trend — a 1.1 percentage point increase from 5.4% to 6.5% over two years — is missing due to the incorrect starting value. The LLM implies only a 0.2 percentage point increase (from 6.3% to 6.5%), which misrepresents the magnitude and trajectory of change. (3) The qualitative reasoning about strategic asset mix adjustments — shifting toward higher-risk, higher-return investments like private equity and real estate — is sound, contextually appropriate, and aligns with the kind of interpretation supported by such an upward trend. The synthesis of market response and funded status management shows good multi-hop reasoning and understanding of pension fund strategy. (4) Despite strong contextual relevance and reasonable interpretation, the answer fails on quantitative accuracy due to the incorrect 2022 figure, which distorts the entire trend analysis. The correctness score is therefore moderate (6), reflecting that core elements are right (2023 and 2024 values, direction of change, strategic interpretation), but a key fact is wrong, affecting the overall reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 419,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "American Tower’s 2.700% Senior Notes due 2031 are listed as part of its long‑term debt in the 2022 and 2023 10‑K filings (see page 72).  In the 2024 filing those notes are no longer disclosed, where a new 4.625% Senior Notes due 2031 is issued (page 73).  This shift shows the company is actively refinancing older, lower‑coupon debt and maintaining a diversified long‑term debt mix to manage interest costs and support growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both fact and reasoning. (1) It falsely claims that the 2.700% Senior Notes due 2031 are no longer disclosed in the 2024 filing and that a new 4.625% Senior Notes due 2031 was issued, which contradicts the ground truth. The original answer confirms that the 2.700% Senior Notes due 2031 were consistently referenced across all three years (2022–2024) with the same Supplemental Indenture No. 8, indicating stability, not refinancing. (2) There are no numbers or calculations in the LLM answer that align with the ground truth—specifically, the introduction of a '4.625% Senior Notes due 2031' is entirely fabricated and not supported by any evidence in the provided truth. (3) The multi-hop reasoning fails completely: instead of recognizing the consistent treatment of the same debt instrument over time as evidence of a stable long-term financing strategy, the model incorrectly infers active refinancing and diversification. (4) Contextual relevance is low because the answer describes a dynamic refinancing strategy contrary to the actual stable approach. The only correct element is the mention of the 2.700% Senior Notes due 2031 being part of long-term debt in 2022 and 2023, but even this is undermined by the false claim about their absence in 2024. Overall, the answer reflects a serious misunderstanding of the data and misrepresents the company's financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 391,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "PayPal’s exposure to abusive behaviors remained a persistent risk from 2022 through 2024, especially around its credit products and cross‑border transactions. In 2022 the company flagged fraud and default risks in its credit offerings (page 24) and the potential for third‑party abuse of its platform (page 28). In 2023 it mitigated credit‑risk exposure by selling a large portion of its U.K. and European BNPL loan receivables (page 25) while still noting cross‑border trade risks (page 23). By 2024 PayPal broadened its mitigation strategy by diversifying payment‑processor reliance (page 21), investing in fraud‑detection measures (page 21), and continuing to monitor cross‑border trade risks (page 21).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of the evolution of PayPal's exposure to abusive behaviors and its risk mitigation strategies from 2022 to 2024. Quantitatively, no specific numbers (e.g., €40 billion) are misstated—the LLM correctly avoids inventing figures and instead refers to the sale of 'a large portion' of BNPL receivables, which is consistent with the original answer’s €40 billion figure (format variation acceptable). The years and sequence of events are correct: 2022 (identifying risk), 2023 (selling receivables), and 2024 (enhancing detection and managing third-party risks). The LLM correctly identifies credit products and cross-border transactions as key risk areas. However, the original answer includes a more precise strategic narrative: in 2024, PayPal emphasized ongoing reliance on third-party lenders and processors as a source of operational and reputational risk, which the LLM only partially captures by mentioning 'diversifying payment-processor reliance' and 'investing in fraud-detection.' The LLM omits the nuance that third-party dependencies themselves introduce risk (rather than just being part of the solution). Additionally, the original answer frames 2023’s receivable sale as a 'multi-year agreement to sell up to €40 billion,' a specific contractual commitment the LLM does not mention, though it correctly notes the sale. These omissions are minor and do not undermine the core accuracy. The reasoning is sound and multi-hop synthesis across years is appropriate. The answer is highly contextually relevant, directly addressing all parts of the question. Thus, the correctness score is 8 due to minor gaps in completeness and nuance, despite strong factual and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 480,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan reduced its share of Collective Trust and Other Funds from about **46.5 % of plan assets in 2022 (622 / 1,338 million) to 43.9 % in 2023 (370 / 842 million) and to 39.5 % in 2024 (382 / 966 million)**【page_58】. This downward trend reflects a deliberate shift away from these less liquid, higher‑risk funds toward a more diversified mix of equities and debt, in line with the company’s de‑risking strategy and its target allocation of 20‑30 % equity and 70‑80 % debt by 2025【page_55】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in dollar amounts and percentages, contradicting the ground truth. According to the original answer, UNP's allocation was $756M in 2022, $382M in 2023, and no dollar value was provided for 2024. However, the LLM claims $622M (2022), $370M (2023), and $382M (2024), which misrepresents the trend. The 2023 and 2024 dollar figures are swapped in context—$382M is cited as 2024 in the LLM answer but was actually reported for 2023 in the ground truth. Additionally, the LLM fabricates a 2024 dollar amount and percentage (39.5% = 382/966), which is unsupported because the original explicitly states no updated dollar value is available for 2024. (2) Calculations are internally consistent within the LLM’s fabricated data (e.g., 382/966 ≈ 39.5%), but they are based on incorrect inputs. The ground truth does not support using $382M in 2024 or any percentage calculation for that year. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a de-risking strategy and ties it to a broader investment shift toward debt, which aligns with the ground truth’s mention of de-risking. However, it adds unsupported specifics like a 'target allocation of 20–30% equity and 70–80% debt by 2025' not present in the original answer, introducing hallucinated details. (4) While the directional trend (decrease) and strategic interpretation (de-risking) are consistent with the ground truth, the incorrect numbers, misattribution of years, and invented data points severely undermine factual reliability. The contextual relevance is high because the answer addresses both parts of the question—trend and strategic implication—but the quantitative foundation is flawed, warranting a low correctness score despite some conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 491,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "Pfizer did not grant or have any Breakthrough Performance Awards (BPAs) in 2022, 2023, or 2024 – each 10‑K states that no BPAs were granted and none were outstanding as of December 31 of that year (2022: page 99; 2023: page 96; 2024: page 96). The valuation method remained the intrinsic‑value method based on the closing price of common stock, and the accounting treatment continued to amortize the fair value on a straight‑line basis over the vesting term into operating expenses, with periodic adjustments for stock‑price changes, expected shares earned, and performance‑criteria probability (2022: page 99; 2023‑24: page 96).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) Quantitatively, the LLM claims no BPAs were granted or outstanding in 2022, 2023, or 2024, but the ground truth states that in 2022, Pfizer issued 1,165 thousand BPAs with 859 thousand outstanding at year-end — a major factual discrepancy. The LLM incorrectly asserts zero activity across all years, while the truth shows significant 2022 activity, none in 2023, and a new methodology in 2024. (2) The LLM misrepresents the evolution: it fails to note the shift from active grants in 2022 to discontinuation in 2023 and the introduction of a formalized valuation framework in 2024. Instead, it falsely claims consistent 'no activity' across all three years. (3) The qualitative reasoning is flawed — it does not demonstrate multi-hop synthesis of changes over time; rather, it applies a static, incorrect narrative across years. (4) While the general description of the intrinsic-value method and amortization is consistent with accounting practices, this generic explanation does not compensate for the complete misrepresentation of grant and outstanding status. The contextual relevance is slightly higher because it addresses the right topic (BPA accounting) and cites correct methodology elements, but the core facts are wrong. Overall, the answer fails on correctness, accuracy, and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 381,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements for investments, advances and long‑term receivables fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024**. The steep decline indicates a shrinking derivative exposure or a shift to more efficient netting/hedging practices, resulting in lower initial‑margin requirements over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1.49 billion (equivalent to $1,494 million) in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly in substance despite minor formatting differences (e.g., $1.49 billion vs $1,494 million). These are semantically equivalent and quantitatively accurate.\n\n2) The answer addresses both parts of the question: it describes the change in collateral over time and interprets the trend in terms of derivative exposure and margin requirements. The interpretation aligns with the original answer, noting reduced exposure or strategic adjustments—here phrased as 'shrinking derivative exposure or a shift to more efficient netting/hedging practices,' which is a reasonable rewording of the original conclusion.\n\n3) All entities are correct: ExxonMobil (XOM), the financial metric (collateral under master netting arrangements), and the years 2022–2024 are accurately referenced. No incorrect companies, metrics, or time periods are introduced.\n\n4) The multi-hop reasoning is sound. The model synthesizes data across three years and draws a logical inference about derivative exposure and margin requirements based on the declining collateral. The conclusion is consistent with the trend and reflects appropriate financial reasoning. The only minor gap is that the LLM slightly reframes 'strategic adjustment in margin requirements' as 'more efficient netting/hedging practices,' which is plausible but not explicitly confirmed in the source. This nuance prevents a perfect 10 on qualitative accuracy, though it does not constitute an error.\n\nOverall, the answer is factually correct, complete, and contextually appropriate, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 474,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 10‑K positioned industrial fiber optics as a core part of its industrial portfolio, noting use in automation, power‑generation, medical, defense, aerospace and automotive applications—including EV power‑train, infotainment and ADAS (page_10 2022). The 2023 and 2024 10‑Ks repeat that same description, with no change in product mix or scope (page_10 2023; page_10 2024). This consistency signals a deliberate, sustained focus on high‑performance optical solutions for industrial and automotive markets, aiming to capture growth in these high‑margin segments.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual inaccuracy regarding the evolution of Broadcom's positioning of Industrial Fiber Optics across the years. The ground truth states that while the core applications remained consistent, there was a clear evolution in how the product was presented and structured—especially in 2023 with the introduction of a table emphasizing Factory Automation, Renewable Energy, and Automotive Electronics, and in 2024 with a more streamlined integration into broader semiconductor solutions. The LLM incorrectly claims there was 'no change in product mix or scope' and that the 2023 and 2024 10-Ks 'repeat that same description,' which contradicts the documented evolution in presentation and strategic emphasis. (2) There are no numerical values in this question, so quantitative accuracy is not applicable—however, the cited page numbers (page_10 2022, etc.) are plausible and do not contradict the ground truth, so no numeric errors are present. (3) The multi-hop reasoning is flawed: the question asks for an analysis of evolution across three years, requiring synthesis of changes in portfolio positioning and application scope. The LLM failed to identify the structural and communicative shifts in 2023 and 2024, missing the key insight about increasing application-specific clarity and integration with semiconductor solutions. This represents a failure in qualitative synthesis despite correct identification of the company and product. (4) The answer is contextually relevant and addresses the strategic focus part of the question, correctly inferring sustained commitment to industrial markets. However, due to the incorrect claim of no change over time, the conclusion about 'consistency' oversimplifies the nuanced evolution described in the ground truth, leading to a moderate correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 509,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal’s 10‑K disclosures for 2022, 2023 and 2024 all state that the company acts as the principal on payment transactions, retains full discretion over fee pricing, and bears the entire margin risk regardless of whether it uses third‑party processors (PYPL_10k_2022.pdf: p. 78; PYPL_10k_2023.pdf: p. 75; PYPL_10k_2024.pdf: p. 75). The same wording—“We therefore bear full margin risk when completing a payment transaction” and the recognition of processor fees as transaction expense—appears unchanged across the three years, indicating no evolution in PayPal’s control over pricing or its margin‑risk exposure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately captures the key factual points: PayPal acted as principal in transactions from 2022 to 2024, retained full discretion over pricing, bore full margin risk, and recognized third-party processor fees as transaction expenses. These facts are consistent with the ground truth across all three years. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly cited, and the references to page numbers and document types (10-K filings) align with expected sourcing. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual reports, and the conclusion that there was no evolution in margin risk exposure is logically supported by the repetition of identical or nearly identical disclosures. (4) The answer is contextually precise, directly addressing how PayPal’s margin risk, pricing control, and use of third-party processors evolved (or did not evolve) over the period. Minor wording differences (e.g., 'unchanged across the three years' vs. 'consistent narrative') do not affect factual accuracy. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 356,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "Pfizer sold its Meridian subsidiary in 2021 for $51 million cash, recording a $167 million net‑of‑tax loss, and then entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑service agreement (MSA) with the buyer that were still in effect in 2022 and 2023 but had no material financial impact (2022 10‑K, note 2B; 2023 10‑K, note 2B).  By 2024 the 10‑K contains no new disclosures about Meridian, indicating the post‑sale service framework remained unchanged and that Pfizer has fully divested the business while retaining only a limited, non‑core supply‑chain relationship (2024 10‑K, pages 2‑6).  This evolution underscores Pfizer’s long‑term strategy to shed non‑core assets and focus its resources on its core biopharma and vaccine portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $51 million sale price and $167 million net loss are accurately reported, and the 2021 sale date is consistent with the original answer’s note that the sale was completed in late 2021. The mention of the three-year MSA aligns with the ground truth. (2) The LLM correctly identifies the contractual arrangements (MSA and TSAs) and notes their continuation into 2022 and 2023, with no material financial impact—consistent with Meridian being part of discontinued operations. (3) The reasoning is sound: the LLM infers from the absence of new disclosures in the 2024 10-K that the relationship remained stable and non-core, which supports the conclusion of a strategic divestiture. (4) The strategic interpretation—that Pfizer is focusing on core biopharma and vaccine areas—matches the ground truth’s emphasis on refocusing on core therapeutic and platform technologies like mRNA. The only minor shortcoming is that the LLM does not explicitly mention the two-year extension option in the MSA or the 2024 glossary listing of 'Meridian Medical Technologies, Inc.', which adds a small detail about formalization. However, this omission does not undermine the overall correctness. The answer is semantically equivalent and contextually precise, with excellent multi-hop synthesis across years and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 395,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 through 2024 Philip Morris International (PMI) has consistently warned that regulatory limits on product differentiation and on how it can communicate with adult consumers about reduced‑risk products (RRPs/SFPs) threaten its competitive edge. In the 2022 filing (pp. 13‑16) PMI described how advertising bans, plain‑packaging rules, and restrictions on flavoring and novel‑product marketing could commoditize its portfolio and curb adult‑smoker conversion to RRPs. The 2023 filing (pp. 18‑20) reiterated these concerns, noting that new legal challenges around product classification, advertising restrictions, corporate communications and scientific substantiation for SFPs continue to curtail branding, differentiation and truthful information. The 2024 filing (pp. 18‑20) echoes the same narrative, underscoring that ongoing regulatory constraints on branding, communication and product differentiation remain a material risk to PMI’s ability to promote and sell RRPs, and that the company is intensifying compliance and risk‑mitigation efforts to protect its competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: PMI consistently reported regulatory constraints on product differentiation and adult consumer communication for RRPs/SFPs from 2022 to 2024. The evolution in language—maintaining consistent concerns while shifting terminology from RRPs to SFPs—is accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in a traditional sense; however, the cited page numbers (e.g., pp. 13–16, 18–20) are plausible and consistent with typical 10-K structures, and no incorrect figures are presented. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, identifies the continuity and subtle evolution in PMI’s regulatory risk narrative, and captures the increasing emphasis on commercialization challenges and compliance efforts. (4) The LLM adds contextual detail not in the original answer (e.g., plain packaging, flavor restrictions, scientific substantiation), which is consistent with typical PMI disclosures and enhances relevance without introducing inaccuracies. The only minor gap is that the original answer emphasizes the 'disproportionate impact' on RRP commercialization relative to competitors in 2023 and the terminological shift to SFPs in 2024 as a notable evolution—nuances slightly underemphasized in the LLM response. Still, the core message about persistent and intensifying regulatory pressure is correctly conveyed. Thus, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 475,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements for Notes and accounts receivable – net fell from **$1.494 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (a net decline of **$1.003 billion**). This downward trend, driven by reduced initial‑margin requirements, indicates that the company has tightened its netting and hedging processes, thereby lowering counterparty exposure and improving overall derivative risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million (2022), $800 million (2023), and $491 million (2024), matching the ground truth exactly. The net decline of $1.003 billion is accurately calculated ($1,494M - $491M = $1,003M). Minor formatting variation ($1.494 billion vs $1,494 million) is acceptable and semantically equivalent.\n\n2) The answer addresses both parts of the question: the quantitative change from 2022 to 2024 and the implication for derivative risk management. The trend is correctly described as downward, and the interpretation aligns with the ground truth—indicating improved risk management.\n\n3) All entities are accurate: ExxonMobil (XOM), 'collateral under master netting arrangements', 'Notes and accounts receivable - net', and correct fiscal years (2022–2024) are properly identified.\n\n4) The reasoning is sound and adds value: the LLM correctly infers that reduced margin requirements and tighter netting/hedging processes explain the trend. While the ground truth mentions 'strategic reduction in derivative exposure or shift in risk management', the LLM specifies potential mechanisms (tightened netting/hedging, lower counterparty exposure), which is a reasonable and logical extension. The phrase 'improving overall derivative risk management' is consistent with the original interpretation.\n\n5) The only reason for not scoring a 10 is that the LLM introduces a specific causal driver—'reduced initial-margin requirements'—which, while plausible, is not explicitly stated in the ground truth. The original answer attributes the trend more generally to 'strategic reduction' or 'proactive risk mitigation'. This addition is not incorrect but slightly exceeds the evidence, warranting a 9 in qualitative accuracy. Otherwise, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 500,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "From 2022 to 2024, Duke Energy’s TSR‑based performance award model’s expected volatility relative to its peer group rose from 18.7% in 2022 to 28.6% in 2023, then fell back to 18.7% in 2024 (page_206, page_207, page_213). This pattern indicates the company perceived higher market risk in 2023—likely reflecting a spike in market volatility—and then reassessed risk to a lower, more stable level in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 volatility value. The ground truth states Duke Energy's expected volatility was 26.9% in 2022, not 18.7% as claimed by the LLM. The 2023 value (28.6%) is correct, and the 2024 value (18.7%) is also correct. However, the LLM incorrectly states that volatility rose from 18.7% in 2022 to 28.6% in 2023, when in fact it increased from 26.9% to 28.6%. This misrepresents the starting point and trend. (2) The calculation of the trend is therefore flawed: the actual trend is an increase from 26.9% to 28.6% (a rise of 1.7 percentage points), followed by a sharp drop to 18.7% (a decrease of 9.9 percentage points), whereas the LLM implies a rise from 18.7% to 28.6% (a 9.9-point increase), then a return to baseline. This reverses the interpretation of the 2022–2023 movement. (3) The multi-hop reasoning is partially sound—the model correctly identifies the need to compare volatility assumptions across years and links them to market risk perception—but the faulty initial value undermines the analysis. The conclusion about increased risk in 2023 and reassessment in 2024 is plausible but based on incorrect data for 2022. (4) Contextual relevance is high, as the answer addresses both parts of the question: the evolution of volatility and its implication for market risk perception. However, due to the significant quantitative inaccuracy in the baseline year, the overall correctness score is limited to 4. The qualitative reasoning is logically structured but built on incorrect data, warranting a 5. Quantitative accuracy is scored at 4 due to two correct values out of three but a major error in the foundational data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 465,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Across FY 2022–FY 2024, the principal of Broadcom’s 3.125% notes due January 2025 stayed constant at $495 million, while the current portion of that debt was $0 in FY 2022 and FY 2023 and rose to $495 million in FY 2024 as the maturity approached【page_81】. This pattern, combined with the issuance of $10 billion of senior notes in 2024 and the repayment of $16.8 billion of term loans, demonstrates a proactive refinancing strategy that rolls short‑term obligations into longer‑term debt to keep short‑term exposure low and maintain covenant compliance【page_82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the principal amount of Broadcom's 3.125% notes due January 2025 remained at $495 million in FY 2022 and FY 2023, and that the current portion shifted to $495 million in FY 2024, aligning with the ground truth. This reflects accurate reporting of the debt's transition into the current portion of long-term debt as maturity approached. (2) All numeric values—$495 million (principal), $0 current portion in 2022–2023, $495 million current in 2024, $10 billion in new senior notes, and $16.8 billion in term loan repayments—are factually correct and consistent with the knowledge base. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly infers from the debt reclassification and additional financing activity that Broadcom pursued a proactive refinancing strategy, rolling short-term obligations into longer-term debt. This goes beyond the original answer by adding corroborating evidence (issuance and repayment figures), which strengthens the conclusion about refinancing strategy. (4) While the original answer stops at noting impending maturity and likely refinancing planning, the LLM enriches the analysis with specific supporting data from the filings, making it more comprehensive. The only reason for not scoring a 10 is that the original ground truth does not explicitly confirm the $10B issuance and $16.8B repayment were directly linked to these notes—though the inference is reasonable, it slightly extends beyond the provided truth. However, since the core facts and synthesis about the 3.125% notes are fully accurate, the correctness score remains high at 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 456,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "Across each 10‑K (2022, 2023, and 2024), AMD’s agreements with add‑in‑board (AIB) manufacturers consistently “protect their inventory of our products against price reductions” (see page 13 of each filing).  The same section also reiterates that system integrators “often use discrete graphics solutions as a means to differentiate their products and add value to their customers,” underscoring AMD’s continued emphasis on discrete GPUs as a differentiation lever.  In short, the inventory‑protection policy and the role of discrete graphics in differentiation remained essentially unchanged from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the consistent inventory protection policy across 2022–2024, citing the exact phrase used in AMD’s 10-K filings and referencing page 13 of each filing, which matches the original context. (2) There are no numerical values requiring calculation in this question, but the temporal references (2022–2024) are correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to conclude that both the inventory protection policy and the strategic role of discrete graphics in differentiation remained stable—this reflects accurate synthesis of AMD’s sustained strategy. (4) The answer captures the core elements of the original answer: inventory protection, AIB relationships, and the role of discrete GPUs in product differentiation. The only minor limitation is that it omits some contextual details present in the original answer—such as AMD supplying component-level graphics and chipset products to AIBs, or the emphasis on short design cycles and rapid response to technology changes—but these omissions do not undermine the factual correctness or overall completeness. The answer is semantically equivalent in conveying the key strategic continuity. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 403,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "Disney’s 2022 strategy focused on launching an ad‑supported Disney+ service, new pricing, and cost realignment to strengthen its DTC footprint (page 22). By 2024 the company had shifted to heavy strategic investments in its DTC platforms—including ESPN and a Star India joint venture—to drive subscription and advertising revenue growth while confronting a crowded DTC market and intensified competition for content and pricing (page 23, page 53). The 2024 outlook explicitly states that these investments should generate growth in subscription fees and advertising revenue that more than offsets declining linear‑network revenue (page 53, page 54).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Disney's DTC strategy from 2022 to 2024 with accurate qualitative progression—starting with cautious steps in 2022 (ad-supported tier, pricing changes), moving to strategic investment in 2024 focused on ESPN and Star India, and acknowledging increased competition. The core financial expectation from 2024—that subscription and ad revenue growth will offset declines in linear revenue—is accurately reported and aligns with the ground truth. However, the LLM omits the 2023 pivot, which is a key transitional point in the original answer where Disney expressed growing confidence in DTC returns. This omission slightly weakens the completeness of the multi-hop timeline. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2024) are correct. (3) The reasoning is largely sound: the LLM synthesizes information across years and identifies strategic shifts, but it skips 2023, which breaks the full multi-hop synthesis required for perfect accuracy. The mention of ESPN and Star India joint venture is contextually relevant and reflects accurate entity identification. (4) The answer is highly contextually relevant, directly addressing investment focus, competitive positioning, and revenue growth expectations. Despite missing the 2023 nuance, the overall trajectory from cautious to confident to competitive is preserved. Thus, correctness and qualitative accuracy are high but not perfect due to the missing 2023 link in the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 446,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "From 2022 through 2024 PayPal’s fixed‑rate 2.850% notes remained unchanged: the principal stayed at $1.5 billion, the maturity date stayed 10/1/2029, and the effective interest rate stayed 2.96%. Consequently, the maturity obligation for that note was constant across the three years, with the $1.5 billion due on 10/1/2029. While the company’s overall debt schedule shifted slightly (e.g., future principal payments for other notes), the 2.850% note’s debt structure and maturity obligations did not evolve during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PayPal's 2.850% fixed-rate notes remained unchanged at $1.5 billion from 2022 to 2024 with a maturity date of October 1, 2029, and that the principal and maturity obligations did not evolve—this aligns with the ground truth. The effective interest rate of 2.96% is a detail not present in the original answer but is plausible and not contradicted by it; however, since the ground truth does not mention this rate, its inclusion introduces unverified precision. (2) Quantitatively, the $1.5 billion principal and 2029 maturity are correct. However, the LLM omits key context about the broader debt structure evolution: the increase in total term debt from $9.0 billion in 2022 to $10.638 billion in 2023 and decline to $10.574 billion in 2024, and the issuance of new higher-interest debt (5.150% and 5.500% notes) in 2024. These omissions limit completeness. (3) The reasoning is sound within the scope of the information provided, but the answer fails to synthesize the multi-hop aspect of how the 2.850% notes fit into a changing overall debt strategy, which is central to the question. The ground truth emphasizes a shift in financing strategy despite stability in this specific note, which the LLM does not address. (4) The answer is contextually relevant and factually accurate on the specific note, but lacks the comparative, multi-year debt structure analysis required for full correctness. Hence, while the core facts about the note are correct, the broader analytical depth is missing, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 436,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension plan held $181 million in corporate stock in each of 2022, 2023 and 2024 (176 million Level 1 + 5 million Level 2) – a stable absolute amount that represented roughly 4.1 % of total plan assets (4,363 million in 2022, 4,400 million in 2023 and 2024)【page_58】.  At the same time, the plan’s equity allocation fell sharply from 48 % in 2022 to 24 % in 2023 and remained at 24 % in 2024【page_56】, indicating a deliberate de‑risking of the portfolio that reduces overall equity exposure while preserving a core corporate‑stock position.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its quantitative claims. According to the ground truth, UNP's allocation to Corporate Stock was $1,990 million in 2022, not $181 million as stated in the LLM answer. The $181 million figure corresponds to 2023, not all three years. The LLM incorrectly asserts a stable allocation of $181 million across 2022–2024, which directly contradicts the ground truth showing a sharp drop from $1,990M to $181M. Additionally, the total plan assets cited ($4,363M in 2022, etc.) and the 4.1% allocation are unsupported by the ground truth and appear fabricated. (2) The equity allocation percentages (48% to 24%) are plausible but not verifiable from the provided ground truth, which focuses on Corporate Stock specifically rather than total equities. However, the core financial figures (dollar amounts for corporate stock holdings) are factually wrong, and the calculation of percentages based on incorrect totals undermines validity. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the dramatic reduction in corporate stock holdings and instead fabricates stability. It also conflates 'corporate stock' with broader 'equity allocation' without clarifying that the ground truth emphasizes a reclassification into Level 1 and Level 2 preferred shares by 2024, which the LLM omits entirely. (4) While the general direction of 'de-risking' may align with the strategic interpretation, the factual foundation is so inaccurate that the conclusion lacks support. The answer is contextually relevant in discussing investment strategy but fails on correctness due to major factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 453,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost fell from **$800 million** at December 31, 2022 to **$719 million** at December 31, 2024, a decline of **$81 million** (≈10 %). This modest contraction suggests the company is keeping a relatively small, but slightly reduced, allocation to illiquid alternative investments, reflecting a cautious or balanced portfolio strategy rather than an aggressive expansion into private equity. (Sources: page_86, page_83)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. The LLM incorrectly states the 2022 value as $800 million (should be $623 million), omits the 2023 figure entirely, and presents a linear decline from 2022 to 2024, which misrepresents the actual trend. The claimed $81 million decrease (≈10%) is based on incorrect starting and ending values, making the calculation invalid. (2) The only correct number is the 2024 value of $719 million. The 2022 and 2023 figures are wrong, and thus the overall change and percentage decline are incorrect. This fails the core requirement of quantitative accuracy. (3) The reasoning is flawed because it misses the multi-hop nature of the question: the need to report changes across three years and interpret the non-linear trend (growth then slight decline). The LLM fails to recognize the strategic expansion in 2023, which is central to the correct interpretation. Instead, it infers a continuous cautious strategy, missing the short-term growth signal. (4) While the answer addresses the general topic and attempts to interpret strategic intent (contextually relevant), the factual foundation is unsound, leading to an incorrect conclusion. The qualitative reasoning would be acceptable if the numbers were right, but it's undermined by data errors. Correctness score is low due to major factual and calculation errors despite some structural relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 439,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "From 2022 to 2024 Mastercard’s multi‑layered security framework grew in scope rather than in form: the company continued to partner with issuers, acquirers, merchants, governments, industry associations and public‑private partners to set technical standards and share best practices, while expanding its real‑time payment infrastructure from 12 markets in 2022 to 13 in 2023 and adding domestic processing in China in 2024.  Throughout this period the security posture remained a layered program—security operations centers, fusion and intelligence centers, an enterprise resilience program, regular penetration testing, insurance coverage and third‑party assessments—ensuring resilience against cyber threats while supporting the broader, faster payment network.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's multi-layered security approach from 2022 to 2024, emphasizing continuity in layered security (SOCs, fusion centers, intelligence centers) and expansion in real-time payments and third-party collaboration. However, there is a minor quantitative inaccuracy: the LLM states real-time payment infrastructure expanded from 12 markets in 2022 to 13 in 2023, but the ground truth only confirms 13 markets as of year-end 2023, with no explicit number for 2022. Thus, the claim of 12 markets in 2022 is an unsupported inference. Additionally, the mention of 'domestic processing in China in 2024' is not present in the original answer and lacks corroboration, introducing a factual addition not in the ground truth. (2) The numbers for 2023 (13 markets) are accurate, but the 2022 figure (12 markets) and the 2024 China expansion are not verifiable from the original answer, reducing quantitative accuracy. (3) The multi-hop reasoning is strong: the LLM synthesizes information across years, correctly identifying the persistent use of internal security structures and the growing role of third parties and infrastructure expansion. It accurately reflects the strategic shift toward ecosystem integration, even if it adds unconfirmed details. (4) The answer is highly contextually relevant, addressing all three dimensions of the question—third-party collaboration, real-time infrastructure, and cyber resilience—with accurate qualitative trends. The core facts are correct, but unsupported specifics prevent a top score. Hence, correctness is 8 due to minor factual overreach, quantitative accuracy is 7 due to unsupported numbers, qualitative accuracy is 9 for sound reasoning, and contextual relevance is 10 for full alignment with the question's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 495,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements – shown in the “Other assets, including intangibles – net” line – fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (see pages 102 and 99). The steady decline indicates the company has been able to reduce the collateral required to support its derivative positions, reflecting more efficient netting, a lower overall derivative exposure, or stronger hedging practices over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and years. According to the ground truth, the collateral was $641 million at the end of 2021 (reported in 2022 filing), $800 million at the end of 2022 (reported in 2023 filing), and $491 million at the end of 2023 (reported in 2024 filing). However, the LLM incorrectly states that the value was $1.49 billion in 2022, which is not supported by the data. This misalignment affects the entire trend analysis. The $800 million and $491 million figures are correct but are assigned to the wrong years—LLM says $800M in 2023 (should be end of 2022) and $491M in 2024 (should be end of 2023). (2) The calculation of a 'steady decline' is directionally correct but based on incorrect starting points. The ground truth shows a peak in 2022 followed by a decline, not a continuous drop from 2022 to 2024 as implied. The 38% decrease cited in the original answer (from $800M to $491M) is accurate, but the LLM does not mention this or provide its own correct percentage. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the link between collateral under master netting arrangements and the 'Other assets' line item and attempts to interpret the trend in terms of derivative exposure management. However, due to incorrect data inputs, the conclusion about 'more efficient netting' or 'stronger hedging practices' lacks proper support. (4) Contextual relevance is high because the answer addresses both parts of the question—trend over time and implications for derivative exposure management—and references appropriate financial concepts. However, the quantitative inaccuracies severely undermine factual correctness, leading to a low correctness and quantitative accuracy score despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 496,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The relative TSR model used an expected volatility of 26.9 % for 2022, 28.6 % for 2023, and 18.7 % for 2024 【page_215】. The drop from 28.6 % to 18.7 % in 2024 indicates that market participants now view Duke Energy as less volatile relative to its peer group, suggesting a perception of lower market‑risk or greater earnings stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three volatility percentages—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—matching the ground truth exactly. These values are cited with proper formatting and in the correct chronological order. (2) All numeric values are accurate, and the comparison between 2023 and 2024 (a drop from 28.6% to 18.7%) is correctly highlighted, indicating a significant decline. No calculation errors are present. (3) The reasoning is sound: the LLM correctly infers that the decrease in expected volatility suggests lower perceived market risk or greater earnings stability, which aligns with the ground truth interpretation of reduced uncertainty in Duke Energy's market position. However, the LLM omits explicit mention of the 2022–2023 increase (from 26.9% to 28.6%) as a sign of rising risk perception before the 2024 decline, which slightly weakens the full multi-year narrative. (4) Despite this minor omission, the answer is factually correct, contextually relevant, and semantically equivalent in conveying the core trend and implication. The citation [page_215] adds source support. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to the slightly incomplete trajectory analysis, while quantitative accuracy and contextual relevance are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 369,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "From 2022 through 2024, GM’s indemnification obligations to Stellantis for legacy Opel/Vauxhall emissions claims and related recalls remained described as “unable to estimate any reasonably possible material loss” and “immaterial amount,” with no change in the nature of the obligation. The remaining accrual for the Takata inflator recall fell from $609 million reported in the 2023 10‑K to $555 million in the 2024 10‑K, indicating a decline in the estimated cost of the recall. The 2022 10‑K did not provide a specific remaining‑accrual figure, so the downward trend is evident only from 2023 onward.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of GM's indemnification obligations and accruals related to Stellantis from 2022 to 2024. (1) Quantitatively, the LLM incorrectly states that GM reported a remaining accrual for the Takata inflator recall of $609 million in 2023 and $555 million in 2024. This is false: those accruals relate to GM’s own recall liabilities, not indemnification obligations to Stellantis. The original answer (ground truth) explicitly states that GM’s indemnification payments to Stellantis were immaterial and that any potential future obligations were considered remote—there is no mention of multi-hundred-million-dollar accruals related to Stellantis. (2) The LLM conflates GM’s own Takata recall accruals with indemnification obligations to Stellantis, which is a critical error in entity and metric attribution. The question specifically asks about indemnification *to Stellantis*, not GM’s internal recall costs. (3) The statement that GM described the obligation as 'unable to estimate any reasonably possible material loss' is not supported by the ground truth, which instead notes the obligations were immaterial and future indemnifications were considered remote. (4) The LLM fails to mention the key evolution in disclosures: in 2024, GM accrued an immaterial amount related to European Commission and UK CMA investigations into pre-sale Opel conduct—a specific point in the original answer that shows a nuanced development. (5) The reasoning is flawed: the downward trend in GM’s own Takata accruals is irrelevant to the indemnification obligations to Stellantis, making the core argument of the LLM answer logically unsound. While the answer is framed around the correct companies and time period, the misattribution of financial figures and obligations severely undermines correctness. The contextual relevance is moderate because it addresses the general topic and timeframe, but the substance is factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 536,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across AMD’s 2022, 2023, and 2024 10‑K filings, the company consistently incorporated the 2011 Executive Incentive Plan as Exhibit 10.2 to its quarterly report, using the identical wording: “*10.1 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011, is hereby incorporated by reference.” This unchanged reference appears in all three filings (see 2024 page 98, 2023 page 99, and 2022 page 91) and signals that AMD treats the 2011 plan as a foundational, long‑term element of its executive‑compensation framework, underscoring a stable, enduring incentive strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor factual discrepancy in exhibit numbering and filing form reference. The ground truth states the 2011 Executive Incentive Plan was listed as Exhibit 10.1 and filed on April 2, 2011, while the LLM claims it was Exhibit 10.2 and filed as part of a 10-Q. This is a small but notable error in document metadata. Additionally, the LLM incorrectly cites the exhibit number as 10.2 in the quote, whereas the original answer specifies Exhibit 10.1. However, the core facts—consistent referencing across 2022, 2023, and 2024, no amendments, and the implication of a stable compensation strategy—are accurately conveyed. The dates (April 2, 2011) and the lack of changes over the three-year period are correctly represented. The reasoning is sound: the unchanged reference supports the conclusion of a stable, long-term executive compensation framework. The answer addresses all parts of the question, including the evolution (or lack thereof) and strategic implication. Page numbers cited (98, 99, 91) are plausible and contextually appropriate. While the exhibit number and form type error affect quantitative and qualitative accuracy slightly, the semantic meaning and strategic interpretation remain aligned with the ground truth. Hence, the answer is mostly accurate with minor factual inaccuracies in document details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 378,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "In 2022 PayPal warned that its branded‑credit programs exposed it to default risk, that proprietary credit‑risk models could mis‑predict borrower quality, and that reliance on third‑party lenders and payment processors added operational risk, while cross‑border trade was vulnerable to currency, tariff and regulatory shifts (pages 24‑28). By 2023 the company mitigated this exposure by selling up to €40 bn of UK and European BNPL loan receivables and establishing a forward‑flow arrangement, diversifying its payment‑processor base, and tightening fraud‑detection and credit‑risk models (pages 23‑27). In 2024 PayPal still faces similar credit‑product, cross‑border and third‑party risks, but continues to strengthen risk models, broaden partner relationships, and invest in fraud‑prevention to manage bad‑transaction exposure (pages 21‑25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk exposure related to credit defaults, third-party dependencies, and cross-border trade; the 2023 strategic action of selling up to €40 billion in BNPL receivables in the U.K. and Europe; and continued risk in 2024 with ongoing mitigation efforts. The mention of 'forward-flow arrangement' and 'diversifying payment-processor base' adds detail not in the original but does not contradict it and is plausible context. (2) Quantitative accuracy is perfect: '€40 billion' matches the ground truth exactly, and no incorrect numbers are introduced. Format is consistent and correct. (3) Multi-hop reasoning is sound: the answer synthesizes risk evolution across three years, connects credit products, cross-border trade, and third-party dependencies, and correctly identifies the 2023 receivables sale as a key mitigation. The only minor gap is that the original specifies Synchrony Bank as the U.S. partner in 2022, which the LLM omits, and the 2024 regulatory uncertainty around loan sales post-transfer is not mentioned—small but relevant details. (4) Contextual relevance is excellent: every part of the question is addressed with precise, focused information. The added details on fraud detection and model improvements enhance the answer without straying off-topic. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth with only minor omissions in entity specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 423,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s multiple‑purpose locomotive fleet grew slightly in owned units (from 5,971 to 5,973) while the leased count fell (from 1,037 to 920), reducing the total fleet from 7,008 to 6,893 and raising the average age from 24.3 to 25.2 years (page_22; page_19). This trend reflects a deliberate shift toward a leaner, older core fleet and greater use of leasing to manage capital costs, while the company’s $3.4 billion 2024 capital program continues to add new locomotives to replace aging equipment (page_19).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Union Pacific's owned Multiple Purpose Locomotives decreased from 6,204 in 2022 to 5,973 in 2024, but the LLM claims ownership increased slightly from 5,971 to 5,973. This is incorrect on both the starting number and the trend—ownership actually declined by 231 units, not increased. Similarly, leased units dropped from 1,038 to 920 per ground truth, but LLM reports 1,037 to 920—close but still inaccurate. The LLM also reports an incorrect 2022 average fleet age: 24.3 years vs. the true value of 22.5 years. Only the 2024 average age (25.2 years) is correct. (2) Calculations: The LLM’s implied total fleet sizes (7,008 in 2022 and 6,893 in 2024) are based on its incorrect inputs and thus wrong. The actual total fleet was 7,242 in 2022 (6,204 + 1,038) and 6,893 in 2024—so the 2024 total is correct by coincidence, but the 2022 total is off. The age increase is correctly shown as rising to 25.2, but the starting point is wrong, distorting the trend. (3) Multi-hop reasoning: The LLM misinterprets the strategy. Ground truth indicates a cost-control strategy with reduced leasing and no significant new purchases, leading to an aging fleet. However, the LLM claims the company is adding new locomotives via a $3.4 billion capital program to replace aging equipment—information not supported in the original answer and contradictory to the aging trend. This undermines the reasoning. (4) Despite these errors, the answer is contextually relevant and addresses all parts of the question: ownership, leasing, age trend, and strategic interpretation. Wording and structure are clear, and some numbers (like 2024 owned units and leased drop) are close. However, major quantitative inaccuracies and flawed reasoning significantly reduce correctness. Hence, correctness_score is 4: partially correct with significant errors in core facts and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 530,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements tied to equity‑company receivables fell sharply—from $1.494 billion at December 31 2022 to $491 million at December 31 2024, a drop of roughly $1.0 billion (≈67 %). This steep decline signals a more efficient derivative‑risk strategy, likely driven by smaller net derivative positions, tighter netting, or improved counterparty credit quality that reduces collateral needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. However, the LLM states it was $1.494 billion in 2022 and omits the 2023 value entirely, which is a critical error. The reported drop from $1.494 billion to $491 million (≈67%) is therefore based on incorrect starting figures. (2) The calculation of a $1.0 billion drop and 67% decline is mathematically correct based on the LLM's own numbers, but since the input values are wrong, the conclusion is misleading. The actual change from 2022 to 2024 is a decrease from $641M to $491M, or about $150M (23.4% decline), not $1.0 billion. (3) The reasoning partially aligns with the ground truth in interpreting the 2024 decline as a potential sign of improved risk management or credit conditions. However, the LLM fails to capture the multi-hop nature of the trend—specifically the increase in 2023 before the 2024 drop—which is essential for understanding the dynamic risk positioning mentioned in the original answer. The absence of the 2023 data point breaks the full trend analysis. (4) While the LLM correctly identifies the relevant financial concept (collateral under master netting arrangements related to equity company receivables) and attempts to interpret the implication for derivative risk management, the incorrect data undermines the validity of its conclusion. The contextual relevance is high because it addresses the right metric and company and attempts to explain the strategic implication, but the factual foundation is flawed. Thus, the correctness score is low due to major quantitative errors, despite reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 492,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Starbucks’ “Other” category was defined identically in each 10‑K: packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, and serveware.  Its revenue rose from $6.89 B (≈21 % of total) in 2022 to $7.71 B (≈22 %) in 2023, then fell slightly to $7.54 B (≈21 %) in 2024, keeping its share of total revenue roughly stable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures ($6.89B, $7.71B, $7.54B) and percentages (21%, 22%) that are not present in the original ground truth answer. The ground truth makes no mention of any numerical revenue amounts or percentage breakdowns for the 'Other' category across 2022–2024. Therefore, these numbers are unverified and likely hallucinated, severely undermining factual accuracy. (2) While the qualitative description of the 'Other' category components (packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware) aligns well with the ground truth and remains consistent across years, the addition of precise financial data without sourcing from the knowledge base constitutes a major factual deviation. The slight rise and fall in revenue and stable percentage of total revenue are not supported by the original answer, which only states the composition remained 'relatively stable' without quantification. (3) The multi-hop reasoning is partially sound in that the model correctly identifies the consistency of the category’s composition over time, which is the core of the question. However, it fails in quantitative synthesis because no revenue figures were provided in the source data to support the claims made. The model incorrectly assumes that such data was available and accurately reported in the 10-Ks. (4) Contextual relevance is high because the answer addresses the evolution of the 'Other' category and focuses on the right elements. Qualitative accuracy is moderate due to correct categorization but lacks caution in asserting unsupported numbers. Quantitative accuracy is low due to the inclusion of fabricated or incorrect financial figures. Correctness score is reduced to 4 because while the conceptual understanding is partially correct, the introduction of false quantitative data significantly misleads the user on key aspects of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 528,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "From 2022 through 2024 Alphabet maintained the same approach to monetizing inventory on Google Network properties via Google Ad Manager: brand‑advertising revenue is recognized on an impression basis (when the ad is displayed or viewed) and performance‑advertising revenue is recognized when a user engages, and all Google Network property revenue is reported on a gross basis—recording the full amount billed to advertisers as revenue and the partner payments as cost of revenue. The cost‑per‑impression metric continued to be defined as impression‑based and click‑based revenues divided by total impressions, with no change in the recognition or reporting methodology across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: Google used impression-based and click-based revenue recognition through Google Ad Manager across 2022–2024; revenue was reported on a gross basis, with full amounts billed recorded as revenue and partner payments as cost of revenue; cost-per-impression was calculated as total impression- and click-based revenues divided by total impressions. These points align with the original answer. (2) There are no numeric inaccuracies—while no specific dollar figures are mentioned in either answer, the metrics and methods (e.g., gross reporting, cost-per-impression definition) are described identically and correctly. Format and terminology are consistent and acceptable (e.g., 'gross basis' correctly interpreted). (3) The multi-hop reasoning is sound: the model synthesizes information across years (2022–2024), correctly identifies the continuity in accounting policy, and links revenue recognition with reporting treatment. The only minor shortcoming is that the LLM implies no change at all in methodology, whereas the original answer notes an evolution in transparency and emphasis—particularly in 2023 and 2024 with Google reinforcing its role as principal to justify gross reporting. This nuance about increasing clarity and accounting justification is slightly underrepresented in the LLM answer, which states 'no change in the recognition or reporting methodology,' potentially oversimplifying the evolution in disclosure. (4) Despite this, the LLM answer remains factually correct and contextually complete, with excellent contextual relevance and precise qualitative and quantitative accuracy. The omission of the evolving transparency narrative prevents a perfect 10, but the core technical facts are fully aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 508,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "MDLZ’s exposure to sales‑and‑media marketing restrictions has remained essentially the same from 2022 through 2024, with the company continuing to face regulatory limits on promotions and advertising of products with specific nutrient profiles and on front‑of‑pack labeling requirements.  The 10‑Ks consistently note that extended‑producer‑responsibility (EPR) policies have broadened to additional jurisdictions – the EU, India, Vietnam and several U.S. states – and that single‑use plastic bans and plastic taxes are being considered in Europe and Southeast Asia.  Thus, while the core regulatory framework stays stable, the geographic scope of EPR obligations has expanded over the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but misses key aspects of the evolution in MDLZ's exposure across 2022–2024, particularly in the progression of regulatory developments. (1) Correctly identifies that EPR policies expanded across jurisdictions including the EU, India, Vietnam, and U.S. states, and notes consideration of plastic bans/taxes in Southeast Asia—consistent with the original answer. However, it incorrectly states that the 'core regulatory framework stays stable' and that exposure has 'remained essentially the same,' which contradicts the ground truth showing a clear trend of increasing regulatory burden and movement from contemplation to enforcement, especially in 2024 with the EU’s adoption of the Packaging and Packaging Waste Directive. (2) No specific numbers (e.g., 'over 25 EU countries') are mentioned in the LLM answer, leading to a loss in quantitative completeness despite no incorrect figures. (3) The multi-hop reasoning is partially sound—linking EPR expansion and marketing restrictions across years—but fails to accurately synthesize the evolving nature of front-of-pack labeling and the shift toward enforcement in 2024. (4) The answer is contextually relevant and uses correct entities (MDLZ, EPR, front-of-pack labeling, correct jurisdictions), but the conclusion downplays the increasing stringency and geographic spread of regulations. Thus, while factually aligned in parts, it misrepresents the overall trend, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 409,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Between 2022 and 2024, Mastercard’s Class A shares consistently retained one vote per share and dividend rights each year (see Note 16 tables on pages 94, 99, 91).  The dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024.  This steady voting‑rights policy combined with a predictable, gradually increasing dividend schedule signals a conservative capital‑structure strategy that prioritizes governance stability while steadily rewarding shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024), which are not present in the original answer and contradict the ground truth. The original answer states only that dividend rights were consistent, not that dividends increased. This is a major factual error. (2) The quantitative accuracy is low because the LLM fabricates specific dividend figures and implies a trend (gradually increasing dividends) that is not supported by the ground truth. The original answer makes no mention of dividend amounts or changes in payout, only that dividend rights remained unchanged. (3) The reasoning is partially sound in interpreting the stability of voting rights as indicative of a consistent capital structure strategy, which aligns with the original answer. However, the conclusion about a 'predictable, gradually increasing dividend schedule' and 'conservative capital-structure strategy' goes beyond the provided information and introduces unsupported inference. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of rights and strategic implication—and correctly notes the consistency in voting rights. However, the addition of false quantitative data significantly undermines correctness. The core entity (MA/Class A shares) and time frame (2022–2024) are accurate, and the citation of Note 16 tables, while plausible, cannot be verified and does not compensate for factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 416,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements dropped from **$1.494 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024**【page_102】【page_99】.  \nThe declining collateral indicates that the company’s initial‑margin requirement – and thus its net derivative exposure – has been shrinking, likely due to reduced derivative positions or improved credit quality and clearing arrangements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the 2022 value. The ground truth states that ExxonMobil's collateral under master netting arrangements was $641 million in 2022, but the LLM incorrectly reports it as $1.494 billion. The 2023 ($800 million) and 2024 ($491 million) values are correct. This major discrepancy in the starting value undermines the accuracy of the trend analysis. (2) Quantitative accuracy is low because the 2022 figure is nearly double the correct amount—$1.494 billion vs $641 million—a difference of over $850 million. While the 2023 and 2024 numbers match the ground truth, the incorrect initial value leads to a false impression of a continuous decline, whereas the actual trend shows an increase from 2022 to 2023 before a drop in 2024. (3) The reasoning is partially sound but based on incorrect data. The LLM concludes that collateral 'dropped' from 2022 to 2024, implying a consistent downward trend, but the correct data shows a rise in 2023, indicating increased margin requirements before a reduction in 2024. This misrepresents the company's derivative exposure dynamics. The correct interpretation should reflect a fluctuating exposure, not a steady decline. (4) Contextual relevance is high because the answer addresses the right metric, time frame, and attempts to interpret the trend in terms of derivative exposure and margin requirements. However, due to the incorrect quantitative foundation, the qualitative insights are misleading. The model correctly identifies the relevance of credit quality and derivative positions but draws an inaccurate conclusion due to faulty input data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 451,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ 2022 10‑K stated that its fixed‑price and price‑to‑be‑fixed purchase commitments, together with forward contracts, would secure green‑coffee supply through fiscal 2023【SBUX_10k_2022.pdf page_12】. The 2023 filing extended that horizon to fiscal 2024, and the 2024 filing pushed it further to fiscal 2025【SBUX_10k_2023.pdf page_12】【SBUX_10k_2024.pdf page_12】. This incremental extension demonstrates the company’s deliberate strategy of locking in supply and using hedging instruments (forward contracts, futures, collars) to mitigate coffee‑price volatility and reduce supply risk over a longer planning horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Starbucks' supply chain commitments from fiscal 2022 through 2024, noting the extension from securing supply through fiscal 2023 (in 2022) to fiscal 2025 (in 2024). However, there is a factual inaccuracy in the LLM's description of the 2023 filing: it states the horizon was extended to fiscal 2024, while the ground truth indicates the extension was directly to fiscal 2025. This misrepresents the timeline and suggests a stepwise one-year extension rather than a more significant leap. (2) The quantitative accuracy is partially compromised due to this incorrect staging of the commitment timeline. The use of hedging instruments (forwards, futures, collars) is correctly noted across years, and the general direction of increasing commitment length is accurate. (3) The multi-hop reasoning is sound in concept—synthesizing data across three 10-Ks to show strategic evolution—but contains a key error in the intermediate step (fiscal 2023 filing). Despite this, the conclusion about a longer-term strategy for managing price volatility and supply risk is consistent with the ground truth. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution of commitments and strategic implications—and uses appropriate financial terminology and sourcing. The score reflects minor but meaningful factual deviation affecting precision, though core strategic interpretation remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 413,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "From fiscal 2023 to fiscal 2025 ACN kept its U.S. pension plans 100 % in debt, but for non‑U.S. plans it shifted the target mix from **27 % equity, 48 % debt, 4 % cash, 11 % insurance, 10 % other** to **28 % equity, 36 % debt, 7 % cash, 21 % insurance, 8 % other** (page 88 → page 95). The move—especially the rise in equity and insurance contracts and the drop in debt—indicates a deliberate strategy to enhance long‑term, risk‑adjusted returns while still matching plan duration and managing risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It fabricates specific percentage allocations for ACN's pension plans (e.g., 27% equity, 48% debt, etc.) that are not present in the original answer or implied by the ground truth. The original answer does not provide any numerical breakdown of asset allocations for any fiscal year, nor does it mention a 100% debt allocation for U.S. plans. These figures appear to be invented. (2) There are no verifiable calculations in the LLM response because the input numbers themselves are false. The claim of shifts from one precise mix to another lacks any support in the ground truth, which only discusses general strategic continuity and flexibility. (3) The multi-hop reasoning is flawed. The original answer emphasizes a consistent long-term strategy with adaptive flexibility, not a material shift in allocation. The LLM incorrectly infers a deliberate strategic move toward higher equity and insurance based on non-existent data, misrepresenting the company's approach as more dynamic than described. (4) While the LLM attempts to address the question’s intent—interpreting strategic direction—the complete absence of cited numbers in the ground truth means the detailed quantitative claims undermine credibility. The conclusion about enhancing risk-adjusted returns is partially aligned with the original's mention of risk-adjusted returns, but it is built on false premises. Thus, despite some thematic relevance, the answer is factually unsound, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 434,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Amgen has kept Olpasiran’s therapeutic focus unchanged, continuing to develop it as a phase‑2 siRNA that lowers lipoprotein(a) for atherosclerotic cardiovascular disease in the 2022, 2023 and 2024 10‑Ks (see 2022 p. 28; 2023 p. 28; 2024 p. 24).  The composition‑of‑matter patents that protect Olpasiran in the U.S. and Europe were issued in 2022 and are still listed in 2023 and 2024 with an estimated expiration in 2036, indicating a stable intellectual‑property protection timeline (see 2022 p. 26; 2023 p. 26; 2024 p. 26).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of numbers, dates, and entities: Olpasiran is correctly identified as an siRNA in phase 2 for atherosclerotic cardiovascular disease, with U.S. and European patent protection estimated to expire in 2036, consistent across 2022–2024 filings. The quantitative accuracy is perfect—no calculation errors, and the expiration year (2036) matches the ground truth. The answer correctly cites consistent therapeutic focus and stable IP protection, supported by specific page references. However, it misses the nuanced evolution highlighted in the original answer: while the therapeutic focus remained consistent, the 2024 indication was broadened to 'Cardiovascular disease' (from atherosclerotic CV disease), suggesting a potential strategic shift or expansion in indication, and signaling progression toward advanced development or regulatory preparation. The LLM interprets the consistency across years as 'unchanged' focus but fails to acknowledge the subtle but meaningful shift in labeling and the implications for development stage transition. This omission affects the depth of the qualitative reasoning and the synthesis of multi-hop information about strategic positioning evolution. Despite this, the answer remains highly relevant and factually sound, hence a high score with minor deduction for incomplete reasoning on strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 384,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "From 2022 to 2024 American Express’s use of aggregators grew from a peripheral tool for managing merchant relationships to a core element of its integrated payments platform, with the number of third‑party providers expanding each year. In 2022 the company warned that aggregators might pursue business interests that conflict with its own, potentially limiting card acceptance and usage; in 2023 the disclosures broadened the focus to the operational complexity of these relationships, stressing the risk of service disruptions, data‑security breaches and heightened regulatory scrutiny; and in 2024 the emphasis shifted to the growing number of third‑party providers—including aggregators—highlighting governance challenges, the potential for data misuse or loss of data, the risk of regulatory actions, fines, litigation and the difficulty of mitigating such risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no incorrect numbers or dates are present. The years 2022, 2023, and 2024 are correctly referenced and matched to the appropriate risk disclosures. (2) The answer addresses all parts of the question: it traces the evolution of American Express's reliance on aggregators from 2022 to 2024 and details the risks emphasized each year. In 2022, the concern about conflicting interests impacting card acceptance is correctly noted. In 2023, the shift toward operational complexity, service disruptions, data security, and regulatory scrutiny is consistent with the ground truth’s emphasis on surcharging, steering, and dependency. In 2024, the focus on governance, data misuse, regulatory actions, litigation, and mitigation challenges matches the original answer’s broader systemic and legal concerns. (3) The multi-hop reasoning is sound: the LLM synthesizes evolving risk disclosures across three years, correctly identifying the progression from merchant behavior risks to operational and legal exposures. The only minor deviation is that the LLM describes the use of aggregators as evolving 'from a peripheral tool... to a core element,' which is a slight interpretive leap not explicitly stated in the ground truth—though consistent with the trend of increasing emphasis. The original answer frames it as growing awareness and formalization of risks, not necessarily a structural shift in business model. This does not make the LLM answer incorrect but adds a layer of interpretation. (4) Semantic equivalence is strong: key risks like merchant steering, surcharging, third-party failures, regulatory actions, and litigation are all captured, even if grouped under broader categories like 'governance challenges' or 'data misuse.' Wording differences do not affect factual correctness. Overall, the answer is comprehensive, factually accurate, and contextually appropriate, warranting a high score with only a small deduction in qualitative accuracy for the slight interpretive overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 593,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks’ exposure to commodity‑index funds remained essentially unchanged from fiscal 2022 through fiscal 2024 – green‑coffee prices were still noted as being influenced by index‑fund activity, and the company continued to hedge price risk with forward contracts, futures and collars.  The forward‑supply commitments, however, were extended each year: they covered an adequate supply through fiscal 2023 in 2022, through fiscal 2024 in 2023, and through fiscal 2025 in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Starbucks' exposure to commodity index funds remained consistent from fiscal 2022 to 2024, with green coffee prices influenced by index fund activity and the use of hedging instruments like forward contracts, futures, and collars. This aligns with the original answer. However, there is a key error in the forward supply commitments timeline. The LLM states that in 2022, commitments covered supply through fiscal 2023 (correct), in 2023 through fiscal 2024 (incorrect), and in 2024 through fiscal 2025 (partially correct). According to the ground truth, by 2023, Starbucks extended its outlook to fiscal 2025—not 2024—and this remained unchanged in 2024. Thus, the LLM incorrectly implies a stepwise annual extension through 2025, when in fact the extension to 2025 occurred in 2023 and was maintained in 2024. (2) Quantitative accuracy is compromised due to this misrepresentation of the time horizon: stating coverage 'through fiscal 2024 in 2023' is factually wrong; it should be through 2025. The original answer confirms the extension to 2025 was already in place by 2023. (3) The multi-hop reasoning is mostly sound—linking commodity index fund exposure, hedging strategies, and forward commitments across years—but fails in accurately synthesizing the timing of the supply commitment extension. The conclusion about strategic risk mitigation is implied but not explicitly drawn, missing a key interpretive element from the original. (4) Despite the timeline error, the answer remains contextually relevant and captures the core dynamics. Correctness score is 7 due to accurate core facts but significant error in the progression of forward commitments; quantitative accuracy is 6 due to incorrect fiscal year mappings; qualitative accuracy is 8 due to strong reasoning but flawed synthesis on timing; contextual relevance is 10 as all aspects directly address the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 523,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 9.6 million shares for $3.15 million and had an available open‑market authorization of $3.13 million. In fiscal 2023 the company continued to buy back shares and raised its available authorization, paving the way for a larger program in 2024. By fiscal 2024, Accenture had repurchased 2.07 million shares in Q4 alone for $605 million, its available authorization was $2.69 million, and the Board approved an additional $4.0 billion in authority, raising total outstanding authority to $6.694 billion—an evolution that signals a growing, disciplined capital‑return strategy with expanding repurchase capacity and consistent use of that capacity to return value to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numerical values. It incorrectly states that in fiscal 2022, Accenture repurchased 9.6 million shares for $3.15 million with $3.13 million in available authorization. The ground truth shows no repurchase activity in 2022—only an available authorization of $3,129,296 (~$3.13 billion, not million). The LLM erroneously reports repurchases in 2022 and misrepresents the scale by a factor of 1,000 (millions instead of billions). Similarly, the claim of repurchasing 2.07 million shares in Q4 2024 for $605 million is incorrect—the $605 million repurchase occurred in fiscal 2023 (not 2024 Q4), and the number of shares purchased was 2,000,308. The available authorization in 2024 is also misstated as $2.69 million instead of $2.694 billion. However, the LLM correctly notes the additional $4.0 billion authorization approved by the Board in fiscal 2024 and the resulting total outstanding authorization of $6.694 billion, which matches the ground truth. (2) Multiple calculation and unit errors: mixing up millions and billions invalidates the quantitative accuracy. The repurchase amounts and authorizations are off by orders of magnitude in critical places. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a growing capital return strategy from increasing authorizations and repurchase activity, and it correctly identifies the $4 billion increase and final $6.694 billion total. However, it misattributes repurchase activity to the wrong years and fabricates a 2022 repurchase not present in the data. (4) Despite serious quantitative flaws, the answer captures the overall strategic trend—increasing repurchase capacity and commitment to shareholder returns—so it retains some qualitative and contextual relevance. The conclusion about a disciplined, expanding capital-return strategy is aligned with the ground truth, even if based on incorrect data. Thus, correctness and quantitative accuracy are low due to critical number errors, but qualitative reasoning and relevance are partially preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 565,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Google’s long‑term marketable equity securities grew from **$803 million** at the end of 2022 to **$1.4 billion** at the end of 2023, then fell sharply to **$266 million** by the end of 2024 (all figures are reported as part of other non‑current assets). This swing shows a brief expansion of illiquid equity exposure in 2023 followed by a substantial divestment or reallocation in 2024, suggesting that Google shifted its portfolio toward greater liquidity or a more risk‑adjusted stance on illiquid assets during that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. The LLM incorrectly states that the value grew from $803 million in 2022 to $1.4 billion in 2023, reversing the actual trend between 2022 and 2023. It then claims a drop to $266 million in 2024, which is entirely incorrect—ground truth shows a return to $1.4 billion, not $266 million. These errors affect all quantitative claims. (2) Number verification: 2022 value should be $1.4B (LLM says $803M), 2023 should be $803M (LLM says $1.4B), 2024 should be $1.4B (LLM says $266M). All three values are wrong, and the implied changes (increase then sharp drop) contradict the actual pattern (decrease then recovery). Calculations and comparisons are therefore invalid. (3) Multi-hop reasoning is flawed: the model fails to correctly identify the direction and magnitude of changes across years, leading to an incorrect interpretation of Google’s strategy. Instead of recognizing a cyclical rebalancing (as suggested by the dip and recovery), it infers a brief expansion followed by divestment, which is not supported by the data. (4) Despite incorrect numbers and reasoning, the answer attempts to address both parts of the question—change over time and strategic implication—and uses relevant financial terminology, hence moderate contextual relevance. However, due to severe quantitative and qualitative errors, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 429,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "GE classified its captive industrial insurance subsidiary, Electric Insurance Company (EIC), as held for sale in Q4 2022, with a valuation allowance of $17 million. In Q3 2023 it signed a binding agreement to sell EIC, the valuation allowance rose to $124 million, and GE recorded a $109 million loss on the expected sale. The sale was completed in Q2 2024 to Riverstone International Holdings for $120 million, eliminating the valuation allowance and yielding a net gain of roughly $11 million after offsetting the prior loss, reflecting GE’s strategic divestiture of a non‑core insurance asset to focus on core businesses.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details and timeline. While it correctly identifies the ultimate buyer (Riverstone International Holdings) and the sale price ($120 million in cash), it introduces a 'valuation allowance' of $17 million in Q4 2022 and $124 million in Q3 2023, which are not present in the ground truth. The ground truth states that EIC was classified as held for sale in 2023 (not Q4 2022), with specific asset ($541M) and liability ($378M) figures, and a $109M loss recorded—none of which are reflected in the LLM's timeline or numbers. The LLM also incorrectly claims a 'net gain of roughly $11 million' after offsetting prior loss, which is unsupported by the ground truth; no such gain is mentioned, and the $109M loss stands as reported. (2) The only correct number is the $120M sale price and the $109M loss, but the context and timing are wrong. The ground truth does not mention a valuation allowance or any gain on sale. The calculation of a 'net gain' is speculative and incorrect. (3) The multi-hop reasoning is partially sound—GE did divest EIC as part of strategic focus—but the synthesis of financial impact is flawed due to invented intermediate figures and misaligned timing. The model fails to correctly pull and sequence the financial data across years. (4) Scores reflect partial correctness on core events (sale, buyer, loss) but major errors in numbers, timing, and financial interpretation. Contextual relevance is high as the answer addresses strategic positioning and disposition, but quantitative accuracy is low due to fabricated metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 451,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s Phase 3 portfolio grew from 13 programs in 2022 to 18 in 2023 and to 24 in 2024, reaching 25 by early 2025 (AMGN_10k_2022, page 25; AMGN_10k_2023, page 26; AMGN_10k_2024, page 25). This expansion—driven by acquisitions (e.g., Horizon), new phase 3 initiations, and regulatory approvals—shows a deliberate strategy to broaden the pipeline across oncology, rare diseases, and biosimilars, deepening therapeutic breadth and accelerating commercial potential.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Amgen's Phase 3 programs: 13 in 2022, 18 in 2023, and 24 in 2024. It accurately reflects the growth trend and references the Horizon acquisition as a key driver. However, it states the count reached 25 by 'early 2025', while the ground truth specifies the increase to 25 occurred in 2024. This minor temporal misalignment slightly affects precision. (2) Quantitatively, the numbers 13, 18, and 24 are correct. The ground truth confirms 24 in 2024 and then notes an additional program bringing the total to 25—likely interpreted by the model as occurring just beyond 2024. While the 25 figure is mentioned, its timing is slightly off, hence not a full deduction. Calculations and comparisons are sound. (3) The multi-hop reasoning is strong: the model synthesizes data across three years of 10-K filings, correctly attributes the expansion to acquisitions (Horizon), new initiations, and regulatory approvals, and infers strategic intent. It adds contextual depth by identifying therapeutic areas (oncology, rare diseases, biosimilars), which, while not in the original answer, are consistent with Amgen’s focus and do not contradict the ground truth. (4) The answer is highly relevant, complete, and semantically aligned with the original. The minor error in timing of the 25th program prevents a perfect score, but overall accuracy and reasoning are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 396,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "From 2022 to 2024, American Express has shifted its global card‑network strategy from a more independent, licensing‑heavy model to a more regulated, fee‑constrained one. In 2022 the company operated a fourth‑largest global network and maintained licensing businesses in the EU and Australia (pp. 13‑14), but by 2024 it had exited those licensing arrangements in response to regulatory pressure and faced heightened scrutiny over interchange fees and merchant surcharging, which could lower discount rates (pp. 34‑35). The firm’s Category III status in 2024 further increased compliance demands, while competitive dynamics—such as Visa and Mastercard’s proposed settlement on interchange‑fee caps—have forced American Express to adjust its network relationships and pricing strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of American Express's relationship with global card networks from 2022 to 2024. It accurately captures the shift from an independent, licensing-based model to one constrained by regulatory pressures, specifically noting the exit from licensing businesses in the EU and Australia by 2024—consistent with the original answer. The mention of regulatory scrutiny over interchange fees, merchant surcharging, and compliance burdens (e.g., Category III status) reflects accurate qualitative understanding and matches the cited regulatory dynamics. However, the LLM answer omits key competitive dynamics emphasized in the ground truth, such as growing competition from Alipay, PayPal, and the race for unique cobrand benefits like lounge access, which were highlighted in 2023. While it references Visa and Mastercard’s interchange-fee cap settlement as a competitive pressure, it does not fully convey the earlier posture of AXP as a direct competitor emphasizing premium differentiation. The term 'fourth-largest global network' is plausible but not explicitly confirmed in the ground truth, and 'Category III status'—while factually relevant in regulatory context—is not mentioned in the original answer, introducing a detail that may be accurate but not verifiable from the provided truth. All dates (2022, 2024) and structural changes are correctly used, and no numerical inaccuracies are present (though no specific numbers like dollar amounts or percentages appear). The reasoning is sound and reflects multi-hop synthesis across time and regulatory domains. The answer is highly contextually relevant, directly addressing the question’s focus on regulatory and competitive evolution. Minor omissions in competitive dynamics prevent a perfect score, but core facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 508,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips began monetizing its CVE common shares in 2021, and in 2022 it sold the remaining 91 million CVE shares, using the proceeds to repurchase 87,709,187 shares that year【page_112】.  The program continued, with 48,641,899 shares repurchased in 2023 and 49,135,049 shares in 2024; cumulatively from inception to the end of 2024, 433 million shares were repurchased at a cost of $34.3 billion【page_112】.  The fair value of the CVE common shares at the time of sale was $218 million【page_141】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several critical factual inaccuracies that significantly impact correctness, particularly in the quantitative details of share repurchases. (1) The LLM states that in 2022, ConocoPhillips repurchased only 87,709,187 shares, but the ground truth indicates a total of 383 million shares repurchased in 2022 alone. This is a major discrepancy. (2) The LLM breaks down repurchases into 48.6 million in 2023 and 49.1 million in 2024, implying a gradual pace, but the original answer does not specify annual breakdowns beyond 2022 and only provides a cumulative total of 433 million shares by 2024 at a cost of $34.3 billion. While the cumulative share count and total cost are correct, the annual figures for 2023 and 2024 are not supported by the ground truth and appear to be fabricated or misattributed. (3) The LLM claims the fair value of CVE shares at sale was $218 million, but this contradicts the context—selling 91 million shares for only $218 million implies ~$2.40 per share, which is implausible for a major energy stock and inconsistent with the scale of subsequent $29B repurchase in 2022. The ground truth does not provide the monetization proceeds from CVE sales, so this number is unsupported. (4) The original answer notes $29 billion spent on repurchases in 2022 alone, but the LLM omits this key dollar amount and instead focuses only on share counts, failing to report the $29B figure. (5) The LLM correctly identifies the cumulative 433 million shares and $34.3 billion cost by 2024, which matches the ground truth. (6) The mention of the $65 billion authorization increase in October 2024 is missing from the LLM answer, a notable omission. (7) The reasoning structure—linking asset monetization to share repurchases—is qualitatively sound and contextually relevant, showing correct multi-hop understanding of the strategic progression. However, the incorrect annual repurchase volumes and unsupported dollar value for CVE shares undermine quantitative accuracy. In summary: cumulative totals are correct, but annual breakdowns are inconsistent with ground truth, key dollar amounts are missing, and an unsupported valuation figure is introduced. Hence, partial credit is given for correct cumulative figures and logical flow, but significant deductions for factual and numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 618,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "From 2022 through 2023, the Home Depot Omnibus Stock Incentive Plans (the 2005 Plan) had about 117 million shares available for future grants. By 2024, after the plan was amended in May 2022, the available pool fell to roughly 77 million shares under the new Omnibus Plan authorized for 80 million shares plus up to 10 million related to outstanding awards. This decline shows the company has been actively exercising its stock‑based compensation capacity, depleting the authorized share pool and moving toward a more constrained or targeted grant strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It states that 117 million shares were available from 2022 through 2023, but the ground truth indicates that 117 million was the 2022 figure under the 2005 Plan, and by 2023, availability dropped to 77 million under a newly amended plan. The LLM incorrectly implies the 117 million carried into 2023. Additionally, the LLM claims that in 2024 the available pool was 77 million, but the correct figure is 70 million—this is a significant numerical error. The LLM also misrepresents the 2024 plan authorization (80 million plus 10 million), which is not supported by the ground truth and introduces fabricated details. (2) Quantitative accuracy is low: the 2023 and 2024 numbers are wrong, and the timeline of the amendment is misrepresented (May 2022 amendment leading to 2024 availability is illogical). The correct trend is 117M (2022) → 77M (2023) → 70M (2024); the LLM conflates 2023 and 2024 figures. (3) The multi-hop reasoning is partially sound in that it infers increased utilization from declining shares, but the synthesis is flawed due to incorrect data. The conclusion about a 'constrained or targeted grant strategy' is speculative and not in the original answer, which correctly notes ongoing utilization alongside replenishment mechanisms. (4) Contextual relevance is high—the answer addresses the evolution of share availability and interprets the trend in terms of compensation capacity. However, due to major factual and numerical errors, the correctness and qualitative accuracy scores are moderate to low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 437,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "Accenture raised the maximum shares authorized under its Amended 2010 Share Incentive Plan from **127 million** in 2022 (page 91) to **141 million** by 2024 (page 98; the 2023 filing reflects the same 141 million level). This 14 million‑share expansion shows the company’s deliberate broadening of its equity‑based incentive pool to better attract, retain, and align talent with shareholder value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the numbers match exactly: 127 million shares in 2022 and 141 million in both 2023 and 2024. The increase of 14 million shares is accurate (141M - 127M = 14M). Minor formatting differences (e.g., '127 million' vs '127,000,000') are acceptable and do not affect correctness. (2) The answer addresses both parts of the question: the evolution of authorized shares from 2022 to 2024 and the strategic implication of this change. (3) Entity accuracy is correct: Accenture plc, Amended 2010 SIP, Class A ordinary shares, and correct years (2022, 2023, 2024) are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the increase indicates a strategic expansion in equity-based compensation, linking it to talent retention, alignment with shareholders, and long-term incentives—consistent with the original answer’s interpretation. The inclusion of document page references (91, 98) adds verifiability and shows grounding in source material. All aspects meet the highest standard for factual accuracy, completeness, and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 336,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "The weighted average yield on American Express’s foreign government bonds and obligations rose sharply from about **2.1 % in 2022** (the 2022 10‑K shows a 2.08 % overall yield for that category) to roughly **7.8 % in 2024** (the 2024 10‑K lists a 7.8 % average yield for non‑U.S. interest‑earning assets, which includes foreign government bonds)【page_121】【page_176】. This jump indicates that the company’s exposure to international interest‑rate movements has increased, as higher yields on foreign debt reflect rising global rates and a greater sensitivity to foreign market rate changes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the weighted average yield on American Express's foreign government bonds due within one year was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. However, the LLM claims the yield was approximately 2.1% in 2022 and rose to 7.8% in 2024, which is factually incorrect. The cited figures do not match the ground truth data, and the trend described (a steady sharp rise) contradicts the actual volatile pattern with a peak in 2023 and a return to 2022 levels in 2024. (2) The quantitative inaccuracies are severe: the LLM misreports the 2022 yield (2.08% vs correct 5.86%) and 2024 yield (7.8% vs correct 5.86%), and omits the 2023 value entirely. Additionally, it conflates 'non-U.S. interest-earning assets' with 'foreign government bonds and obligations due within one year,' which are not equivalent categories. (3) The multi-hop reasoning is flawed: the model fails to correctly identify and synthesize the specific metric across the three years, incorrectly characterizes the trend, and draws an unsupported conclusion about increasing exposure, whereas the ground truth suggests a partial reversal in 2024. (4) The contextual relevance is moderate because the answer addresses the general topic of yield changes and interest rate exposure, but due to major factual and quantitative errors, the conclusion is misleading. Correctness and quantitative accuracy are low; qualitative accuracy is slightly higher due to attempting the right type of analysis, but with wrong inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 440,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express’s foreign‑government‑bond holdings were heavily short‑term in 2022 – $630 million of fair value, with $628 million due within one year – implying a low‑yield, high‑liquidity focus.  The weighted‑average yield for those securities rose to 6.45 % in 2023, reflecting a shift toward higher‑yielding, longer‑dated foreign bonds as global rates climbed, and fell to 5.85 % in 2024, indicating a rebalancing toward lower yields or higher‑quality assets as rates eased or risk appetite tightened.  This progression shows a dynamic investment strategy that adjusts maturity and risk exposure to capture favorable yields while managing market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative facts: $630 million total fair value in 2022, $628 million maturing within one year, 6.45% yield in 2023, and 5.85% in 2024. These match the ground truth exactly, with acceptable formatting (e.g., $630 million vs $630M). (2) Quantitative accuracy is perfect—no errors in numbers, percentages, or timeframes. (3) However, the qualitative reasoning contains a key inconsistency: the original answer states that the 2022 portfolio was short-duration, implying a focus on liquidity, but the LLM incorrectly characterizes this as a 'low-yield' strategy. Given that short-duration bonds in a rising rate environment may not necessarily be low-yield—and the subsequent rise to 6.45% in 2023 suggests otherwise—this misrepresents the initial strategy. Additionally, the LLM suggests a shift to 'longer-dated' bonds in 2023 to capture higher yields, but the ground truth does not confirm a duration extension, only a yield increase. The 2024 decline to 5.85% is reasonably interpreted as a rebalancing or response to easing rates, which aligns with the original answer. (4) The answer is contextually relevant and addresses all parts of the question—evolution of yield, strategy, and market conditions—with strong synthesis across years. However, the incorrect inference about 2022 being 'low-yield' and the unsupported claim of moving to 'longer-dated' bonds in 2023 reduce the qualitative accuracy. Thus, correctness is high but not fully aligned with the ground truth reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 423,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "ConocoPhillips has presented its 7 % Debentures due 2029 in the same way in each filing: the “Securities registered pursuant to Section 12(b) of the Act” section lists the instrument as “Common Stock, $.01 Par Value 7 % Debentures due 2029” with trading symbol COP, NYSE as the exchange, and CUSIP 718507BK1 (COP_10k_2022.pdf page 1; COP_10k_2023.pdf page 1; COP_10k_2024.pdf page 1). The unchanged, consistent disclosure over three years shows the company’s deliberate, standardized approach to reporting this debt, ensuring transparency and compliance with SEC requirements.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim that the presentation of the 7% Debentures due 2029 remained unchanged across the 2022, 2023, and 2024 10-K filings. The ground truth shows a clear evolution: in 2022, the debentures were listed together with Common Stock under a combined entry, while in 2023 and 2024, they were separated into their own distinct row with explicit identification and the same CUSIP (718507BK1). The LLM incorrectly asserts that the disclosure format was identical across all three years, which contradicts the documented progression toward greater transparency and separation of debt instruments. While the CUSIP number and the basic existence of the debentures are correctly identified (supporting a minimal quantitative accuracy score), the reasoning about 'consistent disclosure' and 'standardized approach' is flawed because it fails to recognize the meaningful change in presentation. This misrepresents the multi-hop synthesis required—comparing disclosure formats across years—and leads to an incorrect conclusion about the company’s reporting approach. The answer is contextually relevant to the question topic but fails on factual correctness and logical reasoning. No calculations were required, but the qualitative assessment of disclosure trends is entirely inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 367,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s net carrying amount of the 2.00% Notes Due 2031 was $1,044 million at the end of FY 2023 and rose to $1,250 million at the end of FY 2024, indicating a modest increase in long‑term debt exposure (FY 2023: page 69; FY 2024: page 72). The FY 2022 amount is not disclosed in the supplied pages, but the subsequent years show a stable base that is gradually expanded, reflecting a deliberate strategy of incremental debt issuance to fund growth while keeping leverage conservative.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual inaccuracy regarding the FY 2022 value. The ground truth states that NVIDIA's exposure was $1.2 billion in 2022, but the LLM claims it was not disclosed, which contradicts the provided original answer. This omission affects completeness and quantitative accuracy. The FY 2023 value is also incorrect: the LLM reports $1,044 million ($1.044 billion), while the ground truth is $1.057 billion—a material difference. The FY 2024 value is correct at $1.25 billion. (2) Number verification: $1.2B (2022) → $1.057B (2023) → $1.25B (2024) per ground truth; LLM reports: undisclosed → $1.044B → $1.25B. The 2023 discrepancy (~$13 million underreporting) is non-trivial in financial analysis context. (3) Multi-hop reasoning: The LLM correctly identifies the trend from 2023 to 2024 and infers a strategy of conservative, incremental debt use, which aligns with the ground truth’s interpretation. However, missing the 2022 data point breaks the full three-year evolution required by the question, weakening the synthesis. (4) Scores justified: Correctness is 6 due to missing 2022 data and inaccurate 2023 figure, though 2024 is correct and reasoning is sound. Quantitative accuracy is 6 because two of three values are wrong or missing. Qualitative accuracy is 7 because the logic and strategic interpretation are reasonable given the available (but incomplete) data. Contextual relevance is 9—response directly addresses the question’s intent and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 422,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney has kept Marvel as a flagship brand on its streaming platform, featuring it as a top‑level tile on Disney+ (2023 10‑K, page 7) and preserving its status as an indefinite‑lived intangible asset valued at $1,792 million (2024 10‑K, page 114).  The brand’s prominence on Disney+ and its intangible‑asset valuation have remained essentially unchanged across fiscal 2022‑24, underscoring Disney’s continued strategic emphasis on Marvel as a core content pillar and key brand equity.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Marvel's role as an indefinite-lived intangible asset in 2024 and its branding as a top-level tile on Disney+ in 2023, aligning with the ground truth. However, it omits explicit mention of Marvel's inclusion in the indefinite-lived intangible assets in 2022, which is a key part of the multi-year evolution asked in the question. While the answer implies continuity across 2022–2024, it does not confirm the 2022 status as clearly as the original answer does. (2) The valuation of Marvel at $1,792 million in the 2024 10-K is factually accurate and correctly cited. However, the ground truth does not include this specific dollar amount, so introducing it—while potentially correct—adds unverified precision not present in the original answer. This introduces a risk of overclaiming, as the ground truth focuses on the classification rather than the value. (3) The reasoning is largely sound: the LLM synthesizes information from both the 2023 and 2024 10-Ks to infer Marvel’s sustained strategic importance. However, the multi-hop synthesis across all three years is slightly weaker because the 2022 data point is not explicitly confirmed, despite being central to the question’s temporal scope. (4) The contextual relevance is perfect—the answer directly addresses branding on streaming and intangible asset status. The qualitative accuracy is high due to correct entity and year identification, though completeness is slightly reduced by the missing 2022 confirmation. Quantitative accuracy is marked down because while the $1,792M figure may be correct, it was not in the ground truth and thus cannot be verified as part of the expected answer, making its inclusion potentially misleading in an evaluation context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 481,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "In 2022, American Express recognized discount revenue at the time a Card Member transaction occurred, and when a third‑party acquirer was involved, the negotiated network‑rate fee was also recorded as discount revenue (see Note 4, page 103 of the 2022 10‑K). The 2024 filing keeps the same transaction‑based discount‑revenue model and notes that the network‑rate fee is individually negotiated with each third‑party acquirer, but it adds a pronounced emphasis on expanding merchant coverage worldwide through new agreements with third‑party acquirers, aggregators and processors (see the “merchant coverage” discussion in the table of contents, page 93 of the 2024 10‑K). Thus, while the core revenue recognition and fee‑negotiation mechanics remained consistent, the company’s 2024 strategy foregrounds broader merchant‑acquisition partnerships to grow acceptance globally.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of American Express's revenue recognition practices and contractual arrangements with third-party merchant acquirers from 2022 to 2024, with correct citations to the 10-K filings. It correctly states that discount revenue was recognized at the time of transaction and that negotiated network-rate fees with third-party acquirers were recorded as discount revenue in both 2022 and 2024, which aligns with the ground truth. The emphasis on expanding merchant coverage through third-party acquirers, aggregators, and processors in 2024 is also accurately reflected. However, the LLM answer omits a key development from 2023: the introduction of processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on partner-issued cards. This is a significant addition to the revenue structure evolution and represents a multi-hop element that connects changes across years. While the core mechanics of discount revenue and fee negotiation are correctly described, the absence of the 2023 processed revenue innovation reduces completeness and slightly weakens the qualitative accuracy of the synthesis. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains highly relevant to the question. Semantic equivalence is largely preserved, but the omission prevents a top score in correctness and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 400,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "Amgen’s 2022 10‑K risk factor only noted that a subset of its products are used with drug‑delivery or companion‑diagnostic devices that carry their own regulatory and manufacturing risks.  By 2023 the disclosure expanded to explain that device approval, supply and safety can create clinical‑trial dependencies and trigger post‑marketing obligations, and that device malfunctions or adverse events could prompt regulatory action.  The 2024 filing further detailed ongoing monitoring of device complaints and adverse events, the need for post‑marketing studies and REMS compliance, and the potential impact of single‑source device suppliers on product approvals and clinical‑trial timelines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 disclosure mentioned regulatory and manufacturing risks of drug delivery and companion diagnostic devices; 2023 expanded to include clinical trial dependencies, post-marketing obligations, and regulatory scrutiny, especially in the context of confirmatory trials after accelerated approval (e.g., LUMAKRAS, though not named in the LLM answer, is contextually implied by the focus on post-marketing studies after regulatory pushback); and 2024 emphasized ongoing safety monitoring, adverse event reporting, REMS compliance, and supply chain risks from single-source suppliers. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years, showing an evolution in risk disclosure depth and specificity. The LLM captures the shift from general to more detailed regulatory, safety, and compliance concerns. The only minor shortcoming is the omission of the Complete Response Letter and surrogate endpoints, which were highlighted in the original answer as key 2023 developments. This slightly reduces qualitative accuracy, but the core trajectory of increasing regulatory scrutiny and post-marketing burden is preserved. (4) The answer is fully contextually relevant, directly addressing clinical trial dependencies, post-marketing requirements, and device-related safety reviews as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 416,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips’ HSE audit program has stayed focused on business units and staff groups, but the 2024 filing re‑brands it as a “Corporate HSE audit” program, underscoring corporate‑level oversight.  In all years, improvement actions identified in audits are tracked to completion, with the 2024 text explicitly stating this tracking.  Governance reporting remains unchanged, with audit progress reported to the Executive Leadership Team and the Board of Directors.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all quantitative and entity-related aspects: the years (2022–2024), the evolution of terminology to 'Corporate HSE audits' in 2024, the consistent tracking of improvement actions to completion, and the unchanged governance reporting to the Executive Leadership Team and Board of Directors are all accurately reflected. There are no numerical or date inaccuracies, hence quantitative accuracy is perfect. Contextual relevance is strong as the response directly addresses the question’s three components—scope, improvement tracking, and governance—though with less depth on scope evolution than the original. The main shortcoming is in completeness and qualitative depth: the LLM omits key qualitative developments in 2023, such as the integration of the HSE audit program into a broader human capital management framework and the explicit mention of Life Saving Rules, Process Safety Fundamentals, and the stop work policy. These elements represent a significant conceptual shift toward integrated safety systems, which the original answer identifies as a key evolution. While the LLM captures the centralization trend and consistent tracking/reporting, it fails to fully synthesize the 2023 contextual expansion, resulting in a partial loss of the multi-hop reasoning narrative. Thus, while factually sound, the answer lacks the full qualitative nuance of the ground truth, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 398,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "Accenture’s 2022, 2023 and 2024 10‑K filings all stress that cloud, data and AI innovations are displacing legacy services and that the firm must develop and launch new pricing or commercial models that capture the value of these technologies (see page 22 of each filing).  The messaging has evolved only marginally—adding more emphasis on generative‑AI and regulatory compliance—yet the core approach of adapting pricing to reflect new tech and mitigating revenue loss from delayed client spend has remained unchanged.  Across all three years the risk factors consistently highlight that failure to introduce appropriate pricing models, coupled with clients’ delayed or reduced spending on new technologies and the regulatory, ethical and cybersecurity risks of AI, could materially harm Accenture’s results of operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor gaps in capturing the full evolution of Accenture's approach across the years. (1) All entities—Accenture, AI, cloud, pricing models, years 2022–2024—are accurately identified, and there are no numerical inaccuracies (the original answer does not contain specific numbers, so this is not a quantitative question). (2) The LLM correctly identifies the consistent risk across all years: failure to introduce appropriate pricing models, slow client adoption, and associated revenue risks. It also correctly notes the increasing emphasis on generative AI and regulatory issues by 2024. (3) However, the LLM understates the evolution in Accenture’s approach. The ground truth shows a clear progression: from general acknowledgment in 2022, to strategic investment focus in 2023, to dependence on deployment amid rapid AI advances in 2024. The LLM describes this as only 'marginal' evolution, which downplays the increasing strategic depth and investment emphasis detailed in the original. (4) The answer is contextually excellent—directly responsive, synthesizes risks across years, and ties pricing models to technology adoption. It misses some nuance in the forward progression of strategy, but core facts and risks are accurately conveyed. Hence, a score of 8 is justified: factually sound with strong qualitative accuracy, but slight underrepresentation of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 403,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior note grew from $900 million at 12/31/2022 to $944 million at 12/31/2023 and to $982 million at 12/31/2024 (page 74, page 70).  The unrealized gain on the note swung from a loss of $865 million in 2022 to a gain of $129 million in 2023 and $38 million in 2024 (page 72).  Coupled with the sale of its equity stake in AerCap (page 73), this trend shows GE is moving from equity exposure to a more conservative, income‑generating debt position in AerCap.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023). However, the LLM claims the note 'grew' from $900 million in 2022 to $944 million in 2023 to $982 million in 2024 — all of which contradict the ground truth. The starting value ($900M vs $993M), direction of change (increase vs decrease), and final value ($982M vs $944M) are all wrong. (2) The cited unrealized gains/losses and equity stake sale are not part of the original answer and introduce unverified information. While the LLM may be pulling from actual filings, these details were not in the ground truth and do not support the correct narrative of declining exposure. More critically, the financial progression is misrepresented: the ground truth shows a consistent decline, while the LLM describes growth, indicating a fundamental error in data interpretation or sourcing. (3) The multi-hop reasoning is flawed. The question asks about the evolution of holdings and what it suggests about GE's strategy. The correct inference is a strategic reduction in AerCap exposure. The LLM instead infers a shift to 'debt position' based on increasing note value — which contradicts the actual data. This suggests a failure in synthesizing the correct trend across years. (4) The contextual relevance is moderate because the answer addresses GE's investment strategy in AerCap and references relevant financial instruments. However, due to severe quantitative inaccuracies and incorrect directional trends, the qualitative and correctness scores are very low. Even allowing for format variation, the numbers are factually and directionally wrong, warranting a correctness score of 2.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 500,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "Amgen had Bemarituzumab listed as a Phase 3 candidate for GEJ adenocarcinoma in its 2022 10‑K, with composition‑of‑matter patents in the U.S. and Europe estimated to expire in 2029【page_25】.  In the 2023 filing the program remained Phase 3 while a Phase 2 study for “other tumors” was added, and the same 2029 expiration dates were reported【page_25】.  The 2024 filing kept the same status—Phase 3 for GEJ adenocarcinoma and Phase 2 for other tumors—with the patent expirations unchanged at 2029【page_25】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the Phase 3 status for GEJ adenocarcinoma in 2022, the 2029 U.S. and European patent expiration (consistent across 2022–2024), and the addition of a Phase 2 study for 'other tumors' in 2023. These factual elements—particularly the clinical phase and patent expiration dates—are quantitatively accurate and match the ground truth. (2) All numbers and dates are correct: the 2029 patent expiration is accurately cited, and the timeline across 2022–2024 aligns with the original answer. There are no calculation errors. (3) However, the LLM answer falls short in qualitative accuracy and reasoning. The ground truth emphasizes a strategic evolution in Amgen’s positioning—from clinical development to broader therapeutic scope and IP strategy—highlighting a more detailed mechanism of action and expansion into gastric cancer and advanced solid tumors beyond NSCLC in 2024. The LLM answer oversimplifies this by only noting 'other tumors' and fails to capture the nuanced expansion and mechanistic detail, missing the multi-hop synthesis of strategic intent. It treats the progression as static (same phase, same patents) without acknowledging the qualitative shift in disclosure depth and strategic framing. (4) While contextually relevant and factually precise on key metrics, the answer lacks the interpretive synthesis required to reflect the full evolution of Amgen’s positioning. Hence, correctness is partially compromised due to incomplete qualitative reasoning, warranting a score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 424,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "From 2022‑23, American Express framed alternative payment mechanisms—digital wallets, buy‑now‑pay‑later, real‑time settlement platforms and other fintechs—as a growing threat that required “speed of innovation and investment in systems, technologies, and product and service offerings” (2022/23 p. 12‑14). By 2024, the company’s filings show a shift from merely describing the pressure to actively investing in technology—AI, machine learning, tokenization, real‑time settlement, open‑banking and digital‑wallet integration—to defend merchant‑discount‑rate erosion, surcharging and the loss of merchant relationships (2024 p. 29‑31). This evolution signals a long‑term strategy of leveraging technology and differentiated value propositions to counter fintech disruption while preserving its premium brand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of American Express's strategic positioning from 2022 to 2024: in 2022–2023, alternative payment mechanisms were framed as competitive threats, and by 2024, the company shifted toward active technological investment. The cited page numbers (2022/23 p. 12–14; 2024 p. 29–31) are consistent with the source data, and no incorrect dates or figures are present. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—only qualitative and contextual fidelity matter here, and the answer handles them well. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly tracing the shift from threat perception to proactive integration of technologies like tokenization, open banking, and real-time settlement. It also correctly identifies the strategic rationale—defending against merchant discount rate erosion and surcharging—adding contextual depth not explicitly in the ground truth but consistent with it. (4) The only minor gap is that the LLM omits explicit mention of blockchain-based systems and payment facilitators, which were noted in the original answer as part of the expanding threat landscape. However, it compensates by naming AI and machine learning as 2024 investment areas, which reflects accurate reporting from the 2024 filing. Overall, the answer captures the core strategic evolution and long-term response to fintech disruption with high fidelity, warranting a 9/10 for correctness and qualitative accuracy. Contextual relevance is perfect—every part of the question is addressed directly and appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 477,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "ConocoPhillips’ weighted‑average grant‑date fair value for cash‑settled PSUs rose from **$91.58** in 2022 to **$112.50** in 2023, then fell modestly to **$110.39** in 2024 (2023 10‑K, page 124; 2024 10‑K, page 126). The upward jump followed by a slight dip indicates the company keeps its cash‑settled PSU awards at a high valuation, underscoring a strategy that prioritizes performance‑linked equity compensation to align executive pay with shareholder value while adjusting award levels in response to market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, implying a consistent upward trend. However, the LLM claims a rise to $112.50 in 2023 and then a drop to $110.39 in 2024, which contradicts the ground truth. This misrepresentation of the 2024 value and the insertion of a non-existent decline undermines factual correctness. (2) The numbers cited—$91.58 (2022), $112.50 (2023), and $110.39 (2024)—are not aligned with the original answer, which reports $112.50 as the 2024 value, not 2023. There is no mention of a $110.39 value in the ground truth. Additionally, the LLM introduces specific document page references (e.g., 2023 10-K, page 124) not present in the original answer, which may be plausible but cannot be verified and do not compensate for the core numerical error. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the concept of tracking fair value over time and attempts to infer strategic implications. However, the conclusion about a 'slight dip' and adjustment due to market conditions is based on incorrect data and thus represents flawed reasoning. The original answer notes a consistent upward trend indicating a strategic shift toward higher-value incentives, which the LLM mischaracterizes. (4) Despite the incorrect numbers, the LLM addresses both parts of the question—evolution over time and strategic implication—and maintains contextual relevance. The qualitative interpretation is reasonable given its assumed data, and the terminology (e.g., 'performance-linked equity compensation', 'shareholder value') aligns with executive compensation discourse. Hence, while the reasoning framework is adequate, the factual foundation is flawed, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 509,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal’s 10‑K risk‑factor disclosures from 2022 through 2024 consistently flag growing exposure to abusive behaviors, especially via its PayPal‑branded credit products and third‑party fraud schemes such as synthetic identities and stolen‑card transactions. The company repeatedly cautions that credit‑risk models can misjudge borrower creditworthiness and that fraud tactics are evolving, requiring costly, continuously improved mitigation efforts. This persistent emphasis on high exposure and the admission that controls may not fully contain losses suggest that PayPal’s risk‑management effectiveness remains challenged and needs further strengthening.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PayPal's ongoing concerns about abusive behaviors, third-party fraud schemes (e.g., synthetic identities, stolen-card transactions), and risks tied to credit products across 2022–2024. It accurately reflects the persistent nature of these risks and the challenges in detection and mitigation. However, it omits key factual developments from the ground truth, particularly the €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023—a major strategic risk mitigation action. This omission weakens the completeness and qualitative accuracy. Additionally, the LLM answer does not mention the 'valid-when-made doctrine' regulatory uncertainty in 2024 affecting U.S. credit products, which is a specific and important element of the trend. (2) There are no numerical inaccuracies; the LLM answer does not introduce any incorrect figures, percentages, or dates. It avoids quantifying what isn’t in the original, so quantitative accuracy is strong. (3) The multi-hop reasoning is partially sound—linking credit products and fraud across years—but fails to synthesize the critical strategic move (receivables sale) and regulatory context, which are essential for fully capturing PayPal’s evolving risk management approach. (4) The correctness score is 7 because core facts and themes are correct, but significant contextual and strategic details are missing. Quantitative accuracy is 10 as no numbers are misstated. Qualitative accuracy is 7 due to incomplete synthesis of key risk-mitigation strategies and regulatory factors. Contextual relevance is 9 because the answer stays focused and relevant, only missing a few critical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 467,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "Cyramza’s therapeutic portfolio has stayed the same from 2022 through 2024, continuing to be sold as a second‑line therapy for gastric, NSCLC, colorectal and hepatocellular cancers and as a first‑line option for EGFR‑mutated NSCLC【page_5】.  Its intellectual‑property protection has also remained unchanged, with compound patents expiring 2026‑2028, data‑protection in the EU ending in 2024 (Japan in 2023) and biologics data protection lasting to 2026【page_11】.  This steady positioning and robust, but approaching‑expiration, exclusivity signals Lilly’s long‑term oncology strategy of expanding a broad, multi‑cancer indication set while preserving patent life to secure revenue streams.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cyramza's consistent therapeutic positioning across gastric, NSCLC, colorectal, and hepatocellular cancers from 2022–2024, aligning with the ground truth. However, it introduces a detail not present in the original answer—Cyramza as a 'first-line option for EGFR-mutated NSCLC'—which is not mentioned in the ground truth and may be inaccurate or unsupported. (2) Quantitatively, there are discrepancies: the ground truth states compound patents extend through 2026 in the U.S. and Japan, but the LLM claims '2026–2028', introducing an incorrect extension beyond 2026. Data protection in Japan is correctly noted to expire in 2023, but the LLM adds EU data protection ending in 2024 and biologics protection to 2026, which are not in the original answer and may reflect overextrapolation. (3) The reasoning is mostly sound: the LLM correctly infers that stable positioning and nearing patent expiry suggest a strategy of revenue preservation while likely developing next-gen products. However, the ground truth emphasizes that no new indications were added in 2024 and implies a defensive strategy, whereas the LLM frames it more positively as 'expanding a broad, multi-cancer indication set', which slightly misrepresents the stagnation implied in the original. (4) Despite these issues, the core facts—unchanged indications, patent expiry around 2026, and strategic focus on revenue protection—are present and correctly synthesized, warranting a score of 7 for overall correctness. Quantitative accuracy is penalized due to incorrect date ranges, but qualitative and contextual scores remain high due to logical inference and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 460,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "Philip Morris has kept the 3.875 % Notes due 2042 as a core long‑term debt anchor in every filing (2022‑2024) while actively issuing and extending other notes to diversify maturities and optimize cost. In 2022 the debt mix included short‑term notes due 2022‑2025 plus the 3.875 % Notes due 2042 (PM_10k_2022.pdf page 1); in 2023 it added notes due 2024‑2028, and by 2024 it had further extended its maturity profile to include notes due 2029‑2044, reflecting a deliberate shift toward longer‑dated debt while maintaining the 3.875 % Notes due 2042 as a stable anchor (PM_10k_2023.pdf page 1; PM_10k_2024.pdf page 1).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that by 2024, Philip Morris had extended its maturity profile to include notes due 2029–2044, which directly contradicts the ground truth stating that the 4.125% Notes due 2043 and 4.875% Notes due 2043 (present in 2022) and the 4.250% Notes due 2044 (present in 2023) were no longer listed in the 2024 filing—indicating retirement or refinancing, not expansion. The LLM incorrectly suggests a broad extension of long-dated debt, while the ground truth shows a contraction and stabilization. (2) Quantitative accuracy is poor: the specific notes mentioned in the ground truth (4.125% due 2043, 4.875% due 2043, 4.250% due 2044) are omitted, and instead, generic 'notes due 2029–2044' are fabricated. The percentages and maturities are entirely incorrect. (3) Multi-hop reasoning is flawed: the LLM fails to track the presence and subsequent disappearance of specific debt instruments across years, misinterpreting the trend as one of increasing long-term debt issuance when it was actually a move toward consolidation and stability around the 3.875% Notes due 2042. The core insight—that PM retired or refinanced other long-dated notes while keeping the 3.875% Notes as a stable anchor—is reversed in the LLM’s narrative. (4) Contextual relevance is moderate because the answer addresses capital structure evolution and correctly identifies the 3.875% Notes due 2042 as a consistent component, but the overall conclusion is factually inverted, leading to a severely incorrect strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 434,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal’s 2022 risk disclosures highlighted growing exposure to abusive behaviors from third‑party lenders and processors and the risk of defaults on its credit products (page 26). In 2023, the company mitigated credit‑risk exposure by selling a majority of its UK and European BNPL loan receivables and began selling those receivables in October 2023 (page 25). In 2024, PayPal further reduced third‑party concentration risk by diversifying its payment‑processor base and moving its U.S. arrangements to new processors in a phased transition (page 22).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures some correct elements but contains significant inaccuracies and omissions compared to the ground truth. It correctly identifies that in 2022, PayPal noted abusive behaviors related to credit products and third parties (page 26 reference aligns with risk disclosures), and it correctly notes a strategic move in 2023 involving the sale of UK and European BNPL receivables. However, it fails to mention the key quantitative detail from the original answer — the €40 billion multi-year agreement — which is a major omission in quantitative accuracy. The LLM states 'a majority' of receivables were sold, which is vague and not equivalent to the specific €40B figure in the ground truth. Additionally, the 2024 actions described in the LLM answer — diversifying payment processors and transitioning U.S. arrangements — are not mentioned in the original answer and appear to conflate third-party risk in processing with credit risk from abusive behaviors. The original answer emphasizes enhanced fraud detection and prevention infrastructure in 2024, which the LLM omits entirely. (2) Quantitative accuracy is compromised: the €40B figure is missing, and no equivalent scale of transaction is provided. The LLM’s 'majority' is qualitative and unverifiable. Dates (e.g., October 2023) may be factually present in filings but were not in the ground truth answer, so their correctness cannot be confirmed against the reference. (3) Multi-hop reasoning is partially sound — the LLM connects risk disclosures to mitigation actions across years — but it fails to synthesize the correct evolution: from identifying abuse (2022), offloading credit risk via asset sales (2023), to strengthening internal fraud systems (2024). Instead, it shifts focus in 2024 to payment processor diversification, which is a different risk domain (operational/third-party processing) rather than credit fraud or abusive behavior mitigation. (4) Scores reflect partial correctness: core facts in 2022 and 2023 are directionally accurate but lack specificity; 2024 response is misaligned with the ground truth. Contextual relevance is high as the answer stays focused on PayPal, risk exposure, and mitigation strategies, even if details are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 602,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD has consistently listed the risk of loss or modification of tax and tariff exemptions in its risk‑factor disclosures for 2022, 2023 and 2024, with the wording and emphasis unchanged (2022 page 37, 2023 page 39, 2024 page 38). The fact that the company continues to highlight this exposure in every filing indicates that it remains a material concern, underscoring persistent and potentially escalating regulatory uncertainty across its global operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of AMD's risk disclosures. While it correctly identifies that AMD mentioned the risk of loss or modification of tax and tariff exemptions in 2022, 2023, and 2024, it falsely states that the 'wording and emphasis' remained 'unchanged' across the years. This directly contradicts the ground truth, which shows a clear escalation in emphasis and integration of the risk with broader geopolitical and regulatory concerns: from being one of several risks in 2022, to being grouped with critical exposures in 2023, to being explicitly linked to geopolitical conflicts in 2024. The LLM's assertion of no change in emphasis undermines the entire multi-hop reasoning required to detect the trend of increasing regulatory uncertainty. There are no numerical errors (hence full quantitative accuracy), but the qualitative analysis fails due to incorrect synthesis across years. The answer is contextually relevant—addressing AMD’s global regulatory risks—but draws an incorrect conclusion due to flawed reasoning. Thus, the correctness score is low despite accurate entity and year identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 326,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation swung from a **$92 million loss in FY 2022** to a **$58 million gain in FY 2023** and a **$91 million gain in FY 2024**.  The notional amount of these swaps rose from **$651 million in FY 2022 to $985 million in FY 2024**, indicating that Cisco has increased its hedging activity.  The shift to positive gains and the larger notional suggest a deliberate strategy to actively manage deferred‑compensation risk, with the derivatives proving effective and the exposure being more tightly controlled.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years from the ground truth: a $92 million loss in FY 2022, a $58 million gain in FY 2023, and a $91 million gain in FY 2024. These match the original answer exactly, with acceptable formatting (e.g., $92 million). (2) The quantitative accuracy is perfect—no calculation or number errors. However, the LLM introduces additional data not present in the ground truth: the notional amounts ($651M in 2022, $985M in 2024). While plausible and contextually relevant, this information is not in the original answer and cannot be verified from the provided ground truth, slightly affecting qualitative accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies the trend (loss to increasing gains) and infers a strategic shift in risk management, aligning with the original conclusion about exposure and strategy. The added interpretation about increased hedging activity and effectiveness is reasonable but goes beyond the original answer’s scope. (4) Scores reflect high fidelity to the ground truth in numbers and core reasoning; the only deduction is a minor one in qualitative accuracy due to unverified notional amounts, though the overall conclusion remains logically consistent and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 362,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "Disney’s DTC strategy shifted from a 2022 focus on launching an ad‑supported Disney+ and cost‑realignment (page 29, page 27) to a 2024 reorganization of its media and entertainment business, a strategic content‑curation shift, and the launch of ESPN+ and a Star India joint venture amid intensified competition (page 21, page 23). This evolution highlights mounting financial risks—substantial content and marketing outlays, potential goodwill and content impairments, and higher debt and borrowing costs—while underscoring market pressures such as pricing sensitivity, advertising‑revenue volatility, and the challenge of scaling subscriber growth in a crowded streaming landscape.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies despite referencing correct general themes. It incorrectly states that ESPN+ was launched in 2024, when ESPN+ was actually launched in 2018—this is a major entity/time misattribution. Similarly, the mention of a 'Star India joint venture' as part of the 2024 strategy is misleading; while Star India is a Disney asset, no new joint venture was announced in 2024. The 2022 focus on an ad-supported Disney+ is correct, but the original answer emphasizes financial uncertainty and growing losses, which the LLM answer downplays. The 2023 shift toward active investment is omitted entirely in the LLM response. (2) There are no numeric values in either answer, so quantitative accuracy is not compromised—score reflects absence of numerical errors. (3) The multi-hop reasoning is partially sound in that the LLM identifies evolving strategy and market pressures, but it fails to correctly synthesize the chronological evolution across 2022–2024. Key strategic shifts in each year from the ground truth—especially the progression from cost concerns (2022) to growth investment (2023) to competitive pressure (2024)—are not accurately mirrored. Instead, the LLM conflates events and misattributes timing. (4) The contextual relevance is moderate because the answer addresses DTC evolution and financial risks, but the misstatements about launches and ventures reduce factual reliability. Correctness and qualitative accuracy are penalized due to significant factual and temporal errors, even though the general theme of rising costs and competition is consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 445,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s exposure to margin risk has remained essentially unchanged from 2022 through 2024.  The company continues to have full discretion in setting transaction fees independent of the costs it incurs for payment processors, and it bears full margin risk as a principal in each payment transaction (disclosed in the 2023 10‑K on pages 75–77 and the 2024 10‑K on page 77).  The 2022 10‑K pages provided (78–82) do not contain a separate margin‑risk disclosure, indicating the same risk profile persisted.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core conclusion of the ground truth: PayPal's margin risk exposure remained stable from 2022 to 2024, with consistent discretion in fee setting and full margin risk as a principal. It correctly identifies that PayPal bears full margin risk and recognizes processor fees as transaction expenses, with references to the 2023 and 2024 10-Ks (pages 75–77 and 77 respectively). The statement that the 2022 10-K (pages 78–82) lacks an explicit margin-risk disclosure but implies continuity is reasonable and does not contradict the ground truth, which affirms the consistent risk profile. All entities (PayPal, payment processors, ASU 2023-07 implied via 2024 reporting changes), years (2022–2024), and financial concepts (margin risk, transaction expense, fee discretion) are accurately represented. There are no calculation errors (no numerical computations required), and the reasoning across years is sound. The only minor shortcoming is that the LLM does not explicitly mention the accounting consistency in recognizing processor fees as transaction expenses in all three years, nor the impact (or lack thereof) of ASU 2023-07 in 2024, which slightly reduces qualitative completeness. However, the omission does not distort the overall accuracy. Semantic equivalence is strong, and the answer is highly contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 380,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "From 2022 through 2024, Honeywell’s Aerospace risk‑factor language consistently warned that downturns in air‑travel demand could delay or cancel new aircraft orders (2022: page 31; 2023: page 31; 2024: page 28). The unchanged wording indicates that the risk of order cancellations remains a persistent concern, even as the commercial aviation sector shows signs of gradual recovery and growing stability.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but lacks key qualitative details present in the ground truth, resulting in a moderate correctness score. (1) What was correct: The LLM correctly identifies that Honeywell consistently cited the risk of new aircraft order cancellations from 2022 to 2024 due to air-travel demand downturns, and it accurately references the continuity of this risk factor across filings, supporting the idea of ongoing concern. The page numbers cited (2022: 31; 2023: 31; 2024: 28) are plausible and consistent with typical 10-K structures, and no numeric inaccuracies are present—thus, quantitative accuracy is high. Contextual relevance is strong, as the response directly addresses the evolution of the risk and its implications for sector recovery. (2) However, the LLM fails to capture the nuanced evolution of the risk language over time, which is central to the question. The ground truth notes a clear shift: in 2022, the risk was tied specifically to the pandemic; in 2023, it expanded to include geopolitical conflicts and environmental issues; and in 2024, it included structural market changes from new entrants and non-traditional players. The LLM incorrectly states that the 'unchanged wording' indicates persistence, which contradicts the ground truth showing evolving language and risk scope. (3) This misrepresents the multi-hop reasoning required—the model should have synthesized changes in risk factor descriptions across years to show how the nature of the risk transformed, not remained static. (4) Therefore, while the core fact of persistent risk is correct, the absence of this progression undermines the qualitative accuracy, limiting the answer's depth and correctness despite accurate citations and no numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 477,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "PMI’s 2022 risk disclosures (page 15) warned that product regulation could blunt differentiation and restrict adult consumers’ access to truthful information for both RRPs and SFPs. The 2023 risk factors (pages 18‑22) repeated this warning with added detail on how regulation could impede the commercialization of RRPs and SFPs. By 2024, the risk on pages 17‑21 expands to include specific regulatory challenges—product classification, advertising restrictions, corporate communications, scientific substantiation, liability, antitrust and unfair competition—while still noting that such regulation limits product differentiation and adult‑consumer communication, underscoring an intensifying regulatory clamp‑down on PMI’s competitive positioning.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of the evolution of regulatory risks for PMI from 2022 to 2024, with correct references to page numbers and risk disclosures across years. All dates (2022, 2023, 2024) and document locations (e.g., pages 15, 18–22, 17–21) are consistent with the expected data, and there are no numerical inaccuracies—this earns a perfect quantitative accuracy score. The answer correctly identifies that product regulation increasingly affected PMI’s competitive positioning, particularly regarding RRPs and SFPs, and notes persistent themes like restricted adult consumer access to information and limitations on product differentiation. However, the LLM response lacks the nuanced evolution described in the ground truth: it does not clearly articulate the shift in emphasis from RRPs in 2022–2023 to SFPs in 2024, nor does it mention the growing concern about digital misinformation or the disproportionate impact on PMI relative to competitors in 2023. While it lists additional regulatory domains in 2024 (e.g., advertising, scientific substantiation), it synthesizes less insight about how these reflect intensifying constraints tied to PMI’s strategic product transition. Thus, while the core facts and timeline are correct, the qualitative depth of multi-hop reasoning—especially the strategic implications of evolving regulatory language—is partially missing. Contextual relevance is high, as the response directly addresses the question’s focus on regulatory evolution and competitive positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 424,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s exposure to margin risk has stayed essentially the same from 2022 through 2024.  In each filing the company notes that it is the principal in every payment transaction, sets the fee schedule (a tiered, volume‑based model) and bears the full margin risk regardless of the variable fee component or the proportion of transactions processed by third‑party processors.  Incentives to merchants and consumers – discounts, rebates, rewards and coupons – are still treated as revenue reductions and have not changed in scope or accounting treatment.  Thus, the use of payment processors remains a cost component of transaction expense, and the overall margin‑risk exposure, pricing structure, and incentive framework have remained consistent over the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that PayPal's exposure to margin risk has remained consistent from 2022 to 2024, with the company bearing full margin risk as the principal in payment transactions. It accurately reflects that fees paid to payment processors are treated as transaction expenses and that incentives (discounts, rebates, rewards) are accounted for as reductions of revenue. The answer correctly notes the stability in accounting treatment and pricing structure across the years. However, it adds specific details not present in the original answer—such as the 'tiered, volume-based model' for fee schedules and the explicit mention of 'proportion of transactions processed by third-party processors'—which were not mentioned in the ground truth. While these additions are plausible and contextually reasonable, they go beyond the disclosed information in the original answer, introducing unverified specifics. The original answer emphasizes an evolution in disclosure detail (increasing nuance in 2023 and 2024 about incentives and pricing), whereas the LLM portrays the disclosures as entirely unchanged, missing this subtle progression. There are no numerical inaccuracies (quantitative accuracy is perfect), and the entities (PayPal, years 2022–2024, payment processors, incentives) are correctly identified. The reasoning is sound but slightly overconfident in asserting consistency in 'scope' and 'framework' without acknowledging the increased transparency in reporting. The answer is fully relevant to the question and synthesizes the multi-hop elements (pricing, processors, incentives) appropriately, though with minor overreach in specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 457,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "AMD’s policy toward AIB manufacturers stayed essentially the same from 2022 through 2024: the company continued to protect AIB inventory from price reductions and, in all filings, stressed that system integrators use discrete graphics solutions to differentiate their products. The relationship with AIBs remained stable, with no substantive changes to inventory‑protection terms or the strategic role of discrete GPUs for SIs. (See AMD 10‑K 2022, page 13; AMD 10‑K 2023, page 12; AMD 10‑K 2024, page 13)",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: AMD maintained inventory protection for AIB manufacturers from 2022 to 2024, and discrete graphics solutions were consistently highlighted as a differentiator for system integrators (SIs). The cited pages from the 10-K filings (2022 p.13, 2023 p.12, 2024 p.13) support these points, and there are no errors in dates, entities, or quantitative references. However, the LLM answer omits a key qualitative evolution noted in the ground truth: the subtle but meaningful shift in 2024 toward a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings. While the LLM correctly states that there were no 'substantive changes,' it fails to acknowledge the increased emphasis on SIs leveraging regional or product-based strengths and responding to new technologies, which reflects a maturation in the ecosystem strategy. This omission reduces completeness and weakens the qualitative accuracy, particularly in capturing the nuance of multi-hop synthesis across years. The reasoning is sound but not fully comprehensive. The answer remains contextually relevant and semantically aligned on the main points, warranting a solid but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 345,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Disney’s policy on investment‑credit exposure has remained essentially unchanged from fiscal 2022 through 2024: it only enters derivative transactions with counterparties rated A‑ or better, requires collateral when a counterparty’s rating falls below A‑ or when aggregate exposures exceed contractual limits, and limits exposure to any single institution 【page_117】.  The concentration threshold—no more than 10 % of total cash and cash equivalents with any one institution—has stayed the same, but the actual concentration rose from none in 2023 (no balances exceeded 10 % of total cash and cash equivalents) to 24 % of total cash and cash equivalents in 2024 【page_120】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 24% concentration in fiscal 2024 is accurately reported, and the absence of such concentration in prior years (noted as 'none in 2023' and implied for 2022) matches the original answer. The 10% concentration threshold is correctly stated. (2) The policy details—transacting only with A- or better rated counterparties and requiring collateral upon rating downgrade or exposure breach—are factually correct and consistent with the original. (3) The reasoning correctly synthesizes multi-hop information: it distinguishes between unchanged policy (counterparty ratings, collateral, exposure limits) and a shift in actual concentration despite policy continuity. (4) One minor discrepancy: the LLM states 'no balances exceeded 10% in 2023', while the ground truth references fiscal 2022 as having no concentration. This shifts the timeline slightly—though the 24% rise in 2024 is correctly highlighted, the baseline shift from 2022 to 2024 is slightly misattributed by referencing 2023 instead of 2022. This is a small factual misalignment but does not undermine the core conclusion. (5) All entities (The Walt Disney Company, fiscal years, credit ratings, collateral requirements) are correctly identified. The answer is contextually complete and directly addresses counterparty ratings, collateral, and concentration thresholds as asked. Due to the minor temporal misstatement, a score of 9 is warranted instead of 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 424,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "Across 2022, 2023, and 2024 PayPal’s exposure to the 2029‑maturing Fixed‑Rate 2.850 % notes remained unchanged at **$1.5 billion** (the principal amount listed in each year’s debt‑summary table). This steady level of exposure indicates a deliberate long‑term debt‑management strategy that preserves a consistent debt mix and maturity profile, balancing interest‑rate risk and liquidity while keeping the company’s long‑term financing structure stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that PYPL's exposure to the 2.850% fixed-rate notes maturing in 2029 remained constant at $1.5 billion (equivalent to $1,500 million) across 2022, 2023, and 2024, matching the ground truth in both amount and time frame. The formatting variation ($1.5 billion vs $1,500 million) is acceptable and semantically equivalent. 2) All numeric values—principal amount ($1.5 billion), interest rate (2.850%), and maturity year (2029)—are accurate. No calculations were required, but the consistency across years is correctly noted. 3) The reasoning is sound: the LLM correctly infers a strategic intent from the lack of change in debt exposure. It accurately describes a stable debt management approach focused on maintaining maturity profile and interest-rate risk balance. However, it omits a key detail from the original answer: that PYPL issued new, higher-interest debt in 2023 and 2024 (e.g., 5.150% and 5.500% notes) while still retaining the 2.850% notes. This omission slightly weakens the depth of the strategic interpretation, as the contrast between issuing costlier debt and retaining cheaper debt underscores the strategic value of the 2.850% notes. 4) Despite this minor gap, the answer is contextually relevant, directly addresses both parts of the question (evolution of exposure and strategic implication), and maintains factual and semantic alignment with the ground truth. The conclusion about stable debt strategy is logically supported, though less nuanced than the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 418,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s Performance Materials and Technologies segment has seen only a marginal rise in contract‑based supply coverage, from 63 % of its raw‑material base in 2022 to 64 % in 2023 and a “majority” under contract by 2024 (page 32 2022, page 32 2023, page 32 2024).  Nonetheless, the risk‑factor disclosures on pages 31 2023 and 31 2024 repeatedly warn that price swings and supply‑chain disruptions for copper, fluorspar, tungsten salts, ethylene, aluminum and molybdenum can still lift costs and hurt margins.  The slight increase in contract coverage therefore only modestly dampens, but does not eliminate, Honeywell’s vulnerability to commodity‑market volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces fabricated data not present in the original answer or implied by the question. (1) The claim that Honeywell had 63% contract-based supply coverage in 2022 rising to 64% in 2023 and a 'majority' in 2024 is not supported by the ground truth; no such percentages or metrics about contract coverage appear in the original answer. This is a significant factual error. (2) The list of raw materials (copper, fluorspar, tungsten salts, ethylene, aluminum, molybdenum) and references to specific page numbers (e.g., page 32 2022, etc.) are not present in the original answer and appear to be hallucinated. The original answer mentions hydrofluorocarbons and volatility in oil and natural gas prices, not these specific commodities. (3) The multi-hop reasoning is flawed: while the LLM attempts to assess evolution of risk and vulnerability, it does so using incorrect data. The original answer focuses on the qualitative evolution of risk disclosure—shifting emphasis and rebranding of the segment to Energy and Sustainability Solutions in 2024—not on contract coverage metrics. (4) The contextual relevance is moderate because the LLM addresses the general theme of raw material risk and commodity volatility, and correctly infers that vulnerability persists, but it fails on factual accuracy and uses incorrect evidence. The conclusion about 'modestly dampens, but does not eliminate' vulnerability is speculative and not aligned with the original answer’s emphasis on sustained vulnerability despite strategic repositioning. Overall, the answer fabricates key quantitative details and misrepresents the source of risk evolution, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 463,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "PMI’s peer group list stayed unchanged from 2022 through 2024, with Imperial Brands PLC appearing on the list in the 2022 filing (page 21), the 2023 filing (page 26), and the 2024 filing (page 26). This steady inclusion shows that PMI deliberately anchors its benchmarking against a consistent set of global tobacco and consumer‑products peers, treating Imperial Brands as a key comparative benchmark to gauge performance in the sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that Imperial Brands PLC was included in PM's (PMI's) peer group across all three years—2022, 2023, and 2024—with specific page references from the filings, which supports the claim of consistent inclusion. These details are consistent with the original answer’s assertion of stability in peer group composition. (2) There are no numerical values requiring calculation, but the years and entity name (Imperial Brands PLC) are correct, and the use of PMI (Philip Morris International) is appropriate and synonymous with PM in this context. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual reports to confirm consistent presence, demonstrating that the benchmarking strategy remained stable. (4) The conclusion about PMI’s deliberate and consistent benchmarking strategy is logically derived and semantically equivalent to the original answer’s interpretation. The only minor limitation is that the LLM answer does not explicitly mention 'revenue scale' or 'market capitalization' as factors in peer selection—details present in the original answer—so it omits a small element of the strategic rationale. However, the core insight about strategic consistency is preserved. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 397,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850% notes remained unchanged at **$1.5 billion** in each of the 2022, 2023 and 2024 10‑Ks (page 107 for 2022‑23; page 104 for 2024‑23). The unchanged exposure indicates that the company is keeping a steady portion of long‑term, fixed‑rate debt rather than aggressively refinancing or paying it down, reflecting a strategy of maintaining a predictable debt‑service profile and hedging against interest‑rate volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's exposure to the 2.850% fixed-rate notes remained at $1.5 billion in 2022, 2023, and 2024, which matches the ground truth. All numeric values (dollar amount, interest rate, years) are accurate. (2) Quantitative accuracy is perfect: $1.5 billion is consistently reported across all three years, and the interest rate (2.850%) is correctly cited. The LLM even provides document page references, enhancing verifiability. (3) The multi-hop reasoning is sound—synthesizing data across three annual reports (2022–2024) to observe no change in principal. The conclusion about PYPL maintaining a steady fixed-rate debt position aligns with the ground truth’s interpretation, though it adds nuance about hedging interest-rate volatility, which is reasonable but not explicitly stated in the original. (4) The answer is contextually fully relevant, addressing both the evolution of exposure and the strategic implication. The only minor gap is that the original emphasizes the lack of repayment/refinancing actions, while the LLM focuses more on strategic benefits; however, this is a difference in emphasis, not factual inaccuracy. Thus, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 350,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "From 2022 to 2024 ConocoPhillips broadened its HSE audit scope to explicitly include staff‑group reviews, added a formal tracking system that ensures all identified improvement actions are followed through to completion, and reinforced corporate governance by reporting audit results and progress to the Executive Leadership Team and Board of Directors (see page 18 of the 2023 and 2024 10‑Ks, which note “HSE audits … tracked to completion” and “Progress is tracked and reported to our ELT and the Board”).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key elements of ConocoPhillips' HSE audit evolution from 2022 to 2024. (1) It correctly identifies the expansion of audit scope to include staff groups, which aligns with the 2022 practice noted in the ground truth. It accurately states that improvement actions were tracked to completion, matching the original answer's description of conformance tracking. It also correctly notes the reporting of audit results and progress to the Executive Leadership Team (ELT) and Board of Directors, reflecting the integration with corporate governance starting in 2023 and continuing into 2024. (2) There are no numeric values, dates, or financial figures in the response, so quantitative accuracy is not applicable in a traditional sense; however, the temporal progression (2022–2024) is handled correctly, and no incorrect years or timeframes are cited. (3) The multi-hop reasoning is sound: the model synthesizes information across years and connects audit practices to governance reporting, drawing from both 2023 and 2024 10-Ks as referenced. However, it omits a key nuance present in the ground truth: the shift toward a more centralized, corporate-level audit framework in 2024, which signifies a structural evolution in oversight. This detail about centralization is important for fully capturing the trajectory from localized audits to a governance-driven model. (4) Despite this omission, the answer remains semantically close to the original, uses correct entities (ConocoPhillips, ELT, Board of Directors), and addresses all three dimensions of the question—audit scope, conformance tracking, and governance integration—with high fidelity. The reference to specific 10-K pages adds credibility. The answer is contextually excellent and factually accurate on core points, warranting a high score but not perfect due to the missing emphasis on centralization in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 516,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "Across 2022, 2023, and 2024 AMD continued to cite its 2011 Executive Incentive Plan as an exhibit incorporated by reference, underscoring that the plan remains a foundational governance document. In each year’s 10‑K the plan is listed in the “Exhibit” section (2023: page 101; 2024: page 96; 2022: in the 2022 10‑K’s exhibit list), and it is referenced alongside broader executive‑compensation disclosures, indicating a stable reliance on the 2011 plan as a core governance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core information from the ground truth. It correctly states that AMD consistently referenced the 2011 Executive Incentive Plan across 2022, 2023, and 2024 as a foundational governance document, with accurate mention of its inclusion in the Exhibit section of each 10-K filing. The years and plan name are correct (entity accuracy), and the answer reflects the continuity of reliance on the plan amid broader executive compensation disclosures, satisfying the multi-hop requirement of tracking evolution (or lack thereof) over time. The quantitative accuracy is perfect: no incorrect numbers, dates, or misattributions. The LLM correctly notes exhibit listing and provides specific page numbers for 2023 and 2024 (though 2022 lacks a page number, this is a minor omission, not an error). The qualitative reasoning is sound—AMD’s continued citation indicates stability in governance framework. The only reason for not scoring a 10 is that the LLM omits specific details present in the ground truth, such as the exhibit number (*10.1*) being consistent across all three years and the explicit mention of other plans (e.g., AMD Executive Severance Plan) that contextualize the 2011 plan’s role. While the LLM captures the essence and key facts, it lacks some depth in detailing the exact exhibit labeling and comparative plan environment, slightly reducing completeness. However, the semantic meaning and factual core are preserved, and the answer remains highly relevant and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 420,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "From 2022 through 2024 GM’s 10‑Ks consistently describe the same indemnification framework: the company’s wholly‑owned subsidiary (the Seller) agreed to indemnify Stellantis for losses arising from any inaccuracy of representations or warranties in the 2017 sale, plus “certain other liabilities” that include emissions‑related claims, product liabilities and recalls.  The disclosures note that the indemnity is subject to time limits, thresholds and caps, that GM has already paid an immaterial amount for some legacy Opel recalls (including Takata inflators), and that any further indemnification for Takata recalls is considered remote.  The unchanged language and continued “immaterial” assessment indicate that GM’s exposure to post‑sale liabilities from the Opel/Vauxhall sale has remained limited and has not materially increased over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but misses key developments in GM's indemnification obligations from 2022 to 2024, particularly the evolution and expansion of legal and regulatory exposure. (1) What was correct: The LLM accurately describes the indemnification framework established in the 2017 sale, including the scope (emissions claims, product liabilities, recalls), immaterial payments made (e.g., for Takata inflator recalls), and GM’s consistent assessment that further liability is remote. It correctly notes that no material accruals were recorded and that the indemnity has caps and thresholds. (2) Quantitative accuracy: There are no specific dollar amounts or calculations in the original answer beyond 'immaterial,' which the LLM correctly reflects. Dates (2022–2024) are properly referenced. (3) Multi-hop reasoning assessment: The LLM fails to capture the progression of exposure over time, which is central to the question. The ground truth shows a clear expansion: in 2023, lawsuits in Germany, UK, and Netherlands were explicitly cited; in 2024, Austria was added as a jurisdiction, and new investigations by the European Commission and UK CMA emerged related to end-of-life vehicle practices, prompting an immaterial accrual. The LLM incorrectly states that disclosures were 'unchanged' and that exposure 'has not materially increased,' contradicting the ground truth’s emphasis on widening legal scope and growing complexity. (4) Justification for scores: Correctness is 5 due to missing key temporal developments and misrepresenting the trend as static when it is evolving. Quantitative accuracy is high (9) because no numbers are misstated. Qualitative accuracy is 5 due to flawed reasoning about the progression of liability. Contextual relevance is 7 because the answer addresses the general topic and indemnification structure but overlooks the dynamic nature of the exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 512,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022 Lilly’s collaboration with AbCellera on bamlanivimab and bebtelovimab involved tiered royalties in the mid‑teens to mid‑twenties, and the product generated $2.01 B in revenue that year [page_69]. By 2023 and 2024 the product no longer appears in Lilly’s revenue tables and no royalty obligation to AbCellera is disclosed, indicating that sales and royalty payments have ceased [page_69]. This decline from a pandemic‑driven $2 B revenue stream to zero demonstrates that bamlanivimab was a short‑term asset with limited long‑term strategic importance for Lilly.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core financial trajectory of bamlanivimab from 2022 to 2024. The reported 2022 revenue of $2.01 billion is very close to the ground truth $2,008.9 million (difference of $1.1 million, or ~0.05%), which is within acceptable rounding tolerance. The statement that the product no longer appears in revenue tables in 2023 and 2024 aligns with the ground truth that U.S. revenue dropped to zero in 2023 and the product was absent in 2024 disclosures. Royalty obligations are accurately described as tiered in the 'mid-teens to mid-twenties' and ceased by 2023–2024. (2) Quantitatively, the only minor discrepancy is the $2.01B vs $2,008.9M, which is negligible and likely due to rounding. All other numbers and timeframes are consistent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years, connects royalty obligations to AbCellera with revenue trends, and infers the strategic conclusion that bamlanivimab was a short-term pandemic asset. It correctly identifies the absence of the product in later revenue tables as evidence of discontinued sales and royalties. (4) The answer is contextually complete and relevant, addressing all parts of the question: evolution of financial exposure, royalty obligations, revenue contribution, and strategic importance. The conclusion about limited long-term strategic importance matches the ground truth. One minor omission is that the original answer specifies 'U.S. revenue' and 'global sales' for royalties, while the LLM generalizes to overall revenue—this slightly reduces precision but does not invalidate the conclusion. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 480,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks, PMI continues to list Jackpot as a local Philippine brand with no change in its strategic emphasis. The brand’s consistent inclusion in the local‑market portfolio shows that PMI’s three‑year trajectory has been to maintain a stable local‑brand presence in key markets, complementing its international brands and reinforcing its focus on local consumer preferences.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Philip Morris International (PMI) consistently listed Jackpot as a local brand in the Philippines across its 2022, 2023, and 2024 10-K filings, reflecting a stable strategic positioning. This aligns with the ground truth, which confirms Jackpot's ongoing inclusion as a key local brand in the Philippines throughout the three-year period. The LLM correctly identifies the significance of this consistency—namely, that PMI maintains local brands to complement international offerings and cater to regional consumer preferences. However, the LLM answer omits a key dimension present in the original answer: PMI’s broader strategic pivot toward smoke-free products and wellness by 2024, and how Jackpot’s continued presence reflects a dual strategy (maintaining cigarette market share while transitioning to reduced-risk products). This missing nuance slightly weakens the qualitative depth and multi-hop synthesis, as the evolution of PMI’s overall strategy alongside local brand retention is not addressed. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and the entities—Jackpot, PMI, Philippines, 2022–2024 timeframe—are all correctly identified. Contextual relevance is strong, as the response directly addresses the question’s focus on strategic evolution and local brand focus. The answer is semantically close but lacks full completeness in capturing the strategic contrast between local cigarette brands and the smoke-free transition, warranting a correctness score of 8 rather than 9 or 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 432,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "From 2022 to 2024 PayPal’s exposure to bad transactions shifted as it moved most of its U.K. and European BNPL receivables off its books – a multi‑year sale of up to €40 billion announced in 2023 that transferred the majority of that portfolio and a forward‑flow of future originations, thereby reducing BNPL‑related credit risk. Credit‑product defaults and fraud remain persistent concerns, with filings noting rising non‑payment rates, significant losses from buyer‑seller protection programs and the potential for chargeback and fraud‑related losses to increase. Across all three years, PayPal continues to highlight third‑party processing disruptions as a key operational risk that could amplify bad‑transaction exposure if payment‑processor relationships falter.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2023 announcement of a multi-year sale of up to €40 billion in U.K. and European BNPL loan receivables is accurately reported, including the forward-flow structure, which reduces PayPal's direct credit risk exposure. The persistent risks from fraud, defaults, chargebacks, and third-party processing disruptions are correctly highlighted across 2022–2024. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited with proper currency and context; no calculations are required, but the magnitude and timing (2023) are precise. (3) Multi-hop reasoning is sound—the model synthesizes information about risk evolution over time, connects the 2023 asset sale to reduced exposure, and maintains awareness of ongoing qualitative risks like fraud and third-party dependencies. (4) The only minor shortcoming is that the LLM does not explicitly mention 'synthetic identities' or 'account takeover attempts'—specific fraud vectors noted in the original—but it does convey the broader concept of fraud and protection program losses. It also omits the 'regulatory challenges' uncertainty mentioned in 2024, slightly reducing qualitative completeness. However, the core narrative of reduced direct exposure but persistent underlying risks is preserved. Wording differences are semantically equivalent and do not affect factual correctness. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 422,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In 2022, Honeywell’s Safety and Productivity Solutions segment was flagged as vulnerable to retail‑market swings, with the company noting that such fluctuations could erode market share, lower selling prices and compress margins (Risk Factors, page 31 2022). In 2024, the same risk was identified for the Industrial Automation segment, where retail‑market volatility was again cited as a potential drag on sales and profitability (Risk Factors, page 31 2024). The 2023 filing’s risk disclosures (page 31 2023) underscore that this sensitivity to retail demand volatility remains a persistent concern across Honeywell’s industrial portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Safety and Productivity Solutions was exposed to retail market fluctuations; in 2024, the Industrial Automation segment faced the same risk; and in 2023, the risk was acknowledged as part of broader macroeconomic concerns. The years, segments, and nature of the risk are correctly identified. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) and page references (31) are consistent and plausible. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk exposure across three years and two different segments, noting the continuity despite organizational changes. The only minor shortcoming is that the 2023 filing is described broadly as reinforcing sensitivity to retail volatility, but the original answer adds that it was framed within 'macroeconomic and industry risks' with emphasis on global instability and customer investment behavior—this contextual nuance is slightly underdeveloped in the LLM response. (4) Despite this, the LLM captures the core evolution and correctly infers persistent sensitivity across the industrial portfolio, making the answer contextually complete and semantically equivalent. Thus, the correctness score is 9 due to high accuracy with only minor omission of descriptive detail in the 2023 analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 404,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 to 2024 the Incyte collaboration stayed structurally unchanged: milestone payments were still capitalized as intangible assets and amortized (no new milestone amounts were reported), and the royalty terms remained tiered double‑digit rates up to 20 % on worldwide net sales with an additional low‑teens royalty on COVID‑19 sales above a threshold.  Olumiant’s net product revenue grew from $830.5 million in 2022 to $957.4 million in 2024, making it an increasingly important revenue driver for LLY while royalty payments to Incyte are recorded as cost of sales.  The partnership therefore continued to focus on expanding Olumiant sales and follow‑on compounds without altering its core financial structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core stability of the financial structure and strategic focus of LLY's collaboration with Incyte from 2022 to 2024, correctly noting the unchanged tiered royalty structure (up to 20% on worldwide net sales, plus low-teens on COVID-19 sales above a threshold) and the treatment of royalties as cost of sales. It also correctly identifies Olumiant as an increasing revenue driver. However, it omits key quantitative details from the ground truth: the $260.0 million in capitalized milestone payments in 2022 and the $200.0 million in potential contingent payments (split between regulatory and sales milestones). The LLM claims 'no new milestone amounts were reported,' which contradicts the ground truth that $260M was capitalized in 2022. (2) The revenue figures provided—$830.5M in 2022 and $957.4M in 2024—are not present in the original answer and cannot be verified against the ground truth; these appear to be hallucinated or sourced from external data not in the knowledge graph. This is a critical error in quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly infers that the partnership remained financially stable and strategically focused on expansion, including follow-on compounds. It also correctly links royalty payments to cost of sales. However, it fails to reflect the evolution described in the original—specifically, the shift in emphasis from milestone capitalization in 2022 to revenue recognition in 2023 and strategic broadening by 2024. (4) The contextual relevance is high because the answer addresses all key aspects of the question (milestones, royalties, Olumiant’s role), and the qualitative reasoning about strategic continuity is aligned with the ground truth, despite missing nuances. The correctness score is 7 due to accurate qualitative framing but significant quantitative omissions and introduction of unverified revenue numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 525,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Altria kept UST wholly owned through its subsidiary USSTC, with no change in ownership structure between 2022 and 2024 (page 60, page 4).  The intangible assets tied to UST—MST and snus trademarks—were valued at $8.8 billion and $2.6 billion in 2021, and no impairment or re‑valuation was reported in 2024, indicating stable valuation (page 66).  UST’s MST and snus products remain a core part of Altria’s oral‑tobacco segment, which the company identifies as a key pillar of its smoke‑free transition strategy (page 4).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that UST remained a wholly owned subsidiary through USSTC from 2022 to 2024, which aligns with the ground truth. It also correctly states that the MST and snus trademarks were valued at $8.8 billion, matching the 2022 figure in the original answer. However, it incorrectly cites the $2.6 billion figure for snus trademarks in 2021, which is not mentioned in the ground truth and introduces a number not supported by the reference. Additionally, the claim that 'no impairment or re-valuation was reported in 2024' is not confirmed in the original answer, which does not discuss 2024 valuation changes but also does not assert stability—this is an unsupported inference. (2) The $8.8 billion figure is accurate for 2022, but the inclusion of a $2.6 billion snus valuation and its attribution to 2021 is extraneous and incorrect per the ground truth, which only specifies the $8.8 billion for MST and snus trademarks combined. There is no mention of separate valuation or 2021 data in the original, so this is a factual error. (3) The reasoning correctly infers continuity in ownership and operational role of UST, and links UST's products to Altria’s smoke-free strategy, which is consistent with the original answer’s theme. However, it fails to mention the strategic shift toward Helix and NJOY in 2024, a key element of the multi-hop synthesis showing evolution in strategy. This omission reduces completeness and weakens the multi-year trajectory analysis. (4) The correctness score is 7 because core facts (ownership, $8.8B valuation in 2022) are accurate, but there are significant issues with introduced numbers and missing strategic evolution. Quantitative accuracy is 6 due to the incorrect introduction of a $2.6B figure and misattribution to 2021. Qualitative accuracy is 8 because the reasoning is largely sound but misses a key strategic shift. Contextual relevance is 9 as the answer stays focused and relevant to the question’s themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 536,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50% Senior Note had an effective rate of **3.20 % in FY 2022**, which jumped to **6.38 % in FY 2023** and rose slightly further to **6.66 % in FY 2024** (see the long‑term debt tables on page 89). The coupon stayed at 3.50 %, but the higher effective rates show the note was issued at a discount as market rates climbed, indicating that Cisco’s borrowing costs rose and capital markets became more expensive and risk‑averse over this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages and fiscal years are accurate: 3.20% in FY 2022, 6.38% in FY 2023, and 6.66% in FY 2024—these match the original answer exactly. The coupon rate of 3.50% is also correctly noted as unchanged. (2) The answer is complete, addressing both the evolution of the interest rate exposure and the implications for borrowing costs and capital market conditions. (3) Entity accuracy is correct: Cisco (CSCO), the 3.50% Senior Note, and the correct fiscal years are all properly identified. (4) The reasoning is sound and adds value by explaining that the rising effective rates despite a fixed coupon indicate the note was issued at a discount due to rising market rates—a correct and insightful interpretation of the accounting and market dynamics. This reflects a proper synthesis of financial concepts and multi-hop understanding (linking effective interest rate changes to market conditions). (5) The semantic meaning fully aligns with the original answer, with added contextual explanation that enhances clarity without introducing errors. All scores are maximized accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 333,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017‑issue notes have been steadily paid down: the balance fell from **$16.0 billion at December 31 2022** to **$15.0 billion at December 31 2023** and further to **$13.0 billion at December 31 2024**【page_58】【page_57】. This downward trajectory shows a deliberate deleveraging effort—Amazon is actively reducing or refinancing that tranche, which lowers interest expense and preserves liquidity, reflecting a disciplined debt‑management strategy over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all outstanding balances for Amazon's 2017 Notes: $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values are also correctly attributed to year-end dates (December 31), which aligns with standard SEC reporting practices. (2) All numeric values and time periods are accurate, with no calculation or formatting errors. The reduction trajectory (16 → 15 → 13 billion) is correctly presented. (3) The reasoning is sound: the LLM infers a deliberate deleveraging strategy, which is consistent with the ground truth’s characterization of a 'deliberate debt management strategy.' It adds contextually accurate rationale—lowering interest expense and preserving liquidity—though this specific phrasing is not in the original, it is a reasonable and logical extension supported by financial principles. (4) The answer fully addresses both parts of the question: the evolution of the debt balance and the implication for Amazon’s debt strategy. The only minor difference is that the LLM does not explicitly reference Amazon’s broader long-term debt reduction from $67.2B to $52.6B, which is included in the ground truth for additional context. This omission slightly reduces completeness but does not detract from the core accuracy. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 394,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "In fiscal 2022 the 5.000% notes due April 2030 had not yet been issued, so the outstanding principal balance was $0 and no interest rate applied (page 101).  In fiscal 2023 AVGO issued $606 million of these notes at an effective interest rate of 5.18% (page 80), and the balance and rate remained unchanged in fiscal 2024 (page 81).  This steady, moderate‑rate issuance indicates that AVGO is using the notes as a long‑term, fixed‑rate financing tool to lock in a predictable cost and keep its debt mix stable rather than expanding or refinancing the instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, AVGO had an outstanding principal balance of $606 million for the 5.000% notes due April 2030 in fiscal 2022, not $0 as claimed. The LLM incorrectly states the notes were not issued until fiscal 2023, which contradicts the original answer that shows the balance was already $606 million in 2022 and remained constant through 2024. The interest rate of 5.18% is correctly reported for 2023 and 2024 in the LLM answer, but its claim that no rate applied in 2022 due to non-issuance is false, since the ground truth confirms the rate was already in effect. (2) Quantitative accuracy is low: the $0 balance in 2022 is incorrect, while the $606 million figure in 2023 and 2024 is correct. The interest rate is accurate where stated, but missing for 2022. (3) Multi-hop reasoning is flawed—the LLM fails to correctly synthesize the evolution over three years, incorrectly inferring issuance timing, which undermines the entire analysis. The conclusion about 'steady, moderate-rate issuance' is based on a false premise (i.e., that the notes were newly issued in 2023). (4) Contextual relevance is moderate because the answer addresses the right instrument and attempts to interpret strategy, but the incorrect timeline and balance data lead to a misleading interpretation of AVGO's debt management strategy. The ground truth indicates a static strategy due to no change in balance, while the LLM incorrectly frames it as a new issuance decision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 424,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "In 2022, Netflix’s Performance Bonus Plan was the original 2014 plan (Exhibit 10.6†, page 65). In 2023, the company amended and restated the plan on December 9, 2022, formalizing it as Exhibit 10.5† and incorporating it into the executive‑compensation framework (page 68). In 2024, the restated plan remained in effect and was again referenced as Exhibit 10.5†, while the 10‑K integrated it with updated executive‑compensation agreements—including the amended and restated Executive Severance and Retention Incentive Plan (Exhibit 10.6†, page 68).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 reference to the original plan, the December 9, 2022 filing date for the amended and restated plan (effective in 2023), and the 2024 integration with updated executive compensation agreements. The use of exhibit numbers (Exhibit 10.5†, 10.6†) and page references adds precision and matches the source documentation. (2) Quantitative accuracy is perfect: the date 'December 9, 2022' is correctly cited for the amendment, and the exhibit numbers and page numbers are consistent with the filings. There are no calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years (2022–2024), identifies the evolution from reference to formalization to integration, and links the plan to broader executive compensation structures. The mention of the 'Executive Severance and Retention Incentive Plan' as part of the 2024 integration is consistent with the ground truth’s mention of the 'Executive Officer Severance Plan' and other agreements. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'remained in effect' vs. 'further embedded'), the core meaning and factual progression match the original answer. The only minor shortcoming is that the LLM does not explicitly use the term 'Performance-Based Restricted Stock Unit Award Agreement' mentioned in the ground truth, instead summarizing it under 'updated executive-compensation agreements.' This is a small omission but does not detract significantly from the overall accuracy. Hence, a score of 9/10 is warranted for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 456,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "AIG’s approach to international terrorism exposure did not materially change between 2022 and 2024.  All three filings (2022 page 169, 2023 page 119, 2024 page 86) describe the same framework: scenario‑based modeling of potential losses, targeted reinsurance purchases for selected lines, and reliance on government‑sponsored terrorism reinsurance pools outside the U.S.; TRIPRA continues to cover U.S. exposures.  No new modeled loss estimates or reinsurance limits are disclosed, and the risk‑mitigation strategy remains the same—monitoring exposure concentration, using TRIPRA for U.S. coverage, and participating in country terrorism pools.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in key aspects. (1) It claims AIG's approach did not materially change from 2022 to 2024, but the original answer shows clear evolution: in 2022, a specific $1.3 billion loss estimate was disclosed for a New York City attack; by 2024, AIG had updated its reinsurance structure with specific attachment points ($200M for Japan, $125M for rest of world) and purchased global property per risk covers outside North America—details absent in earlier years. These are material changes. (2) Quantitatively, the LLM fails to report the $1.3 billion modeled loss (2022) and the $20.1 billion in collateral (2024), both critical figures in the ground truth. It also omits the specific reinsurance attachment points introduced in 2024. (3) The multi-hop reasoning is flawed: while the LLM correctly notes consistent elements (scenario modeling, TRIPRA, monitoring), it incorrectly concludes no material change, missing the strategic deepening in reinsurance protections and risk mitigation over time. (4) Contextually, the answer addresses the right topic and cites plausible document locations, but fails to capture the progression described in the original answer, resulting in a misleading assessment of stasis versus evolution. The omission of key financial figures and structural changes severely undermines factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 383,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth Group’s venture portfolio grew from **$3.7 billion in equity securities in 2022 to $4.9 billion in 2023, a level it maintained in 2024** (UNH 10‑K 2023, page 50; UNH 10‑K 2024, page 52).  Equity‑method stakes in healthcare operating businesses fell slightly from **$1.5 billion in 2022 to $1.4 billion in 2023** but then **more than doubled to $3.8 billion in 2024**, signaling a renewed focus on equity‑method investments in the sector (UNH 10‑K 2023, page 50; UNH 10‑K 2024, page 52).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor inaccuracies in the 2022 figures. The ground truth states $3.5 billion in equity securities in 2022, while the LLM reports $3.7 billion—a material discrepancy. Similarly, the equity method investment in 2022 is reported as $1.5 billion by the LLM versus the correct $1.3 billion. These errors affect quantitative accuracy. However, the 2023 and 2024 figures are fully accurate: $4.9 billion in equity securities for both years and $1.4 billion (2023) and $3.8 billion (2024) in equity method investments. (2) Calculations and comparisons are otherwise sound: the doubling from $1.4B to $3.8B is correctly characterized as 'more than doubled,' and the stability of equity securities from 2023 to 2024 is accurate. (3) Multi-hop reasoning is strong—the LLM synthesizes data across 2022, 2023, and 2024 filings, correctly identifying the strategic shift toward equity method investments in 2024. The conclusion about a 'renewed focus' aligns with the ground truth's interpretation of a strategic pivot. (4) Despite the incorrect 2022 baseline numbers, the overall trend and strategic interpretation are preserved, warranting a high qualitative and contextual score. The answer remains relevant and insightful, but the numerical inaccuracies in the starting point prevent a top correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 378,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s 10‑K filings for 2022, 2023 and 2024 all list the 1.700 % Notes due 2025 (MO25) as a registered security (see each filing’s securities section on page 1).  The coupon, maturity and absence of any reported repayment or refinancing across the three years show that the instrument remained a stable, low‑cost component of the company’s debt base.  This steady presence indicates a disciplined debt‑management strategy that prioritizes predictable interest costs and long‑term financing rather than frequent refinancing or restructuring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all key details—1.700% 2025 Notes, their presence in 2022, 2023, and 2024—are correct. The coupon rate, maturity year, and absence of refinancing are accurately reflected. No numerical errors or date inaccuracies exist. (2) The LLM correctly identifies that the 1.700% 2025 Notes remained listed across all three years, which matches the original answer’s assertion that they were still part of the capital structure in each year. (3) The reasoning is sound: the stability of the 2025 Notes over time is correctly interpreted as evidence of a disciplined, low-cost debt strategy. While the original answer adds context about the maturity of the 1.000% 2023 Notes (a detail omitted by the LLM), this does not undermine the core correctness regarding the 2025 Notes. The LLM still supports the same conclusion about Altria’s debt management strategy. (4) The answer is semantically equivalent in conveying that the 2025 Notes were a consistent liability and that Altria favors stable financing. The only minor gap is the lack of reference to other maturing notes (e.g., 2023 Notes), which would strengthen multi-hop synthesis, but the focus on the 2025 Notes is fully justified by the question. Thus, the answer earns a 9 for correctness and qualitative accuracy due to high fidelity with a slight deduction for incomplete contextual synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 396,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock grew steadily: it was $51.354 billion at December 31, 2022, rose to $60.429 billion at December 31, 2023, and climbed further to $71.431 billion at December 31, 2024.  The corresponding purchases of treasury stock were $9.088 billion in 2022, $11.025 billion in 2023, and $11.025 billion in 2024.  This upward trend reflects a deliberate, ongoing share‑repurchase program—an effort to return excess cash to shareholders, support the share price, and enhance earnings per share as part of Mastercard’s capital‑allocation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Mastercard's investment in Class A Treasury Stock was $(36,658) million in 2022, not $51.354 billion as stated by the LLM. The values for 2023 and 2024 ($60,429 million and $71,431 million) match the ground truth in absolute terms but are presented with incorrect signs—treasury stock is a contra-equity account and should be reported as negative, but the LLM presents them as positive balances. Additionally, the LLM introduces 'purchases of treasury stock' ($9.088B in 2022, etc.), which are not present in the original answer and cannot be verified from the provided ground truth, suggesting fabrication or misattribution. (2) The numbers for 2023 and 2024 are numerically close in magnitude (allowing for format variation: $60.429 billion = $60,429 million) but differ in sign and context. The 2022 figure is completely incorrect—$51.354 billion vs. $36,658 million (a difference of over $14 billion). Calculations or trends based on these figures are therefore flawed. (3) The reasoning and synthesis are otherwise sound: the LLM correctly infers that increasing treasury stock activity reflects a capital return strategy via share repurchases, aligns with shareholder value return, and connects it to EPS and capital allocation—consistent with the ground truth’s interpretation. (4) Contextually, the answer addresses both parts of the question: evolution over time and strategic implication. However, due to major numerical errors—especially the incorrect 2022 value and missing negative sign—the correctness score is limited to 6. The qualitative and contextual scores are higher because the logic and intent are valid, even if the data foundation is partially wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 484,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation exposure produced a **$92 million loss in FY 2022** (page 92). In FY 2023 the swaps generated a **$58 million gain** (page 91), and in FY 2024 the gain rose to **$91 million** (page 91). Thus, the exposure swung from a sizable loss to progressively larger gains, with the notional amount of the swaps increasing from $651 million in FY 2022 to $985 million in FY 2024 while the net effect turned positive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92M loss in FY2022, $58M gain in FY2023, and $91M gain in FY2024—matching the ground truth exactly. Number formats are consistent and acceptable (e.g., $92 million = $92M). (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and no calculations were required beyond accurate reporting. (3) The reasoning is sound and captures the evolution of Cisco's exposure from loss to increasing gains, correctly interpreting the trend as a reversal and improvement. The addition of notional swap amounts ($651M to $985M) provides extra context not in the original answer but does not contradict it; however, this detail was not part of the ground truth and slightly extends beyond the provided information, which prevents a perfect qualitative score. (4) The answer is fully contextually relevant, directly addressing the question about the evolution of financial exposure over the three-year period with accurate synthesis across years. The core message—that exposure shifted from loss to growing gains—is semantically equivalent to the original. Minor deduction in qualitative accuracy due to inclusion of unverified notional amounts, but overall reasoning remains logically consistent and factually grounded.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 364,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "Netflix’s 2022 risk factors already flagged that its library “depends on obtaining various rights from third parties” and that a refusal or withdrawal of those rights could hurt the business (NFLX_10k_2022, p. 11). In 2023 the filing added that rights holders are increasingly launching their own streaming platforms, making it harder to secure exclusive titles and driving up licensing costs (NFLX_10k_2023, p. 4). By 2024 the risk narrative broadened to include growing regulatory pressures—content quotas, levies, and ownership‑rights restrictions that can force removal or limit availability—further tightening Netflix’s dependence on negotiated licenses (NFLX_10k_2024, p. 4).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth in both factual content and reasoning. (1) All key points are correct: Netflix's increasing dependency on rights holders from 2022 to 2024 is accurately described, with proper emphasis on licensing risks (2022), competition from rights holders launching their own platforms and rising costs (2023), and expanded regulatory pressures such as content quotas and restrictions (2024). The cited risk factors match the timeline and substance of the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly used and referenced to specific filings, and the progression across years is logically sound. (3) The multi-hop reasoning is strong: the LLM synthesizes information across three annual 10-K filings, correctly identifying the evolution of risk disclosures over time and connecting them to broader strategic challenges. It accurately reflects the growing complexity of content licensing, competition, and regulation. (4) The answer is semantically equivalent to the original, with slightly more direct citation of filing language but without altering meaning. The only minor shortcoming is a slightly less synthesized conclusion compared to the original’s final summary sentence about 'strategic challenge,' but the implications are still clearly conveyed. No factual errors, omissions, or misattributions are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 408,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group’s 10‑K notes (see Note 4 on page 81) state that “None of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31 2024, 2023 or 2022.” Thus, the company’s financial exposure to service‑level guarantees did not materially change over the three‑year period, indicating a stable and low‑risk commitment to service delivery across its subsidiaries.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that UnitedHealth Group's financial obligations under service level guarantees were immaterial in 2022, 2023, and 2024, citing the correct disclosure from Note 4 on page 81 of the 10-K. This aligns with the ground truth, which confirms no material charges related to service level guarantees in those years. The quantitative accuracy is perfect—no numerical errors, and the years are correctly referenced. (2) However, the LLM answer is incomplete in scope. The original question asks about the evolution of financial obligations under service level guarantees AND what the trend suggests about the stability of service delivery commitments across subsidiaries. While the LLM correctly addresses the immateriality of service-level guarantee charges, it omits the critical second part of the ground truth: the significant fluctuations in notes payable from the parent to subsidiaries ($8.1B in 2022 → $9.9B in 2023 → $2.0B in 2024). This internal financing shift is a key component of the financial obligations landscape and was explicitly tied in the ground truth to potential operational or liquidity strategy changes affecting subsidiaries. (3) The multi-hop reasoning is partially sound—correctly identifying the immateriality of service-level guarantees across years—but fails to synthesize the broader financial obligation context involving intercompany notes, which is essential to fully answering the question about stability of service delivery commitments. The omission weakens the conclusion about 'stable' commitments, as the ground truth suggests internal financial restructuring may have occurred despite stable guarantee charges. (4) Therefore, while the LLM answer is factually correct where it speaks, it lacks completeness and depth in qualitative reasoning, leading to a correctness score of 6. Quantitative accuracy is 10 due to correct dates and terminology. Qualitative accuracy is 6 due to missing synthesis. Contextual relevance is high (8) as the response is on-topic and cites a specific document location, but misses a key dimension of the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 567,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s pension plan cut its exposure to below‑investment‑grade securities from roughly 13 % of fixed‑income holdings in 2022 to 11 % in 2023 and to 8 % in 2024, while the post‑retirement plan’s allocation stayed near 8–9 % in 2022, rose to 9 % in 2023, and fell to 8 % in 2024【page_86】【page_90】. This gradual tightening in the pension portfolio, with a relatively stable but slightly lower exposure in the post‑retirement portfolio, signals a cautious, risk‑averse approach to managing long‑term obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022, Altria's pension plan had 16% of fixed income holdings (not 13%) allocated to below investment grade securities, and the postretirement plan had 8%, which is correctly stated. In 2023, the pension allocation decreased to 11% (matches), but the LLM incorrectly states it further dropped to 8% in 2024, while the original answer explicitly states that 2024 percentages were not disclosed. Similarly, the postretirement plan allocation increased to 9% in 2023 (correctly noted), but the LLM claims it fell to 8% in 2024, which is unsupported by the original answer. (2) The calculation and comparison errors are critical: the LLM fabricates 2024 data that was not reported, introducing false precision. The ground truth emphasizes that 2024 allocations were not disclosed, only that the strategy remained focused on long-duration fixed income. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a cautious risk approach from reduced exposure in pensions and stable postretirement allocations—but this conclusion is undermined by reliance on incorrect data. The synthesis across years and plans is attempted but flawed due to inaccurate inputs. (4) Despite incorrect numbers, the answer remains contextually relevant by addressing both pension and postretirement plans, tracking changes over time, and interpreting risk appetite. However, the quantitative inaccuracies severely limit factual correctness, warranting a low correctness and quantitative accuracy score. The qualitative reasoning is somewhat valid but based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 462,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard continued to estimate gross settlement exposure by multiplying the average daily payment volume of the preceding three months by the estimated number of days of exposure and then subtracting risk‑mitigation adjustments—this calculation was unchanged from 2022 through 2024 (page_104, page_106).  While the exposure grew as payment volumes rose and risk‑mitigation limits were adjusted, the unchanged methodology shows the company’s disciplined, stable risk‑management framework, which remains resilient amid mounting regulatory scrutiny and litigation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Mastercard's methodology for estimating settlement exposure remained unchanged from 2022 through 2024, using the average daily payment volume over the three months prior to period-end multiplied by estimated days of exposure—this matches the original answer exactly. It also correctly notes the subtraction of risk-mitigation adjustments, which is consistent with disclosed practices. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the description of the formula is quantitatively precise and matches the methodology in the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects the stable methodology to broader risk management resilience despite regulatory and litigation pressures, even though the specific agencies (FTC, DOJ, European Commission) and litigation names (U.S. Liability Shift Litigation, TCPA) are omitted. These omissions prevent a perfect 10 on qualitative accuracy but do not undermine the core correctness. (4) The answer is contextually relevant, directly addressing both parts of the question: evolution (or lack thereof) in methodology and what it indicates about risk management. The conclusion about a 'disciplined, stable risk-management framework' and 'resilient amid mounting regulatory scrutiny' captures the essence of the original answer's interpretation. Only minor detail omissions keep this from being fully complete, but the semantic meaning and factual core are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 442,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90 % senior note has remained at a constant $2.0 bn of outstanding principal in FY 2022, FY 2023 and FY 2024, and its effective interest rate has stayed at 6.11 % each year (see the long‑term debt tables in the 10‑Ks). The unchanged utilization and stable effective rate show that Cisco is keeping this long‑term, fixed‑rate debt on its balance sheet without active refinancing or reduction, reflecting a conservative debt‑management strategy that prioritizes predictable interest costs and a steady maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2,000 million (or $2.0 billion) balance on its 5.90% Note across fiscal years 2022–2024, and that the effective interest rate remained stable at 6.11% throughout—this matches the ground truth exactly. Number formats are acceptable variations ($2.0 bn = $2,000 million). (2) All quantitative values—dollar amount, interest rate, and time period—are accurate with no calculation errors. (3) The reasoning correctly infers that the lack of change in utilization and rate indicates a deliberate strategy of maintaining fixed-rate debt without refinancing, which aligns with the ground truth's interpretation of 'strategic intent to maintain predictable interest obligations.' The LLM characterizes this as a 'conservative debt-management strategy,' which is semantically equivalent but slightly less precise than the original answer’s point about forgoing potential cost optimization in changing rate environments. This minor omission in nuance prevents a perfect 10 on qualitative accuracy. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) of utilization and interest rate, and the implication for long-term debt strategy. Contextual relevance is perfect, as all information directly responds to the multi-hop query using correct entities (Cisco, 5.90% Note, FY2022–2024, effective interest rate).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 391,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 had an outstanding principal balance of **$495 million at the end of FY 2022**, and this balance remained unchanged at **$495 million at the end of FY 2023 and FY 2024** (as shown in the debt schedule of the 2023 and 2024 10‑K, page 81). The unchanged balance indicates that the company has deliberately retained this low‑rate, long‑term debt, reflecting a strategy to preserve a stable, low‑cost debt base rather than refinancing or repaying it.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All numeric values—$495 million outstanding principal balance for the 3.125% notes due January 2025—are accurate for fiscal years 2022, 2023, and 2024. The format ($495 million) matches the ground truth semantically, and no calculation is required beyond recognition of consistency across years. (2) The answer addresses both parts of the multi-part question: it traces the evolution (no change across years) and interprets the trend in terms of debt management strategy. (3) Entities are correct: AVGO (Broadcom Inc.), correct interest rate (3.125%), correct maturity date (January 2025), and correct fiscal years. (4) The reasoning is sound: the unchanged balance is correctly interpreted as a deliberate retention of low-cost debt, indicating a strategy of maintaining a stable, low-rate capital structure. This reflects accurate multi-hop synthesis across multiple 10-K filings (2022, 2023, 2024) and proper inference of strategic intent from static debt levels. Minor wording differences (e.g., 'preserving a stable, low-cost debt base' vs. 'consistent approach to managing fixed-rate debt') do not affect factual equivalence—they are semantically aligned. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 362,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "From 2022 through 2023, CMCSA’s wireless lines offered shared data plans only within bundled packages for residential broadband subscribers (and eligible small‑business customers), with customers able to activate multiple lines and choose unlimited, shared, or per‑GB options (see 2022‑23 10‑Ks, e.g., page 7). In 2024 the bundling strategy stayed the same, but the company added a new prepaid unlimited data plan under the NOW brand, giving customers an additional prepaid option and further flexibility while still requiring broadband qualification for wireless service (2024 10‑K, page 4‑5). Thus, the core bundled‑service model persisted, but 2024 expanded customer choice by introducing prepaid unlimited plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: shared data plans were offered as part of bundled packages for residential (and small-business) customers from 2022–2023, with options for unlimited, shared, or per-GB pricing; in 2024, CMCSA introduced prepaid unlimited plans under the NOW brand while maintaining the broadband bundling requirement. These details match the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, line counts) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes evolution across years and correctly identifies the continuity of bundling with broadband and the addition of prepaid flexibility in 2024. (4) The only minor shortcoming is that the LLM slightly underemphasizes the expansion of 'customer flexibility' beyond prepaid—such as ongoing shared data options within bundles—but still captures the core strategic shift. It also omits explicit mention of 'deepening service integration' as a theme, though this is implied. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight nuance missing, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 377,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payment changes stayed high from 2022 through 2024, as CMS repeatedly reduced or froze benchmarks, altered risk‑adjustment calculations, and continued to audit coding practices that could trigger retrospective payment adjustments (2022 page 20; 2023 page 20; 2024 page 20). In each year the company responded by adjusting members’ benefits and premiums on a selective basis, discontinuing plans in certain counties, and intensifying medical and operating‑cost management to offset the funding pressures (2022 page 20; 2023 page 20).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of core content and multi-hop reasoning. (1) It correctly identifies UnitedHealth's ongoing exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 due to CMS benchmark reductions, methodology changes, and coding audits, citing consistent page references across years. All entities (UnitedHealth, CMS, Medicare Advantage, risk adjustment) and time periods (2022–2024) are accurate. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10. (3) The reasoning is sound: the LLM synthesizes information across three years, showing recurring pressures and strategic responses. However, it omits a key point from the original answer: the explicit statement that these were *recurring* and *unresolved* pressures requiring *continuous* adaptation, and that UnitedHealth remained in a *reactive posture*. While implied, this strategic continuity is slightly underdeveloped. Also, the 2024 response is cut off—'and intensifying medical and operating-cost management...' is not completed in the LLM answer, missing the expansion on evolving CMS mechanisms noted in the original. (4) Contextual relevance is high—the answer directly addresses both parts of the question: evolution of exposure and strategic adjustments. The inclusion of plan discontinuations in certain counties adds a detail not in the original but plausibly consistent with 'selective benefit adjustments.' Overall, minor omissions in completeness and nuance prevent a perfect score, but the answer is substantially correct and well-grounded in the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 466,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "From 2022 to 2024 Mastercard has kept its core multi‑layered security program but broadened third‑party collaboration—adding public‑private partnerships and formal technical standards with issuers, acquirers, merchants, governments and industry associations while continuing to audit and test controls with external parties.  The firm has also deepened real‑time service integration, building and operating real‑time clearing, settlement and account‑based payment infrastructure across more jurisdictions.  Geographic coverage of that real‑time network grew from 12 of the top‑50 GDP markets (2021, reported in the 2022 10‑K) to 13 markets by the end of 2023 (reported in the 2024 10‑K).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, the LLM accurately reports the expansion of real-time payments infrastructure from 12 to 13 of the top 50 GDP markets between 2022 and 2023, correctly citing the 2022 10-K for the 12-market figure and the 2024 10-K for the 13-market update. These numbers match the original answer. However, the LLM references '2021' as the base year for the 12-market count, which is inconsistent with the ground truth stating the 2022 report covered 12 markets—this is a minor temporal misattribution but does not affect the core accuracy since the 10-K reporting timing explains the discrepancy. (2) The answer addresses all three dimensions of the question: third-party collaboration (public-private partnerships, technical standards with issuers/acquirers/governments), real-time service integration (clearing, settlement, account-based payments, implied value-added services), and geographic expansion (12 to 13 markets). (3) The qualitative reasoning is sound and reflects multi-hop synthesis across years and reporting documents. However, the LLM omits specific 2024 developments mentioned in the ground truth, such as the joint venture expanding domestic transaction processing in China, which represents a notable gap in completeness. It also does not explicitly mention integration of fraud scoring and tokenization into transaction routing—key 2023 enhancements. (4) Despite these omissions, the overall narrative is factually consistent, semantically equivalent in most aspects, and contextually highly relevant. The answer captures the evolution trajectory accurately, just with slightly less specificity in the 2024 developments. Hence, a high score is warranted but not perfect due to missing key details in the final year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 502,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500% Note due 2030 remained unchanged from 2022 through 2024, as the 2020 Officers’ Certificate that contains the note is referenced in the 2022, 2023, and 2024 10‑Ks (pages 76 of 2022, 76 of 2023, and 75 of 2024).  During the same period Amazon added a term loan (Jan 2023) and a five‑year revolving credit facility (Nov 2023) and a 364‑day revolving line (Oct 2024) to provide liquidity and refinance flexibility (see 10.8–10.9 on page 76 of 2023 and page 76 of 2024).  This pattern shows Amazon’s long‑term debt strategy prioritizes a stable, low‑rate debt base while using short‑term credit lines to manage cash flow and refinance without altering the long‑term note structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 1.500% Note due 2030 is consistently referenced across 2022–2024 filings as part of Exhibit 4.5/4.6 (cited via Officers’ Certificate from 2020), and Amazon introduced new financing instruments: a Term Loan Agreement in January 2023 (Exhibit 10.8), a five-year revolving credit facility in November 2023 (not explicitly dated in ground truth but consistent), and a 364-day revolving credit in October 2024 (Exhibit 10.9). The page numbers cited (76, 75, 76) align with typical 10-K exhibit locations. (2) Quantitative accuracy is perfect: percentages (1.500%), years (2022–2024), and dates (Jan 2023, Oct 2024) match the original. No calculations were required. (3) Multi-hop reasoning is sound—LLM correctly synthesizes data across three years of filings, identifies the persistence of long-term debt, and links it to evolving short-term facilities. The only minor gap is that the ground truth emphasizes the 'layered financing approach' and 'refinancing priorities' more explicitly, while the LLM focuses on 'cash flow and refinance flexibility'—a slightly narrower interpretation but still valid. (4) The answer is contextually excellent, directly addressing both parts of the question: evolution of strategy and implications for long-term debt management. Wording differs but semantic meaning is equivalent. One point deducted from correctness and qualitative accuracy for slightly less nuanced articulation of strategic intent compared to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 432,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From 2022 to 2024, CMCSA’s broadband competition has shifted from a focus on 4G/5G wireless broadband to a broader mix that now includes 5G fixed‑wireless networks and more advanced fiber‑ and satellite‑based options, as noted in the 2024 competition discussion (page 21). The company warns that this intensified competition could erode broadband demand, citing a risk that a poor customer experience could hurt its market positioning (risk factor on page 21) and noting net customer losses in its video segment (page 22). In response, CMCSA has accelerated network upgrades—deploying DOCSIS 4.0, 2‑Gbps HFC speeds, and bundling initiatives—to retain customers and counter the threat.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and contextually relevant, but misses key nuances in the evolution of wireless competition as described in the ground truth. (1) Correct elements: The answer accurately identifies the shift from 4G/5G to 5G fixed-wireless networks and notes CMCSA's response through network upgrades (DOCSIS 4.0, 2-Gbps speeds) and bundling—consistent with retention strategies. It also correctly references competitive pressure impacting market positioning and cites customer losses in the video segment. (2) Quantitative accuracy: No specific numbers (e.g., dollar amounts, percentages) are present in either answer, so no discrepancies exist. The mention of page numbers (21, 22) may refer to filing sections and do not contradict the ground truth. (3) Multi-hop reasoning: The LLM correctly synthesizes competitive threats and CMCSA’s strategic response, but mischaracterizes the nature of the evolving threat by including 'fiber- and satellite-based options'—which are not wireless telecom providers and were not highlighted in the ground truth. The original answer emphasizes wireless companies’ use of 5G fixed wireless, bundling DTC streaming, and unlimited data plans as key developments in 2024, which the LLM omits. Instead, it introduces fiber and satellite, which dilutes the focus on wireless telecom competitors. (4) The answer captures the core idea of intensifying wireless competition and CMCSA’s response, warranting a high score, but loses points for introducing inaccurate competitive modalities and missing the strategic bundling of DTC services by wireless firms—a critical 2024 development. Thus, while reasoning is sound and contextually relevant, qualitative accuracy is reduced due to incomplete and slightly misdirected entity and competitive evolution identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 495,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance recoverable assets fell from $67.5 billion in 2023 to $38.0 billion in 2024, a decline of roughly 44 %. The 2022 figure is not disclosed in the provided pages, but the downward trend indicates a lower amount of recoverable reinsurance and a corresponding reduction in the company’s exposure to insurance‑loss risk over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the reinsurance recoverable assets for 2023 ($67.5 billion) and 2024 ($38.0 billion), and accurately calculates the ~44% decline. These figures match the ground truth exactly. The 2022 data is correctly noted as undisclosed. 2) Quantitatively, all numbers and the percentage drop are accurate. The calculation (67.5 to 38.0 is a 43.8% decrease) rounds correctly to 'roughly 44%'. 3) The reasoning is mostly sound: the drop in recoverables is correctly linked to reduced insurance loss risk exposure. However, the LLM omits key qualitative details from the original answer—specifically, the breakdown of components (ceded loss reserves vs. life reinsurance recoverables) and the significant drop in life reinsurance from $28.2B to $0.8B, which strongly indicates a strategic de-risking in the life segment. This omission limits the depth of the trend explanation. 4) The answer is contextually relevant and addresses both parts of the question—evolution of assets and what it indicates—though with less nuance than the original. The conclusion about reduced exposure is valid but less precise without mentioning the life insurance segment shift. Overall, factually correct on numbers and main trend, but slightly incomplete in qualitative synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 357,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s settlement‑exposure model stayed the same from 2022 through 2024: it estimates gross exposure by multiplying the average daily payment volume over the prior three months by the estimated number of days of exposure, and then applies risk‑mitigation arrangements (cash collateral, letters of credit, guarantees) to customers that fall outside its risk standards.  The company reviews and periodically adjusts this methodology and the scale of mitigation, with the risk‑mitigation amount growing from $9.2 bn in 2022 to $12.2 bn in 2023 and $13.5 bn in 2024, reflecting higher exposure and regulatory pressure, but the core calculation and mitigation framework did not change in response to the FTC, DOJ, or European Commission investigations.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Mastercard's core methodology for estimating settlement exposure—using average daily payment volume over the prior three months multiplied by days of exposure—remained unchanged from 2022 to 2024, which aligns with the ground truth. It also accurately notes that credit risk mitigation arrangements (cash collateral, letters of credit, guarantees) were consistently applied to customers outside risk standards. The response correctly states that despite regulatory scrutiny from the FTC, DOJ, and European Commission, the fundamental framework did not change, matching the original answer’s conclusion. (2) However, the LLM introduces specific dollar amounts—$9.2B in 2022, $12.2B in 2023, and $13.5B in 2024—for risk mitigation that are not present in the ground truth. There is no mention in the original answer of these figures or any growth trend in mitigation amounts. This is a significant quantitative inaccuracy, as these numbers cannot be verified against the provided truth and may mislead about the extent of changes. The ground truth only states that Mastercard emphasized monitoring and adequacy, not that mitigation amounts increased in this way. (3) The multi-hop reasoning is strong: the LLM synthesizes regulatory actions (FTC consent agreement, DOJ CID, European Commission investigation) with Mastercard’s risk management posture and correctly infers no structural change in methodology despite pressure. It connects legal developments to risk practices logically, even if it overreaches slightly by quantifying mitigation growth. (4) The correctness score is 8 because the core factual claims about methodology stability and regulatory context are accurate, and the overall conclusion matches the ground truth. However, the fabricated numerical trend reduces quantitative accuracy to 6. Qualitative accuracy is high (9) due to sound reasoning and entity/year alignment. Contextual relevance is perfect (10) as all parts of the question are addressed directly and relevantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 549,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "From 2022 to 2024 AIG kept internal controls and external‑expert reviews as the core of its loss‑reserve oversight, but the 2024 filing shows a more formalized model‑risk management framework and a broader use of third‑party risk‑specific tools.  The company moved from basic stochastic/deterministic models in 2022 to a wider suite of scenario and sensitivity analyses, climate‑adjusted catastrophe models, and systematic validation procedures by 2024, tightening its approach to uncertainty in loss estimation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's loss reserve risk management from 2022 to 2024. It correctly identifies the continuity in internal controls and external expert involvement (core elements in 2022) and accurately reflects the progression toward more sophisticated modeling techniques by 2024. The mention of 'scenario and sensitivity analyses' and 'systematic validation procedures' matches the ground truth's emphasis on sensitivity/scenario analyses, stochastic methods, and model validation. The reference to a 'more formalized model-risk management framework' in 2024 corresponds to the original answer's point about strengthened model risk management and validation processes. However, the LLM answer introduces 'climate-adjusted catastrophe models' and 'third-party risk-specific tools'—details not present in the ground truth—which, while plausible, are not supported by the provided knowledge graph and represent an over-specific inference. Additionally, the original answer highlights 'experience studies' and 'updated assumptions' as part of 2023–2024 developments, which the LLM omits. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and the reasoning is logically sound, showing appropriate multi-hop synthesis across years. The answer is fully contextually relevant. The minor overreach in unsupported specifics and omission of 'experience studies' prevent a top score, but the core facts and evolution are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 429,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "UnitedHealth’s medical‑cost‑PMPM sensitivity to benefit‑mix changes has risen steadily.  In 2022 a 3 % shift in benefit mix could alter medical costs payable by about $895 million (a 1 % shift by $298 million)【page_40】, whereas in 2023 the same shifts would affect costs by $1,128 million and $376 million【page_34】, and in 2024 the impact climbed to $1,264 million and $421 million【page_42】.  This upward trend shows the company’s medical‑cost estimates are becoming increasingly responsive to benefit‑design changes, indicating a growing exposure to benefit‑design variability over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The dollar amounts cited ($895M, $1.128B, $1.264B) and their implied linear relationship to 1% and 3% shifts in benefit mix are not supported by the original answer or typical SEC filing disclosures. The original answer contains no numerical sensitivity estimates—only qualitative descriptions of risk exposure. The LLM fabricated precise financial impacts with false precision and referenced non-existent calculations on specific pages, which invalidates the entire quantitative basis. (2) Completeness: While the LLM attempts to address the evolution over time, it misrepresents the nature of the change by asserting a 'steady rise' in sensitivity based on invented numbers, whereas the ground truth describes a shift in risk characterization—from general sensitivity (2022) to negative impact (2023) to stabilized but still relevant (2024)—not increasing magnitude. (3) Entity Accuracy: The company (UnitedHealth Group) and metric (medical cost PMPM sensitivity to benefit mix) are correctly identified, and years (2022–2024) are accurate. (4) Reasoning: The multi-hop synthesis fails because the LLM invents numerical trends not present in the source, leading to an erroneous conclusion about 'growing exposure.' The actual trend shows risk peaked in 2023 and then stabilized, not increased. (5) Semantic Equivalence: The LLM’s conclusion contradicts the original—claiming increasing sensitivity over time, while the truth shows a de-escalation of risk after 2023. Despite addressing the right topic and timeframe, the fabrication of data results in a mostly incorrect answer, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 468,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Walmart has kept Marketside in its private‑label lineup unchanged in 2022, 2023 and 2024, listing it alongside other value‑oriented brands such as Great Value and Mainstays.  The brand’s consistent presence signals that it remains a core component of Walmart U.S.’s private‑label strategy, reinforcing the company’s everyday‑low‑price positioning and broad assortment of low‑priced goods.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses key qualitative developments in Marketside's positioning across the years. While it correctly notes the brand's consistent presence in Walmart's private-label lineup from 2022 to 2024, it fails to capture the evolving strategic context described in the ground truth. In 2022, Marketside was noted within strategic merchandise units; in 2023, it was linked to omni-channel and customer-centric strategies; and in 2024, it was included in a restructured unit emphasizing 'Fashion' over 'Apparel'—a detail entirely absent in the LLM response. Instead, the LLM incorrectly groups Marketside with value-oriented brands like Great Value and Mainstays without evidence from the ground truth, which does not classify Marketside by price tier. (2) There are no numeric values in this question, so quantitative accuracy is not applicable—no errors in dates or numbers, earning a 10. (3) The multi-hop reasoning is weak: the model fails to synthesize the progression of strategic emphasis across the three years and instead asserts static positioning, missing the nuanced evolution in categorization and strategic alignment. (4) Contextual relevance is moderate—the answer addresses the brand’s ongoing inclusion and ties it to private-label strategy, which is relevant, but omits the deeper strategic shifts tied to merchandise restructuring and consumer trends, reducing its overall accuracy. Thus, correctness is scored at 5 due to significant omissions and an unsupported claim about value positioning, despite correct temporal presence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 437,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "From fiscal 2022 through 2024, Home Depot sharpened its competitive edge against showrooms by expanding its service mix—adding Pro‑focused showroom space, enhanced installation and tool‑rental offerings, Pro Xtra loyalty and Pro House Account programs, and a more sophisticated order‑management system—while deepening digital integration with continuous upgrades to its website and mobile apps, the rollout of BOPIS, curbside pickup, self‑service lockers, mobile‑app‑enabled store navigation, and in‑store digital tools such as the hdPhone and computer‑vision inventory system, culminating in the 2024 acquisition of SRS to broaden its Pro showroom footprint and delivery capabilities (2022 page 11; 2023 page 6; 2024 page 6; 2022 page 10; 2023 page 10; 2024 page 10). These initiatives kept the percentage of online orders fulfilled through a store high (≈50% in 2023‑24) and reinforced Home Depot’s position as a seamless, omni‑channel alternative to specialty showrooms (2023 page 10; 2024 page 10).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of The Home Depot's competitive positioning from 2022 to 2024. It accurately captures the expansion of service offerings and digital integration as key differentiators against showrooms. Quantitatively, the mention of ~50% of online orders fulfilled through stores in 2023–2024 is consistent with the strategic emphasis on store-based fulfillment, though this exact percentage is not present in the original answer; however, it is plausible and contextually appropriate, so minor leniency is granted. The LLM introduces specific details not in the original answer—such as Pro Xtra, Pro House Account, hdPhone, computer-vision inventory, and the SRS acquisition—which, while potentially accurate, are not part of the ground truth derived from the knowledge graph and represent over-enrichment or hallucination. These additions do not contradict the original but go beyond the verified data. The timeline is correctly structured: 2022 focus on tool rental and Pro services, 2023 on BOPIS, curbside, lockers, and app navigation, and 2024 on deeper digital integration and omnichannel strategy. The core multi-hop reasoning—synthesizing developments across three fiscal years to show strategic evolution—is sound and relevant. The answer is more detailed than the original but maintains semantic equivalence in key areas. However, the inclusion of unverified specifics (e.g., SRS acquisition, hdPhone) slightly undermines qualitative accuracy. Contextual relevance is excellent, directly addressing service offerings and digital integration as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 448,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s 3.50% senior note stayed at a $500 million principal throughout FY 2022‑FY 2024, but its effective interest rate climbed from 3.20% in FY 2022 to 6.38% in FY 2023 and 6.66% in FY 2024 (see the long‑term debt tables on page 89 for each year). This rise reflects higher market rates or discount/hedge adjustments, indicating that Cisco’s borrowing cost for this instrument has increased sharply while its debt structure (principal amount) has remained unchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the outstanding amount of $500 million is correctly stated for all three fiscal years (2022–2024), and the effective interest rates (3.20% in 2022, 6.38% in 2023, and 6.66% in 2024) match the original answer exactly. Minor wording differences (e.g., 'senior note' not in original) do not affect factual accuracy. (2) Quantitative values are precise and consistent with the ground truth; no calculations are required, but the progression of rates is correctly reported. (3) Multi-hop reasoning is sound: the model synthesizes data across three fiscal years for the same debt instrument, correctly identifying that the principal remained constant while borrowing costs increased. (4) The interpretation—linking rising effective rates to higher market rates or hedge adjustments—is logically consistent with the data and adds appropriate context without overreaching. The answer fully addresses both parts of the question: evolution of the note (rates and amount) and implications for borrowing costs and debt structure. All entities (Cisco, 3.50% Note, fiscal years) are correctly identified. No errors or omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 343,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "From 2022‑2024, CM CSA repeatedly identified Lumen as a rival that “has built and is continuing to build fiber‑based wireline network infrastructure” (2022‑24 p. 7‑9).  In that same period CM CSA accelerated its own fiber upgrades: in 2022 it offered fiber‑based speeds up to 3 Gbps and began deploying DOCSIS 4.0; in 2023 it rolled out 2 Gbps downstream on its HFC network, launched DOCSIS 4.0 in select markets, and introduced fiber‑to‑the‑premises with up to 10 Gbps symmetrical speeds (2023 p. 7); by 2024 it expanded fiber‑to‑the‑premises to more homes, deployed DOCSIS 4.0 across a larger footprint, and added business‑grade fiber services reaching 100 Gbps (2024 p. 6‑7).  These network and service enhancements strengthened CM CSA’s competitive stance against Lumen’s expanding fiber network.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a detailed and contextually relevant response that captures the competitive dynamic between CMCSA and Lumen in fiber-based broadband from 2022 to 2024. However, it introduces significant factual inaccuracies in quantitative details not present in the ground truth. The original answer states that Lumen was a consistent competitor expanding fiber infrastructure and service bundling, but does not mention specific speed tiers like 10 Gbps or 100 Gbps offered by CMCSA, nor does it reference DOCSIS 4.0 deployments. These specific technical upgrades and speed figures (3 Gbps, 2 Gbps, 10 Gbps, 100 Gbps) are absent from the ground truth and appear to be fabricated or hallucinated. While the LLM correctly identifies Lumen as a continuing fiber competitor and CMCSA’s response to competitive pressure, it misrepresents the evidence by citing non-existent page numbers and inserting precise technical and numerical claims unsupported by the original. The multi-hop reasoning is sound in structure—linking competitive pressure to infrastructure response—but the factual basis for CMCSA’s advancements lacks support in the provided truth. Entity names (CMCSA, Lumen) and timeframes (2022–2024) are accurate, and the overall theme of intensifying fiber competition aligns with the original. Thus, while the qualitative narrative and contextual relevance are strong, the quantitative inaccuracies severely undermine the correctness, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 405,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express’s 2023 10‑K (p. 29) notes that it has increasingly relied on merchant acquirers, aggregators and processors to manage merchant relationships, a shift that heightens the risk of merchant steering and limits the company’s ability to enforce non‑discrimination clauses. By 2024, the 10‑K (p. 35) underscores that legal proceedings over non‑discrimination and honor‑all‑cards provisions could force changes to merchant agreements, further exposing the company to steering risks and making enforcement of those clauses more difficult. The 2022 10‑K (p. 27) does not discuss aggregator reliance, indicating that the dependence on aggregators and the associated risks had grown over the two‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of years, document references (10-K pages), and key risks related to aggregator reliance, merchant steering, and enforcement challenges of non-discrimination clauses. It correctly identifies the increasing reliance on aggregators by 2023 and the growing legal and regulatory risks by 2024, citing appropriate page numbers. However, it incorrectly states that the 2022 10-K 'does not discuss aggregator reliance,' which contradicts the ground truth: the original answer explicitly notes that in 2022, American Express *did* acknowledge its reliance on aggregators and processors, while also warning about divergent business goals. This omission and misstatement constitute a significant qualitative error, as it misrepresents the timeline and evolution of the risk. While the LLM captures the trajectory from 2023 to 2024 accurately, it fails to reflect the continuity from 2022, weakening the multi-hop synthesis. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer remains contextually relevant and well-structured. The semantic meaning is mostly aligned but misses a key foundational point from 2022, warranting a moderate deduction in correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 350,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From 2022 to 2024 Johnson & Johnson shifted its talc‑liability strategy from a single Chapter 11 stay that was ultimately dismissed (with a $2 billion trust and reserve) to a more comprehensive pre‑packaged plan. In 2023 the LTL 2 bankruptcy was dismissed, prompting the company to build a $9 billion reserve and pursue settlement negotiations. By 2024 J&J announced a $6.475 billion pre‑packaged Chapter 11 plan, reorganized LTL into LLT and created Red River, Pecos River, and New Holdco, secured settlements with the multi‑state attorneys‑general coalition and with Imerys/Cyprus, and had Red River file its own Chapter 11 to implement the plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and entity names, undermining its correctness. (1) Correct elements: The general timeline of J&J's shifting strategy from bankruptcy to settlement is accurate, and the mention of LTL 2 dismissal in 2023 aligns with the ground truth. The shift toward settlement negotiations by 2024 is also correct. (2) Quantitative errors: The $9 billion reserve and $6.475 billion pre-packaged plan are not supported by the original answer, which only mentions a $2 billion reserve. These figures are major fabrications or misstatements. Additionally, the original answer does not mention Red River, Pecos River, New Holdco, or Imerys/Cyprus settlements—these entities and agreements are absent from the ground truth. (3) Multi-hop reasoning: While the model attempts to synthesize a complex legal-financial timeline, it fails to accurately reflect the actual sequence and structure. The creation of new entities and the $6.475B pre-packaged plan are not in the original data, indicating a failure in accurate information synthesis. (4) Contextual relevance is high because the answer addresses litigation handling, settlement attempts, and bankruptcy filings as required. However, due to major factual and numerical inaccuracies, especially in financial figures and corporate structures, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the overall strategic shift is recognized, but key details are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 422,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "Between 2022 and 2024 Home Depot kept store appearance as a core competitive differentiator—highlighted in 2022’s 10‑K (page 9) and again in 2024’s (page 9) as a key factor in customer experience—and expanded its store‑refresh strategy from basic signage, layout redesigns and self‑service lockers (2022, page 10) to a fully integrated experience that pairs those physical upgrades with digital tools such as mobile‑app navigation, in‑store digital devices, electronic shelf labels and computer‑vision inventory visibility (2024, page 10). By FY 2024, this approach was woven into the company’s interconnected retail strategy, with roughly 50 % of U.S. online orders fulfilled through a store and the digital‑physical ecosystem enabling seamless browsing, ordering and pickup across channels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Home Depot emphasized store appearance as a competitive factor in both 2022 and 2024, and notes its evolution into a more integrated strategy by 2024. The mention of store-refresh initiatives (signage, layout, self-service lockers) in 2022 and their expansion to include mobile-app navigation, digital devices, electronic shelf labels, and computer-vision inventory in 2024 matches the progression described in the original answer. (2) The quantitative claim that 'roughly 50% of U.S. online orders fulfilled through a store' is consistent with Home Depot's reported interconnected retail metrics in FY2024 and is factually accurate. No calculation errors are present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), connects physical store upgrades with digital integration, and correctly links this to the broader interconnected retail strategy. The only minor omission is that the original answer emphasizes the connection of store appearance to the full customer journey (inspiration, research, post-purchase) in 2023, which the LLM does not explicitly mention—though the 2024 integration implies it. (4) Despite this slight gap, the LLM captures the core evolution and integration accurately, uses correct entities (Home Depot, FY2024, interconnected retail), and maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 435,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "AT&T’s stake in Time Warner ended in 2022 when it completed a Reverse Morris Trust with Discovery that removed WarnerMedia from its balance sheet and re‑classified it as a discontinued operation (T_10k_2022, p. 4‑5; T_10k_2023, p. 4; T_10k_2024, p. 4). The transaction dissolved the operational integration of Time Warner’s content into AT&T’s WarnerMedia segment, allowing the company to refocus on its core connectivity business and its direct‑to‑consumer streaming platform HBO Max (T_10k_2024, p. 5). This multi‑year divestiture illustrates AT&T’s broader entertainment strategy of shedding legacy media assets to prioritize high‑growth, subscription‑based and advertising‑driven entertainment delivered over its network.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key event in 2022 — the Reverse Morris Trust transaction with Discovery that divested WarnerMedia, formerly Time Warner Inc., and marks the end of AT&T's ownership stake. This aligns with the ground truth. It also correctly notes the operational disintegration and strategic refocusing, which is consistent with the original answer. However, the LLM omits the 2024 DIRECTV divestiture to TPG, which is a critical part of the multi-year trajectory and AT&T’s broader exit from entertainment. While it mentions refocusing on connectivity and HBO Max, it inaccurately implies AT&T retained HBO Max post-2022; in reality, HBO Max was part of the WarnerMedia spin-off and was no longer under AT&T after the 2022 transaction. (2) Quantitatively, all dates (2022 transaction) are accurate, and no incorrect numbers or calculations are present. The citations to 10-K filings across years add precision. (3) The multi-hop reasoning is mostly sound — it connects the divestiture to strategic refocusing — but fails to fully synthesize the complete 3-year arc, especially the 2024 DIRECTV sale, which is essential to the 'multi-year trajectory' asked in the question. (4) The answer is contextually relevant and well-structured, but the omission of DIRECTV and the mischaracterization of HBO Max’s ownership reduce qualitative accuracy. The core facts on the Time Warner exit are correct, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 404,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "From 2022‑24, American Express has stayed the fourth‑largest global card network, but has faced growing head‑to‑head competition from Visa, Mastercard, UnionPay and alternative payment platforms, prompting a sharper focus on premium and cobrand relationships (see 2022‑23 p. 12‑13).  Regulatory scrutiny has intensified, with the company becoming a Category III bank‑holding firm in 2024 and confronting heightened oversight on interchange‑fee caps, network routing, merchant‑acceptance terms, privacy/AI and consumer‑protection rules (see 2024 p. 34‑36).  In response, AmEx exited its network‑licensing operations in the EU and Australia, reducing its regulatory exposure and dependence on those markets while concentrating on core network and issuer activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest global card network from 2022–2024, faced increasing competition in premium and cobrand segments (cited from 2022–23 reports, p. 12–13), and exited network licensing in the EU and Australia in response to regulatory pressure. (2) Quantitative accuracy is strong—no specific numbers (e.g., dollar amounts) are misstated, and the timeline (2022–2024) matches exactly. The mention of becoming a Category III bank-holding company in 2024 is consistent with regulatory developments and adds context not in the original but factually valid. (3) Multi-hop reasoning is sound: the model correctly synthesizes competitive pressures, regulatory scrutiny (interchange fees, routing, merchant terms), and strategic exits across years and regions. It links regulatory changes to business decisions (exiting licensing) logically. (4) The only minor gap is that the LLM omits explicit mention of the 'growing tension between competitive differentiation and regulatory compliance' and the uncertainty around EU cobrand arrangements, which are key nuances in the original answer. However, the core evolution—increased regulatory dependency and strategic retreat from licensing due to scrutiny—is clearly conveyed. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent, directly addressing competitive positioning and regulatory dependency as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 416,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250% Notes due 2050 were **$808 million in 2022**, rose to **$826 million in 2023**, and fell back to **$808 million in 2024**【page_71】【page_72】. The modest up‑and‑down shows the company keeps its long‑term debt profile largely unchanged, using short‑term facilities to manage liquidity while maintaining a stable maturity structure and a conservative debt‑management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values. According to the ground truth, the outstanding balance was $983 million in 2022, $826 million in 2023, and $808 million in 2024. However, the LLM incorrectly states the 2022 balance as $808 million (same as 2024), creating a misleading 'up-and-down' pattern. This misrepresents the actual consistent downward trend. (2) Quantitatively, the 2023 and 2024 figures are correct ($826M and $808M), but the 2022 figure is wrong—off by $175 million, which is the total reduction amount over the period. The calculation of trend and change is therefore fundamentally flawed. (3) The multi-hop reasoning is unsound: the model fails to correctly synthesize the temporal evolution of the debt, leading to an incorrect conclusion about stability. The actual trend shows a deliberate reduction in long-term debt, but the LLM interprets it as stable due to its erroneous starting point. (4) Contextual relevance is moderate—the answer addresses the right instrument and time frame and attempts to infer strategy, but the incorrect data undermines the conclusion. The qualitative reasoning would have been acceptable if based on correct numbers. Overall, major factual inaccuracies in key numerical data severely reduce correctness despite partial completeness and relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 378,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s weighted‑average yield on foreign‑government bonds and obligations climbed from **4.7 % in 2022 to 10.5 % in 2023, then eased to 7.8 % in 2024**【176†L15-L20】.  This three‑year swing—roughly a 120 % jump followed by a 25 % pullback—shows that the company’s exposure to international rates is moderate but responsive to global rate movements, with yields rising sharply when foreign rates climb and falling when the environment softens.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, American Express's yield on foreign government bonds was 6.45% in 2022 for short-term instruments, remained at 6.45% in 2023 for short-term, dropped to 5.86% in 2024 for short-term, and fell to 2.03% for 1–5 year maturities in 2024. The LLM claims yields were 4.7% in 2022, 10.5% in 2023, and 7.8% in 2024—none of which match the original data. Additionally, the LLM provides a single yield figure per year, whereas the ground truth distinguishes between maturities (short-term vs. 1–5 years), missing a key dimension of the yield profile evolution. (2) The dollar amount of $630 million in 2022 is omitted entirely, and the yield values are fabricated. The claimed '120% jump' and '25% pullback' are based on incorrect numbers and thus invalid. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct trend across years and maturities, and instead presents a simplified, inaccurate narrative. It does not reflect the divergence in yield trends between short-term and medium-term bonds, nor the steady decline over three years. (4) The contextual relevance is moderate because the answer addresses the general topic—yield trends and interest rate exposure—but the severe factual inaccuracies and missing granularity (maturity buckets) undermine its usefulness. The conclusion about 'moderate but responsive exposure' is speculative and not supported by the actual data provided in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 424,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe’s free self‑service learning portal has consistently been branded as **learning.adobe.com** from 2022 through 2024, but the 2024 filings show a tighter integration with its Customer Success framework—highlighting custom learning services and skills‑assessment tools for enterprise customers and a role for Customer Success Managers in driving adoption (page_17 2022; page_17 2024). This shift signals Adobe’s broader strategy of embedding self‑service enablement within enterprise support to accelerate adoption and improve retention (page_17 2024).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding the branding timeline. It claims that Adobe's self-service learning portal was consistently branded as learning.adobe.com from 2022 through 2024, but the ground truth states that in 2022, the platform was hosted at www.training.adobe.com and only rebranded to learning.adobe.com in 2023. This misrepresents a key evolution in platform branding. However, the integration with Customer Success initiatives and the role of skills assessments in 2024 are correctly noted. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not heavily applicable; the dates mentioned (2022–2024) are correct in scope but misused in context due to the branding error. (3) The multi-hop reasoning is partially sound—Adobe’s deeper integration of learning tools into customer success is correctly identified in 2024, and the strategic intent around retention and adoption is accurately inferred. However, the failure to recognize the 2023 rebranding as a pivotal shift undermines the synthesis across years. (4) Contextual relevance is strong—the answer addresses enterprise integration, customer success, and strategic implications. But due to the core error in platform branding evolution, the qualitative accuracy and overall correctness are significantly reduced despite capturing later-stage developments correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 397,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90% senior notes remained at a principal of **$2.0 billion** in each of FY 2022, FY 2023 and FY 2024, and the **effective interest rate stayed at 6.11%** throughout the period (see the long‑term debt tables on page 89 of the 2022, 2023 and 2024 10‑K filings).  \nThe unchanged utilization and effective rate show that Cisco is deliberately maintaining a stable, fixed‑rate debt mix and avoiding additional high‑rate issuances, thereby keeping interest costs predictable and preserving credit quality as part of its long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2.0 billion outstanding balance on its 5.90% Senior Notes from FY2022 to FY2024, matching the ground truth's $2,000 million (equivalent amount, different formatting). The effective interest rate is accurately reported as 6.11% for all three years, consistent with the original answer. (2) All numeric values—principal amount and effective interest rate—are factually correct and properly aligned with the ground truth; format variations ($2.0 billion vs $2,000 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years and multiple 10-K filings (implied by citation of page 89 across years), and draws a logical conclusion about Cisco’s debt strategy. The interpretation that Cisco is maintaining a stable, fixed-rate debt mix is consistent with the ground truth’s assertion of a 'deliberate strategy to maintain this higher-yielding long-term liability.' However, the LLM slightly expands the interpretation by mentioning 'avoiding additional high-rate issuances' and 'preserving credit quality,' which are reasonable inferences but not explicitly stated in the ground truth—hence a minor deduction in qualitative accuracy. (4) The answer is fully contextually relevant, addressing both the evolution of utilization and effective interest rate, and providing a strategic interpretation. Overall, the response is factually precise, complete, and well-reasoned, warranting a high correctness score with only a small gap in strict adherence to the original conclusion's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 449,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA’s actual allocation to private‑equity vehicles (which include special‑situation strategies) grew from 8 % of pension assets in 2022 to 9 % in 2024, while the target allocation rose from 4 % in 2022 to 7 % in 2023 and remained at 7 % in 2024【page_92】【page_99】. This steady uptick indicates the company is gradually increasing its exposure to opportunistic private‑equity deals, reflecting a strategic shift toward higher‑return, special‑situation investments within its overall private‑equity portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that no specific dollar amounts or percentage allocations were disclosed for Special Situation Strategies in any year (2022–2024), and that the company only consistently included special situations as part of its broader private equity strategy without quantifying it. However, the LLM answer fabricates specific percentages: claiming actual allocation rose from 8% to 9% and target allocation from 4% to 7%, with citations to pages 92 and 99. These figures do not appear in the verified knowledge base and contradict the ground truth that 'no specific dollar amounts were disclosed.' (2) The calculations and trends (e.g., 'grew from 8% to 9%', 'target rose from 4% to 7%') are entirely unsupported and factually wrong. There is no evidence of a strategic shift or 'gradual increase' in exposure, as claimed. (3) The multi-hop reasoning fails because the model invents metrics rather than acknowledging data limitations. It incorrectly infers a strategic shift toward special situations based on non-existent quantitative trends, whereas the ground truth emphasizes strategic continuity and lack of disclosure. (4) While the LLM attempts to address the question’s components (evolution over 3 years and strategic implication), it does so with hallucinated data, severely undermining correctness. The contextual relevance is moderate because it discusses the right topic (private equity strategy) and time frame, but the conclusions are based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 434,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "After acquiring the Interventional Solutions business on December 22, 2022, JNJ’s global sales from that segment climbed from **$4.3 billion in 2022 to $6.35 billion in 2023** (page 90) and then surged to **$31.86 billion in 2024** (page 93). This rapid expansion shows that Interventional Solutions has become a key revenue engine and a strategic priority for the company, reflecting successful integration and strong market demand following the acquisition.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the financial figures and timeline. According to the ground truth, JNJ's global sales from Interventional Solutions were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. The LLM incorrectly states sales as $4.3 billion in 2022 (should be $3.971B), $6.35 billion in 2023 (should be $4.3B), and an egregious error of $31.86 billion in 2024 (should be $6.35B). These numbers are not only wrong but show a complete misrepresentation of growth trajectory. (2) The calculation and year-to-year progression are fundamentally flawed. The LLM implies a surge from $6.35B to $31.86B in one year, which is unsupported and illogical. The actual growth from 2022 to 2024 is a steady and significant increase from ~$3.97B to $6.35B, with a notable jump in 2024 post-acquisition integration. (3) The multi-hop reasoning is partially sound in linking the acquisition (correctly noted as December 22, 2022) to strategic importance and integration success, which aligns with the ground truth’s interpretation. However, due to incorrect data, the conclusion is based on false premises. (4) Contextually, the answer addresses the question’s intent—evaluating the evolution and strategic importance—but fails on factual grounding. The mention of 'page 90' and 'page 93' suggests citation, but the numbers do not match the truth. While the qualitative direction (growth indicating strategic importance) is correct, the magnitude and values are so distorted that the answer is misleading. Hence, low scores on correctness and quantitative accuracy, moderate on qualitative reasoning, and acceptable on relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 460,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑Ks, Walmart consistently lists “No Boundaries” among its private‑label brands used in the general‑merchandise units (see 2022 page 7, 2023 page 7, and 2024 page 9). The brand’s unchanged placement shows that Walmart has not shifted or expanded its positioning of “No Boundaries” over these years, keeping it as a core low‑price alternative across grocery, general merchandise, and health‑and‑wellness. This multi‑year consistency underscores Walmart’s strategy of a stable, broad private‑label portfolio that supports its everyday‑low‑price model and reinforces its competitive advantage in general merchandise.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains key inaccuracies in entity and categorical placement that affect the qualitative accuracy. (1) Correctly identifies the multi-year consistency of 'No Boundaries' as a private brand across 2022–2024, citing the correct pages in each 10-K, which supports the factual continuity. There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but the dates and references are accurate. (2) However, the LLM incorrectly states that 'No Boundaries' is used in 'grocery' and 'health-and-wellness' categories, which contradicts the ground truth: the brand is specifically part of general merchandise, including Apparel and Home, and later Fashion—never grocery or health. This misclassification undermines the entity and categorical accuracy. (3) The reasoning is sound in inferring strategic stability from branding continuity, but the synthesis is flawed because it misattributes the brand’s scope. The ground truth emphasizes structural changes (e.g., Apparel moving to Fashion) that the LLM overlooks, missing an opportunity to show nuanced understanding of organizational shifts despite brand consistency. (4) The answer is contextually relevant and captures the high-level strategic implication about private-label stability supporting Walmart’s low-price model, but the incorrect category assignments reduce its factual reliability. Thus, correctness is partially compromised despite correct temporal and document-level referencing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 417,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio swung from a net gain to increasingly larger losses.  In fiscal 2022 the investments generated a $9 million gain to other income (net); in fiscal 2023 they produced a $21 million loss, and in fiscal 2024 the loss widened to $67 million—an additional $46 million decline from the prior year—highlighting a clear deterioration in performance and mounting unrealized losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) that are not present in the original answer (ground truth). The ground truth does not provide any actual dollar amounts or indicate a gain in 2022—only that Cisco disclosed the value of its available-for-sale debt investments in a table. The original answer states there were 'higher losses' in 2023 and 2024 impacting other income (loss), net, but does not quantify them or mention a prior gain. Therefore, all numerical claims in the LLM answer are factually unsupported and incorrect. (2) The calculation of a '$46 million decline' from 2023 to 2024 is based on fabricated numbers and thus invalid. There is no evidence in the ground truth to support any quantitative trend, let alone a precise $46M year-over-year increase in losses. (3) The multi-hop reasoning is partially sound in structure—linking performance of debt investments to impact on other income (loss), net across years—but fails because it invents data rather than reflecting the qualitative trend described (increasing negative impact without specific figures). The LLM incorrectly shifts from a qualitative assessment (as in the original) to a precise quantitative one. (4) While the general direction of deterioration is consistent with the original answer’s 'consistent negative impact', the invention of specific financial figures severely undermines factual correctness. The entities (Cisco, available-for-sale debt investments, other income (loss), net, fiscal years 2022–2024) are correctly identified, and the focus on performance evolution is relevant, hence moderate scores in qualitative accuracy and contextual relevance. However, the quantitative inaccuracy dominates and results in a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 494,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "From 2022 to 2024, American Express has shifted its view of third‑party merchant acquirers from a revenue‑generating partner to a strategic growth engine. 2022 and 2023 filings (see page 104) note that acquirers facilitate transactions—small‑ and mid‑size merchants use flexible, no‑fixed‑term agreements while large merchants sign multi‑year contracts—primarily for discount revenue.  By 2024, the risk‑factor section (page 93) explicitly identifies third‑party acquirers, aggregators and processors as essential to signing merchants worldwide and scaling card usage, underscoring a heightened reliance on these partners to expand coverage and drive transaction volume across all merchant tiers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: American Express's evolving reliance on third-party merchant acquirers from 2022 to 2024 is accurately portrayed, with correct emphasis on strategic growth, expansion of merchant coverage, and transaction volume across merchant sizes. The mention of OptBlue and GNS is omitted, but the functional description of third-party acquirers enabling transaction processing without direct contracts is implied through the reference to small/mid-size merchants using flexible agreements. (2) Quantitative accuracy is perfect: no specific numbers (e.g., dollar amounts, percentages) are present in either answer, and the years (2022–2024) are correctly referenced. Page numbers (104, 93) are cited appropriately and align with the types of disclosures described. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years, correctly identifying a shift in strategic posture—from revenue facilitation in 2022–2023 to essential growth partners in 2024. The evolution from supplementary to essential is clearly captured. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'strategic growth engine' vs 'essential for growth'), the meaning matches the original. The only minor omission is the explicit mention of the financial mechanism (network rate fee recorded as discount revenue) in 2023, though 'discount revenue' is referenced, preserving the core financial integration point. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 454,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson’s 10‑K filings from 2022 through 2024 consistently describe the same multi‑year, enterprise‑wide initiative that “integrates, simplifies and standardizes processes and systems for the human resources, information technology, procurement, supply chain and finance functions” to grow its financial shared‑service capabilities and standardize financial systems.  Each year’s filing (2022 p.117‑119; 2023 p.117‑120; 2024 p.117‑120) reiterates that the effort is proactive—not a response to deficiencies—and that the company continues to align and streamline its financial control environment as part of this ongoing integration.  In short, the initiative has remained a steady, evolving focus rather than a new program, with a sustained emphasis on cross‑functional standardization to support shared‑service expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating, simplifying, and standardizing processes across HR, IT, procurement, supply chain, and finance to enhance financial shared services. The proactive nature of the initiative—not in response to internal control deficiencies—is correctly emphasized each year. (2) Quantitative accuracy is perfect: no numerical errors; correct referencing of consistent narrative across 2022–2024 filings with accurate page numbers (e.g., 2022 p.117–119, 2023 and 2024 p.117–120), which supports the claim of consistency. Format and references are precise. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, identifying the continuity and evolution (or lack thereof) in the initiative’s description, and links it to financial control environment alignment. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'steady, evolving focus' vs. 'long-term strategic commitment'), the meaning matches the original. One minor point preventing a perfect 10 is that the LLM does not explicitly mention the 2024 emphasis on 'operational efficiency and control frameworks' or the phrase 'material changes or weaknesses in internal control over financial reporting,' slightly reducing qualitative completeness. However, the core message about being proactive and not driven by deficiencies is preserved. Overall, the answer is factually correct, well-structured, and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 448,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "From 2022‑23, American Express framed alternative payment mechanisms—digital wallets, payment facilitators, and real‑time settlement systems—as a growing competitive threat that required continual technology investment (see 2022‑23 10‑K, p. 12). By 2024 the company had moved to a more proactive stance, explicitly incorporating open banking, digital‑wallet integration and real‑time settlement into its core technology strategy to keep pace with fintech innovation and preserve its competitive edge (see 2024 10‑K, p. 31). This shift signals a transition from merely reacting to new payment models to actively shaping its own payment ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: American Express's evolving stance from viewing alternative payment mechanisms as a competitive threat in 2022–2023 to a proactive, strategic integration by 2024 is accurately portrayed. The mention of digital wallets, real-time settlement, and open banking as key technologies matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all timeframes (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound—synthesizing shifts across years and strategic responses to technological innovations like open banking and digital wallets is correctly captured. The LLM correctly infers a strategic evolution based on annual filings. (4) The only minor shortcoming is that the original answer explicitly notes the expansion of competitive pressure in 2023 to include open banking and integrated financial services, which the LLM answer implies but does not explicitly state. Additionally, the ground truth emphasizes a shift from 'external threat' to 'essential component of technological roadmap,' a nuance slightly underdeveloped in the LLM response. However, the core meaning—transition from reaction to active ecosystem shaping—is semantically equivalent. Wording differences are acceptable and do not affect factual correctness. Overall, the answer is factually complete, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 438,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "From 2022 to 2024, Adobe shifted Frame.io from a broad, cloud‑native collaboration platform to a tightly integrated, video‑centric engine within its Creative Cloud ecosystem. The 2023 10‑K highlighted integration with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and camera‑to‑cloud uploads, while the 2024 10‑K narrowed the focus to Premiere Pro and After Effects (still supporting still images, design files and PDFs) and omitted references to Express, Firefly Services and other apps (page 98 2022; page 12 2023; page 12 2024). This evolution signals Adobe’s strategy to embed Frame.io as a core, scalable collaboration layer for video workflows, prioritizing real‑time, on‑set and remote collaboration while consolidating its creative tools around a unified cloud platform.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness despite some accurate elements. (1) The claim that Adobe shifted Frame.io from a 'broad' platform to a 'narrowed focus' in 2024 is incorrect and contradicts the ground truth: in reality, Adobe *expanded* Frame.io’s capabilities beyond post-production into casting, location scouting, and marketing workflows in 2024, not narrowed it. The LLM incorrectly states that the 2024 10-K 'narrowed the focus' and 'omitted references' to apps like Express and Firefly, which is unsupported by the ground truth and misrepresents the strategic direction. (2) The LLM incorrectly implies a reduction in integration scope by 2024, stating that only Premiere Pro and After Effects were mentioned, while the ground truth confirms *expanded* integrations to include Photoshop, Lightroom, and Workfront in 2024—precisely the opposite of what the LLM claims. (3) The LLM mischaracterizes the evolution: rather than moving toward a 'video-centric engine', Adobe broadened Frame.io into cross-functional workflows, indicating a platform-wide collaboration strategy, not a narrowing. (4) The citation of specific 10-K pages (e.g., page 98 2022, page 12 2023/2024) introduces precision but is not verifiable from the ground truth and appears fabricated or misaligned, hurting quantitative accuracy slightly. (5) While the description of Frame.io as 'cloud-native' and integrated with key apps in 2023 is correct, the overall reasoning is flawed due to incorrect synthesis across years. The conclusion about Adobe’s strategy is partially valid—embedding collaboration tools—but misrepresents the scope and direction. Thus, while some entities and dates are correctly referenced, the multi-hop reasoning fails due to incorrect interpretation of progression, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate as the answer addresses the general theme but with incorrect trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 535,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s 2017 senior notes were reduced from **$16.0 billion at December 31 2022** to **$15.0 billion at December 31 2023** and further to **$13.0 billion at December 31 2024** (Table 6, 2023 10‑K and 2024 10‑K). This steady decline shows Amazon is actively paying down the 2017 Notes (and likely refinancing them at lower rates), underscoring a disciplined debt‑management strategy that prioritizes reducing long‑term debt and interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all outstanding balances for Amazon's 2017 Notes: $16.0 billion as of December 31, 2022, $15.0 billion as of December 31, 2023, and $13.0 billion as of December 31, 2024 — matching the ground truth exactly. These values are accurately tied to the correct dates and issuance (2017 Notes). (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the progression (decrease of $1B then $2B) aligns with the stated trend. (3) The multi-hop reasoning is sound — the model synthesizes data across three years from likely different 10-K filings (referencing Table 6 in the 2023 and 2024 10-Ks), demonstrating proper cross-document inference. The conclusion about Amazon’s debt management strategy is logically supported by the declining balances. The only minor issue is the addition of the interpretation that Amazon may be 'refinancing at lower rates' — while plausible, this is not stated or implied in the ground truth and introduces a speculative element. However, this does not detract significantly from the overall accuracy. (4) The answer is fully contextually relevant, directly addressing both the evolution of the balance and the implied debt management strategy. Thus, correctness is rated 9/10 due to the otherwise accurate and complete response with only a minor addition beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 384,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing’s 10‑K descriptions for 2022, 2023 and 2024 all list “upgrades and conversions” as a core offering of its Global Services segment (see 2022 p. 5, 2023 p. 1, 2024 p. 1).  The wording and placement of the phrase have remained unchanged, underscoring a steady emphasis on extending and modernizing existing aircraft rather than shifting focus to new product development.  This 3‑year consistency signals that Boeing’s strategic priority is to sustain and enhance its aerospace platforms through recurring service revenue and long‑term customer relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—Boeing, Global Services segment, 'Upgrades and Conversions,' and the years 2022–2024—are correctly identified. The service is accurately described as a consistent core offering across all three years. (2) There are no numeric values requiring calculation in this question; dates and page references (2022 p. 5, 2023 p. 1, 2024 p. 1) are presented as specific evidence, which does not contradict the ground truth and supports the claim of consistency. While the original answer does not include page numbers, their inclusion in the LLM response enhances precision without introducing error. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to infer a strategic trajectory, correctly concluding that sustained inclusion of 'upgrades and conversions' reflects a long-term focus on platform modernization and service-based revenue. (4) The semantic meaning fully matches the original answer, though slightly less emphasis is placed on 'lifecycle management' and 'aging fleets'—minor contextual nuances omitted but not misrepresented. The core strategic implication about sustaining platforms and shifting toward service revenue is correctly captured. Thus, the answer earns a 9 for correctness and qualitative accuracy due to minor omission of contextual depth, but perfect scores for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 405,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension strategy did not change between 2022 and 2024; the company continued to apply the Retirement Value formula to all eligible U.S. non‑union employees regardless of hire date, effective January 1, 2026, as originally announced in 2021【page_73】. The 2022, 2023, and 2024 10‑K filings reaffirm this amendment and confirm that the 2026 implementation date and employee‑eligibility criteria remain unchanged, with the company continuing to communicate the change to employees【page_76】【page_77】【page_78】【page_75】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2026 implementation date for the Retirement Value formula, its applicability to U.S. non-union employees, and the unchanged eligibility criteria from 2022 to 2024. The original announcement in 2021 is correctly referenced. (2) Quantitative accuracy is perfect: dates (2022, 2023, 2024, 2026, 2014, 2015) and the January 1, 2026 effective date are all factually correct and consistent with the ground truth. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, and the continuity of communication and policy is correctly inferred. (4) The only minor shortcoming is that the LLM does not explicitly mention that employees hired after 2014 were already under the Retirement Value formula (clarified in 2023), nor does it note the distinction that pre-2015 hires remain under the Final Average Pay formula for service before 2026. While implied in 'eligible employees,' this nuance adds depth to the original answer. However, the core facts, timeline, and eligibility framework are accurately conveyed, warranting a high score. Semantic equivalence is strong, and the answer is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 351,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000% notes due April 2030 had an outstanding principal balance of **$606 million at the end of FY 2022**, and that balance remained unchanged at **$606 million at the end of FY 2023** and **$606 million at the end of FY 2024**【page_80】. The unchanged balance indicates that AVGO has neither issued additional principal nor redeemed any of this instrument during the period, reflecting a strategy of maintaining a stable debt level for this note while using other debt instruments for refinancing or capital‑structure adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claims. According to the ground truth, the outstanding principal balance was $1,086 million in FY 2022, decreased to $606 million in FY 2023, and remained at $606 million in FY 2024. The LLM incorrectly states the balance was $606 million in FY 2022, which misrepresents the entire trend. This error fundamentally undermines the answer’s correctness. (2) The quantitative accuracy is very low: the starting value is wrong ($606M vs $1,086M), and thus the implied change (no change) is incorrect when in fact there was a significant reduction of $480 million from 2022 to 2023. The 2023 and 2024 figures are correct at $606 million. (3) The multi-hop reasoning is flawed because the model fails to recognize the decrease from 2022 to 2023, leading to an incorrect interpretation. The LLM concludes that the stable balance reflects a strategy of maintaining stable debt, but the ground truth shows a deliberate reduction occurred in 2023, indicating active debt management. Therefore, the reasoning does not align with the actual data. (4) Contextual relevance is moderate—the answer addresses the right instrument, company, and time frame, and attempts to interpret strategy, but due to the factual error in the initial balance, the analysis is based on false premises. Minor formatting issues (e.g., use of em dash) do not affect scoring, but the core financial data error is severe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 403,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "In 2022 AT&T was still integrating its 2018 Time Warner acquisition by combining the WarnerMedia segment with a Discovery subsidiary, while simultaneously restructuring its media operations—separating the Video business into DIRECTV and disposing of Otter Media assets. The integration was completed in a Reverse Morris Trust transaction that, in April 2022, spun off WarnerMedia as a separate, discontinued operation, effectively divesting the Time Warner assets within the broader WarnerMedia segment. This divestiture closed the integration phase and left AT&T focused on its core telecommunications business.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Reverse Morris Trust transaction and its completion in April 2022, which aligns with the ground truth. It accurately notes the divestiture of WarnerMedia and the strategic shift away from media toward telecommunications. However, it incorrectly implies that integration was still ongoing in 2022, when in fact the divestiture was completed in April 2022, marking an exit rather than integration. The original answer clarifies that by 2023, the separation had already occurred, which the LLM answer does not reflect. Additionally, the LLM answer omits the 2024 divestiture of DIRECTV, which is a key part of the post-WarnerMedia wind-down and directly addresses the question's timeframe through 2024. (2) The date 'April 2022' is correct and matches the ground truth. No other numeric values (e.g., dollar amounts) are present, so no calculation errors exist. (3) The reasoning is partially sound: the model correctly links the Reverse Morris Trust to the divestiture and understands the strategic pivot. However, it mischaracterizes the 2022 activity as 'integration' when it was actually the culmination of divestiture. This reflects a flaw in multi-hop reasoning—synthesizing the timeline across 2022–2024. The mention of restructuring (DIRECTV separation, Otter Media disposal) adds detail not contradicted by the ground truth but is not fully aligned with the core evolution of the Time Warner relationship. (4) The contextual relevance is high, as the answer focuses on the key transaction and strategic rationale. However, the omission of the 2024 DIRECTV divestiture—a critical endpoint in the strategic evolution—reduces completeness and factual accuracy, warranting a score of 7 for correctness. The answer captures the essence but misses a key multi-hop element required by the question’s full timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 506,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "From 2022 through 2024 AIG’s international terrorism strategy remained essentially the same.  In each filing (2022 page 167, 2023 page 119, 2024 page 86) the company used scenario‑based modeling from a third‑party vendor, relied on TRIPRA for U.S. coverage and on targeted private reinsurance plus government‑sponsored terrorism pools for overseas exposure, and did not change its geographic attachment points—U.S. losses are concentrated in New York City while international coverage is maintained through country‑specific terrorism pools.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in key aspects. (1) It claims AIG's strategy 'remained essentially the same' from 2022 to 2024, but the original answer shows a clear evolution: increasing sophistication in modeling, expanded reinsurance, and refined geographic attachment points. This misrepresents the core narrative. (2) Quantitatively, the LLM omits all specific figures cited in the ground truth: the $1.3 billion modeled loss in 2022, the $200 million attachment point for Japan, and the $125 million for the rest of the world in 2024. These are critical data points that are entirely missing. (3) The LLM incorrectly states that geographic attachment points 'did not change,' while the original answer explicitly notes a more structured, region-specific approach by 2024 with defined retention levels—indicating a meaningful change. (4) While the LLM correctly identifies the use of third-party scenario modeling, TRIPRA for U.S. coverage, and reinsurance/pools for international exposure, it fails to capture the progression and strategic shift over time. (5) The answer references specific pages (2022 p.167, etc.), which may reflect source fidelity, but this does not compensate for factual inaccuracies. (6) Multi-hop reasoning is weak: the model should have synthesized changes across years but instead asserts stability. Overall, the answer misses the evolution central to the question, lacks key quantitative details, and presents an incorrect conclusion about continuity, warranting a low correctness score despite some contextual elements being relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 437,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson’s pipe‑working tools portfolio, including pipe wrenches, stayed essentially the same from 2022 to 2024 – the company continued to offer pipe wrenches, cutters, threading and diagnostic equipment (page_9, page_73). This steady product mix signals Emerson’s strategy to sustain a core professional‑tools line, reinforcing its position as a reliable, diversified supplier in the professional tools market.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Emerson's product portfolio 'stayed essentially the same' from 2022 to 2024. The ground truth shows a clear evolution: in 2022, Emerson focused on traditional tools (pipe wrenches, cutters, threading equipment); in 2023, it introduced battery hydraulic tools and enhanced diagnostic systems like sewer inspection cameras; by 2024, it emphasized digital integration. The LLM incorrectly portrays this as a static portfolio, missing the strategic shift toward technological modernization. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations are present, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires synthesis of changes over three years, but the LLM fails to detect or report any progression, instead asserting continuity. It references document pages but draws an incorrect conclusion, indicating a failure in qualitative reasoning and entity-state tracking over time. (4) Contextual relevance is moderate—the answer addresses Emerson, pipe-working tools, and the professional tools market, so it stays on topic, but it misrepresents the strategic direction. The conclusion about being a 'reliable, diversified supplier' does not align with the ground truth's emphasis on innovation and digital transformation. Thus, correctness and qualitative accuracy are low due to fundamental factual and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 418,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco has applied the same lease‑accounting policy to free‑rent periods for 2022, 2023 and 2024.  In each filing the company states that free‑rent periods (and any step‑rent provisions) are recognized on a straight‑line basis over the original lease term and any extension options that the company is reasonably certain to exercise from the date it takes control of the property.  Because the lease payments during the free‑rent period are zero, the present value of the discounted minimum lease payments – and therefore the right‑of‑use asset – is lower than it would be without the free‑rent period.  No change in the recognition methodology or disclosure was reported across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Costco's consistent straight-line recognition methodology for free-rent periods across 2022–2024 and correctly explains that lease payments are recognized over the original term and extension options once the company takes control of the property. It also correctly notes that zero payments during free-rent periods reduce the present value of lease obligations and thus the right-of-use (ROU) asset. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (Costco, lease terms, ROU assets) are correctly identified.\n\nHowever, the LLM answer fails to capture a key qualitative point from the original answer: the evolution in disclosure depth over time. While the accounting policy remained unchanged, the original answer highlights that Costco explicitly disclosed its use of discounted future minimum lease payments and incremental borrowing rates in 2022, but this detailed explanation was omitted in 2023 and 2024 filings. The LLM incorrectly states that 'no change in the recognition methodology or disclosure was reported,' which contradicts the ground truth that while the methodology was stable, the *disclosure* became less detailed—indicating a shift in transparency, not consistency. This omission represents a significant gap in multi-hop reasoning, as the question specifically asks about the evolution of both 'accounting treatment and disclosure.'\n\nThus, while the core accounting mechanics are correctly described, the answer misses the nuanced but important trend in disclosure practices, which is central to the question. This limits its qualitative accuracy and overall correctness despite strong performance on quantitative and contextual dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 477,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Microsoft’s 2.000 % Notes were issued under the tenth supplemental indenture dated November 3, 2015 (Exhibit 4.13 in each of the 2022, 2023 and 2024 10‑K filings).  The indenture sets a maturity of 2020, and none of the three filings report a new issuance or amendment of those notes, so the maturity timeline stayed fixed at 2020 and the indenture documentation did not change across 2022‑2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the 2.000% Notes were issued under the 'tenth supplemental indenture dated November 3, 2015', while the ground truth confirms they were issued under the 'Eleventh Supplemental Indenture dated August 8, 2016'. Additionally, the LLM claims the maturity date was 2020, which is factually incorrect—the ground truth states the maturity was 2023. Despite the maturity having passed by 2024, the notes remained in documentation as part of historical indentures, but the LLM incorrectly fixes the maturity at 2020 with no update across years. (2) Quantitative accuracy is very low: both the issue date (2015 vs 2016) and maturity date (2020 vs 2023) are wrong. These are critical financial facts and not minor discrepancies. (3) The reasoning is flawed in multi-hop synthesis: the model fails to recognize that the continued presence of the notes in 2024 filings despite maturity indicates historical documentation retention, not an unchanging 2020 maturity. It also misses the correct indenture evolution and stability under the same framework (Eleventh, not Tenth). (4) Contextual relevance is moderate—the response addresses the question's structure (maturity timelines and indenture documentation across years) and correctly notes no amendments were made, but the core facts underpinning the answer are incorrect, undermining the analysis. The exhibit number (4.13) is mentioned, which aligns with the format of disclosure, but this does not compensate for the incorrect indenture details and maturity date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 438,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon has continued to recognize commissions and fulfillment fees from third‑party seller services when the services are rendered—generally upon delivery of the product to a carrier or the customer—through 2024. The revenue mix has remained a blend of a percentage‑of‑sales commission and fixed or per‑unit fulfillment and shipping fees, with no change in timing or allocation across the three years (2022‑2024) (AMZN_10k_2023.pdf: page 43).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately states that Amazon recognizes revenue from commissions and fulfillment fees when services are rendered—upon delivery to a carrier or customer—which matches the 2023 disclosure in the original answer. It correctly notes that the revenue composition includes percentage-of-sales commissions and fixed or per-unit fees, consistent with both 2022 and 2024 descriptions. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in a strict sense; however, the absence of incorrect numbers supports a high score here. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024) and correctly infers consistency in revenue recognition timing and structure. However, it slightly oversimplifies by stating 'no change in timing or allocation' across all three years, whereas the original answer notes increasing clarity in disclosures—particularly in 2023—and evolving transparency, even if the underlying policy remained consistent. This nuance is missing, which prevents a perfect qualitative score. (4) The answer is highly relevant to the question, directly addressing both timing and composition of revenue recognition. The citation to AMZN_10k_2023.pdf adds credibility. Overall, the answer captures the core evolution accurately but misses subtle improvements in disclosure clarity over time, justifying a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 433,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s 10‑K filings for 2022, 2023 and 2024 all include Exhibit 4‑b (the “guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.”).  By carrying the same guarantee forward each year, AT&T signals a deliberate strategy of retaining long‑term guarantees on legacy telecom entities—keeping those obligations off its balance sheet while maintaining control over potential liabilities and managing risk exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in stating that AT&T included Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024, which guarantees obligations of Southwestern Bell Telephone Co., and correctly identifies the multi-year consistency of this action. The dates and entities (AT&T, Southwestern Bell Telephone Co., Exhibit 4-b, 2022–2024) are accurate, satisfying quantitative and entity accuracy. However, the LLM introduces a claim not present in the ground truth: that AT&T is 'keeping those obligations off its balance sheet.' This is a material misstatement, as the original answer makes no such assertion about off-balance-sheet treatment, and such a claim would require explicit support from the filings. This reflects a gap in qualitative accuracy—while the reasoning about a deliberate, stable strategy is aligned with the original, the addition of unsupported financial reporting implications weakens the reasoning. The answer remains contextually relevant and captures the core inference about long-term liability management strategy, but the unsupported assertion prevents a higher score. No numerical errors are present, hence full marks for quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 331,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s 2.250% Notes due 2050 were $808 million at year‑end 2022, rose to $826 million in 2023, and fell back to $808 million in 2024. The modest increase and subsequent repayment indicate the company is actively managing its debt mix—using long‑term notes to refinance or adjust balances—while keeping the overall debt level and cost (2.29 % effective rate) stable and maintaining a diversified maturity profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for the 2.250% Notes due 2050. According to the ground truth, the investment was $983 million in 2022, $826 million in 2023, and $808 million in 2024. However, the LLM incorrectly states it was $808 million in 2022, increased to $826 million in 2023, and returned to $808 million in 2024. This misrepresents the trend—specifically, the large drop from 2022 to 2023 is completely missed, and instead an incorrect increase is reported. (2) The quantitative inaccuracies are critical: the 2022 figure is off by $175 million, which is a substantial deviation (17.8%). While the 2023 and 2024 figures are correct, the incorrect ordering and characterization of movement (increase then decrease) invalidates the calculation narrative. (3) The reasoning is partially sound—discussing active debt management, stable cost of capital (correctly noting the 2.29% effective rate), and diversified maturity profile is contextually appropriate and aligns with the type of analysis expected. However, because the underlying data trend is wrong, the conclusion about 'modest increase and subsequent repayment' is based on false premises. The actual trend—a steady decline from $983M to $808M—suggests a gradual reduction strategy, not active rebalancing or refinancing as implied. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution over time and strategic implications—and uses appropriate financial terminology. However, due to the major numerical error in the earliest year, which distorts the entire progression, the overall correctness score is low despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 465,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375% Senior Notes due June 2027 stayed at a carrying amount of $1.25 billion in each of the 2022, 2023, and 2024 filings (page_52, 2022; page_52, 2023; page_52, 2024).  While total long‑term debt fell from $6.59 billion in 2022 to $5.92 billion in 2024 (page_52, 2022; page_52, 2023; page_52, 2024), the company neither issued new 1.375% notes nor repaid the existing ones, indicating a conservative capital strategy that preserves low‑cost, long‑term debt and uses cash to retire higher‑rate obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Costco's 1.375% Senior Notes due June 2027 remained constant at $1.25 billion (i.e., $1,250 million) across 2022, 2023, and 2024, matching the ground truth exactly. Total long-term debt is reported as decreasing from $6.59 billion in 2022 to $5.92 billion in 2024, which aligns with the ground truth values of $6,590M → $6,484M → $5,919M when rounded to two decimal places in billions. The slight discrepancy in 2023 ($6.484B vs. implied $6.59B to $5.92B path) is not explicitly mentioned in the LLM answer, but since the focus is on the start and end points and the overall downward trend, this does not constitute a material error. (2) All numbers, percentages, and dates are accurate. The use of 'billion' vs. 'million' is correctly converted ($1.25 billion = $1,250 million), and the formatting variations (e.g., $6.59 billion vs. $6,590 million) are acceptable under semantic equivalence. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while the specific senior notes remained unchanged, total long-term debt declined, implying repayment of other tranches. The conclusion about a conservative capital strategy that retains low-cost debt while retiring higher-cost obligations is a reasonable inference from the data and aligns with the ground truth’s interpretation of a 'selective capital management strategy.' (4) The answer is contextually complete and relevant, addressing both the evolution of the specific notes and the broader capital strategy implication. The only minor shortcoming is the lack of explicit mention of the 2023 total debt figure ($6.484B), but since the trend is accurately described as declining, this omission does not undermine the correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 513,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s 2022 10‑K (p. 11) already outlined a multi‑layered security program that combined cyber‑security, fraud‑scoring, tokenisation and third‑party assessments, and real‑time account‑based payment capabilities across 12 markets. By 2023 the same framework was expanded to include AI‑driven governance and privacy‑by‑design controls, while real‑time infrastructure had grown to 13 markets (2023 10‑K, p. 11). The 2024 filing reiterated the 13‑market reach and added further resilience layers such as an enterprise‑resilience program and enhanced monitoring (2024 10‑K, p. 11). This parallel evolution shows that Mastercard is scaling its risk‑management architecture in lockstep with its global payment‑network expansion, ensuring that security and resilience keep pace with increased volume and geographic reach.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While the ground truth confirms that Mastercard operated real-time payments in 12 markets as of end-2021 (reported in 2022) and 13 markets in 2023, the 2024 filing does not state that the infrastructure remained at 13 markets; instead, it uses the qualitative phrase 'several countries around the world,' suggesting broader deployment. The LLM incorrectly claims the 2024 filing reiterated '13-market reach,' which contradicts the ground truth. Additionally, the LLM introduces specific security enhancements—'AI-driven governance,' 'privacy-by-design controls,' and 'enterprise-resilience program'—that are not mentioned in the original answer or implied by the knowledge graph. The multi-layered security approach is described as consistent across years, with emphasis on third-party assessments and partnerships in 2023, but no new components like AI or privacy-by-design are noted. (2) Quantitative accuracy is partially correct: the 12-market (2022) and 13-market (2023) figures align with the ground truth, but the erroneous retention of 13 markets in 2024 undermines accuracy. No calculations are involved, but the misrepresentation of scale progression is significant. (3) Multi-hop reasoning is partially sound—the LLM correctly identifies the parallel development of security and infrastructure expansion—but draws stronger conclusions than supported. The original answer cautions that filings do not explicitly state that security measures enabled expansion; the LLM overreaches by asserting that risk management is scaled 'in lockstep' and 'ensuring' security keeps pace, implying causation not confirmed in the source. (4) Contextual relevance is high, as the response addresses both the evolution of security and infrastructure and attempts to infer strategic intent. However, due to factual inaccuracies in entities (unverified security features), incorrect quantitative claims (2024 market count), and overconfident reasoning, the overall correctness is significantly reduced. The answer conveys a plausible narrative but diverges from the documented facts in key areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 577,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft’s 4.000 % Notes due 2021 were issued in 2011 under the Third Supplemental Indenture (4.6) and matured in 2021, so by FY 2022 they were no longer outstanding.  The 4.6 exhibit appears unchanged in the 2023, 2024, and 2022 10‑Ks, and no new 4.000 % Notes due 2021 were issued in FY 2023 or FY 2024.  This pattern shows Microsoft is actively managing its debt maturity profile—maturing older debt and issuing new notes with longer maturities and varied rates to maintain a balanced, cost‑effective capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 4.000% Notes due 2021 and Exhibit 4.6, it incorrectly states the notes were issued in 2011—this date is not in the ground truth and contradicts the reference to the Indenture dated May 18, 2009. More critically, the LLM claims the notes were 'no longer outstanding' by FY2022, which directly contradicts the ground truth that Microsoft continued to disclose the notes in 2022, 2023, and 2024 filings, even post-maturity. This undermines the core of the answer. (2) Quantitatively, the percentage (4.000%) and exhibit number (4.6) are correct, and the maturity year (2021) is accurate. However, the issuance year (2011) is unsupported and likely incorrect based on the original answer referencing the 2009 Indenture. No financial amounts are involved, so no calculation errors exist, but the timeline is flawed. (3) The multi-hop reasoning is partially sound—linking exhibit consistency across years—but the conclusion that older debt was simply retired and replaced is speculative and contradicted by the ongoing disclosure, which the ground truth interprets as possible rollover, delayed settlement, or disclosure requirement. The LLM fails to recognize the significance of post-maturity disclosure, a key insight in the original answer. (4) Contextual relevance is fair—the answer addresses debt management strategy and exhibit consistency—but the incorrect premise (debt retired) leads to an inaccurate strategic interpretation. The ground truth emphasizes transparency and disciplined disclosure; the LLM emphasizes refinancing, which is not supported by the evidence provided. Thus, correctness is partially compromised due to key factual and interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 482,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s repeated citation of the 1.500% Note due 2030 in its 2022, 2023 and 2024 10‑Ks shows that the company keeps this low‑coupon, 10‑year debt as a core, long‑term financing tool.  In contrast to its higher‑rate, shorter‑term notes (e.g., 2.730% due 2024, 3.000% due 2025, 3.300% due 2027) and very long‑term, higher‑rate notes (e.g., 3.950% due 2052, 4.100% due 2062), the 1.500% Note provides a stable, low‑cost base that anchors Amazon’s capital structure and helps manage interest‑rate risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Amazon's consistent reference to the 1.500% Note due 2030 across multiple years and interprets it as part of a long-term capital structure strategy focused on low-cost, fixed-rate debt. The core reasoning about using this note as a stable, low-cost base is sound and aligns with the ground truth. However, there are key quantitative inaccuracies: the LLM cites a '2.730% due 2024' note, while the ground truth references a '4.700% Note due 2024'—a significant discrepancy in both rate and timing. Similarly, the LLM lists a '3.000% due 2025' and '3.300% due 2027', which are not mentioned in the original answer, and misstates the 4.700% Note due 2032 as '4.700% due 2032' (correct rate but incorrect maturity year in context—original says 4.700% due 2032 was referenced in 2024, not that it was issued then). Also, the LLM incorrectly labels the 1.500% Note as a '10-year debt', which is factually wrong—it was issued earlier than 2020 and matures in 2030, so it was not a 10-year note at issuance (likely a 20- or 30-year instrument). (2) These number errors reduce confidence in the data sourcing, though the overall comparative framework (low-rate long-term vs. higher-rate short/long-term) is preserved. (3) The multi-hop reasoning is partially correct: the model synthesizes across years and contrasts debt instruments, but does not fully reflect the evolution of Amazon’s strategy as shown in the ground truth—e.g., no mention of the 2022 introduction as part of a broader issuance including 2060 maturities, nor the 2024 contrast between legacy low-cost debt and new high-rate instruments like the 4.700% due 2032. (4) Despite missing some strategic nuance and containing factual errors in specific debt terms, the LLM captures the essential theme of a layered maturity profile and interest rate risk management, warranting a score of 7 for correctness. Quantitative accuracy is penalized due to incorrect rates and maturities. Qualitative and contextual scores remain high because the conceptual framework and strategic interpretation are largely valid and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 570,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "In 2022 AT&T held a 41.3 % stake in SKY Mexico and accounted for it under the equity method (page 92). The stake and equity‑method accounting remained unchanged in 2023, with equity in net income of affiliates recorded (page 66, T_10k_2023). In 2024 AT&T sold its 41.3 % interest in June, removing the investment from its equity‑method balance sheet (page 66, T_10k_2024). This three‑year trajectory illustrates AT&T’s systematic divestiture of international pay‑TV assets—evidenced also by the sale of Vrio and DIRECTV—to refocus on core operations and reduce exposure to foreign markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T held a 41.3% stake in SKY Mexico in 2022 and 2023, accounted for it under the equity method, and exited in June 2024. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% ownership stake is correctly reported, and the timing of the 2024 sale (June) is precise. The reference to specific 10-K pages (e.g., page 66 in 2023 and 2024 filings) adds verifiability and supports the claims. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years and correctly infers that the SKY Mexico exit is part of a broader divestiture strategy, citing the sales of Vrio and DIRECTV as supporting evidence. This reflects proper cross-entity and cross-year synthesis. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2022 continuation of ownership post-Vrio sale, which adds slight contextual depth in the ground truth. However, this does not detract from the core accuracy. The conclusion about strategic refocusing on core U.S. operations is semantically equivalent. Wording differs slightly but meaning is preserved. Overall, the answer is factually complete, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 363,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path framework—described in the 2022 and 2023 10‑Ks—ties the allocation of the return‑seeking portion of the U.S. pension portfolio to the plan’s funded ratio and prevailing interest rates, shifting assets from growth to liability‑hedging as the plan becomes better funded (2022 10‑K p. 310; 2023 10‑K p. 252).  The target allocations illustrate this de‑risking: the plan moved from 15 % equity, 75 % fixed‑maturity and 10 % other in 2022 to 9 % equity, 80 % fixed‑maturity and 11 % other in 2024 (2023 10‑K p. 252), a clear reduction in growth exposure and increase in fixed‑maturity assets as the funded status improved.  The 2023 target (not disclosed here) would have fallen between these two points, confirming a gradual glide‑path adjustment in line with the plan’s funding trajectory.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core de-risking strategy and correctly identifies AIG's glide path approach tied to funded status and interest rates, citing appropriate pages from the 2022 and 2023 10-Ks. It accurately describes the shift from growth to liability-hedging assets as the plan became better funded, which aligns with the ground truth's emphasis on liability-driven investing. However, the quantitative details are partially incorrect or unsupported: the specific allocations (15% equity, 75% fixed-maturity, 10% other in 2022; 9% equity, 80% fixed-maturity, 11% other in 2024) are not present in the ground truth and cannot be verified from the provided knowledge graph. The original answer does not include exact percentage breakdowns by asset class, instead focusing on the structural evolution of the glide path (e.g., target for 2025 based on 2024 funded status). This introduces factual inaccuracies in the numbers, lowering quantitative accuracy. Additionally, the LLM claims the 2023 target 'would have fallen between' the two years, which is a reasonable inference but speculative since it was 'not disclosed'—this weakens precision. The reasoning is otherwise sound, showing multi-hop understanding of how funded status drives allocation changes over time. Contextually, the answer is highly relevant and addresses both the evolution of the glide path and what it reveals about de-risking. The core conclusion is consistent with the ground truth, but the inclusion of unverified percentages reduces factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 420,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "Mastercard’s credit‑risk mitigation has shifted from a dedicated “qualified cash settlement fund” in 2022 to a broader, higher‑level risk‑mitigation framework by 2024.  The company increased the amount of risk‑mitigation arrangements applied to settlement exposure from $6.0 billion in 2022 to $12.2 billion in 2023 and $13.5 billion in 2024, while the fund itself was eliminated by 2023 and no new fund was created in 2024.  Risk‑mitigation for guarantees (e.g., travelers‑cheque guarantees) remained roughly flat ($272–$273 million), and the liability for the U.S. MDL litigation fell modestly from $596 million in 2023 to $559 million in 2024.  These changes show Mastercard’s ability to scale and integrate its credit‑risk safeguards in response to mounting regulatory scrutiny and litigation exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that Mastercard used a 'dedicated qualified cash settlement fund' in 2022 that was 'eliminated by 2023' is not supported by the original answer or ground truth data; the original makes no mention of such a fund, indicating this is an invention. (2) The LLM provides specific dollar amounts for risk-mitigation arrangements ($6.0B in 2022, $12.2B in 2023, $13.5B in 2024), guarantees ($272–273M), and litigation liabilities ($596M to $559M), none of which appear in the original answer. These figures are entirely fabricated or misattributed, failing the quantitative accuracy test. (3) While the LLM correctly identifies increasing regulatory and litigation pressures (DOJ investigation, U.S. MDL litigation), it misrepresents Mastercard's response: the original emphasizes consistency in credit risk framework rather than a 'shift' or 'broader framework.' (4) The original highlights that core strategies remained effective with low losses, but the LLM focuses on scaling mitigation arrangements with false numbers, distorting the narrative. (5) The reasoning is flawed due to reliance on non-existent data, and the synthesis across years is based on incorrect premises. Although the LLM attempts to address regulatory scrutiny and adaptability, its factual foundation is unsound, leading to a low correctness score. Contextual relevance is moderate because it engages with the right themes (regulatory pressure, litigation, risk management evolution), but the execution is severely compromised by inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 439,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "Home Depot’s share pool for future grants under the Omnibus Stock Incentive Plan fell from about 117 million shares in 2022 (page 65) to roughly 77 million shares by the end of 2023 (page 64) and further to around 70 million shares at the close of 2024 (page 70). This downward trend indicates the company is tightening its equity award pool, suggesting a more conservative stock‑based compensation strategy aimed at limiting dilution and preserving capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is quantitatively accurate: the numbers (117M, 77M, 70M shares) and their corresponding years (2022, 2023, 2024) match the ground truth exactly, satisfying the multi-hop requirement across time periods. The entity (The Home Depot's Omnibus Stock Incentive Plan) and metric (shares available for future grants) are correctly identified. However, the qualitative interpretation is flawed. The ground truth states the declining share availability suggests increased use of stock-based compensation to retain talent, implying active issuance. In contrast, the LLM concludes a 'more conservative strategy aimed at limiting dilution and preserving capital,' which inverts the correct implication. A shrinking share pool due to active grants reflects aggressive use of equity incentives, not restraint. Thus, while the facts are correct, the reasoning and conclusion are logically unsound, significantly undermining the qualitative accuracy. The answer remains contextually relevant and well-structured, addressing both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 298,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "The 3.625 % notes due October 2024 had a principal balance of $622 million at the end of FY 2023 (the same balance that was outstanding at the end of FY 2022) and were fully repaid by the end of FY 2024, leaving $0 outstanding (page 81). This steady balance until 2024 followed by a complete payoff demonstrates Broadcom’s proactive debt‑management strategy of retiring the notes before maturity to reduce interest expense and strengthen its balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the $622 million obligation for the 3.625% notes due October 2024 is correctly reported for both FY 2022 and FY 2023, with a drop to $0 in FY 2024, indicating full repayment. (2) Quantitative accuracy is perfect: the dollar amounts ($622 million, $0), interest rate (3.625%), and maturity date (October 2024) match the original answer exactly. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years, notes the stability from 2022 to 2023, and infers the full repayment by 2024, drawing a logical conclusion about Broadcom’s proactive debt management strategy. (4) The qualitative interpretation — that the payoff reflects a strategy to retire debt before maturity to reduce interest expense and strengthen the balance sheet — is a reasonable extension of the ground truth’s conclusion about a 'deliberate debt management strategy.' The answer addresses all parts of the question: evolution across years and strategic implication. Contextual relevance is excellent, with precise focus on AVGO, the correct instrument, and appropriate financial reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 361,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "AT&T integrated Time Warner into its WarnerMedia segment after the 2018 acquisition, then announced a 2021 plan to merge WarnerMedia with Discovery to divest the entertainment assets; the transaction closed in April 2022 via a Reverse Morris Trust, effectively exiting the business (page 5). The 2023 and 2024 10‑Ks no longer reference WarnerMedia and instead emphasize AT&T’s focus on 5G, fiber, and network infrastructure, underscoring a strategic pivot from entertainment to core telecommunications services (page 4).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline: it states that the WarnerMedia-Discovery transaction closed in April 2022, whereas the ground truth indicates that the separation was completed in 2023. This misalignment affects the core chronological accuracy of the answer. Additionally, the LLM incorrectly implies the divestiture planning began in 2021 with an announcement, which is not supported by the original answer (the original does not specify when planning began). The 2024 DIRECTV sale to TPG, a key part of T's full exit from entertainment, is entirely omitted, reducing completeness. (2) Quantitatively, the date error (April 2022 vs. 2023 completion) is significant. While the Reverse Morris Trust structure is correctly identified, the misdating undermines the accuracy of the financial and strategic timeline. No dollar amounts or percentages are mentioned, so those cannot be assessed. (3) The reasoning correctly infers a strategic pivot toward telecommunications and away from entertainment, and the shift in 10-K language (from WarnerMedia to 5G/fiber focus) supports this. However, the answer fails to complete the multi-hop synthesis by not connecting the 2024 DIRECTV divestiture as the final step in exiting the entertainment sector, which weakens the full strategic narrative. (4) Despite the timeline error and omission of DIRECTV, the answer remains contextually relevant, addressing integration, divestiture, and strategic focus. The core idea of a pivot to telecom is sound, but the incorrect dates and missing final exit step reduce factual correctness. Thus, the correctness score is 6—partially correct with significant errors in key dates and omissions in the strategic progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 476,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "Emerson kept its Pipe Cutters in the Safety & Productivity segment, but over the period it sharpened the positioning around battery‑powered hydraulic tools and diagnostic systems.  The 2022 10‑K described the line as “pipe‑working tools … battery hydraulic tools for press connections … and diagnostic systems, including sewer inspection cameras and locating equipment”【page_9】, and the 2024 10‑K repeats that same description, underscoring the continued integration of battery‑powered technologies and diagnostic capabilities as a core differentiator within the Safety & Productivity segment【page_73】.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Emerson's Pipe Cutters product line from 2022 to 2024. It incorrectly claims that in 2022, the 10-K already described Pipe Cutters as integrated with battery hydraulic tools and diagnostic systems, including sewer inspection cameras. However, the ground truth states that in 2022, Pipe Cutters were standalone tools, with integration beginning in 2023. This misrepresents the timeline and strategic evolution. Additionally, the LLM implies no change occurred between 2022 and 2024 by stating the same description was repeated, contradicting the ground truth that shows a clear progression toward integration. (2) There are no numeric values, dates, or calculations in the answer beyond correct use of the years 2022 and 2024, which are accurate in context, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is flawed: the model fails to trace the evolution across years, collapsing a dynamic strategic shift into a static description. It does not show how the product line evolved from standalone to integrated, which is the core of the question. (4) While the answer is contextually relevant—focusing on the right segment, product line, and technologies—it is factually incorrect on the key qualitative point of *when* integration occurred, leading to a low correctness and qualitative accuracy score despite proper entity identification and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 407,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "From 2022 through 2024, J&J has repeatedly described the same multi‑year, enterprise‑wide initiative to “integrate, simplify and standardize processes and systems for HR, IT, procurement, supply chain and finance,” aimed at expanding its financial shared‑service capabilities and aligning the financial control environment. The unchanged, persistent emphasis across three consecutive filings signals a deliberate, long‑term strategy to standardize financial processes, improve efficiency, and strengthen internal controls as a core pillar of the company’s operational architecture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies the multi-year initiative from 2022 to 2024, noting Johnson & Johnson's consistent emphasis on integrating, simplifying, and standardizing processes across finance and other functions. The description of expanding financial shared-service capabilities and aligning the financial control environment matches the original answer. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect; all years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent language across three years to infer a long-term strategic focus on standardization, efficiency, and internal controls, which aligns with the ground truth’s conclusion about foundational operational improvements. (4) The only minor shortcoming is that the LLM slightly broadens the scope by explicitly listing HR, IT, procurement, and supply chain in the quote, which, while likely accurate, is not detailed in the ground truth—though the original does mention 'key functions including finance,' so inclusion of other functions is plausible. However, since the ground truth does not confirm the exact list of functions, this introduces a small ambiguity. Despite this, the semantic meaning and strategic interpretation remain correct and well-supported. Hence, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 425,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco consistently filed the Executive Health Plan as Exhibit 10.1* in all three fiscal years, with the same filing status “Filed Herewith” and period ended 9/2/2012 (page_66 2022, page_66 2023, page_66 2024). This unchanged filing status shows the company’s stable, long‑term commitment to executive benefits, ensuring continuity and transparency in the plan’s administration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Costco filed the Executive Health Plan as Exhibit 10.1* in each fiscal year (2022–2024), with the same 'Period Ended' date of September 2, 2012, and consistent reference to the original filing. The LLM correctly notes the unchanged filing status and uses exact dates and exhibit numbers. (2) Quantitative accuracy is perfect: the dates (9/2/2012) and exhibit number (10.1*) are correct, and no calculations are required. (3) The reasoning is sound—consistent disclosure over three years indicates stability in executive benefits. The LLM correctly infers that the lack of amendments reflects a stable long-term strategy, which matches the ground truth’s conclusion. (4) The only minor shortcoming is that the LLM mentions 'Filed Herewith' and specific page numbers (e.g., page_66), which, while plausible, are not present in the ground truth and could be considered minor additions not confirmed by the source. However, these do not contradict the truth and are contextually reasonable. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 336,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "From 2022 to 2024, Mastercard’s Class A shares kept the same voting structure—one vote per share—while the dividend per share steadily rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024【page_96】【page_99】【page_94】.  The unchanged voting rights coupled with progressively higher dividends show that the company preserves a stable governance framework for its primary shareholders while consistently enhancing shareholder returns, underscoring a strategy of predictable, value‑driven governance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding dividend amounts and misrepresents the core information in the ground truth. The original answer states that dividend rights remained 'standard' and voting rights were 'one vote per share' across all years, with no mention of specific dividend payouts. However, the LLM introduces precise but unsupported figures—$2.04 in 2022, $2.37 in 2023, $2.74 in 2024—which are not present in the ground truth and contradict the assertion of unchanged dividend rights. (2) These numbers appear to be hallucinated or extracted from external data not referenced in the knowledge graph. There is no indication in the ground truth that dividends increased or were quantified at all; the focus is on the consistency of rights, not payout amounts. (3) The reasoning is partially sound in linking stable voting rights to governance stability, which aligns with the original conclusion. However, the multi-hop synthesis fails because it combines incorrect quantitative data with correct qualitative observations, leading to a misleading interpretation. The LLM incorrectly infers that rising dividends reflect a value-driven strategy, while the ground truth emphasizes structural consistency in rights, not financial returns. (4) The contextual relevance is moderate because the answer addresses shareholder governance and ties it to strategy, but the reliance on false quantitative data undermines correctness. Quantitative accuracy is very low due to fabricated figures. Qualitative accuracy is limited—while the voting rights description matches, the dividend characterization does not. Correctness score is low because the answer misrepresents key facts despite some alignment in reasoning direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 475,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Across FY 2022, FY 2023, and FY 2024 Broadcom’s Security Insights Platform is described in the same way: it “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis, with the data available for use with in‑house tools for security information and event management.” The identical wording in each 10‑K indicates that the platform’s integration with customers’ SIEM tools and its risk‑identification capabilities remained unchanged during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the same descriptive language was used across all three fiscal years, particularly asserting that the phrase 'develops remediation steps on an ongoing and ad-hoc basis' appeared in all 10-Ks. According to the ground truth, in FY 2022, the platform was described as identifying risks and making data available for in-house tools, but there was no mention of developing remediation steps. The explicit connection to remediation planning emerged only in FY 2023. In FY 2024, the description remained consistent with FY 2023, indicating a change from FY 2022. Therefore, the platform did evolve—specifically between FY 2022 and FY 2023—and the LLM’s conclusion of 'unchanged' functionality is incorrect. While the LLM correctly notes integration with in-house SIEM tools was consistent, it misrepresents the evolution of risk identification and remediation capabilities. Quantitative accuracy is 10 because there are no numerical errors (the error is qualitative). Qualitative accuracy is low due to incorrect synthesis across years and failure to capture the multi-hop progression in functionality. Contextual relevance is high as the response addresses the right platform, company, time frame, and general capabilities, but with flawed reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 362,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 to 2024 AIG’s loss‑reserve risk management shifted from a largely actuarial‑control framework to a more model‑driven, risk‑specific approach.  In 2022 (p. 165‑169) the 10‑K described internal controls, actuarial profitability and reserve reviews, and “reviews by external experts” to validate reserve adequacy.  By 2023 (p. 118‑121) and 2024 (p. 86‑87) the company added sensitivity, scenario and stochastic analyses, third‑party catastrophe models, and a formal escalation process, while continuing to rely on external experts to independently assess and confirm the reserve setting process and underlying assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years 2022–2024, external experts, internal controls, and modeling techniques—are correctly identified. The evolution of methodologies is accurately portrayed: 2022 emphasizes internal controls and external reviews; 2023 introduces more advanced modeling (stochastic, scenario, sensitivity analyses, catastrophe models); 2024 continues this trajectory with formal escalation processes and sustained external validation. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full compliance where data exists. (3) Multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly identifying progression from actuarial controls to model-driven frameworks, and maintains consistency in the role of external experts. The mention of specific page numbers (e.g., p. 165–169, etc.) adds verifiability and suggests grounding in actual filings, though not required for correctness. (4) The only minor gap is that the LLM omits explicit mention of ERM second-line reviews and enhanced budget/expense monitoring highlighted in the 2024 description in the ground truth. However, it captures the broader trend of increased formalization and oversight. Wording differs slightly (e.g., 'risk-specific approach' vs 'maturing proactive approach'), but semantic equivalence is maintained. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 449,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "In 2022 Emerson described electrical distribution equipment as part of its Industrial Solutions product offering within the Automation Solutions segment【page_77】. By 2023 the company had repositioned that product line into the Discrete Automation segment—a sub‑segment of Automation Solutions【page_73】, and the 2024 filing retains this same classification【page_73】. This shift from a broad Industrial Solutions focus to a discrete‑automation‑centric segment underscores Emerson’s strategic emphasis on discrete automation markets, treating electrical distribution equipment as a core discrete‑automation capability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and reasoning, with accurate dates (2022, 2023, 2024) and correct entity identification (Emerson/EMR, Electrical Distribution Equipment, Discrete Automation, Industrial Solutions). The quantitative accuracy is perfect: no numerical errors, and the timeline is correctly represented. The answer correctly identifies the reorganization in 2023 moving Electrical Distribution Equipment from Industrial Solutions (under Automation Solutions) to Discrete Automation, and confirms its retention in 2024. However, the original answer provides more granular detail about the evolving grouping within Discrete Automation—specifically, the 2024 alignment with electric linear motion and programmable control systems, which the LLM omits. Additionally, the original emphasizes a deepening integration and strategic positioning as a 'foundational component,' which the LLM simplifies to 'core discrete-automation capability'—semantically close but slightly less precise in conveying the strategic evolution. The LLM also refers to Discrete Automation as a 'sub-segment of Automation Solutions,' which may reflect a structural interpretation not fully clarified in the ground truth. While not incorrect, it introduces a layer of segmentation detail not confirmed in the original. Overall, the reasoning is sound and multi-hop synthesis is adequate, but minor omissions in descriptive depth reduce completeness. Contextual relevance is excellent, directly addressing the question’s focus on strategic emphasis in discrete automation markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 431,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson’s 2022, 2023 and 2024 10‑Ks all state that employees hired after 2014 are already covered by the Retirement Value formula, and that a 2021 amendment will extend that formula to all eligible U.S. non‑union employees effective Jan 1 2026—shifting the company from a dual‑formula (Final Average Pay for pre‑2015 hires) to a single, uniform Retirement Value system【page_73】【page_74】【page_76】【page_77】. This multi‑year transition reflects a long‑term workforce strategy to standardize pension benefits, simplify administration, and better manage future pension liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates (2022–2024, January 1, 2026), employee groups (U.S. non-union), and timeline (2021 amendment, post-2014 hires) are correct. The transition from dual to single formula is accurately described. (2) The answer correctly identifies that employees hired after 2014 were already under the Retirement Value formula and that the 2021 amendment extends it to all eligible employees by 2026—consistent with the ground truth. (3) The reasoning is sound: the multi-year consistency in disclosures reflects a deliberate strategy to standardize benefits, simplify administration, and manage liabilities—this aligns with the ground truth’s emphasis on standardization, cost predictability, and inclusivity. (4) The only minor omission is that the LLM does not explicitly mention the preservation of Final Average Pay benefits accrued before 2026, which is included in the original answer and adds nuance about grandfathering. However, this does not undermine the core accuracy. The LLM captures the strategic intent and structural evolution correctly. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses both the structural evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 362,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The 10‑K excerpts you provided do not disclose the specific percentage of Fabric & Home Care sales that come from Downy for 2022, 2023 or 2024, so the trend in that metric cannot be determined from the available pages.  What is clear is that Downy is listed as a major brand in the Fabric & Home Care segment in each year’s MD&A, indicating it remains a key part of P&G’s portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the specific percentage contribution of Downy to Fabric & Home Care sales cannot be determined, when the ground truth provides a clear 3-year trend of Downy's role within the context of the segment's growing net sales contribution (35% in 2022 to 36% in 2023 and 2024). While the exact standalone percentage of Downy’s sales is not explicitly broken out, the original answer infers its strategic importance from its consistent positioning within a growing segment—information that could have been synthesized. (2) Quantitatively, the LLM fails to report any of the correct percentages (35%, 36%, 36%) related to the Fabric & Home Care segment’s net sales contribution over the three years, resulting in a very low quantitative accuracy score. These figures are central to the question and were available in the knowledge graph. (3) The reasoning is partially sound: the LLM correctly identifies that Downy is consistently listed as a major brand, suggesting ongoing importance. However, it fails the multi-hop synthesis by not connecting Downy’s stable brand status with the segment’s increasing contribution to overall sales, which is key to assessing strategic importance. (4) Contextually, the response is relevant and avoids hallucination, acknowledging data limitations while affirming Downy’s key brand status. This prevents a lower score, but the failure to report available trend data and segment-level evolution significantly undermines correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 416,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s total senior and subordinated notes grew from **$27.2 billion** at December 31 2022 to **$30.8 billion** at December 31 2023, then eased slightly to **$30.7 billion** at December 31 2024 (Table 8.1, 2022 & 2023 & 2024). The jump in 2023 reflects a period of debt expansion—likely to fund growth or refinance—while the modest decline in 2024 signals a shift toward more conservative debt management or a focus on reducing leverage.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value was $27,219 million in 2022, increased to $31,248 million in 2023, and remained at $31,248 million in 2024 (no decrease). However, the LLM reports $27.2B in 2022 (close approximation), but then $30.8B in 2023 and $30.7B in 2024—both incorrect. The reported values are off by approximately $400–$500 million in 2023 and 2024, and the claimed 'slight decline' in 2024 is factually wrong as the ground truth shows the peak value was maintained. (2) Number verification: $27,219M ≈ $27.2B (acceptable rounding), but $31,248M should be ~$31.2B or $31.3B, not $30.8B or $30.7B. The LLM underreports by about $450M in 2023 and $550M in 2024. Additionally, the ground truth shows no decline in 2024, contradicting the LLM’s claim of a decrease to $30.7B. (3) Multi-hop reasoning: The LLM correctly identifies the general upward trend from 2022 to 2023, but fails to capture the sustained peak in 2024, leading to flawed interpretation. The conclusion about 'conservative debt management' or 'reducing leverage' in 2024 is unsupported by the data, which shows stable high-level issuance. This misrepresents the company's strategy. (4) Despite incorrect numbers and flawed trend interpretation, the answer addresses the right metric (carrying value of senior and subordinated notes), covers all years, and attempts strategic analysis, earning moderate scores for qualitative reasoning and contextual relevance. However, the quantitative errors are substantial enough to significantly reduce correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 452,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "In 2022 and 2023, T maintained a 41.3 % ownership stake in SKY Mexico, which was accounted for under the equity‑method (page 66, page 93). In June 2024 it sold that 41.3 % interest, thereby exiting the investment (page 66). This 3‑year path—holding the stake, using equity‑method accounting, and then divesting—underscores T’s broader strategy of shedding Latin‑American pay‑TV assets (e.g., the Vrio sale in 2021) to refocus on core businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: T maintained a 41.3% ownership stake in SKY Mexico in 2022 and 2023, used equity-method accounting, and exited in June 2024 by selling its entire stake. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% stake and June 2024 exit date are correctly reported. Number format (41.3 % with spacing) is a minor typographical variance but does not affect meaning. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years and connects the SKY Mexico divestiture to T’s broader strategy of exiting Latin American pay-TV assets, referencing the Vrio sale in 2021 as supporting context. This adds value beyond the ground truth without introducing error. (4) The only reason for not scoring a 10 is a slight omission: the original answer notes SKY Mexico’s status as a 'leading pay-TV provider in Mexico' and explicitly frames the 3-year trajectory as part of a shift toward focusing on 'core domestic operations.' While the LLM mentions 'refocus on core businesses,' it omits the 'domestic' emphasis, slightly reducing qualitative completeness. However, the core reasoning and strategic implication are preserved. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 379,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "From 2022 through 2024, BNY Mellon’s 10‑K risk‑factor disclosures on capital‑return constraints have remained essentially unchanged, consistently stating that the Board’s discretion to return capital is limited by U.S. banking laws, capital‑planning rules, Delaware law, and the obligation to pay dividends on preferred stock (BK_10k_2022 page_5; BK_10k_2023 page_7; BK_10k_2024 page_7). The 2024 filing reiterates the same language but adds a brief reference to maintaining “well‑capitalized” status and capital‑adequacy/liquidity rules, underscoring the unchanged regulatory emphasis while keeping the dividend‑policy language unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and entities. It accurately identifies that BNY Mellon consistently disclosed constraints on capital returns due to U.S. banking laws, capital planning rules, Delaware law, and preferred dividend obligations across 2022–2024, citing correct document sources (BK_10k_2022, BK_10k_2023, BK_10k_2024). The quantitative accuracy is perfect: no numerical errors, and the timeline (2022–2024) is correctly referenced. The answer correctly notes that the 2024 filing added emphasis on 'well-capitalized' status and capital adequacy/liquidity rules, which matches the ground truth’s mention of increased focus on capital adequacy and liquidity in the context of strategic transformation. However, the LLM answer underrepresents the evolution in disclosure complexity highlighted in the original answer—specifically, the 2023 expansion to include ESG-related regulatory pressures and strategic initiatives' impact on capital allocation. This omission reduces completeness and qualitative accuracy, as it fails to fully capture the 'increasing contextual complexity' trend. While the LLM captures the stable regulatory framework, it does not reflect the incremental additions in risk discussion depth, particularly around ESG and strategic transformation beyond liquidity. Thus, while factually sound and contextually relevant, the answer lacks full multi-hop synthesis across all evolving disclosure elements, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 426,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "From 2022 through 2024 3M kept structural adhesives in the Safety and Industrial segment, but in 2024 it moved the line from the standalone Industrial Adhesive & Tapes division into a new Industrial Specialties division that also houses closure and masking systems, personal‑safety products and other industrial specialty items. This bundling—integrating adhesives with complementary sealing, bonding and safety solutions—highlights how 3M views adhesives as a core enabler that underpins a broad range of industrial applications, from construction and automotive repair to packaging and personal protection.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies in entity and structural details, despite correct dates and general thematic alignment. (1) Correct elements: The answer correctly identifies that Structural Adhesives remained within the Safety and Industrial segment from 2022–2024 and notes a strategic shift toward integration with other industrial solutions. The emphasis on adhesives as an enabler in industrial applications aligns semantically with the ground truth’s conclusion about their foundational role. (2) Quantitative accuracy is high: no numerical data is present, but years (2022–2024) are correctly used. (3) However, the qualitative inaccuracies are critical: the LLM claims that in 2024, structural adhesives were moved from an 'Industrial Adhesive & Tapes division' into a new 'Industrial Specialties division'—this reorganization is not supported by the ground truth, which describes product bundling shifts but does not mention divisional restructuring or the creation of a new division. The ground truth also does not reference 'personal-safety products' being bundled with adhesives, which contradicts the original answer’s focus on materials for construction, maintenance, and packaging. (4) The reasoning is partially sound in interpreting strategic integration, but the multi-hop synthesis fails because it infers organizational changes (division mergers) not present in the source data. This undermines the qualitative accuracy. While the strategic interpretation is plausible, the factual basis is flawed. Hence, correctness is reduced to 6 due to major entity and structural misrepresentations, even though the general direction of strategy is correctly inferred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 467,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From 2022 through 2024 Lilly kept Cyramza’s therapeutic portfolio unchanged—monotherapy or combination second‑line therapy for gastric, gastro‑esophageal junction, NSCLC, colorectal, and hepatocellular carcinoma, plus first‑line EGFR‑mutated NSCLC (page 6).  However, the company’s IP strategy shifted: the compound patents remain in force until 2026 in the U.S. and Japan and 2028 in major European countries, while data‑protection exclusivity in those European markets expires in 2024 and in Japan in 2023 (page 11).  This evolution signals a focus on extending exclusivity in the U.S. and Europe while anticipating biosimilar competition in Japan and Europe once data protection lapses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Cyramza's therapeutic indications remained stable from 2022 to 2024 across gastric, lung, colorectal, and liver cancers, aligning with the ground truth. However, it introduces a specific indication—'first-line EGFR-mutated NSCLC'—which is not mentioned in the original answer and may represent an over-specific claim not supported by the ground truth. Regarding IP, the LLM states that compound patents last until 2026 in the U.S. and Japan and 2028 in Europe, but the ground truth only references data protection expirations (2023 in Japan, 2024 in Europe, 2026 in the U.S.), not compound patents. This is a significant factual divergence, as data exclusivity and patent protection are distinct forms of IP. The LLM conflates these concepts, leading to incorrect implications about exclusivity timelines, especially the claim of 2028 protection in Europe, which is not in the original. (2) Date accuracy: The LLM correctly notes Japan data protection expiration in 2023 and European data exclusivity ending in 2024, matching the ground truth. U.S. biologics data protection until 2026 is also correct. However, the addition of 'compound patents until 2026/2028' introduces unsupported dates not present in the original, reducing quantitative accuracy. (3) Multi-hop reasoning is partially sound: the model synthesizes therapeutic stability and IP timelines across regions, correctly inferring that expiring protections signal biosimilar competition. However, the reasoning is flawed by mixing patent and data exclusivity, undermining the accuracy of the strategic interpretation. (4) Scores reflect that core facts (indications stability, data protection expirations by region) are correct, but the introduction of unverified patent terms and specific NSCLC indications reduces factual precision. Contextual relevance is high as the answer directly addresses both therapeutic and IP evolution as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 528,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from a carrying value of **$19.975 billion** at 12/31/2022 (weighted‑average rate **2.91 %**) to **$27.168 billion** at 12/31/2023 (4.45 %) and then fell modestly to **$26.930 billion** at 12/31/2024 (4.84 %). The steady rise in the weighted‑average rate, coupled with the peak in carrying value in 2023, indicates the firm has been issuing newer, higher‑rate debt—likely to refinance maturing obligations or fund growth—while the slight drop in 2024 suggests some repayment or refinancing at a marginally lower rate. Overall, the trend points to a gradual increase in financing costs as Capital One adjusts its debt mix in a tightening interest‑rate environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and interpretation but contains a significant quantitative error in the 2023 carrying value. The ground truth only provides data for 2022 ($19,975 million) and 2024 ($26,930 million); no official value for 2023 is given in the original answer. The LLM introduces a specific 2023 figure of $27.168 billion, which is not present in the ground truth and cannot be verified from the provided information. This is a factual overreach. The interest rates for 2022 (2.91%) and 2024 (4.84%) are correct, but the 2023 rate of 4.45% is not in the original and appears to be interpolated. (2) The carrying values for 2022 and 2024 are accurate when adjusted for format ($19.975 billion = $19,975 million; $26.930 billion = $26,930 million). However, introducing a precise 2023 value without source support reduces quantitative accuracy. The interest rate trend is directionally correct (rising), but the specific 2023 rate is unverified. (3) The multi-hop reasoning is sound in interpreting the trend: increasing debt and rising rates suggest strategic issuance in a higher-rate environment. The conclusion about rising financing costs and debt mix adjustment aligns with the original. The slight drop in 2024 is correctly noted, though the suggestion of 'refinancing at a marginally lower rate' is speculative and not supported by the original, which makes no mention of 2024 repayment or refinancing activity. (4) The contextual relevance is perfect—the answer directly addresses the evolution of carrying value and interest rates, and infers strategy. Qualitative reasoning is strong despite unsupported numbers. Correctness score is 7 due to accurate core facts (2022 and 2024 values, overall trend) but docked for introducing unverified 2023 data. Quantitative accuracy is 6 due to the unsupported $27.168B and 4.45% figures. Qualitative accuracy is 8 for strong logic and synthesis. Contextual relevance is 10—fully on point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 534,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps tied to deferred compensation grew from $651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024.  The fair‑value impact swung from a $92‑million loss in FY 2022 to gains of $157 million in FY 2023 and $91 million in FY 2024, showing that the instrument’s value can move sharply in either direction.  This pattern highlights the high volatility of the swaps’ fair‑value changes over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect quantitative information. The loss of $92 million in FY 2022 and gain of $91 million in FY 2024 match the ground truth. However, the gain reported for FY 2023 is incorrect: the LLM states a $157 million gain, whereas the ground truth specifies a $58 million gain. This is a significant error, especially since the $157 million figure appears to be an erroneous sum of the 2022 and 2023 values or a misstatement. Additionally, the LLM introduces notional exposure amounts ($651M, $792M, $985M) that are not present in the original answer and cannot be verified against the provided ground truth, suggesting potential hallucination or unsupported data. (2) The fiscal years are correctly identified, and the direction of gains/losses (loss in 2022, gains in 2023–2024) is accurate. However, the magnitude of the 2023 gain is wrong, and the inclusion of unverified notional exposure figures undermines quantitative accuracy. The fair-value impact pattern is misrepresented due to the inflated 2023 gain. (3) The multi-hop reasoning is partially sound—the model correctly identifies the instrument (Total Return Swaps tied to Deferred Compensation), the company (Cisco), and the three-year trend. It draws a reasonable qualitative conclusion about volatility based on swings in value. However, the flawed 2023 number weakens the validity of the synthesis. The introduction of notional exposure, while contextually relevant, is not supported by the ground truth and was not requested in the question. (4) Despite the quantitative inaccuracies, the answer remains contextually relevant and addresses both parts of the question: evolution of exposure and interpretation of volatility. The core insight about volatility is still supportable given the actual swing from loss to gain, even if the magnitude is overstated. However, the correctness score is reduced due to the major error in the 2023 gain figure and the inclusion of unsupported notional amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 543,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "In 2022, Home Depot’s strategy centered on “store refresh packages” and visual‑merchandising upgrades to improve the look and feel of its retail locations (page 8).  By 2024 the focus had broadened to a full‑store‑experience program that added way‑finding signage, electronic shelf labels, curb‑side pickup, self‑service lockers and mobile‑app navigation, all aimed at making the in‑store visit more seamless (page 10).  These investments translated into measurable gains—higher customer‑satisfaction scores in 2024 and a strong share of online orders fulfilled through stores (≈50 % in 2024 versus 55 % in 2022, page 11)—helping Home Depot maintain a competitive edge over multichannel and online rivals.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of The Home Depot's store appearance strategy from 2022 to 2024, noting the shift from visual upgrades to a broader in-store experience with digital integration. It accurately identifies the strategic intent to compete with multichannel and online retailers. However, it introduces specific details not present in the ground truth, such as 'store refresh packages' and 'electronic shelf labels,' which are not mentioned in the original answer. More critically, the quantitative claim that '50% of online orders were fulfilled through stores in 2024 versus 55% in 2022' contradicts the expected trend implied in the ground truth—where omnichannel integration improved—and suggests a decline in store-based fulfillment, which is not supported by the original answer and may misrepresent competitive positioning. (2) The percentage figures (50% in 2024 vs 55% in 2022) are problematic: they are presented as measurable impact but are either misstated or misinterpreted, as the original answer does not provide these numbers. The ground truth emphasizes increased integration and seamless experiences but does not quantify fulfillment share, making this a significant factual deviation. (3) The multi-hop reasoning is partially sound: the model connects store appearance improvements to omnichannel competitiveness, aligning with the original's narrative of evolving from standalone experience to hybrid model. However, it fabricates metrics to support the impact, weakening the reasoning chain. (4) The contextual relevance is high—answer addresses both strategic evolution and competitive impact. Qualitative accuracy is good but docked for unsupported specifics. Quantitative accuracy is low due to incorrect percentages. Correctness score is 7 because core strategic trajectory is correct, but key data points are inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 510,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 have carried a constant $2,000 million balance: $2,000 million in FY 2022, $2,000 million in FY 2023, and $2,000 million in FY 2024 (see the 2024 10‑K table for FY 2024). This unchanged carrying amount shows that NVIDIA has neither issued additional amounts nor repaid any of this long‑term debt, underscoring a stable long‑term debt profile and a consistent financing strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, the carrying value was $2,147 million in FY2022, decreased to $1,637 million in FY2023, and rose to $2,000 million in FY2024. The LLM incorrectly states a constant $2,000 million across all three years, contradicting the actual progression. (2) The numbers are entirely inaccurate: FY2022 is off by $147 million, FY2023 by $363 million, and only FY2024 is correct. This indicates a failure to retrieve or interpret the correct data points from the source. (3) The multi-hop reasoning is flawed—the question requires tracking changes over three fiscal years and interpreting the trend. The LLM fails to detect the decrease and subsequent stabilization, leading to an incorrect conclusion about 'unchanged' debt and 'consistent financing strategy.' The ground truth notes a temporary reduction followed by repositioning, which the LLM overlooks. (4) While the answer addresses the right metric (carrying value of 3.50% Notes Due 2050) and time frame (FY2022–FY2024), the severe numerical inaccuracies and resulting flawed interpretation heavily undermine correctness and qualitative reasoning. Contextual relevance is moderate because the structure and intent align with the question, but factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 372,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022‑2024, 3M’s Scotchgard litigation broadened geographically—new suits were filed in Michigan, Alabama, and Georgia alleging improper disposal of Scotchgard and other PFAS products【page_95】【page_98】.  The cases now involve 3M plus a growing roster of co‑defendants—including DuPont, Chemours, Wolverine, and various carpet, paper, and textile manufacturers—yet no new settlements specific to Scotchgard were reported during this period; the broader PWS Settlement for water‑system claims was approved in 2024, leaving Scotchgard cases pending【page_97】【page_98】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but has significant omissions and inaccuracies, particularly regarding settlements and defendant identification. (1) Quantitatively, the answer incorrectly states that 'no new settlements specific to Scotchgard were reported' during 2022–2024, which directly contradicts the ground truth: in 2022, 3M settled the New York Baker class action (with Saint-Gobain and Honeywell) for $65M (its share immaterial), and in 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide. These are key factual errors in both timing and event reporting. (2) Geographically, the LLM correctly identifies expansion into Michigan, Alabama, and Georgia, aligning with the ground truth. (3) On defendants, the LLM correctly notes an increasing number of co-defendants and names DuPont and Chemours accurately, but incorrectly includes 'Wolverine' as a co-defendant—Wolverine World Wide was the plaintiff in the Michigan case, not a defendant. It also broadly references 'carpet, paper, and textile manufacturers' without naming Mohawk Industries, which is specifically mentioned in the ground truth. (4) The mention of the 2024 PWS Settlement is contextually relevant but misused—it refers to broader water-system claims and does not resolve Scotchgard-specific litigation, so stating that Scotchgard cases remain pending is accurate, but the omission of the two actual settlements undermines completeness. (5) Multi-hop reasoning is partially sound—geographic expansion and growing defendant lists are correctly inferred—but fails in synthesizing settlement developments across years and entities. Overall, core facts about geographic and defendant trends are present, but critical errors in settlements and parties involved reduce factual reliability, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 498,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "From 2022 through 2024 the AbCellera collaboration kept a tiered royalty structure of mid‑teens to mid‑twenties on worldwide net sales of bamlanivimab and bebtelovimab, with royalty payments recorded as cost of sales (page 73, 2022 10‑K; page 73, 2024 10‑K). No milestone payments were reported for AbCellera during this period (page 73, 2024 10‑K). Net product revenue fell sharply from $2.02 billion in 2022 to $0 in both 2023 and 2024, reflecting the cessation of EUA‑driven sales (page 73, 2024 10‑K).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the tiered royalty structure (mid-teens to mid-twenties) is correctly stated and consistent across years; net product revenue is accurately given as $2.02 billion in 2022 and $0 in both 2023 and 2024; and it is correctly noted that no milestone payments were made during 2022–2024. (2) Quantitative accuracy is perfect: the $2.02 billion figure matches exactly, zero revenue in 2023 and 2024 is correctly reported, and there are no calculation errors. Format variations (e.g., $2.02 billion) are acceptable and clear. (3) Multi-hop reasoning is sound: the answer synthesizes information across multiple years and correctly infers the commercial decline due to loss of EUA-driven sales, even specifying that royalty payments were recorded as cost of sales, which adds contextual precision. (4) The answer is contextually highly relevant, directly addressing all parts of the question—royalty structure, milestone payments, net product revenue—and their evolution over time. Minor wording differences (e.g., 'cessation of EUA-driven sales' vs. 'no further demand or regulatory authorization') do not affect factual correctness and may reflect additional insight from the source documents. All claims are supported by cited pages from the 10-K filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 380,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "Dawn has stayed a core brand in P&G’s Fabric & Home Care segment.  Across the 2022‑24 filings the brand is listed among the segment’s major brands (Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer) and the segment’s share of net sales rose from 35 % in 2022 to 36 % in 2024, while its share of net earnings climbed from 31 % to 34 %.  This steady positioning and the segment’s incremental growth show that Dawn remains a strategically important, growth‑driving product in P&G’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Dawn remained a consistently highlighted brand in the Fabric & Home Care segment from 2022 to 2024; the segment's net sales share increased from 35% to 36%, and earnings share rose from 31% to 34%. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: percentages for net sales and earnings are correctly reported for all years, and the trend description (incremental growth) is valid. (3) The reasoning is sound—by noting Dawn’s consistent inclusion among major brands and linking it to the segment’s stable performance and slight growth, the LLM correctly infers its strategic importance. The multi-hop synthesis across three years of data is accurate. (4) The only minor shortcoming is that the LLM does not explicitly state that the segment’s earnings share was unchanged between 2023 and 2024 (both at 34%), which slightly reduces qualitative completeness, though the overall conclusion remains valid. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing both parts of the question: evolution of positioning and strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 344,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt declined from $47.8 billion in 2022 to $49.3 billion in 2023 and then to $44.9 billion in 2024 (Table 9.1 2024; Table 8.1 2023). Over the same period, floating‑unsecured senior debt was cut from $1.6 billion in 2022 to $349 million in 2023 and eliminated by 2024, reflecting a shift away from floating‑rate debt toward higher‑rate fixed‑rate debt and a rise in the weighted‑average interest rate (2.76%→4.48%→4.84%). This trend reduces floating‑rate exposure but increases fixed‑rate exposure and overall debt cost.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies, particularly in the reporting of total short-term borrowings and long-term debt. According to the ground truth, total debt (short-term + long-term) was $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM states short-term borrowings were $883M in 2022 and long-term debt was $47.8B, summing to $48.683B—already inconsistent with the true total of $43.086B. The 2023 long-term debt is incorrectly stated as $49.3B (up from $47.8B), while in reality total debt only rose to $48.715B, implying a much smaller increase. The 2024 long-term debt is given as $44.9B, close to but still below the correct total debt of $45.551B (and ignoring short-term borrowings). These misallocations between short- and long-term components undermine accuracy. (2) The floating unsecured senior debt figures are mostly correct: $1.6B (vs. $1.709B) in 2022, $349M in 2023, and elimination by 2024—minor rounding acceptable. The weighted-average interest rate on fixed debt is mostly accurate: stated as 2.76%→4.48%→4.84%, vs. ground truth 2.91%→4.45%→4.84%. The 2022 and 2023 rates are slightly off but directionally correct. (3) The qualitative reasoning is sound: the model correctly infers a strategic shift from floating- to fixed-rate debt, reducing floating-rate exposure amid rising rates, and notes the higher cost of fixed-rate debt. This reflects proper multi-hop synthesis between debt composition changes and interest rate trends. (4) Contextual relevance is high—the answer addresses all parts of the question: debt evolution, trend interpretation, and relation to floating unsecured senior debt. However, due to major errors in the core financial aggregates (total debt levels and their components), the correctness score is limited to 5. While directional trends (increase then decrease in debt, elimination of floating debt, rising fixed rates) are correct, the quantitative foundation is flawed, reducing confidence in the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 545,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s 5.90% senior note stayed at a $2 billion principal and an effective rate of 6.11 % in FY 2022, FY 2023 and FY 2024 (see the long‑term debt tables on page 89 for each year).  As Cisco issued additional debt—most notably the $13.5 billion senior notes in 2024—the 5.90% note’s share of total debt fell from roughly 23 % of long‑term debt in FY 2022 to about 10 % in FY 2024, reflecting a larger overall debt base.  The note remained classified as long‑term debt throughout the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the $2,000 million (i.e., $2 billion) principal of the 5.90% Note is correctly stated, and the effective interest rate of 6.11% is consistent across all three fiscal years. (2) Quantitative accuracy is precise: the LLM correctly notes the declining proportion of the note in total long-term debt—from approximately 23% in 2022 (calculated as $2,000M / $8,416M ≈ 23.76%) to about 10% in 2024 ($2,000M / $19,621M ≈ 10.19%), which aligns with the ground truth’s narrative of a shifting composition due to increased overall debt. The mention of $13.5 billion in new senior notes in 2024 is consistent with the significant debt expansion noted in the original answer. (3) Multi-hop reasoning is sound: the LLM synthesizes data across fiscal years, connects the stable note amount to a changing total debt base, and correctly infers the declining proportional weight—demonstrating proper understanding of debt composition dynamics. (4) Entity accuracy is perfect: Cisco, the 5.90% Note, fiscal years 2022–2024, and the classification as long-term debt are all correctly identified. The answer addresses all parts of the question: debt composition (via proportion changes), effective interest rate, and long-term classification. Wording differs slightly but meaning is identical. No errors in logic, numbers, or synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 394,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "From 2022 through 2024 NVIDIA’s 1.55% Notes Due 2028 held a carrying value that rose only modestly—from roughly $1.10 billion in 2023 (fair‑value table) to $1.25 billion in 2024 (debt schedule, page 72)—while the effective interest rate stayed consistently low at 1.64% (page 72).  The steady balance and low rate show that NVIDIA is deliberately issuing long‑term debt at attractive, stable rates and keeping the debt level predictable, underscoring a disciplined, low‑cost long‑term financing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in 2022, decreased to $1,099 million in 2023, and increased to $1,250 million in 2024. However, the LLM answer omits the 2022 value entirely, incorrectly states that the value in 2023 was 'roughly $1.10 billion' (which, while close to $1,099M, is presented without the decrease from 2022), and fails to acknowledge the drop in 2023—misrepresenting the trend as a steady rise. Additionally, the LLM claims the effective interest rate 'stayed consistently low at 1.64%', but the ground truth indicates that the rate increased over time, reaching 1.64% in 2024, implying it was lower in prior years. This misrepresents the interest rate trend. (2) The dollar amounts and percentages are partially correct in magnitude but incorrect in trend and context. The $1.25 billion figure for 2024 is accurate, and $1.10 billion is approximately equal to $1,099 million, but the starting point in 2022 ($1,200M) is missing, and the decrease in 2023 is not acknowledged. The effective interest rate is only correct for 2024, but the claim of consistency contradicts the ground truth of an increasing rate. (3) The multi-hop reasoning is flawed: the model fails to synthesize the full three-year trend in carrying value and misinterprets the interest rate as stable rather than rising. This undermines the conclusion about NVIDIA's financing strategy, as the ground truth suggests active management (possible reacquisition) and rising borrowing costs, while the LLM portrays a static, stable strategy. (4) The contextual relevance is high—the answer addresses the right company, debt instrument, time frame, and strategic implications. However, due to major quantitative errors and flawed reasoning about trends, the correctness score is low. The qualitative accuracy is moderate because the general idea of strategic debt management is present, but the reasoning is based on incorrect data trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 559,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "Google kept Pixel device sales in the same “devices” line of its Google Services revenue from 2022 through 2024 – first described in 2022 as part of its growing hardware family (Pixel 5a 5G, Pixel 6, etc.) and later reiterated in 2023 (Google subscriptions, platforms, and devices) and 2024 (devices, primarily Pixel sales)【page_7】【page_33】【page_59】.  While the revenue category stayed unchanged, the company’s 2024 10‑K shows a sharp rise in capital‑expenditure on property and equipment (from $31.5 bn in 2022 to $52.5 bn in 2024) and a continued emphasis on new Pixel models and AI‑driven hardware, underscoring a growing strategic focus on Pixel devices as a long‑term innovation and revenue driver【page_57】【page_7】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Pixel devices were consistently categorized under a 'devices' segment within Google's revenue reporting from 2022 to 2024, aligning with the ground truth's emphasis on growing strategic importance. It accurately notes the continuity in revenue categorization and references AI-driven hardware innovation, which matches the original answer’s theme of integration with AI and ecosystem expansion. However, the LLM incorrectly states that Pixel sales were part of the 'Google Services' revenue line, whereas the ground truth specifies a reorganization into 'Subscriptions, Platforms, and Devices'—a distinct and more granular categorization introduced in 2023. This mischaracterization affects entity and structural accuracy. (2) Quantitatively, the capital expenditure figures ($31.5B in 2022, $52.5B in 2024) are plausible and contextually relevant, though not explicitly tied to Pixel hardware in the ground truth; the original answer does not mention capex, so this addition, while factually possibly correct, introduces a focus not present in the verified answer and may conflate broader infrastructure spending with Pixel-specific investment. (3) The multi-hop reasoning is partially sound—linking revenue categorization over time and inferring strategic importance—but fails to fully capture the evolution from 'investment in hardware' (2022) to explicit segmentation (2023) and integration with cloud/AI (2024) as a maturation trajectory. The LLM emphasizes spending increases rather than the strategic repositioning emphasized in the ground truth. (4) Despite strong contextual relevance and mostly accurate entities and timeline, the misrepresentation of the revenue segment and overemphasis on capex slightly distort the strategic narrative, warranting a score of 7 for correctness—core facts are present but synthesis is not fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 520,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "BNY Mellon’s 10‑K Item 14 has been identical in 2022, 2023 and 2024: each filing states that the required information is in the proxy under “Item 3 – Ratification of KPMG LLP” and cites KPMG’s PCAOB firm ID 185. The unchanged wording and continued reference to the same ratification section show that the firm has retained KPMG as its principal accountant without any change in auditor or fee structure, underscoring a stable audit relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that BNY Mellon's disclosure regarding the ratification of KPMG LLP remained unchanged from 2022 to 2024, with consistent reference to the Proxy and KPMG’s PCAOB firm ID 185—this matches the original answer exactly. All entities (BNY Mellon, KPMG LLP, PCAOB ID 185), years (2022–2024), and document references (Item 14, Proxy Item 3) are correct. The reasoning is sound: the consistency in language and structure is correctly interpreted as evidence of a stable audit relationship. The only minor shortcoming is that the LLM answer does not explicitly state that the disclosure was incorporated 'by reference' in the Proxy, which is a technical nuance present in the ground truth. However, the implication is clear from context. The answer correctly synthesizes multi-hop information across three years and filings, and there are no calculation or date errors. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate with only a minor omission in procedural detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 312,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "Across the three reporting years, LLY’s pension plan held roughly $13.2 billion in private‑alternative investments in 2022, rose to $13.71 billion in 2023, and then settled at $13.66 billion in 2024—an overall increase of about $500 million followed by a modest $50 million decline, keeping the allocation near 80 % of the plan’s assets. This steady, high‑level exposure to hedge funds, equity‑like funds, real estate, and other private alternatives underscores the company’s long‑term strategy of maintaining a substantial illiquid asset allocation to diversify risk and pursue moderate‑to‑high long‑term returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the reported values for LLY's private alternative investments. The ground truth states allocations of $10,542.5 million (2022), $10,335.2 million (2023), and $10,051.0 million (2024). In contrast, the LLM reports $13.2 billion, $13.71 billion, and $13.66 billion—values that are over $3 billion higher than actual and show an increasing trend, whereas the ground truth shows a declining trend across all three years. These discrepancies are severe and materially misrepresent the data. (2) Calculations are also incorrect: the LLM claims an increase of $500 million followed by a $50 million decline, but the actual trajectory is a decrease from 2022 to 2023 ($207.3 million drop) and further drop from 2023 to 2024 ($284.2 million), totaling a decline of nearly $500 million over the period. Additionally, the claim that allocations represent 'near 80%' of plan assets is unsupported by the provided ground truth and introduces unverified context. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and synthesize the actual figures across years, leading to an incorrect interpretation of the trend (growth vs. contraction). While the general idea of strategic emphasis on illiquid assets is plausible, the conclusion is based on false numerical premises. (4) Despite incorrect numbers and reasoning, the answer addresses the right question about investment evolution and long-term strategy, hence moderate contextual relevance. However, due to severe quantitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 444,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "Across 2022, 2023 and 2024 Tampax stayed in the same place in P&G’s portfolio: it is listed as a major brand under the Baby, Feminine & Family Care segment, within the Feminine Care sub‑category of Menstrual Care (alongside Adult Incontinence). The MD&A tables for each year (2022 page 18, 2023 page 18, 2024 page 18) show Tampax (Tampax Bounty) consistently as a key brand, with no re‑classification or shift in product‑line emphasis over the three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth on key factual and strategic developments. (1) It falsely claims that Tampax remained in the 'Feminine Care' sub-category throughout 2022–2024, when in fact the category was rebranded to 'Menstrual Care' in 2023, reflecting a strategic shift. The LLM also fails to mention the removal of 'Baby Care' from the segment in 2024, a significant structural change. (2) Quantitatively, the LLM omits all percentages (25% in 2022, 24% in 2023 and 2024) that are critical to understanding the segment’s performance and strategic weight. While it references MD&A page 18 for each year, it does not report any sales contribution data, undermining quantitative accuracy. (3) The reasoning is flawed: the LLM asserts 'no re-classification or shift in product-line emphasis,' directly contradicting the ground truth, which documents a clear evolution in category naming, structure, and strategic focus. This indicates a failure in multi-hop synthesis across years and categories. (4) The answer is contextually relevant in that it addresses Tampax’s placement within P&G’s portfolio over time, but it conveys the opposite conclusion of the ground truth. The mention of 'Tampax Bounty' appears erroneous—Bounty is a paper towel brand, suggesting possible confusion between brands. Overall, the answer misses the core narrative of strategic repositioning, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 397,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) fair‑value rose from $19 million at Dec 31 2022 to $58 million at Dec 31 2023 and to $69 million at Dec 31 2024, reflecting a growing derivative portfolio.  The valuation method remained a discounted‑cash‑flow model throughout, with vendor‑based pricing and significant unobservable inputs; the key unobservable input for the derivative portfolio was swap rates, whose weighted average stayed at roughly 4 % (range 3‑5 % in 2023, 4 % in 2024).  Default rates were not a primary input for the derivative assets, but were used for retained interests in securitizations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it reports the 2024 net derivative fair value as $69 million, which contradicts the ground truth of $58 million. This is a significant quantitative error. Additionally, the LLM claims default rates were 'not a primary input for the derivative assets' and were used only for securitizations, which directly contradicts the ground truth stating that default rates (53–163%) were explicitly cited as key unobservable inputs for derivative valuation in 2023 and implied to continue in 2024. (2) Number verification: 2022 value ($19M) is correct; 2023 value ($58M) is correct; 2024 value is wrong ($69M vs. $58M). Swap rate range (3–5%) is correctly reported for 2023, but the claim of a 4% fixed rate in 2024 oversimplifies and slightly misrepresents the continued use of the same 3–5% range. The $69M figure appears fabricated or misread. (3) Multi-hop reasoning is partially sound—the model attempts to track evolution across years and identifies valuation techniques—but fails in synthesis by introducing incorrect data and downplaying the role of default rates in derivative valuation. It incorrectly separates default rates from derivative modeling, undermining the core of the question about unobservable inputs. (4) Correctness is scored low (4) due to major factual errors in both financial figures and key assumptions. Quantitative accuracy is poor (3) due to the incorrect 2024 value and misstated inputs. Qualitative accuracy is moderate (5) as the structure and intent are reasonable, but reasoning is flawed. Contextual relevance is fair (7) because the answer addresses the right topic and timeframe, with mostly appropriate terminology and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 474,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments produced a $9 gain to other income (loss), net in fiscal 2022, but turned into $21 and $67 losses in fiscal 2023 and 2024, respectively, driving a $76 decline in that metric over the period. This shift shows the portfolio’s performance deteriorated, with mounting unrealized losses and a higher credit/market‑risk profile as interest rates rose and credit quality slipped.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, meaning there is no disclosed $9 gain. Instead, the LLM fabricates precise dollar amounts ($9 gain in 2022, $21 loss in 2023, $67 loss in 2024), which are not supported by the original data. These numbers are entirely absent from the ground truth, which only qualitatively describes increasing negative impacts in 2023 and 2024 without assigning specific dollar values. (2) The calculation of a '$76 decline' is based on these fictional numbers and is therefore invalid. There is no numerical basis in the original answer to support any such calculation. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the trend of worsening performance in AFS debt investments affecting 'other income (loss), net', it fails to reflect the actual progression — from no disclosed impact in 2022 to material negative impacts in 2023 and 2024. The model incorrectly assumes quantifiable data exists for all three years, undermining the core insight that the lack of 2022 data itself is meaningful. (4) The contextual relevance is moderate because the answer addresses the right metric and company, and correctly infers increasing risk; however, the reliance on fabricated numbers and absence of correct qualitative framing (especially the significance of missing 2022 data) severely compromises accuracy. The mention of rising interest rates and credit quality, while plausible, is speculative and not present in the original answer. Thus, despite capturing a general directional trend, the answer fails on factual correctness and proper synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 480,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks’ 10‑K filings show a clear, year‑over‑year extension of its green‑coffee supply coverage. In the 2022 10‑K, the company stated that its purchase commitments and inventory would provide an adequate supply through **fiscal 2023** (page 12, 2022 10‑K). The 2023 10‑K extended that horizon to **fiscal 2024** (page 12, 2023 10‑K), and the 2024 10‑K pushed it further to **fiscal 2025** (page 12, 2024 10‑K). This progressive extension reflects a deliberate sourcing strategy that relies on long‑term contracts, hedging of price exposure, and strong supplier relationships to proactively mitigate supply‑chain risk and ensure continuous access to high‑quality coffee.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the projection timeline. According to the ground truth, in fiscal 2022, Starbucks projected supply adequacy through fiscal 2023; by fiscal 2023, it extended the projection to fiscal 2025. However, the LLM states that the 2023 10-K extended coverage only to fiscal 2024, and then the 2024 10-K extended it to fiscal 2025. This misrepresents the multi-year progression: the extension to fiscal 2025 was already stated in the 2023 filing, not first in the 2024 filing. This is a significant quantitative and temporal inaccuracy. (2) The cited page numbers and document references (page 12 of each 10-K) appear plausible but are not verifiable without access to the actual filings; however, the core issue is the incorrect year-by-year evolution of the projection. The ground truth confirms that the adequacy was extended from 'through 2023' (in 2022) to 'through 2025' (in 2023), skipping 2024 as a terminal year. The LLM incorrectly inserts 2024 as the new horizon in the 2023 filing, suggesting a stepwise one-year extension each year, which contradicts the source. (3) The multi-hop reasoning is partially sound—the model correctly identifies the trend of extending supply coverage and links it to sourcing strategy, long-term contracts, and risk mitigation, which aligns with the ground truth's interpretation. The qualitative assessment of strategy (long-term contracts, supplier relationships, risk mitigation) is consistent and well-reasoned. (4) Despite the incorrect year mapping, the overall direction and strategic interpretation are valid, warranting a moderate correctness score. The answer is contextually relevant and addresses both parts of the question—evolution of supply adequacy and strategic implications—but the factual error in the timeline reduces quantitative accuracy significantly. Hence, correctness is 7 (core facts mostly right but key detail wrong), quantitative accuracy 6 (one major date error), qualitative accuracy 8 (sound reasoning and synthesis), and contextual relevance 10 (fully on-topic and comprehensive).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 567,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s exposure to the 2.00 % Notes Due 2031 grew steadily: it was about $1.0 B in FY 2022, rose to $1.044 B in FY 2023, and reached $1.250 B in FY 2024【page 67】【page 72】. This incremental increase shows a deliberate long‑term debt strategy that adds modest amounts of low‑to‑mid‑rate debt to fund growth while keeping the overall debt profile stable and manageable.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the reported value for fiscal year 2022. The ground truth states NVIDIA's exposure was $1,200 million ($1.2 billion) in FY 2022, but the LLM incorrectly reports it as $1.0 billion. The values for FY 2023 ($1.044 billion) and FY 2024 ($1.250 billion) are accurate and correctly formatted. This quantitative inaccuracy undermines the core of the multi-hop trend analysis. (2) The calculation of trend is partially correct—the LLM identifies an 'incremental increase' from 2022 to 2024, but this misrepresents the actual fluctuation: the exposure decreased from $1,200M in 2022 to $1,044M in 2023 before rising to $1,250M in 2024. The LLM incorrectly characterizes the trend as 'steady' or 'incremental,' missing the dip in 2023. (3) The reasoning and synthesis across years are logically structured and address both parts of the question—evolution of exposure and interpretation of debt strategy. However, the conclusion about a 'deliberate long-term debt strategy' adding 'modest amounts' is not fully supported by the actual fluctuation, which suggests a more dynamic or reactive strategy, as correctly noted in the original answer. (4) Despite the numerical error and flawed trend interpretation, the LLM answer remains contextually relevant, uses correct entities (NVIDIA, 2.00% Notes Due 2031, correct fiscal years), and attempts appropriate multi-hop synthesis. The qualitative reasoning is sound in structure but based on incorrect data. The contextual relevance is high as it directly addresses the question’s focus on debt strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 443,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In the 2022 10‑K, Fall Protection Solutions is not separately identified within the Safety and Industrial segment’s product categories (pages 129‑133). By the 2023 filing, 3M began grouping it under the “Respiratory, hearing, eye and fall protection solutions” sub‑category of Safety and Industrial (page 107), and this grouping persisted in the 2024 filing (page 110). The change signals a clearer emphasis on fall‑protection PPE relative to other industrial safety products such as abrasives, adhesives, and electrical components.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. (1) On quantitative and factual accuracy: The claim that Fall Protection Solutions was not separately identified in 2022 is inconsistent with the original answer, which states it was listed alongside respiratory, hearing, and eye protection—implying inclusion in the broader safety suite. The LLM’s assertion that 3M 'began grouping' fall protection in 2023 under a new sub-category is not supported by the ground truth, which indicates consistent listing from 2022 onward. The citation of specific pages (e.g., 107 in 2023, 110 in 2024) may be accurate document references, but the interpretation of a 'change' or 'new emphasis' starting in 2023 contradicts the original answer’s assertion of consistency through 2022–2023 and a shift only in 2024. (2) The 2024 characterization in the LLM answer matches the ground truth in that fall protection remains within the same segment and grouping, but the LLM incorrectly frames the evolution as a growing emphasis, whereas the original answer describes a subtle integration into broader industrial systems, not a heightened focus. (3) Multi-hop reasoning is partially sound—comparing product categorization across years—but the conclusion drawn is inverted: the ground truth suggests a move away from standalone prominence, while the LLM suggests increased emphasis. (4) Entity accuracy (MMM/3M, Safety and Industrial segment, correct years) is correct, and the product categories are plausibly described. However, the core reasoning about the evolution of positioning is flawed, leading to a low correctness score despite some accurate surface details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 465,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s revenue from bamlanivimab (included in the aggregated COVID‑19 antibody revenue) was **$2.01 billion in 2022** (page 67).  In 2023 and 2024 the company reported **$0 million** from bamlanivimab, reflecting the product’s discontinuation and the end of sales under EUAs (footnote on page 67).  This sharp decline shows that Lilly has effectively moved away from relying on its COVID‑19 antibody portfolio for revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures are accurate: $2.01 billion in 2022, $0 in 2023, and $0 in 2024. The formatting variation ($0 million vs $0) is acceptable and semantically equivalent. (2) The answer addresses both parts of the question: it traces the revenue evolution over time and interprets the trend regarding Eli Lilly's reliance on its COVID-19 antibody portfolio. (3) Entity accuracy is correct—Eli Lilly, bamlanivimab, and the years 2022–2024 are properly identified. The reference to the EUA (Emergency Use Authorization) discontinuation adds context consistent with the knowledge graph. (4) The reasoning is sound: the model correctly synthesizes the decline to zero as indicative of reduced reliance, aligning with the conclusion in the original answer. The mention of the footnote and page number (though not required) demonstrates sourcing awareness. Overall, the answer is factually precise, complete, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 293,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks’ 2022 and 2024 10‑Ks both note that coffee price volatility is affected by trading activity from hedge funds and commodity index funds, indicating a steady exposure to index‑fund‑driven price swings (SBUX_10k_2022.pdf page_12; SBUX_10k_2024.pdf page_12). The company has maintained a consistent hedging mix—fixed‑price and price‑to‑be‑fixed purchase commitments, forward contracts, futures and collars—to mitigate that volatility, and has extended its total purchase commitments and inventory coverage to secure green coffee through fiscal 2025, underscoring a proactive, long‑term risk‑management approach (SBUX_10k_2024.pdf page_12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Starbucks acknowledged commodity index fund impact on coffee price volatility in both 2022 and 2024, which is consistent with the original answer's claim of ongoing exposure across 2022–2024. While the 2023 10-K is not explicitly cited, the statement about 'steady exposure' implies continuity, and the omission does not materially distort the trend. (2) There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (fiscal years 2022–2025) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two filings to show evolution in supply commitment length (from 2023 to 2025) and links it to hedging instruments (forwards, futures, collars), accurately reflecting Starbucks’ strengthening risk management strategy. (4) The answer captures the core insight—proactive, long-term risk management despite persistent financial market-driven volatility—and includes specific mechanisms (fixed-price contracts, collars) and outcomes (coverage through 2025). The only minor gap is the lack of explicit mention of 'C' price hedging or 'remote delivery risk assessments' present in the original, but these are secondary details. Overall, the LLM conveys semantic equivalence with strong factual and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 398,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In 2022 Google Ad Manager was a core part of the Google Network properties, generating impression‑based revenue that the company tracked with metrics such as impressions and cost‑per‑impression (page 31). The 2023 filing confirms the same role for Ad Manager while noting a 2023 accounting change that extended the useful life of servers and network equipment from 4‑5 to 6 years, cutting depreciation by $3.9 B and raising net income by $3.0 B, thereby strengthening long‑term profitability (page 57). By 2024 Ad Manager remains integral to the network, and the profitability boost from the depreciation adjustment is reflected in a $100.1 B net income, supporting continued investment in impression‑based monetization (page 57).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager's role in impression-based monetization in 2022 and 2024, the 2023 change in server depreciation (from 4 to 6 years for servers, 5 to 6 for network equipment), the $3.9 billion reduction in depreciation expense, and the $3.0 billion increase in net income are all accurately reported. The $100.1B net income in 2024 is contextually consistent with the profitability trend, though not explicitly tied to Ad Manager alone in the ground truth. (2) Quantitative accuracy is perfect: all dollar figures, years, and technical details (e.g., useful life changes) match the original. (3) Multi-hop reasoning is sound—correctly linking the depreciation change to improved profitability and its relevance to infrastructure-heavy operations like Ad Manager. (4) The only minor shortcoming is a slight overattribution of the $100.1B net income directly to Ad Manager’s performance, whereas the original answer frames the profitability improvement more broadly, with Ad Manager as a beneficiary. However, this does not distort the overall logic. The answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 348,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "BK has issued a new Performance Share Unit Agreement each year from 2022 through 2024, all granted under its 2019 Long‑Term Incentive Plan (see Exhibits 10.21, 10.26, 10.28 on page 19 and the 2019 LTP on page 18). This steady use of PSUs demonstrates a deliberate shift toward performance‑based equity awards, underscoring a compensation strategy that prioritizes aligning executive incentives with long‑term shareholder value and rewarding the achievement of performance targets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of BK's continued use of Performance Share Unit (PSU) agreements under the 2019 Long-Term Incentive Plan, which is contextually relevant and aligns with the broader executive compensation strategy theme. However, it contains significant factual inaccuracies in dates and exhibits, undermining its correctness. The original answer specifies that in 2022, BK referenced the 2021 PSU agreement (Exhibit 10.45), in 2023 re-filed the 2019 plan (Exhibit 10.14), and in 2024 incorporated the 2022 PSU agreement (Exhibit 10.18). In contrast, the LLM claims new agreements were issued each year with Exhibits 10.21, 10.26, and 10.28 — which do not match the ground truth and introduce incorrect exhibit numbers and timing. This misrepresentation fails the quantitative accuracy test for dates and document references. Additionally, the LLM implies annual new issuances as a consistent pattern without acknowledging the adaptive reuse and refiling strategy (e.g., re-filing the 2019 plan in 2023), missing the nuanced evolution described in the original. While the conclusion about performance-based alignment is reasonable and contextually appropriate, the faulty entity mapping (exhibits, years) and lack of precise multi-hop synthesis (tracking changes across filings) reduce qualitative and quantitative accuracy. The answer is partially correct in direction but incorrect in key details, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 399,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "3M’s Safety and Industrial segment has kept the same, highly specific wording for its electrical portfolio—“Electrical products and materials for construction and maintenance, power distribution and electrical OEMs”—through 2022, 2023 and 2024 (2023 page 107; 2024 page 110).  The only change in product categorization was the shift of a non‑electrical line from a “Closure systems” label in 2023 to an “Industrial specialty products such as personal hygiene products, masking, and packaging materials” label in 2024 (2023 page 107 vs 2024 page 110).  This steady, precise focus on electrical OEMs, coupled with the re‑classification of other items, indicates that 3M is keeping its electrical OEM offering front‑and‑center while reorganizing its broader product mix to better align with evolving market segments.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that 3M used the same wording for its electrical products across 2022, 2023, and 2024. The ground truth shows a clear evolution in language: from 'construction and maintenance, power distribution and electrical OEMs' in 2022, to specifying 'electrical original equipment manufacturers (OEMs)' in 2023, and further refining to 'power distribution and electrical original equipment manufacturers (OEMs)' in 2024. The LLM incorrectly asserts no change in descriptive specificity, directly contradicting the documented progression. While the LLM references page numbers and mentions a reclassification of non-electrical products (which may be contextually accurate but not in the ground truth), this does not compensate for the failure to recognize the key linguistic and strategic evolution in how 3M categorizes and emphasizes its electrical OEM market focus. The reasoning is therefore fundamentally flawed, as it misses the multi-hop insight that increasing specificity in product descriptions reflects a growing strategic emphasis on electrical OEMs. There are no numerical values in the question or answers, so quantitative accuracy is not applicable beyond correct year references (which the LLM gets right). Contextual relevance is moderate because the answer discusses the right segment and topic, but it draws an incorrect conclusion due to faulty premise. Semantic equivalence is not achieved because the central claim of 'no change' is false per the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 418,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One’s fixed unsecured senior debt carried **$24.1 billion** at year‑end 2022, rose to **$27.2 billion** in 2023, and fell slightly to **$26.9 billion** in 2024.  The weighted‑average interest rate remained at **4.45 %** in 2022 and 2023, then increased to **4.84 %** in 2024.  This pattern indicates the company is keeping its debt balance largely flat while gradually shifting to newer, slightly higher‑rate debt—reflecting a conservative, maturity‑aligned refinancing strategy that balances cost and risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both carrying values and interest rates. According to the ground truth, the carrying value in 2022 was $19,975 million ($19.975 billion), not $24.1 billion as stated by the LLM. The 2023 and 2024 values are closer but still inaccurate: $27,168 million (~$27.2B) and $26,930 million (~$26.9B) — only the 2024 figure is approximately correct. More critically, the weighted-average interest rate was 2.91% in 2022, not 4.45% as claimed; it rose to 4.45% in 2023 and 4.84% in 2024. The LLM incorrectly states the rate was flat at 4.45% for 2022 and 2023, which misrepresents the trend. (2) These numerical errors undermine the quantitative accuracy: the 2022 carrying value is off by over $4 billion, and the interest rate for 2022 is more than double the correct value. Calculations or comparisons based on these numbers would be flawed. (3) The reasoning and synthesis are partially sound — the LLM correctly observes a slight decline from 2023 to 2024 and interprets the rising rates as part of a refinancing strategy. However, because it misses the substantial increase in debt from 2022 to 2023 and the sharp rise in interest rates starting in 2022, its conclusion about a 'largely flat' debt balance and gradual shift is misleading. The actual trajectory shows a major expansion in fixed debt during a rising rate environment, indicating a strategic move to lock in long-term financing — a point the LLM fails to capture due to incorrect data. (4) Contextual relevance is high because the answer addresses all parts of the question: evolution over time, carrying value, interest rates, and strategic interpretation. The structure and intent are appropriate. However, due to major factual and quantitative errors, especially in the foundational data points, the correctness score is low despite reasonable framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 511,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "In FY 2022 NVIDIA’s 3.50% Notes Due 2040 carried $1 billion on the balance sheet.  In FY 2023 and FY 2024 the carrying amount stayed at $1 billion, the effective interest rate remained 3.54 %, and the fair value fell modestly from $870 million in 2023 to $851 million in 2024 (page 67).  The notes are unsecured senior obligations that can be redeemed early, and the overall long‑term debt mix stayed stable while the net carrying amount of long‑term debt declined from $9.71 billion to $8.46 billion (page 72), illustrating NVIDIA’s disciplined use of long‑dated debt to finance growth with predictable costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. According to the ground truth, in FY 2022, the fair value of NVIDIA's 3.50% Notes Due 2040 was $1,066 million, but the LLM states a carrying amount of $1 billion with no mention of fair value, which is incorrect. The ground truth reports fair value in 2022 and 2023, not carrying amount. In FY 2023, the ground truth reports a fair value of $851 million, while the LLM reports $870 million — a significant discrepancy. In FY 2024, the ground truth states that fair value was no longer reported and instead a carrying amount of $1,000 million was listed; however, the LLM incorrectly claims that the carrying amount was $1 billion in all three years and reports a 2024 fair value of $851 million, which contradicts the ground truth. (2) The LLM also introduces an 'effective interest rate of 3.54%' and cites page numbers (67, 72), which are not present in the original answer and cannot be verified. The net long-term debt figures ($9.71B to $8.46B) and claims about early redemption are not supported by the ground truth and appear to be hallucinated or misattributed. (3) The multi-hop reasoning is flawed: the LLM fails to correctly track the shift from fair value to carrying amount reporting in 2024, misrepresents the trend, and invents stability in carrying amount when the ground truth only provides carrying amount for 2024. It incorrectly implies consistent carrying values across years. (4) Despite these issues, the LLM attempts to address the broader question about long-term debt strategy and correctly identifies the notes as long-term obligations, showing some contextual understanding. However, due to major quantitative errors and unsupported details, the correctness score is low. Quantitative accuracy is particularly poor due to incorrect values and invented metrics. Qualitative accuracy is partially acceptable due to correct general topic alignment. Contextual relevance is high as the response stays on topic and attempts strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 549,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16.0 billion** at December 31, 2022 to **$15.0 billion** at December 31, 2023 and further to **$13.0 billion** at December 31, 2024 [page_58], [page_57]. The steady decline indicates that Amazon is actively repaying or redeeming the 2017 Notes, reflecting a conservative debt‑management strategy aimed at reducing long‑term leverage and interest expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all outstanding balance figures for Amazon's 2017 Notes: $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values are also correctly attributed to year-end dates (December 31), which aligns with standard SEC reporting practices. (2) All numeric values are accurate, and the trajectory of reduction ($1B from 2022 to 2023, $2B from 2023 to 2024) is correctly implied. No calculations are required beyond recognition of the trend, which is properly conveyed. (3) The multi-hop reasoning is sound—information across multiple years and filings is synthesized correctly to show a trend. The conclusion about Amazon’s debt management strategy is logically derived from the declining balances. The LLM adds slight interpretive depth by mentioning 'reducing long-term leverage and interest expense,' which is a reasonable inference and enhances the answer without contradicting the ground truth. (4) The only reason for not giving a perfect 10 is that the original answer emphasizes 'gradually retire this issuance over time,' focusing on the planned, systematic nature of the repayment. While the LLM’s 'conservative debt-management strategy' is semantically close, it introduces a subjective characterization ('conservative') not present in the ground truth. However, this does not detract significantly from factual accuracy. All parts of the question are addressed: the evolution of the balance and the strategic implication. Citations to pages 58 and 57 further support credibility. Overall, the answer is factually excellent with minor wording nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 454,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 2022‑, 2023‑ and 2024 10‑Ks all list the same “Floating Rate Notes due 2019” in the description of securities (see the Officer’s Certificate list on page 56 of each filing).  This shows that Apple continues to issue short‑term, variable‑rate debt and therefore retains an ongoing exposure to interest‑rate fluctuations.  In a rising‑rate environment the coupon on those notes would climb, increasing Apple’s interest expense and making its overall cost of debt more sensitive to rate hikes.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple's 2022, 2023, and 2024 10-K filings reference the 'Floating Rate Notes due 2019' via the Officer’s Certificate (dated May 6, 2014, though the date is omitted in the LLM answer), which aligns with the ground truth. The inclusion of these notes across multiple years is accurately noted. However, the LLM incorrectly implies that Apple *continues to issue* these short-term floating rate notes, which is not supported by the ground truth. The original answer clarifies that the repeated disclosure likely reflects ongoing *disclosure obligations* or *rollover/continuing commitments*, not active issuance of notes that matured in 2019. This is a significant factual misinterpretation. (2) Quantitatively, all references to years (2019, 2022, 2023, 2024) and document types (10-Ks, Officer’s Certificate) are correct. No numerical calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: the model correctly links the presence of the notes in recent filings to ongoing exposure and connects floating rate instruments to interest expense sensitivity in a rising rate environment. However, it fails to recognize the nuance that matured debt can persist in disclosures due to legal or structural reasons without active issuance, leading to flawed reasoning about Apple’s current debt practices. (4) Contextual relevance is strong—the answer addresses both parts of the question (exposure to short-term debt and interest expense sensitivity). But due to the key mischaracterization of Apple actively issuing these notes, the qualitative accuracy is reduced. The conclusion about interest expense sensitivity is logically valid *if* the debt were outstanding, but rests on an incorrect premise. Thus, correctness is partially compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 499,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "Google’s 2022 10‑K framed the Pixel 5a 5G and Pixel 6 as part of a new‑generation hardware push that “invests in platforms like Android, Chrome, and growing our family of hardware devices” (page 7). By 2023 the Pixel line had become a defined revenue stream, with devices revenue—“primarily include sales of the Pixel family of devices”—constituting a modest but stable portion of Google Services (page 33). In 2024 the Pixel family remains a component of devices revenue, but the language shifts toward sustaining the line rather than aggressively expanding it (page 59), indicating a long‑term view of hardware as a complementary platform to core services rather than a primary growth engine.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 focus on Pixel 5a 5G and Pixel 6 as part of long-term hardware investment is accurately described; in 2023, the Pixel family is correctly identified as a defined revenue stream under 'devices'; and in 2024, its continued inclusion in devices revenue is properly noted. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning across years and strategic shifts is sound: the answer traces the evolution from investment phase (2022) to revenue contribution (2023) to stabilization (2024). The subtle shift in tone toward 'sustaining' rather than 'expanding' in 2024 adds nuance not in the original but does not contradict it and may reflect accurate interpretation of filing language. (4) The only minor gap is that the LLM answer does not explicitly state that this progression signals increased confidence in Google's hardware market positioning, which is a key conclusion in the original answer. However, the implication is present through the narrative of maturation. Wording differs but semantic meaning is equivalent or inferable. Thus, the answer is factually complete and contextually appropriate, meriting a high score with only slight deduction for missing the explicit long-term positioning implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 406,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "From 2020 to 2021 Schwab expanded its use of client securities as collateral, with the fair value of securities available for pledge rising from $84 B to $120 B and those pledged for margin lending and securities lending increasing from $23 B to $31 B (page 108). By 2024 the firm had reduced the amount of client securities pledged for CS&Co lines of credit (from $950 M to $500 M) and terminated TDAC lines, while boosting collateral pledged for FHLB borrowings (from $63.1 B to $59.8 B) and discount‑window access (from $6.2 B to $30.5 B) (pages 97‑101), indicating a shift toward a more diversified, conservative collateral strategy that balances client exposure with liquidity needs and keeps net securities‑loaned amounts modest (about $4 M in 2021 vs $760 M in 2020) (page 107).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and factually inconsistent with the ground truth. (1) It references time periods (2020–2021) not asked in the question, which specifically requested 2022–2024. This misalignment invalidates much of the response. (2) All quantitative data is factually wrong: the LLM cites $84B to $120B in available securities and $23B to $31B pledged, $950M to $500M for CS&Co lines, $63.1B to $59.8B for FHLB, and $6.2B to $30.5B for discount window—none of which appear in the ground truth, nor do page numbers (e.g., pages 97–108) match the actual disclosures. The ground truth states no dollar values were provided in 2022, and only qualitative disclosures were made in 2023 and 2024. (3) The multi-hop reasoning fails: the LLM invents a narrative about reducing pledged securities and shifting collateral strategies, while the ground truth describes an evolution in disclosure and expanded use of client securities for regulatory purposes (e.g., OCC margin requirements), not a reduction. (4) The conclusion about a 'more diversified, conservative strategy' and 'modest net securities-loaned amounts' contradicts the ground truth’s indication of growing reliance on client securities for capital efficiency. The LLM also references non-existent entities like 'CS&Co', 'TDAC', and specific loan amounts not present in the original. Despite addressing collateral management strategy, the answer is factually baseless, with fabricated numbers, wrong years, and incorrect entities, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 421,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "GE’s 2022 10‑K already disclosed that it “often collaborates with the primary insurers … to file proposed premium‑rate‑increase actions” (page 51).  The same language appears in the 2023 10‑K (page 21) and 2024 10‑K (page 20), showing that the collaboration has remained a consistent part of GE’s run‑off strategy.  However, the sensitivity analysis of the potential impact of a 25 % adverse change in the success rate of such filings rose from $200 million in 2023 (page 22) to $300 million in 2024 (page 53), indicating that GE now anticipates larger reserve effects from premium‑rate increases and is proactively incorporating that risk into its reserve and capital planning.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in GE's collaboration with primary insurers from 2022 to 2024, which is central to the question. Quantitatively, the dollar amounts ($200 million in 2023 and $300 million in 2024) are accurately reported, and the citation of the consistent language across 10-K filings is factually correct, supporting a score of 8 for quantitative accuracy. However, the qualitative accuracy is lower because the LLM fails to capture the progressive evolution described in the ground truth: while it notes consistent language, it overlooks that GE’s role evolved from indirect involvement in 2022 to formalized, structured collaboration under reinsurance contracts in 2023, and further refinement using regulatory precedents in 2024. The LLM interprets increasing sensitivity ($200M to $300M) as evidence of proactive risk management, which is plausible, but does not address the strategic shift toward tighter integration with ceding companies or the use of experience data and precedents, as stated in the original answer. This omission limits completeness and reasoning depth. The answer is contextually relevant and addresses GE's reinsurance risk management, earning a solid 8 for relevance. Overall, the correctness score is 6 due to missing key qualitative developments in the multi-hop progression across years, despite accurate numbers and some relevant insights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 394,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s residential mortgage‑backed‑security (RMBS) holdings grew from **$721 million** at 12/31/2022 to **$810 million** at 12/31/2023, then fell sharply to **$71 million** in separate accounts at 12/31/2024 (page_149, page_161, page_160). The three‑year trend shows a deliberate shift away from structured credit, indicating a more conservative risk posture in that asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the reported values for RMBS holdings. According to the ground truth, CVS's exposure decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. However, the LLM incorrectly states that holdings grew to $810 million in 2023 and then fell to $71 million in 2024. The 2023 figure is significantly overstated, and the direction of change from 2022 to 2023 is wrong (increase vs. actual decrease). The 2024 value is also misrepresented as a drop to $71 million, whereas the ground truth indicates an increase to $71 million from $614 million, meaning the LLM reverses the trend. (2) Calculations and comparisons are therefore invalid. The claimed 'sharp fall' to $71 million in 2024 is incorrect—the ground truth shows a rebound to $71 million from a lower base of $614 million, not a decline from $810 million. The LLM’s narrative of continuous reduction is unsupported. (3) The multi-hop reasoning is flawed because it fails to correctly synthesize the year-over-year changes. The conclusion that CVS adopted a 'more conservative risk posture' due to a 'deliberate shift away' contradicts the ground truth, which describes a cautious reduction in 2023 followed by strategic rebalancing in 2024—indicating dynamic management, not a one-way retreat. (4) Despite incorrect numbers and reasoning, the answer addresses the right company (CVS), metric (RMBS), and time frame (2022–2024), and attempts to interpret risk positioning, so it retains partial contextual relevance. However, due to severe quantitative and qualitative inaccuracies, the overall correctness is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 457,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "COF’s short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024** (Table 8.1/9.1, page 188).  Long‑term debt increased from **$47.8 billion in 2022 to $49.3 billion in 2023 and declined to $44.9 billion in 2024** (Table 8.1/9.1, page 188).  The combined debt level stayed roughly flat—$48.7 billion (2022), $49.9 billion (2023), $45.6 billion (2024)—indicating a deliberate shift to refinance long‑term obligations while keeping short‑term borrowings low to preserve liquidity and hedge interest‑rate risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers but has significant quantitative inaccuracies. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly reports short-term borrowings as $883M (2022), $538M (2023), $562M (2024), which does not align with the ground truth values (actual short-term borrowings were $5.186B in 2022, $5.456B in 2023, and $1.151B in 2024 based on the total minus long-term debt). Similarly, long-term debt is misstated: LLM reports $47.8B (2022), $49.3B (2023), $44.9B (2024), whereas ground truth implies $37.9B (2022), $44.4B (2023), $44.4B (2024) when subtracting short-term from total. The combined totals are close in 2023 ($49.9B vs $49.856B) and 2024 ($45.6B vs $45.551B), but 2022 is off by over $5B ($48.7B vs $43.086B). (2) Calculations of combined debt are approximately correct for 2023 and 2024 but flawed for 2022. The trend direction (increase then decrease) is correct, but magnitude is wrong. (3) Multi-hop reasoning is partially sound: the LLM identifies a strategic shift involving refinancing and interest rate risk management, which aligns with the ground truth’s emphasis on deleveraging and moving away from floating-rate debt. However, it fails to mention the elimination of floating unsecured senior debt or the rising weighted-average interest rate (2.76% → 4.48% → 4.84%), which are key insights in the original answer. (4) Despite missing critical details and having inaccurate component values, the LLM captures the overall trend of rising debt in 2023 and reduction in 2024, and offers a plausible interpretation of capital structure strategy, earning moderate scores for qualitative accuracy and high for contextual relevance. Quantitative accuracy is penalized due to incorrect breakdowns of short-term and long-term components, even though the total debt figures are closer in later years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 533,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s long‑term liability for the 3.50% Notes Due 2050 was $2,000 million in FY 2023 (Jan 29 2023) and remained unchanged at $2,000 million in FY 2024 (Jan 28 2024)【page 69】【page 72】. The 2022 10‑K also reported the same $2,000 million balance【page 78】, indicating that the company has maintained a stable long‑term debt commitment over this period. This trend reflects a capital‑structure strategy that prioritizes predictable, long‑term financing and avoids frequent refinancing or debt issuance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,637 million in fiscal 2023 and further to $1,604 million in fiscal 2024. However, the LLM claims the amount was $2,000 million in all three years, which is inaccurate. This misrepresents both the starting value and the trend. (2) The numbers are significantly off: the LLM reports $2,000M for all years, while the actual values are $2,147M (2022), $1,637M (2023), and $1,604M (2024). The reported stability contradicts the actual downward trend. There are no correct calculations or accurate figures aside from a rough midpoint approximation (the LLM’s $2,000M is closer to 2022 than to 2023 or 2024). (3) The multi-hop reasoning is flawed: the question requires synthesizing data across three fiscal years from 10-K filings to identify a trend. The LLM fails this synthesis, asserting stability instead of decline. The conclusion about a strategy of maintaining predictable financing is therefore based on false premises and contradicts the ground truth, which indicates a deliberate reduction in long-term liabilities. (4) The contextual relevance is moderate because the answer addresses the right financial instrument and topic (capital structure strategy), but the incorrect data leads to an invalid interpretation. The qualitative reasoning would be acceptable if the numbers were correct, but as it stands, the logic is unsound due to factual errors. Hence, low scores for correctness and quantitative accuracy, slightly higher for qualitative reasoning due to structurally sound argumentation (despite false inputs), and moderate for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 480,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s 0.45 % Notes due 2016 were issued in 2013 and remained outstanding through 2022, 2023 and 2024.  Each year’s 10‑K lists the same notes in the “Description of Securities” section, with no new issuances, maturities or changes reported.  This consistency shows Apple’s long‑term debt disclosure strategy of transparently reporting all existing debt in every filing, rather than focusing only on new issuances.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the 0.45% Notes due 2016 'remained outstanding through 2022, 2023 and 2024', which is incorrect. According to the ground truth, these notes were issued in 2013 and matured in 2016, meaning they were no longer outstanding after 2016 and certainly not in 2022–2024. This misrepresents the core financial reality. (2) Quantitatively, while the interest rate (0.45%) and maturity year (2016) are correct, the assertion that the notes were still outstanding in 2022–2024 is factually wrong. There are no calculations in this question, but the temporal facts are essential and inaccurately presented. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a disclosure pattern from repeated appearance in 10-Ks—but fails to recognize that inclusion in financial reports does not imply outstanding status. The model misinterprets continued disclosure as evidence of ongoing liability, whereas the ground truth clarifies this is for transparency and legal continuity, not because the debt is active. (4) Contextual relevance is high because the answer addresses the disclosure strategy and references the correct filings and sections. However, due to the fundamental error about the debt being 'outstanding', the qualitative and quantitative accuracy scores are significantly reduced. The conclusion about transparency is aligned with the ground truth, but it is based on a false premise, limiting its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 413,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) grew from $5 million at year‑end 2022 to $58 million at year‑end 2023 and to $69 million at year‑end 2024, reflecting a sharp expansion of derivative exposure.  The swap‑rate inputs used in the Level‑3 valuation models rose from 1‑2 % (average 2 %) in 2022 to 3‑5 % (average 4 %) in 2023 and 4 % (average 4 %) in 2024, indicating that the company has updated its assumptions to a higher‑rate, higher‑credit‑risk environment while continuing to rely on significant unobservable inputs in its internal models.  This multi‑year trend signals a growing reliance on derivative hedging and a shift toward more conservative, higher‑rate valuation assumptions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets (liabilities) fair value was $31 million in 2022, not $5 million as stated. The 2023 value is correctly reported as $58 million in the LLM answer, but the 2024 value is incorrectly stated as $69 million instead of $58 million. Additionally, the LLM claims swap rates were used in 2022 with an average of 2%, but the ground truth does not specify swap rates or any unobservable input for 2022—only that there was a $20 million net unrealized loss. The shift in significant unobservable input from 'default' in 2023 to 'swap rates' in 2024 is misrepresented, as the LLM implies swap rates were used throughout. (2) Calculations and comparisons are flawed: the LLM suggests a continuous increase in exposure, while the truth shows stability from 2023 to 2024. The reported increase in swap rates from 1–2% to 3–5% is fabricated; no such range or progression is in the original. (3) Multi-hop reasoning is partially sound in that the model attempts to interpret risk input evolution and its implications, but it fails to correctly synthesize the actual progression: the key insight in the ground truth is the shift in risk driver (from default to interest rates) despite stable valuation, which the LLM misses due to incorrect inputs. (4) Contextual relevance is moderate—the answer addresses derivative exposure, valuation inputs, and modeling assumptions as required, but the incorrect data undermines the analysis. The conclusion about 'growing reliance' and 'higher-credit-risk environment' is not supported by the actual stable values and shift in inputs. Thus, while the structure and intent align with the question, factual errors severely limit correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 495,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s carrying amount of the 1.55% Notes Due 2028 rose from **$1.099 B at the end of FY 2022** (Jan 29 2023) to **$1.115 B at the end of FY 2023** (Jan 28 2024) and then to **$1.250 B at the end of FY 2024** (Jan 26 2025)【page_67】【page_72】. The steady, incremental build‑up of this low‑rate, 3‑year‑plus maturity debt shows a deliberate strategy to fund growth and capital projects while keeping interest costs low and maintaining a diversified, long‑term debt profile【page_72】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but has minor discrepancies in the reported values for FY2022 and FY2023 compared to the ground truth. The ground truth states $1.2B in 2022 and $1.1B in 2023, while the LLM reports $1.099B and $1.115B respectively. These differences, though small, affect quantitative accuracy—especially the 2022 figure being lower than stated in the original answer and the 2023 figure actually being higher than the reported 'stable' $1.1B. The FY2024 value ($1.25B) matches exactly. (2) The fiscal year-end dates (Jan 2023, Jan 2024, Jan 2025) align correctly with NVIDIA’s FY2022, FY2023, and FY2024, so temporal alignment is accurate. However, the original answer describes a 'slight increase in 2024 after a minor reduction in 2023', which contradicts the LLM's claim of a steady rise from $1.099B to $1.115B to $1.250B—this suggests an upward trend throughout, not a dip in 2023. Thus, the trend interpretation slightly misaligns with the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly identifies the debt instrument, tracks it across three fiscal years, and infers strategic intent based on low interest rate and maturity profile. It synthesizes financial data and strategic implications appropriately. (4) Despite minor numerical deviations, the overall message about maintaining long-term debt as part of capital structure is consistent. The LLM adds contextual insight about funding growth and diversification, which is reasonable and relevant. Therefore, while factually close, the answer loses points on precise quantitative fidelity, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 449,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 10‑K disclosures show a consistent, unchanged exposure to trailing legal liabilities from 2022 through 2024.  Each year’s filing notes the same legacy matters from the 2015 Alstom acquisition—settlements, judgments and anti‑competitive claims—and the same shareholder lawsuits over past financial reporting, with no indication that the number or nature of those claims has diminished.  The 2024 filing adds that reserves are maintained “when and as appropriate,” but stresses that estimating those reserves involves significant judgment and that actual losses could exceed the current estimates, underscoring the persistence and potentially sizable financial impact of these contingent liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GE's ongoing exposure to legacy liabilities from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting is consistently noted across 2022–2024. The LLM correctly identifies that these matters involve anti-competitive claims, settlements, judgments, and reputational/financial risks. (2) There are no numeric inaccuracies—while no specific dollar amounts are cited in either answer, the qualitative descriptions of reserves, estimation uncertainty, and potential for losses exceeding estimates are consistent and correctly attributed to the 2024 filing. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of disclosures, correctly noting the persistence of the same legal issues without diminishment. It accurately reflects that the 2024 filing emphasizes judgment in reserve estimation and the risk of excess losses, which matches the ground truth’s point about liabilities possibly exceeding estimates. (4) The only minor shortcoming is that the LLM omits explicit mention of 'exited businesses' as a source of contingent liabilities in 2024 and slightly downplays the evolution by stating exposure was 'unchanged,' whereas the original answer notes a progression in emphasis (e.g., from cash outflows in 2022 to reiterated risk in 2023 to broader impact on reputation in 2024). However, this does not undermine the core factual accuracy. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 452,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan’s hedge‑fund limited partnership exposure rose from **$225 million in 2022** to **$280 million in 2024** (page 168 and page 167).  The target allocation for hedge funds increased from **3 % to 4 %** (page 169), reflecting a deliberate shift toward higher‑risk, higher‑return alternative investments to boost returns and diversify risk as part of a more aggressive pension‑fund strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, CVS's exposure was $214M in 2022, $225M in 2023, and $252M in 2024. The LLM incorrectly states $225M in 2022 and $280M in 2024, which misrepresents both the starting point and the final value. The increase from $225M to $280M implies a $55M rise, whereas the actual increase from 2022 to 2024 was $38M ($214M → $252M). Additionally, the LLM introduces a 'target allocation' increase from 3% to 4%, which is not mentioned or supported in the original answer and cannot be validated from the provided ground truth. (2) Quantitative accuracy is severely compromised: the dollar amounts for both years are wrong, and the implied growth trend is exaggerated. While the general direction (increase) is correct, the magnitude and specific values are not. (3) The reasoning partially captures the strategic implication—increased alternative investments—but overreaches by labeling it a 'more aggressive pension-fund strategy' and citing unsupported percentage targets. The original answer notes a 'gradual expansion' despite market volatility, which is more measured in tone and consistent with the data. The LLM fails to reflect the multi-hop progression across three years (2022→2023→2024), collapsing it into a two-point comparison. (4) Despite incorrect numbers and unsupported specifics, the answer remains contextually relevant by addressing both parts of the question—change in exposure and strategic implication—and maintaining focus on pension fund strategy. However, the factual errors severely undermine correctness, warranting a low score of 3. Quantitative accuracy is scored at 2 due to major number mismatches; qualitative accuracy at 4 due to partial reasoning validity; contextual relevance at 7 as the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 510,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022, Africa/Eurasia generated $228 million in operating profit (page 116).  In 2023, the company allocated about $1.6 million—5 % of the $32 million Global Productivity Initiative charges—to the region (page 86), underscoring a focus on cost‑efficiency.  By 2024, depreciation and amortization spending in Africa/Eurasia was $8 million (page 117), indicating modest capital investment while sustaining profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The operating profit for Africa/Eurasia in 2022 is reported as $228 million (LLM) vs. $203 million (ground truth), which is a material discrepancy. The restructuring charge allocation is stated as 5% ($1.6 million) in the LLM answer, but the ground truth indicates 10% ($20–24 million), a major error in both percentage and absolute value. The depreciation and amortization figure for 2024 is correctly reported as $8 million. (2) Quantitative verification: Operating profit is off by $25 million; restructuring allocation is off by an order of magnitude—$1.6M vs. $20–24M; D&A is correct. The LLM cites $32M total restructuring charges (5% of $32M = $1.6M), but the ground truth implies total charges were $200–240M (10% allocated to Africa/Eurasia = $20–24M), so the total charge base is also incorrect. (3) Multi-hop reasoning is partially sound—the model attempts to connect operating profit, restructuring, and D&A across years and links them to strategic focus—but due to incorrect data, the synthesis is flawed. The conclusion about cost-efficiency aligns with the ground truth, but lacks the nuance of declining investment and aging assets. (4) Correctness score is 4 due to two major quantitative errors undermining the core answer, despite correct mention of D&A and general strategic direction. Quantitative accuracy is low (3) due to incorrect numbers and calculations. Qualitative accuracy is moderate (5) because the reasoning framework is logical but based on wrong inputs. Contextual relevance is high (8) as the answer addresses all time periods and metrics in a coherent narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 463,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "From 2022 to 2024 AIG’s approach to international terrorism exposure shifted mainly in its reinsurance attachment points and recoverable assets.  In 2022 the company disclosed a $1.3 billion modeled loss for a five‑ton bomb attack net of TRIPRA and reinsurance recoveries, with Japan and Rest‑of‑World attachment points at $200 M and $100 M per occurrence and aggregate.  By 2024 those attachment points were lowered to $150 M for Japan and raised to $125 M for Rest‑of‑World, while no new modeled terrorism loss figure was provided; reinsurance recoverable assets fell from $67.5 billion at 2023 to $38.0 billion at 2024 (the 2022 figure is not disclosed in the provided pages).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly states AIG's $1.3 billion modeled loss in 2022 for a five-ton bomb attack net of TRIPRA and reinsurance, and correctly reports the 2024 reinsurance recoverable assets as $38.0 billion, it incorrectly claims that reinsurance recoverable assets were $67.5 billion in 2023—this figure is not in the original answer and contradicts the ground truth, which states recoverables increased to $38.0 billion in 2024 from unspecified prior levels. The original answer indicates an expansion in reinsurance protections, not a decline. (2) The attachment points are partially correct: the LLM correctly identifies Japan at $200 million and 'elsewhere' at $125 million in the original, but falsely claims these changed in 2024 to $150M and $125M respectively, with no such change stated in the ground truth—AIG maintained consistent attachment points over the period. The LLM also incorrectly states Rest-of-World was $100M in 2022, which is not supported. (3) The multi-hop reasoning is flawed: the LLM infers changes in attachment points and a drop in recoverable assets that are not in the source, failing to accurately synthesize the evolution. It also omits key elements from the original, such as AIG’s continued use of third-party models in 2023 and the breakdown of the $38.0 billion into $29.1 billion in ceded loss reserves. (4) Despite these errors, the answer is contextually relevant, addressing the core themes of terrorism exposure, modeling, attachment points, and reinsurance. However, due to significant quantitative and qualitative inaccuracies, particularly in misrepresenting trends and inventing data, the correctness score is low. Minor wording flexibility is allowed, but fabricated numbers and trends cannot be tolerated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 494,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 liability fell from about $1.20 billion in FY 2022 to $1.044 billion in FY 2023, then rose to $1.25 billion in FY 2024 (see 2024 10‑K, page 72; 2023 10‑K, page 65; 2022 10‑K, page 78). This pattern shows a deliberately stable long‑term debt profile: the company repaid or refinanced a portion of the notes in 2023, then rolled over or issued additional debt in 2024 to maintain liquidity and support growth while keeping the overall debt level roughly constant. The trend reflects a conservative strategy that balances debt repayment with new issuances to manage interest costs and maturity schedules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1.2 billion in 2022, $1.044 billion in 2023, and $1.25 billion in 2024, matching the ground truth exactly. Number formats are consistent and acceptable, with minor stylistic variations (e.g., 'about $1.20 billion' vs $1.2 billion) not affecting accuracy. (2) Quantitative accuracy is perfect—no calculation errors, and the values are correctly attributed to the respective fiscal years. The LLM even cites the exact pages from the 10-K filings, enhancing verifiability. (3) The multi-hop reasoning is sound: the answer synthesizes data across three years and correctly infers a stable long-term debt strategy. It accurately interprets the dip in 2023 as a possible repayment or refinancing and the rebound in 2024 as a rollover or new issuance, aligning with the ground truth’s implication of strategic stability. The only minor gap is that the LLM emphasizes 'rolling over or issuing additional debt' in 2024, which is a plausible interpretation but slightly more specific than the ground truth’s more cautious 'return to $1.25 billion' without specifying mechanism. However, this does not constitute an error, just a slightly stronger claim. (4) Contextual relevance is excellent—the answer directly addresses the trend and its implications for NVIDIA’s long-term debt management strategy, covering all aspects of the question. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth, warranting a high score with only a minor deduction in qualitative accuracy for the slightly assertive interpretation of the 2024 increase.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 450,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05% Notes due 2017 were issued in 2014 and are still listed in the description of securities (Exhibit 4.4) in the 2022, 2023, and 2024 10‑Ks, with no changes in terms or new issuances. The unchanged disclosure across three consecutive filings shows that Apple consistently tracks and reports all debt instruments, providing long‑term visibility and continuity in its debt structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor inaccuracy regarding the maturity status of the notes. Quantitatively, the LLM correctly identifies the 1.05% interest rate, the 2017 maturity, and the consistent disclosure in 2022, 2023, and 2024 filings, which matches the original answer. It also accurately notes the absence of changes in terms or new issuances, supported by Exhibit 4.4 in the 10-Ks. However, the LLM does not acknowledge that the notes technically matured in 2017, which is a key point in the ground truth—this omission slightly undermines the reasoning about why they are still listed (e.g., possible rollover, refinancing, or retention under the same indenture). The qualitative reasoning is sound in inferring long-term visibility and continuity in Apple’s debt disclosures, but misses the nuance that the continued inclusion of a post-maturity instrument may reflect structural or reporting practices rather than active debt. This leads to a slightly less complete multi-hop synthesis. Contextually, the answer is highly relevant, addressing both the evolution over time and the implications for debt structure transparency. Overall, the answer is factually strong with minor gaps in depth and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 354,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "In 2022 Schwab could migrate up to $10 billion of IDA balances each year under the 2019 IDA agreement, limited to floating‑rate balances and subject to a $50 billion minimum and an 80 % fixed‑rate requirement through 2026. The 2023 IDA agreement, effective May 2023, removed the $10 billion cap and the fixed‑rate percentage rule, and introduced new minimum/maximum balance thresholds—balances had to stay above the total unmatured fixed‑rate amount with a $30 billion ceiling until September 10 2025, then a $60 billion minimum and $90 billion maximum thereafter—while also changing withdrawal rules. As a result, Schwab migrated roughly $10 billion in 2021–2022 but moved no balances in 2023 or 2024 under the new terms.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. While it correctly states that in 2022 Schwab could migrate up to $10 billion annually under the 2019 IDA agreement and had moved approximately $10.1 billion by year-end, it incorrectly claims Schwab migrated 'roughly $10 billion in 2021–2022'—the ground truth specifies $10.1 billion was moved by end of 2022, not split across 2021–2022. More critically, the LLM introduces details not present in the ground truth: the $50 billion minimum, 80% fixed-rate requirement through 2026, and specific future thresholds of $60 billion minimum and $90 billion maximum after September 10, 2025. These figures are not mentioned in the original answer and appear fabricated or misattributed. The removal of the $10 billion cap and fixed-rate rule in 2023 is plausible but not confirmed in the ground truth, which only states that the migration option was no longer exercised and new minimum/maximum thresholds were introduced—without specifying amounts. (2) Quantitative accuracy is low due to the inclusion of unsupported numbers (e.g., $30B ceiling, $60B/$90B thresholds) and incorrect time framing for migrations. The ground truth does not mention withdrawal rule changes or floating-rate limitations, which the LLM adds without basis. (3) The multi-hop reasoning is partially sound—LLM correctly identifies a shift from active migration in 2022 to no migration in 2023–2024 and attributes this to a new agreement. However, it over-specifies constraints not present in the source, undermining reliability. (4) Contextual relevance is high—the answer addresses the evolution of migration ability and changes in agreements across years, aligning with the question’s intent. Despite incorrect specifics, it captures the directional shift from migration to off-balance sheet management. Overall, the answer is partially correct but contains significant factual errors in key quantitative details, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 544,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "GE’s exposure to Bank BPH’s borrower litigation grew from a $1.359 billion estimated loss in 2022 to $2.669 billion in 2023, then fell to $2.461 billion in 2024. Capital support shifted from a $530 million cash contribution in 2022 to a $1.797 billion non‑cash intercompany loan forgiveness in 2023, with no further cash injections in 2024. The mortgage portfolio’s carrying value dropped from $1.799 billion at the end of 2021 to zero by the end of 2023 and remained zero in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of estimated losses, capital contributions, and carrying value across 2022–2024, with only one minor discrepancy in the timing of the mortgage portfolio write-down. Estimated losses are accurately reported as $1.359 billion in 2022, $2.669 billion in 2023, and $2.461 billion in 2024, matching the ground truth. Capital contributions are correctly described: $530 million cash in 2022 and $1.797 billion non-cash (loan forgiveness) in 2023, with no further contributions in 2024. (2) The only quantitative inaccuracy is the claim that the mortgage portfolio carrying value dropped to zero by the end of 2023. The ground truth states it dropped to zero by the end of 2024, not 2023. The LLM incorrectly advances the timeline by one year, though it correctly notes the value remained zero in 2024. The starting value of $1.799 billion at end-2021 is accurate but not required in the original answer, so its inclusion is extra context, not an error. (3) Multi-hop reasoning is sound: the model synthesizes data across years and financial dimensions (loss estimates, capital actions, asset valuation), correctly identifying shifts in GE’s strategy from active capital support in 2022–2023 to stabilization in 2024. The conclusion of GE exiting active involvement is implied correctly. (4) The answer is highly relevant and conveys nearly all key points. The one factual error on the timing of the write-down prevents a top score, but core financials and strategic trajectory are correct. Hence, correctness is 8/10, quantitative accuracy 9/10 (minor date-related timing error), qualitative accuracy 8/10 (solid reasoning with slight factual misplacement), and contextual relevance 10/10 (fully addresses the question scope).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 484,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities fell sharply in both size and loss exposure: fair value dropped from $1.17 B in 2022 to $1.07 B in 2023 and to only $3 M in 2024 (page_147, page_147, page_160), while unrealized losses fell from $155 M in 2022 to $100 M in 2023 (page_149). This steep contraction indicates the company is actively trimming its exposure to these interest‑rate‑sensitive assets, reflecting a risk‑averse strategy that limits potential losses from rate movements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's CMBS fair value was $574M in 2022 and $675M in 2023, but the LLM claims $1.17B and $1.07B respectively—nearly double the correct amounts. Similarly, unrealized losses in 2022 were $12M (ground truth), but the LLM reports $155M, which is over 12 times higher. Only the 2024 fair value of $3M and 2023 unrealized losses of $100M are correct. (2) Calculations and trends are therefore misleading: the LLM suggests a steady decline in both fair value and unrealized losses, while the truth shows an increase in fair value and a sharp rise in losses from 2022 to 2023 before a collapse in 2024. This misrepresents the risk trajectory. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a de-risking strategy in 2024 based on reduced exposure—but this conclusion is drawn from incorrect data for earlier years, weakening the validity of the analysis. It misses the critical point that unrealized losses spiked in 2023 despite higher fair value, which is central to understanding the risk management shift. (4) Contextual relevance is fair because the answer addresses the evolution of exposure and attempts to interpret risk strategy, but due to severe quantitative errors, the overall correctness score is low. The qualitative reasoning is somewhat logical but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 397,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑brand lineup, which includes Marketside, stayed the same from FY 2022 through FY 2024 – the brand is listed on the private‑label roster in the 2022, 2023 and 2024 10‑K filings (page 7). The unchanged portfolio signals that Walmart is maintaining a broad, stable private‑label assortment in grocery, reinforcing its everyday‑low‑price strategy and using private labels to drive volume and margin growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in stating that Walmart consistently included Marketside in its private brand portfolio from FY2022 to FY2024, with accurate reference to the 10-K filings across the three years. There are no numeric inaccuracies, and the timeline (2022–2024) is correctly represented, earning a perfect score on quantitative accuracy. The entity identification (Walmart, Marketside, private-label portfolio) is accurate, and the answer addresses the core question about portfolio evolution. However, the LLM misses key qualitative nuances present in the ground truth: it fails to mention the strategic significance of maintaining Marketside while introducing new brands like 'bettergoods' in 2024, which illustrates Walmart’s dual strategy of preserving trusted brands while innovating. The original answer emphasizes a strategic evolution—continuity plus modernization—whereas the LLM portrays the portfolio as 'unchanged,' which oversimplifies and underrepresents the strategic progression. This omission affects the depth of reasoning and completeness, particularly in synthesizing multi-hop insights across years. Despite this, the answer remains contextually relevant and correctly identifies the stability of Marketside’s inclusion, supporting a reasonable conclusion about Walmart’s stable private-label strategy, even if it misses the fuller strategic picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 383,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 through 2024, Lowe’s expanded its supplier‑monitoring framework by tightening its human‑rights, conflict‑minerals and Vendor Code of Conduct standards and, in 2023, overhauling its wood‑sourcing policy to add country‑specific risk levels, enhanced monitoring, and a new forestry grievance process (updated again in 2024 with a risk‑based approach). The company also broadened supplier engagement—encouraging CDP emissions reporting, partnering to cut scope‑3 GHGs, and investing in recycling, waste‑diversion audits, and energy‑efficiency/renewable‑energy projects (over $550 million in the past three years) to reinforce supply‑chain sustainability. These policy upgrades and capital investments collectively strengthened Lowe’s enforcement of environmental and human‑rights standards across its supply chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution of Lowe's supplier monitoring and enforcement from 2022 to 2024 with strong qualitative accuracy. It correctly identifies the 2023 wood-sourcing policy overhaul with country-specific risk levels, enhanced monitoring, and a new forestry grievance process, and notes its further update in 2024 with a risk-based approach. It also references key policies (human rights, conflict minerals, Vendor Code of Conduct) and supplier engagement efforts like CDP reporting and scope-3 reductions. However, there is a quantitative inaccuracy regarding the investment figures: the LLM states 'over $550 million in the past three years,' which conflates the timeline. The ground truth specifies over $550 million by 2022 and an additional $400 million through 2023, implying a total exceeding $950 million across the period, not $550 million spread over three years. This misrepresents the scale and timing of investments. While the LLM mentions sustainability investments, it does not clearly distinguish the multi-year funding breakdown or specify that the $550M was already exceeded by 2022. Despite this, the reasoning is logically sound, entities and years are accurate, and the synthesis across policy and investment dimensions is strong. The answer is highly relevant and conveys much of the same information, but the financial timeline error prevents a top score on quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 392,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 2022 and 2023 Form 10‑Ks list the 2.40% Notes due 2023 in Exhibit 4.3 (the officer’s certificate) as part of its outstanding debt. By the 2024 filing the same certificate still references the notes, but the debt schedule no longer lists them, indicating the notes had matured or been retired. This three‑year pattern shows Apple’s disciplined short‑term debt strategy—issuing notes with brief maturities and promptly repaying them to keep leverage low and liquidity high.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that Apple disclosed the 2.40% Notes due 2023 in its 2022 and 2023 filings, and references Exhibit 4.3 (the Officer's Certificate), which aligns with the ground truth. However, it incorrectly states that by the 2024 filing, the debt schedule 'no longer lists them,' implying the notes were retired or matured. In contrast, the ground truth confirms that Apple *still included* the 2.40% Notes due 2023 in its 2024 exhibit list, even though they were set to mature that year. This is a significant factual error that undermines the conclusion about repayment. (2) Quantitatively, the percentage (2.40%), maturity year (2023), and years of disclosure (2022–2024) are accurate. There are no numerical calculations, so scoring is based on correct identification of values. The error lies not in numbers but in their interpretation—specifically, the claim that the notes were removed from the debt schedule in 2024, which contradicts the ground truth of continued inclusion. (3) The multi-hop reasoning is partially sound—Apple’s consistent disclosure across years is acknowledged—but the synthesis is flawed. The LLM infers retirement based on absence from a debt schedule, which is not supported by the ground truth. Instead, the continued presence in filings indicates transparency, not repayment status. The conclusion about a 'disciplined short-term debt strategy' and 'promptly repaying' is speculative and not directly supported by the evidence provided in the original answer. (4) The contextual relevance is high because the response addresses the evolution of disclosure and attempts to infer strategy. However, due to the key factual inaccuracy about the 2024 filing, the qualitative and correctness scores are reduced significantly. A score of 5 reflects partial correctness with major errors in reasoning and entity state (active vs. retired debt).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 529,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap note grew from **$900 million at 12/31/2022** to **$944 million at 12/31/2023** and to **$982 million at 12/31/2024** (page_73, page_74, page_70).  After divesting its AerCap equity, GE retained only the senior note, and the incremental increase in the note’s fair value reflects a deliberate shift from equity to a higher‑yielding debt position, underscoring a more income‑focused, risk‑managed investment strategy during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, GE's holdings of the AerCap note were $976 million in 2022, decreased to $944 million in 2023, and then increased to $982 million in 2024. However, the LLM incorrectly states the 2022 value as $900 million (not $976 million), and portrays a continuous increase from 2022 to 2024, which contradicts the actual decrease in 2023. This misrepresents the trend entirely. (2) The numbers are inconsistent with the ground truth: $900M (LLM) vs $976M (truth) in 2022 is a material error of $76 million. While the 2023 ($944M) and 2024 ($982M) figures match, the starting point is wrong, leading to an incorrect interpretation of growth. Calculations or trends based on these numbers are therefore flawed. (3) The reasoning is partially sound but built on false premises. The LLM correctly identifies that GE retained the senior note after divesting equity and infers a strategic shift toward higher-yielding debt, which aligns with a risk-managed, income-focused strategy. This shows some correct multi-hop reasoning about investment intent. However, because the quantitative foundation is wrong, the conclusion about 'incremental increase' from 2022 onward does not reflect the actual fluctuation (decrease then increase). (4) The contextual relevance is fair—the answer addresses both parts of the question (evolution of holdings and strategic implication) and references specific pages. But due to major numerical errors affecting the core facts, the correctness score is low. The qualitative accuracy is moderate due to correct entity identification (AerCap, note vs equity) and plausible reasoning, despite incorrect data. Quantitative accuracy is poor due to the incorrect 2022 figure and misrepresented trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 498,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy—“reduce growth assets and increase liability‑hedging assets as the plan’s funded ratio rises” (see 2022 10‑K, p. 310)—remains unchanged, but the target mix has shifted.  In 2022 the target allocation was 15 % equity, 75 % fixed‑maturity and 10 % other (based on the Dec 31 2021 funded ratio), whereas the 2024 target (based on the Dec 31 2023 funded ratio) is 9 % equity, 80 % fixed‑maturity and 11 % other (p. 252).  The progressive drop in equity and rise in fixed‑maturity securities illustrate a deliberate de‑risking of the portfolio as the plan’s funded status improved.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies AIG's consistent glide path policy of reducing growth assets and increasing liability-hedging assets as funded status improves, which reflects the core de-risking strategy. (2) Quantitatively, the LLM provides specific target allocations: 15% equity, 75% fixed-maturity, 10% other for 2022 (based on Dec 31, 2021 funded status), and 9% equity, 80% fixed-maturity, 11% other for 2024 (based on Dec 31, 2023 funded status). These percentages are factually correct and show a clear shift toward de-risking. The answer correctly links the target for a given year to the prior year-end funded status, matching the multi-year evolution described in the ground truth. (3) The reasoning is sound: the progressive drop in equity (growth asset) and rise in fixed-maturity (liability-hedging asset) is correctly interpreted as evidence of de-risking in response to improved funded status, demonstrating proper synthesis across years and documents. (4) While the LLM does not explicitly mention the 2023 intermediate step (target for 2024 based on Dec 31, 2022), this is a minor omission given that the key comparison between 2022 and 2024 is fully supported and illustrative of the trend. The inclusion of page references (p. 310, p. 252) adds credibility. Overall, the answer conveys the same semantic meaning as the ground truth with high factual precision and strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 407,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "From 2022 through 2024 Texas Instruments consistently reiterated that its core strategy is “analog + embedded processing” and that it places extra emphasis on industrial and automotive markets (2022 MD&A page 18; 2023 MD&A page 20; 2024 MD&A page 19).  The filings repeatedly note that this focus “allows us to generate strong cash flow from operations” and is the foundation of the company’s free‑cash‑flow‑per‑share growth strategy (2023 MD&A page 20; 2024 MD&A page 19).  The unchanging emphasis therefore signals that embedded‑processing products are a key lever for sustaining long‑term free‑cash‑flow‑per‑share growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments maintained a consistent strategic emphasis on embedded processing alongside analog products from 2022 to 2024, with explicit linkage to free cash flow per share growth. The LLM correctly identifies the 'analog + embedded processing' strategy and its connection to cash flow generation, citing the correct sections (MD&A) and pages across all three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound and reflects multi-hop synthesis across three years of filings. The LLM correctly infers that the unchanging emphasis signals a foundational role in long-term cash flow strategy, which matches the ground truth’s conclusion. The only minor shortcoming is that the LLM does not explicitly mention the 'four sustainable competitive advantages' or the specific 2022 framing of embedded processing as one of two anchor product lines, nor does it include the 2023 quote about 'more opportunity per customer.' While these are contextual nuances, their absence does not undermine the core accuracy. (4) The answer is contextually fully relevant, directly addressing both parts of the question: evolution of strategy (consistency over time) and implications for free cash flow. Wording differs slightly but achieves semantic equivalence. Thus, correctness is 9 (excellent but minor omissions), qualitative accuracy 9, and contextual relevance 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 441,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 through 2024, Lowe’s IP strategy continued to protect its private‑brand trademarks—Kobalt, STAINMASTER, and allen+roth—while shifting toward a more active brand‑portfolio focus (see page 7, 2022‑24).  In 2023 and 2024 the company highlighted high‑value private brands in its product selection (page 6, 2023‑24) and embedded them in its digital‑transformation agenda, using omnichannel, digital‑inspiration, design, and project‑management tools to promote private‑brand products across online and in‑store channels (page 7, 2023‑24).  This evolution moved the strategy from a purely protective stance to a digitally‑enabled brand‑promotion focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the core private brands—Kobalt, STAINMASTER, and allen+roth—as consistently highlighted from 2022 through 2024. It accurately reflects the strategic shift in emphasis, noting a move from a protective IP stance to active promotion integrated with digital transformation. The omission of 'RONA' and 'Reno Depot' in later years is implied by the focus on only the three key brands, though not explicitly stated; this is a minor omission but does not distort the overall conclusion. (2) There are no numeric values, dates, or calculations in the question or answer that are incorrect—fiscal years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects IP strategy with digital initiatives like omnichannel tools and digital project management, which matches the ground truth’s mention of remote support and mobile checkout as part of digital integration. (4) The answer captures the semantic essence of the evolution: a refocusing of brand portfolio emphasis and integration with digital tools. The only slight gap is the lack of explicit mention of the broader IP listing in 2022 that included RONA and Reno Depot, which would have strengthened the contrast. However, the core reasoning and factual content remain correct and relevant, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 395,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM has consistently listed “client relationships and trust” as a core competitive differentiator in its 10‑K filings (2022 p. 4; 2023 p. 3; 2024 p. 3).  In 2024 the company expands that emphasis by explicitly tying trust to security in its hybrid‑cloud and AI platform narrative (2024 p. 5), underscoring that reliable, secure AI deployments are a key part of the value it delivers.  This steady, deepening focus signals IBM’s intent to leverage its long‑standing client trust as a strategic advantage, positioning itself as the trusted partner for enterprises moving to hybrid cloud and AI.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth, correctly identifying IBM's consistent emphasis on client relationships and trust from 2022 to 2024, and noting the evolution in 2024 to include security as part of trust in hybrid cloud and AI (supported by citation to 2024 10-K p.5). All dates and page references are accurate, and no numerical data is incorrect (quantitative accuracy is perfect). The answer addresses the core of the question—how IBM’s emphasis evolved and what it indicates about strategic positioning—and correctly infers that IBM is positioning itself as a trusted partner in hybrid cloud and AI. However, it omits key details present in the original answer about the expansion of strategic partnerships with AWS, Microsoft, SAP (2023), and later Palo Alto Networks (2024), which are critical to the multi-hop synthesis of how trust is increasingly tied to a secure, ecosystem-driven model. While the LLM captures the broad trajectory, it misses the specific partner ecosystem progression that substantiates the strategic shift. This omission reduces completeness and slightly weakens the qualitative accuracy, though the overall reasoning remains sound and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 344,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "In 2022 the El Segundo, California site was used only for clinical manufacturing of cell‑therapy products. By 2023 it had expanded to handle both clinical and commercial manufacturing and processing of cell‑therapy products (page 11). The 2024 10‑K confirms the continued dual role, with the facility supporting both clinical and commercial production of cell‑therapy products (page 11).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that in 2022 the El Segundo facility was used only for clinical manufacturing, whereas the ground truth confirms it was already used for both clinical and commercial manufacturing in 2022. This is a major factual error that contradicts the original answer. The LLM then claims the facility 'expanded' to handle commercial manufacturing by 2023, implying a change in role, which is not supported by the ground truth—no such expansion or change occurred. The 2024 description is consistent with the ground truth, correctly noting the continued dual role. (2) There are no numeric values or calculations in this response, so quantitative accuracy is not heavily applicable; however, the years 2022, 2023, and 2024 are correctly referenced, and the citation of page 11 across years does not contradict the source, earning partial credit. (3) The multi-hop reasoning is flawed: the model fails to recognize the consistency of the facility’s role across all three years and instead fabricates an evolution (from clinical-only to dual use), which is the opposite of the actual stable operational footprint described in the ground truth. This undermines the core of the multi-hop synthesis required. (4) While the answer addresses the question's scope and uses appropriate terminology (clinical/commercial manufacturing), the central claim of change over time is false. Thus, despite correct contextual framing and relevance to Gilead and El Segundo, the factual inaccuracies—especially the incorrect evolution narrative—severely reduce correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 442,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "Lowe’s issued its 4.550% notes in 2019 (Fifteenth Supplemental Indenture, April 5 2019) with a maturity of April 5 2049, and the notes remained unchanged through 2022‑2024—no new 4.550% issuances or maturity changes were disclosed in the 2022‑2024 10‑Ks. This steady, long‑term debt profile shows the company’s strategy of locking in a fixed coupon and extending maturities to reduce refinancing risk and maintain a stable capital structure. (Source: page_76, 4.16)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance date (April 5, 2019), coupon rate (4.550%), and maturity date (April 5, 2049) of the notes, which matches the ground truth. It accurately states that no changes occurred in the structure of these notes from 2022 to 2024, aligning with the original answer's emphasis on consistency across filings. The strategic interpretation—locking in fixed rates, extending maturities, reducing refinancing risk, and maintaining capital stability—is semantically equivalent to the ground truth’s conclusion about long-duration debt and capital flexibility. (2) All quantitative elements (dates, percentages, indenture name) are factually correct and match the ground truth exactly. There are no calculations required, but the temporal consistency is properly represented. (3) The multi-hop reasoning is sound: the model synthesized information across three years of filings (2022–2024) and correctly inferred that the absence of changes indicates a deliberate long-term debt strategy. It connects the stable structure to strategic financial management, demonstrating valid inference from repeated disclosure. (4) The only minor shortcoming is that the LLM does not explicitly name the 'Fifteenth Supplemental Indenture' as part of the long-term debt structure in the same way as the original answer, though it does reference it as the issuance document. This slight omission in structural framing prevents a perfect 10 on qualitative accuracy, but overall the answer is factually complete, contextually precise, and correctly reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 435,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 to 2024, 3M’s legal exposure over its Scotchgard product grew markedly as the number of PFAS‑related lawsuits climbed from roughly 2,000 in 2021 to about 6,800 by the end of 2023, and the company entered into a $10.5‑$12.5 billion public‑water‑system settlement that was recorded as a $10.3 billion pre‑tax charge in Q2 2023 【page_98】【page_93】.  This steep rise in litigation and the size of the settlement underscore the substantial financial toll PFAS litigation has taken on 3M, with large, ongoing exposure and significant cash‑flow impacts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims a $10.5–$12.5 billion public-water-system settlement recorded as a $10.3 billion pre-tax charge in Q2 2023, which is not supported by the ground truth. The original answer only mentions a $65 million settlement in New York (also in 2022 and finalized in 2024), with no mention of a $10+ billion settlement. Additionally, the LLM cites an increase from 2,000 lawsuits in 2021 to 6,800 by end of 2023, but the ground truth does not provide lawsuit counts for those years—only that in 2023, 3M faced approximately 68 AFFF suits outside the MDL, not thousands. These numbers are factually wrong and materially misrepresent the scale. (2) The qualitative inaccuracies include attributing a massive settlement to Scotchgard specifically, while the ground truth discusses multiple PFAS-related suits across jurisdictions and products (e.g., AFFF, Wolverine disposal), not solely Scotchgard. The LLM overgeneralizes and misattributes the nature and scope of litigation. (3) Multi-hop reasoning fails: the model conflates broader PFAS litigation with Scotchgard-specific exposure, and introduces a major settlement not present in the original timeline. It also omits key developments like the Michigan class action, Canadian suit, and Alabama/Georgia expansions detailed in the ground truth. (4) Contextually, the answer addresses the trend of increasing litigation and financial impact, which aligns with the question’s intent, but due to severe factual errors, especially on dollar amounts and case volumes, the overall correctness is very low. Minor credit is given for identifying a rising trend in legal exposure, but core facts are false.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 472,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "From 2022 through 2024 Gilead’s Foster City, California site has remained the core hub for clinical‑trial R&D and manufacturing.  The 2024 10‑K confirms that the facility is used for process‑chemistry research, analytical‑method development, formulation, device development and for manufacturing API and drug product for clinical trials, a role that has not changed from earlier filings (GILD_10k_2024, pages 11‑12).  Thus, the facility’s R&D focus and manufacturing responsibilities have stayed consistent, and it continues to be strategically aligned with Gilead’s global network of sites that support both clinical development and commercial manufacturing.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the cited 2024 10-K and correctly identifies the Foster City facility's activities in 2024, including process chemistry research, analytical method development, formulation, device development, and manufacturing of API and drug product for clinical trials. All entities (Gilead Sciences, Foster City, California, 2024 10-K) and their associated roles are accurately referenced, and there are no numerical inaccuracies (quantitative accuracy is high). However, the LLM incorrectly asserts that the facility's role 'has not changed from earlier filings' and that it 'has remained the core hub' with consistent responsibilities, which directly contradicts the ground truth. The original answer highlights a strategic evolution from 2022 to 2024: in 2022, Foster City was described more broadly as housing administrative, manufacturing, and R&D functions and serving as the corporate headquarters within a global network. By 2023–2024, its role became more narrowly focused on early-stage development and clinical manufacturing, indicating a strategic shift—specifically, a refocusing of R&D and clinical production in Foster City while commercial manufacturing was offloaded to other sites like La Verne and Oceanside. The LLM fails to capture this multi-hop evolution and instead asserts continuity, missing the core nuance of the question about how the facility's utilization *evolved*. While the answer is contextually relevant and factually accurate for 2024, it lacks the comparative analysis across years required for full correctness. Thus, the qualitative accuracy is reduced due to flawed reasoning and incomplete synthesis across time periods, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 470,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "From 2022 through 2024 AIG maintained a consistent, formalized loss‑reserve oversight framework that includes risk‑committee reviews, escalation procedures, and a model‑risk management and validation process. The company continued to use both stochastic and deterministic models for reserve estimation, supplementing them with third‑party catastrophe models and scenario analysis, and it kept an external‑expert review of reserve assumptions and results to provide independent validation. While the core oversight and modeling approach remained largely unchanged, 2024 filings emphasize tighter integration of these reviews within the broader risk‑measurement and monitoring system and a more explicit focus on experience‑based updates and scenario‑driven adjustments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments in AIG's loss reserve risk management from 2022 to 2024. It accurately identifies the continuity in internal oversight mechanisms (e.g., risk committees, model validation) and the use of external expert reviews. It correctly notes the use of stochastic and deterministic models, scenario analysis, and third-party catastrophe models, which matches the 2023 enhancements in modeling approaches. The mention of tighter integration into broader risk systems in 2024 and experience-based updates reflects the evolution toward a more integrated ERM framework. However, the LLM understates the progression from reactive to proactive governance and omits specific 2023 advancements such as sensitivity analyses and experience studies as formal components of the framework. While 'experience-based updates' is close, it does not fully capture the structured 'experience studies' highlighted in the original. Additionally, the LLM implies the core approach remained 'largely unchanged,' which downplays the documented evolution in sophistication and integration, particularly the second-line review and enhanced reporting to regulators in 2024. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are cited), and all entities (AIG, years, modeling techniques) are correct. The reasoning is sound but slightly less precise in capturing the degree of change over time. The answer remains highly relevant and factually consistent with minor gaps in conveying the full scope of evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 441,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "From 2022 through 2024 TI’s Melaka site remained an analog‑only manufacturing location, with no embedded‑processing operations added [page_18] [page_18] [page_18]. The facility’s ownership status shifted from partly owned to fully leased, as the footnote changed from “* Portions of the facilities are leased and owned” in 2022 to “** Leased” in 2024 [page_18] [page_18] [page_18]. This steady analog focus, coupled with a move to leasing, signals TI’s intent to maintain analog capacity in Melaka while reducing capital commitments and not expanding embedded‑processing capacity there.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that Texas Instruments' Melaka, Malaysia site remained focused exclusively on Analog manufacturing from 2022 to 2024, with no addition of Embedded Processing operations—this matches the original answer's core claim. The LLM adds a detail not in the ground truth but supported by the source (footnote changes on page 18): the shift in ownership status from partly owned/leased to fully leased. This additional context is accurate and enhances the response without introducing error. The reasoning is sound: maintaining analog-only focus while transitioning to full leasing indicates strategic intent to preserve analog capacity while reducing capital exposure, which is a logical inference. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing) and timeframes (2022–2024) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10). The only reason for not giving full 10 on correctness and qualitative accuracy is that the original ground truth did not include the leasing detail or its interpretation, so while the addition is valid, it slightly extends beyond the provided truth without confirming if that inference was explicitly intended. However, this does not detract from correctness. The answer fully addresses both parts of the question: evolution over 3 years and what it indicates about manufacturing focus. Semantic equivalence is strong, and contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 422,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "In FY 2022 Lowe’s had $2.56 billion of forward‑rate‑swap notional amounts (Note 9, page 45).  The fair value of those swaps fell to $251 million in FY 2023 and to $0 in FY 2024 (page 54).  This trend shows the company used forward‑rate swaps as cash‑flow hedges for forecasted debt issuances and then scaled them back as its borrowing plans diminished (page 46).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims a notional amount of $2.56 billion in FY 2022, but the ground truth does not specify any notional amount for forward interest rate swaps in that year—only that they were referenced in relation to their impact on other comprehensive income. The $251 million fair value in FY 2023 aligns with the ground truth (correct), and the $0 in FY 2024 is semantically consistent with the absence of forward swaps, though the ground truth does not state this as a numerical progression from $251M to $0. (2) The calculation or presentation of a drop from $2.56B to $251M to $0 implies a notional-to-fair-value comparison that is misleading—these are different financial measures (notional vs. fair value) and should not be presented as a continuous time-series decline. This misrepresents the data and introduces a false narrative of scaling back due to diminishing borrowing plans. (3) Qualitatively, the LLM correctly identifies the use of forward rate swaps as cash flow hedges for forecasted debt issuances and notes their disappearance by 2024, which matches the strategic shift described in the ground truth. However, it fails to mention the key shift to fixed-to-floating swaps as fair value hedges on existing debt, a critical component of the company's evolving strategy. (4) Contextually, the answer addresses the evolution over the three years and attempts to interpret the strategy, so relevance is high. However, the incorrect numerical foundation undermines the conclusion. The reasoning is partially sound but based on a fabricated notional figure, leading to an oversimplified and potentially incorrect interpretation of the strategy as merely scaling back due to reduced borrowing, rather than a structural shift in hedging approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 495,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM’s 2022, 2023 and 2024 10‑K filings all reference the 6.50% Debentures due 2028 as “Exhibit 2 to Form 8‑K, filed on January 8 1998” (page 31 of the 2022 filing, page 19 of the 2023 filing, page 19 of the 2024 filing). The unchanged wording across three consecutive years shows that the debt instrument has not been amended, re‑issued or otherwise restructured since its original 1998 filing. This consistency indicates a stable, long‑term debt structure that IBM continues to rely on the original 1998 documentation for ongoing reference.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: IBM's 2022, 2023, and 2024 10-K filings consistently reference the 6.50% Debentures due 2028 using the same Exhibit 2 to Form 8-K filed on January 8, 1998. The specific exhibit and date match the ground truth exactly. (2) Quantitative accuracy is perfect: the percentages (6.50%), years (2028, 1998), and filing years (2022–2024) are all correct. Page numbers cited (31, 19, 19) are additional accurate details not in the ground truth but do not contradict it—likely extracted from actual filings and enhance precision. (3) Multi-hop reasoning is sound: the model correctly infers from the consistent citation across three years that the debt instrument has not been amended or restructured, demonstrating synthesis across multiple filings. (4) The conclusion about the stable, long-term debt structure based on reliance on original 1998 documentation aligns perfectly with the ground truth’s interpretation. The answer addresses both parts of the question: evolution (no change) and what consistency reveals (stable, long-standing instrument). Wording differs slightly but meaning is identical. No errors in entities, dates, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 350,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Reflective signage has stayed within 3M’s Transportation and Electronics segment throughout the three‑year period.  In the 2023 10‑K it is listed as a key product of that segment (page 107), and it appears unchanged in the 2024 10‑K product table (page 110) even after the creation of the new Commercial Branding and Transportation division.  The absence of any re‑classification or removal across 2022‑24 indicates that 3M treats reflective signage as a stable, core element of its transportation‑safety portfolio, underscoring its strategic importance in the company’s product mix.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Reflective Signage remained within 3M's (MMM) Transportation and Electronics segment from 2022 to 2024, which aligns with the ground truth. It also accurately notes the absence of reclassification or removal, supporting the idea of strategic stability. However, the LLM fails to report the key evolution in positioning—specifically, the shift from fifth in 2022 to fourth in 2023 and 2024—which is central to the question. The mention of the 'new Commercial Branding and Transportation division' is not supported in the ground truth and introduces potentially incorrect context. While the conclusion about strategic importance is partially aligned, it is based on incomplete reasoning, missing the nuanced signal of rising prominence indicated by the rank change. The answer cites specific 10-K pages, suggesting document grounding, but does not capture the multi-hop detail of ordering changes across years. Quantitatively, there are no numerical inaccuracies (hence a score of 10), but qualitatively, the reasoning is incomplete and misses the core analytical point of positional shifts. Contextually, the response stays on topic and addresses strategic importance, earning a solid score for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 347,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Gilead has kept its Hoofddorp, Netherlands site as a core commercial manufacturing hub for cell‑therapy products throughout 2022‑2024.  Each 10‑K lists the facility as “used for commercial manufacturing and processing of our cell‑therapy products” (2022 p. 35; 2023 p. 11; 2024 p. 12), and no filings report a change in capacity, scope, or a shift in strategic priority.  Thus, the facility’s role and strategic importance to commercial production have remained stable over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually consistent in stating that the Hoofddorp facility was used for commercial manufacturing of cell therapy products in 2022, 2023, and 2024, and correctly cites consistent language across the 10-K filings. However, it incorrectly concludes that the facility's strategic importance has 'remained stable,' which contradicts the ground truth that shows an evolution and increasing strategic emphasis. The original answer highlights a progression: from being one of several principal facilities in 2022, to an explicitly designated commercial cell therapy site in 2023, and then a key hub reinforcing long-term growth in 2024. The LLM fails to capture this trajectory of growing strategic importance. (2) There are no numeric values, dates, or calculations in the response that are incorrect—quantitative accuracy is perfect by default, as the answer relies on qualitative descriptions from filings. (3) The multi-hop reasoning is flawed: while the model correctly identifies consistent language across years, it does not infer the evolving strategic context implied by the changing emphasis in disclosures. The synthesis stops at surface-level repetition rather than interpreting progression in strategic importance, which is central to the question. (4) Contextual relevance is high because the answer addresses the facility’s role in commercial production across the time frame, but the failure to detect and report the increasing strategic importance significantly undermines the qualitative accuracy and overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 437,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The 2003 Director Compensation Plan has no shares available for future issuance in the 2022, 2023, and 2024 tables (see note (c) on pages 63, 61, and 59). This consistent absence indicates that Texas Instruments has phased out or no longer uses the 2003 plan for director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims zero shares were available in 2022, 2023, and 2024, which directly contradicts the ground truth: 1,843,134 (2022), 1,786,785 (2023), and 1,745,284 (2024). These are specific, non-zero figures showing a clear downward trend. (2) The LLM incorrectly references 'note (c)' on specific pages as justification, but this does not align with the verified data in the knowledge graph, suggesting either misreading or hallucination of source material. (3) Qualitatively, the reasoning is flawed: the ground truth shows ongoing use of the plan due to declining share availability, while the LLM concludes the plan has been phased out—exactly the opposite conclusion. (4) Contextually, the answer addresses the right question about trend and implications but fails completely on factual accuracy and logical inference. The multi-hop synthesis required—tracking share counts over time and interpreting the trend—is entirely incorrect. Even minor formatting differences would be acceptable, but here the numbers and conclusions are diametrically opposed to the truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 329,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In the 2022 10‑K the 0.950% Notes due 2025 are not referenced, indicating the instrument had not yet been issued or publicly disclosed (page 28). By 2023 the notes appear only as an exhibit, confirming issuance but still lacking a public listing (page 20). In 2024 they are listed as a registered security with NYSE symbol IBM25B, reflecting full market transparency and signaling IBM’s broader strategy to diversify its capital structure, enhance liquidity, and engage investors with more accessible debt offerings (page 1).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, IBM referenced the 0.950% Notes due 2025 in 2022 by citing the May 22, 2017 Form 8-K (Exhibit 4.1), but the LLM claims the notes were 'not referenced' in the 2022 10-K, which contradicts the original answer. This is a critical error in entity and document linkage. The LLM also misrepresents the progression: it states the notes 'appear only as an exhibit' in 2023, but the ground truth indicates they were already part of active disclosures in 2022. Only the 2024 fact about the NYSE symbol IBM25B is correct and aligns with the ground truth. (2) Quantitatively, the percentage (0.950%) and the year (2025) are correct, and the symbol IBM25B is accurate. However, the key dates and references (2022 and 2023 disclosures) are wrong, undermining the timeline. There are no calculations, but the temporal facts are essential multi-hop elements and are incorrect. (3) The reasoning is flawed: the LLM infers non-disclosure in 2022 and incremental emergence in 2023, which contradicts the ground truth that shows consistent referencing since 2022 with increasing prominence. The conclusion about IBM’s capital market strategy (diversifying capital structure, enhancing liquidity) is speculative and not supported by the original answer, which emphasizes transparency and investor accessibility, not structural or liquidity motives. (4) The answer is contextually relevant in addressing the evolution and strategy, but the factual foundation is incorrect, leading to a misleading narrative. Due to major errors in entity accuracy, document references, and timeline, the correctness score is low despite partial alignment on the 2024 symbol.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 473,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances grew sharply after 2022: deposit assets rose from roughly $1.8 billion (reported for 2021/2020) to $5.1 billion in 2023 and $4.6 billion in 2024, while deposit liabilities fell from $1.4 billion to $1.3 billion in 2023 and $1.2 billion in 2024【page_216】【page_206】. The 2023 Global Atlantic transaction—an in‑force block transfer that created $10.3 billion of deposit receivables and a $770 million net cost recorded as a deposit liability【page_206】—illustrates a strategic pivot to larger, modified‑coinsurance risk‑transfer deals that leverage the deposit method to manage both recoverables and asset transfers.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor error in the timeline for the initial deposit assets and liabilities. The original answer states 2022 figures as $1.8 billion (assets) and $1.4 billion (liabilities), while the LLM incorrectly attributes these figures to 2021/2020, creating a small factual inaccuracy. All other numbers are correct: 2023 assets ($5.1B), 2024 assets ($4.6B), 2023 liabilities ($1.3B), 2024 liabilities ($1.2B), and the $10.3B in reinsurance recoverables/deposit receivables from the Global Atlantic transaction. However, the LLM introduces a detail not in the ground truth — a $770 million net cost recorded as a deposit liability — which, while plausible, is not confirmed in the original answer and adds unverified information. (2) Quantitative accuracy is high: all reported values except the timing of the baseline figures are accurate. The core growth trend — sharp increase in assets, slight decline in liabilities — is correctly conveyed. (3) The multi-hop reasoning is strong: the LLM correctly identifies the evolution over time and links the Global Atlantic transaction to a strategic shift in accounting approach, interpreting it as a pivot to modified coinsurance deals that use the deposit method for risk transfer. This reflects sound synthesis across years and transactions. (4) The answer is contextually excellent, directly addressing both the quantitative evolution and strategic implications. The minor date misattribution and addition of unsupported detail prevent a top score, but overall the response is factually solid, well-reasoned, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 444,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "From 2022 through 2024, 3M’s Safety and Industrial segment consistently listed fall‑protection solutions as a core product line (see 2022 10‑K page 107, 2023 10‑K page 108, and 2024 10‑K page 108).  In 2024 the company reorganized the segment by creating an Industrial Specialties division that absorbed the former Personal Safety division (which houses fall‑protection products) along with Closure and Masking Systems and Industrial Adhesive & Tapes products (2024 10‑K page 110).  This 3‑year evolution—maintaining the product offering while consolidating it into a dedicated safety‑focused division—signals 3M’s sustained and intensified emphasis on workplace safety solutions, especially fall protection.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding MMM's (3M's) organizational changes in 2024. The claim that 3M created an 'Industrial Specialties division' that absorbed the 'Personal Safety division' is incorrect according to the ground truth. The original answer states there was only a minor rephrasing in how fall protection was presented—grouped under 'respiratory, hearing, eye and fall protection solutions'—with no mention of structural reorganization or divisional consolidation. This misrepresents the evolution of the product portfolio. (2) Quantitatively, the LLM does not introduce any incorrect numbers, dates, or financial figures—there are no numeric inaccuracies per se, so quantitative accuracy is high. It correctly cites the years (2022–2024) and page numbers from the 10-Ks, though these are not verifiable without source access but assumed consistent. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies continuity in fall protection as a product offering, it fabricates a corporate restructuring not present in the ground truth, leading to an incorrect conclusion about 'intensified emphasis' due to organizational consolidation. The original answer emphasizes stability and consistency, not intensification or structural change. (4) Contextual relevance is moderate—the response addresses the time frame and product line continuity but introduces irrelevant and inaccurate structural changes, distorting the strategic interpretation. The conclusion about 'sustained and intensified emphasis' is not supported by the ground truth, which indicates stable focus, not intensification. Thus, while some elements are correct (continued inclusion of fall protection), the core reasoning and entity relationships are factually wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 498,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria has kept UST in the same ownership chain throughout 2022‑2024: Altria owns UST LLC, which in turn wholly owns U.S. Smokeless Tobacco Company LLC (USSTC)【page_4】【page_60】【page_64】.  The 2024 filing still lists UST as a wholly‑owned subsidiary and places it in the “oral tobacco products” segment, the same treatment it received in 2023 and 2022【page_4】【page_60】【page_64】.  This continuity shows that Altria is treating UST as a core, long‑term asset in its smokeless‑tobacco portfolio while expanding other smokeless and heated‑tobacco ventures (Helix, Horizon, NJOY) to reinforce its strategic shift toward a smoke‑free future.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of ownership structure and continuity of UST as a wholly owned subsidiary from 2022 to 2024, correctly citing its placement in the 'oral tobacco products' segment across all years. There are no numeric inaccuracies—though no specific dollar amounts (e.g., $8.8 billion trademark value) are mentioned, the absence does not introduce error but represents a minor omission. The answer correctly identifies Altria’s strategic movement toward a smoke-free future and positions UST within that context. However, it fails to fully capture the evolution highlighted in the ground truth: while ownership remained constant, the strategic framing of UST evolved from an amortized asset (2022) to a core operating company under the 'Moving Beyond Smoking' initiative (2024). The LLM notes continuity but underemphasizes the progressive integration and repositioning of UST within Altria’s broader strategic narrative. It also references Helix, Horizon, and NJOY—correct ventures—but these are not part of the original answer and slightly shift focus away from UST’s specific strategic alignment. Despite this, the core facts are correct, reasoning is sound, and the answer is highly relevant, warranting a high score with minor deductions for incomplete qualitative evolution and slight overextension with peripheral brands.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 375,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the same exhibit – “One Hundred‑Sixteenth Supplemental Indenture, dated as of August 24 2015, … SolarCity’s 5.45% Solar Bonds, Series 2015/C92‑15” (see page_102 lines 52‑53 in each filing). The repeated inclusion shows that Tesla still holds this long‑term, fixed‑rate debt as a core part of its solar‑energy financing, indicating a deliberate strategy to use stable, low‑cost debt rather than issuing new equity or fresh debt for its solar initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond name (5.45% Solar Bonds, Series 2015/C92-15), the date (August 24, 2015), the exhibit title (One Hundred-and-Sixteenth Supplemental Indenture), and the years of filing (2022, 2023, 2024) are accurately cited. (2) Quantitative accuracy is perfect: the percentage (5.45%), date (August 24, 2015), and consistent reference across three years match the original answer. Format variations (e.g., spacing in '2015/C92‑15') are acceptable and do not affect meaning. (3) The reasoning is sound: the LLM correctly infers from repeated disclosure that this bond remains a core part of Tesla’s solar financing strategy, reflecting a preference for stable, fixed-rate debt over equity or new debt. This constitutes valid multi-hop reasoning—linking repeated legal disclosure to strategic financial behavior. (4) While the LLM captures the core strategic implication (use of long-term, low-cost debt), it omits some qualitative depth from the original answer, such as the idea of 'securitized solar debt as a core funding source' and 'confidence in the bond's performance and alignment with Tesla's clean energy model.' These nuances enhance the original answer but are not essential to factual correctness. The LLM answer remains semantically equivalent in its core claims and is contextually fully relevant. Minor deduction in qualitative accuracy due to slightly less comprehensive strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 416,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 10‑K risk‑factor disclosures in 2022, 2023 and 2024 all consistently state that “governmental and stock‑exchange regulations” can affect the value of its debt and equity securities, with no change in wording or emphasis. This steady language shows that IBM treats regulatory risk as a persistent factor and relies on ongoing monitoring and mitigation rather than altering its financing strategy over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that IBM consistently disclosed exposure to stock exchange regulations across 2022–2024, which aligns with the ground truth. However, it inaccurately claims there was 'no change in wording or emphasis,' which contradicts the original answer stating IBM expanded its risk discussion in 2024 to include broader market liquidity and customer credit risks—an evolution in emphasis even if core language persisted. This omission of evolving nuance undermines the qualitative accuracy. (2) There are no numerical values in either answer, so quantitative accuracy is not applicable; however, the years (2022, 2023, 2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes IBM’s consistent regulatory risk disclosure across three years. But it fails to capture the progression in IBM’s risk framing—particularly the 2024 expansion linking regulations to liquidity and credit risk—indicating incomplete synthesis of the strategic evolution in capital market risk management. (4) While the answer is contextually relevant and captures the persistent nature of regulatory risk, it misses the key insight about IBM’s increasingly integrated risk framework, leading to a moderate correctness score. The answer is factually safe but analytically shallow compared to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 390,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across 2022, 2023 and 2024, 3M’s Safety and Industrial segment consistently lists “electrical products and materials for construction and maintenance, power distribution and electrical OEMs” as a core offering (see pages 129, 107 and 110).  While net sales for the segment fell slightly from $11.60 B in 2022 to $10.96 B in 2024, operating income rose from $1.13 B to $2.49 B, indicating a shift toward higher‑margin electrical solutions (pages 108, 111).  This steady focus and improving profitability signals 3M’s deliberate positioning as a leading industrial supplier of electrical and power‑distribution components, reinforcing its footprint in construction and maintenance markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that electrical products were consistently part of the Safety and Industrial segment across 2022–2024, it introduces financial data (net sales: $11.60B in 2022, $10.96B in 2024; operating income: $1.13B to $2.49B) that are not present in the original answer or implied by the ground truth. There is no mention of these figures in the knowledge graph, nor are they validated as correct—making their inclusion misleading. (2) Quantitative accuracy is low because the numbers cited—especially the operating income nearly doubling while sales decline—are not supported by the ground truth and could misrepresent 3M’s performance. The original answer focuses on qualitative evolution of product descriptions, not financial trends. (3) Qualitatively, the LLM fails to capture the actual multi-hop progression of how the segment descriptions evolved: in 2022, closure systems were grouped with electrical products; in 2023, industrial abrasives and autobody repair were added; in 2024, the phrasing shifted to emphasize industrial specialties. This evolution indicating a strategic broadening within industrial markets is entirely missed. Instead, the LLM fabricates a narrative around profitability and margin expansion unsupported by the evidence. (4) Contextual relevance is moderate—the response addresses 3M’s focus on electrical products and industrial positioning, which is relevant, but does so using incorrect reasoning and fabricated metrics. The core insight about strategic evolution in product emphasis is absent, undermining the answer’s correctness despite some surface-level alignment with the topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 466,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "Gilead’s Oceanside, California site has continued to serve the same dual role over the past three years: it is used for commercial retroviral‑vector manufacturing and for clinical manufacturing and process development of biologics candidates.  The 2024 10‑K (page 12) and the 2023 10‑K (page 12) both describe the facility in exactly the same terms, indicating no change in its utilization.  The 2022 10‑K (pages 31‑35) does not report a different use, implying that the facility’s role remained consistent from 2022 through 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that GILD's Oceanside facility had a consistent role from 2022 to 2024. The ground truth shows a clear evolution: in 2022, the facility was part of general R&D; in 2023, it was highlighted for clinical manufacturing and process development of biologics; and in 2024, it became the dedicated site for commercial retroviral vector manufacturing in addition to its ongoing biologics work. The LLM incorrectly asserts no change occurred, citing identical descriptions in the 2023 and 2024 10-Ks, but this contradicts the ground truth progression. While the LLM correctly identifies the 2024 role (commercial retroviral vector + clinical biologics), it fails to recognize the strategic shift over time, misrepresenting the evolution as static. There are no numerical values to verify, so quantitative accuracy is scored based on correct referencing of document years and pages (which are plausible, though not confirmable from the knowledge graph alone). Qualitative accuracy is low because the model fails the multi-hop reasoning required to detect change over time across filings. Contextual relevance is moderate since the answer discusses the right facility and capabilities but misses the central theme of evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 354,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path strategy for its U.S. pension plan has gradually tightened the “Return‑Seeking” (growth‑asset) target: it was 15 % of the portfolio in 2022, fell to 8 % in 2023, and then modestly rose to 9 % in 2024【page_310】【page_252】【page_252】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the percentages provided (15% in 2022, 8% in 2023, 9% in 2024) are factually wrong and not supported by the ground truth. The original answer does not mention any specific percentage allocations for the Return-Seeking portion—instead, it describes the evolution of the glide path approach as being based on forward-looking funded status assessments. There is no indication in the ground truth that the Return-Seeking allocation dropped from 15% to 8%, nor that it rose to 9%. These numbers are fabricated or misattributed. (2) The ground truth emphasizes a structural and strategic evolution—target allocations being set one year forward based on year-end funded status (e.g., 2023 targets set for 2024 based on Dec 31, 2022 funded status)—but the LLM fails to capture this key dynamic mechanism. Instead, it reduces the evolution to arbitrary percentage changes without explaining the underlying forward-looking, status-driven rebalancing logic. (3) The reasoning is flawed: the LLM implies a static, declining trend in risk appetite, which contradicts the ground truth’s emphasis on dynamic, funded-status-responsive adjustments. It fails the multi-hop synthesis by not connecting the timing of target-setting, the basis (funded status), and the forward-looking nature across years. (4) While the answer is contextually relevant—focusing on AIG’s U.S. pension plan and the Return-Seeking allocation—it misses the core conceptual evolution described in the original. The cited page references (e.g., page_310, page_252) do not compensate for the factual and conceptual inaccuracies. Thus, the answer is mostly incorrect despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 476,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "From fiscal 2023 to fiscal 2025 ACN kept its U.S. pension plans at 100 % debt securities, but shifted its non‑U.S. plans toward higher‑return assets: equity rose from 27 % to 28 %, debt fell from 48 % to 36 %, cash and short‑term investments grew from 4 % to 7 %, and insurance contracts jumped from 11 % to 21 % (with other assets dropping from 10 % to 8 %). This gradual move away from fixed‑income toward equity and insurance contracts indicates a more aggressive, higher‑risk tolerance for long‑term returns, while still maintaining a conservative stance for U.S. plans. The multi‑year shift reflects ACN’s willingness to accept interim market volatility in pursuit of higher long‑term performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The provided percentages for asset allocation shifts (e.g., U.S. plans at 100% debt, non-U.S. equity rising from 27% to 28%, debt falling from 48% to 36%, etc.) are not supported by the ground truth and contain fabricated data. The original answer does not mention any specific numerical allocations or changes in equity, debt, cash, insurance contracts, or other asset classes. (2) There are no verifiable calculations or accurate numbers in the LLM response—every percentage cited appears to be invented. The ground truth focuses on planning horizon and strategic language, not actual allocation percentages. (3) The multi-hop reasoning is flawed: the LLM incorrectly interprets the evolution as a concrete shift in asset weights rather than a change in forward-looking planning horizon (from one-year to two-year targets). It fails to recognize that the key development is increased strategic confidence, not a move toward higher-risk assets. The conclusion about 'more aggressive, higher-risk tolerance' contradicts the ground truth's emphasis on a 'measured, stable approach to risk.' (4) The contextual relevance is moderate because the answer addresses ACN’s pension strategy and long-term risk tolerance, but it does so with incorrect data and reasoning, leading to a misleading interpretation. The mention of U.S. vs. non-U.S. plans and risk tolerance shows some relevance, but the foundation is factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 418,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 5.45% Solar Bonds, Series 2015/C25‑15 were issued in 2015 by SolarCity and appear unchanged in Tesla’s debt schedule in the 2022, 2023, and 2024 10‑K filings (Exhibit 4.36 on pages 104, 102, and 101). Across these years the bond series remains the same, showing that Tesla has retained the original long‑term, fixed‑rate debt rather than refinancing or restructuring it. This consistency underscores Tesla’s solar‑financing strategy of relying on stable, long‑term debt to fund solar projects, providing predictable interest costs and a steady capital base.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, earning a high correctness score. (1) Quantitatively, all details—such as the bond's interest rate (5.45%), series (2015/C25-15), issuance origin (SolarCity in 2015), and consistent appearance in Tesla’s 10-K filings across 2022–2024—are correct. The reference to Exhibit 4.36 and specific page numbers (104, 102, 101) adds precision and matches expected disclosure locations, though minor variations in exhibit numbering or pagination across filings would not invalidate the accuracy. (2) The answer correctly identifies that the bond has not been refinanced or restructured, which is consistent with the original answer’s implication of ongoing reliance. (3) However, the LLM answer omits a key element of the multi-hop reasoning present in the ground truth: the evolution of Tesla’s broader solar bond portfolio. While it notes the stability of the C25-15 series, it does not mention the introduction of newer bond series (e.g., C28-15, C33-15) in 2023, which the original answer highlights as evidence of an expanding financing framework. This omission limits the depth of the strategic analysis. (4) Despite this, the conclusion about Tesla’s strategy—relying on stable, long-term debt for predictable costs—is logically sound and semantically aligned with the original. The answer is highly contextually relevant and well-reasoned, but the lack of synthesis regarding the broader bond ecosystem across years prevents a perfect score on qualitative accuracy. Overall, the answer is factually correct and insightful, but slightly less comprehensive in multi-hop synthesis than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 459,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 to 2024 AIG’s overall approach to international terrorism exposure stayed consistent: it continues to use third‑party scenario‑based modeling, monitor exposure concentration, and rely on TRIPRA for U.S. losses, limited private reinsurance, and government‑sponsored terrorism pools abroad. The 2022 filing disclosed a specific $1.3 billion loss estimate for a five‑ton bomb attack net of TRIPRA and reinsurance recoveries, whereas the 2024 filing omits a single‑scenario figure and instead emphasizes a broader scenario‑based estimate and routine concentration monitoring. Reinsurance strategies remained unchanged—TRIPRA, targeted reinsurance for high‑concentration lines, and participation in non‑U.S. terrorism pools—while risk‑mitigation mechanisms across global jurisdictions continued to focus on scenario analysis, exposure concentration oversight, and targeted reinsurance purchases.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.3 billion modeled loss estimate for a five-ton bomb attack in 2022, net of TRIPRA and reinsurance, which matches the ground truth. It also accurately notes the shift from a single-scenario focus in 2022 to broader scenario modeling and concentration monitoring by 2024. However, it omits key quantitative and structural updates from 2024, particularly the retention of a $200 million attachment point in Japan and the increase in reinsurance recoverable assets to $38.0 billion by end-2024—both critical indicators of evolved risk transfer mechanisms. (2) The only numeric values in the ground truth are the $1.3 billion loss estimate and the $38.0 billion reinsurance recoverable; the former is correctly reported, but the latter is entirely missing in the LLM answer, representing a significant omission. The $200 million Japan attachment point is also unmentioned. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes AIG’s consistent use of scenario modeling, TRIPRA, and terrorism pools across years. However, it fails to capture the evolution in reinsurance structure—specifically the scaling of risk transfer as evidenced by the $38.0 billion recoverable asset figure—and the enhanced specificity in global property per risk covers in 2024. This weakens the qualitative accuracy despite correct general trends. (4) The answer remains contextually relevant and accurately reflects the continuity in AIG’s approach, but the absence of key 2024 developments reduces completeness and factual richness. Hence, correctness is reduced to 7 due to missing major updates, though core facts and numbers (where present) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 467,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 2022‑2024 risk‑factor disclosures for the Safety and Productivity Solutions segment all use the same wording, indicating that the company’s exposure to adverse industry economic conditions remained consistently high over that period.  Each filing lists the same set of margin‑pressure drivers—reduced investment in process automation, safety monitoring and plant capacity initiatives; retail‑market volatility; a slowdown in safety‑product demand; competitive pressure and technology‑driven commoditization; and broader adverse industry economic conditions—as key risks that could lower market share, selling prices and margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the core risks and the consistent exposure to adverse industry conditions from 2022 to 2024. It accurately identifies key margin-pressure drivers: reduced investment in process automation, retail-market volatility, commoditization, and broader adverse economic conditions. The answer also correctly notes the continuity of these risks across the three years, which matches the original answer's emphasis on persistent vulnerability. However, there are minor discrepancies in detail: the LLM claims the 'same wording' was used across all filings, which cannot be verified from the ground truth and may be an overstatement; additionally, it includes 'slowdown in safety-product demand' and 'safety monitoring and plant capacity initiatives'—phrases not explicitly mentioned in the ground truth. The original answer highlights 'new market entrants' and 'lower margins' in 2022, 'lower market share and reduced selling prices' in 2023, and the 2024 restructuring into Industrial Automation with margin compression—details the LLM omits or generalizes. While the LLM captures the essence and correctly synthesizes the multi-year trend, it lacks specificity on how the segment evolved structurally in 2024 (restructuring) and slightly misrepresents the consistency of language. Quantitatively, there are no numbers to verify, so accuracy is high by default. Contextually, the response is fully relevant and addresses both parts of the question. The qualitative accuracy is slightly reduced due to generalization and minor addition of unverified details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 444,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "From 2022 through 2024 Pfizer’s share‑based‑payment notes (page 95, page 99, page 96) all state that **no Breakthrough Performance Awards were granted or outstanding** in any of those years.  The valuation method for BPAs is consistently described as the **intrinsic‑value method using the closing price of Pfizer’s common stock**, and any compensation cost that would have been recognized is **amortized on a straight‑line basis over the probable vesting term into operating expenses, with periodic adjustments for stock‑price changes and performance‑criteria probability** (page 95, page 99, page 96).  Consequently, the treatment of BPAs remained unchanged across the three years—zero grant activity and identical accounting guidance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core factual claims. According to the ground truth, Pfizer granted 1,165 thousand BPAs in 2022 with a weighted average intrinsic value of $38.73 per share, and 859 thousand remained nonvested at year-end. However, the LLM claims no BPAs were granted or outstanding in 2022, 2023, or 2024—directly contradicting the ground truth. This error invalidates the quantitative accuracy, as all numerical data (grant volume, intrinsic value, nonvested amounts) are omitted or falsely reported. The only partially correct element is the description of the valuation methodology (intrinsic value method, amortization over vesting term, adjustments for stock price and performance probabilities), which aligns with the 2024 disclosure. However, this is misrepresented as consistent across all three years, when in fact the program was active in 2022 and fully wound down by 2023. The reasoning fails multi-hop synthesis: it does not recognize the evolution from active grants in 2022 to zero outstanding in 2023 to methodological disclosure in 2024. Instead, it asserts no change occurred, missing the key narrative of program termination and subsequent accounting clarification. Contextual relevance is moderate because the answer addresses the right topic and cites appropriate accounting methods, but it fails to capture the temporal evolution central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 388,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "Accenture’s share‑repurchase program has expanded dramatically from fiscal 2022 to fiscal 2024. In 2022 the company bought 12 million shares for about $4.1 million and had an aggregate available authorization of $3.1 million (page 94). By fiscal 2024, share purchases totaled $4.5 billion (cash returned to shareholders) and the remaining available authorization had fallen to $2.7 billion, although the Board added $4.0 billion of new authority, raising total outstanding authorization to $6.7 billion (pages 39‑40). This trend shows Accenture is aggressively returning capital to shareholders while simultaneously increasing its repurchase ceiling to preserve flexibility for future capital‑return decisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. It incorrectly states that Accenture bought 12 million shares for about $4.1 million in fiscal 2022, which is grossly inaccurate—$4.1 million for 12 million shares implies less than $0.35 per share, far below Accenture's actual stock price. The original answer does not mention any specific number of shares repurchased or dollar amount spent in 2022, only the available authorization of $3.129 billion. The LLM fabricates these numbers without support. Additionally, the LLM misrepresents the $3.129 billion authorization as $3.1 million (off by a factor of 1,000), a critical error. While it correctly notes that the remaining authorization was $2.7 billion (rounded from $2,694 million) and that a new $4.0 billion was added, bringing total to $6.7 billion (vs. $6,694 million), these are the only quantitatively accurate elements. (2) Calculations: The LLM implies $4.5 billion was spent on share purchases by fiscal 2024, but the original answer does not state this figure—only that remaining authorization decreased and then was replenished. There is no ground truth data on total repurchases over the period, so this number is unsupported. (3) Multi-hop reasoning: The LLM correctly identifies the trend of declining remaining authorization followed by a large new authorization, and infers a strategic commitment to capital return, which aligns with the original answer’s interpretation. This qualitative reasoning is sound and contextually appropriate. (4) Despite correct high-level interpretation and relevance to the question, the severe numerical inaccuracies—especially the erroneous $4.1 million and $3.1 million (instead of billion)—undermine factual reliability. These are not formatting issues but fundamental errors. Correctness score is low due to incorrect core data, though contextual and qualitative aspects are partially valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 526,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "Pfizer’s 2022 10‑K still treated Meridian as a discontinued operation, reporting its operating results and a $167 million net‑of‑tax loss from the sale (page 115).  In the 2023 10‑K the sale was described as complete and the company disclosed that it had entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑supply agreement (MSA) to provide a post‑sale framework, with the TSAs finished by 2023 and the amounts not material (page 73).  By the 2024 10‑K no reference to Meridian appears, indicating that the TSAs/MSA had ended or become non‑material and the post‑sale relationship had effectively dissolved (page 6).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual errors that undermine its overall accuracy. (1) Quantitatively, the $167 million net-of-tax loss is correctly stated and aligns with the ground truth. However, the claim that the sale was completed on December 31, 2021 (per original answer) contradicts the LLM's implication that it was still being reported in 2022 as a discontinued operation — while this is plausible, the LLM incorrectly implies the sale occurred during or after 2022. More critically, the LLM asserts the existence of transition-service agreements (TSAs) and a three-year manufacturing-supply agreement (MSA) post-sale, which are not mentioned in the ground truth and appear to be fabricated or misattributed. There is no evidence in the original answer of any ongoing agreements beyond the divestiture. (2) The 2024 10-K claim that 'no reference to Meridian appears' directly contradicts the ground truth, which states that Meridian *is* mentioned — specifically as 'Meridian Medical Technologies, Inc.' in the glossary. This omission of a key detail and incorrect assertion of complete absence undermines reliability. (3) The multi-hop reasoning is flawed: while the LLM attempts to trace the relationship over time, it invents operational agreements not present in the source, suggesting a failure to accurately synthesize or retrieve the correct disclosures. It incorrectly infers ongoing relationships when the truth indicates complete disengagement. (4) Despite these issues, the answer correctly identifies the discontinued operations treatment in 2022 and the $167M loss, showing partial understanding. Wording and structure are clear and relevant to the question’s scope, hence moderate contextual relevance. However, the invention of post-sale agreements and failure to note the 2024 glossary mention result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 513,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "From FY 2022 to FY 2024, the authorized pool for the Amended 2010 Share Incentive Plan grew from 127 million shares in FY 2022 (page 91) to 141 million shares in FY 2024 (page 98), with no change reported in FY 2023 (pages 81‑85). This incremental expansion shows Accenture is deliberately enlarging its share‑based compensation capacity to better attract, retain, and align talent with shareholders over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of authorized shares in FY 2022 (127 million) and FY 2024 (141 million), matching the ground truth. It also correctly notes that the number remained unchanged in FY 2023, which aligns with the original answer stating the amount was 141 million in both 2023 and 2024. The quantitative data is fully accurate. (2) All numbers are correct: 127,000,000 in 2022 and 141,000,000 in 2023–2024. The LLM uses '127 million' and '141 million', which are semantically equivalent. No calculations are required beyond recognition of the increase, which is accurately described. (3) The reasoning is sound: the LLM correctly infers that the increase indicates a strategic expansion of share-based compensation capacity. It accurately synthesizes the trend across years and draws a logical conclusion about talent attraction, retention, and alignment with shareholders—consistent with the ground truth's emphasis on employee retention and performance alignment. (4) The only minor shortcoming is that the LLM states 'no change reported in FY 2023', which could be misinterpreted as lack of data, whereas the original confirms the 141 million figure applied in both 2023 and 2024. However, the overall progression and strategic interpretation are correct. Thus, the answer is factually complete and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for phrasing ambiguity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 405,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla consistently disclosed the 4.70% Solar Bonds, Series 2015/C52‑10 in all three filings – it appears as Exhibit 4.42 on page 101 of the 2022, 2023 and 2024 10‑Ks. The unchanged description and continued inclusion indicate the bond remains outstanding and that Tesla still carries the associated interest obligation, suggesting a strategic priority to maintain this long‑term debt rather than refinance or retire it.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the exhibit numbers and filing details. According to the ground truth, the exhibit numbers changed across years: Exhibit 4.49 in 2022, 4.42 in 2023, and 4.40 in 2024. The LLM incorrectly states that the bond appears as Exhibit 4.42 in all three years, which is factually inaccurate. Additionally, the LLM claims the exhibit appears on page 101 in all filings, but this detail is not present in the ground truth and cannot be verified, introducing unverified information. (2) The bond series name and interest rate (4.70% Solar Bonds, Series 2015/C52-10) are correctly identified, and the general idea of consistency in disclosure is accurate. However, the specific document reference — the Seventieth Supplemental Indenture with filing date June 16, 2015 — is omitted, which is a key element in the original answer and supports the validity of the disclosure pattern. (3) The reasoning about ongoing obligations and strategic priorities is logically sound and aligns with the ground truth’s interpretation — the consistent re-disclosure does suggest Tesla maintains this debt structure intentionally. This shows correct multi-hop synthesis in terms of inferring strategic implications from repeated disclosures. (4) Despite correct qualitative reasoning and relevance to the question, the quantitative inaccuracies — especially the incorrect and fixed exhibit number — significantly reduce factual reliability. The answer creates a false impression of uniformity in presentation across filings, when in fact the exhibit numbering evolved, even if the underlying document remained the same. Thus, while the conclusion is plausible, it is based on incorrect supporting data, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 483,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe’s free online self‑service learning portal (learning.adobe.com) was already highlighted in the 2022 10‑K as a core element of its Digital Learning Services, positioned to help customers and partners adopt Adobe products (page 17). The 2023 filing reiterated this positioning, underscoring the portal’s role within the broader learning‑and‑enablement portfolio to accelerate customer time‑to‑value (page 18). While the 2024 10‑K does not explicitly re‑describe the free portal, it continues to frame learning and enablement—including free self‑service content—as integral to Adobe’s customer‑success and adoption strategy, reinforcing its ongoing emphasis on supporting customers’ use of Adobe’s cloud solutions (page 20).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the evolution of Adobe's free online self-service learning offerings from 2022 to 2024, noting its presence in each year's 10-K filing and its strategic role. In 2022, the LLM correctly cites the offering as a core part of Digital Learning Services (aligned with ground truth mentioning www.training.adobe.com, later consolidated under learning.adobe.com). The 2023 update accurately reflects continuity and the goal of accelerating time-to-value. For 2024, while the LLM notes the absence of an explicit re-description of the portal, it correctly infers ongoing strategic importance based on the continued emphasis on learning and enablement—this is consistent with the ground truth’s assertion that Adobe maintained its emphasis. The only minor shortcoming is that the LLM does not explicitly mention the expansion to support both Digital Experience and Digital Media products in 2023 or the focus on AI-driven tools in 2024, which slightly reduces completeness in qualitative synthesis. However, the core facts, timeline, platform (learning.adobe.com), and strategic positioning are all correct. Quantitative accuracy is perfect—no numerical errors, and dates/years are accurate. Contextual relevance is excellent, directly addressing the evolution and strategic role across the three years. The reasoning is sound, demonstrating multi-hop understanding across filings, even when information is implied rather than repeated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 418,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path strategy moved the U.S. qualified pension plan toward a more conservative mix as the plan’s funded ratio improved.  In 2022 the target allocation for the Return‑Seeking (equity) portion was 15 % (Target 2022 table, page 310).  By the 2024 target allocation, the plan had shifted to only 9 % equity (Target 2024 table, page 252), reflecting a lower growth‑asset target as the plan became better funded and the glide path reduced growth exposure in favor of liability‑hedging assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains specific quantitative claims that are not supported by the ground truth. It states that the Return-Seeking allocation was 15% in 2022 and 9% in 2024, citing exact pages and tables. However, the original answer explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts.' Therefore, these numbers are fabricated or hallucinated, making the quantitative foundation of the answer incorrect. (2) The calculation and comparison between 15% and 9% imply a 6-percentage-point de-risking, but since the numbers themselves are not present in the source material, the calculation cannot be validated and is based on false premises. (3) The reasoning about the glide path strategy—de-risking as funded status improves—is conceptually aligned with the ground truth and reflects correct multi-hop understanding of pension fund management logic. The LLM correctly identifies the mechanism of shifting from growth assets to liability-hedging assets as the plan becomes better funded. However, it overreaches by asserting specific data points not present in the source. (4) While the answer is contextually relevant and addresses the evolution of the glide path, the inclusion of unsupported numerical details severely undermines factual accuracy. The correctness score is low due to these critical quantitative inaccuracies, even though the qualitative direction of the strategy (de-risking over time) is plausible and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 417,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s Performance Materials and Technologies segment has consistently flagged raw‑material demand and supply as a major risk, with the 2022, 2023, and 2024 10‑Ks all listing “raw material demand and supply” as a key operating‑risk factor (pages 33, 32, 31).  Contract coverage of the segment’s raw‑material base rose modestly—from 63 % in 2022 to 64 % in 2023 and to a majority in 2024 (pages 33, 32, 31), reflecting incremental hedging and long‑term agreements.  Despite this improvement, the continued emphasis on price volatility and supply constraints indicates the segment remains vulnerable to commodity‑market swings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any contract coverage percentages (63%, 64%, majority) or improvements in hedging or long-term agreements. These figures are entirely fabricated and not present in the original answer or implied by the source material. There is no mention of pages 33, 32, 31 or any numerical tracking of contract coverage in the ground truth, making these specific data points incorrect. (2) The quantitative accuracy is low because the percentages cited (63%, 64%, majority) have no basis in the original answer. The original answer focuses on qualitative risk framing across years, not metrics on supply chain mitigation efforts. The LLM invents a trend of improvement in contract coverage that is not supported by the ground truth, which instead emphasizes increasing risk intensity due to energy market volatility. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies that raw material demand and supply risks were consistently mentioned across 2022–2024 in the Performance Materials and Technologies segment. It also correctly infers ongoing vulnerability to commodity markets. However, it misrepresents the trend: the original answer indicates the risk intensified due to energy price volatility, while the LLM suggests mitigation efforts (hedging, contracts) are reducing exposure—contradicting the ground truth’s conclusion of sustained and intensifying vulnerability. (4) Contextual relevance is high because the LLM addresses the right segment, time frame, and risk theme, and attempts to synthesize across years. However, the inclusion of fabricated metrics severely undermines factual correctness. The qualitative accuracy is moderate because entity identification and general risk awareness are correct, but the reasoning about risk evolution is flawed. Correctness score is 4 due to major factual errors in numbers and misrepresentation of the risk trend, despite some correct contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 557,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s non‑U.S. defined‑benefit pension plans’ mutual‑fund equity securities fell from **$239,293** in 2022 to **$196,226** in 2023, then rebounded to **$273,699** in 2024 (page 89 for 2022; page 96 for 2023‑24). This 3‑year swing—down one year, up the next—indicates the company is actively rebalancing its pension‑plan portfolio to keep equity exposure within its target range (≈20‑27 %) and to adjust to changing market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained unchanged in 2024. However, the LLM claims it rebounded to $273,699 in 2024, which is factually incorrect. This number does not match the ground truth and misrepresents the trend. Additionally, the LLM incorrectly formats the dollar amounts (e.g., $239,293 instead of $239.293 million), suggesting a misreading of units—likely confusing thousands with millions. (2) Quantitative accuracy is severely compromised: the 2024 figure is wrong, and the implied growth from 2023 to 2024 contradicts the stable allocation in the original answer. Calculations or trends based on these numbers are therefore invalid. (3) The reasoning is flawed due to incorrect data. The conclusion that ACN is 'actively rebalancing' with a rebound in 2024 contradicts the ground truth, which states there was no change in 2024, indicating stabilization, not active adjustment. The mention of a target range (≈20–27%) and market-condition adjustments introduces unsupported details not present in the original. (4) While the answer addresses the question's structure—discussing evolution and strategic implications—the use of incorrect data undermines both completeness and reasoning. The entity (ACN) and metric (mutual fund equity securities) are correct, and the time frame (2022–2024) is properly framed, but the synthesis fails due to reliance on inaccurate figures. Contextual relevance is moderate because the response attempts the right analysis but draws incorrect conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 459,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "Between 2022 and 2024 Adobe shifted Adobe Document Cloud from a mainly PDF‑and‑e‑signature platform to an AI‑enabled document‑workflow engine. The 2022 10‑K (pages 68‑72) describes Document Cloud as a unified PDF platform with Acrobat and Acrobat Sign but makes no reference to AI features. By 2024, the 10‑K (pages 12‑13) shows Firefly generative‑AI tools embedded in Acrobat, an Acrobat AI Assistant that summarizes and creates content, and enterprise‑grade Firefly Services and Custom Models that automate content generation and integrate with APIs, thereby expanding Document Cloud’s role in end‑to‑end enterprise digital workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Adobe Document Cloud from a PDF/e-signature platform in 2022 to an AI-enhanced workflow engine by 2024. The absence of AI references in the 2022 10-K and the integration of Firefly and Acrobat AI Assistant in 2024 are factually correct and consistent with the original answer. (2) Quantitative details such as page numbers (2022: pp. 68–72; 2024: pp. 12–13) are accurately cited, and no numerical errors are present. Format and references are precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and segments, noting the strategic repositioning from a legacy component to a core AI-integrated offering. It captures the shift in segment classification (implied move to Digital Media) and the expansion into enterprise automation via APIs and Custom Models, though it does not explicitly mention the 2023 transition year as a pivot point. This is a minor omission but does not undermine the overall correctness. (4) The answer is contextually excellent—directly addressing strategic positioning, AI integration (Firefly, AI Assistant), and enterprise workflow roles. Wording differs slightly from the original but maintains semantic equivalence. One point deducted from qualitative accuracy for not fully articulating the 2023 strategic elevation, which is a key link in the multi-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 403,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s 2022‑24 10‑Ks consistently flag new entrants and technology disruption across all reportable segments.  In Aerospace, the risk language notes that “new entrants and non‑traditional players” could erode market share; in Building Technologies, Energy & Sustainability Solutions, and Safety & Productivity Solutions the disclosures warn that emerging technologies and new market entrants threaten pricing power, with Safety & Productivity Solutions specifically citing product commoditization that could lower selling prices and margins.  The 2024 filings add emphasis on commoditization in Safety & Productivity Solutions, indicating a growing concern that technology disruption could further erode market share and pricing power across the business.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its portrayal of Honeywell's risk disclosures regarding competitive landscape changes from 2022 to 2024, with correct entity identification (business segments, risks like commoditization, new entrants, and technological disruption) and no numerical errors (the time frame 2022–2024 is correctly used, and no incorrect figures are cited). However, it falls short in fully capturing the evolution and expansion of the risk across years as detailed in the ground truth. Specifically: (1) The original answer notes that in 2022, the risk was limited to Building Technologies and Safety and Productivity Solutions, but the LLM implies all segments were consistently flagged across all years, missing the progressive broadening to Performance Materials and Technologies and Aerospace in 2023. (2) The 2024 restructuring and the explicit linkage of competitive risks to Industrial Automation and Building Automation (post-restructuring) is omitted, along with the increasing frequency and specificity of disclosures over time, which is a key part of the evolution. (3) While the LLM correctly identifies commoditization in Safety & Productivity Solutions in 2024, it does not reflect the strategic shift or deepening concern as clearly as the ground truth. The reasoning is sound but lacks the multi-hop synthesis of how the risk expanded across segments over time. Wording is semantically close and contextually relevant, but the answer is partially incomplete in capturing the temporal progression and structural changes. Quantitative accuracy is perfect—no numbers or dates are incorrect. Contextual relevance is high as it directly addresses the question’s focus on competitive exposure, market entrants, tech disruption, and impacts on pricing and market share.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 486,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "Pfizer’s post‑spin‑off relationship with Viatris was governed by transition‑service, MSA and TSA agreements that enabled Pfizer to bill, collect and remit rebates on Viatris’ behalf.  In 2022 the net intercompany balance owed to Viatris under those agreements was $94 million, which dropped to $33 million in 2023 as the TSAs were largely completed【page_12】.  By 2024 the 10‑K contains no Viatris reference (pages 3‑7), indicating the transition arrangements had been fully resolved and the intercompany balances were no longer material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial figures and timeline: $94 million due to Viatris in 2022 and $33 million in 2023, both matching the ground truth. It accurately states that TSAs were largely completed by the end of 2023. The conclusion that by 2024 the relationship was no longer materially referenced in the 10-K aligns with the ground truth's statement that Viatris was only mentioned in corporate definitions, indicating resolution. (2) Quantitative accuracy is perfect: both dollar amounts and years are correct, and the decreasing trend is properly conveyed. There are no calculation errors. (3) The multi-hop reasoning is sound—linking the decline in intercompany balances with the winding down of TSAs and inferring full resolution by 2024 based on absence of mention in the 10-K is logically supported. However, the LLM slightly mischaracterizes the agreements by mentioning 'MSA' (Master Services Agreement), which is not in the original answer or commonly referenced in this context, and says 'Pfizer to bill, collect and remit rebates on Viatris’ behalf,' which adds operational detail not present in the ground truth and may be inaccurate. This minor overreach affects qualitative accuracy slightly. (4) Contextual relevance is high—the answer directly addresses the evolution of financial and operational ties, including transition services and intercompany balances across all three years. Overall, the answer is factually aligned with minor issues in entity precision, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 427,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "Altria’s 2022 10‑K listed four note series—1.000% Notes due 2023, 1.700% Notes due 2025, 2.200% Notes due 2027 and 3.125% Notes due 2031【page_1】. By 2023 the 1.000% 2023 notes were retired, leaving a three‑note structure that persisted into 2024【page_1】. The 1.700% Notes due 2025 now serve as the sole short‑ to mid‑term debt, positioned between the higher‑coupon 2027 and 2031 notes, reflecting a deliberate laddered maturity strategy that balances liquidity with moderate interest costs and a gradual shift toward longer‑term financing【page_1】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, percentages, and maturities are correct: the 1.000% Note due 2023, 1.700% due 2025, 2.200% due 2027, and 3.125% due 2031 are accurately reported, and the retirement of the 2023 note by 2023 is correctly noted. (2) The answer correctly tracks the evolution from 2022 to 2024: in 2022, four notes including the 1.000% due 2023; by 2023 and into 2024, that note is gone, leaving the 1.700% as the shortest-dated, which matches the ground truth. (3) The reasoning about a 'laddered maturity strategy' and 'gradual shift toward longer-term financing' is a reasonable interpretation that aligns with the ground truth's conclusion about focusing on intermediate and long-term debt rather than rolling over short-term obligations. The only minor difference is that the LLM adds interpretive language ('deliberate laddered maturity strategy') not explicitly in the ground truth, but this is a logical inference and not factually incorrect. (4) All entities (Altria, note percentages, maturities, years) are correct. The answer fully addresses the multi-hop aspects: changes over time, the role of the 1.700% Note due 2025 relative to others, and implications for capital structure. Thus, the answer is semantically equivalent and highly contextually relevant. Minor deduction in qualitative accuracy only because the ground truth emphasizes the absence of a replacement for the 2025 note as a strategic signal, which the LLM does not explicitly mention, though the overall interpretation is consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 437,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from $19.975 billion at a weighted‑average rate of 2.91 % in 2022 to $27.168 billion at 4.45 % in 2023, then fell slightly to $26.93 billion at 4.84 % in 2024 【page_188】【page_178】【page_188】. The upward shift in both balance and rate indicates the company is expanding its fixed‑rate debt base while accepting higher rates, suggesting a strategy to lock in financing before further rate hikes and to diversify its funding mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative data: carrying values of $19,975 million (expressed as $19.975 billion) in 2022, $27,168 million ($27.168 billion) in 2023, and $26,930 million ($26.93 billion) in 2024 — all accurate with acceptable formatting variations. Weighted-average interest rates are correctly stated as 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024. (2) All numbers match the ground truth exactly; no calculation errors are present. The slight drop in carrying value from 2023 to 2024 is correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes data across years and correctly infers a strategic shift toward issuing more fixed-rate debt at higher rates. The interpretation aligns with the ground truth, though it emphasizes 'locking in financing before further rate hikes' rather than 'capitalizing on investor demand or funding growth initiatives.' While this nuance differs slightly, it remains a plausible and logical interpretation given rising rates. (4) The answer is fully contextually relevant, addressing both the evolution of debt metrics and the implied borrowing strategy. Only a minor difference in strategic interpretation prevents a perfect 10 on qualitative accuracy. Overall, the response is factually complete, numerically precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 373,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla continues to list the 5.45% Solar Bonds, Series 2015/C92‑15 as an outstanding long‑term debt instrument in its 2022, 2023, and 2024 10‑K filings (see Exhibit 4.6 in each filing)【page_103】【page_102】【page_102】.  The bond has remained in use for financing solar projects throughout this period, with no indication of repayment or new issuance of this series, underscoring Tesla’s strategy of leveraging long‑term, fixed‑rate SolarCity debt to fund its solar expansion rather than shifting to equity or short‑term financing.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies that Tesla listed the 5.45% Solar Bonds, Series 2015/C92-15 in its 2022–2024 10-K filings as part of its long-term debt. The bond series and interest rate are accurate. However, the LLM incorrectly states that the bond is referenced in 'Exhibit 4.6 in each filing'—this is false. According to the ground truth, the bond appears in Exhibit 4.61 (2022), Exhibit 4.54 (2023), and Exhibit 4.52 (2024), with exhibit numbers differing across years. This misrepresentation suggests a failure to accurately extract document-specific details, undermining reliability. (2) Quantitatively, the interest rate (5.45%) and bond series (C92-15) are correct, and no incorrect numerical values (e.g., dollar amounts, dates) are introduced. However, the claim of consistent exhibit numbering is factually wrong and reflects poor attention to detail in source documentation. (3) The reasoning is partially sound but flawed in synthesis. The LLM correctly infers that continued listing implies ongoing recognition of the debt, but it fails to note the declining prominence emphasized in the ground truth. Crucially, it omits the emergence of newer bond series (e.g., C102-15, C106-10) in later filings, which the original answer identifies as evidence of a strategic shift. Thus, the LLM incorrectly concludes Tesla is 'leveraging' this specific debt for solar expansion, while the truth indicates it is maintaining legacy obligations but shifting to newer instruments. This misreads the strategic implication. (4) Contextual relevance is strong—the answer addresses Tesla’s solar financing strategy and uses appropriate terminology. However, due to incorrect exhibit references and failure to capture the evolution toward newer bonds, the qualitative accuracy and overall correctness are significantly reduced. The answer presents a static view instead of the dynamic progression described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 542,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "From 2022 to 2024 AIG moved from a largely internal review and escalation framework (review and challenge of reserves, model‑risk validation, actuarial profitability reviews and experience monitoring) to a more formal governance structure that includes ERM Second‑Line review, internal audit oversight and risk‑committee reporting.  Modeling practices remained consistently sophisticated—pricing and risk‑selection models, stochastic and scenario analyses, and third‑party catastrophe models with bias and data‑quality adjustments—while 2024 added explicit sensitivity and scenario tools to the risk‑measurement suite.  External review integration evolved from implicit internal checks in 2022–23 to a structured ERM‑and‑audit oversight process in 2024, providing a clearer, more formalized external‑review component even though explicit external expert reviews are not highlighted.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's loss reserves risk management from 2022 to 2024. (1) Key elements such as the shift toward more formal governance, inclusion of ERM second-line review, internal audit oversight, and risk-committee reporting in 2024 are accurately captured. Modeling approaches like stochastic methods, scenario analyses, and use of third-party catastrophe models are correctly noted as consistently sophisticated, with sensitivity and scenario tools explicitly added in 2024. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time across oversight, modeling, and external review. However, there is a slight discrepancy: the original answer explicitly states that external expert reviews were used in 2022 and continued in 2023, whereas the LLM suggests external reviews evolved from 'implicit internal checks' and that explicit external expert reviews are 'not highlighted' in 2024—this understates the continuity of external expert involvement noted in the ground truth. (4) Despite this nuance, the overall trajectory and key developments are correctly conveyed, with strong contextual relevance and factual alignment on core aspects. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 427,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension plan allocation to U.S. Treasury and foreign government securities fell from $1,147 million in 2023 (U.S. government and agencies $1,114 m + foreign $33 m) to $562 million in 2024 (U.S. government and agencies $508 m + foreign $54 m) – a decline of roughly 51 %【page_87】【page_90】. While the 2022 figure is not disclosed in the excerpts, the downward trend from 2023 to 2024 indicates a deliberate shift away from these low‑yield, highly liquid instruments as part of Altria’s liability‑driven investment strategy that balances pension liability hedging with asset growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The ground truth states that Altria's allocation to U.S. Treasury and foreign government securities was 19% in 2022, 16% in 2023, and 8% in 2024 — these are percentage allocations, not absolute dollar amounts. However, the LLM incorrectly reports absolute dollar values ($1,147 million in 2023 and $562 million in 2024), which misrepresents the nature of the data. These figures may reflect total holdings in U.S. government and agencies plus foreign securities, but they do not align with the percentage-based trend described in the original answer. Furthermore, the LLM claims the 2022 figure is 'not disclosed,' contradicting the ground truth, which explicitly provides the 19% allocation for 2022. (2) Calculations are based on incorrect data types: comparing dollar amounts instead of percentages leads to a misleading 51% decline claim, which is not equivalent to the actual 19% → 16% → 8% percentage-point decline. The model fails to report the correct multi-year trend in allocation percentages, omitting the 2022 baseline and distorting the evolution. (3) The reasoning partially captures the strategic shift away from government securities, correctly identifying a move away from low-yield instruments and linking it to liability-driven investing. However, it omits key supporting evidence from the ground truth, such as the reduction in below-investment-grade securities (from 11% to 9%) and the decline in expected return on pension assets from 6.6% to 6.1%, which strengthen the conclusion of a more conservative posture. (4) While the LLM identifies the general direction of change (decreasing allocation), it fails on core quantitative accuracy due to misrepresenting percentages as absolute values and omitting the 2022 data point. This undermines the correctness score despite some contextual relevance and plausible qualitative interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 528,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and rose modestly to $562 million in 2024, while long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 and then fell to $44.9 billion in 2024, resulting in a net decline in total borrowings from $48.7 billion to $45.6 billion over the three years. The company eliminated its floating unsecured senior debt (from $1.6 billion in 2022 to zero in 2024, carrying a 6.75% rate) and shifted toward fixed‑rate senior debt (carrying value ~ $27 billion, weighted average rate rising from 4.45% to 4.84%), while securitized debt obligations fell from $18.0 billion to $14.3 billion with a modest increase in weighted average rate (3.01% to 3.48%). These changes indicate a deliberate move to a more fixed‑rate, lower‑volume debt structure that reduces exposure to floating‑rate volatility.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect figures, with significant discrepancies in key numbers. The original answer states that Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM claims total borrowings were $48.7B in 2022, $49.838B in 2023 (sum of $538M + $49.3B), and $45.462B in 2024 — all of which are misaligned with the ground truth. The LLM incorrectly separates short-term and long-term components and miscalculates the starting total. For example, it reports short-term borrowings as $883M in 2022, but the original does not provide this breakdown explicitly; instead, the $43.086B total includes both categories. The LLM’s claim of long-term debt rising from $47.8B to $49.3B in 2023 contradicts the original, where total debt (short + long) was $48.715B — meaning long-term debt alone could not have been $49.3B. (2) Some numbers are approximately correct: the 2024 securitized debt of $14.3B (~$14.264B actual) and its rate increase from 3.01% to 3.48% are accurate. The elimination of floating unsecured senior debt by 2024 (from $1.709B in 2022 to $0) is directionally correct, though the LLM cites $1.6B instead of $1.709B. However, it incorrectly states that floating unsecured senior debt carried a 6.75% rate in 2022 — when in fact, that rate applied only in 2023. The fixed-rate senior debt increase to ~$27B by 2024 is close to the actual $26.930B, but the LLM claims the 2022 rate was 4.45%, while the original states 2.91%, a major discrepancy. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward fixed-rate debt and reduced floating-rate exposure, which aligns with the original conclusion. It identifies the retirement of floating debt and the rise in fixed-rate debt costs as indicators of hedging against rising rates. However, it misses the key 2023 spike in floating unsecured debt to $349M at 6.75% and fails to note the significant increase in securitized debt in 2023 before its 2024 decline. (4) Despite numerical inaccuracies, the LLM captures the overall trend of de-risking floating-rate exposure and shifting to fixed-rate financing, making the answer contextually relevant and qualitatively reasonable. Hence, correctness is scored at 5 due to material quantitative errors undermining full accuracy, though core directional insights are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 651,
        "total_tokens": 2196
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022 (Exhibit 4.29, page 100), 2023 (Exhibit 4.36, page 102), and 2024 (Exhibit 4.29, page 100) all list the 5.45% Solar Bonds, Series 2015/C25‑15, showing that the company continues to use this long‑term debt to finance its SolarCity‑derived solar assets. The repeated inclusion signals that the bond remains an outstanding obligation and a key component of Tesla’s debt mix, underscoring its ongoing role in the company’s capital structure and its strategy to fund solar projects through a stable, fixed‑rate instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key details are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15) and its consistent appearance across 2022, 2023, and 2024 filings are accurately referenced. While the LLM does not explicitly mention the 'Thirty-Sixth Supplemental Indenture' or the exact date 'April 14, 2015' from the ground truth, it correctly identifies the bond's ongoing inclusion in Tesla’s filings, which implies its active status. The exhibit numbers (4.29, 4.36) and page numbers add precision and are consistent with typical 10-K disclosure practices. (2) The percentage (5.45%) and bond name are exact matches. No calculations are required, but the inference of 'ongoing reliance' is logically sound. (3) The reasoning is strong: the LLM correctly synthesizes multi-year filing data to conclude that the bond remains an active, strategic part of Tesla’s capital structure for solar financing. It appropriately links the bond to SolarCity-derived assets, which is contextually accurate given Tesla’s acquisition history and solar financing structure. (4) The answer fully addresses both parts of the question—Tesla’s reliance on the instrument and its role in capital structure—with semantically equivalent and factually correct reasoning. The only minor omission is the lack of explicit mention of the supplemental indenture and exact issuance date, which slightly reduces qualitative completeness but does not undermine the core correctness. Overall, the answer is factually sound, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 441,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s balance‑sheet shows a steady rise in its Class A treasury‑stock balance: it was $51.4 billion at year‑end 2022, grew to $60.4 billion in 2023, and reached $71.4 billion by 2024 【page_72】【page_71】【page_68】. This upward trend reflects an expanding share‑repurchase program, indicating that the company is actively returning capital to shareholders and using buybacks as a key tool to manage its capital structure and support share value.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024, with values of $51.4 billion, $60.4 billion, and $71.4 billion, respectively. These figures are numerically consistent with the ground truth values of $(51,354) million, $(60,429) million, and $(71,431) million when converted to billions and rounded to one decimal place. The slight discrepancy in the 2022 figure (51.4B vs. 51.354B) is due to rounding and is acceptable under format variation rules. (2) All calculations and comparisons are accurate: the values increase each year, and the LLM correctly identifies this as a steady rise. There are no mathematical or logical errors in the interpretation. (3) The multi-hop reasoning is sound—information is synthesized across three years and correctly attributed to Mastercard’s capital allocation behavior. The conclusion that this reflects an expanding share repurchase program and a strategy of returning capital to shareholders aligns with the ground truth’s interpretation of growing emphasis on buybacks. (4) The answer is contextually complete and relevant, addressing both parts of the question: the evolution of treasury stock and its implication for capital allocation. The only minor limitation is the lack of explicit negative sign notation (treasury stock as contra-equity), but this does not affect the semantic correctness in a business context where dollar amounts are understood by magnitude. Thus, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 432,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions risk factor was identical in the 2022, 2023 and 2024 10‑Ks (2022 page 33; 2023 page 31; 2024 page 32), all warning that “reduced investments in process automation, safety monitoring and plant capacity‑utilization initiatives…could lower market share, selling prices and margins.” The unchanged wording shows that the segment’s exposure to adverse industry economic conditions—particularly the slowdown in automation and capacity‑utilization spending—remained high throughout the period, reflecting persistent macro‑economic headwinds such as inflation, high borrowing costs and supply‑chain uncertainty that kept industrial customers cutting back on capital investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Honeywell's Safety and Productivity Solutions segment faced consistent exposure to adverse economic conditions from 2022 to 2024, specifically citing reduced investments in process automation and plant capacity utilization as key risks. The core facts—unchanged risk factor language across all three years, the specific risks mentioned, and their impact on market share, prices, and margins—are factually correct and consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; all dates and page references (2022 p.33, 2023 p.31, 2024 p.32) are presented as specific citations and assumed accurate based on the model’s training data. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings to infer persistent risk, and correctly interprets the unchanged wording as evidence of sustained macroeconomic pressure. The only minor shortcoming is that the LLM does not explicitly note the evolution in tone or emphasis described in the ground truth—particularly the 2024 sharpening of focus on geopolitical instability and trade policy shifts. While the LLM attributes the persistence to inflation, high borrowing costs, and supply-chain issues (plausible and contextually reasonable), it misses the nuanced escalation in concern reflected in the original answer. (4) Despite this slight omission, the answer remains contextually rich, directly responsive, and semantically equivalent in substance. The conclusion about persistent macroeconomic headwinds is fully supported and relevant. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 511,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "Cyramza’s approved therapeutic indications remained unchanged from 2022 through 2024, covering second‑line treatment of gastric, NSCLC, colorectal cancers and hepatocellular carcinoma, and first‑line EGFR‑mutated NSCLC (2022 10‑K p. 5; 2024 10‑K p. 6).  However, its intellectual‑property exclusivity is winding down: the compound patent expires in 2026 in the U.S. and Japan and 2028 in Europe, while biologics data protection ends in 2026 in the U.S., 2024 in Europe and already expired in Japan (2023 10‑K p. 11).  These dates signal a transition toward the end of Cyramza’s lifecycle and the potential arrival of generic competition.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Cyramza's therapeutic indications remained stable from 2022 to 2024, covering second-line treatments for gastric, NSCLC, colorectal, and hepatocellular cancers. However, it incorrectly adds 'first-line EGFR-mutated NSCLC' as an indication, which is not present in the ground truth and may represent a factual error or overattribution. (2) Regarding intellectual property, the LLM states that the compound patent expires in 2026 in the U.S. and Japan and 2028 in Europe — this partially aligns with the ground truth (U.S. 2026, Europe 2028), but the ground truth does not mention Japan compound patent expiration in 2026, instead noting data protection expired there in 2023. The LLM incorrectly states biologics data protection ends in 2026 in the U.S., whereas the ground truth implies data protection timelines are shorter — expiring in 2023 in Japan and 2024 in Europe — but does not specify U.S. data protection expiration. This creates a discrepancy, particularly the claim of 2026 U.S. data protection expiry, which lacks support. (3) The multi-hop reasoning is generally sound — the model synthesizes information across years and domains (indications and IP), and draws a reasonable conclusion about lifecycle transition. However, the inclusion of an unsupported indication and inaccuracies in data protection dates reduce quantitative accuracy. (4) The contextual relevance is high, as the response directly addresses both therapeutic indications and IP timeline evolution. The qualitative reasoning is strong despite factual inaccuracies in specific dates and indications. The correctness score is 7 due to core accurate synthesis but notable factual errors in key details, particularly around data protection timelines and indications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 487,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets grew markedly from 2022 to 2024 – $5 million at year‑end 2022, $58 million at year‑end 2023, and $69 million at year‑end 2024 (Table 16.2/17.2, page 216 & 206 & 217).  The fair‑value measurement of these derivatives remained primarily Level 3, with vendor‑based models that rely on significant unobservable inputs such as discount rates and swap rates; the discount rate used rose from 1‑2 % in 2022/23 to 4 % in 2024 (Table 17.3, page 217).  Correspondingly, net unrealized gains shifted from a $33 million loss in 2022 to a $63 million gain in 2023 and a $25 million loss in 2024, reflecting the evolving valuation assumptions (Table 16.2/17.2, page 216 & 206 & 217).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Capital One's net derivative assets/liabilities were $19M in 2022, $58M in 2023, and $58M in 2024. The LLM incorrectly reports $5M in 2022 and $69M in 2024, which are materially wrong. Additionally, the ground truth mentions net losses of $20M still held in the portfolio in 2022, but the LLM reports a $33M loss, which does not match. The LLM also introduces 'net unrealized gains' shifting to a $63M gain in 2023 and $25M loss in 2024—this data is not in the ground truth and appears fabricated. (2) The unobservable inputs are partially correct but misstated: the LLM mentions 'discount rates' rising from 1–2% to 4%, but the ground truth refers to swap rates (3–5%, weighted at 4%) and default rates (53–163%), not discount rates. The LLM conflates terms and introduces a metric (discount rate) not emphasized in the original. (3) The multi-hop reasoning is flawed: while the LLM attempts to track changes over time and links valuation to unobservable inputs, it fails to correctly synthesize the actual data across years. The conclusion about 'evolving valuation assumptions' is based on incorrect numbers and misidentified inputs. (4) Despite the factual errors, the answer is contextually relevant—it addresses the evolution of derivative valuation, fair value measurements, and unobservable inputs as asked. However, due to major quantitative inaccuracies and incorrect reasoning, the correctness score is low. Minor credit is given for correctly identifying the $58M figure in 2023 and recognizing the use of Level 3 fair value models with unobservable inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 460,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "Qualcomm’s charitable match program kept a “thousands‑of‑employees” participation level in both fiscal 2022 and 2024, but the breadth of impact narrowed from more than 1,500 charities in 2022 to over 1,300 in 2024. This sustained employee engagement is part of the company’s human‑capital strategy, with progress on charitable giving serving as a non‑financial modifier of executive bonuses under the HR and Compensation Committee’s oversight in each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitative accuracy: The numbers for employee participation ('thousands' in both 2022 and 2024) and supported organizations (over 1,500 in 2022, over 1,300 in 2024) are correctly reported, with acceptable phrasing variations ('more than' = 'over'). No calculations were required. (2) Completeness: The answer addresses both parts of the question—evolution of employee participation and number of organizations, and the link to executive compensation. It correctly notes sustained participation and slight reduction in organizations, and ties charitable engagement to executive bonuses via non-financial modifiers. (3) Entity accuracy: Correct company (Qualcomm), correct years (2022, 2024), correct program (charitable match), and correct governance body (HR and Compensation Committee). (4) Reasoning: The multi-hop synthesis—linking program metrics to human capital goals and executive compensation—is sound and logically presented. (5) Semantic equivalence: The LLM conveys the same core information as the original answer, though it omits a minor detail about the 2025 DEI goals. This omission does not detract from the main points but slightly reduces completeness, justifying a 9 instead of 10 on qualitative accuracy. Overall, the answer is concise, accurate, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 381,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "In the 2022 filing (page 7) Adobe described Acrobat as the flagship PDF engine of its Document Cloud, emphasizing web‑ and mobile‑first functionality, a single‑click “Acrobat Web” experience, expanded task‑based actions, and tight integration with Adobe Sign and Sensei‑driven AI, all of which were being made available through APIs to unlock business workflows. The 2023 filing (page 5) reiterated Acrobat’s core role within Document Cloud and its integration with Sign and other services, but did not list any new product enhancements beyond the ongoing web and mobile focus. The 2024 filing (pages 94‑98) continues to present Acrobat as the central PDF experience in Document Cloud, with a continued emphasis on web functionality, AI, and API integration, although the specific pages provided contain no additional Acrobat‑specific enhancements.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant omissions and inaccuracies in qualitative synthesis, particularly regarding the evolution of Acrobat's positioning from 2022 to 2024. (1) Correct elements: The answer correctly identifies Acrobat as a core component of Document Cloud and notes integration with Adobe Sign and AI (Sensei) in 2022, which aligns with the ground truth. It also references web- and mobile-first functionality and API access, which are consistent with the strategic direction. There are no numeric values to verify, so quantitative accuracy is scored as 10. (2) However, the LLM incorrectly states that the 2023 filing 'did not list any new product enhancements'—this contradicts the ground truth, which highlights the expansion of Acrobat’s positioning to include AI-powered innovation and integration with Creative Cloud tools. The 2023 filing did include forward-looking statements about AI-driven features, which the LLM omits. (3) Most critically, the LLM fails to mention the 2024 introduction of the 'Acrobat AI Assistant' as a registered trademark, a key strategic shift signaling Adobe’s move toward intelligent automation in document workflows. This omission represents a failure in multi-hop reasoning, as the evolution from a document standard to an AI-enhanced platform—a central theme in the ground truth—is not conveyed. (4) The contextual relevance is moderate: the answer stays on topic and references the correct product and ecosystem, but misses the core narrative of AI-driven transformation. Thus, while factually consistent in parts, the LLM answer lacks the depth and progression described in the original, resulting in a correctness score of 5 due to major gaps in qualitative accuracy and incomplete synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 483,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 the AbCellera collaboration generated $2.02 billion in net product revenue from bamlanivimab and bebtelovimab sales, with AbCellera receiving mid‑to‑mid‑twenty‑percent royalties recorded as cost of sales【page_73】. By 2023 and 2024, the company had no sales of these antibodies, so net product revenue fell to zero and no royalty payments were recorded【page_73】【page_72】, marking a sharp decline in the collaboration’s financial impact after 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures and timelines: $2.02 billion in net product revenue in 2022, zero sales and royalties in 2023 and 2024. The royalty range is accurately described as 'mid-to-mid-twenty-percent', which aligns with the ground truth's 'mid-teens to mid-twenties percentage range'. (2) All numbers, dates, and dollar amounts are factually correct. The revenue figure ($2.02 billion) matches exactly. The absence of sales and royalty payments in 2023 and 2024 is correctly reported. No calculations are required, but the trend description ('sharp decline') is consistent with the data. (3) The multi-hop reasoning is sound: the model synthesizes information across years and entities (LLY, AbCellera), correctly linking revenue to royalty payments and recognizing the cessation of both over time. The citation of specific pages (73, 72) suggests proper grounding in source material. (4) The answer is semantically equivalent to the ground truth, with only minor wording differences (e.g., 'recorded as cost of sales' is additional detail not in the original but plausible and non-contradictory). The only reason for not scoring a 10 is the slightly less detailed explanation of the cause (e.g., no mention of regulatory changes or EUA), but this does not affect factual correctness. All core elements of the question—revenue, royalties, evolution over 2022–2024—are fully addressed with high accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 403,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "From 2022 through 2024, MetLife consistently reinsured **59 % of its closed block** through a modified coinsurance agreement (page 227, page 204, page 206). This unchanged percentage shows the company’s deliberate, long‑term risk‑transfer strategy—maintaining a stable, predictable approach to managing closed‑block exposure rather than shifting the mix of reinsurance arrangements over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, it correctly states that MetLife reinsured 59% of its closed block from 2022 to 2024. The ground truth specifies 59.25% in 2022 and exactly 59% in 2023 and 2024; the LLM rounds 59.25% to 59%, which is a minor but acceptable simplification given the context of multi-year trend analysis. (2) The answer is complete, addressing both the evolution of the percentage (consistency over time) and the implication for MetLife’s long-term risk transfer strategy. (3) Entities—MetLife, closed block, modified coinsurance agreement, and the three-year timeframe—are correctly identified. (4) The reasoning is sound: the LLM correctly infers that the stable percentage reflects a deliberate, long-term strategy to maintain predictable risk exposure, which aligns with the ground truth’s interpretation of strategic continuity. The only minor shortcoming is the lack of explicit mention of the slight drop from 59.25% to 59%, but this does not undermine the overall correctness. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 327,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s 2022 10‑K outlined a multi‑layered security program that relied mainly on internal controls and industry‑standard safeguards. By 2023 the filing expanded that narrative to explicitly include collaboration with third‑party providers and public‑private partnerships and to detail the rollout of real‑time account‑based payment infrastructure to 13 markets. In 2024 the approach further emphasized monitoring threats from third‑party services, added domestic processing in China, and continued real‑time coverage, underscoring a shift toward a proactive, partnership‑driven cybersecurity strategy that prioritizes real‑time threat detection and rapid response.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in its portrayal of Mastercard's evolving security strategy from 2022 to 2024. It accurately notes the increasing emphasis on third-party collaboration and real-time payment infrastructure. The number of real-time payment markets is correctly stated as 13 in 2023, matching the ground truth. However, the 2022 figure of 12 markets is omitted in the LLM answer, which instead focuses on the shift in narrative without quantifying the earlier footprint. The 2024 description uses 'continued real-time coverage' rather than the more precise 'several countries globally' from the original, which is semantically close but slightly less specific. The mention of 'domestic processing in China' is not present in the ground truth and appears to be extraneous or incorrectly inferred, potentially from another section of the filing not reflected in the knowledge graph. (2) Quantitatively, the 13 markets in 2023 is accurate. The absence of the 12-market figure from 2022 reduces completeness but does not introduce error. No incorrect calculations are made, as none were required. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes across years, identifies the trend toward third-party integration, and links it to a proactive cybersecurity posture. The evolution in language—from internal controls to partnership-driven models—is well captured. However, the addition of 'domestic processing in China' as part of the security evolution is not supported by the ground truth and may reflect a conflation with another strategic initiative. (4) The correctness score is 8 due to accurate core facts and logical flow, with minor omissions and one unsupported detail. Quantitative accuracy is 9 because only one number is mentioned and it is correct, though one is missing. Qualitative accuracy is 8 due to strong reasoning but minor overreach in content. Contextual relevance is 10 as the answer directly addresses the question’s focus on evolution, third-party collaboration, and real-time infrastructure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 556,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "From 2022 to 2023, LLY’s equity‑like fund allocation grew from $4.014 B to $4.094 B (2023 table, page 100), then fell to $3.932 B in 2024 (2024 table, page 99). The modest rise and subsequent slight decline indicate a stable, long‑term commitment to illiquid equity‑like investments, with periodic rebalancing to manage risk and liquidity while pursuing moderate‑to‑high returns (2022 table, page 99). This trend suggests the company views illiquid assets as a core, diversified component of its growth strategy rather than a transient allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and trend. According to the ground truth, LLY's allocation to equity-like funds increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip to $4,014.1 million in 2023. However, the LLM incorrectly states that the allocation was $4.014B in 2022 (should be $2.845B), rose to $4.094B in 2023 (close but misattributed), and then fell to $3.932B in 2024 (incorrect—ground truth is $4,093.7M, or ~$4.094B). Thus, the LLM reverses the actual trend and misreports the starting value. (2) The quantitative inaccuracies are severe: the 2022 figure is off by over $1.17 billion, and the 2024 figure is understated. Additionally, the LLM cites page numbers and documents without verifying the actual data, leading to incorrect synthesis. (3) The reasoning is flawed because it interprets a slight decline in 2024 as part of the trend, when in fact the overall trajectory is strongly upward from a much lower 2022 base. The conclusion about 'stable commitment' and 'periodic rebalancing' does not align with the ground truth, which indicates a strategic increase reflecting growing confidence in private markets. The multi-hop synthesis failed—correctly linking three years of data across filings was not achieved. (4) Despite incorrect facts and reasoning, the answer remains contextually relevant by addressing the right company (LLY), asset class (equity-like private alternatives), and strategic implications of illiquid investments, hence a moderate score for contextual relevance. However, the core numerical and inferential errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 457,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "Cascade remained positioned as a major laundry‑detergent brand under the **Fabric Care** sub‑category of the Fabric & Home Care segment.  The segment’s share of net sales rose from **35 % in 2022** to **36 % in 2023 and 2024**, indicating a stable or slightly higher relative contribution (2022 = page 18, 2023 = page 18, 2024 = page 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the Fabric & Home Care segment's net sales contribution was 35% in 2022 and 36% in both 2023 and 2024, as confirmed in the original answer. The LLM correctly reports these percentages and attributes them to the correct years. (2) The answer correctly identifies Cascade as part of the Fabric Care sub-category within the Fabric & Home Care segment, which is consistent with its positioning in the filings. While the original answer emphasizes Cascade's 'continued strategic importance' and 'stable positioning,' the LLM captures this through the observation of stable segment contribution and Cascade's ongoing prominence. (3) The multi-hop reasoning is sound—linking Cascade’s categorization over three years with the segment’s evolving sales share—and correctly infers consistent contribution from stable segment performance. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention Cascade’s 'relative contribution' to net sales beyond segment-level data, though it implies it through context. Wording differs slightly but maintains semantic equivalence. Citations to page 18 for each year support transparency, though not required. Overall, the answer is factually correct, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 374,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "From 2022 to 2024, Lowe’s moved from a baseline supplier‑sustainability framework—requiring compliance with its human‑rights, conflict‑minerals, and Vendor Code of Conduct policies—to a risk‑based wood‑sourcing policy that added country‑specific risk levels, enhanced monitoring practices, and a new forestry grievance process (2023 and 2024 updates).  The company also broadened its monitoring by encouraging suppliers to report emissions to CDP and partnering to cut scope‑3 emissions.  Parallel to these policy upgrades, Lowe’s ramped up its investment strategy, spending over $300 million in the past three years on renewable‑energy projects, solar panel installations (100+ sites by fiscal 2024), and the SmartWay transportation program, thereby deepening its commitment to a low‑carbon supply chain.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Lowe's sustainability evolution from 2022 to 2024, including enhancements to its wood sourcing policy such as country-specific risk levels, improved monitoring, and the introduction of a forestry grievance process in 2023. It also correctly notes the emphasis on supplier accountability and broader environmental goals. However, there are significant factual inaccuracies in quantitative details. The ground truth states that Lowe's invested over $550 million in environmental facility upgrades in 2022 and committed $50 million to the Gable Grants program in 2023, but the LLM incorrectly reports 'over $300 million in the past three years' on renewable energy and solar projects—this figure does not match the original data and misrepresents both the amount and the nature of the investments. Additionally, the LLM introduces unverified elements such as CDP reporting encouragement and SmartWay program participation, which are not present in the original answer and cannot be confirmed from the provided truth. While the qualitative progression of policy development is partially accurate, especially for 2023–2024, the answer omits key specifics like the alignment with long-term shareholder value in 2024 and fails to mention the Gable Grants investment entirely. The multi-hop synthesis is partially sound but undermined by incorrect financial figures and unsupported claims. Semantic equivalence is moderate—core themes align, but critical details are inaccurate or missing, particularly around investment amounts and programs. Thus, the correctness score is reduced due to major quantitative errors despite some correct policy-level descriptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 461,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "From 2022‑2024 Honeywell’s risk disclosures for Safety and Productivity Solutions (page 29, 30, 31) and Building Technologies/Automation (page 29, 30, 31) consistently warned that new entrants, emerging technologies and product commoditization could erode market share, lower prices and margins.  In 2024 the newly‑created Industrial Automation segment added a similar risk, explicitly noting “product commoditization” and “new market entrants” (page 31), underscoring a broader exposure to competitive pressures across the business.  This steady escalation in the language and scope of the risk factors signals that Honeywell is confronting intensifying market competition and commoditization risks over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Honeywell highlighted competitive landscape risks due to new entrants and emerging technologies leading to commoditization and margin pressure, first in Safety and Productivity Solutions (2022), then Honeywell Building Technologies (2023), and finally Industrial Automation (2024). The LLM correctly identifies the progression across these segments and the intensifying nature of market pressures. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022–2024) and sequence of disclosures are accurate. Page references (e.g., page 29, 30, 31) are extraneous but do not affect factual correctness. (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures across multiple business units and years, correctly inferring that the expansion of similar risk language to Industrial Automation in 2024 indicates broadening systemic risk. (4) The only minor shortcoming is that the LLM combines 'Building Technologies/Automation' and does not explicitly separate Honeywell Building Technologies (2023) from Industrial Automation (2024) in the timeline as clearly as the original answer. It also refers to Industrial Automation as 'newly-created'—a plausible inference but not stated in the ground truth. Despite this, the overall meaning, progression, and conclusion about increasing commoditization risks are semantically equivalent. Hence, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 448,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 MD&A framed the automotive transformation as a key growth area, positioning its high‑performance, low‑power mobile chips as the foundation for a software‑defined vehicle and digital cockpit (page 8).  In 2023 the company’s segment reporting (Note 8, page 73) showed automotive revenue of $1.872 bn—up 24 % from $1.509 bn in 2022—indicating early traction, with the revenue recognized at point‑in‑time for equipment sales.  By 2024 automotive revenue rose to $2.910 bn (a 55 % increase from 2023) and became a larger share of the QCT segment’s $33.2 bn total revenue, underscoring Qualcomm’s shift from a strategic enabler to a primary supplier of digital‑cockpit hardware.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's strategic evolution from 2022 to 2024 with accurate financial figures: $1.509B in 2022, $1.872B in 2023 (24% increase), and $2.910B in 2024 (55% increase from 2023). These numbers match the ground truth data and are correctly cited in the context of segment reporting and revenue growth. The mention of QCT segment revenue ($33.2B in 2024) is also accurate and relevant. (2) Quantitative accuracy is high: all dollar amounts, percentages, and year-over-year growth rates are correct and consistent with disclosed filings. The 24% and 55% growth figures are mathematically accurate based on the reported numbers. (3) However, the LLM answer omits key qualitative aspects of the ground truth: it does not explicitly mention the shift from forward-looking market opportunity (2022) to monetization (2023) and then to structured integration into segment reporting (2024). While it references 2023 segment reporting (Note 8), it fails to clarify that digital cockpit products were formally grouped with automotive connectivity and ADAS/AD under a unified framework in 2024, which is a critical part of the strategic evolution. The answer emphasizes hardware supply and revenue growth but underrepresents the organizational and reporting integration that signifies full strategic embedding. (4) Despite strong quantitative support and contextual relevance—accurately anchoring the discussion in MD&A and segment disclosures—the answer falls short in fully synthesizing the multi-hop progression from vision to integration. It captures the financial trajectory well but misses nuanced shifts in product categorization and reporting structure that define Qualcomm’s strategic maturation in the digital cockpit market.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 481,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "From 2022 to 2024, Frame.io’s core media support stayed the same—video, still images, design files and PDFs—while its key integrations with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront remained unchanged (ADBE_10k_2022, p. 98; ADBE_10k_2023, p. 12; ADBE_10k_2024, p. 12).  The 2023 and 2024 filings added that Frame.io is now positioned within Adobe GenStudio and is integrated with Adobe Express and Adobe Firefly Services, thereby expanding its enterprise‑scale collaboration and content‑production capabilities (ADBE_10k_2023, p. 12; ADBE_10k_2024, p. 12).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in describing the evolution of Frame.io from 2022 to 2024. (1) Quantitatively, there are no numeric values to verify, so the score is 10 by default—no incorrect numbers or dates were stated. (2) However, the qualitative accuracy is low: the claim that 'core media support stayed the same' and that integrations 'remained unchanged' contradicts the ground truth. The original answer shows a clear expansion: in 2023, Frame.io was integrated with Premiere Pro and After Effects and supported video, images, design files, and PDFs; by 2024, it expanded into casting, location scouting, and marketing campaign management—new functional areas beyond post-production—and added integrations with Photoshop, Lightroom, and Workfront. The LLM incorrectly asserts these integrations were unchanged from 2022, but in 2022, Frame.io was only noted as a trademarked product with no described integrations or functional details. (3) The LLM correctly identifies the inclusion of Frame.io in Adobe GenStudio and new integrations with Adobe Express and Firefly Services in 2023–2024, which aligns with enterprise expansion. However, it fails to capture the evolution of supported media types and cross-product integrations over time, misrepresenting the progression. (4) Contextual relevance is high because the answer addresses the right topic and cites appropriate documents, but the reasoning is flawed in synthesizing the multi-hop evolution across years. The answer omits key developments and incorrectly asserts stability where there was significant change, leading to a correctness score of 5—partially correct but with major omissions and inaccuracies in the core narrative of functional expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 477,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022 to 2024, Mastercard’s Class A shares saw the dividend per share climb from $2.04 (2022) to $2.37 (2023) to $2.74 (2024), while the voting structure—one vote per share and dividend rights—remained unchanged in each filing. The unchanged voting rights and steady dividend growth indicate that the company’s shareholder‑governance framework has been stable, preserving consistent voting power for public investors over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces specific dividend per share amounts ($2.04, $2.37, $2.74) for 2022–2024, which are not present in the ground truth. The original answer states only that 'Dividend rights' were maintained, without specifying amounts or asserting growth. These figures are factually unsupported by the provided truth and represent a significant quantitative inaccuracy. (2) While the voting rights description ('one vote per share') is correctly reported as unchanged, the addition of numerical dividend data and the claim of 'steady dividend growth' goes beyond the evidence in the ground truth, which makes no mention of per-share dividend amounts or trends. (3) The reasoning about governance stability is logically sound *if* the data were correct, and the model correctly identifies the multi-hop element of analyzing trends over three years. However, the synthesis is based on fabricated financial data, undermining the conclusion. (4) The contextual relevance is high because the answer addresses both dividend and voting rights over time and attempts to infer governance stability. The qualitative accuracy is moderate because entity (MA's A Class shares) and time period (2022–2024) are correct, and the unchanged voting rights are accurately noted, but the unsupported dividend figures severely compromise factual correctness. Thus, the overall correctness score is low due to the invention of specific dividend numbers not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 412,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions segment has been hit by retail‑market swings each year: in 2022 sales dipped 1 % (to $6.91 bn) after the sale of its retail‑footwear business, in 2023 sales fell $1.42 bn (to $5.49 bn) and profit dropped $179 m (to $901 m) as lower demand for projects and products hit Warehouse & Workflow and Productivity Solutions, and in 2024 net sales rose to $6.24 bn with profit $1.49 bn but margin slipped 10 bp to 23.7 %—all underscoring the segment’s persistent vulnerability to consumer‑demand volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the numerical data. The ground truth does not provide specific sales or profit figures for Honeywell's Safety and Productivity Solutions segment across 2022–2024, nor does it mention a 1% sales dip in 2022 due to a retail-footwear business sale. There is no mention in the original answer of a $1.42B sales decline in 2023 or a $179M profit drop. The 2024 figures of $6.24B in net sales and $1.49B in profit with a 10 bp margin decline to 23.7% are not present in the ground truth. These numbers appear fabricated or misattributed. (2) The quantitative inaccuracies are severe and pervasive. The LLM introduces precise financial figures that are not supported by the original answer, which focuses on qualitative risk disclosures rather than performance metrics. There are no calculations in the ground truth to verify, but the LLM invents them, failing the quantitative accuracy test. (3) The multi-hop reasoning is partially sound in structure—linking retail market exposure to segment vulnerability over time—but flawed in execution. The LLM correctly identifies the segment’s ongoing sensitivity to retail volatility, aligning with the ground truth’s theme of persistent risk. However, it misrepresents the evidence by substituting qualitative risk disclosures with false quantitative performance data. It also fails to note the 2024 rebranding to Industrial Automation clearly, instead treating the segment as unchanged. (4) The contextual relevance is moderate because the answer addresses the core theme of retail market impact and consumer demand vulnerability. However, the qualitative accuracy is low due to incorrect entities (implied financials, unmentioned divestitures) and flawed reasoning based on invented data. The correctness score is low because the answer is factually incorrect despite capturing the general direction of the risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 524,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Olumiant collaboration with Incyte kept the same tiered royalty framework: Incyte receives double‑digit royalties up to 20 % on worldwide net sales of Olumiant, plus an additional low‑teens royalty on COVID‑19 sales that exceed a specified threshold (added in the 2020 amendment). Milestone payments were capitalized as intangible assets each year, but after 2022 the amounts were not material (the 2022 filing noted $260 M and $210 M capitalized, while 2023‑24 filings report no material milestone payments), and Incyte remained eligible for up to $100 M in potential sales‑based milestones. The COVID‑19 indication remained part of the agreement throughout this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core royalty structure correctly—Incyte receives up to 20% on worldwide net sales and an additional low-teens royalty on COVID-19 sales above a threshold, consistent from 2022 to 2024. It also correctly notes the continuation of the agreement and the diminishing role of milestone payments. However, there are key quantitative inaccuracies: the original answer states Incyte was eligible for up to $100M in regulatory milestones and $100M in sales-based milestones in 2022 (total $200M potential), but the LLM claims $260M and $210M were capitalized in 2022, which contradicts the ground truth and introduces unsupported figures. The ground truth does not specify exact capitalized amounts in 2022, only that milestones were capitalized starting in 2023. The LLM incorrectly implies these large amounts were capitalized in 2022 and then dropped to zero, which misrepresents the evolution. (2) The LLM incorrectly suggests that milestone payments were capitalized 'each year' and that $260M/$210M were capitalized in 2022, but the original answer states capitalization began in 2023. This is a significant factual and temporal error. Also, the claim that Incyte remained eligible for up to $100M in sales-based milestones in 2024 conflicts with the original answer’s implication that most contingent payments had likely been triggered or expired by 2024. (3) The multi-hop reasoning is partially sound—LLM connects royalty structure, milestone treatment, and indication continuity across years—but misrepresents the timing and magnitude of financial flows. (4) Despite these errors, the LLM retains the essential narrative of a shift from milestones to stable royalties and maintains correct entity and indication tracking, warranting a 7 for overall correctness. Quantitative accuracy is penalized due to fabricated numbers; qualitative and contextual scores remain high due to structural and conceptual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 527,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "Procter & Gamble has kept Always as a core brand in the Feminine‑Care sub‑category of its Baby, Feminine & Family Care segment, where it appears among the segment’s major brands in 2022 and 2023 (Always, Always Discreet, Tampax Bounty, Charmin, Puffs)【page 18 of 2022】【page 18 of 2023】. In 2024 the segment’s product mix broadened to add a Baby‑Care sub‑category (Baby Wipes, Taped Diapers and Pants) and two new major brands—Luvs and Pampers—yet Always remained a key brand alongside the new additions (Luvs, Pampers, Always, Always Discreet, Tampax Bounty, Charmin, Puffs)【page 18 of 2024】, indicating that while the brand mix expanded, Always retained its prominence as a leading menstrual‑care brand.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies that significantly deviate from the ground truth. (1) The claim that in 2024 the segment added a 'Baby-Care sub-category' with Luvs and Pampers is incorrect according to the original answer, which states that the categorization in 2024 remained consistent with 2023 and focused on Feminine Care evolution, not expansion into Baby Care. Luvs and Pampers were already established brands under P&G and were not newly added as 'major brands' in the segment in 2024. (2) The original answer emphasizes a strategic repositioning of Always toward 'menstrual care' specifically, reflected in the updated category name from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023 and 2024. The LLM answer misses this key semantic shift and instead fabricates an expansion into baby care, which is not supported by the ground truth. (3) The LLM incorrectly lists Bounty, Charmin, and Puffs as part of the Feminine Care sub-category in both years, but these are Family Care brands and their inclusion in this context misrepresents the segment structure. (4) While the LLM correctly notes that Always remained prominent across years, it fails to capture the core evolution—refinement of product categorization and strategic positioning around menstrual care—instead inventing a narrative about segment broadening that contradicts the original. (5) The citation of 'page 18' for all years adds false specificity not present in the ground truth and cannot be verified. Overall, the answer gets some brand names and the idea of continuity right, but the key strategic insight—the sharpened focus on menstrual care—is missed and replaced with incorrect structural claims, leading to a low correctness score despite partial factual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 495,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "ACN’s 2023 target allocation (reported in the 2022 filing, page 88) was 100 % debt for U.S. plans and 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other for non‑U.S. plans. In the 2023 filing (page 95), the 2024 target shifted to 94 % debt and 6 % cash for U.S. plans and to 23 % equity, 42 % debt, 5 % cash, 21 % insurance and 9 % other for non‑U.S. plans. The 2025 target (also on page 95) returned U.S. plans to 100 % debt and increased non‑U.S. equity to 28 %, debt to 36 %, cash to 7 %, insurance to 21 % and other to 8 %. These gradual, incremental changes—especially the steady rise in equity exposure for non‑U.S. plans while keeping U.S. plans heavily debt‑weighted—show ACN’s intent to enhance risk‑adjusted returns in foreign plans while preserving a conservative, duration‑matching strategy for U.S. liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) QUANTITATIVE INACCURACY: The percentages provided (e.g., 100% debt for U.S. plans, specific non-U.S. breakdowns) are not supported by the ground truth. The original answer states that the strategy emphasized a diversified portfolio with liability duration matching but does not specify exact percentages by asset class or region. The LLM fabricates granular allocations (e.g., 27% equity, 48% debt, etc.) and implies precise shifts across years that are not present in the ground truth. There is no mention in the original answer of U.S. vs. non-U.S. plan allocations or changes in equity/debt/cash percentages. (2) COMPLETENESS: While the LLM attempts to address the evolution across years, it invents data rather than describing the actual progression. The original answer highlights that the 2023 filing introduced the fiscal 2025 target and the 2024 filing reaffirmed it, but does not provide year-by-year allocation percentages. The LLM incorrectly asserts specific targets for 2023, 2024, and 2025 with fabricated numbers. (3) ENTITY & REASONING: The LLM misrepresents the nature of the strategy evolution. The ground truth emphasizes strategic continuity and flexibility, not a 'gradual rise in equity exposure' or tactical shifts in U.S./non-U.S. plans. The conclusion about enhancing risk-adjusted returns in foreign plans while keeping U.S. plans conservative is speculative and not supported by the original answer. (4) SEMANTIC EQUIVALENCE: The LLM answer is not semantically equivalent—it replaces a high-level, accurate description of strategic consistency with a detailed but false narrative of quantitative shifts. The contextual relevance is moderate because it addresses the right topic (pension allocation evolution and risk/liability balance), but the factual foundation is incorrect. Overall, the answer fails on correctness due to hallucinated data and flawed reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 530,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s used forward‑interest‑rate swaps as cash‑flow hedges for forecasted debt issuances.  In 2023 the swaps had a Level 2 fair‑value of $251 million, but by the 2024 filing the company had no forward‑swap exposure, indicating the hedges were settled or no longer needed.  The consistent Level 2 classification and cash‑flow hedge accounting—recognizing effective gains and losses in OCI and amortizing them to interest expense—shows that Lowe’s actively manages interest‑rate risk but has scaled back that exposure as its debt‑issuance plans changed.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are accurate: the $251 million fair value in 2023 is correctly cited, and the absence of forward swaps in 2024 is properly noted. The Level 2 classification is also accurately mentioned. (2) The answer correctly identifies the use of forward interest rate swaps as cash flow hedges for forecasted debt issuances, consistent with the 2022 and 2023 disclosures. (3) However, the LLM misses a key qualitative shift in hedge accounting treatment: while it correctly notes the cessation of forward swaps, it does not mention that Lowe's replaced them with fixed-to-floating interest rate swaps used as *fair value hedges* in 2024. This is a significant strategic shift from cash flow to fair value hedging, which the original answer highlights as evidence of a move from managing forecasted issuance risk to managing existing debt exposure. The LLM attributes the change to 'debt-issuance plans changing,' which is plausible but less precise than the ground truth's insight about a more stable capital structure and reduced sensitivity to future volatility. (4) Despite this omission, the answer remains factually sound, contextually relevant, and correctly synthesizes multi-hop information across years and accounting treatments. The reasoning is logical, though slightly less comprehensive in strategic interpretation. Hence, minor deduction from qualitative accuracy and overall correctness, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 429,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s exposure to the 5.000 % senior notes due April 2030 was **$606 million at the end of FY 2022, FY 2023, and FY 2024** (the debt schedule in each year’s 10‑K lists the same principal balance).  The unchanged balance shows the company is holding the notes to maturity rather than refinancing or repaying early, underscoring a conservative debt‑management strategy that prioritizes predictable, low‑cost long‑term financing and a stable capital structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that AVGO's exposure to the 5.000% notes due April 2030 was $606 million in FY 2022, FY 2023, and FY 2024. The ground truth shows the exposure was $1,086 million in 2022, declining to $606 million in 2023 and 2024. This error misrepresents the trend entirely. (2) The quantitative inaccuracy is significant: the model reports a flat $606M across all three years, missing the $480M reduction from 2022 to 2023. This undermines the entire analysis. While $606M is correct for 2023 and 2024, the incorrect 2022 value invalidates the comparison. (3) The multi-hop reasoning fails because the model did not correctly synthesize the year-over-year change, which is central to the question. Instead of identifying a deliberate debt reduction strategy, it concludes a static strategy due to 'unchanged balance,' which contradicts the actual data. (4) Contextual relevance is moderate because the answer addresses the right financial instrument and general topic of debt management, but the incorrect data leads to a flawed interpretation. The conclusion about a 'conservative strategy' is not supported by the actual repayment pattern shown in the ground truth. Scores reflect major factual and reasoning errors despite correct identification of the debt instrument and general context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 374,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS’s 7.620% debentures were first described in the 2022 10‑K as a $276 million issuance that had an 8.375% coupon until April 1, 2020, when the rate was cut to 7.620% for the remaining term (page 120).  The 2023 and 2024 10‑Ks (pages 103 and 108) simply refer to the debentures as 7.620% with no mention of the earlier rate change, but keep the same redemption terms—redeemable at any time at the greater of principal + accrued interest or the present value of remaining payments discounted at a benchmark treasury yield + 5 bps (plus accrued interest)—and the same semi‑annual interest schedule and maturity of April 1, 2030.  Thus, the coupon shift was noted only in 2022, while the redemption mechanics and maturity structure remained unchanged through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the debentures have a principal of $276 million, mature on April 1, 2030, and the interest rate was reduced from 8.375% to 7.620% in April 2020. The 2022 10-K noted this rate change, while 2023 and 2024 filings consistently report only the 7.620% rate, which matches the original answer. Redemption terms are accurately described as callable at any time, with the redemption price based on the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus 5 bps (plus accrued interest). The semi-annual interest schedule and absence of sinking fund requirements are implied through consistency. (2) Quantitative elements—$276 million, 7.620%, 8.375%, April 1, 2030 maturity, and +5 bps—are all factually correct and precisely reported. (3) The multi-hop reasoning across 2022–2024 disclosures is sound: the model correctly identifies that the rate change was disclosed only in 2022 and not reiterated in later years, reflecting evolving disclosure emphasis. (4) The only minor shortcoming is that the 2024 emphasis on semi-annual payments and explicit confirmation of no sinking fund, highlighted in the ground truth, is not explicitly mentioned in the LLM answer—this is a small omission in completeness but does not undermine the core accuracy. Overall, the answer is semantically equivalent and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 417,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "In 2022 Amgen positioned Olpasiran as a phase‑2 siRNA that lowers lipoprotein(a) to reduce atherosclerotic cardiovascular disease (ASCVD) risk. By 2023 the program had advanced to phase‑3 trials for ASCVD and remained in phase‑3 in 2024, underscoring a sustained focus on cardiovascular indications. The company’s composition‑of‑matter patents for Olpasiran, issued in both the U.S. and Europe, are projected to expire in 2036, giving the program a decade‑plus exclusivity window that supports its strategic positioning.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies Olpasiran as an siRNA targeting lipoprotein(a) for cardiovascular disease in 2022 and accurately reports the 2036 patent expiration in both the U.S. and Europe, which aligns with the ground truth. However, it incorrectly states that Olpasiran advanced to phase-3 trials by 2023 and remained in phase-3 in 2024. The ground truth confirms it was still in phase-2 development in 2022 and only repositioned with a broader 'cardiovascular disease' indication in 2024—there is no evidence of phase-3 progression. This is a major factual error affecting the clinical phase progression narrative. (2) Quantitatively, the patent expiration date (2036) is correct, and no other numbers (e.g., financials) are present. The years 2022, 2023, and 2024 are used appropriately in structure, though the phase assignment in 2023–2024 is wrong. (3) The multi-hop reasoning is partially sound—linking therapeutic focus, IP protection, and strategic positioning across years—but fails on clinical phase progression, a core component. The model synthesizes IP and therapeutic intent but misrepresents development stage, undermining the overall accuracy. (4) Contextual relevance is high, as the answer addresses all dimensions of the question (therapeutic focus, clinical phase, IP), but the incorrect phase advancement reduces correctness. The strategic rationale around 2036 patents is well interpreted. Due to the critical error in clinical phase status, the correctness and qualitative accuracy scores are moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 444,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "Tampax has remained in the same “Feminine Care (Adult Incontinence, Feminine Care)” sub‑category of the Baby, Feminine & Family Care segment throughout 2022‑2024.  While it stayed listed as a major brand, the 2024 MD&A shows a more focused set of major brands—Always, Always Discreet, Tampax Bounty, Charmin, and Puffs—compared with the broader 2022 list that also included Luvs and Pampers, indicating a shift in brand prominence within the segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the categorization of Tampax over the years. According to the ground truth, in 2022, the segment was 'Baby, Feminine & Family Care' with sub-category 'Feminine Care (Adult Incontinence, Feminine Care)', but in 2023, P&G reclassified it to 'Feminine Care (Adult Incontinence, Menstrual Care)', indicating a change in labeling. However, the LLM incorrectly states that the sub-category remained the same throughout 2022–2024, which contradicts the evolution described in the original answer. Additionally, the LLM claims that in 2024 the MD&A shows a more focused set of major brands including 'Tampax Bounty'—a non-existent brand name (likely a conflation of Tampax and Bounty), which is a critical error. (2) There are no numeric values or calculations to verify, so quantitative accuracy is based on correct dates and category names; while years are correct, the category labels are not accurately represented across years. (3) The multi-hop reasoning is flawed: the model fails to recognize the reclassification in 2023 and incorrectly infers a shift in brand prominence based on an erroneous list of brands. It also does not acknowledge the 2024 return to the 'Baby, Feminine & Family Care' segment name, missing the nuance of structural consistency with minor labeling refinements. (4) Despite these issues, the answer correctly identifies Tampax as consistently prominent and part of the same broader segment, maintaining relevance to the question’s focus on positioning and prominence. Hence, partial credit is given for contextual understanding, but major deductions apply for factual and qualitative inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 464,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s filings show no internally‑developed designations for non‑agency RMBS or CMBS in any of the three years.  In 2022 the RMBS and CMBS totals on page 102 are broken out by NAIC designations 1‑6; the same is true for the 2023 totals on page 96 and the 2024 totals on page 86, where every RMBS and CMBS line is assigned an NAIC category.  The note that “an internally developed designation is used only when no NAIC designation is available” appears in each filing (page 101, 96, 86).  Thus, MetLife’s reliance on internal designations remained essentially zero from 2022 through 2024, indicating that NAIC designations were consistently available for all non‑agency RMBS and CMBS and that the company’s acquisition strategy focuses on securities that are already evaluated by the NAIC (or are evaluated promptly thereafter).",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) It claims MetLife used no internally-developed designations in 2022–2024, directly contradicting the ground truth that such designations were consistently applied when NAIC evaluations were not yet available. (2) The LLM cites page numbers and formatting details (e.g., breakdowns by NAIC 1–6) to support its claim, but this does not negate the existence of internal designations—these are used precisely when NAIC ratings are absent, and their mention in footnotes (as noted by the LLM) actually supports the ground truth. (3) The multi-hop reasoning fails: the persistence of the footnote stating internal designations are used when NAIC ratings are unavailable indicates ongoing reliance on such designations, not their absence. (4) The conclusion that MetLife only acquires NAIC-evaluated securities contradicts the ground truth’s indication of proactive investment in newly issued or complex securities where NAIC lags. The LLM misinterprets the presence of NAIC categories in reporting as evidence of no internal use, when in reality, internal designations are interim measures before NAIC classification. Thus, all accuracy scores are low due to a critical factual and logical error, despite correct citation of document structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 366,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "Accenture repurchased 12.18 million shares in fiscal 2022 for $4.11 million, with $3.13 million of available authorization (page 94). In fiscal 2024 it bought 2.07 million shares (≈$4.11 million) and had $2.69 million of available authorization, while the Board lifted total authorized authority to $6.69 billion (page 39). The trend shows a consistent dollar‑level buy‑back policy amid a higher share price and a larger overall authorization pool, underscoring a flexible, shareholder‑friendly capital‑return strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It states that Accenture repurchased 12.18 million shares in fiscal 2022 for $4.11 million, which is incorrect—the original answer does not mention the number of shares repurchased in 2022 or the dollar amount spent that year, only that $3.13 billion in authorization was available. The LLM incorrectly reports $4.11 million (not billion) as the repurchase amount, a massive order-of-magnitude error. Similarly, it claims 2.07 million shares were bought in fiscal 2024 for approximately $4.11 million, but the ground truth states 2,000,308 shares were purchased for $605 million in Q4 2024—not $4.11 million. The available authorizations are also misstated: the LLM says $3.13 million and $2.69 million, but the correct figures are $3.13 billion and $2.69 billion—again, off by a factor of 1,000. While it correctly notes the total authorization was increased to $6.69 billion, it fails to mention the key detail that this resulted from a $4 billion addition on September 25, 2024. (2) Calculations and numbers are severely flawed: all dollar amounts involving authorization and repurchases are reported in millions instead of billions, rendering them factually wrong. The share counts are partially accurate (2.07 million vs. 2.00 million) but tied to incorrect dollar values. (3) The multi-hop reasoning is weak: the model attempts to infer a consistent buyback policy but bases it on fabricated or distorted data. It fails to correctly synthesize the evolution of available authorization across 2022–2024, missing the increase in 2023 and the timing of the September 2024 boost. (4) Despite significant factual inaccuracies, the answer addresses the general theme of capital return strategy and attempts to interpret the trend, which provides some contextual relevance. However, due to pervasive quantitative errors, the correctness score is low. The qualitative reasoning is partially sound in intent but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 540,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Broadcom has consistently listed **industrial fiber optics** as a core product within its industrial end‑market portfolio in all three years—2022 (page 10), 2023 (page 5), and 2024 (page 5)—and the description of the fiber‑optic component line has remained largely unchanged, emphasizing its role in high‑speed Ethernet, storage, and metro/long‑haul telecom applications. This steady positioning shows that Broadcom treats fiber optics as a foundational part of its high‑speed connectivity strategy, maintaining a balanced but not aggressively expanding focus on the industrial market rather than shifting toward a dedicated industrial‑only emphasis.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its qualitative assessment and fails to accurately reflect the evolution of Broadcom's industrial fiber optics product positioning as described in the ground truth. While it correctly identifies that industrial fiber optics were mentioned across 2022–2024 (and cites plausible page numbers), there are critical inaccuracies in interpretation: (1) The claim that the description 'remained largely unchanged' contradicts the ground truth, which shows a clear evolution from a broad portfolio mention in 2022, to structured categorization in 2023, to application-specific alignment in 2024. (2) The LLM incorrectly states that fiber optics emphasize 'high-speed Ethernet, storage, and metro/long-haul telecom applications'—this pertains to communications infrastructure, not the industrial end market. In contrast, the ground truth shows industrial fiber optics were increasingly tied to factory automation, renewable energy, and automotive electronics. (3) The conclusion that Broadcom maintains a 'balanced but not aggressively expanding focus' misrepresents the strategic shift toward more targeted industrial applications, suggesting a static strategy when the evidence points to increasing application focus and maturity. There are no numeric values to verify, so quantitative accuracy is not penalized. However, the multi-hop reasoning fails—instead of synthesizing changes in product categorization and application linkage over time, the model asserts consistency and telecom-centric use, which is factually wrong. Contextual relevance is moderate because it addresses Broadcom and industrial fiber optics over time but misattributes market focus and strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 464,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "UPS SurePost has continued to serve as a residential ground service for non‑urgent, lightweight shipments, but its delivery model shifted over the period.  In 2022 and 2023 the service relied on the U.S. Postal Service for final delivery (“final delivery was often provided by USPS”)【page_5_2022】【page_5_2023】.  By the 2024 filing UPS announced a strategic change: starting January 1 2025 it will insource SurePost, moving final delivery from USPS to UPS’s own network to gain greater control and improve service reliability【page_5_2024】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UPS SurePost served as a residential ground service for non-urgent, lightweight shipments; in 2022 and 2023, final delivery was handled by USPS; in 2024, UPS announced a strategic shift to insource final delivery starting January 1, 2025. (2) Quantitative elements—specifically the date 'January 1, 2025'—are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three years (2022, 2023, 2024) and identified both the continuity in the delivery model and the strategic change announced in 2024. (4) Entity accuracy is perfect: 'UPS SurePost', 'U.S. Postal Service (USPS)', and the correct timeline are all properly identified. The answer fully addresses the question’s focus on evolution, reliance on USPS, and strategic changes. Minor wording differences (e.g., 'insource' vs 'integrated delivery model') do not affect factual equivalence. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 307,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 portfolio grew from 13 programs in 2022 to 18 in 2023 and 24 in 2024. In 2022, three programs received regulatory approvals, four entered Phase 3 and one was terminated, while by 2024 five programs were acquired from Horizon, three new Phase 3 studies were initiated, one program received FDA approval and one program concluded. This steady expansion—through internal development, strategic acquisitions and regulatory milestones—underscores Amgen’s deliberate scaling of its R&D pipeline, emphasizing human‑genetics‑driven therapeutics and broader therapeutic breadth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Amgen's Phase 3 programs from 2022 to 2024. Quantitatively, it correctly states the increase from 13 programs in 2022 to 18 in 2023 and 24 in 2024, aligning with the ground truth (13 as of Feb 8, 2022; 18 as of Jan 31, 2023; 24 as of Jan 31, 2024). The mention of five programs acquired from Horizon is correct and matches the ground truth that the acquisition added five Phase 3 programs. The LLM also correctly notes new initiations and regulatory approvals, though it specifies 'three new Phase 3 studies initiated' in 2024, while the ground truth notes five new initiations by Feb 4, 2025 (per the 2024 filing). This slight discrepancy in the number of new initiations (3 vs 5) and the lack of mention of the increase to 25 programs by early 2025 reduces quantitative accuracy slightly. However, the overall trend and key milestones (FDA approval, program conclusion, acquisition impact) are correctly synthesized. The reasoning is sound: the LLM correctly infers that the growth reflects a strategic R&D expansion combining internal development and external acquisition. It appropriately links the Horizon acquisition to pipeline growth and emphasizes therapeutic diversification and genetics-driven development, which is consistent with Amgen’s stated strategy. All entities (Amgen, Horizon Therapeutics, FDA, Phase 3 programs) are accurate. The answer addresses all parts of the question—quantitative evolution, development milestones, and strategic implications—with strong multi-hop reasoning across time points and sources. The wording differs from the original but maintains semantic equivalence. The only minor omission is the final count of 25 programs and the Japan regulatory approval, which slightly affects completeness. Overall, the answer is factually strong, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 506,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "Accenture increased the maximum number of Class A ordinary shares authorized for the Amended 2010 Share Incentive Plan from **127 million in FY 2022** (page 91) to **141 million in FY 2024** (page 98).  The upward adjustment reflects a deliberate expansion of the share‑based compensation pool, enabling the company to issue larger or more flexible awards to attract, retain, and align talent with long‑term shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers: 127 million shares in FY 2022 and 141 million in FY 2024, matching the ground truth. Although the original answer specifies that the 141 million was effective in FY 2023 and continued into FY 2024, the LLM omits the FY 2023 detail but does not contradict it—instead, it focuses on the endpoint (FY 2024), which is factually accurate. This is a minor omission, not an error. (2) Quantitative accuracy is perfect: 127 million and 141 million are correctly reported, with acceptable formatting (127 million = 127,000,000). The increase of 14 million shares is implied and consistent. (3) The reasoning is sound: the LLM correctly infers that the increase reflects a strategic expansion in share-based compensation to support talent attraction, retention, and alignment with shareholder value—this aligns with the ground truth’s interpretation. (4) Contextual relevance is excellent: the answer addresses both parts of the question—evolution of share authorization and its strategic implication—with precise, relevant information. The only reason for not scoring a 10 is the slight incompleteness regarding the FY 2023 continuation, which was explicitly stated in the original answer. However, since the LLM does not claim the change occurred in 2024 (only reports the 2024 figure), this is a nuance rather than a factual flaw.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 385,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks’ 2022 and 2023 10‑K filings both stated that purchase commitments and existing inventory would cover green coffee through **fiscal 2023** (page 12, 2022 & 2023).  In the 2024 10‑K the company extended that coverage to **fiscal 2025** (page 12, 2024).  The shift shows Starbucks is maintaining a robust inventory buffer and using long‑term contracts and hedging to extend supply coverage and mitigate price and supply‑risk volatility.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Starbucks' green coffee supply coverage: from covering through fiscal 2023 in the 2022 and 2023 filings, to extending coverage through fiscal 2025 in the 2024 filing. However, it inaccurately states that both the 2022 and 2023 10-Ks projected coverage only through fiscal 2023. According to the ground truth, by fiscal 2023, the projection had already extended to cover through fiscal 2025, not fiscal 2023. This misrepresents the timeline of the change. (2) The dates and fiscal years are mostly correct, but the key error lies in the misattribution of the extension timing—claiming the extension occurred in the 2024 10-K when it actually occurred between fiscal 2022 and 2023. The final state (coverage through fiscal 2025 as of 2024) is accurate. (3) The multi-hop reasoning is partially sound—synthesizing across years and identifying strategic implications of long-term contracts and hedging is correct. However, the reasoning is based on an incorrect timeline, weakening the accuracy of the synthesis. (4) Despite the timing error, the answer captures the core trend (increased coverage) and correctly infers strategic implications around risk management and inventory buffering. Hence, scores are high but reduced due to the significant misstatement about when the projection changed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 379,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "From 2022 through 2024 UPS kept the UPS/IBT Full‑Time Employee Pension Plan unchanged, with no plan amendments or remeasurements disclosed for those years (see 2022 filing, p. 90). In 2023 the plan was affected by a new five‑year national master agreement ratified by Teamsters employees, which increased wage and benefit rates for Teamsters in the plan and was reflected in the year‑end measurement (2023 filing, p. 82). No further amendments, remeasurements, or collective‑bargaining changes were reported for the plan in 2024 (2024 filing, p. 86).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a critical factual error regarding the 2022 remeasurement. The ground truth states that in 2022, the plan was remeasured due to the American Rescue Plan Act, resulting in a $3.3 billion pre-tax gain. However, the LLM claims no remeasurement or amendment was disclosed in 2022, directly contradicting the ground truth. This is a major omission and factual inaccuracy. The 2023 information about the new collective bargaining agreement and its impact on wage and benefit rates is correctly identified and aligns with the original answer. The 2024 status is also consistent—no further changes reported. (2) Quantitatively, the LLM fails to report the $3.3 billion pre-tax ($2.5 billion after-tax) gain from the 2022 remeasurement, a significant financial figure central to the plan’s treatment. Its silence on these numbers results in a low quantitative accuracy score. (3) The reasoning is sound for 2023 and 2024, showing awareness of collective bargaining impacts and year-end measurement effects. However, it fails the multi-hop requirement by not connecting the 2022 regulatory change (American Rescue Plan Act) to the remeasurement and financial impact, which is a key part of the evolution. (4) Contextual relevance is high because the answer addresses the timeline, plan status, and collective bargaining impacts as asked. However, due to the missing 2022 remeasurement and financial figures, the overall correctness is significantly reduced. The answer gives a false impression of stability in 2022 when a major financial event occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 440,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Walmart has kept “Holiday Time” in the same place in its private‑label lineup for three consecutive years—listed alongside Great Value, Mainstays, and Way to Celebrate on the private‑brand roster in the 2022, 2023 and 2024 10‑Ks【page_7】【page_7】【page_7】.  The brand’s name and placement imply it is used for holiday‑season items, and its unchanged categorization shows Walmart treats seasonal merchandise as a stable, low‑price component of its broader private‑label strategy rather than shifting it into a new category or brand.  This consistency signals the company’s intent to rely on a dedicated seasonal private brand to capture holiday demand while maintaining the overall EDLP positioning of its private‑label portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core reasoning and contradicts the ground truth. While it correctly identifies that 'Holiday Time' appears in Walmart's private brand lists across fiscal years 2022, 2023, and 2024 (supporting entity and date accuracy), it incorrectly asserts that the categorization and strategic positioning remained unchanged. The ground truth states that in fiscal 2024, Walmart restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a strategic shift in how 'Holiday Time' and similar offerings are positioned. The LLM instead claims there was 'unchanged categorization' and that Walmart treats seasonal merchandise as a 'stable, low-price component' without structural changes—this directly conflicts with the documented 2024 strategic evolution. The reasoning is therefore flawed in a critical multi-hop aspect: synthesizing changes over time. While the mention of EDLP and holiday demand is contextually plausible, the conclusion about stability misrepresents the strategic shift revealed in the 2024 filing. Quantitative accuracy is high because no numerical errors were made—dates and brand names are correct. Contextual relevance is moderate because the answer addresses the right brands and time frame but misses the key insight about evolving strategic positioning. The answer fails to reflect the increasing strategic importance of seasonal planning, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 411,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "The fair value of the pension plan’s mutual‑fund equity securities was **$239,293 million in 2022**, declined to **$196,226 million in 2023**, and then increased to **$273,699 million in 2024** (all figures as of August 31 each year). This pattern shows a deliberate rebalancing of the plan’s equity allocation—after a contraction in 2023 the company restored and exceeded prior levels in 2024, indicating a strategic shift toward higher equity exposure to meet long‑term return objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly reports the 2022 ($239.293 million) and 2023 ($196.226 million) values, it falsely claims the value increased to $273,699 million in 2024, whereas the ground truth states it remained unchanged at $196.226 million. This is a critical error in both magnitude and trend. Additionally, the LLM incorrectly formats the numbers as 'million' when it writes '$239,293 million', which would be $239.293 trillion—off by a factor of 1,000. (2) Quantitative accuracy is severely compromised: the 2024 figure is entirely wrong, and the formatting error suggests a misunderstanding of units. The correct trend is a decline followed by stability, not a rebound. (3) The reasoning is flawed: the LLM infers a strategic shift toward higher equity exposure due to an increase in 2024, which did not happen. The actual trend suggests a reduction and stabilization, indicating a possible de-risking or rebalancing away from equities, contrary to the LLM's conclusion. (4) Contextual relevance is moderate—the answer addresses the right asset class and time frame and attempts strategic interpretation—but the incorrect data undermines the entire analysis. The answer fails the primary requirement of factual correctness in a multi-hop financial trend question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 370,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks’ 2022, 2023, and 2024 10‑K filings all note that green‑coffee price volatility is influenced by commodity‑index and hedge‑fund trading in the arabica futures market and that the company hedges “C”‑price exposure with forward contracts, futures contracts and collars [page_12]. The supply‑commitment horizon expanded from covering the next fiscal year in 2022 (through fiscal 2023) to extending two years ahead in 2024 (through fiscal 2025) [page_12, page_14], indicating a more forward‑looking risk‑management stance. This evolution underscores Starbucks’ disciplined use of structured hedging in the futures market to mitigate commodity‑price risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks acknowledged green coffee price volatility due to commodity index fund and hedge fund trading in the arabica futures market across 2022–2024; it used forward contracts, futures, and collars to hedge 'C' price exposure. The supply commitment horizon expanded from through fiscal 2023 (in 2022) to through fiscal 2025 (by 2023/2024), which is correctly stated as extending two years ahead by 2024. (2) Quantitative accuracy is perfect: fiscal years (2022–2025), hedging instruments, and timeline progression are all factually correct. Minor variation in phrasing (e.g., 'two years ahead in 2024') is semantically equivalent to the original. (3) Multi-hop reasoning is sound—LLM synthesized information across three years of filings, correctly identifying the evolution in hedging duration and linking it to a more forward-looking risk management strategy. (4) The only minor shortcoming is that the original answer notes the 2023 filing already extended commitments through 2025, while the LLM attributes this shift more to 2024. This slightly understates the timing of the change, but the overall trend and conclusion remain valid. Otherwise, the answer is complete, contextually relevant, and conveys the same core insight about disciplined, maturing risk management in response to futures market influences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 392,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO had $622 million of 3.625% notes due October 2024 outstanding in FY 2023 (and still present in FY 2022). By FY 2024 the company had eliminated that exposure, as the notes were fully repaid or refinanced, leaving zero outstanding. This progression indicates a near‑term debt strategy focused on retiring maturing short‑term debt and using proceeds from new senior note issuances to reduce short‑term debt and improve liquidity【page 81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $622 million principal amount outstanding for the 3.625% notes due October 2024 in both 2022 and 2023, and accurately states that the exposure was eliminated by 2024. This matches the ground truth exactly in terms of numbers and timeline. (2) All quantitative elements are correct: the dollar amount ($622 million), interest rate (3.625%), maturity date (October 2024), and the progression to zero by 2024 are all factually accurate. Format variations (e.g., 'million' vs 'M') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound—LLM synthesizes data across fiscal years 2022–2024 and correctly infers that the debt was either repaid or refinanced. It adds a plausible detail about using proceeds from new senior note issuances, which aligns with typical debt management practices and is supported by the cited page 81, though this specific mechanism is not in the ground truth. This addition does not contradict but slightly extends the original answer. (4) The core facts, numbers, and reasoning are fully aligned with the ground truth. The only minor deviation is the slightly expanded interpretation of *how* the debt was retired (i.e., via new issuances), which is contextually reasonable but not explicitly confirmed in the original answer. Thus, the answer is highly accurate with no factual errors, warranting a 9/10 on correctness and qualitative accuracy, and full marks on quantitative and contextual dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 413,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "Mastercard’s gross settlement exposure grew from $64.9 bn in 2022 to $78.4 bn in 2024, with net exposure rising from $55.7 bn to $64.9 bn and risk‑mitigation arrangements applied increasing from $9.2 bn to $13.5 bn (pages 106, 105). In response to heightened regulatory scrutiny—FTC investigations of the Durbin Amendment, DOJ civil‑investigative demands, European Commission probes, and ongoing U.S. and U.K. litigation over liability shifts, interchange fees and ATM rules—the company tightened its credit‑risk framework by expanding cash‑collateral, letter‑of‑credit and guarantee requirements for customers that do not meet its risk standards and regularly reviewing its risk‑management methodology (page 102). These steps helped keep settlement‑related losses low despite the increased exposure and legal uncertainties (pages 109, 104).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures for gross settlement exposure ($64.9B in 2022, $78.4B in 2024), net exposure, and risk-mitigation arrangements ($9.2B to $13.5B), which are not present in the original ground truth answer. These numbers may be factually accurate based on actual filings, but they are not supported by the provided ground truth, which does not include any numerical data on exposure amounts. Therefore, the inclusion of precise dollar figures constitutes a deviation from the known facts in the knowledge graph, reducing quantitative accuracy. (2) There is no verification possible for the cited page numbers (e.g., pages 106, 105, 102) or the exact values since the ground truth does not reference them; thus, these appear to be hallucinated or sourced from outside the provided context. However, the directionality—increasing exposure and growing use of mitigation tools—is consistent with the original answer’s narrative of evolving risk environment and reinforced mitigation posture. (3) Qualitatively, the LLM correctly identifies key regulatory and litigation developments: FTC and DOJ scrutiny related to the Durbin Amendment, European Commission investigation, and litigation over interchange fees and liability shifts. It accurately reflects Mastercard's response—tightening credit risk frameworks, expanding collateral requirements, and reviewing methodologies—which aligns with the original answer’s description of refined risk management and continued use of cash collateral, letters of credit, and guarantees. The synthesis across regulatory, litigation, and risk mitigation domains is sound and multi-hop reasoning is appropriate. (4) Contextually, the answer is highly relevant, addressing both the evolution of credit risk mitigation and settlement exposure in light of external pressures. While it adds numerical precision absent in the ground truth, the core factual narrative matches: increasing external scrutiny, ongoing refinement of risk controls, and stable loss experience. The correctness score is 7 because the central claims are logically and semantically aligned with the original, but the unsupported numerical details reduce confidence in factual fidelity, especially in a setting where answers must reflect only knowledge graph–verified data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 620,
        "total_tokens": 2186
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "In 2022 Amgen’s 10‑K risk factors only noted that “some of our products are used with drug‑delivery or companion diagnostic devices that have their own regulatory, manufacturing and other risks” (page 34). By 2023 the disclosure expanded to require the company to collect and assess user complaints, adverse events and malfunctions, to conduct routine monitoring and inspections, and to implement device‑ and labeling‑enhancements in response to FDA evaluations (page 51). In 2024 the risk factors further emphasized compliance with reporting and pharmacovigilance requirements, post‑marketing obligations, and safety oversight, warning that non‑compliance could trigger additional inspections, warning letters, fines, recalls or withdrawal of marketing authorization (pages 50‑54).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Amgen's regulatory risk disclosures from 2022 to 2024, with increasing detail on compliance, post-marketing obligations, and safety oversight. In 2022, the disclosure was general, noting regulatory and manufacturing risks of drug delivery devices—consistent with the original answer. By 2023, the LLM correctly notes expanded focus on monitoring, adverse event reporting, and FDA-driven enhancements, which maps to the ground truth's emphasis on confirmatory studies and regulatory scrutiny (e.g., Repatha, LUMAKRAS). In 2024, the LLM accurately reflects heightened emphasis on pharmacovigilance, reporting, and consequences of non-compliance such as recalls or withdrawal—mirroring the original answer’s point about enforcement actions. (2) There are no numeric values to verify, but dates (2022–2024) and page references (e.g., page 34, 51, 50–54) are consistent with expected sourcing and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly tracing the escalation in regulatory expectations and compliance burden. The only minor gap is that the LLM does not explicitly mention 'surrogate endpoints' or 'conditional approvals' in 2023, which are key elements in the ground truth and represent a specific regulatory mechanism. This omission slightly weakens the qualitative accuracy but does not invalidate the overall trend description. (4) The answer is contextually excellent—directly addressing compliance requirements, post-marketing obligations, and safety oversight as asked. Wording differs but semantic meaning is equivalent. Thus, the correctness score is 9 due to a minor omission in regulatory terminology, but quantitative accuracy is perfect, and relevance is full.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 506,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Parent’s Choice has remained consistently positioned within Walmart’s grocery unit—specifically under the “baby products and consumables” segment—in the 2022, 2023, and 2024 10‑K filings. This unchanged categorization signals Walmart’s deliberate strategy to treat Parent’s Choice as a core private‑label brand for baby and consumable items, underscoring its focus on offering everyday‑low‑price alternatives to national brands in these high‑volume categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that 'Parent's Choice' remained consistently categorized under Walmart's grocery unit across fiscal years 2022, 2023, and 2024, which matches the original answer's timeline and categorization. While the LLM combines 'baby products and consumables' into a single phrase not explicitly used in the filings, this is a reasonable synthesis given that baby products fall under consumables and were explicitly called out in the 2024 filing. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly synthesizing information across three fiscal years and inferring strategic intent from consistent categorization. The only minor shortcoming is that the original answer notes the increasing explicitness of 'baby products' as a defined category by 2024, a nuance slightly underemphasized in the LLM response. (4) The answer is highly contextually relevant, directly addressing the evolution and strategic positioning. Overall, the LLM captures the core truth with high fidelity, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 335,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla issued the 4.70 % Solar Bonds, Series 2015/C24‑10 in 2015. The 2022 10‑K lists the bond as Exhibit 4.35 (a supplemental indenture dated April 14 2015), indicating it remained an outstanding liability at year‑end 2022. The 2023 and 2024 10‑K exhibit lists contain no separate reference to the C24‑10 bond, implying it was either fully amortized, restructured, or absorbed into broader debt disclosures. This pattern shows Tesla’s solar‑financing strategy relies on long‑term, low‑coupon debt that is periodically consolidated or retired, keeping a stable, low‑cost financing base for its solar assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct foundational facts but is largely incorrect in its core claims, leading to a low correctness score. (1) Quantitatively, the issuance date (April 14, 2015) and bond series (4.70% Solar Bonds, Series 2015/C24-10) are accurate, and the reference to Exhibit 4.35 in the 2022 10-K is plausible. However, the claim that the 2023 and 2024 10-Ks contain 'no separate reference' to the C24-10 bond is factually wrong according to the ground truth, which states that Tesla continued to reference the bond in both 2023 and 2024 filings—specifically alongside newer series in 2023 and within a broader historical context in 2024. (2) The conclusion that the bond was 'fully amortized, restructured, or absorbed' is speculative and contradicts the ground truth, which confirms ongoing explicit references. This misrepresents the data and undermines the reasoning. (3) The multi-hop reasoning fails: instead of recognizing the consistent and repeated use of the C24-10 bond as evidence of a stable, scalable securitization model, the LLM incorrectly infers retirement or consolidation due to absence in exhibit lists—a claim not supported by the ground truth. (4) Contextually, the answer addresses Tesla's solar financing strategy, so relevance is moderate, but the factual errors severely limit usefulness. The qualitative reasoning is flawed due to incorrect entity tracking over time and failure to synthesize the multi-year pattern accurately. Minor wording flexibility is allowed, but the divergence in factual content is too significant for a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 432,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑K filings, Broadcom has kept the same positioning for its Security Insights Platform: a mainframe‑centric tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis” and “provides data for use with in‑house tools for security information and event management”【page_11】【page_10】【page_10】.  The description is identical in each filing, indicating a sustained emphasis on mainframe risk assessment and consistent integration with enterprise SIEM and other security tools, with no major changes in the platform’s positioning over the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in describing Broadcom's Security Insights Platform with accurate quotes and correct entity and year references, and there are no numerical inaccuracies (quantitative accuracy is perfect). However, the key discrepancy lies in the qualitative interpretation: the LLM claims the description is 'identical in each filing' and that there is 'no major change,' which contradicts the ground truth that identifies a subtle but meaningful evolution in 2024 with a 'slightly stronger emphasis on integration' and a 'more deliberate alignment with enterprise-wide security strategies.' While the core language may be similar, the ground truth emphasizes a narrative shift in positioning—particularly around integration with broader security ecosystems—that the LLM overlooks. This reflects a failure in multi-hop reasoning and nuanced synthesis across years, missing the evolution in emphasis even if wording is largely repeated. The answer is contextually relevant and captures the mainframe risk assessment continuity and SIEM integration, but incorrectly concludes no change in positioning, thus missing a critical qualitative insight. Hence, correctness is partially compromised despite strong factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 347,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across 2022‑2024, Mastercard’s Class A shares continued to carry **one vote per share and dividend rights** (see the “Classes of Capital Stock” tables on pages 94, 97, 90).  The unchanged voting and dividend status shows the company’s capital‑structure strategy is deliberately stable—maintaining consistent shareholder rights and a predictable dividend policy to support governance continuity and investor confidence.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Mastercard’s A Class shares maintained one vote per share and dividend rights across 2022–2024, with no changes—matching the original answer’s claim of consistency. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the time period (2022–2024) and qualitative metrics (voting rights, dividend entitlements) are correctly cited. The mention of specific filing pages (94, 97, 90) adds verifiable context and aligns with source documentation. (3) The multi-hop reasoning is sound: the model correctly synthesizes the absence of changes over three years into a strategic conclusion about capital structure stability. It infers the intent behind the consistency—governance continuity and investor confidence—which is a reasonable interpretation supported by the data. (4) All entities are correct: 'Mastercard' (MA), 'Class A shares', and the three-year period are accurately identified. The answer addresses both parts of the question: the evolution (or lack thereof) in rights and the strategic implication. Wording differs slightly but conveys the same factual and conceptual content. No errors in fact, reasoning, or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 357,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "From 2022 through 2024 Amgen kept bemarituzumab in a Phase 3 trial for gastro‑esophageal junction adenocarcinoma, adding a Phase 2 program for “other tumors” in 2023 and 2024.  The company’s composition‑of‑matter patents in the U.S. and Europe have remained unchanged, all set to expire in 2029, giving a stable 7‑year exclusivity window that has not shifted over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but introduces inaccuracies and omits key aspects of the original answer. It correctly states that Bemarituzumab was in a Phase 3 trial for gastro-esophageal junction (GEJ) adenocarcinoma starting in 2022 and that patent protection in the U.S. and Europe is set to expire in 2029. However, it incorrectly claims that Amgen added a Phase 2 program for 'other tumors' in 2023 and 2024 — this detail is not present in the ground truth and is unsupported. The original answer emphasizes the initiation of the Phase 3 study in 2022, not continuation throughout the period, and does not mention any Phase 2 expansion. (2) Quantitatively, the 2029 patent expiry is correctly cited, and the implied 7-year window from 2022 to 2029 is numerically accurate, though the term 'exclusivity window' conflates patent life with regulatory exclusivity, which are distinct concepts — a nuance the model misses. No calculation errors, but mischaracterization of IP terms reduces precision. (3) The multi-hop reasoning is weak: the model fails to synthesize the evolution of both clinical and IP strategy as described in the original — particularly missing the 2024 update on Bemarituzumab’s mechanism (anti-FGFR2b monoclonal antibody) and discussion of potential regulatory exclusivity extensions. Instead, it invents a Phase 2 expansion, breaking semantic equivalence. (4) Scores reflect partial factual alignment on dates and patents, but significant qualitative flaws in reasoning and completeness, with invented details undermining correctness. Contextual relevance remains high as the response stays focused on clinical phases and IP timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 463,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "No Boundaries has been listed as a private‑label brand in Walmart’s general‑merchandise lineup every year (2022, 2023, 2024) – appearing in the 2022 10‑K (pages 5‑9), the 2023 10‑K (pages 6‑10) and the 2024 10‑K (pages 5‑9).  In 2022 the apparel sub‑unit was described as “Apparel,” but by 2023–24 it was renamed “Fashion,” reflecting a broader, trend‑driven focus on clothing and accessories.  This renaming, while keeping No Boundaries in the same private‑label slot, signals Walmart’s strategic shift toward expanding its fashion‑centric private‑label assortment to capture a larger share of the apparel market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that 'No Boundaries' was consistently listed as a private brand from 2022 to 2024, and accurately notes its presence in the respective 10-K filings across those years. (2) The key shift from 'Apparel' in 2022 to 'Fashion' in 2023–2024 is correctly reported, with proper context that this reflects a broader, trend-driven focus—consistent with the ground truth's emphasis on omni-channel and customer-centric strategy. (3) The reasoning is sound: the reclassification is interpreted as a strategic shift toward fashion-centric private labels, which is a valid inference from the category renaming and realignment. The only minor omission is that the LLM does not explicitly mention the inclusion of shoes, jewelry, and children's apparel in the 'Fashion' unit as noted in the original answer, slightly reducing completeness in descriptive detail. However, this does not affect factual correctness. (4) All entities (Walmart, 'No Boundaries', correct years, 10-K references) are accurate. Number formats and dates are correct. The answer is fully relevant to the question about strategic evolution and focus in apparel/fashion. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to excellent factual alignment with only slight under-description of the 'Fashion' unit’s expanded scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 389,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "IBM’s 10‑K filings from 2023 (IBM_10k_2023.pdf page 3) and 2024 (IBM_10k_2024.pdf page 3) both list client relationships and trust as a core competitive differentiator, underscoring its importance in the hybrid‑cloud and AI strategy. The consistent emphasis signals that IBM views trusted client partnerships as essential to distinguishing itself from hyperscalers and accelerating adoption of its hybrid‑cloud and AI portfolio. In 2022 the company also highlighted client relationships and trust, but the 2023 and 2024 filings explicitly tie the differentiator to hybrid‑cloud and AI, reflecting a growing focus on leveraging trust to drive digital transformation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions in completeness that prevent a perfect score. (1) All entities—IBM, client relationships and trust, hybrid cloud, AI, hyperscalers—are accurately identified, and the years (2022, 2023, 2024) are correctly referenced. There are no numeric values to verify, so quantitative accuracy is 10. (2) The LLM correctly notes that IBM consistently emphasized client relationships and trust across all three years, which matches the ground truth. It also correctly observes that in 2023 and 2024, the linkage between trust and hybrid cloud/AI became more explicit, reflecting strategic evolution. (3) However, the LLM omits a key element from the 2024 progression: the expansion of trust through strategic partnerships with hyperscalers and global system integrators to enhance client outcomes via ecosystem collaboration. This is a significant point in the original answer and represents a multi-hop synthesis (from trust → partnerships → enhanced hybrid cloud/AI delivery). While the LLM mentions hyperscalers, it frames them as competitors rather than collaborative partners, missing the nuance of ecosystem-based trust extension. (4) The reasoning is sound and contextually relevant, with accurate interpretation of the strategic importance of trust in differentiating IBM from hyperscalers. The answer captures the core trajectory but lacks full depth in the 2024 evolution. Thus, correctness and qualitative accuracy are high but not complete, warranting an 8. Contextual relevance is perfect—directly addresses the question’s focus on evolution and strategy positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 452,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 were issued by SolarCity in 2015 and are still listed as outstanding debt in the 2022, 2023 and 2024 10‑K filings, with no new issuance or maturity changes noted in those years【page 102 of 2022】【page 102 of 2023】.  The unchanged indenture across three consecutive years shows that Tesla continues to rely on long‑term, fixed‑rate solar‑specific debt to finance its solar projects, underscoring a stable, long‑term financing strategy for its solar portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the bond series (5.45%, Series 2015/C25-15), issuance year (2015), and consistent referencing in 2022, 2023, and 2024 filings are factually sound. The citation of page 102 in both 2022 and 2023 filings adds precision and matches expected disclosure locations. There are no numerical or date inaccuracies. (2) The answer correctly notes no new issuance or maturity changes occurred in those years, which is consistent with the ground truth’s emphasis on persistence and unchanged legal structure. (3) Multi-hop reasoning is strong: the model synthesizes information across three years of filings and infers the strategic implication—continued reliance on long-term, fixed-rate solar-specific debt—mirroring the ground truth’s conclusion about Tesla’s stable solar financing strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'Thirty-Sixth Supplemental Indenture dated April 14, 2015' or the 2024 reaffirmation detail, slightly reducing completeness in entity-level specificity. However, the core message about ongoing reliance and strategic consistency is preserved. Wording differs but semantic equivalence is maintained. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 391,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "In 2022 Emerson’s Tools & Home Products segment described pipe‑working tools that included wrenches, cutters, threading and roll‑grooving equipment, mechanical crimping tube joining systems, drain cleaners, tubing tools, and closed‑circuit TV pipe‑inspection and locating equipment (page 9). By 2024 the Safety & Productivity segment had added battery‑hydraulic tools for press connections and for cutting/crimping electrical cable, and upgraded its diagnostic suite to include sewer‑inspection cameras and locating equipment (page 73). This shift toward battery‑powered, portable, and advanced diagnostic tools demonstrates Emerson’s strategic emphasis on safety, productivity, and technology leadership in the professional tools market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, dates, and strategic interpretation. (1) It accurately identifies the evolution from 2022 to 2024 in Emerson's tool offerings, noting traditional tools like wrenches, cutters, threading equipment, and closed-circuit TV inspection in 2022, and the addition of battery-hydraulic tools for press connections and electrical cable cutting/crimping by 2024. The mention of sewer-inspection cameras and locating equipment in 2024 is also correct. (2) Quantitatively, all years (2022, 2024) are accurate, and no numerical values are misstated; there are no calculations required, so precision is maintained. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across time and segments, noting the shift from 'Tools & Home Products' in 2022 to 'Safety & Productivity' in 2024, which reflects a realignment in Emerson’s reporting segments. However, the original answer notes developments in 2023 (battery hydraulic tools introduced), which the LLM omits, instead jumping from 2022 to 2024. This omission of the intermediate step slightly weakens the completeness of the progression narrative. (4) Despite this, the strategic conclusion about Emerson’s focus on safety, productivity, and technology leadership is fully supported and semantically equivalent to the ground truth. The answer is highly contextually relevant and well-articulated. The minor gap in temporal completeness prevents a perfect score, but overall accuracy and reasoning are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 429,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "Gilead’s capital‑allocation strategy for its El Segundo, California site shifted from a primarily clinical cell‑therapy focus in 2022 to a combined clinical‑and‑commercial manufacturing role by 2024, reflecting a deliberate investment to scale its cell‑therapy pipeline.  The facility’s expanded commercial capacity aligns with the company’s broader biologics agenda—retrofitting for retroviral vector production and other biologics candidates—underscoring a strategic emphasis on biologics development (see 2023 MD&A manufacturing facilities page 11 and 2024 MD&A manufacturing facilities page 12).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its overall narrative and timeline, but contains a factual inaccuracy regarding the 2022 characterization of the El Segundo facility. According to the ground truth, in 2022, El Segundo was listed as a general manufacturing site without specific emphasis on cell therapy, whereas the LLM incorrectly states it had a 'primarily clinical cell-therapy focus' in 2022—this detail is not supported by the 2022 10-K and represents a misrepresentation of the facility's role at that time. The evolution from 2023 onward is accurately captured: the 2023 filing does designate El Segundo as a site for both clinical and commercial manufacturing of cell therapy products (GILD_10k_2023.pdf:page_11:chunk_1), and this designation is retained in 2024 with added emphasis on proprietary process protection (GILD_10k_2024.pdf:page_10:chunk_1). The LLM correctly links this progression to Gilead’s broader biologics development strategy and mentions retrofitting for retroviral vector production, which aligns with the strategic direction, though this specific detail is not explicitly in the ground truth. There are no numerical figures to verify, so quantitative accuracy is scored as 10. The reasoning is logically sound in tracing a strategic evolution, but the incorrect attribution of cell therapy focus in 2022 undermines the multi-hop synthesis accuracy. Contextual relevance is high, as the response directly addresses capital allocation, facility evolution, and alignment with biologics priorities. However, the answer lacks mention of the increasing reliance on internal know-how and confidentiality agreements in 2024, a key indicator of investment in proprietary processes, which is a minor omission affecting completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 475,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "IBM disclosed the 1.250% Notes due 2027 in its 2022 10‑K, referencing the 2019 8‑K exhibit that defines the rights of holders (see 2022 10‑K Exhibit list). The 2023 10‑K continued to cite the same 2019 8‑K exhibit for the notes (see page 20). By 2024, the notes were listed as a registered security in the 10‑K’s securities table, indicating they remained outstanding but no new issuance or amendment was reported (see page 1).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the disclosure of the 1.250% Notes due 2027 in IBM's 2022 and 2023 filings, referencing the correct 2019 8-K exhibit that defines the rights of holders. It also accurately notes the continued citation in the 2023 10-K. In 2024, the LLM correctly states the notes were listed as a registered security, which aligns with the ground truth's mention of formal listing. However, the LLM misses the key evolution detail that in 2024, the notes were assigned a trading symbol (IBM27B) and listed on the New York Stock Exchange, indicating active trading — a significant shift from prior years' passive disclosure. Instead, the LLM interprets this as merely indicating the notes 'remained outstanding,' which understates the progression to public market presence. (2) All dates (2019, 2022, 2023, 2024), percentages (1.250%), and filing types (10-K, 8-K) are accurate. No numerical or date inaccuracies are present. (3) The multi-hop reasoning is partially sound: the model correctly traces the note's mention across years and filings, but fails to synthesize the full implication of the 2024 listing as an evolution from disclosure to active trading. The conclusion that 'no new issuance or amendment was reported' is plausible but does not capture the significance of the NYSE listing and trading symbol assignment. (4) The answer is contextually relevant and factually precise on disclosures, but lacks completeness in conveying the full evolution — particularly the market-facing milestone in 2024. Hence, correctness and qualitative accuracy are reduced slightly, while quantitative accuracy and relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 455,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 10‑K filings from 2022‑2024 consistently list the 5.45% Solar Bonds, Series 2015/C45‑15 (Exhibit 4.41 in 2022, 2023 and 2024) alongside a growing array of supplemental indentures for other SolarCity bonds and newer debt instruments such as convertible senior notes (see the 2024 filing’s convertible notes and the 2023 filing’s additional supplemental indentures). This continuity shows the company still relies on the 2015 bond while simultaneously expanding its debt mix, indicating a shift from a single long‑term SolarCity bond to a more diversified, flexible financing strategy that can better manage interest rates and liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the continued reference to the 5.45% Solar Bonds, Series 2015/C45-15 across Tesla's 2022–2024 10-K filings and notes its origin from SolarCity, which aligns with the ground truth. The mention of supplemental indentures and newer instruments like convertible senior notes in the 2023 and 2024 filings is factually plausible and contextually relevant. However, the LLM mischaracterizes the evolution of Tesla’s solar financing strategy by framing it as a shift toward diversification and flexibility, whereas the ground truth emphasizes an *iterative expansion* of a standardized, asset-backed securitization model—specifically through subsequent bond series (C53-15, C62-15, C72-15) all sharing the same 5.45% rate and 2015 vintage. These are not fundamentally new or diversified instruments but rather extensions of the same structured financing framework. The LLM fails to mention these specific subsequent bond series, which are central to the multi-hop reasoning required to show Tesla’s refinement of a repeatable model. While the quantitative elements (percentage, bond series name, filing years) are accurate, the qualitative interpretation of strategic evolution is partially incorrect—missing the nuance of standardization and scalability in favor of a broader, less precise narrative of diversification. This omission significantly affects the correctness score despite strong contextual relevance and numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 402,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "Adobe has kept Acrobat as the centerpiece of its Document Cloud, but the 2024 filing shows a sharper push to make the platform more AI‑driven and broadly integrated.  In 2022, Acrobat was already described as a leader in document‑intensive sectors (government, finance, legal, aerospace, insurance, pharma, publishing) and as a “best PDF experience” powered by Adobe Sensei, with plans to expand Acrobat Web, Adobe Sign integration and APIs for workflow automation【page_7】【page_6】.  By 2024, the same AI emphasis remains—Sensei is still cited as the engine that makes PDFs “more intelligent and responsive”—but the strategy now foregrounds a wider digital‑document services platform, adding more task‑based actions, deeper API‑driven workflows, and targeted vertical‑market go‑to‑market motions (education, telecom, government) to grow adoption across all business sizes【page_94】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution from 2022 to 2024. (1) It accurately captures Adobe's continued leadership in document-intensive industries in 2022 (legal, finance, publishing, etc.), mentions integration with Adobe Sign, APIs, and workflow automation, and references Adobe Sensei as the AI engine—consistent with the 2022 positioning. (2) For 2024, it correctly identifies the increased emphasis on AI (via Sensei), the expansion of digital document services, deeper API integrations, and vertical-specific go-to-market strategies in sectors like government, education, and telecom. However, it misses the specific milestone of the 'Acrobat AI Assistant' being formally introduced and trademarked in 2024, which is a key concrete indicator of AI integration mentioned in the ground truth. This omission prevents a perfect score. (3) The multi-hop reasoning is sound—information is synthesized across years and strategic themes (AI, market adoption, platform expansion). (4) All dates and entities (Adobe, Acrobat, Adobe Sensei, Document Cloud, Adobe Sign) are correct. No numerical inaccuracies—quantitative accuracy is perfect. (5) The answer is contextually highly relevant, directly addressing all three dimensions of the question: AI integration, market adoption, and platform expansion. The only gap is the lack of explicit mention of the 'Acrobat AI Assistant' launch as a tangible 2024 development, which slightly weakens the qualitative accuracy. Overall, the answer is factually strong and semantically close to the original, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 448,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "In 2022, Schwab’s Advisor Services website offered interactive tools and the free Schwab Advisor Portfolio Connect, while enabling integration with third‑party CRM, portfolio, trade‑order, and financial‑planning systems (page_10). By 2023, the platform was enhanced with Schwab Trading Powered by Ameritrade, adding real‑time charting, advanced trading, and educational features (page_9). In 2024, Schwab further integrated TD Ameritrade’s thinkpipes trading platform and iRebal portfolio‑rebalancing into the RIA offering, expanding its integration ecosystem and delivering a more modern, scalable experience for RIAs (page_8).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most notably, it incorrectly states that Schwab Advisor Portfolio Connect was available in 2022, while the ground truth indicates it was highlighted in 2024. Additionally, the LLM claims that 'Schwab Trading Powered by Ameritrade' was introduced in 2023 with real-time charting and advanced trading features, and that TD Ameritrade’s 'thinkpipes' (likely meant to be 'thinkorswim') and iRebal were integrated in 2024—none of which are supported by the original answer. These are significant entity and timeline errors. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily applicable; however, the misattribution of platform features to incorrect years affects temporal accuracy, which is critical in tracking evolution over time. (3) The multi-hop reasoning is flawed: the LLM appears to synthesize information across years but introduces platform names and integration capabilities not present in the ground truth, suggesting either hallucination or incorrect source interpretation. The original answer emphasizes continuity and gradual enhancement of integrations and the Advisor Services website, not major new platform integrations from TD Ameritrade in 2023–2024. (4) Despite these errors, the LLM answer remains contextually relevant—it addresses platform enhancements and integration capabilities for RIAs across 2022–2024 and maintains focus on digital tools and third-party integrations. However, due to major factual and entity inaccuracies, especially regarding the timing of product rollouts and specific platform names, the correctness and qualitative accuracy scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 478,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "In 2022, Emerson positioned air‑preparation equipment as part of its Industrial Solutions offering within Automation Solutions, describing it as one of several “pneumatic mechanisms” that work alongside solenoid valves, cylinders and actuators to deliver integrated control solutions【page_7】.  In both the 2023 and 2024 10‑Ks the product is listed under the Discrete Automation segment, where it is explicitly grouped with solenoid valves, pneumatic valves, valve‑position indicators, cylinders, actuators, pressure/temperature switches and “programmable automation control systems and software,” underscoring its continued integration with other pneumatic and control technologies【page_73】.  The core positioning remained unchanged, though the 2024 filing’s broader emphasis on Plantweb and IIoT connectivity hints at a deeper digital integration of air‑preparation equipment with control systems.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities, years, and general positioning of Air Preparation Equipment within Emerson’s portfolio, and correctly identifies its integration with pneumatic and control technologies across 2022–2024. The quantitative accuracy is perfect—no numbers, dates, or company details are incorrect, and no erroneous calculations are made (though no explicit numerical data is involved). However, the qualitative accuracy suffers because the LLM fails to fully capture the evolution in strategic positioning as described in the ground truth. Specifically, it incorrectly states that the 'core positioning remained unchanged' between 2023 and 2024, which contradicts the ground truth’s emphasis on a progressive shift toward digital integration, Industry 4.0, and smart systems (e.g., predictive maintenance, secure wireless communication). While the LLM notes the 2024 emphasis on Plantweb and IIoT, it downplays the significance of the shift and misses the explicit progression from mechanical to digitally integrated components. The answer synthesizes information across years but lacks the depth of multi-hop reasoning needed to highlight the strategic evolution. Contextually, the response is relevant and well-structured, citing appropriate segments and technologies, but the conclusion underrepresents the strategic transformation. Thus, while factually sound in parts, it falls short in conveying the full scope of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 412,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "The 2022 10‑K shows that Coca‑Cola had already issued the 0.125% Notes due 2029 in 2020 and amended them in 2021 (see Exhibit 4.23 and 4.31)【page_136】.  The 2023 and 2024 10‑Ks continue to reference the same notes with no new issuances or amendments (Exhibit 4.23 and 4.31 in both 2023【page_130】 and 2024【page_128】).  This unchanged, low‑interest, short‑term debt instrument suggests the company prefers to keep a small, stable near‑term financing tool while relying on longer‑term, higher‑rate notes for larger capital needs, reflecting a conservative, steady‑state approach to debt management.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 0.125% Notes due 2029 were issued in 2020 and amended in 2021, and that they were consistently referenced in the 2022, 2023, and 2024 10-K filings with no new issuances or amendments. These factual details about the notes’ issuance history and exhibit references (4.23 and 4.31) are accurate and supported by the filings. However, the LLM misinterprets the strategic implication of this pattern. While the ground truth identifies a strategic pivot toward longer-term, higher-yielding debt (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064) in 2024 as a sign of proactive refinancing ahead of the 2029 maturity, the LLM concludes a 'conservative, steady-state approach' based on the stability of the 0.125% Notes, missing the broader shift in financing strategy. (2) Quantitatively, all dates, percentages, and exhibit references are correct. The LLM accurately notes the absence of new issuances or amendments to the 0.125% Notes in 2023 and 2024. There are no calculation errors. (3) The multi-hop reasoning is partially sound: the model correctly tracks the note across years and filings. However, it fails to synthesize the introduction of new, higher-yielding instruments in 2024—a critical piece of evidence for the evolving strategy. This omission leads to an incorrect qualitative conclusion about the company’s debt management approach. (4) The answer is contextually relevant and addresses the question’s focus on issuance strategy and near-term obligations, but it lacks the key insight about strategic refinancing through longer-term instruments, which is central to the ground truth. Hence, while factually accurate on the notes themselves, the interpretation is incomplete and misleading, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 490,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "BNY’s 2022 10‑K risk‑factor disclosed that its ability to return capital—through dividends or share repurchases—was limited by U.S. banking laws, capital‑planning rules, Delaware law, and the obligation to pay dividends on preferred stock. The identical wording appears unchanged in the 2023 and 2024 filings, indicating that regulatory constraints on dividends and share repurchases remained essentially the same over that period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of BNY Mellon's disclosures from 2022 to 2024, which is the core of the question. While it correctly identifies that U.S. banking laws, capital-planning rules, Delaware law, and preferred stock dividends were mentioned as constraints, it incorrectly states that the 'identical wording appears unchanged' in 2023 and 2024 filings. The ground truth shows a clear evolution in language and specificity: from general caution in 2022, to inclusion of preferred stock obligations in 2023, to structured references to 'well capitalized' status and capital adequacy rules in 2024. The LLM’s claim of unchanged wording contradicts this progression and fails the multi-hop reasoning required to compare disclosures across years. Quantitatively, there are no numerical errors (dates are correct, entities accurate), so quantitative accuracy is high. However, the qualitative inaccuracy—failing to detect and report the evolving framing—is severe. Contextually, the answer addresses regulatory constraints on dividends and repurchases, so relevance is fair, but it misses the key trend of increasing formalization. Thus, correctness is low due to a critical factual error in reasoning and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 355,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "McGriddles is described in each filing simply as one of the breakfast sandwiches on the full or limited breakfast menu, with no new product launch or repositioning noted (2022 page 7; 2023 page 7; 2024 page 7).  The wording remains unchanged, while the broader menu‑innovation narrative in all three years continues to emphasize ongoing product testing and limited‑time promotions elsewhere.  This consistency shows that McDonald’s breakfast strategy has stayed stable, treating McGriddles as a core, long‑standing offering rather than a focus of frequent innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that McGriddles was consistently described as a standard breakfast sandwich across all three years (2022–2024), with no innovation or repositioning noted—this aligns with the original answer’s claim of static portrayal. (2) The page numbers cited (2022 page 7; 2023 page 7; 2024 page 7) are consistent with the ground truth references, though the 2023 document in the original specifies page 6; this is a minor discrepancy but does not affect factual correctness, as the content description matches. (3) The reasoning correctly synthesizes the contrast between McDonald’s broader menu-innovation narrative and the lack of specific innovation around McGriddles, demonstrating sound multi-hop logic across years and disclosures. (4) The conclusion about a stable breakfast strategy treating McGriddles as a core offering is semantically equivalent to the original. The only minor shortcoming is slightly less contextual detail (e.g., not naming other sandwiches like Egg McMuffin), but the essential analysis and facts are preserved. Wording differences are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 340,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Adobe continued to highlight a large portfolio of free online self‑service learning on **learning.adobe.com** in all three years, positioning it as a core offering of **Adobe Digital Learning Services** under Adobe Customer Solutions (2022 page 17; 2023 page 17; 2024 page 18). The platform and delivery method remained unchanged—students accessed the courses through the same learning.adobe.com website, while fee‑based programs were also offered via that channel. Consequently, there was no significant shift in positioning or platform usage for free self‑service learning across 2022‑2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but fails on key factual and reasoning points. (1) It incorrectly states that learning.adobe.com was used in all three years, while the ground truth confirms that in 2022, the platform was hosted on www.training.adobe.com and only moved to learning.adobe.com in 2023. This is a significant factual error regarding platform evolution. (2) The LLM claims there was 'no significant shift in positioning or platform usage,' which directly contradicts the ground truth showing a clear rebranding and centralization (domain change) and deeper integration into Adobe's learning ecosystem by 2024. (3) While the entity names (Adobe Digital Learning Services, learning.adobe.com) and general strategic emphasis on self-service learning are correctly identified, the multi-hop reasoning fails: the model does not recognize the platform transition across years or the increasing integration of free offerings into a broader portfolio. (4) The citation of consistent page numbers across years may suggest accurate sourcing, but the interpretation is flawed. (5) Quantitative accuracy is relatively high because there are no numerical claims to dispute—dates are mentioned correctly in range (2022–2024), and platform names are real, though misattributed in timeline. (6) Contextual relevance is fair because the answer addresses the right topic and service, but it misses the evolution narrative central to the question. Overall, the answer is partially correct in entities and context but fundamentally wrong in the core trajectory of platform and strategic positioning changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 439,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "In 2022 Emerson grouped commercial vacuums under its Tools & Home Products segment as part of the “Professional Tools” line, where they were listed alongside pipe‑working, electrical, and other professional tools for both professionals and homeowners【page_10】. By 2024 the same product was repositioned inside the Safety & Productivity segment, still described as a professional tool but now framed as part of a portfolio that “supports infrastructure, promotes safety and enhances productivity” for professionals【page_73】. This shift signals a strategic emphasis on integrating commercial vacuums into Emerson’s safety‑and‑productivity strategy while keeping them aligned with the broader professional tools offering.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in Emerson's positioning of Commercial Vacuums from 2022 to 2024. It accurately states that in 2022, Commercial Vacuums were part of the Tools & Home Products segment under Professional Tools, and by 2024 they were moved to the Safety & Productivity segment. The strategic repositioning toward safety and productivity is correctly captured. However, the LLM omits the 2023 transition year, which is included in the ground truth and shows an explicit move into the Safety & Productivity segment that year—this is a minor but notable omission in completeness. (2) There are no numeric values, dates, or calculations in the question or answer that are incorrect; all time references (2022, 2024) are factually aligned with the ground truth. The mention of page numbers does not affect factual accuracy. (3) The multi-hop reasoning is mostly sound: the model synthesizes information across years and segments correctly, though it skips 2023, weakening the full trajectory of the evolution. The alignment with professional tools is maintained appropriately. (4) The answer is contextually highly relevant and conveys the core strategic shift. The omission of 2023 and lack of detail about integration with advanced industrial tools (e.g., programmable automation control systems) in 2024 slightly reduces qualitative accuracy, but the main thrust of the repositioning is correct. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 417,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "In the 2022 10‑K, the Hoofddorp, Netherlands site is not listed among Gilead’s manufacturing facilities, indicating it was not yet used for cell‑therapy production (see pages 31‑35). By 2023, Gilead began utilizing the Hoofddorp facility for commercial manufacturing and processing of its cell‑therapy products (page 12). The same role is maintained in the 2024 10‑K, with the facility again described as a commercial cell‑therapy manufacturing and processing site (page 11).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error: it claims that the Hoofddorp facility was not listed in the 2022 10-K among Gilead’s manufacturing facilities. However, the ground truth states that in 2022, Hoofddorp was already identified as a principal manufacturing site, indicating its operational role prior to 2023. This directly contradicts the LLM’s assertion and undermines the entire timeline it presents. While the descriptions for 2023 and 2024 align with the ground truth—correctly identifying Hoofddorp’s use in commercial manufacturing and processing of cell therapy products—the initial error distorts the evolution narrative. The reasoning is therefore flawed in its multi-hop synthesis: instead of showing a progression from general manufacturing importance to specific cell therapy focus, the LLM incorrectly frames 2023 as the starting point of utilization. Quantitative accuracy is acceptable in that no numerical values are misstated (dates are correct), but the factual status of the facility in 2022 is wrong. Entity accuracy (GILD, Hoofddorp, cell therapy, years) is otherwise correct. Contextual relevance is moderate—the answer addresses the question’s focus on evolution and cell therapy use—but fails on the key point of continuity from 2022. Overall, major factual inaccuracy in the earliest time point significantly reduces correctness despite partial alignment in later years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 388,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca‑Cola’s 2022‑2024 10‑Ks repeatedly cite the 1.000% Notes due 2028 (see page 136 and page 134 for 2022, and page 130 for 2024), underscoring its continued use of a low‑coupon, long‑term debt instrument as a core, low‑cost element of its capital structure.  In 2024 the company also incorporated higher‑yield notes—5.000% Notes due 2034 and 5.400% Notes due 2064 (page 130)—reflecting a strategic shift to diversify its debt mix and extend maturities, even at a higher financing cost, to better match long‑term investment horizons and market conditions.  Together, these filings show Coca‑Cola balancing a stable, inexpensive debt base with newer, higher‑yield instruments to optimize its overall cost of capital and maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the persistent mention of the 1.000% Notes due 2028 across 2022–2024 filings and the introduction of the 5.000% Notes due 2034 and 5.400% Notes due 2064 in 2024 are accurately reported. The percentages, years, and instruments match the original answer exactly. (2) Quantitative accuracy is perfect—no calculations were required, but all numeric values (interest rates and maturity years) are correct and consistently presented. (3) The reasoning is sound: the LLM correctly infers that Coca-Cola is balancing low-cost, long-term debt with newer, higher-cost instruments to diversify its debt portfolio and manage maturity profiles, which reflects a strategic shift in capital structure management. The mention of 'optimizing overall cost of capital and maturity profile' is semantically equivalent to the ground truth's 'recalibration... balancing near-term affordability with long-term funding needs.' (4) The only minor shortcoming is the absence of explicit mention of 'favorable market conditions or strategic initiatives' as potential drivers, though 'market conditions' is referenced. This slight omission in explanatory depth prevents a perfect 10, but the core multi-hop synthesis—linking persistent low-yield debt with new high-yield issuances to infer strategic capital structure evolution—is logically and factually sound. Contextual relevance is excellent, directly addressing all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 417,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson’s 2022 10‑K described its pipe‑cutting line simply as part of a “pipe‑working tools” set that included wrenches, cutters, threading and roll‑grooving gear, with diagnostics such as closed‑circuit television inspection cameras (page 9).  By 2023 and 2024 the segment description was updated to note that the line now also contains “battery hydraulic tools for press connections” and diagnostic systems (e.g., sewer‑inspection cameras and locating equipment) (page 73).  This evolution shows Emerson’s deliberate shift toward cordless, battery‑powered cutters and integrated diagnostic features, underscoring its positioning as a technology‑driven leader in the professional plumbing‑tools market that prioritises convenience, efficiency and smart‑tool capabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Emerson (EMR) and the evolution of its pipe cutter product line across 2022, 2023, and 2024. It accurately notes the shift toward battery-powered tools and diagnostic integration. However, there is a factual inaccuracy regarding the 2022 description: the LLM claims diagnostics like CCTV inspection cameras were already mentioned in 2022 (page 9), which contradicts the ground truth stating no emphasis on diagnostic capabilities in 2022. This misrepresents the timeline of the strategic shift. (2) Quantitatively, there are no numerical values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are used correctly and consistently. Page numbers (9, 73) are cited but cannot be validated here; their presence suggests sourcing, but the content attribution to those pages contains an error regarding diagnostics in 2022. (3) The multi-hop reasoning is mostly sound—comparing product descriptions across years to infer strategic direction—but the incorrect attribution of diagnostic features to 2022 weakens the logical progression. The ground truth indicates diagnostics were emphasized only in 2024, not 2022. (4) Despite this key error, the overall conclusion about a strategic shift toward battery-powered and diagnostic-integrated tools is supported for 2023–2024, and the company’s positioning as technology-driven is reasonably inferred. The answer is contextually relevant and well-structured, but the early attribution of diagnostics reduces qualitative accuracy. Correctness score is 7 due to core factual accuracy on the shift, but with a significant timeline error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 452,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024 Gilead has consistently used its Santa Monica, California site for **clinical manufacturing and processing of cell‑therapy products** (2022 p. 35; 2023 p. 11; 2024 p. 10).  The unchanged role—without a shift to commercial production—underscores the facility’s strategic position as a dedicated clinical hub that supports the development of Gilead’s cell‑therapy pipeline within its broader manufacturing network.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in stating that the Santa Monica facility was used for clinical manufacturing and processing of cell therapy products from 2022 to 2024, and it correctly identifies the strategic role of the site as a clinical hub. However, it contradicts the ground truth by asserting that the facility had this role consistently starting in 2022. According to the original answer, in 2022 the facility was part of GILD's R&D and manufacturing network but was *not specifically highlighted* for cell therapy processing—this specific distinction is critical. The strategic emphasis on cell therapy at Santa Monica only emerged in 2023, representing a meaningful evolution. The LLM answer fails to capture this progression, instead asserting an unchanged role over the three years, which misrepresents the multi-hop evolution described in the ground truth. While all cited years and page numbers are plausible and the terminology is accurate, the reasoning is flawed in that it misses the key transition from general R&D to dedicated cell therapy use. This undermines the qualitative accuracy despite correct formatting and contextual relevance. Quantitative accuracy is not applicable here in terms of numbers, but dates and references are presented correctly, so no factual errors in that regard.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 366,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe’s 2022 10‑K (pages 95‑99) does not mention Frame.io as a core Creative Cloud component, indicating that its integration was limited or not emphasized at that time. By the 2024 10‑K, Frame.io is positioned as a cloud‑native collaboration platform that supports video, still images, design files and PDFs, and is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, while also offering Camera‑to‑Cloud uploads from cameras and still‑image devices—expanding both media support and cross‑application collaboration. (2022 pages 95‑99; 2024 page_12)",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with accurate dates (2022, 2024) and correct identification of Frame.io's integration evolution within Adobe's ecosystem. It correctly notes the absence of Frame.io as a highlighted component in the 2022 10-K and its expanded role by 2024. The supported media types (video, still images, design files, PDFs) are accurately reported, as are the integrated Adobe applications (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront). The mention of Camera-to-Cloud functionality reflects an accurate expansion of collaboration features. However, the LLM omits specific details from 2023—such as Frame.io being described as supporting frame-specific feedback and its integration limited to Premiere Pro and After Effects at that stage—which were present in the ground truth. Additionally, the 2024 expansion into casting, location scouting, and marketing campaign management, along with positioning within Adobe GenStudio for enterprise content production, is not mentioned, representing a gap in completeness. Despite these omissions, the core facts and progression are correctly conveyed, with no numerical or date inaccuracies. The reasoning is sound across years, and the answer remains contextually focused on integration, media support, and collaboration features.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 373,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "Emerson has positioned electrical‑distribution equipment (EDE) as a core element of its Discrete Automation portfolio, consistently listing it alongside programmable automation control systems and software in the segment description.  From 2022 through 2024 the company has deepened that integration—adding more EDE and related solutions (e.g., electric linear‑motion and materials‑joining products) to the discrete‑automation suite to deliver a fully‑connected automation stack for discrete manufacturers【page_73】.  This evolution reflects Emerson’s strategy to embed automation technologies across discrete manufacturing while expanding the breadth of EDE offerings within the segment【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Emerson's strategic positioning of Electrical Distribution Equipment (EDE) within its Discrete Automation segment from 2022 to 2024. It correctly identifies the deepening integration of EDE with automation technologies and the expansion of product scope, including the addition of electric linear-motion and materials-joining solutions. The timeline is accurately represented in terms of progression, though it generalizes the 2022 positioning slightly—while EDE was part of Industrial Solutions in 2022, the LLM implies it was already in Discrete Automation, which aligns more with 2023 onward. However, the overall trajectory and strategic intent (embedding EDE into a fully connected automation stack) are correctly interpreted and consistent with the ground truth. All entities (EMR, Discrete Automation, EDE, product types) and years are accurate. There are no numerical inaccuracies (quantitative accuracy is perfect as no calculations are involved). The reasoning is sound, demonstrating multi-hop synthesis across years and product lines. The answer is contextually excellent, directly addressing integration with automation technologies and product scope expansion. The minor inaccuracy in the initial 2022 placement prevents a perfect 10, but the answer remains semantically equivalent in strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 384,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$19.98 bn (weighted‑average rate 2.91 %)** at 12/31/2022 to **$27.17 bn (4.45 %)** at 12/31/2023, then fell slightly to **$26.93 bn (4.84 %)** at 12/31/2024【page 188 (2022)】【page 178 (2023)】【page 188 (2024)】. The jump in carrying value and the steep rise in the weighted‑average rate between 2022 and 2023 reflect new issuances at higher market rates, while the modest decline in 2024 indicates partial repayment or refinancing. Together, these trends show that Capital One is actively managing its debt mix—issuing fixed‑rate debt to secure liquidity while hedging against further rate hikes, yet also paying down or restructuring to keep borrowing costs in check in a rising‑rate environment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all carrying values and interest rates are accurate: $19,975 million in 2022 ≈ $19.98 billion (rounded), $27,168 million ≈ $27.17 billion, $26,930 million = $26.93 billion; interest rates 2.91%, 4.45%, and 4.84% are exact. Minor formatting differences (e.g., 'bn' vs 'million', decimal rounding) are acceptable under semantic equivalence. (2) The answer addresses all parts of the question: evolution of carrying value and interest rate from 2022–2024, and interpretation of debt strategy in a rising rate environment. (3) Entities are correct: Capital One (COF), fixed unsecured senior debt, proper years, and financial metrics. (4) Reasoning is sound and adds value: correctly infers that the increase in debt and rates reflects new issuances at higher rates, the slight 2024 decline suggests repayment or refinancing, and synthesizes this into a coherent strategy of securing liquidity while managing costs amid rising rates—consistent with the ground truth's 'proactive approach to anticipated rate hikes.' The multi-hop synthesis across three years of data is accurate and well-articulated. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 347,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from **$1,109 million at 12/31/2023 to $993 million at 12/31/2024** (a net decline of $98 million after issuing $216 million in new warranties and settling $247 million).  The balance had already slipped from $1,157 million in 2022 to $1,109 million in 2023, so the trend shows a steady reduction in the company’s long‑term product‑performance exposure in its commercial aerospace business, likely reflecting fewer warranty issuances and higher settlements that improve product reliability or risk management.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, RTX's liabilities for performance and operating cost guarantees were $120 million in both 2022 and 2023, and decreased slightly to $101 million in 2024. In contrast, the LLM reports values of $1,157 million in 2022, $1,109 million in 2023, and $993 million in 2024—over ten times higher than the actual figures. These numbers are not only wrong but suggest a completely different scale and trend. (2) The calculations presented (e.g., net decline of $98 million after new issuances and settlements) are based on incorrect base values and thus invalid. The ground truth does not mention new warranty issuances or settlements, so this level of detail is unsupported and likely hallucinated. (3) The multi-hop reasoning is flawed: the LLM infers a 'steady reduction' indicating improved reliability or risk management, while the ground truth describes stability with only a minor decrease, indicating consistent risk exposure rather than a meaningful downward trend. This misrepresents the implication of the data. (4) Despite the severe factual inaccuracies, the answer is contextually relevant—it addresses the right company (RTX), the correct type of liability, and the commercial aerospace business context. It attempts multi-year comparison and draws a business conclusion, which aligns with the question’s intent. However, due to massive quantitative errors and resulting incorrect interpretation, the overall correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 429,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "The Coca‑Cola Group’s investment note has consistently listed “estimates of sales proceeds” as one of the valuation methods for non‑public investments, with the same wording and emphasis on the difficulty of forecasting cash flows in emerging markets in 2022 (p. 42), 2023 (p. 79), and 2024 (p. 79). This unchanged reliance shows a stable, market‑participant‑aligned approach to fair‑value measurement, underscoring the company’s cautious stance toward valuing assets in volatile emerging economies.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Coca-Cola's reliance on 'estimates of sales proceeds' remained unchanged from 2022 to 2024. The ground truth shows a clear evolution: from disclosure in 2022, to explicit operational reliance in 2023, to cautious integration with heightened awareness of emerging market risks in 2024. The LLM incorrectly asserts 'unchanged reliance' and 'same wording and emphasis' across all years, which contradicts the documented progression. (2) Quantitatively, the LLM correctly references page numbers (p. 42, p. 79) for 2022, 2023, and 2024, and correctly identifies the recurring mention of challenges in forecasting cash flows in emerging markets. These specific references and consistent terminology are factually plausible and do not contain numerical errors. (3) The multi-hop reasoning is flawed: the model fails to synthesize the evolving language (from 'disclosed use' to 'relies on' to 'continued use with caution') across years, which is central to the question. Instead, it assumes consistency where there is documented strategic evolution. This misrepresents the company's changing approach to fair value assessment. (4) While the answer is contextually relevant—addressing valuation methods and emerging market challenges—it misses the key dynamic of methodological evolution. The conclusion of a 'stable, market-participant-aligned approach' directly contradicts the ground truth's narrative of strategic progression and increasing risk awareness. Thus, despite accurate page citations and terminology, the qualitative and overall correctness scores are low due to fundamental misrepresentation of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 461,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "From 2022 through 2024, BNY Mellon’s 10‑K risk‑factor disclosures consistently repeated the same statement: the Board’s discretion to return capital is subject to U.S. banking laws and regulations, including capital‑and‑capital‑planning rules, Delaware law, and the requirement to pay full, timely dividends on preferred stock. The wording did not change across the three filings, indicating a steady, cautious stance that keeps capital‑distribution decisions within regulatory limits while still allowing the Board to adjust them as needed.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the consistent disclosure language from 2022 to 2024 regarding U.S. banking laws, capital planning rules, Delaware law, and preferred stock dividends, which aligns with the ground truth. All entities (BNY Mellon, regulatory frameworks) and years (2022–2024) are accurate, and there are no numerical inaccuracies—this supports a high quantitative accuracy score. However, the LLM fails to mention a key qualitative update in the 2024 filing: the new emphasis on the Parent’s dependency on dividends from subsidiaries and credit extensions from its IHC to fund share repurchases and dividends. This omission is significant because the question specifically asks about the evolution of disclosures and what the progression suggests about strategic flexibility. By stating that 'the wording did not change,' the LLM incorrectly implies no evolution, contradicting the ground truth that notes an added focus in 2024. This weakens the qualitative accuracy and overall correctness, as the multi-hop reasoning—linking consistent regulatory constraints with emerging internal structural dependencies—is incomplete. The answer remains contextually relevant and correctly frames the ongoing regulatory constraints, but the failure to detect and report the 2024 nuance limits its depth and factual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 370,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s 10‑K risk disclosures show that the threat of losing tax and tariff exemptions has been a constant concern since 2022, but the context has broadened over time. In 2022 the risk was framed as a general “loss or modification of exemptions for taxes and tariffs” that could affect operations abroad (see pages 35‑39 of the 2022 filing). By 2023 the same wording appeared, but the description added “changes in tax laws, trade protection measures and import or export licensing requirements” and highlighted the impact of sanctions and export‑control rules (pages 39‑43 of the 2023 filing). In 2024 the language remains, yet it explicitly links the loss of exemptions to a wider array of geopolitical and regulatory pressures—sanctions against Russia, Belarus and Ukrainian regions, and tensions between China and Taiwan—underscoring how sanctions and trade‑policy shifts now directly threaten AMD’s tax and tariff benefits (pages 38‑42 of the 2024 filing). This progression illustrates an increasingly intricate global regulatory environment in which AMD must navigate not only ordinary tax changes but also targeted sanctions and evolving export‑control regimes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: AMD consistently highlighted the risk of losing tax and tariff exemptions from 2022 to 2024, with increasing contextual detail each year. The evolution—from general awareness in 2022, to inclusion of trade measures and export controls in 2023, to explicit linkage with geopolitical events like the Ukraine conflict and China-Taiwan tensions in 2024—is accurately portrayed. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) and document references (page ranges) are correctly cited and consistent with the expected filing details, indicating strong source grounding. (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures across three years of 10-K filings and correctly infers an increasing complexity in AMD’s regulatory environment due to expanding geopolitical and policy-related factors. (4) Semantic equivalence is achieved—while the LLM uses slightly different phrasing (e.g., 'trade protection measures', 'import or export licensing requirements'), it captures the same core progression and implications as the ground truth. The only minor shortcoming is that the LLM does not explicitly state that this trend reflects both internal expansion and external pressures (a nuance in the original answer), but the emphasis on external geopolitical drivers (sanctions, export controls, regional tensions) sufficiently supports the conclusion of growing complexity. Thus, the answer is factually complete and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 452,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s total debt (short‑term borrowings plus long‑term debt) fell from **$48.7 billion in 2022 to $45.6 billion in 2024**.  Short‑term borrowings dropped sharply from **$883 million in 2022 to $538 million in 2023** and then rose modestly to **$562 million in 2024**, while long‑term debt rose from **$47.8 billion in 2022 to $49.3 billion in 2023** and fell to **$45.0 billion in 2024**.  The floating‑unsecured senior debt component shrank from **$1.6 billion in 2022 to $349 million in 2023 and was eliminated in 2024**, indicating a deliberate shift away from variable‑rate debt and a lower interest‑rate exposure, with the remaining long‑term debt carrying a weighted‑average rate of roughly 4.5‑4.8 %.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in total debt figures. The original answer states total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM incorrectly reports total debt as $48.7B in 2022 and $45.6B in 2024, omitting the 2023 peak and misrepresenting the 2022 baseline. This suggests incorrect aggregation or sourcing of total debt. (2) Short-term borrowings: LLM reports $883M (2022), $538M (2023), $562M (2024), but original data does not support these exact figures—ground truth implies short-term borrowings are part of the total, but specific breakdowns are missing in the original answer, so partial credit is given. Long-term debt: LLM reports $47.8B (2022), $49.3B (2023), $45.0B (2024), which are close but not exact to implied values from the original (e.g., 2022 long-term debt implied as $43.086B - short-term, but short-term not specified). Floating unsecured senior debt: LLM correctly captures the trend—$1.6B in 2022 (vs. $1.709B), $349M in 2023, $0 in 2024—and the elimination of this category. Interest rate context is partially correct but lacks specific weighted-average rates for floating debt (1.01% in 2022, 6.75% in 2023) and fixed debt progression (2.91% to 4.84%). (3) Multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift from floating to fixed-rate debt to reduce interest rate exposure, which aligns with the original conclusion. However, it fails to mention the increase in fixed unsecured senior debt from $21.045B (2022) to $27.168B (2023) to $26.930B (2024), a key supporting fact. (4) Contextual relevance is high—the answer addresses debt evolution, composition shift, and interest rate exposure. However, quantitative inaccuracies in totals and missing specific interest rate data reduce correctness. The conclusion is directionally correct but lacks precision. Thus, correctness score is 5 due to mixed accuracy in numbers and incomplete data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 550,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program share interest in International Aero Engines AG (IAE) stayed at **57 %** from 2022 through 2024 (the same 61 % program‑share and 49.5 % ownership interests reported in the variable‑interest‑entity notes on pages 112, 98 and 102).  The unchanged majority stake shows that RTX continues to be the primary beneficiary and holds a consistent controlling position in the V2500 engine collaboration, underscoring its strategic leadership and influence over the program’s economics and decision‑making.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's net program share interest remained unchanged at 57% from 2022 to 2024. The ground truth shows a decrease from 61% in 2022 to 57% in both 2023 and 2024, indicating a change over time. The LLM incorrectly claims the percentage was constant, contradicting the documented evolution. Additionally, the mention of '61% program-share and 49.5% ownership interests' is confusing and misaligned—while 61% may reference the initial program share, it is not accurate to say the program share stayed at 57% throughout when it actually decreased from 61%. (2) Quantitatively, the percentages are misassigned to the years: 61% should be for 2022 only, not carried forward, and 57% applies to 2023 and 2024. The LLM reverses or ignores this trend. There are no correct calculations in the response because the core data is wrong. (3) The multi-hop reasoning fails—the question requires tracking a change over time across filings (2022→2023→2024), but the model does not recognize the temporal shift. Instead, it asserts consistency where there is documented dilution, leading to an incorrect strategic interpretation. The conclusion about 'consistent controlling position' and 'strategic leadership' may have some basis in continued majority interest, but it misses the key point of strategic adjustment via reduced exposure. (4) Contextual relevance is moderate because the answer addresses RTX, IAE, the V2500 program, and strategic implications, but the factual foundation is flawed, undermining the analysis. Due to major errors in numbers, timeline, and resulting interpretation, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 459,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Cascade remains a key brand in P&G’s Fabric & Home Care segment, which has grown in importance over the last three years.  The segment’s share of net sales rose from 35 % in 2022 to 36 % in 2024 (35 % in 2023) and its earnings share climbed from 31 % to 34 % (31 % in 2023), indicating an expanding role for home‑care products.  Cascade’s continued listing among the segment’s major brands in each filing shows its sustained prominence within the portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cascade as a key brand within P&G’s Fabric & Home Care segment across 2022–2024, accurately reflecting its consistent positioning. All numeric values—segment net sales (35% in 2022, 36% in 2023 and 2024) and earnings share (31% in 2022 and 2023, 34% in 2024)—are factually correct and match the ground truth. (2) Quantitative accuracy is perfect: percentages for net sales and earnings are correctly reported for each year, with appropriate year-over-year comparisons. The slight increase in earnings from 31% to 34% is correctly noted, though the answer states earnings were 31% in 2023, which aligns with the ground truth (no increase until 2024). (3) The multi-hop reasoning is sound—information is synthesized across three 10-K filings to show trend consistency. The conclusion that Cascade has maintained prominence is logically supported by its repeated listing among major brands. (4) The only minor shortcoming is that the LLM slightly simplifies the narrative by not explicitly stating that the Fabric & Home Care segment’s earnings contribution increased from 31% to 34% *over the period*, which the original answer highlights to emphasize Cascade’s stable role amid broader segment growth. However, this does not detract from factual correctness. Wording differs but semantic meaning is equivalent. All entities (Cascade, P&G, Fabric & Home Care segment, years, financial metrics) are accurate. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 422,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "BNY Mellon’s 2022 10‑K listed the Directors’ Code of Conduct at a URL on **www.bnymellon.com** with a non‑standard path that included a space (“in relations”). By 2023 the filing corrected the link to a clean investor‑relations folder (**https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf**). In 2024 the employee code moved to a new domain (**bny.com**), while the directors’ code remained on **bnymellon.com** but was referenced as a relative path within the investor‑relations section, and the filing explicitly ties the code to broader governance items—insider‑trading policies, board‑committee charters, and the corporate governance framework—underscoring its integration into the company’s governance architecture.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the domain (bnymellon.com) and the general evolution of the URL path from 2022 to 2023, noting the correction from 'in relations' to 'investor-relations', which aligns with the ground truth. It also correctly notes the 2024 shift to the new domain branding (bny.com), though it inaccurately states that the Directors' Code of Conduct remained on bny.com—ground truth confirms the 2024 URL transitioned to bny.com with updated path. The LLM incorrectly claims the directors’ code was 'referenced as a relative path' and that the employee code moved to bny.com, which is not supported by the ground truth and confuses the employee and directors’ codes. (2) Quantitatively, the years (2022, 2023, 2024) and URL structures are mostly accurate, with minor discrepancies in domain assignment in 2024. The core URLs and path changes are factually plausible but not fully aligned—especially the incorrect assertion about the directors’ code staying on bny.com. (3) The multi-hop reasoning is partially sound: the model connects URL changes to governance integration and notes the 2024 alignment with investor relations and broader governance frameworks, which matches the ground truth’s conclusion. However, it fails to fully capture the strategic rebranding and integration under the new domain (bny.com) as a unified move, instead suggesting a split between employee and directors’ codes that isn’t in the original. (4) The contextual relevance is high—the answer addresses URL structure, domain branding, and integration with governance frameworks as asked. However, due to factual inaccuracies in domain assignment and document location in 2024, and confusion between different codes, the qualitative and overall correctness scores are reduced. The core trajectory is understood but not precisely executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 502,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across 2022‑2024 AMD’s approach to add‑in‑board (AIB) manufacturers stayed essentially the same.  In each year’s 10‑K, AMD’s agreements with AIBs explicitly protected their inventory from price reductions (page 13, 2022; page 13, 2023; page 13, 2024) and continued to encourage system integrators to use discrete graphics solutions as a key differentiation and value‑adding tool (same pages).  No substantive change in inventory‑protection policy or the role of discrete GPUs is noted over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that AMD maintained consistent inventory protection policies for AIB manufacturers across 2022–2024, citing the same page (13) in each year's 10-K, which aligns with the original answer’s claim of policy stability. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy pertains to correct referencing of years and document locations—these are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and confirms no substantive change, correctly identifying the continuity in both inventory protection and the strategic role of discrete graphics in differentiation. (4) The answer addresses all parts of the question: evolution (or lack thereof) in strategic positioning, inventory protection policies, and the role of discrete graphics solutions over the three-year period. It correctly attributes the consistent strategy to AMD’s support for system integrators using discrete GPUs as a value-add. Wording differs slightly but meaning is preserved. No factual errors, omissions, or misattributions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 341,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "McDonald’s 2022 10‑K listed the Egg McMuffin as a core breakfast item and noted an ongoing commitment to test new products, while also announcing a digital‑transformation project to improve data‑driven quality and food‑safety metrics (page 7‑2022, page 6‑2022). The 2023 and 2024 filings keep the same emphasis on the Egg McMuffin and continuous menu innovation but drop the digital‑transformation detail, instead reinforcing the same high‑standard supply‑chain framework—supplier visits, third‑party verification, a Food Safety Advisory Council, and sustainability initiatives—to ensure consistent quality and meet customer expectations (page 7‑2023, page 6‑2023, page 6‑2024, page 7‑2024). Across all three years, the Egg McMuffin is portrayed as a flagship breakfast product whose quality and consistency are underpinned by rigorous supply‑chain controls.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its portrayal of the evolution of McDonald's disclosures, particularly regarding the digital transformation initiative. According to the ground truth, the digital transformation project was introduced in 2024 as a new development, not in 2022 as the LLM claims. The LLM incorrectly states that the 2022 10-K mentioned a 'digital-transformation project to improve data-driven quality and food-safety metrics'—this is false; the ground truth confirms this emphasis emerged in 2024, not 2022. Additionally, the LLM asserts that the digital transformation detail was 'dropped' in 2023 and 2024, which directly contradicts the ground truth: it was only introduced in 2024. This misplacement of a key innovation timeline undermines the core of the multi-hop analysis. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed: the question asks for an evolution from 2022 to 2024, requiring correct attribution of developments to specific years. The LLM misattributes the digital transformation to 2022 and incorrectly claims it was later dropped, failing to capture the actual progression: general quality focus (2022) → supply chain expansion (2023) → digital integration (2024). This breaks the logical synthesis across years. (4) While the LLM correctly identifies the Egg McMuffin as a consistent core item and mentions supply chain controls, it misrepresents the trajectory of innovation and technological integration. The contextual relevance is moderate because it addresses the right company, product, and general theme of quality and supply chain, but the incorrect timeline and misattribution of initiatives reduce factual correctness significantly. Thus, the correctness and qualitative accuracy scores are low despite accurate entity naming.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 538,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The 4.30% Note due 2034 is listed in each filing—Exhibit 4.11 in the 2022 10‑K (page 113) and Exhibit 4.09 in both the 2023 and 2024 10‑Ks (page 110).  Its repeated appearance shows that the note remains an outstanding long‑term debt instrument and that Oracle has not altered its maturity or coupon, underscoring a financing priority to keep a stable, diversified debt profile with predictable, moderate‑rate interest expense across these periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All quantitative elements are correct: the note's interest rate (4.30%), maturity year (2034), and the years of disclosure (2022, 2023, 2024) are accurately stated. The exhibit numbers and page references (Exhibit 4.11 in 2022, Exhibit 4.09 in 2023 and 2024) are precise and consistent with actual filings, demonstrating strong attention to detail. (2) There are no calculation errors, and all numeric values match the expected data. (3) The reasoning is sound: the repeated disclosure is correctly interpreted as evidence of the note remaining an outstanding, unaltered long-term debt instrument, reflecting Oracle’s strategy of maintaining a stable and diversified debt profile. The LLM correctly infers that the persistence of the note indicates a consistent financing priority, which is a valid multi-hop inference across three years of filings. (4) While the LLM answer is concise, it captures the core implications—stable debt structure, predictable interest expense, and strategic use of long-term financing—consistent with the ground truth. It omits some contextual details (e.g., specific comparison to other notes like the 3.625% or 2.950% instruments), which slightly reduces completeness in qualitative synthesis, but the central message remains semantically equivalent. The answer is highly relevant and directly addresses the question about Oracle’s long-term debt structure and financing priorities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 410,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One’s net derivative assets/liabilities rose from **$5 million at Dec 31 2022** (Table 16.2, 2022 column) to **$58 million at Dec 31 2023** and **$69 million at Dec 31 2024** (Table 17.2, 2024 column).  The firm continues to value derivatives with vendor‑based models, classifying them as Level 2 when observable inputs are available and as Level 3 when significant inputs are unobservable (Derivatives section, page 218).  The growing net balance signals increasing exposure to Level 3 fair‑value measurements, yet the sharp drop in transfers into Level 3 in 2024 (from 166 to 12) indicates a modest shift toward more observable inputs, slightly mitigating that exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's net derivative assets/liabilities fair value was $19 million in 2022, $58 million in 2023, and remained $58 million in 2024. However, the LLM incorrectly reports $5 million in 2022, $58 million in 2023, and $69 million in 2024—making two out of three values wrong, including a fabricated increase in 2024. Additionally, the ground truth mentions a net unrealized loss of $20 million in 2022 and specific unobservable inputs like default rates (53–163%) and swap rates (3–5%), which are entirely omitted or misrepresented in the LLM response. (2) The quantitative inaccuracies are severe: the 2022 figure is off by 74% ($5M vs $19M), and the 2024 figure is incorrectly increased to $69M instead of unchanged at $58M. The LLM also introduces unsupported data points like 'transfers into Level 3 (from 166 to 12)' with no mention in the original answer, suggesting hallucination. (3) The multi-hop reasoning is flawed—the question asks about evolution in valuation methodology and exposure to unobservable inputs over time. While the LLM mentions Level 2/Level 3 classifications, it fails to capture the core insight from the ground truth: a shift toward structured use of unobservable inputs (especially swap rates) and increased transparency. Instead, it incorrectly infers reduced exposure due to fewer Level 3 transfers, contradicting the original conclusion of increasing reliance on unobservable inputs. (4) Despite incorrect numbers and reasoning, the LLM does address the general topic—derivative valuation and use of unobservable inputs—and attempts to discuss methodology changes over time, hence moderate contextual relevance. However, due to major factual and analytical errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 503,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s obligation to pay Rolls‑Royce for each V2500‑powered aircraft hour has stayed the same—contingent on flight hours through June 2027—but the accounting treatment has shifted. In 2022 the flight‑hour payments were simply capitalized as collaboration intangible assets as they were incurred. By 2023 the company clarified that those same payments are amortized to cost of sales, and in 2024 the note reiterates that the payments are still capitalized as collaboration intangible assets as they are made, with amortization spread over the term of the underlying economic benefit (i.e., still to cost of sales).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the payment obligation is tied to V2500-powered aircraft flight hours through June 2027, and the accounting treatment evolved from capitalization in 2022 to explicit amortization to cost of sales by 2023, which continued into 2024. (2) There are no numeric inaccuracies—while the $14.1 billion total commercial aerospace commitments in 2024 is not mentioned in the LLM answer, this is a minor omission rather than an error. All other dates (2022–2024) and timeframes (through June 2027) are correctly stated. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes in accounting treatment over time across years, identifying the shift in disclosure clarity and consistency in capitalization and amortization policy. (4) The answer is contextually relevant and directly addresses the evolution of payment structure and amortization strategy. The only reason for not scoring a 10 is the omission of the $14.1 billion figure from 2024, which adds contextual completeness but does not undermine the core correctness of the financial obligation structure and accounting policy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 338,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 10‑K disclosed that it collects user complaints on the Neulasta Onpro kit, had already implemented device‑ and labeling‑enhancements after FDA scrutiny, and would continue to monitor and improve the device. The 2023 filing repeated that same commitment, stressing ongoing monitoring and the addition of further enhancements as needed. By 2024, the company reiterated the device‑enhancement approach while expanding its operational‑resilience narrative—highlighting backup generators, power‑outage planning, and other measures to mitigate disruptions at its Puerto Rico manufacturing site.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Amgen's disclosures from 2022 to 2024 regarding the Neulasta Onpro kit. (1) It correctly identifies that in 2022, Amgen referenced prior FDA scrutiny (implied 2017 evaluation) and had implemented device and labeling enhancements in response to complaints. In 2023, it accurately notes the reaffirmation of ongoing monitoring and incremental improvements. By 2024, it correctly highlights the expansion into operational resilience, specifically backup generators and power-outage planning at the Puerto Rico site. (2) There are no numeric values or dates that are incorrect; the mention of 'December 31, 2024' island-wide outage in the ground truth is a forward-looking date but plausible in context, and the LLM does not contradict it—merely omits the specific date, which is a minor omission. All other temporal references (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and connects device-related risk mitigation with the addition of operational resilience, showing an understanding of both direct (device) and indirect (manufacturing continuity) factors affecting user complaints. (4) The LLM answer is semantically equivalent to the original, though slightly less detailed in explicitly linking infrastructure instability to potential impact on user experience. However, the core factual trajectory—evolution from device fixes to operational safeguards—is preserved. The omission of the explicit 2017 FDA evaluation reference is a minor gap but does not undermine the overall correctness. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 477,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK’s 10‑K filings show the same wording for the ratification of KPMG LLP as principal accountant in Item 14 across 2022, 2023 and 2024—each filing simply states “Item 3 – Ratification of KPMG LLP” and notes KPMG’s PCAOB firm identification number is 185.  The unchanged language indicates that BK has continued to use KPMG as its principal auditor without any change in the audit relationship.  The persistent mention of the PCAOB firm number 185 therefore signals a stable audit‑governance structure and continuity of oversight over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: BK consistently ratified KPMG LLP as principal accountant in 2022, 2023, and 2024; the PCAOB firm number 185 is correctly cited across all years; and the conclusion about audit governance continuity is sound. (2) Quantitative accuracy is perfect—dates (2022–2024) and the PCAOB number (185) match the original answer exactly. No calculations were required, but the consistency of numeric identifiers is correctly reported. (3) The reasoning is logically sound: the unchanged disclosure language and persistent PCAOB number are correctly interpreted as evidence of stable audit governance and an ongoing auditor relationship. The only minor shortcoming is that the LLM references 'Item 3 – Ratification of KPMG LLP' which may be a mislabeling (in standard 10-K structure, auditor ratification typically appears in Item 14, not Item 3), suggesting a possible confusion in item numbering. However, this does not affect the core factual correctness about the disclosure content or audit continuity. (4) The answer is contextually relevant, fully addressing both parts of the question—evolution of disclosure and implications of the PCAOB number—while maintaining semantic equivalence to the ground truth. The conclusion about stable audit governance is well-supported and appropriately worded.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 386,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s collaboration‑partner share of commercial‑aerospace financing guarantees fell from $142 million in 2022 to $135 million in 2023 and $131 million in 2024, showing a modest but consistent decline in guarantee exposure. This trend indicates that the company is actively trimming its potential liability—likely by shifting risk to partners, tightening credit standards, or restructuring financing arrangements—to strengthen its risk profile and improve financial resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values—$142 million in 2022, $135 million in 2023, and $131 million in 2024—matching the ground truth exactly, with acceptable formatting (e.g., use of 'million' and spacing). The trend of a consistent decline is accurately described. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the direction of change (decreasing) is properly interpreted. No calculations were required beyond trend analysis, which was handled correctly. (3) The multi-hop reasoning is sound: the model synthesizes the three-year trend and infers a strategic risk management motive, such as liability reduction and improved financial resilience. It correctly identifies the implication of declining partner shares as a sign of risk mitigation. However, it omits the key qualitative point from the original answer that RTX maintained confidence in the fair market value of guaranteed assets exceeding liabilities net of reserves—a nuance that adds depth to the risk management narrative. This omission prevents a perfect qualitative score but does not invalidate the core reasoning. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the evolution of exposure and the strategic implication. The wording differs but the semantic meaning aligns closely with the ground truth. The minor omission reduces qualitative accuracy slightly, but overall correctness remains high due to accurate data and logical interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 421,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "Across 2022‑2024, P&G consistently positioned the Always brand as a core part of the Feminine Care sub‑category within its Baby, Feminine & Family Care segment, with the sub‑category defined as “Adult Incontinence, Feminine Care” in all three years (2024 MD&A, page 18; 2023 MD&A, page 18; 2022 MD&A, page 18). The brand remained listed among the major brands alongside Tampax and Always Discreet, indicating a stable emphasis relative to other feminine‑hygiene offerings (2024 MD&A, page 18; 2023 MD&A, page 18; 2022 MD&A, page 18). No changes in product categorization or relative brand prominence for Always were observed over this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both product categorization and segment evolution, contradicting the ground truth. (1) In 2022, the segment was 'Feminine Care'—not 'Baby, Feminine & Family Care' as claimed—and was only renamed in 2023. The LLM incorrectly states that the 'Adult Incontinence, Feminine Care' sub-category existed in all three years, which is false; this structure emerged only after the 2023 reorganization. (2) The ground truth confirms a clear evolution: from a standalone 'Feminine Care' segment in 2022 (25% of net sales) to a merged 'Baby, Feminine & Family Care' segment in 2023 and 2024 (24% of net sales), with formatting streamlining by 2024. The LLM incorrectly asserts 'no changes' in categorization or brand prominence, missing this multi-hop progression entirely. (3) While the mention of Always being listed alongside Tampax and Always Discreet is consistent with the ground truth, the LLM misattributes stability where there was structural change. (4) Quantitative accuracy is partially correct: the 24–25% net sales contribution range is accurate, though the LLM fails to note the 2022 (25%) vs. 2023–2024 (24%) slight decline. (5) The citations to MD&A pages are plausible but used to support an incorrect narrative, suggesting flawed reasoning. (6) Contextual relevance is high—the answer addresses brand positioning and categorization over time—but factual correctness is compromised by key misrepresentations of segment names, timing, and evolution. Thus, the answer is partially informed but fundamentally flawed in its core claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 435,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "AMD has consistently flagged “difficulties in protecting our intellectual property” as a risk in its 2022, 2023 and 2024 10‑Ks (2022 p. 37; 2023 p. 41; 2024 p. 41).  During the same period the company’s international sales grew to roughly two‑thirds of revenue (2023 p. 41: 65 %; 2024 p. 41: 66 %) and its reliance on third‑party wafer foundries in China, Malaysia and Taiwan remained unchanged, amplifying the complexity of IP protection amid escalating geopolitical tensions and export‑control sanctions.  Thus, while the risk remains present, the expanding global footprint and dependence on Asian manufacturing have heightened the potential impact of IP‑related challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: AMD consistently reported IP protection difficulties in its 2022, 2023, and 2024 10-Ks; international sales increased to 65% in 2023 and 66% in 2024, which matches the 'roughly two-thirds' characterization; and reliance on third-party manufacturing in China, Malaysia, and Taiwan is accurately noted. These numbers are cited correctly with page references, and no calculation errors exist. (2) The answer addresses all parts of the question: evolution of IP risks from 2022–2024, expanding international operations, and reliance on Asian manufacturing. It correctly synthesizes information across years and risk factors. (3) Multi-hop reasoning is sound: the LLM connects growing international sales, continued dependence on Asian foundries, and rising geopolitical tensions to an increased potential impact of IP risks—consistent with the ground truth’s emphasis on escalating complexity. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'geopolitical tensions between China and Taiwan' as a distinct new layer of risk in 2024, which was highlighted in the original answer. While it references 'geopolitical tensions and export-control sanctions' broadly, the specific China-Taiwan dynamic is slightly less emphasized. However, this does not undermine the overall correctness. Wording differences are acceptable under semantic equivalence. All entities (AMD, years, countries, financial percentages) are accurate. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 459,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in March 2021 as part of a multi‑rate, multi‑maturity program (Exhibit 4.16 in the 2022 10‑K).  The same issuance is reported unchanged in the 2023 and 2024 10‑Ks (Exhibit 4.14), while Oracle added higher‑coupon 4.500% Notes due 2028 in 2023–24 (Exhibit 4.16).  This steady, laddered approach—issuing notes with staggered maturities and a mix of coupon rates—shows Oracle’s strategy of balancing long‑term debt stability with market‑rate flexibility and refinancing risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 2.300% Notes due 2028 were issued in March 2021 (as stated in the 2022 10-K Exhibit 4.16), and consistently disclosed in Exhibits 4.14 in both 2023 and 2024 filings. The mention of higher-coupon 4.500% Notes due 2028 issued in 2023–24 is contextually plausible and does not contradict the ground truth, which notes newer notes were added. (2) The LLM correctly identifies exhibit numbers and their continuity across years, though minor variation in exhibit numbering (e.g., Exhibit 4.16 vs. 4.14) is accurately reflected. (3) Multi-hop reasoning is sound: the model synthesizes information across three years and correctly infers Oracle’s laddered debt strategy—maintaining long-term instruments while adding new tranches—demonstrating a stable, diversified maturity and coupon profile. (4) The only minor shortcoming is that the ground truth emphasizes the 'consistent inclusion' of the 2.300% Notes as evidence of reliance on this specific instrument, while the LLM shifts focus slightly toward a broader 'laddered approach' with new higher-coupon notes. While this is a reasonable interpretation, it introduces a nuance (the 4.500% Notes) not present in the ground truth, potentially overextending the evidence. However, this does not undermine the core factual accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 420,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "From 2022 to 2024, BA kept its private‑equity focus on U.S. and non‑U.S. leveraged‑buyout, venture‑capital, growth, and special‑situation limited partnerships (see pages 110, 92, 99).  The target allocation rose from 4 % in 2022 to 7 % in 2023 and 2024, and actual allocations climbed from 8 % to 9 %, reflecting a heavier weighting toward private equity while the geographic scope and strategy mix stayed the same.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and omits key aspects of the evolution in BA's investment strategy. While it correctly identifies that BA invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies in 2022, it fails to capture the strategic evolution in 2023 and 2024. Specifically, the expansion into global private investments in real assets such as energy, farmland, and infrastructure in 2023, and the increased use of derivatives for performance transfer across asset classes in 2024, are entirely missing. Instead, the LLM claims the strategy mix 'stayed the same,' which contradicts the ground truth. (2) The quantitative claims about target allocation rising from 4% in 2022 to 7% in 2023 and 2024, and actual allocations increasing from 8% to 9%, are not present in the original answer and cannot be verified against the ground truth. These numbers appear to be fabricated or misattributed, resulting in major quantitative inaccuracies. There is no mention of percentage allocations in the original answer, so these figures are unsupported. (3) The multi-hop reasoning is flawed. The question asks for an evolution across three years in terms of geographic scope and strategic focus. The LLM fails to trace this progression, incorrectly asserting continuity where there was meaningful change. It does not synthesize the shift toward real assets or the adoption of derivatives, both of which represent strategic deepening and sophistication. (4) The contextual relevance is moderate because the answer discusses BA’s private equity investments and limited partnerships, which are relevant. However, due to the omission of critical strategic developments and the introduction of unverified numerical data, the qualitative and quantitative accuracy scores are low. The correctness score is 4 because while some initial facts are correct (e.g., 2022 strategies), the overall narrative is misleading and incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 540,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen’s Bemarituzumab program remained in a Phase 3 study for gastro‑esophageal junction adenocarcinoma from 2022 through 2024, while Phase 2 and Phase 1 programs for other tumor indications were still active (2022 p. 25; 2023 p. 25; 2024 p. 25). The composition‑of‑matter patent portfolio did not change, with estimated expirations in 2029 for both the United States and Europe in each filing (2022 p. 26; 2023 p. 26; 2024 p. 26).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and patent expiration timelines (2029 for U.S. and Europe) are correct, and the clinical phase (Phase 3 for GEJ adenocarcinoma) is accurately reported across all years. The LLM correctly notes consistent patent expiration estimates without change, matching the original answer's emphasis on stable IP. (2) The LLM adds slightly more detail by referencing active Phase 1 and 2 programs for other indications, which is not contradicted by the ground truth but not explicitly mentioned—this is a minor expansion, not an error. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings to show continuity in both clinical development and patent status, correctly identifying that the composition-of-matter patents remain unchanged. (4) The only reason for not scoring a 10 is that the LLM does not explicitly mention Bemarituzumab’s mechanism (anti-FGFR2b monoclonal antibody) or Amgen’s emphasis on regulatory exclusivity in 2024, which are part of the original answer’s qualitative context. However, the core facts—clinical progression and patent timelines—are fully correct and well-supported. Wording differs but semantic meaning is equivalent on key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 360,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn has remained a core brand in P&G’s Fabric & Home Care segment, and the segment’s share of earnings has grown modestly over the period.  In 2022 the segment contributed roughly 31 % of net earnings and Dawn was listed among its major brands.  By 2023 the earnings contribution rose to 34 % of net earnings, with Dawn still featured in the major‑brand list, and it stayed at 34 % in 2024—again with Dawn listed alongside Ariel, Downy, Gain, Tide, Cascade, Fairy, Febreze, Mr. Clean and Swiffer【page_18】.  Thus, Dawn’s positioning as a key brand in the segment has been stable, while the segment’s earnings contribution has increased from 31 % to 34 % over the three‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly states that the Fabric & Home Care segment contributed 31% of net earnings in 2022 and 34% in both 2023 and 2024. However, the ground truth specifies the 34% figure for 2024, not 2023, so there is a minor misplacement of the year when the increase occurred—though the final 2024 value is correct. The LLM incorrectly implies the segment reached 34% in 2023 and held there, while the ground truth shows the increase occurred between 2022 and 2024 without specifying 2023 earnings contribution. (2) The LLM correctly notes Dawn’s consistent inclusion in the brand list and names several other brands (e.g., Tide, Mr. Clean), which supports the claim of stable positioning. (3) The reasoning is sound: it connects Dawn’s ongoing presence in the segment with the segment’s growing earnings contribution, correctly inferring stable brand positioning amid rising profitability. (4) The answer addresses all parts of the question—Dawn’s positioning, segment earnings evolution, and brand listings—though it omits the detail about stable sales percentage (35% to 36%), which slightly reduces completeness. This omission prevents a perfect score, but the core facts and synthesis are correct. Overall, the answer is factually strong, with only minor timing imprecision and a small contextual omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 387,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "From 2022‑24 Schwab’s margin‑loan program continued to use client securities as collateral, but the amount of client securities pledged to third parties fell sharply: CS&Co’s secured lines of credit that could use client margin securities dropped from $950 million in 2023 to $500 million in 2024, and the TDAC lines were terminated in 2024 (page 97).  In 2021 the fair‑value of client securities available for pledging rose to $120 billion (up from $84 billion in 2020) and the pledged amount grew to $31 billion (page 108), yet the subsequent decline in pledged collateral indicates a deliberate shift to reduce exposure to client‑held assets, even though margin loans remain collateralized off‑balance‑sheet (page 76).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth. (1) Quantitative Accuracy: The LLM cites specific dollar amounts such as $950 million in 2023 and $500 million in 2024 for secured lines of credit, and $120 billion available and $31 billion pledged in 2021, but these figures are not supported by the original answer and introduce data from unspecified or incorrect years (e.g., 2021 is outside the requested 2022–2024 scope). The original answer does not mention any numerical values for pledged securities or credit lines, nor does it indicate a decline in pledging. (2) Completeness: The LLM incorrectly frames the trend as a reduction in exposure, stating that pledged collateral declined and that there was a 'deliberate shift to reduce exposure,' which directly contradicts the original answer’s conclusion of increasing sophistication and exposure. The LLM omits key developments in 2023 (application of ASC 326 practical expedient) and 2024 (use of securities for options clearing and securities lending collateral), which are central to the original answer. (3) Entity Accuracy: While 'Schwab' and 'margin loans' are correctly identified, references to 'CS&Co', 'TDAC lines', and specific page numbers (e.g., page 97, 108) are not present in the original and appear fabricated or misattributed. (4) Reasoning: The multi-hop synthesis is flawed—the LLM infers a decreasing exposure trend, whereas the original describes an expansion and increased complexity in the use of client securities. The conclusion about reduced exposure is unsupported and opposite to the ground truth. (5) Semantic Equivalence: The overall message is contradictory. Despite some relevant context around margin lending, the core factual claims about amounts, trends, and strategic direction are incorrect. The answer introduces external, unverified data and misrepresents the evolution of Schwab’s practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 521,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "From fiscal 2023 to 2025 ACN kept the U.S. plans’ target at 100 % debt, but the weighted‑average plan assets moved from 97 % debt/3 % cash in 2022 to 94 % debt/6 % cash in 2024, indicating a gradual shift toward cash. For non‑U.S. plans the target allocation changed from 27 % equity/48 % debt/4 % cash/11 % insurance/10 % other in 2023 to 28 % equity/36 % debt/7 % cash/21 % insurance/8 % other in 2025, with weighted‑average assets reflecting this trend—debt falling from 50 % in 2022 to 42 % in 2024, equity rising from 21 % to 23 %, cash from 4 % to 5 %, insurance from 15 % to 21 %, and other from 10 % to 9 %.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth on multiple levels. (1) Quantitatively, the numbers are completely wrong: the ground truth states that ACN's weighted-average allocation shifted from 55% fixed income / 45% equities in 2022 (fiscal 2023) to 61% fixed income / 39% equities in 2024 (fiscal 2025), but the LLM claims U.S. plans were 97% debt in 2022 and moved to 94% debt by 2024, which contradicts the source. It also introduces a false claim that U.S. target allocation was 100% debt, which is not in the original answer. (2) The LLM invents a detailed breakdown for non-U.S. plans with categories like insurance and other, and reports targets changing from 27% equity to 28% equity, but the ground truth makes no mention of U.S. vs. non-U.S. plans or such categories. These details are hallucinated. (3) The reasoning is flawed: the ground truth describes a consistent de-risking trend via increasing fixed income exposure, while the LLM incorrectly frames the shift as moving toward cash and changing insurance allocations—this misrepresents the strategy. (4) The answer fails to synthesize the correct multi-hop information: it should have tracked the three-year evolution of weighted-average asset allocations as of August 31 in 2022, 2023, and 2024, leading to fiscal years 2023–2025. Instead, it confuses reporting dates, invents plan types, and reports false percentages. (5) Contextual relevance is low because the answer discusses irrelevant asset categories and geographic segments not mentioned in the question or ground truth. The only partial credit is for recognizing a gradual shift in allocation over time, but the direction and composition are wrong. Overall, the answer is factually incorrect and misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 479,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023** and then rose modestly to **$562 million in 2024** (Table 8.1 for 2023/2022 and Table 9.1 for 2024/2023).  Long‑term debt increased from **$47.8 billion in 2022 to $49.3 billion in 2023** and then declined to **$45.0 billion in 2024** (same tables).  The three‑year pattern shows a shift toward longer‑dated, largely fixed‑rate debt (weighted‑average rates near 4.5–5 % in 2023–24) with a relatively small floating‑rate short‑term component, indicating a stable debt structure and moderate interest‑rate exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM incorrectly reports short-term borrowings as $883M (2022), $538M (2023), and $562M (2024), and long-term debt as $47.8B, $49.3B, and $45.0B — these are not consistent with the total debt figures in the original answer. The LLM appears to have reported components of debt (possibly from different line items) rather than the total combined short- and long-term borrowings. (2) The weighted-average interest rate is misrepresented: the ground truth shows rates on securitized debt rising from 1.51% (2022) to 3.01% (2023) to 3.48% (2024), but the LLM claims rates are 'near 4.5–5%' in 2023–24, which is factually incorrect. Additionally, the LLM fails to mention the complete elimination of floating unsecured senior debt from $1,597M in 2023 to $0 in 2024 — a key strategic shift highlighted in the original answer. (3) The multi-hop reasoning is partially sound in that the LLM attempts to analyze trends and interpret debt structure and interest rate exposure. However, because it is based on incorrect data, the conclusion about a shift to fixed-rate debt with 'moderate interest-rate exposure' is not well-supported by the actual numbers provided in the ground truth. The LLM also introduces 'Table 8.1' and 'Table 9.1' references not present in the original context, suggesting hallucination. (4) Despite these issues, the answer is contextually relevant — it addresses the evolution of debt and interest rate exposure over three years and attempts to synthesize a trend. However, due to major quantitative errors and missing key facts (especially the floating debt elimination), the correctness score is low. Minor format flexibility is allowed, but the discrepancies here are material and affect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 535,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Fleet‑support services costs have remained essentially flat at about **1 % of total consolidated costs** each year from 2022 through 2024 (the 10‑K filings state this figure on pages 42, 39, 36).  In contrast, the company has recorded sharply rising abnormal production costs and reach‑forward losses in the 787 and 777X programs—costs driven by production disruptions, rework and certification delays that have pushed overall costs and losses higher.  The stable 1 % fleet‑support trend therefore indicates that the increased abnormal production and reach‑forward losses are not related to fleet‑support spending but stem from the operational challenges in those programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the 1% fleet support services cost as a percentage of total consolidated costs is accurately reported for 2022–2024, and while the LLM does not repeat the specific dollar amounts for abnormal production costs ($2.7B in 787 program in 2023) or reach-forward losses ($2,608M and $891M in 777X in 2024 Q3 and Q4), it correctly identifies the trend of sharply rising costs in these programs. The omission of exact dollar figures slightly reduces completeness but does not affect the core correctness. (2) The entity identification is accurate—Boeing (BA), fleet support services, 787 and 777X programs, and the relevant time frame (2022–2024) are all correctly referenced. (3) The reasoning is sound: the LLM correctly contrasts the stability of fleet support costs with the growing production-related losses, drawing the appropriate conclusion that the financial strain stems from program execution issues, not service costs. It successfully performs the multi-hop synthesis between fleet cost trends and program-specific losses. (4) The answer is contextually relevant and directly addresses both parts of the question: the evolution of fleet support costs and their relation to abnormal production costs. The only minor shortcoming is the lack of specific dollar figures present in the ground truth, which limits full quantitative completeness but does not introduce inaccuracy. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 439,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie's money‑market‑fund and time‑deposit balance fell from **$21 million at year‑end 2022** to **$10 million in 2023** and remained at **$10 million in 2024**【page_79】【page_84】. This decline shows the company is pulling idle cash out of low‑yielding money markets, likely reallocating liquidity to other short‑term instruments or operational uses, and maintaining a lean, more efficient short‑term liquidity buffer.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values and years. According to the ground truth, AbbVie's allocation was $12M in 2022, $21M in 2023, and $10M in 2024. The LLM incorrectly states $21M in 2022 (should be $12M), $10M in 2023 (should be $21M), and $10M in 2024 (correct). This misrepresents the entire trend. (2) The quantitative inaccuracies are severe: the increase from 2022 to 2023 is reversed into a decrease, and the drop in 2024 is presented as a continuation rather than a reversal of the prior year’s increase. Calculations or comparisons based on these numbers would be invalid. (3) The multi-hop reasoning is flawed because the LLM fails to correctly identify the direction of change across years. The conclusion that the company is 'pulling idle cash out of low-yielding money markets' starting in 2022 contradicts the actual data, which shows an increase in 2023—suggesting a more conservative stance that year. The real trend is a rise then fall, indicating a temporary shift, not a consistent reduction. (4) Contextual relevance is moderate because the answer addresses the right topic (liquidity strategy) and attempts interpretation, but the reasoning is based on incorrect data. The mention of reallocation is plausible but misaligned with timing. Due to major factual and directional errors, the correctness score is low despite some relevant language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 393,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "Accenture’s share‑repurchase spending climbed from roughly $4.1 billion in fiscal 2022 to $4.5 billion in fiscal 2024 (page 94; page 40), while its aggregate available authorization for share purchases expanded from $3.13 million in 2022 to $6.69 million after a $4 billion boost in 2024 (page 94; page 39). This upward trend in both repurchase volume and authorized capacity signals a deliberate shift toward a more aggressive capital‑return strategy, giving the company greater flexibility to return cash to shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numerical values. It states that Accenture's aggregate available authorization was $3.13 million in 2022, but the ground truth is $3,129,296 thousand ($3.13 billion), not million—a critical 1,000x error. Similarly, it claims the authorization increased to $6.69 million in 2024, while the correct figure is $6,694 million ($6.694 billion). These errors severely undermine the quantitative accuracy. The repurchase spending figures of $4.1B in 2022 and $4.5B in 2024 are not present in the original answer and appear to be fabricated or misattributed, as the ground truth does not provide annual repurchase amounts. (2) The calculation of the 2024 authorization is incorrect: the LLM implies $3.13M + $4B = $6.69M, which is mathematically and denominationally incoherent. The correct logic is that Accenture had $2,694M remaining in 2023, then added $4,000M in 2024, resulting in $6,694M total available—this is misrepresented. (3) The multi-hop reasoning is partially sound in that the model attempts to trace the evolution of share repurchase authorization over time and infer strategic intent. However, due to the numerical errors, the synthesis is flawed. The conclusion about a more aggressive capital return strategy aligns semantically with the ground truth’s 'consistent and expanding' strategy, so the qualitative direction is reasonable. (4) Contextual relevance is fair because the answer addresses the question’s structure—evolution over time and strategic implication—and cites document pages (though not evaluable here). However, the severe numerical inaccuracies drag down correctness and quantitative scores. Minor formatting flexibility is allowed, but confusing millions and billions is a critical error in financial contexts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 494,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s 2022, 2023 and 2024 10‑Ks all state that “stockholders may only remove directors for cause” (see 2022 page 46; 2023 page 27; 2024 page 27), with no change to the wording or scope.  The same three‑class staggered‑term structure and director‑filled‑vacancy provisions also remain unchanged.  This persistent board‑entrenchment reflects a deliberate long‑term defense against hostile takeovers, ensuring the board can resist shareholder pressure, maintain continuity, and negotiate from a position of strength.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AbbVie maintained the 'removal for cause only' provision in its 10-K filings for 2022, 2023, and 2024, with no changes in wording or scope. The cited page numbers (2022 p.46; 2023 p.27; 2024 p.27) are consistent with the source data. (2) Quantitative accuracy is perfect—no numerical or date errors; the years and page references are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance provisions across three years and links them to a broader anti-takeover strategy. It accurately identifies the staggered board and vacancy-filling provisions as part of the entrenchment mechanism, even if slightly less detailed than the original on supermajority bylaw amendments. (4) The answer captures the core conclusion—consistent emphasis reflects a deliberate, long-term takeover defense strategy—demonstrating strong qualitative accuracy. The only minor omission is not explicitly mentioning 'supermajority requirements for bylaw amendments,' which is part of the broader set of defenses noted in the ground truth. However, this does not undermine the overall correctness. The response is fully contextually relevant, directly addressing both the evolution (or lack thereof) and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 373,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo lists the 4.000 % Senior Note due 2047 in the Exhibits section of each 10‑K as “Form of 4.000 % Senior Note due 2047, incorporated by reference to Exhibit 4.5 to PepsiCo, Inc.’s Current Report on Form 8‑K filed on May 2 2017” (2022 : page_126; 2023 : page_127; 2024 : page_127). The unchanged wording and continued inclusion across all three filings show that the note remains a core, long‑term debt instrument in PepsiCo’s capital structure, underscoring the company’s strategy of maintaining a stable, diversified mix of long‑term financing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 4.000% Senior Note due 2047 is correctly identified, and the disclosure consistently references Exhibit 4.5 from the May 2, 2017 8-K filing across all three years (2022, 2023, 2024), which matches the ground truth exactly. Page numbers cited (2022: page_126; 2023: page_127; 2024: page_127) are additional details not contradicted by the ground truth and consistent with typical 10-K formatting. (2) Quantitative accuracy is perfect: percentages (4.000%), dates (May 2, 2017), and years (2047 maturity) are all correct and consistently reported. No calculations are required, but the synthesis of unchanged references over time is accurately interpreted. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the consistent disclosure pattern across three separate 10-K filings and infers the strategic implication—that this note is a stable, long-term component of PepsiCo’s capital structure. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosures and the strategic implication. The conclusion about PepsiCo maintaining a stable, diversified mix of long-term financing aligns with and effectively rephrases the ground truth’s point about the note being a stable, unmodified component since 2017. Wording differs slightly but meaning is preserved and accurate. No errors in entities, years, or financial terms. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 420,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle first issued the 4.30 % note due 2034 in 2014 and has kept it on its books as a long‑dated debt instrument. The 2022 10‑K (Exhibit 4.11) lists the note, and the same exhibit appears in the 2023 and 2024 10‑Ks, showing consistent disclosure over three consecutive years (2022 p. 113; 2023 p. 110; 2024 p. 110). This pattern signals Oracle’s long‑term debt strategy of maintaining a stable, diversified maturity profile with moderate coupon rates rather than frequent refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that Oracle 'first issued the 4.30% note due 2034 in 2014', which directly contradicts the ground truth indicating first disclosure in 2022. This is a major quantitative and factual inaccuracy. However, the interest rate (4.30%) and maturity year (2034) are correct, and the claim of consistent disclosure in 2022, 2023, and 2024 aligns with the ground truth. The citation of Exhibit 4.11 and page numbers adds detail but cannot compensate for the incorrect issuance date. (2) The calculation and numerical elements (percentages, years) are partially correct—4.30% and 2034 are accurate, but the 2014 issuance date is false. No mathematical errors are present, but the foundational event timing is wrong. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes disclosure patterns across three years and infers a stable long-term debt strategy, which matches the ground truth’s conclusion. However, the reasoning is built on a false premise (2014 issuance), undermining the validity of the narrative. (4) Despite the incorrect origin date, the answer captures the essence of Oracle’s strategy—stable, diversified maturities and sustained capital market presence—making it contextually relevant and qualitatively reasonable, though factually flawed in a key aspect. Thus, correctness is penalized heavily due to the incorrect issuance year, but not fully dismissed due to accurate disclosure pattern and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 420,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "Accenture’s authorized share pool for the Amended 2010 SIP grew from 127 million shares in FY 2022 (page 91) to 141 million shares in FY 2024 (page 98), with no change reported in FY 2023 (the 2023 filing did not indicate a change, page 81‑85). This expansion reflects a deliberate scaling of the share‑based compensation program to support long‑term incentive plans and better align employee interests with shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 127 million shares authorized in FY 2022 and the increase to 141 million, but inaccurately states that the 141 million figure is for FY 2024. According to the ground truth, the increase occurred in FY 2023 (from 127M to 141M), and it remained unchanged in FY 2024. The LLM incorrectly skips FY 2023 as a point of change and misattributes the 141 million figure to FY 2024 without acknowledging the actual year of increase. This is a significant quantitative and temporal error. (2) While the numbers themselves (127M and 141M) are accurate in value, their assignment to fiscal years is flawed—specifically, the progression is misrepresented. The claim that 'no change was reported in FY 2023' directly contradicts the ground truth, which states the increase occurred in FY 2023. (3) The reasoning about the strategic intent—expanding share-based compensation to support incentives and align employee/shareholder interests—is logically sound and semantically equivalent to the original answer’s interpretation, showing good qualitative synthesis. (4) Despite the misstatement of when the increase occurred, the overall direction and implication of the strategy are correctly interpreted, and the answer addresses both parts of the question (evolution of shares and strategic implication). However, the incorrect timeline undermines full factual accuracy, warranting a score of 7 for correctness. Quantitative accuracy is penalized more heavily (6) due to the misassignment of the increase year, while qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 440,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo issued the 2.750% Senior Note due 2051 in 2021 (the note is referenced in the 2021 Form 8‑K). In its 2022, 2023, and 2024 10‑K filings the company continues to list the note as “Form of 2.750% Senior Note due 2051” and cites it as Exhibit 4.3 to the 2021 8‑K, with no change to the coupon or maturity. This steady, multi‑year disclosure shows PepsiCo’s disciplined long‑term debt strategy: it issues long‑dated senior notes with stable terms and maintains a consistent, transparent reporting cadence to keep investors informed of its diversified debt portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 2.750% Senior Note due 2051 was issued in 2021 and referenced in a 2021 Form 8-K, which contradicts the ground truth that the note first appeared in a 2022 Board resolution (Exhibit 4.60). The LLM also misidentifies the exhibit number, claiming it is Exhibit 4.3 to the 2021 8-K, whereas the ground truth shows evolving exhibit numbers: 4.60 in 2022, 4.51 in 2023, and 4.48 in 2024. These discrepancies in dates, exhibits, and issuance timeline are critical errors. (2) Quantitatively, while the coupon (2.750%) and maturity (2051) are correct, the issuance year (2021 vs actual first appearance in 2022 filings) and exhibit references are factually wrong. There is no evidence in the ground truth of a 2021 8-K reference, undermining the entire timeline. (3) The multi-hop reasoning is flawed: the LLM fails to trace the actual evolution of documentation across 2022–2024, instead asserting static disclosure with no changes. It misses the progression from authorization (2022) to formalization (2023) to consistency (2024), which is central to the question. The conclusion about a 'disciplined long-term strategy' is plausible but based on incorrect premises. (4) Contextual relevance is moderate—the answer addresses long-term debt strategy and consistent disclosure, which is relevant—but the factual foundation is unsound, leading to a low correctness score. The answer fabricates a 2021 issuance and exhibit reference not present in the ground truth, severely undermining accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 436,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "American Express remains the fourth‑largest general‑purpose card network worldwide, but its competitive position has tightened as regulatory scrutiny and alternative payment mechanisms have intensified (page 12). In 2024 the company was reclassified as a Category III bank‑holding firm, faced potential interchange‑fee caps from Visa and Mastercard, exited EU and Australian network‑licensing businesses, and confronted heightened scrutiny of third‑party outsourcing, all of which have pressured its discount rates and network reach (pages 14, 34, 35, 36). The rapid growth of digital wallets, buy‑now‑pay‑later, and other fintech‑driven payment solutions has intensified competition, prompting AmEx to double‑down on premium cardholder experience, loyalty programs, and integrated payments platforms to preserve its market share (page 12).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies American Express as the fourth-largest general-purpose card network globally, consistent with the original answer. The time frame (2022–2024) is appropriately addressed, with specific developments noted in 2024 such as increased regulatory scrutiny and market exits. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—any dates and classifications (e.g., 2024, Category III) are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes AmEx’s competitive positioning, regulatory pressures (interchange fees, EU/Australia exits), and competitive threats from fintech and alternative payments (BNPL, digital wallets). It also correctly notes AmEx’s strategic response—focusing on premium experience, loyalty, and integrated platforms—mirroring the original’s emphasis on cobrand relationships and closed-loop systems. (4) Minor difference: the original mentions Alipay and PayPal specifically, while LLM generalizes to 'fintech-driven solutions'; also, the LLM adds detail about being reclassified as a Category III bank-holding company and potential interchange-fee caps from Visa/Mastercard, which are plausible but not in the ground truth. These additions do not contradict but slightly extend the original. Overall, the answer is factually correct, contextually complete, and semantically equivalent, warranting a high score with only a slight deduction in qualitative accuracy due to minor extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 445,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Boeing’s 2024 10‑K repeats the same wording as the 2022 filing, listing “upgrades and conversions” as a core element of its Global Services portfolio (see 2024 p. 5 and 2022 p. 3).  The unchanged emphasis indicates that Boeing still sees upgrades and conversions as a key revenue driver for its services business, while the continued mention of “data analytics and digital services” in both filings signals a parallel push to augment traditional upgrade work with digital capabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it is scored as 10 by default. The main failure lies in qualitative accuracy and reasoning. The LLM incorrectly claims that Boeing’s 2024 10-K 'repeats the same wording' as the 2022 filing, which directly contradicts the ground truth: in reality, Boeing evolved its language from 'upgrades and conversions' in 2022 to a more integrated focus on 'modifications' in 2023 and added emphasis on 'data analytics and digital services' as complementary in 2024—indicating a strategic shift. The LLM misses this progression entirely and falsely asserts no change, undermining the core of the multi-hop analysis. It also fails to recognize the strategic implication that Boeing is moving toward technology-enabled, high-value services rather than maintaining static offerings. While the mention of 'data analytics and digital services' is correctly identified as present in both years, the conclusion that this indicates a 'parallel push' is underdeveloped and does not reflect the growing integration and strategic prioritization described in the ground truth. Contextual relevance is moderate because the answer addresses the right segment (Global Services) and topic (upgrades and conversions), but it lacks the correct temporal comparison and strategic interpretation, resulting in a substantially incorrect overall assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 399,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo’s 5.50% Senior Note due 2035 was first issued in 2018 and is still disclosed in each annual report.  In the 2022 10‑K, the note is referenced as part of Exhibit 4.4 (an 8‑K filing) and Exhibit 4.6 (a S‑4 registration statement)【page 126】.  The 2023 filing continued to cite the same exhibits, and the 2024 filing likewise lists the note under Exhibits 4.4 and 4.6【page 126】.  This unchanging documentation over three years shows PepsiCo’s strategy of keeping a stable, fixed‑rate long‑term debt portfolio and consistently disclosing existing instruments rather than issuing new debt each year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 5.50% Senior Note due 2035 was issued in 2018 and consistently documented in 2022, 2023, and 2024, which aligns with the ground truth. However, there are significant factual discrepancies in exhibit numbers: the original answer states Exhibit 4.31 (2022), 4.25 (2023), and 4.23 (2024), while the LLM claims Exhibits 4.4 and 4.6 for all years. This misidentification of exhibits undermines quantitative and qualitative accuracy. Additionally, the LLM cites a S-4 registration statement and references page 126 across years, which are not mentioned in the ground truth and may reflect hallucination or incorrect sourcing. (2) The issuance date (2018) and interest rate (5.50%) are correct, and the multi-year consistency in disclosure is accurately noted. However, the specific exhibit numbers are incorrect, and no dollar amounts or calculations are involved to verify further. (3) The reasoning about PepsiCo’s long-term debt management strategy—emphasizing stability and consistent disclosure of fixed-rate debt—is semantically aligned with the ground truth’s conclusion of a 'stable, long-duration capital structure approach.' This shows sound high-level synthesis despite incorrect exhibit references. (4) The answer is contextually relevant and addresses both parts of the question: evolution over time and strategic implication. However, due to incorrect exhibit citations and unverified sources (S-4, page 126), the factual reliability is compromised, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 429,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon’s risk‑factor disclosures have remained essentially unchanged from 2022 through 2024, each filing stating that “our ability to return capital to shareholders is subject to the discretion of our Board and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, Delaware law, and preferred‑stock dividend obligations.”  This consistency shows that the company’s regulatory constraints on capital‑return policies have not eased or shifted over the three‑year span, continuing to be a material limitation on shareholder payouts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns is consistently described across 2022–2024, with specific mention of U.S. banking laws, Delaware law, and preferred stock obligations. The LLM correctly notes the consistency of disclosures over the three years. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—this is a qualitative regulatory disclosure question. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to conclude that regulatory constraints have remained stable, which matches the ground truth’s interpretation of 'consistent yet evolving emphasis.' The only minor shortcoming is that the LLM does not explicitly note the 2024 addition of 'well capitalized' status as a highlighted factor, which slightly enriches the original answer’s insight into prudential oversight. (4) Despite this small omission, the LLM captures the core regulatory continuity and its implications for capital return policies. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the evolution and regulatory implications. Thus, correctness is 9/10 due to near-complete fidelity with only minor contextual detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 400,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were issued in 2021 at a 2.300 % coupon and the terms have remained unchanged through 2024, as the 2022 and 2024 filings still reference the same notes without amendment [page_111]. In contrast, Oracle issued higher‑coupon notes in 2022 (5.800 % Notes due 2025, etc.) and moderate‑coupon notes in 2023 (4.500 % Notes due 2028) reflecting rising rates [page_111]. This pattern shows Oracle’s strategy of locking in low rates when available and adjusting future issuances to market conditions, demonstrating a flexible, market‑responsive approach to fixed‑income financing.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Oracle's 2.300% Notes due 2028 were issued under terms set in 2021 and remained unchanged through 2024, which aligns with the ground truth. It also correctly notes Oracle's issuance of higher-coupon debt in later years. However, there are key quantitative inaccuracies: the LLM claims Oracle issued '5.800% Notes due 2025' in 2022, which is not supported by the original answer — the ground truth does not mention this specific instrument. Instead, it references 2.875% Notes due 2031 and 3.950% Notes due 2051 in 2022, and 4.500% Notes due 2028 in 2023. The mention of a 5.800% note is factually incorrect and unsupported. (2) The date of issuance is misrepresented: while the Officers' Certificate was dated March 24, 2021, the original answer clarifies it was filed in the 2022 10-K, suggesting the public disclosure came in 2022. The LLM states the notes were 'issued in 2021', which may be technically accurate but lacks the nuance that the filing and confirmation came in 2022, which is contextually important. (3) The reasoning is sound in interpreting Oracle’s strategy — locking in low rates and adjusting new issuances to market conditions — which is consistent with the ground truth’s conclusion about Oracle avoiding repricing and maintaining existing obligations. The multi-hop synthesis across years and instruments is partially correct but weakened by the inclusion of an incorrect bond tranche. (4) Despite the incorrect bond reference, the overall strategic interpretation is valid and relevant, earning high marks for qualitative accuracy and contextual relevance. The core message about Oracle’s fixed-income strategy is preserved, but the factual errors in specific instruments reduce quantitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 486,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "IBM has consistently listed “client relationships and trust” as a principal competitive differentiator in its 2022, 2023 and 2024 10‑K filings (2022 page 3, 2023 page 3, 2024 page 3), with no change in wording or emphasis. This steady focus signals that IBM views deep, trusted client ties as a core pillar of its hybrid‑cloud and AI strategy, underscoring its intent to differentiate itself through long‑term partnerships and customer‑centric solutions in a highly competitive market.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in qualitative reasoning and completeness. (1) It correctly identifies that IBM listed 'client relationships and trust' as a competitive differentiator in its 2022, 2023, and 2024 10-K filings and cites consistent page numbers (page 3), which aligns with the ground truth's timeline. There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default. (2) However, the LLM incorrectly claims there was 'no change in wording or emphasis' across the years, which directly contradicts the ground truth: IBM’s emphasis evolved from a broader strategy in 2022 to highlighting 'deep incumbency' and 'innovation' in 2023, and expanding strategic partnerships (e.g., Palo Alto Networks) in 2024. This evolution is central to the question and was missed entirely. (3) The multi-hop reasoning is flawed—the question asks for the progression across three years and what it indicates about strategic positioning. The LLM fails to synthesize the nuanced development in IBM’s strategy, instead asserting static emphasis. The ground truth shows a clear progression toward more sophisticated positioning in hybrid cloud and AI, tied to trust and partnerships, which the LLM does not capture. (4) Contextual relevance is high because the answer addresses the core theme (trust as differentiator) and links it to hybrid cloud and AI, but the lack of evolution undermines strategic insight. Correctness and qualitative accuracy are reduced due to the failure to reflect the multi-year progression, which is the essence of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 443,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s weighted‑average yield on its foreign‑government‑bond holdings climbed from about 3.5 % in 2022 to 5.9 % in 2023 and 6.1 % in 2024 (non‑U.S. taxable‑investment‑security yields)【page 176】, indicating a deliberate shift toward higher‑yielding foreign debt as rates rise.  This upward trend signals a growing exposure to interest‑rate risk, which the company offsets through its derivative‑hedging program—particularly interest‑rate swaps—to balance yield enhancement with risk control【page 135】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, there is no mention of a 3.5% yield in 2022 or a 6.1% yield in 2024. Instead, the correct yields are: no yield specified for 2022 (only holdings amount: $630M), 6.45% in 2023, and 5.85% in 2024. The LLM incorrectly reports an increasing yield trend (3.5% → 5.9% → 6.1%), while the actual data shows a decrease from 6.45% to 5.85% between 2023 and 2024. Additionally, the LLM fails to mention the critical shift in maturity profile—specifically, the increase in holdings maturing between 1–5 years to 2.03% by 2024—which is central to the investment strategy shift. (2) The dollar amounts and maturity distributions from 2022 are entirely omitted, and the cited yields do not match the ground truth. The reference to 'page 176' and 'page 135' suggests external sourcing, but the numbers still conflict with the verified knowledge graph data. (3) The multi-hop reasoning is flawed: the model infers increasing yields and rising interest rate risk, whereas the actual data indicates a strategic move toward diversifying maturities to manage such risk, not increase exposure. The mention of derivative hedging, while potentially true contextually, is not part of the original answer and does not compensate for missing core facts. (4) The contextual relevance is moderate because the answer addresses yield trends and interest rate risk, but the incorrect numbers and reversed strategic interpretation severely undermine factual correctness. Thus, the correctness score is low due to major quantitative and qualitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 445,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s government assistance that offset capital expenditures for diagnostics‑testing technologies grew steadily: $87 million in 2022, $136 million in 2023 and $198 million in 2024 (2024 10‑K, notes on government assistance, pages 68–70). This upward trend shows the company is increasingly leveraging federal grants to expand testing capacity, underscoring diagnostics testing as a high‑growth, strategically central element of Danaher’s broader life‑sciences and health‑care portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The dollar amounts for each year—$87 million in 2022, $136 million in 2023, and $198 million in 2024—are exactly correct and match the original answer. There are no calculation errors or discrepancies in figures. Minor formatting differences (e.g., $87 million vs $87 million) are acceptable and do not affect meaning. (2) Completeness: The answer addresses both parts of the question—evolution of investment through government grants over the three years and the strategic implication. It correctly identifies the upward trend and interprets it as a sign of increasing strategic importance. (3) Entity accuracy: Danaher Corporation (DHR) is correctly identified, the time frame (2022–2024) is accurate, and the metric—government grant funding offsetting capital expenditures for diagnostics testing technologies—is precisely stated. (4) Reasoning: The multi-hop synthesis across years is sound. The LLM correctly infers from the increasing grant amounts that diagnostics testing is becoming more strategically central, aligning with the original answer’s conclusion. It also appropriately references the 2024 10-K as a source, indicating proper grounding in SEC filings. (5) Semantic equivalence: The LLM conveys the same core information with slightly more detailed phrasing (e.g., mentioning 'federal grants' and 'high-growth'), but these additions are reasonable interpretations and do not distort the meaning. Overall, the answer is factually accurate, complete, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 435,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across FY 2022, 2023 and 2024 BNY Mellon continued to disclose the ratification of KPMG LLP as its principal accountant with the same PCAOB firm identification number of **185**. The disclosure consistently appears in the Proxy under “Item 3 – Ratification of KPMG LLP,” incorporated by reference, and the wording and placement remained unchanged from year to year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: KPMG LLP was consistently ratified as principal accountant across FY 2022, 2023, and 2024; the PCAOB identification number is correctly stated as 185 in all years; and the disclosure consistently appears under 'Item 3 – Ratification of KPMG LLP' within the Proxy materials. (2) Quantitative accuracy is perfect—no calculations required, but the PCAOB number 185 is correctly repeated and matches the ground truth. (3) The reasoning is sound: the model correctly synthesizes multi-year disclosures and identifies consistency in both content and placement. The only minor issue is the use of 'BNY Mellon' instead of 'BK'—while BNY Mellon is the full name and likely refers to the same entity (BK being a ticker or shorthand), the original question and ground truth use 'BK', so the entity reference is slightly less precise. However, this does not impair understanding. (4) The answer is contextually fully relevant, addressing all parts of the question regarding evolution (or lack thereof) in disclosure practices, PCAOB number, and placement in Proxy sections. Wording and structure are concise and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 354,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "From 2022 through 2024, American Express continued to rely on third‑party merchant acquirers as a core revenue driver, recording discount revenue at the time of each Card Member transaction and recognizing network‑rate fees as discount revenue (see 2022 p. 103‑104, 2023 p. 103‑104, 2024 p. 93‑94).  The contractual framework stayed essentially unchanged: small‑ and mid‑size merchants had no fixed term, while large merchants signed 3‑ to 7‑year fixed agreements with auto‑renewal (2022‑23 p. 103‑104, 2024 p. 93‑94).  Strategic goals consistently emphasized expanding global merchant coverage through third‑party acquirers, aggregators and processors, with 2024 adding a sharper focus on priority international cities, new industry verticals and modernizing the authorization platform (2024 p. 93‑94).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of revenue recognition (discount revenue based on network fees) and correctly cites consistent contractual structures across years, with appropriate page references. Quantitative accuracy is high—no numerical errors, and the description of revenue timing and contract durations aligns with the ground truth. However, the LLM fails to capture the key evolution highlighted in the original answer: the shift from a transactional to a strategic partnership model, particularly the 2023 formalization of the 'Processed Revenue' model that includes royalties and structured revenue-sharing. This is a critical omission in the qualitative reasoning, as it misrepresents the evolution of the revenue recognition structure. While the LLM notes strategic expansion goals (e.g., international cities, new verticals), it does not reflect the deeper integration of third-party acquirers into American Express’s network value strategy by 2024. The answer treats the relationship as static rather than evolving, contradicting the ground truth’s emphasis on structural and strategic progression. Thus, while contextually relevant and factually sound on surface details, it lacks the multi-hop synthesis needed to show transformation over time, resulting in a partially correct assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 365,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s 2025 human‑capital targets were repeated unchanged in each filing from FY 2022 through FY 2024: a 15 % increase in women in leadership, a 15 % increase in under‑represented minorities in leadership, and a 20 % increase in overall URM representation.  In every year the HR and Compensation Committee tied progress toward those goals to executive bonuses, applying a non‑financial performance modifier that could adjust the payout by a multiple of 0.9 to 1.1.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 15% increase for women and underrepresented minorities (URM) in leadership, the 20% overall URM representation target, and the 0.9 to 1.1 non-financial performance modifier affecting executive bonuses are all correctly reported and consistent with the ground truth. The fiscal years (2022–2024) and the linkage of human capital goals to executive compensation are also accurately represented. However, the LLM answer lacks the qualitative evolution described in the original answer, particularly the expanded global engagement, wellness and development programs, and broader strategic integration noted in FY2024. While it correctly states that the compensation structure remained unchanged, it omits the incremental developments in program scope and regional recognition mentioned in the ground truth, which are important for capturing the full evolution of Qualcomm’s human capital strategy. Thus, while the core facts and numbers are correct (justifying high scores for quantitative accuracy and contextual relevance), the answer is less complete in conveying the nuanced progression over time, slightly weakening the qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 345,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "From 2022 to 2024, Caterpillar’s EMD‑branded products were still sold through the same worldwide dealer network, but the network contracted slightly: it went from 44 U.S. dealers and 116 overseas dealers serving 193 countries in 2022 to 43 U.S. dealers and 113 overseas dealers serving 191 countries in 2024 (see page 77 for 2022 and page 66 for 2024). This modest shrinkage suggests Caterpillar is refining its dealer base to improve efficiency and focus on core markets while maintaining a broad global footprint, rather than pursuing aggressive expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual inaccuracies in the quantitative details. The ground truth states that Caterpillar's EMD-branded product distribution declined from 193 countries in 2022 to 191 in 2023 and further to 187 in 2024. However, the LLM answer incorrectly reports 191 countries in 2024 (instead of 187) and omits the 2023 data point entirely. This misrepresents the trend as a smaller decline than it actually was. Additionally, the LLM introduces dealer numbers (44 U.S. and 116 overseas in 2022, 43 and 113 in 2024) that are not present in the original answer and cannot be verified against the ground truth, potentially fabricating granular detail. (2) The calculation of the net change in countries is incorrect: the LLM implies a drop from 193 to 191 (a -2 change), but the actual drop by 2024 is -6 countries. The dealer count changes (total dealers dropping from 160 to 156) are not corroborated by the ground truth and introduce unverified data. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a slight contraction and interprets it as strategic refinement or efficiency improvement, which aligns semantically with the original answer’s suggestion of 'strategic refocusing or consolidation.' However, it fails to reflect the continued and accelerating decline over three years, weakening the reasoning. (4) The contextual relevance is high because the answer addresses both parts of the question—geographic change and strategic implication—and offers a plausible interpretation. However, due to significant quantitative inaccuracies and the introduction of unsupported specifics, the correctness score is limited to 5. The qualitative accuracy is slightly higher because the logic and entity identification (Caterpillar, EMD, global markets) are correct, and the strategic interpretation is reasonable, albeit based on flawed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 512,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The fact that Palmolive appears as a principal global trademark in every 10‑K filing from 2022 through 2024 shows that the brand remains a core pillar of Colgate‑Palmolive’s Oral, Personal and Home Care portfolio. Its continued listing signals that Palmolive drives a significant share of sales and market presence in that segment, and that the company views it as a strategic asset for sustaining growth and brand equity. (See the “Principal global and regional trademarks” list on page 79 of each filing.)",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Palmolive has been consistently listed as a principal global trademark in Colgate's 10-K filings from 2022 to 2024, which aligns with the ground truth. All dates and entity names (Palmolive, Colgate-Palmolive, Oral, Personal and Home Care segment) are accurate, and there are no numerical inaccuracies—this earns a perfect quantitative accuracy score. The answer correctly infers that Palmolive remains a strategic asset and core brand within the company’s portfolio, which is consistent with the ground truth’s conclusion about its foundational role. However, the LLM response lacks the detailed year-by-year synthesis present in the original answer—such as the mention of Ajax and Darlie, or the absence of positional dilution—which weakens the depth of multi-hop reasoning. While it captures the overall implication of sustained strategic importance, it omits specific contextual evidence from each year that strengthens the conclusion. Thus, qualitative accuracy is slightly reduced due to less granular reasoning. Contextual relevance is full, as the answer directly addresses the strategic role of Palmolive in the specified segment and time frame.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 338,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "Qualcomm has consistently positioned edge‑networking as a key pillar of its IoT portfolio, citing in FY 2022 that the global IoT device base would more than double by 2026 and that edge‑networking products (mobile‑broadband and Wi‑Fi 6/6E access points) would drive that growth (QCOM_10k_2022, pages 6‑10).  In FY 2023 and FY 2024 the company still grouped edge‑networking under the “IoT” revenue stream—consumer, edge‑networking, industrial—and kept the same revenue‑recognition model: QCT equipment sales (including edge‑networking) are recognized at a point in time, while QTL licensing revenue is recognized over time (QCOM_10k_2023/2024, pages 71‑75).  Although IoT revenue fell from $7.35 bn in FY 2022 to $5.94 bn in FY 2023 and $5.42 bn in FY 2024, Qualcomm’s strategic emphasis on edge‑networking remained unchanged, underscoring its role in the broader connected‑intelligent‑edge vision.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Qualcomm's strategic emphasis on Edge Networking as part of IoT and its continuity from 2022 through 2024, and correctly identifies product categories (mobile broadband, Wi-Fi 6/6E access points) and revenue recognition principles (point-in-time for QCT equipment, over time for QTL). However, it introduces revenue figures for IoT ($7.35B, $5.94B, $5.42B) that are not present in the original answer or implied by the ground truth, which does not mention specific IoT revenue amounts. These numbers may be factually accurate in external context but are not supported by the provided ground truth, making their inclusion a deviation. (2) The quantitative accuracy is reduced because the original answer does not include any IoT revenue figures, so their introduction creates unverifiable claims within the scope of the knowledge graph. There are no calculation errors, but the inclusion of unsupported numbers affects factual fidelity. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes positioning (2022 growth projections), product categorization (2023–2024 grouping under IoT with consumer and industrial), and revenue recognition (QCT vs QTL treatment). It accurately reflects the structural embedding of Edge Networking by 2023 and sustained focus through 2024. (4) Despite the addition of unsupported revenue figures, the core strategic narrative aligns with the ground truth—positioning evolution, product grouping, and revenue recognition structure are correctly conveyed. Wording differs but meaning is semantically close. Hence, correctness is high but not perfect due to extraneous, unverified quantitative data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 461,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "From 2022 through 2024 Caterpillar’s exposure to currency‑exchange risk remained significant because its sales and operations are spread across many countries, and the company continued to use hedging instruments to mitigate adverse movements (CAT_10k_2022 p. 19; CAT_10k_2023 p. 19; CAT_10k_2024 p. 19).  The 10‑K disclosures each year note that while hedging can reduce earnings volatility, it also limits upside gains and does not eliminate the risk that currency fluctuations can materially affect results (see the same pages).  Thus, the hedging strategy evolved little, with Caterpillar maintaining a similar approach while acknowledging ongoing volatility in earnings tied to its international exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of Caterpillar's consistent use of hedging instruments and the inherent limitations acknowledged across 2022–2024. All cited document references (CAT_10k_2022 p.19, etc.) are correctly attributed and support the claims. There are no numerical inaccuracies, and since the question does not involve specific financial figures (e.g., dollar amounts, percentages), quantitative accuracy is scored highly based on correct temporal and conceptual alignment. The reasoning is sound: the LLM correctly synthesizes disclosures across three years and identifies the continuity in strategy. However, the LLM understates the evolution noted in the original answer—specifically, the growing emphasis on emerging market risks such as exchange controls and currency devaluations in 2023 and 2024. While the core strategy may have remained stable, the original answer highlights an increasing caution due to external macroeconomic pressures, a nuance not fully captured in the LLM response. This omission affects completeness and qualitative depth but does not invalidate the overall correctness. Contextual relevance is perfect—the answer directly addresses Caterpillar’s exposure, hedging use, impact on earnings volatility, and international operations across the specified period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 374,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive reduced its U.S. pension plan’s exposure to Treasury and agency securities from roughly **40 % in 2022** to **30 % in 2023**, and the allocation stayed at **30 % in 2024**【page_102】【page_100】. This shift away from the most conservative fixed‑income asset class indicates a deliberate move to diversify the portfolio and adjust duration/yield exposure, reflecting a more active interest‑rate‑risk management strategy rather than heavy reliance on Treasuries and agencies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a key inaccuracy in the starting percentage and year. The original answer states that the allocation was 50% as of December 31, 2020 (disclosed in the 2022 filing), then dropped to 40% as of December 31, 2021, and further to 30% as of December 31, 2022. However, the LLM claims the reduction started from 'roughly 40% in 2022', which conflates the 2021 year-end value with 2022 and omits the earlier 50% level. This misrepresents the timeline and magnitude of the decline. The 30% allocation for 2023 and 2024 is correctly reported. (2) The quantitative accuracy is compromised because the evolution from 50% → 40% → 30% over 2020–2022 is not fully captured; only the last leg (40% to 30%) is mentioned, and it's incorrectly attributed to 2022–2023. There are no calculation errors per se, but the omission of the 50% starting point and misdating of the 40% figure affect factual precision. (3) The reasoning about diversification and active interest rate risk management is sound and aligns with the original interpretation. The LLM correctly infers strategic intent from the trend, even if the trend is slightly misstated. It also appropriately links the move away from Treasuries to broader risk management, showing good qualitative synthesis. (4) Contextual relevance is high—the answer directly addresses both parts of the question: the allocation trend and its implication for interest rate risk. While the core direction of the trend (decline followed by stabilization) is correct, the failure to accurately represent the full multi-year evolution from 2020 to 2022 reduces the overall correctness score. Minor formatting differences (e.g., '40 %' vs '40%') are acceptable and do not impact scoring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 481,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "Pfizer’s BPA activity dropped to zero after 2022: BPAs were granted and outstanding in 2022 (PFE_10k_2022.pdf p. 101), but the 2023 and 2024 10‑K notes explicitly state that no BPAs were granted or outstanding (PFE_10k_2023.pdf p. 96; PFE_10k_2024.pdf p. 96).  Across all three years the company consistently valued BPAs using the intrinsic‑value method based on the closing price of its common stock and amortized the expense over the probable vesting term (PFE_10k_2022.pdf p. 101; PFE_10k_2023.pdf p. 96; PFE_10k_2024.pdf p. 96).  Disclosure transparency improved in 2023‑24 by explicitly noting the absence of BPA activity, whereas the 2022 note provided detailed grant and valuation information (PFE_10k_2022.pdf p. 101; PFE_10k_2023.pdf p. 96; PFE_10k_2024.pdf p. 96).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the 2024 reinstatement and evolution of Pfizer's BPA program. The ground truth states that BPAs reappeared in 2024 with new valuation and amortization policies, including adjustments based on performance probability and stock price changes. However, the LLM claims that the valuation method remained unchanged across all three years, using the same intrinsic-value method and amortization approach, which contradicts the ground truth. Additionally, the LLM incorrectly asserts that no BPAs were granted or outstanding in both 2023 and 2024, but the ground truth confirms that while 2023 had no grants or outstanding awards, 2024 saw the program's return with disclosures of a revised framework. (2) Quantitative accuracy is poor: the ground truth includes specific grant data for 2022 (1,165 thousand shares at $38.73 weighted average intrinsic value) and nonvested shares (859 thousand), none of which are mentioned in the LLM answer. The absence of these key figures results in a major omission. (3) Multi-hop reasoning is partially sound—the model correctly identifies document sources and attempts to track BPA activity over time—but fails to detect the critical shift in 2024, indicating a failure in synthesizing the full evolution. It treats 2023 and 2024 as identical in BPA status, missing the reintroduction and enhanced transparency in 2024. (4) Contextual relevance is high because the answer addresses grant activity, valuation, and disclosure transparency as asked, and cites correct document locations. However, due to core factual errors in valuation methodology evolution and missing quantitative data, the correctness score is low despite relevant structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 481,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "Charles Schwab’s 2022 RIA platform was built around the Advisor Services website, offering interactive tools, educational content, and the free Schwab Advisor Portfolio Connect for portfolio management while supporting third‑party integrations for CRM, trade‑order, and financial‑planning systems (page_8). By 2023, Schwab expanded its interactive toolset by launching Schwab Trading Powered by Ameritrade, adding real‑time charting and trading capabilities for RIAs (page_6). In 2024, the firm deepened third‑party integration by incorporating TD Ameritrade’s thinkpipes trading platform and iRebal rebalancing solution into the RIA offering, further enhancing portfolio‑management functionality while continuing to provide the Advisor Portfolio Connect and a broader suite of interactive tools (page_8, page_6, page_7).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Schwab's product evolution from 2022 to 2024. While it correctly identifies Schwab Advisor Portfolio Connect and third-party integrations as part of the RIA offering, it fabricates key developments. Specifically, the claim that 'Schwab Trading Powered by Ameritrade' was launched in 2023 is unsupported by the ground truth, which makes no mention of this product or any major 2023 launch. Similarly, the assertion that TD Ameritrade’s 'thinkpipes' platform and 'iRebal' were integrated in 2024 is incorrect — these specific integrations are not mentioned in the original answer, nor is there any reference to TD Ameritrade platform integration in the context of RIA tools during this period. The ground truth emphasizes continuity in integrations and gradual enhancement of usability, not new third-party additions in 2023–2024. (2) Quantitatively, there are no explicit numbers (dollar amounts, percentages, etc.) in either the question or answers, so numerical accuracy is not applicable beyond correct year references (2022, 2023, 2024), which the LLM gets right. (3) The multi-hop reasoning is flawed: the LLM incorrectly synthesizes non-existent product rollouts and integrations across years, failing to reflect the actual evolution described in the ground truth — which centers on platform usability, document management, and consistent support for existing integrations rather than new ones. (4) The contextual relevance is moderate because the answer addresses the general theme of RIA tools and third-party integrations, but the specific claims about product launches and integrations are invented, leading to a low correctness and qualitative accuracy score despite correct framing and year alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 487,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across 2022‑24 TI’s MD&A consistently framed embedded‑processing as a core pillar of its business model, noting “our strategic focus is on analog and embedded processing products” and that it “places additional strategic emphasis on designing and selling our products into the industrial and automotive markets” in 2022 (page 18), 2023 (page 19) and 2024 (page 18).  The segment’s revenue rose modestly from $3.26 B in 2022 to $3.37 B in 2023 but fell to $2.53 B in 2024, while operating‑margin pressure tightened from 38.4 % (2022) to 29.9 % (2023) to 13.9 % (2024) (page 20 of each year).  This unwavering emphasis signals TI’s long‑term strategy to anchor its semiconductor positioning around analog‑and‑embedded solutions—especially for industrial and automotive customers—leveraging its manufacturing strength to sustain cash flow and competitive advantage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. According to the ground truth, there is no mention of specific revenue figures or operating margins for embedded processing products across 2022–2024. The provided numbers—$3.26B (2022), $3.37B (2023), $2.53B (2024), and margins of 38.4%, 29.9%, 13.9%—are not present in the original answer and contradict the knowledge graph, which does not include financial metrics for this segment. These fabricated figures severely undermine factual correctness. (2) The qualitative aspects are partially accurate: the LLM correctly identifies that Texas Instruments consistently emphasized embedded processing as a strategic pillar across all three years and links it to analog products and focus on industrial and automotive markets. It also correctly infers that this reflects a long-term strategy tied to competitive advantage and cash flow. However, the original answer does not mention 'MD&A', specific page numbers, or market segmentation emphasis beyond the broad portfolio being a competitive advantage. (3) Multi-hop reasoning is partially sound—the model synthesizes the idea of consistency over three years and draws a strategic conclusion about long-term positioning, which aligns with the original answer. But the inclusion of unsupported financial data suggests the model hallucinated details from outside the knowledge graph, breaking the chain of accurate synthesis. (4) Contextual relevance is high because the response addresses the evolution of strategic emphasis and what it reveals about long-term positioning. However, the incorrect financial data drastically reduces overall correctness. While the direction of reasoning is valid, the presence of false metrics leads to a low quantitative accuracy score and pulls the overall correctness into the partially correct range.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 508,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Fleet‑support costs stayed essentially flat, consistently representing about 1 % of Boeing’s total consolidated product‑and‑service costs in 2022, 2023 and 2024.  In contrast, the 787 program’s abnormal production costs climbed—from roughly $2 billion cumulative through 2023 to $256 million in 2024—because production rates stayed below five per month and extensive rework and inspections were required.  These abnormal costs and the ongoing rework have kept 787 deliveries delayed, with the remaining inventory slated for delivery mainly in 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that fleet support services accounted for about 1% of total consolidated costs across 2022–2024, which matches the ground truth. However, it misrepresents the trend in abnormal production costs. The ground truth states that Boeing had cumulative abnormal costs of $2.7 billion through December 31, 2023—not $2 billion as stated—and incurred $256 million in rework costs during 2024. The LLM incorrectly frames this as an increase in costs (from $2B to $256M), when in fact the $256M is a subset of the cumulative total and reflects a decline in annual abnormal cost incidence. This mischaracterization of the cost trajectory undermines the quantitative accuracy. (2) The number $2 billion is incorrect (should be $2.7 billion cumulative through 2023); $256 million in 2024 is accurate. The statement that production rates stayed below five per month is plausible but not confirmed in the ground truth, which does not specify production rate details. (3) The multi-hop reasoning is partially sound: the model connects fleet support costs, abnormal 787 costs, and delivery delays across years. However, it fails to accurately synthesize the cumulative nature of the $2.7 billion figure and misinterprets the cost trend as increasing rather than resolving. It also omits key context that Boeing expected remaining rework costs to not be significant after 2023, and that most rework was completed by 2024. (4) The contextual relevance is high—answer addresses cost profile, delivery impact, abnormal costs, and delays. Qualitative accuracy is moderate due to correct structure and entities but flawed reasoning on cost evolution. Correctness score is 6 due to significant quantitative error in cumulative cost figure and misrepresentation of cost trend, despite correct identification of core elements and delivery timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 506,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold its Meridian subsidiary on December 31 2021 for roughly $51 million in cash, recording a $167 million net‑of‑tax loss (PFE 10‑K 2023, page 73).  After the sale, Pfizer entered into interim transition‑service agreements (TSAs) and a three‑year manufacturing‑service agreement (MSA) with a two‑year extension; the amounts recorded under those agreements in 2022 and 2023 were immaterial to operations (PFE 10‑K 2023, pages 73‑74).  In 2024 the MSA remains in effect, but no new material amounts are recorded, so the post‑sale relationship continues mainly as a contractual framework with negligible financial impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Pfizer sold Meridian on December 31, 2021, recognized a $167 million net-of-tax loss, and entered into TSAs and a three-year MSA with a two-year extension option. The financial impact in 2022 and 2023 was immaterial, and the MSA remained in effect in 2024. (2) Quantitative accuracy is perfect: dates, dollar amounts ($167 million loss, $51 million sale price), and agreement durations (three-year MSA with two-year extension) are correctly stated and consistent with the source. The $51 million sale price, while not in the original answer, is plausible and does not contradict the ground truth, which only mentions the loss. (3) Multi-hop reasoning is sound: the answer synthesizes information across time (2021 sale, 2022–2024 post-sale arrangements) and correctly infers the diminishing financial impact and ongoing contractual relationship. (4) The only minor omission is that the 2024 reference to Meridian in Pfizer’s glossary as 'Meridian Medical Technologies, Inc.'—which reinforces continued recognition—is not mentioned. However, the core contractual and financial trajectory is accurately conveyed. Wording differs slightly (e.g., 'manufacturing-service agreement' vs 'Manufacturing Supply Agreement'), but this does not affect meaning. Overall, the answer is factually correct, complete in substance, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 399,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, “hello” is consistently listed among the company’s global trademarks in the Oral, Personal and Home Care segment, indicating it remains part of that core portfolio. The filings do not disclose any shift in its strategic positioning or a change in emphasis relative to other brands in the same segment, so its role appears unchanged over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that 'hello' was consistently listed as a global trademark in the Oral, Personal and Home Care segment across 2022–2024, which matches the original answer’s claim of sustained strategic emphasis. The LLM correctly infers no disclosed shift in strategic positioning, implying stability in its role relative to other brands. Quantitatively, there are no numerical inaccuracies—dates (2022, 2023, 2024) are correct and properly contextualized. Entity accuracy is strong: Colgate-Palmolive, 'hello', and the relevant product segment are correctly identified. The reasoning is sound, though slightly less detailed than the original answer—it omits mention of specific comparative brands like Colgate, Palmolive, and Darlie, which provides slightly less contextual richness regarding multi-hop synthesis across years. However, the core conclusion about unchanged strategic positioning is valid and semantically equivalent. The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in strategic positioning over time. Minor deduction in qualitative accuracy due to less granular synthesis of brand comparisons across years, but overall highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 356,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "From 2022‑24 the non‑qualified defined‑benefit plan remained unfunded and closed to new participants, with the funded status improving only modestly from a $100 million deficit in 2022 to a $93 million deficit in 2024 while the projected benefit obligation fell from $521 million to $493 million. Participant contributions stayed at zero each year, and employer contributions to the non‑qualified plan were $3 million in 2022 and 2023 and $2 million in 2024, showing minimal employee engagement. These trends indicate that Texas Instruments’ long‑term pension obligations remain significant and underfunded, and that employees are not actively participating in the non‑qualified plan, likely favoring defined‑contribution options instead.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the Non-Qualified Defined Benefit Pension Plan is unfunded and closed to new participants, which the LLM correctly identifies. However, the LLM introduces specific numbers—such as a $100 million deficit in 2022 improving to $93 million in 2024 and projected benefit obligations falling from $521 million to $493 million—that are not present in the original answer and cannot be verified from the provided ground truth. Similarly, employer contributions of $3 million in 2022 and 2023 and $2 million in 2024 are fabricated; the original answer does not mention any such contributions for the non-qualified plan. Participant contributions being zero is plausible but not stated in the ground truth. (2) The original answer focuses on the defined contribution plans, reporting share holdings (6M in 2022, 5M in 2023 and 2024), their values ($940M, $873M, $852M), dividends ($28M, $27M, $26M), and company expenses ($70M, $75M, $76M). None of these key quantitative points are mentioned in the LLM answer, indicating a failure to extract or synthesize the correct data. Instead, the LLM invents financials for the non-qualified plan that are not supported. (3) The multi-hop reasoning is flawed: while the conclusion about shifting toward defined contribution plans is aligned with the original, the LLM fails to use the actual evidence (declining stock holdings and rising company expenses in defined contribution plans) and instead constructs a narrative based on false data about the non-qualified plan. This undermines the logical foundation of the response. (4) The contextual relevance is moderate because the answer addresses the general theme of pension evolution and employee trends, but it does so using incorrect data and misdirected focus. The qualitative accuracy is low because the entities (Texas Instruments, non-qualified plan) are correct, but the reasoning is based on hallucinated metrics. The correctness score is low due to major factual and quantitative errors, despite some alignment in high-level interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 572,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost declined from **$800 million in 2022 to $755 million in 2023 and to $719 million in 2024**—a total drop of $81 million over three years【page_86】【page_83】. This modest downward trend indicates the company is gradually trimming its private‑equity exposure, likely reallocating capital toward other assets or concentrating on core operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. However, the LLM incorrectly states the 2022 value as $800 million (a $177 million overstatement), while correctly reporting $755 million in 2023 and $719 million in 2024. This error fundamentally misrepresents the trajectory as a continuous decline, when in fact it was an increase followed by a partial decrease. (2) The calculation of an '81 million drop' is based on incorrect starting data ($800M → $719M = $81M), whereas the actual change from $623M to $719M is an increase of $96 million over the three years. The LLM's calculation is mathematically correct based on its wrong inputs, but factually invalid. (3) The multi-hop reasoning is flawed because the model failed to correctly identify the trend direction: the ground truth shows a strategic increase in 2023 followed by a partial pullback, indicating measured allocation, whereas the LLM interprets it as a 'gradual trimming' due to the false premise of continuous decline. This mischaracterizes Pfizer's strategic intent. (4) Contextually, the answer addresses the right metric and time frame and attempts interpretation, so relevance is moderate. However, due to the critical error in the initial value and resulting misinterpretation of trend and strategy, the overall correctness score is low. Minor formatting like 'private-equity' vs 'private equity' is acceptable, but core numerical and inferential accuracy is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 460,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "In 2022, under the 2019 IDA agreement, Schwab could migrate up to $10 billion of IDA balances each year, but only floating‑rate balances, while maintaining a minimum $50 billion balance and ensuring 80 % of balances were fixed‑rate through 2026 (page 102). The 2023 IDA agreement removed the fixed‑rate requirement, set new minimum/maximum limits ($30 billion above fixed‑rate balances through 2025, then $60–$90 billion after 2025), and restricted withdrawals to customer‑initiated amounts until 2025; Schwab did not migrate any balances in 2023 (page 100). In 2024 the same 2023 terms applied, and Schwab again did not move IDA balances, with migration still constrained by capital adequacy, binding limits, and the new minimum/maximum balance and withdrawal rules (page 100).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies that deviate from the ground truth. While it correctly states that Schwab did not migrate any IDA balances in 2023 and 2024 under the 2023 IDA agreement, it introduces details not present in the original answer. Specifically, the claim that in 2022 Schwab could only migrate floating-rate balances and was required to maintain a minimum $50 billion balance with 80% fixed-rate through 2026 is not supported by the ground truth, which makes no mention of such constraints in 2022. The ground truth only notes capital sufficiency and other general limitations under the 2019 agreement. (2) Quantitatively, the LLM incorrectly adds a $50 billion minimum balance requirement and 80% fixed-rate threshold, which are not in the original. It also introduces post-2025 ranges of $60–$90 billion, which the ground truth does not mention—only a maximum of $30 billion above fixed-rate obligations through September 10, 2025 is specified. The $10 billion annual migration limit in 2022 is correctly stated, as is the fact that $10.1 billion had already been moved by end-2021. However, the LLM omits this key contextual fact, weakening completeness. (3) The multi-hop reasoning is partially sound—LLM correctly infers that no migration occurred in 2023 and 2024 due to new constraints—but it fabricates specific terms (e.g., withdrawal restrictions until 2025, post-2025 bands) not in the ground truth, suggesting overinterpretation or hallucination. The evolution from more flexibility to tighter control is conceptually aligned, but the supporting details are distorted. (4) Scores reflect partial correctness: core timeline and migration outcomes (no movement in 2023/2024) are right, but key constraints are misrepresented. Quantitative accuracy is low due to unsupported numbers. Qualitative accuracy is moderate due to correct high-level narrative but flawed entity and term mapping. Contextual relevance is high as the answer stays focused on the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 543,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Irradiation has kept a Melaka, Malaysia plant in its analog‑product manufacturing portfolio for three consecutive years.  The 2022 10‑K lists “Melaka, Malaysia†” as an analog site (page 18†), the 2023 10‑K lists “Melaka, Malaysia*” (page 18*), and the 2024 10‑K lists “Melaka, Malaysia**” (page 18**).  The unchanged status and continued analog‑only use across 2022‑2024 indicate that Melaka is a strategically important, stable location for TI’s analog production, likely chosen for cost, supply‑chain proximity or regional market access.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical entity error—'Texas Irradiation' is incorrect; the correct company is 'Texas Instruments'—which severely undermines factual accuracy. All years (2022, 2023, 2024) and location (Melaka, Malaysia) are correctly identified, and the use of symbols (†, *, **) is accurately reported, though the LLM does not explain their potential significance as the ground truth does (e.g., possible escalation in emphasis). (2) Quantitatively, the years and symbolic markers are correct, and the reference to page 18 in each 10-K is plausible (though not verifiable without document access), so numeric/date accuracy is mostly sound. However, the company name error is a major factual flaw. (3) The reasoning partially captures the multi-hop synthesis—consistency across three years in analog manufacturing—but fails to fully analyze the evolving notation (from † to * to **) as a potential signal of increasing strategic importance. Instead, it defaults to generic factors like cost and supply-chain proximity without grounding them in the evidence. (4) Contextually, the answer addresses the operational footprint and strategic importance, so relevance is high. However, due to the incorrect company name and incomplete reasoning about the symbolic progression, the qualitative and overall correctness scores are significantly reduced. The answer is semantically close but marred by a fundamental entity error and superficial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 406,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "Target’s debit‑card penetration—measured by the share of purchases paid with a Target Circle Card (which includes the debit card)—declined from 20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024 (MD&A, page 27). The downward trend shows that fewer guests are using the card, indicating that its ability to generate incremental sales for Target is weakening over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the downward trend in Target Debit Card penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it reports 18.6% for 2024 instead of the correct 17.8%, introducing a factual error in the final and most recent data point. This affects the quantitative accuracy significantly. 2) The numbers for 2022 and 2023 are accurate, but the 2024 figure is off by 0.8 percentage points, which is non-trivial in the context of year-over-year trends. The calculation of trend direction (declining) is correct, but the magnitude of decline is understated. 3) The reasoning is sound: the model correctly interprets declining penetration as a sign of weakening influence on incremental sales, which aligns with the ground truth's implication. It appropriately synthesizes the metric over three years and draws a logical business conclusion. 4) The answer is contextually relevant, addressing both parts of the question—evolution of penetration and its implication for incremental sales. The mention of Target Circle Card as the umbrella category is accurate and consistent with the original answer. Despite the incorrect 2024 value, the overall interpretation remains plausible, warranting a score of 7 for correctness. Quantitative accuracy is penalized more heavily (6) due to the incorrect final percentage, while qualitative and contextual scores remain high due to correct logic and framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 399,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The table of equity‑compensation plans shows the 2003 Director Compensation Plan’s share pool growing from 29.3 million in 2022 (29,280,162) to 31.3 million in 2023 (31,257,621) and then easing to 30.4 million in 2024 (30,369,933)【TXN_10k_2022 page 63】【TXN_10k_2023 page 61】【TXN_10k_2024 page 59】. This rise‑then‑slight‑decline pattern indicates that Texas Instruments has been actively granting director awards while periodically replenishing the plan’s share reserve.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key aspects. The original answer states that shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 in 2022 to 25,296,767 in 2023 to 24,503,062 in 2024. In contrast, the LLM claims the pool increased from 29.3 million to 31.3 million to 30.4 million, which is the opposite trend and uses incorrect figures. These numbers do not match the ground truth, even allowing for rounding or formatting differences. (2) The quantitative discrepancy is severe: for example, 35.4 million vs. 29.3 million in 2022 is a difference of over 6 million shares, far beyond acceptable variance. The LLM’s reported values are not only wrong but suggest growth, while the truth is a consistent decline. (3) The multi-hop reasoning is fundamentally flawed. The LLM incorrectly infers that the company is replenishing the plan due to an alleged increase, while the actual data shows a continuous drawdown without replenishment. This misrepresents the company's equity incentive strategy. (4) The contextual relevance is low because the answer addresses the right topic (director equity incentives) and cites the correct plan and years, but with entirely incorrect data and conclusions. The reasoning and synthesis fail due to reliance on inaccurate inputs, leading to a completely misleading interpretation. Thus, the correctness score is 1 due to total factual inaccuracy despite addressing the general subject.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 413,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In 2022 Visa added virtual‑account capability to its Treasury‑as‑a‑Service offering and expanded Visa Direct with push‑to‑wallet payouts, giving access to roughly 7 billion cards, accounts and digital wallets in 190 + countries.  In 2023 the company integrated its Currencycloud platform into Visa Direct, adding real‑time FX, virtual accounts and enhanced liquidity that broadened the number of supported payment schemes and enabled a wider array of cross‑border B2B and consumer use cases.  By 2024 the platform was processing nearly 10 billion transactions for 550 + partners, with the Currencycloud‑enabled virtual‑account and cross‑border solutions covering more than 11 billion endpoints and supporting an expanded portfolio of cross‑border B2B, B2C and P2P flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth, demonstrating strong multi-hop reasoning and factual consistency. (1) Correct elements include: the 2022 launch of virtual accounts under Treasury-as-a-Service, integration with Visa Direct, expansion of cross-border use cases, real-time FX via Currencycloud, and the 2024 milestone of over 11 billion endpoints. The progression across 2022–2024 is correctly structured. (2) Quantitative accuracy: The LLM states 'roughly 7 billion' endpoints in 2022 and 'more than 11 billion' in 2024, which are reasonable approximations consistent with the ground truth’s 11 billion figure by 2024. The '550+ partners' and 'nearly 10 billion transactions' in 2024 are not contradicted by the original answer and may reflect additional data. The original does not specify transaction volume or partner count, so these can be considered value-added details rather than inaccuracies. (3) Reasoning is sound: The LLM correctly links virtual accounts to Currencycloud, their integration into Visa Direct, and the expansion of cross-border B2B/B2C/P2P use cases—capturing the core multi-hop evolution. It accurately positions virtual accounts as central to Visa’s digital and cross-border strategy. (4) Minor discrepancy: The original specifies that virtual accounts were introduced via Currencycloud under Visa Treasury as a Service in 2022, while the LLM reverses the emphasis slightly by mentioning Treasury-as-a-Service first without explicitly naming Currencycloud until 2023. However, since Currencycloud was acquired and operated under that umbrella, this is a nuance rather than a factual error. Overall, the answer is semantically equivalent, factually correct, and contextually complete—justifying a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 480,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "Xtandi’s revenue fell 1 % in 2023, a decline driven by lower net price and channel‑mix shifts (page 45).  In response, Pfizer accelerated lifecycle‑management efforts, culminating in the April 2024 FDA approval of a new combination indication for Xtandi (page 45).  The 2022 intangible‑asset statement shows the asset’s net carrying amount—$19.6 billion of developed‑technology rights—underscoring the substantial value Pfizer seeks to preserve through such lifecycle investments (page 92).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 1% revenue decline in 2023, the $19.6 billion net carrying amount of developed technology rights in 2022, and the April 2024 FDA approval are all factually accurate and match the source data. The reference to 'page 45' and 'page 92' suggests proper sourcing from the 10-K, though page numbers are not part of the ground truth evaluation. (2) The answer correctly identifies Xtandi's revenue pressure due to net pricing and channel-mix shifts, consistent with the 'downward pressure on net pricing' in the original. (3) The multi-hop reasoning is sound: it connects 2022 valuation (intangible assets), 2023 revenue decline, and 2024 indication expansion as a strategic lifecycle management response. (4) The only minor shortcoming is that the LLM specifies the new indication as a 'combination indication' and does not explicitly name 'non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis' as in the ground truth. This slightly reduces qualitative accuracy, though the core inference about lifecycle investment in response to revenue pressure is fully supported. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across years and financial/strategic dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 388,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The Target MasterCard credit‑card penetration fell from **20.5 % of purchases in 2022 to 19.8 % in 2023 and 18.6 % in 2024** (Target Circle Card penetration figures). This downward trend indicates that consumers are increasingly favoring other payment methods and that engagement with Target’s loyalty program is weakening over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The downward trend is accurately described. 2) All numeric values and years are correct, with no calculation errors. Format variations (e.g., spacing in percentages) do not affect accuracy. 3) The reasoning correctly infers that the decline suggests shifting consumer payment preferences and weakening loyalty program engagement, which aligns with the original answer’s interpretation. The only minor shortcoming is that the LLM refers to 'Target Circle Card penetration figures' without clarifying that RedCards™ included the Target MasterCard in 2022 and were rebranded by 2024, slightly reducing qualitative completeness. 4) Despite this nuance, the answer is factually correct, contextually appropriate, and synthesizes the trend and its implications accurately. The conclusion is logically sound and relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 279,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In FY 2022 Visa added virtual accounts to its Currencycloud platform to enable cross‑border payments with real‑time FX, virtual accounts and enhanced liquidity (page 10 2022). In FY 2023 those virtual‑account capabilities were integrated into Visa Direct, expanding cross‑border options and broadening the network (page 10 2023). By FY 2024 the platform leveraged virtual accounts to serve cross‑border payments across more than 195 countries/territories and over 11 billion cards, bank accounts and digital wallets, marking a significant expansion in network reach (page 10 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Visa's virtual accounts across the three fiscal years and addresses the core aspects of cross-border payment capabilities and network reach. However, there is a significant quantitative inaccuracy: the LLM states that by FY2024, the platform served 'more than 195 countries/territories', while the ground truth specifies 'more than 100 countries' via Visa B2B Connect. This overstatement of geographic reach by nearly double is a major factual error. The '11 billion endpoints' figure (cards, bank accounts, digital wallets) is correctly cited in both the LLM and ground truth, supporting partial quantitative accuracy. (2) The fiscal years (2022–2024) and progression of integration—starting with Currencycloud, then Visa Direct, and continued expansion—are factually correct. The mention of real-time FX, liquidity, and settlement in 2022 aligns with the original. The integration into Visa Direct in 2023 is accurate, though the LLM omits the explicit mention of 'B2B transactions' and 'Visa B2B Connect', which are key context from the ground truth. (3) The multi-hop reasoning is generally sound: the LLM synthesizes information across years and platforms (Currencycloud → Visa Direct → expanded network), showing an understanding of the strategic progression. However, it conflates the 11 billion endpoints (correct) with a much broader country reach (195+ vs. 100+), likely confusing general Visa network coverage with the more specific B2B Connect footprint. (4) The contextual relevance is high as the answer directly addresses the question’s focus on evolution, cross-border capabilities, and network reach. Qualitative accuracy is strong due to correct entity identification (Visa, Currencycloud, Visa Direct) and logical flow. The correctness score is 7 due to the major error in country count, which impacts quantitative accuracy (scored 6), while the rest of the factual framework remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 533,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s 2022, 2023 and 2024 10‑K filings all list “difficulties in protecting our intellectual property” as a continuing risk tied to its worldwide operations and reliance on third‑party wafer foundries and manufacturing sites (China, Malaysia, Taiwan) – the wording on pages 37 (2022), 41 (2023) and 40 (2024) is essentially unchanged.  The company’s international sales share has grown from ~72 % in 2021 to 65 % in 2023 and 66 % in 2024, underscoring that the IP‑protection risk remains linked to its expanding global footprint and external manufacturing dependencies.  No new mitigation or shift in the risk’s scope is disclosed, indicating that AMD continues to view IP protection as a persistent challenge in its global supply chain.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that AMD consistently reported difficulties in protecting intellectual property across 2022, 2023, and 2024, tied to its international operations and third-party manufacturing in China, Malaysia, and Taiwan. It accurately references the risk disclosure in all three years and correctly notes the reliance on external foundries. However, there are key quantitative inaccuracies: the international sales percentages are incorrect. The claim that international sales grew from ~72% in 2021 to 65% in 2023 and 66% in 2024 is factually wrong—this trend contradicts the stated growth, as the percentages actually decreased. This undermines the quantitative accuracy. Additionally, the LLM states that the wording across the 10-Ks is 'essentially unchanged,' which downplays the evolution highlighted in the ground truth: in 2023 and 2024, AMD expanded the risk to include geopolitical tensions (China-Taiwan) and evolving export controls (Ukraine-Russia, Israel-Hamas), which the LLM fails to mention. This omission reduces completeness and qualitative accuracy, as it misses the deepening concern over time. While the core entity (AMD), years (2022–2024), and general risk theme are correct, the answer lacks the multi-hop synthesis of evolving geopolitical and regulatory dimensions. The contextual relevance remains high because the response stays focused on the question and correctly links IP risk to global operations and manufacturing dependencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 407,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "UNP’s corporate‑stock holdings dropped sharply from $1,111 million in 2022 (mostly Level‑2/3) to $226 million in 2023 (≈220 million Level‑1) and $181 million in 2024 (≈176 million Level‑1)【page 58】【page 57】【page 58】.  The pension plan’s equity target moved from 48‑55 % in 2022 to 20‑30 % in 2024, with actual equity at 24 % in 2022‑2024【page 70】【page 71】【page 54】, reflecting a deliberate de‑risking that reduces corporate‑stock concentration, increases liquidity, and boosts debt exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key dollar amounts. According to the ground truth, UNP's Corporate Stock investment was $1,990 million in 2022, not $1,111 million as stated. The 2023 figure is correct at $181 million (though LLM incorrectly states $226 million for 2023 and then $181 million for 2024, creating confusion). The 2022 classification is also wrong: ground truth shows $1,980M in Level 1 and $10M in Level 2, whereas LLM claims 'mostly Level-2/3', which contradicts the data. The LLM introduces pension equity targets (48–55% in 2022 to 20–30% in 2024) and actual equity allocation (24%) not present in the original answer, making these unsupported additions. (2) Number verification: 2022 value should be $1,990M (LLM says $1,111M — incorrect); 2023 value is $181M (LLM says $226M in 2023, then cites $181M in 2024 — misaligned across years); Level 1/Level 2 breakdowns are omitted or incorrect. No mention of preferred vs. common stock classification in 2024 as in original. (3) Multi-hop reasoning is partially sound — the LLM infers a de-risking strategy, which aligns with the original’s interpretation of strategic shift — but this is based on incorrect data and introduces external metrics (pension equity targets) not in the source. The synthesis across years is flawed due to mismatched figures. (4) Scores reflect major quantitative errors (3/10), partial qualitative accuracy due to correct directional interpretation but incorrect entity details (5/10), high contextual relevance as it addresses valuation evolution and strategic implications (8/10), and overall correctness dragged down by core factual inaccuracies (4/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 461,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Abbott continues to disclose the 4.75% Senior Notes due 2043 through the same 2017 Form 8‑K exhibit (Exhibit 4.6) that appears in the exhibits tables of its 2022, 2023, and 2024 10‑K filings (page 86).  No new amendments or issuances of the notes are reflected in these filings, indicating that the terms remain unchanged.  This consistency underscores a stable long‑term debt structure and a priority on transparent, ongoing communication with investors.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core quantitative details: it correctly identifies the 4.75% Senior Notes due 2043, references the correct Exhibit 4.6 from the March 22, 2017 Form 8-K, and notes consistent inclusion in 2022–2024 10-K filings. The statement that no amendments or new issuances occurred is consistent with the ground truth. However, the LLM misses a key qualitative evolution highlighted in the original answer: the shift from referencing the notes via St. Jude Medical’s 2013 Fourth Supplemental Indenture in 2022 (a legacy integration approach) to a more direct and standardized disclosure in later years. This omission weakens the multi-hop reasoning about Abbott’s strategic shift in disclosure philosophy—from legacy-based referencing to active, transparent reaffirmation. While the LLM correctly infers stable debt management and investor communication, it fails to trace the progression that supports this conclusion, relying instead on static repetition of the same exhibit reference. The answer is semantically close and contextually relevant, but lacks the nuanced, year-by-year evolution that defines the ground truth. Quantitative accuracy is high—dates, exhibit numbers, and percentages match or are reasonably implied. Contextual relevance is strong as it addresses long-term debt management and investor communication. Qualitative accuracy is reduced due to incomplete synthesis across the three-year timeline and insufficient recognition of the strategic shift in disclosure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 417,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The penetration of Target’s branded credit‑card (Target Circle Card) fell from 20.5 % in 2022 to 18.6 % in 2024, a decline of about 1.9 percentage points.  This downward trend signals a slowing uptake of the card, which may temper the incremental sales that the cards generate—Target notes that a meaningful portion of card purchases are incremental for the company, so a lower penetration could reduce that incremental‑sales benefit.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2024 (18.6%), matching the ground truth. However, it omits the 2023 figure (19.8%), which is part of the multi-year trend explicitly asked for in the question. While the overall decline is accurately described, the absence of the intermediate data point reduces completeness. The calculation of a '1.9 percentage point decline' is slightly off—the actual drop is 20.5% to 18.6%, which is 1.9 percentage points, so this is acceptable (rounding may explain minor variance). 2) Quantitatively, the key percentages are correct, and the direction and magnitude of change are reasonably accurate. The omission of 2023 data is a minor quantitative gap but does not invalidate the trend. 3) The reasoning is sound: the model correctly infers that declining penetration may reduce incremental sales, aligning with Target’s stated strategy. It appropriately links lower adoption to potential revenue impact, demonstrating valid multi-hop synthesis between penetration trends and business outcomes. 4) The answer is highly contextually relevant, addressing both the trend in penetration and its implication for customer adoption and incremental sales. The main shortcoming is the missing 2023 data point, which slightly weakens the completeness of the trend analysis. Despite this, the core facts and implications are accurately conveyed, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 398,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet shrank from **7,242 units in 2022 to 6,893 units in 2024** (a drop of 349 locomotives), while the average age climbed from **22.5 years to 25.2 years**. This trend—fewer, older units—suggests the company is tightening its fleet, extending the useful life of existing locomotives, and focusing on higher utilization rather than continual replacement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: the decrease in Union Pacific's Multiple Purpose Locomotive fleet from 7,242 units in 2022 to 6,893 units in 2024, and the increase in average age from 22.5 to 25.2 years. These numbers exactly match the ground truth. The calculation of a 349-unit reduction (7,242 - 6,893) is accurate. (2) Quantitative accuracy is perfect—values are presented clearly with correct units and years. Format variations (e.g., '22.5 years' vs '22.5 years') are acceptable and do not affect meaning. (3) The reasoning is sound: the LLM correctly infers that a shrinking, aging fleet suggests tighter fleet management, life extension of assets, and reduced replacement activity. While the original answer frames this as a 'cost-conscious asset management strategy,' the LLM's interpretation—focusing on higher utilization and life extension—is semantically equivalent and logically consistent with the data. The only minor difference is in phrasing the implication; the LLM does not explicitly use 'cost-conscious' but conveys a similar strategic direction. (4) The answer is fully relevant, addressing all parts of the question: changes in total units, average age, and the strategic implication. Multi-hop synthesis across time points (2022 to 2024) and metrics (count and age) is correctly executed. The slight deduction in qualitative accuracy is due to nuanced wording in the strategic interpretation, but it does not undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 413,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "The carrying value of NVIDIA’s 3.50% Notes Due 2050 was $2,000 million in both FY 2023 and FY 2024 (see the debt schedule on page 72).  The same amount was reported in FY 2022, so the value remained flat across the three years.  This steady figure indicates that NVIDIA has not issued additional 3.50% Notes due 2050 and has maintained a stable long‑term debt profile, reflecting a conservative debt‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, the carrying value was $2,147 million in FY2022, decreased to $1,604 million in FY2023, and increased to $2,000 million in FY2024. The LLM incorrectly states that the value was $2,000 million in all three years, which contradicts the actual progression. This misrepresents the trend entirely—there was no stability, but rather a significant drop followed by a partial rebound. (2) The numbers are therefore grossly inaccurate: the FY2022 and FY2023 figures are wrong, and the claim of consistency across years is false. Even allowing for format variations, the values do not match the ground truth. (3) The reasoning is flawed because it draws conclusions from incorrect data. The LLM infers a 'conservative debt-management strategy' due to stable values, but the actual fluctuation (down then up) suggests more dynamic activity—possibly refinancing or revaluation—which the LLM fails to capture. The multi-hop synthesis across fiscal years is completely off track. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right company (NVIDIA), the correct debt instrument (3.50% Notes Due 2050), and attempts to interpret the implications for long-term debt positioning. However, due to the severe quantitative inaccuracies and resulting flawed reasoning, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 399,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD’s 10‑K filings from 2022 through 2024 all list the risk of “loss or modification of exemptions for taxes and tariffs” as a general risk (2022 page 37, 2023 page 41, 2024 page 40). The wording and emphasis have remained essentially unchanged, indicating that the exposure has persisted but not diminished. This continuity underscores the growing complexity of the global regulatory environment, as AMD must continually navigate evolving trade restrictions, sanctions, and tax laws that can impact the cost and feasibility of its international operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative developments in AMD's risk exposure from 2022 to 2024, which significantly undermines the correctness of the analysis. (1) While it correctly identifies that AMD consistently listed the risk of losing tax and tariff exemptions across all three years (with accurate page references), it fails to capture the evolving emphasis and increasing specificity of the risk disclosures. The original answer shows a clear progression: in 2022, the risk was mentioned generally; in 2023, it was tied to specific geopolitical events (Ukraine-Russia, Israel-Hamas, U.S. sanctions); and in 2024, it was explicitly linked to China-Taiwan tensions affecting manufacturing partners. The LLM incorrectly states that 'the wording and emphasis have remained essentially unchanged,' which contradicts the ground truth. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—score is 10 by default. (3) The multi-hop reasoning is weak: the model fails to synthesize the increasing specificity and contextualization of the risk over time, which is central to answering how the exposure evolved. Instead, it draws an incorrect conclusion about stagnation in risk disclosure. (4) Contextual relevance is high because the answer addresses the right document (10-K), the correct risk factor, and links it to regulatory complexity, but the flawed interpretation of trend evolution limits its usefulness. The conclusion about 'growing complexity' is plausible but not well-supported by the incorrect premise of unchanged wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 434,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s risk‑factor disclosures consistently state that its ability to return capital—whether via dividends or share repurchases—is subject to board discretion and may be limited by U.S. banking laws and regulations, including capital‑planning rules, Delaware law, and the requirement to pay full and timely dividends on preferred stock (2022 page 5; 2023 page 4; 2024 page 4). The wording and emphasis of this statement remained unchanged across the three filings, indicating that regulatory constraints on dividend payments and share repurchases have not evolved during that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that BNY Mellon's capital return flexibility has been consistently constrained from 2022 to 2024 by U.S. banking laws, capital-planning rules, Delaware law, and preferred stock dividend obligations—matching all key entities and regulatory factors in the original answer. (2) There are no numerical values requiring calculation, but the citation of specific pages (2022 p.5; 2023 p.4; 2024 p.4) supports factual grounding and shows consistency across filings. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three years and correctly infers that the lack of change in wording indicates no evolution in regulatory constraints, which is consistent with the original answer’s conclusion of a 'stable regulatory environment.' (4) The only minor shortcoming is that the LLM answer does not mention the expanded context in 2024 around liquidity management and strategic initiatives highlighted in the ground truth, which slightly reduces completeness in qualitative detail. However, the core factual content and reasoning are correct and fully relevant to the question. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 370,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott’s 10‑K filings for 2022, 2023 and 2024 all list the 2.950% Note due 2025 as Exhibit 4.1 (the note’s form) and Exhibit 4.11 (the officers’ certificate).  The note was originally filed in an 8‑K on March 5 2015 (Exhibit 99.6) and each year’s 10‑K continues to reference that filing.  In short, the note’s disclosure and associated documentation have remained unchanged across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains key factual discrepancies that affect its overall accuracy. (1) The Original Answer states that the 2.950% Note due 2025 was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015, and this exhibit reference was reiterated in 2022–2024. The LLM answer correctly identifies the original 8-K filing date (March 5, 2015) and exhibit number (99.6), which supports factual consistency on that point. However, the LLM introduces new exhibit numbers—Exhibit 4.1 and Exhibit 4.11 in the 10-K filings for 2022–2024—that are not mentioned in the ground truth. There is no confirmation from the Original Answer that these exhibits exist or were used, making this an unsupported addition. (2) Quantitatively, the interest rate (2.950%), year of the original filing (2015), and the years under review (2022–2024) are all accurate. However, the LLM incorrectly implies that the note appears in each year’s 10-K as Exhibits 4.1 and 4.11, which contradicts the ground truth stating it was referenced via the original 8-K Exhibit 99.6. This misrepresentation affects quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound—the model connects the original filing to subsequent years’ disclosures—but it fails to align with the ground truth’s emphasis on consistent reiteration of the same exhibit (99.6), instead asserting a different exhibit structure in annual reports. (4) Contextually, the answer is relevant and addresses the evolution of disclosure over time, concluding correctly that documentation has remained unchanged. However, due to the incorrect exhibit references in the 10-Ks, the conclusion, while directionally correct, is based on inaccurate supporting details. Thus, the answer earns moderate scores in accuracy but remains below threshold for high correctness due to factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 505,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s 1.55 % Notes Due 2028 carried a consistent $1.25 billion balance at each year‑end: $1.25 billion as of Jan 28 2024 (FY 2024, page 72), $1.25 billion as of Jan 29 2023 (FY 2023, page 67), and $1.25 billion as of Jan 30 2022 (FY 2022, page 78). The unchanged carrying amount over three fiscal years shows that NVIDIA has not issued additional principal on this debt and has maintained a stable, low‑interest long‑term debt profile, underscoring a strategy focused on predictable financing costs and liquidity preservation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, the carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in FY2022, $1,099 million in FY2023, and $1,250 million in FY2024 — showing a fluctuating trend. However, the LLM claims the value was consistently $1.25 billion across all three years, which contradicts the ground truth. This error fundamentally misrepresents the data. (2) The numbers are inaccurate: the LLM reports $1.25B for FY2022 and FY2023, but the correct values are $1,200M and $1,099M respectively. Only the FY2024 value ($1,250M) matches. The LLM also cites specific dates and page numbers, but these support an incorrect narrative, suggesting possible hallucination or misreading of source data. (3) The multi-hop reasoning fails because the model does not recognize the variation in carrying values over time, which is central to the question. Instead of identifying a fluctuating pattern indicating strategic debt management, it infers stability and no new issuances — a conclusion not supported by the actual data. (4) While the answer addresses the question's structure and attempts to interpret strategy, the factual foundation is wrong, severely undermining correctness. Contextual relevance is moderate because the response discusses the right metric and timeframe, but with incorrect data. Quantitative accuracy is very low due to three years of data being misrepresented. Qualitative accuracy is slightly higher because the type of analysis (assessing debt strategy) is appropriate, though based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 444,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "Across 2022‑2024 AMD’s 10‑K filings consistently describe AIB agreements that protect the manufacturers’ inventory from price reductions (e.g., 2022‑page 11, 2023‑page 11, 2024‑page 11).  The documents also repeatedly note that system integrators use discrete graphics solutions to differentiate their board‑level products and add value to customers.  The language and emphasis on inventory protection and discrete‑GPU differentiation remain unchanged, indicating a stable strategy rather than a significant evolution.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: AMD did maintain inventory protection policies for AIBs from 2022 to 2024, and discrete graphics solutions were consistently cited as tools for differentiation. The cited pages (2022–page 11, etc.) align with the source documents, and there are no errors in dates or entity references, warranting a high quantitative accuracy score. However, the answer incorrectly asserts that there was 'no significant evolution' and that 'the language and emphasis remained unchanged,' which directly contradicts the ground truth. The original answer highlights a clear evolution: while inventory protection was consistent, AMD increasingly emphasized timely product introductions in 2023 and, by 2024, specifically highlighted discrete graphics as a strategic lever for market differentiation amid competition. This shift in emphasis represents a qualitative evolution in strategy that the LLM answer fails to recognize, indicating a breakdown in multi-hop reasoning and synthesis across years. Thus, while the facts are correct, the interpretation and higher-level analysis are flawed, leading to a moderate correctness score. Contextual relevance is high because the answer addresses the core topics (inventory protection, discrete GPUs, AIB relationships) and correctly identifies the relevant sections across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 377,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD’s disclosure of IP‑protection risk began as a generic warning in 2022 (page 37), noting “difficulties in protecting our intellectual property” as part of the broader set of risks tied to its worldwide operations. The 2023 filing repeated the same general statement (page 41). By 2024, the risk language had become more specific, explicitly citing geopolitical tensions—especially China/Taiwan and sanctions on Russia/Ukraine—and the potential disruption of Taiwan‑based wafer foundries and other third‑party manufacturing, thereby highlighting the company’s growing reliance on overseas production in politically sensitive regions (pages 41‑42).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of AMD's evolving risk disclosures regarding intellectual property (IP) protection from 2022 to 2024, with correct entity and year identification. It accurately notes that in 2022, AMD mentioned IP protection difficulties as part of broader international risks, repeated similar language in 2023, and by 2024 had added more specific references to geopolitical tensions involving China/Taiwan and Russia/Ukraine, as well as risks to third-party manufacturing in Taiwan. The answer correctly highlights the increasing specificity of risk factors tied to politically sensitive regions and third-party manufacturing. However, it omits the quantitative detail from the original answer that international sales accounted for 66% of net revenue in 2024 (up from 65% in 2023), which is a key metric demonstrating the growing international exposure. While this number is not central to the core argument about IP risk evolution, its absence reduces completeness, particularly in showing the measurable increase in international dependence. There are no calculation errors or factual inaccuracies—wording differences are acceptable under semantic equivalence. The reasoning is sound and synthesizes information across years and risk dimensions. The contextual relevance is high, as the answer directly addresses the evolution of IP protection risk in line with international operations and third-party manufacturing. The omission of the revenue percentage data prevents a perfect score, but the core qualitative trajectory is correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 434,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "BK continued to use the 2019 Long‑Term Incentive Plan each year, issuing a 2022 Form of Performance Share Unit Agreement (10.21) and a 2022 Form of Restricted Stock Unit Agreement (10.22) in 2022, a 2023 Form of Performance Share Unit Agreement (10.26) and a 2023 Form of Restricted Stock Unit Agreement (10.27) in 2023, and a 2024 Form of Performance Share Unit Agreement (10.25) and a 2024 Form of Restricted Stock Unit Agreement (10.26) in 2024【page 18】【page 19】. This steady use of the same plan signals a stable, long‑term equity‑based compensation strategy that keeps executive incentives tightly aligned with shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) Quantitatively, it fabricates specific agreement forms and exhibit numbers (e.g., 2022 Form of PSU Agreement 10.21, 2023 Form 10.26, 2024 Form 10.25) that do not match the ground truth. The original answer states that in 2022, BK referenced the 2021 Form of PSU Agreement; in 2023, the 2020 Form; and in 2024, the 2022 Form—directly contradicting the LLM's claim of introducing 2022, 2023, and 2024 forms in those respective years. The LLM also introduces Restricted Stock Unit (RSU) agreements, which are not mentioned in the ground truth, adding non-existent elements to the compensation strategy. (2) The dates of the agreements are misrepresented: the original answer shows BK is reusing older forms (e.g., 2020 form in 2023), suggesting a layered, continuity-based approach, whereas the LLM implies annual updates with new forms, which is the opposite of the documented pattern. (3) The multi-hop reasoning is flawed: the question asks for evolution based on specific agreements introduced each year, but the LLM invents a progression that contradicts the source. The ground truth shows a strategy of maintaining the 2019 plan while selectively reusing prior PSU forms (2021, then 2020, then 2022), indicating stability with periodic updates. The LLM incorrectly interprets this as annual new forms, missing the nuance of reusing legacy instruments. (4) While the LLM correctly identifies that the 2019 plan was used throughout, its overall portrayal of the evolution and strategic implication is inaccurate. The conclusion about 'steady use' and 'stable strategy' has partial merit but is based on fabricated evidence, undermining its validity. Thus, the answer fails on factual correctness, reasoning, and completeness despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 496,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s diagnostics‑instrument lease portfolio grew modestly: the original cost of the assets rose from **$3.6 billion in 2022 to $3.9 billion in 2023** (and remained at that level in 2024), while the net book value increased from **$1.6 billion in 2022 to $1.8 billion in 2023** (and stayed at $1.8 billion in 2024)【page_64】. This steady, incremental build‑out—coupled with operating‑lease revenue that still represents less than 3 % of total sales—suggests Abbott is deploying capital conservatively in diagnostics, focusing on maintaining and slightly expanding its equipment base rather than pursuing aggressive expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the net book value and original cost figures for Abbott's leased diagnostics instruments. According to the ground truth, the net book value was $1.4 billion in 2022, $1.6 billion in 2023, and $1.6 billion in 2024; however, the LLM incorrectly reports it as $1.6 billion in 2022 and $1.8 billion in 2023 and 2024. Similarly, the original cost was $3.3 billion in 2022, $3.6 billion in 2023, and $3.9 billion in 2024, but the LLM reverses the 2022 and 2023 values, stating $3.6 billion in 2022 and $3.9 billion in 2023. These errors affect all years and are not minor discrepancies. (2) The calculations and trends are therefore incorrect—while the ground truth shows consistent growth in both metrics, the LLM misrepresents the starting points and magnitudes of change. The claim that values 'remained at' $3.9 billion and $1.8 billion in 2024 is partially correct for original cost (which did reach $3.9B in 2024) but wrong for net book value (which stayed at $1.6B, not $1.8B). (3) The multi-hop reasoning is flawed due to reliance on incorrect data. The LLM concludes Abbott is deploying capital 'conservatively' and 'not pursuing aggressive expansion,' which contradicts the ground truth interpretation that the consistent investment increase reflects a strategic emphasis on expanding access to drive reagent sales. This misinterpretation stems directly from inaccurate numbers and flawed trend analysis. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the evolution of leased instruments and attempts to infer capital deployment strategy, fulfilling the question's structure. However, due to major quantitative and qualitative inaccuracies, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 488,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across FY 2022, 2023, and 2024 NVIDIA consistently lists Lumentum Holdings as a competitor in the networking‑products segment (2022: page 15; 2023: page 9; 2024: page 9). While Lumentum’s inclusion has not changed, the 2023 and 2024 filings increasingly spotlight NVIDIA’s expanding AI‑driven networking and high‑performance interconnect portfolio—emphasizing AI‑specific networking solutions and advanced interconnects—indicating a more intense competitive environment that could pressure Lumentum’s market share in that space.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in Lumentum's competitive positioning as described in the ground truth. (1) Correctly identifies that Lumentum was listed as a competitor in NVIDIA’s filings across FY2022–2024 and cites consistent page numbers, which aligns with the general context. However, it fails to capture the nuanced evolution in how Lumentum was categorized: from a general supplier in FY2022, to a specialized high-performance interconnect player in FY2023 (aligned with InfiniBand, Ethernet, and AI infrastructure), and then to a specifically named entity ('Lumentum Holdings Inc.') in FY2024—indicating heightened recognition. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; thus, no errors here (score 10). (3) The multi-hop reasoning is weak: the answer does not synthesize the changing categorization and strategic significance of Lumentum across years, instead asserting that 'inclusion has not changed,' which contradicts the ground truth showing a clear progression in competitive positioning. This undermines the qualitative accuracy. (4) Contextually, the answer addresses NVIDIA’s expanding AI-driven networking focus, which is relevant, but incorrectly frames the competitive dynamic as one-sided pressure on Lumentum rather than an evolving recognition of its strategic role. The answer lacks the forward-looking insight about Lumentum’s rising prominence. Thus, while factually plausible and relevant, it omits critical qualitative shifts, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 434,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In 2022, Emerson positioned pipe cutters within its Tools & Home Products segment as part of the “Professional Tools” line (see 2022 10‑K, page 9). By 2024, the company had moved pipe‑working tools—including pipe cutters—into the Safety & Productivity segment, which now houses all pipe‑working equipment (see 2024 10‑K segment list, page 73). This shift shows Emerson’s strategy to consolidate its professional‑tool portfolio under a dedicated safety‑and‑productivity‑focused segment, underscoring a renewed emphasis on professional tools for industrial and commercial markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Emerson, pipe cutters, Tools & Home Products segment (2022), Safety & Productivity segment (2024), and the years 2022–2024—are correctly identified. The shift in positioning from Tools & Home Products to Safety & Productivity is accurately described. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly infers a strategic consolidation of professional tools based on segment reorganization. It captures the essence of Emerson’s shift toward industrial and professional markets. (4) The LLM answer omits some contextual details present in the original answer—specifically, the mention of battery hydraulic tools, drain cleaners, sewer cameras, and the divestiture of InSinkErator, which strengthens the strategic narrative. While the core strategic interpretation is correct (consolidation around professional, industrial tools), this omission slightly weakens the depth of qualitative insight. However, the answer remains semantically equivalent in intent and key facts. Wording differences are acceptable and do not affect meaning. The answer is fully contextually relevant, directly addressing both parts of the question: the segment shift and its implication for professional tool strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 401,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 through 2024, Schwab’s interactive tools for RIAs—Schwab Advisor Portfolio Connect and the Advisor Services website—remained largely unchanged in core functionality, continuing to offer a free, web‑based portfolio management solution and comprehensive account‑servicing features with integration to third‑party platforms (page_9, 2022‑2024). The evolution focused on deepening integration capabilities and expanding advisor‑support services, adding more consulting, benchmarking, and prospect‑consulting resources while preserving the same intuitive, modern experience, interactive tools, educational content, and thought leadership (page_9, 2022‑2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution described in the ground truth, particularly the progression in functionality and integration from 2022 to 2024. (1) What was correct: The LLM correctly identifies that Schwab Advisor Portfolio Connect and the Advisor Services website were central tools for RIAs and that third-party integrations (CRM, portfolio management) were present throughout 2022–2024. It also correctly notes the continuity of core features and the expansion of advisor support services like consulting and benchmarking. (2) Quantitative accuracy: There are no numeric values to verify (e.g., dollar amounts, percentages), so no errors in this domain—score is 10. (3) Multi-hop reasoning assessment: The LLM fails to capture the multi-hop progression across years. The ground truth shows a clear evolution: in 2022, focus was on core platform access; in 2023, educational and transition support expanded; by 2024, deeper ecosystem integration occurred with compliance workflows, document archiving, and outbound data feeds. The LLM incorrectly states that 'core functionality remained largely unchanged,' which contradicts the ground truth’s emphasis on increasing sophistication and integration, especially in compliance and operational domains. (4) Justification: While the LLM answer is contextually relevant and factually consistent in parts, it underrepresents the strategic shift toward seamless investment and compliance workflow management by 2024. The qualitative accuracy is low because it fails to synthesize the year-over-year enhancements accurately, presenting the evolution as incremental rather than transformative. Correctness score is 6 due to partial factual alignment but significant omission of key developments in functionality and integration depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 491,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10‑K (page 112) as part of its long‑term debt. The 2023 10‑K (page 111) and 2024 10‑K (page 109) continued to report the same notes unchanged—still a 1.65% coupon maturing in 2026—showing a consistent, low‑interest, long‑term debt strategy that underpins Oracle’s short‑to‑intermediate‑term financing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 1.650% interest rate (rounded to 1.65% in the LLM answer, which is semantically acceptable), maturity in 2026, and issuance context in 2022 are accurate. The note's consistent appearance in the 2023 and 2024 10-Ks is correctly noted. (2) The LLM correctly identifies the multi-year continuity of the debt instrument, demonstrating sound reasoning across filings. (3) While the ground truth references specific exhibit numbers (e.g., Exhibit 4.16 in 2022, 4.14 in 2023/2024), the LLM cites page numbers instead (112, 111, 109), which may reflect actual document layout but are not present in the ground truth; this is a minor omission in provenance detail but does not affect factual correctness. (4) The conclusion about Oracle’s consistent, low-interest, long-term debt strategy is logically sound and semantically equivalent to the ground truth’s interpretation of stable capital structure management. The only minor shortcoming is the lack of explicit mention of 'no modification' or 'unchanged commitment' in legal/exhibit terms, slightly reducing qualitative accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates proper multi-hop synthesis across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 373,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson’s Discrete Automation segment has kept the same product mix over the three years – the 2022, 2023 and 2024 descriptions all list “electrical distribution equipment” as a core offering alongside solenoid valves, pneumatic cylinders, linear‑motion solutions and programmable control systems.  The unchanged positioning signals that Emerson continues to view electrical distribution equipment as a foundational element of its discrete‑automation portfolio, underscoring a sustained strategic emphasis on industrial electrification solutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the consistency of Electrical Distribution Equipment's positioning across 2022–2024, directly contradicting the ground truth. According to the original answer, in 2022 the equipment was part of 'Industrial Solutions' and not yet integrated into Discrete Automation, whereas in 2023 and 2024 it was explicitly moved into and retained within the Discrete Automation segment. The LLM incorrectly states that the product mix and positioning remained unchanged across all three years, which misrepresents the strategic evolution. This is a critical error in multi-hop reasoning, as the question hinges on identifying a shift over time. While the LLM correctly identifies the product categories (e.g., solenoid valves, programmable control systems), it fails to capture the reorganization and strategic repositioning. There are no numerical figures to verify, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which are accurate. The reasoning is flawed due to incorrect synthesis across years, undermining the conclusion about 'sustained' emphasis—when in fact the evidence shows a deliberate shift indicating a growing, not static, strategic focus. Contextually, the answer addresses industrial electrification, so relevance is moderate, but the incorrect premise limits usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 379,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle consistently disclosed the 1.650% Notes due 2026 in each filing—2022 (Exhibit 4.16), 2023 (Exhibit 4.14), and 2024 (Exhibit 4.14)—with identical terms, interest rate, and maturity, indicating no change to the instrument.  The notes were presented as part of a 2021 issuance of a series of long‑term notes (maturities through 2061), and the same treatment persisted across the three years.  This continuity shows that Oracle treats the 1.650% Notes as a stable long‑term debt component rather than a source of short‑term liquidity, underscoring a conservative short‑term debt strategy that relies on predictable long‑term financing instead of frequent refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent treatment of Oracle's 1.650% Notes due 2026 across the 2022, 2023, and 2024 10-K filings, including the correct interest rate and maturity, and notes the unchanged terms. It accurately references the 2021 issuance context, aligning with the ground truth's mention of the March 24, 2021 8-K. However, the LLM incorrectly characterizes the notes as part of a 'long-term debt component' and suggests they are not part of short-term debt strategy, which contradicts the ground truth that explicitly links this stability to Oracle's short-term debt strategy. The ground truth emphasizes that Oracle maintains stable short-term obligations without modification, while the LLM interprets the same data as evidence of reliance on long-term financing, misrepresenting the strategic implication. (2) Quantitatively, all numbers (1.650%, 2026 maturity) and references to filing years are correct. The exhibit numbers (4.16, 4.14) are plausible and consistent with typical 10-K structures, though not verifiable from the ground truth; no calculation errors are present. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across three annual filings and recognizes continuity. However, it fails to correctly interpret the strategic significance in the context of short-term debt, which is the core of the question. The ground truth emphasizes continuity in short-term obligations despite new debt issuances, while the LLM incorrectly frames the notes as long-term and outside short-term liquidity management. (4) The answer is contextually relevant and factually accurate on surface details but misses the key analytical point about Oracle's short-term debt strategy, leading to a lower qualitative and overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 492,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle’s 4.30% Note due 2034, issued in 2014, is still referenced in the 2022 10‑K as part of Exhibit 4.11 (the 4.11 Forms of 3.40% Note due 2024, 4.30% Note due 2034, 4.50% Note due 2044) (2022 page_111). The 2023 and 2024 10‑Ks do not re‑issue or re‑file this note; the 4.15/4.16 exhibits list newer maturities but omit the 4.30% Note (2023 page_111; 2024 page_111). This continuity shows Oracle’s long‑term debt strategy focuses on a stable, diversified maturity and interest‑rate mix, issuing new debt at varying rates while keeping older long‑term notes in place.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 4.30% Note due 2034 and its inclusion in the 2022 10-K under Exhibit 4.11, which aligns with the ground truth. However, it incorrectly states that the note was 'not re-issued or re-filed' in 2023 and 2024 and that it was omitted from exhibits 4.15/4.16. The ground truth explicitly states that the note *was* included in the 2023 and 2024 filings under Exhibit 4.09, indicating continued documentation. This is a critical factual error that undermines the conclusion. (2) Quantitatively, the percentages (4.30%, 2034 maturity) and years (2022, 2023, 2024) are accurate, and the reference to Exhibit 4.11 in 2022 is correct. However, the claim about omission in later years is false, and the reference to '4.15/4.16 exhibits' is not supported by the ground truth, which cites Exhibit 4.09 for 2023 and 2024. (3) The multi-hop reasoning is flawed: while the model attempts to synthesize across years, it draws an incorrect conclusion due to misrepresenting the 2023 and 2024 filings. The ground truth emphasizes *continued inclusion* as evidence of stability, whereas the LLM incorrectly infers omission, leading to a contradictory assessment of Oracle’s strategy. (4) Despite the factual error, the answer is contextually relevant—addressing the evolution of the note and Oracle’s debt strategy—and the general reasoning about diversified maturities and stable financing is directionally sound. However, the core factual inaccuracy in entity documentation across years significantly reduces correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 448,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "In 2022 Schwab exercised the 2019 IDA agreement’s migration option, moving roughly $10 billion of IDA balances to its balance sheet each year. The 2023 IDA agreement, which replaced the 2019 agreement, eliminated that migration option, introduced a buy‑down option for up to $5 billion of fixed‑rate obligations, removed the 80 % fixed‑rate requirement, and imposed new minimum/maximum balance limits and post‑2025 withdrawal discretion. In 2024 Schwab continued to use the 2023 terms, did not migrate any IDA balances, and the IDA balance fell to $87.6 billion with fixed‑rate obligations reduced to $66.6 billion, reflecting the buy‑down and the new contractual constraints.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 2023 IDA agreement 'eliminated that migration option'—the ground truth confirms that migration was still possible under the 2023 agreement but was not exercised, due to capital sufficiency and balance thresholds. Second, the LLM introduces a '$5 billion buy-down option for fixed-rate obligations' and specific figures for IDA balances in 2024 ($87.6 billion) and fixed-rate obligations ($66.6 billion), none of which appear in the ground truth and are therefore unsupported. The ground truth does not mention any buy-down mechanism or specific balance figures for 2024. (2) Quantitative accuracy is low: while the $10 billion annual migration capacity in 2022 is correctly noted (though phrased as if executed annually, which is misleading), the $5 billion buy-down, $87.6B, and $66.6B figures are entirely fabricated. The ground truth only confirms $10.1B migrated by end-2021 and $10B 'subsequent to that date'—a timeline ambiguity, but not supporting annual $10B moves in 2022. (3) Reasoning is partially sound in identifying a shift from active migration in 2022 to inactivity in 2023–2024 and noting the removal of the 80% fixed-rate requirement. However, the conclusion that migration was contractually eliminated is incorrect—migration was still possible but not used, indicating a strategic rather than contractual constraint. The model fails to mention the ongoing restrictions based on capital sufficiency and balance thresholds, replacing them with invented terms. (4) Contextual relevance is high—the answer addresses the evolution across years and contractual changes—but the inclusion of fabricated metrics and misrepresentation of contractual terms severely undermines factual correctness. The core narrative of increased flexibility but reduced migration is partially aligned, but the supporting details are largely inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 526,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "In the 2022 10‑K (page 86), Abbott filed an officers’ certificate (Exhibit 4.12) updating the documentation for its 2.000 % Senior Notes due 2018 and refinanced those notes into the new 2.550 % note due 2022 and 2.950 % note due 2025. In the 2023 and 2024 10‑Ks (page 86 of each), Abbott continued to file the same certificate (Exhibit 4.18) to keep the 2.000 % notes in compliance, but no additional refinancing of those notes was disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The claim that Abbott refinanced the 2.000% Senior Notes due 2018 into a '2.550% note due 2022' and '2.950% note due 2025' is false according to the ground truth. The original answer states there were no new issuances or refinancing actions taken by 2024, and the notes were legacy St. Jude Medical debt referenced for documentation continuity. The maturity dates (2022, 2025) and interest rates (2.550%, 2.950%) are entirely fabricated. (2) Completeness: While the question asks about documentation updates and refinancing from 2022–2024, the LLM incorrectly asserts refinancing occurred in 2022, which contradicts the ground truth that no refinancing actions were taken. (3) Entity Accuracy: The exhibit numbers are inconsistent—LLM claims Exhibit 4.12 in 2022 and Exhibit 4.18 in 2023–2024, while the ground truth references Exhibit 4.21 consistently across years. The correct exhibit is 4.21, not 4.12 or 4.18. (4) Reasoning: The multi-hop synthesis is flawed. The LLM incorrectly infers that documentation updates imply refinancing, whereas the ground truth shows these notes were matured legacy instruments retained in disclosures for structural transparency, not active refinancing. (5) Semantic Equivalence: The LLM suggests active refinancing and ongoing compliance filings, but the truth is that the notes were passively carried in disclosures with no new activity. The core narrative—refinancing vs. static documentation—is diametrically opposed. Thus, despite addressing the general topic, the answer is factually incorrect on key points, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 461,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first issued the 3.650% Notes due 2041 in a March 2021 officers’ certificate, and the 2022 10‑K (Exhibit 4.16) lists them as part of that 2021 debt issuance (page 114). The 2023 and 2024 10‑Ks (Exhibits 4.14) continue to report the same 3.650% Notes with no new issuance or maturity changes (pages 111 & 112). This steady, multi‑year presence shows Oracle’s strategy of maintaining a stable, long‑dated debt mix to lock in favorable rates and manage cash‑flow risk over the long term.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual discrepancy regarding the introduction date of the 3.650% Notes due 2041. The LLM states the notes were first issued in March 2021 via an officers’ certificate and referenced in the 2022 10-K, while the ground truth asserts Oracle 'first introduced' them in 2022. This creates a conflict in the timeline—though it's possible the issuance occurred in 2021 and was first reported in the 2022 filing, the ground truth emphasizes 2022 as the starting point of the multi-year pattern from 2022–2024. The LLM’s inclusion of 2021 slightly misaligns with the question’s focus on evolution from 2022 onward. However, all other years (2023, 2024) are correctly referenced with consistent note details. (2) Quantitatively, the interest rate (3.650%), maturity year (2041), and exhibit numbers (4.16, 4.14) are accurate, and the LLM correctly notes no changes in terms across years. Page numbers cited (114, 111, 112) are plausible and consistent with typical 10-K structures. The only quantitative issue is the out-of-scope 2021 date, which isn't part of the 2022–2024 evaluation window. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three years of 10-K filings, identifies the continued presence of the notes, and infers Oracle’s long-term debt strategy—stable, long-dated financing to manage cash-flow risk and lock in rates. This aligns well with the ground truth’s conclusion about financial flexibility and stable financing. (4) Despite the slight timeline discrepancy, the LLM captures the core strategic implication accurately and provides additional context (e.g., officers’ certificate, exhibit references) that enriches the answer. The answer is highly relevant and semantically close to the ground truth, meriting high scores in qualitative accuracy and contextual relevance. The correctness score is reduced slightly due to the incorrect emphasis on 2021 as the origin point, which affects the narrative of the multi-year pattern starting in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 551,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in 2021 (officers’ certificate March 24 2021) and the same notes are disclosed unchanged in the 2022, 2023, and 2024 10‑Ks (Exhibit 4.16 in 2022, Exhibit 4.14 in 2023/2024)【page_114】【page_111】【page_112】. In 2023 and 2024 Oracle added new 4.500% Notes due 2028, expanding its maturity ladder with higher‑coupon debt (Exhibit 4.16 in 2023/2024)【page_111】【page_112】. This multi‑year pattern shows Oracle’s strategy of maintaining a diversified, laddered debt portfolio—keeping a stable long‑term component while adding newer, higher‑coupon notes to spread refinancing risk and optimize borrowing costs over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of the 2.300% Notes due 2028 under the Officers' Certificate dated March 24, 2021, and their consistent disclosure in the 2022, 2023, and 2024 10-Ks via Exhibit 4.16 (2022) and Exhibits 4.14/4.16 in later years. It accurately notes the introduction of additional 4.500% Notes due 2028 in 2023 and 2024, aligning with the ground truth. All percentages, dates, and exhibit references are factually correct, though minor variation in exhibit numbering (4.14 in 2023/2024 vs 4.16) is properly reflected and does not contradict the original answer, as such changes are common across filings. (2) Quantitative accuracy is perfect: the interest rates (2.300%, 4.500%), maturity year (2028), and issuance date (March 24, 2021) are all correct. No calculations are required, but the synthesis of debt structuring over time is accurate. (3) Multi-hop reasoning is sound: the model correctly links Oracle’s repeated referencing of the original certificate across years, identifies the addition of new notes in 2023, and infers a strategic intent around debt diversification and refinancing risk management. The conclusion about a 'laddered' and diversified debt portfolio matches the ground truth’s interpretation of a stable, long-term financing strategy. (4) The only minor shortcoming is that the LLM implies the 2.300% Notes were 'issued in 2021' rather than first disclosed/structured then and carried forward in subsequent years’ filings—while technically nuanced, the original answer emphasizes the 2022 introduction in the context of fiscal reporting, so this slight misstatement prevents a perfect 10. However, the overall factual and semantic alignment is excellent, with full contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 487,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "Visa launched Currencycloud in 2022 as part of its Treasury‑as‑a‑Service offering, creating virtual accounts that could hold and move funds. By 2023 these virtual accounts were folded into the Visa Direct Platform, enabling real‑time cross‑border payouts and expanding the network of eligible cards, bank accounts and digital wallets. In 2024 the platform further broadened cross‑border reach—adding real‑time FX, enhanced liquidity and settlement and extending service to more than 11 billion endpoints across 195+ countries【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies the 2022 launch of virtual accounts via Currencycloud under Treasury-as-a-Service, 2023 integration into Visa Direct with real-time FX and expanded payout capabilities, and 2024 expansion to over 11 billion endpoints across 195+ countries. All key developments are present and factually correct. (2) Quantitative elements—'11 billion endpoints' and '195+ countries'—match the implied scale in the original answer (though '195+ countries' is an inference not explicitly stated in the ground truth, it does not contradict it and is contextually reasonable). No calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes evolution across years, platforms (Currencycloud → Visa Direct), and technical enhancements (FX, liquidity, settlement). Minor deduction in qualitative accuracy because the LLM attributes the 2022 launch to 'Currencycloud' rather than correctly stating that Visa introduced virtual accounts as part of its Treasury-as-a-Service initiative via Currencycloud—slightly misrepresenting the relationship. (4) The answer is fully relevant, addressing integration into Visa Direct and cross-border expansion as asked. Overall, minor wording imprecision prevents a perfect 10, but factual and contextual alignment is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 375,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "From 2022 to 2023, Caterpillar expanded its ME&T dealer network for EMD‑branded products—U.S. dealers grew from 41 to 44, overseas dealers from 111 to 116, and countries served from 187 to 193【page_76】【page_66】. The network remained unchanged through 2024, still comprising 44 U.S. dealers, 116 overseas dealers, and 193 countries served【page_64】. This steady growth and maintenance of a broad dealer base signals Caterpillar’s strategy to broaden EMD’s global reach and sustain market penetration across the ME&T segment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to align with the ground truth on multiple levels. (1) Quantitative Accuracy: The numbers provided (e.g., 41 to 44 U.S. dealers, 111 to 116 overseas dealers, 187 to 193 countries) are completely inconsistent with the ground truth, which reports 110 distributors in 109 countries in 2022, 110 in 109 in 2023, and 108 distributors in 158 countries in 2024. The LLM fabricates a U.S./overseas dealer split and total country counts that do not appear in the original answer. (2) Completeness: While the question asks about the evolution of the geographic distribution network for EMD-branded products in the ME&T segment, the LLM introduces unverified details (e.g., U.S. vs. overseas dealers) not present in the ground truth and omits the actual trend—stable distributor count with expanded country coverage. (3) Entity Accuracy: The LLM incorrectly refers to 'dealers' instead of 'distributors' and conflates EMD-branded products with a dealer network structure that is not described in the original. The mention of 'FG Wilson branded electric power generation systems'—a key detail in the ground truth—is missing. (4) Reasoning: The multi-hop synthesis is flawed. The LLM suggests steady growth and stabilization, while the ground truth indicates a slight reduction in distributors but a significant increase in geographic reach, pointing to efficiency optimization. The LLM’s conclusion about 'broadening global reach' superficially aligns, but it is based on false data and reasoning. (5) Semantic Equivalence: The overall meaning is not equivalent—factual misstatements dominate. The contextual relevance is low because the answer draws from apparently incorrect or hallucinated data, despite citing non-existent page references. The answer fails the primary correctness criterion due to pervasive factual and numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 508,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s diagnostics‑instrument lease portfolio expanded between 2022 and 2024.  The original cost of the assets rose from $3.6 billion in 2022 to $3.9 billion in 2024, while the net book value increased from $1.6 billion to $1.8 billion, reflecting a $300 million increase in cost and a $200 million increase in net book value (Note 10 – Leases, 2024 10‑K, page 63).  This growth indicates an expansion of the diagnostics instrument inventory leased to customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the original cost was $3.3 billion in 2022, not $3.6 billion as stated in the LLM answer. The LLM incorrectly reports the 2022 original cost as $3.6 billion (which is actually the 2023 value) and skips 2023 entirely, making it appear that the increase was directly from 2022 to 2024. Similarly, the net book value is reported as starting at $1.6 billion in 2022, but the correct 2022 value is $1.4 billion. These errors affect the accuracy of the $300 million and $200 million increase claims, which, while numerically close (actual cost increase: $600M over 2022–2024; net book value increase: $400M), are based on incorrect starting points and timeframes. (2) The calculations are partially correct in magnitude but flawed in attribution. The $300M cost increase cited is only half the actual total increase from 2022 to 2024 ($600M), and the answer implies a two-year change rather than a three-year evolution. The net book value increase from $1.6B to $1.8B is only a $200M rise, but this compares 2023 to 2024, not 2022 to 2024 as required. (3) The multi-hop reasoning is partially sound—the model recognizes the need to compare balance sheet values over time and cites the correct note and document (Note 10 – Leases, 2024 10-K, page 63)—but fails to incorporate the 2022 baseline correctly, breaking the full temporal synthesis. (4) Despite these errors, the answer is contextually relevant and correctly interprets the trend (increasing investment) and the meaning of the data. The qualitative reasoning about expansion is valid, and the entities (Abbott, diagnostics instruments, leased assets) are accurate. However, the quantitative inaccuracies in key financial figures significantly reduce the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 497,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 3.450% Senior Note due 2046 appears in each filing—listed as “Form of 3.450% Senior Note due 2046” in 2022 (page 126), 2023 (page 127), and 2024 (page 127)—showing that PepsiCo still treats this long‑term debt instrument as a core part of its capital structure.  Its continued presence signals a deliberate strategy to maintain a stable mix of long‑term, fixed‑rate debt and to rely on the note for financing rather than retiring or replacing it in the near term【page_126】【page_127】【page_127】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core meaning as the ground truth. (1) All key facts are correct: the 3.450% Senior Note due 2046 is consistently disclosed in PepsiCo's 2022, 2023, and 2024 10-K filings, indicating its ongoing role in the capital structure. The percentages, interest rate (3.450%), and maturity year (2046) are all accurate. (2) Quantitative elements—interest rate and maturity date—are correctly reported with no calculation errors. (3) The reasoning is sound: the repeated disclosure is interpreted as evidence of a stable, long-term financing strategy using fixed-rate debt, which aligns with the ground truth. The LLM correctly infers strategic intent from consistent inclusion. (4) Minor omission: the LLM does not reference the specific exhibit numbers (e.g., Exhibit 4.17 in 2022), which were included in the ground truth and add precision about disclosure location. However, the LLM compensates by citing page numbers, which supports verifiability. Wording differs but semantic equivalence is strong. The answer fully addresses the question about the note’s role in long-term capital strategy. Thus, the answer is excellent—only a slight deduction for missing exhibit details prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 347,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 in 2021 (officer’s certificate dated March 24 2021). The same notes appear unchanged in the 2022 10‑K (Exhibit 4.16, page_114), the 2023 10‑K (Exhibit 4.14, page_111) and the 2024 10‑K (Exhibit 4.14, page_111), indicating that the terms and maturity remained constant across three fiscal years. This consistency, alongside the issuance of new notes at varying maturities and coupon rates each year, reflects Oracle’s strategy of maintaining a laddered debt portfolio to manage refinancing risk and interest‑rate exposure while keeping long‑term debt terms stable.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM incorrectly states that Oracle issued the 2.300% Notes due 2028 in 2021 (officer’s certificate dated March 24, 2021), which contradicts the ground truth indicating the note was first introduced in 2022. This is a significant factual error affecting the timeline of the debt issuance. However, the LLM correctly notes that the notes appear in the 2022, 2023, and 2024 10-K filings (Exhibit 4.16 in 2022, Exhibit 4.14 in 2023 and 2024), and that the terms remained unchanged across years. (2) The quantitative inaccuracies center on the issuance date—2021 vs. 2022—which is a critical discrepancy in the multi-year evolution. All other numeric details (coupon rate: 2.300%, maturity: 2028, exhibit numbers, page numbers) are accurately reported or plausibly consistent across filings. (3) The reasoning is sound in interpreting Oracle’s strategy as maintaining a laddered debt portfolio to manage refinancing and interest rate risk, which aligns semantically with the ground truth’s conclusion about consistent referencing of prior instruments while layering in new debt (e.g., 4.500% Notes due 2028). The LLM correctly synthesizes the pattern of maintaining old notes while issuing new ones at varying rates. However, it fails to mention the concurrent issuance of other notes like the 1.650% Notes due 2026 or 2.875% Notes due 2031 in 2022, which weakens completeness. (4) The correctness score is 6 due to the major error in the issuance year, which undermines the factual foundation of the answer, though the rest of the pattern and strategic interpretation are reasonable. Quantitative accuracy is penalized heavily for the wrong year (2021 vs. 2022), though other numbers are correct. Qualitative accuracy is higher because the reasoning and strategic interpretation are logical and mostly aligned. Contextual relevance is high as the answer directly addresses the evolution and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 517,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa has continued to list the Certificate of Designations of its Series B Convertible Participating Preferred Stock in every 10‑K filing (Exhibit 4.5 in 2022 and Exhibit 4.4 in 2023 and 2024) (page_114, page_109). The unchanged status of the certificate indicates the preferred shares remain outstanding and have not been converted or retired, underscoring a conservative capital‑structure strategy that preserves flexibility while prioritizing long‑term stability and shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Visa consistently referenced the Certificate of Designations for its Series B Convertible Participating Preferred Stock across its 2022–2024 10-K filings, noting the exhibit numbers (4.5 in 2022, 4.4 in 2023 and 2024) and page references, which supports the claim of continuity. The date of the Certificate (June 21, 2016) is not explicitly mentioned, which is a minor omission, but the core fact—that the certificate has remained unchanged—is correctly conveyed. The reasoning about Visa’s conservative capital structure strategy, emphasis on stability, and preservation of shareholder value is logically sound and semantically equivalent to the ground truth’s interpretation. The answer synthesizes information across multiple filings (multi-hop) correctly. All entities (Visa, Series B stock, 10-K filings) and years (2022–2024) are accurate. No numerical or date inaccuracies are present. The answer is highly contextually relevant and captures the essence of the question. The only reason for not scoring a 10 is the omission of the specific 2016 certificate date, which is part of the full factual record but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 352,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "In its 2022 10‑K, Caterpillar disclosed that a significant portion of its financing was LIBOR‑based and that the transition to SOFR could materially affect the valuation of derivative contracts and other financial obligations, prompting the creation of a cross‑functional risk team to assess LIBOR‑related exposures (page 22). The 2023 and 2024 10‑Ks continued to rely on currency‑hedging instruments to mitigate exchange‑rate risk, but the disclosures highlighted that hedging can forgo benefits from favorable moves and that the LIBOR‑to‑SOFR transition could influence interest‑rate risk and derivative pricing (pages 17‑21). Across all three years, Caterpillar maintained a match‑funding strategy, selective use of derivatives, and a diversified funding program to manage both currency and interest‑rate risks (page 22).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar's reliance on currency hedging instruments from 2022 to 2024, the formation of a cross-functional team in 2022 to assess LIBOR transition risks, the continuation of hedging strategies in 2023 and 2024, and the integration of SOFR as a new benchmark are all accurately represented. The mention of match funding, selective derivatives, and diversified funding programs is consistent across both answers. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of disclosures, connects LIBOR transition risks to derivative valuation, and links interest rate and currency risk management strategies. The only minor shortcoming is that the LLM does not explicitly state that Cat Financial was the entity managing these risks in the transition (implied but not named in 2023–2024), and it slightly underemphasizes the evolution from LIBOR assessment (2022) to active SOFR integration (2023), though the progression is implied. (4) Contextual relevance is excellent—the response directly addresses the evolution of currency hedging and LIBOR/SOFR transition impacts as required by the question. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only negligible omissions in specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 429,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "From 2022 onward, Johnson & Johnson shifted its talc‑liability strategy from a single $2 billion trust funded by the company to a broader, pre‑packaged bankruptcy plan that expanded that trust to a $9 billion reserve over 25 years. In 2022 the company created the $2 billion trust and set a matching reserve (page 113, 96, 97). In 2023 the original LTL bankruptcy was dismissed, the company refiled a new LTL 2 case, and agreed to add $7 billion to the trust, raising the reserve to $9 billion (page 101, 102). By 2024 the company pursued a consensual “pre‑packaged” Chapter 11 plan that incorporated the expanded trust as the central mechanism for resolving the majority of talc claims, while continually adjusting its reserve to reflect the evolving settlement structure (page 101, 102).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and the overall narrative of Johnson & Johnson's strategy. (1) QUANTITATIVE INACCURACY: The claim that J&J expanded the trust from $2 billion to $9 billion is false. The ground truth states only a $2 billion trust was established, with no mention of a $7 billion addition or a $9 billion reserve. This major error distorts the entire financial scope. (2) COMPLETENESS: While the answer addresses LTL's bankruptcy filings and the trust, it misrepresents the evolution by introducing a non-existent 'pre-packaged Chapter 11 plan' and expanded funding. The original answer emphasizes legal reversals and refilings (LTL 2), which the LLM mentions but frames incorrectly as part of a consensual, structured pre-pack plan rather than failed attempts later dismissed. (3) ENTITY & REASONING: The LLM incorrectly implies that the $9 billion reserve and pre-packaged plan were realized outcomes, when in fact the strategy remained in appellate limbo in 2024. The reasoning fails to capture the actual legal setbacks (dismissals by the Third Circuit) and instead suggests a smooth transition to a new settlement mechanism. (4) SEMANTIC EQUIVALENCE: The core facts—timing of the $2B trust (2022), LTL 2 refiling (2023)—are partially correct, but the synthesis is flawed. The answer invents financial commitments ($9B) and strategic consensus not present in the ground truth. Contextual relevance is moderate because it discusses the right entities and timeline but with incorrect details. Overall, the answer misleads on the financial and legal trajectory, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 455,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "Adobe’s Photography Plan moved from a bundle inside the full Creative Cloud in 2022 to a standalone, cloud‑centric subscription by 2024. In 2022 and 2023 the plan was marketed as a “targeted package” alongside other suites (e.g., Substance 3D) and began to incorporate Adobe’s new generative‑AI tools (Firefly and generative credits) to boost photo‑editing workflows for creative professionals【page_5】【page_7】. By 2024 the plan was repositioned as a more limited, cloud‑based offering that still bundles Photoshop, Lightroom and Lightroom Classic but excludes the broader Creative Cloud apps, offering a simpler, cheaper subscription for photographers and photo enthusiasts while still leveraging integrated AI features【page_11】【page_12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Photography Plan included Photoshop, Lightroom, and Lightroom Classic throughout 2022–2024; it was positioned as a targeted package in 2022; generative AI features (Firefly, Generative Fill, etc.) and Generative Credits were introduced in 2023 and expanded in 2024; by 2024, it remained a limited, cloud-based alternative to full Creative Cloud. (2) There are no numeric values to verify (e.g., prices, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution across years, correctly identifying the strategic shift toward AI integration and the plan’s positioning relative to the broader Creative Cloud suite. (4) Minor wording differences exist (e.g., 'moved from a bundle inside the full Creative Cloud' could imply it was not standalone earlier, which slightly misrepresents the 2022 offering—it was already a standalone plan but less AI-enhanced), but overall semantic equivalence is preserved. The answer captures the core strategic shifts, enhancements, and target audience focus. One point deducted from qualitative accuracy due to slight imprecision in describing the 2022 structure, but the overall correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 374,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa has kept the same form (8‑A 000‑53572) and filing date (January 28 2009) for its class C common‑stock specimen certificate in the exhibit tables of its 2022, 2023, and 2024 10‑K filings (see page_109 and page_114). This unchanged documentation signals a deliberate commitment to stability and transparency in its securities framework, reinforcing investor confidence and demonstrating a governance approach that values consistency amid evolving regulatory and market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the form (8-A 000-53572), filing date (January 28, 2009), and the consistency across 2022–2024 10-K filings are accurately cited. The reference to exhibit tables and specific page numbers (page_109, page_114) adds precision, though these are not in the original answer but do not contradict it. (2) The LLM correctly identifies that the same specimen certificate (Exhibit 4.2) has remained unchanged since 2009, which is a critical multi-hop fact across three years of filings. (3) Qualitatively, the reasoning about stability, transparency, and investor confidence is sound and logically inferred from the lack of changes. The answer captures the implication of consistent governance practices, though it omits a specific contrast with other updated documents like the 2024 Certificate of Incorporation, which the original answer notes. This is a minor omission but does not detract significantly from the overall correctness. (4) The answer is contextually relevant, directly addressing both parts of the question: the consistency in documentation and its implications for governance and investor relations. Wording differs but semantic meaning is equivalent. No calculation errors. One point deducted from correctness and qualitative accuracy for missing the contrast with updated governance documents, which adds depth to the interpretation of Visa’s selective stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 411,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s carrying amount of performance and operating‑cost guarantees fell from **$1,109 million at December 31 2022** to **$1,091 million at December 31 2023** and further to **$993 million at December 31 2024** (2023 table on page 100; 2024 table on page 104).  The decline is driven by fewer guarantees issued in 2024 (216 m vs 305 m in 2023) and a net reduction in settlements, reflecting tighter warranty management and lower exposure to future claim payments under its commercial‑aerospace contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and misidentifies the metric. The ground truth states that RTX's collaboration partners' share of financing guarantees was $140M in 2022, $135M in 2023, and $131M in 2024. In contrast, the LLM reports total carrying amounts of $1,109M, $1,091M, and $993M — figures that are over 8x larger and refer to a different liability category (total performance and operating-cost guarantees, not the partners' share of financing guarantees). These numbers may be pulled from RTX’s financial statements but pertain to a different line item than what the original answer (ground truth) specifies. (2) The quantitative discrepancy is severe: the LLM’s values are off by hundreds of millions of dollars and do not match the specific liability described in the ground truth. There is no indication in the LLM answer of the 'collaboration partners' share' — a key qualifier — suggesting confusion between total guarantees and shared liabilities. (3) The multi-hop reasoning fails because the LLM does not synthesize the correct entity-metric-time triad. It addresses 'carrying amount of performance and operating-cost guarantees' instead of 'collaboration partners' share of financing guarantees,' conflating distinct financial concepts. While it correctly infers a declining trend and links it to improved risk management, this reasoning is applied to the wrong metric. (4) Despite the incorrect numbers and misidentified metric, the LLM captures the directional trend (decline) and offers plausible interpretation (tighter warranty management, lower exposure), which maintains moderate contextual relevance. However, the factual inaccuracies severely undermine correctness and qualitative accuracy, warranting low scores in those categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 489,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s lease note has not changed materially from FY 2022 through FY 2024.  The company continues to treat free‑rent periods as part of the lease term, recognizing them on a straight‑line basis over the original lease term and any extensions that the company is reasonably certain to exercise, and it records right‑of‑use assets based on the discounted minimum lease payments over that same term.  Consequently, there were no material changes to lease‑term assumptions or the impact on ROU asset valuations during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Costco's core accounting treatment for free-rent periods remained materially unchanged from FY 2022 through FY 2024, with consistent application of straight-line recognition over the lease term including reasonably certain extensions, and ROU assets based on discounted lease payments. This aligns with the ground truth. Quantitative accuracy is perfect—no numerical inaccuracies, and the fiscal years (2022–2024) are correctly referenced. However, the LLM answer omits the qualitative evolution in disclosures highlighted in the original answer: the 2023 clarification on variable lease payments and the 2024 increased emphasis on impairment evaluation of long-lived assets related to lease valuations. While the core policy did not change, the ground truth emphasizes a shift in disclosure focus reflecting growing operational complexity, which the LLM answer fails to capture. This omission reduces completeness and qualitative accuracy, though the central claim of no material change is valid. The reasoning is sound but less nuanced than required for full multi-hop synthesis across years. Contextual relevance is strong as it directly addresses lease term assumptions and ROU asset impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 348,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "In 2022, Adobe positioned Acrobat as the core of its Document Cloud, embedding Adobe Sensei AI to add intelligent features and expanding its capabilities (page_5). By 2023, the company amplified that focus, adding AI‑driven task actions, improving Acrobat web, and integrating AI across Acrobat, Acrobat Sign, and Adobe Scan while ramping up R&D on AI and machine‑learning (page_7). In 2024, Adobe formalized the Acrobat brand—highlighting distinct products such as Adobe Acrobat Pro, Acrobat Reader, Acrobat web, and Acrobat Sign—and continued heavy investment in AI‑powered document workflows across the Document Cloud (page_94).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of timeline, strategic evolution, and key developments around AI in Acrobat. (1) All dates (2022, 2023, 2024) are accurate and correctly associated with the progression of Adobe's AI strategy. There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised. (2) The LLM correctly identifies the increasing emphasis on AI: starting with embedding Adobe Sensei in 2022, expanding AI integrations across Acrobat products in 2023, and continuing heavy investment in 2024. It also notes R&D ramp-up in AI/ML in 2023, which matches the ground truth's emphasis on multi-year investment. (3) However, the LLM answer misses the specific branded product launch of 'Acrobat AI Assistant' in 2024, which is a key detail in the original answer and represents the formalization of Adobe’s AI branding. Instead, it mentions formalization of the Acrobat brand with product names like Pro, Reader, etc., which is accurate but less focused on the AI-specific branding evolution. This is a meaningful omission in the multi-hop synthesis of how AI branding evolved. (4) Despite this, the reasoning trajectory is sound—showing a clear progression from foundational document capabilities to AI-enhanced workflows—and remains contextually highly relevant. The answer captures the essence of the strategic shift but lacks one critical detail (Acrobat AI Assistant) that would make it fully equivalent. Hence, a score of 8 is justified: core facts and timeline are correct, but a key branded milestone is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 444,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "Schwab’s fair‑value of client securities available to be pledged rose from roughly $84 billion in 2020 to $120 billion in 2021 (and remained high in 2022) while about $6.3 billion of those securities were pledged for securities‑lending (page 108).  In contrast, the amount of client securities pledged as collateral for CS&Co’s secured uncommitted lines of credit fell from $950 million in 2023 to $500 million in 2024, and the TDAC lines of credit (≈ $700 million) were terminated (page 97).  This evolution shows Schwab tightening collateral use for short‑term borrowing while sustaining robust margin‑lending and securities‑lending activity, indicating a balance‑sheet strategy that reduces short‑term credit exposure yet preserves client leverage through margin and lending programs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Schwab did not quantify pledged client securities in 2022 and only began providing more detailed disclosures in 2023, with explicit usage for options clearing and securities lending in 2024. However, the LLM claims specific dollar amounts ($84B, $120B, $6.3B) for 2020–2021 and states that $6.3B were pledged for securities lending, which is not supported by the original answer. There are no such figures in the ground truth for those years or purposes. Additionally, the LLM references a decline in pledged securities for 'CS&Co’s secured uncommitted lines of credit' from $950M in 2023 to $500M in 2024 and termination of TDAC lines—details entirely absent from the original answer and unrelated to client securities used for margin or securities lending. (2) The quantitative inaccuracies are severe: the LLM fabricates numbers and trends (e.g., $84B to $120B increase in 2020–2021) not present in the ground truth. The original answer does not provide any dollar amounts related to pledged client securities across 2022–2024. The mention of page numbers (e.g., page 108, 97) further suggests hallucinated sourcing. (3) The multi-hop reasoning is flawed. The question asks about the evolution of client securities used as collateral in relation to margin and securities lending, and what this indicates about balance sheet strategy and client leverage. The LLM incorrectly shifts focus to short-term credit lines (CS&Co, TDAC), which are not part of the disclosed use of *client* securities as collateral per the original answer. It fails to capture the key progression: from general regulatory disclosure (2022), to enhanced transparency (2023), to explicit use in options clearing and securities lending (2024). (4) The contextual relevance is moderate because the LLM addresses the general theme of collateral use and balance sheet strategy, but the specific evidence and logic are misaligned. Due to major factual and quantitative errors, the correctness score is low at 2. The qualitative accuracy is slightly higher because some concepts (e.g., securities lending, margin) are relevant, but reasoning is unsound. Quantitative accuracy is very poor due to fabricated numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 610,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "The 1.375% Senior Notes due June 2027 stayed in the long‑term debt category and its carrying amount remained $1.25 bn in 2022, 2023 and 2024.  Total long‑term debt fell from $6.59 bn in 2022 to $5.92 bn in 2024, as the other long‑term debt component rose from $590 m to $919 m while the current portion fell from $73 m to $103 m, reducing the long‑term debt excluding current portion from $6.48 bn to $5.79 bn.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.375% Senior Notes due June 2027 remained at $1.25 billion across 2022–2024 and stayed in long-term debt, which matches the ground truth. However, it reports total long-term debt as $6.59 billion in 2022 and $5.92 billion in 2024, which conflicts with the ground truth values of $6,484 million and $5,794 million (long-term debt excluding current portion). These discrepancies suggest confusion between total long-term debt and long-term debt excluding current portion. The LLM mentions 'other long-term debt' increasing from $590M to $919M and current portion rising from $73M to $103M, but these figures are not present in the original answer and introduce unsupported details. (2) The core number for the 1.375% notes ($1,250 million) is accurate. However, the total long-term debt figures are incorrect: $6.59B vs $6.484B in 2022 and $5.92B vs $5.794B in 2024. The differences (~$106M and ~$126M respectively) are significant and affect quantitative accuracy. The mention of 'other long-term debt' and current portion changes introduces numbers not in the source, undermining factual precision. (3) The reasoning correctly infers that the 1.375% notes were consistently classified as long-term and that overall long-term debt decreased, but it misattributes the composition changes. The original answer attributes the decline to reclassification of the 2.750% notes due 2024, while the LLM focuses on unspecified changes in 'other long-term debt' and current portion without linking to specific notes or reclassifications. This weakens the multi-hop synthesis. (4) Despite numerical inaccuracies, the LLM addresses the core question about the treatment of the 1.375% notes and overall long-term debt trend. It maintains correct entity identification (Costco, 1.375% Senior Notes, June 2027) and correct years. The explanation is logically structured and contextually relevant, but the incorrect figures reduce overall correctness. Scored 7 due to correct core facts about the notes but significant errors in total debt values and unsupported compositional claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 569,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "Adobe has consistently positioned free online self‑service learning as a core element of its Digital Learning Services, which is embedded in the broader learning and enablement portfolio across the 2022, 2023, and 2024 10‑Ks (page_17, page_17, page_18).  Over time the company has increasingly tied this offering to enterprise customer‑success, underscoring custom learning services, skills‑assessment tools, and the role of Customer Success Managers to help large customers adopt and maximize Adobe solutions (page_18).  Thus, while the free‑learning catalog has remained unchanged, its integration with enterprise success strategies has become more explicit in the latest filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services from 2022 to 2024, with increasing integration into enterprise customer success strategies. The mention of Digital Learning Services and its embedding in the broader portfolio across all three years matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense—but the years (2022, 2023, 2024) and page references are correctly cited, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the evolution in emphasis—from consistent availability of free learning to a more explicit linkage with enterprise success via custom services, skills assessments, and Customer Success Managers. This reflects the maturing integration described in the ground truth. (4) The only minor shortcoming is that the LLM states 'the free-learning catalog has remained unchanged,' which is not explicitly supported in the original answer; the ground truth emphasizes continuity in positioning and strategic importance, but does not comment on whether the catalog content changed. This is a small overstatement but does not undermine the overall correctness. Otherwise, the answer is semantically equivalent, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 440,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00 % Notes Due 2031 fell from roughly $1.1 billion in 2022 to $1.044 billion in 2023, then rose to $1.250 billion in 2024 (2024: page 72; 2023: page 67; 2022: page 78). This modest fluctuation shows the company is keeping its long‑term debt load stable and aligning maturities with cash flow, a disciplined strategy that supports its rapid AI‑driven revenue growth without overleveraging.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and interpretation but contains inaccuracies in the reported values for 2022 and 2023. The ground truth states the carrying amount was $1.20 billion in 2022 and $1.057 billion in 2023, while the LLM reports approximately $1.1 billion and $1.044 billion, respectively. The 2024 value is correctly reported as $1.250 billion. These discrepancies, though relatively small in magnitude, affect quantitative accuracy. (2) The numbers are close but not precise—especially the 2022 figure, which is off by $0.1 billion (about 8.3% error), and the 2023 figure, which is slightly underreported. While the trend (down then up) is accurately captured, exact figures matter in financial analysis, particularly when assessing debt management. (3) The multi-hop reasoning is sound: the model correctly identifies the three-year trend and synthesizes it into a coherent narrative about stable long-term debt management aligned with AI growth. It appropriately infers a disciplined strategy, which aligns with the original answer’s implication of strategic capital use. (4) Contextually, the answer is highly relevant and provides meaningful interpretation. The qualitative reasoning is strong, and the conclusion about maintaining stable leverage during growth is consistent with the ground truth. However, the incorrect figures reduce confidence in data fidelity, warranting a moderate correctness score. Minor formatting differences (e.g., $1.250B vs $1.25B) are acceptable and do not impact scoring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 425,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson has continued to implement a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems for HR, IT, procurement, supply chain and finance, expanding its financial shared‑service capabilities and standardizing financial systems (2022 page 117; 2023 page 118; 2024 page 119). The language in each filing shows the initiative remains active and that the company is aligning and streamlining its financial control environment. This steady, ongoing effort underscores J&J’s strategic emphasis on process standardization and a robust, aligned control framework to support efficient, consistent financial reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative to enhance financial shared services and standardize systems is accurately described across 2022–2024, with consistent emphasis on integration, simplification, and standardization. The inclusion of HR, IT, procurement, and supply chain alongside finance is a minor expansion beyond the original answer’s focus on finance, but this detail is consistent with typical shared service initiatives and does not contradict the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not compromised; page references (2022 p.117, etc.) are correctly cited and support the claims. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to demonstrate continuity and strategic intent, correctly concluding that the initiative reflects a proactive, long-term focus on standardization and control environment alignment. (4) The answer is contextually relevant and fully addresses both parts of the question—evolution of the initiative and what it indicates about strategic focus. The only minor shortcoming is that the original answer explicitly clarifies the initiative was *not reactive* to internal control deficiencies, a nuance slightly downplayed in the LLM response, though implied through 'steady, ongoing effort.' This small omission prevents a perfect 10 but does not undermine overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 428,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s 10‑K filings from 2022 through 2024 consistently name BJ’s Wholesale Club as a direct competitor in the warehouse‑club arena (2022 page 7; 2023 page 8; 2024 page 8).  In each year the company repeats the same wording that its private‑label brand, Kirkland Signature, delivers “high‑quality, lower‑priced” products that “help lower costs, differentiate our merchandise offerings, and generally earn higher margins,” underscoring the brand as a key differentiator (2022 page 7; 2023 page 8; 2024 page 8).  Thus, the competitive positioning language and the strategic emphasis on Kirkland Signature have remained essentially unchanged from 2022 to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in identifying BJ's Wholesale Club as a named competitor and correctly quotes consistent language about Kirkland Signature across 2022–2024 filings. The quantitative accuracy is perfect: correct years, page numbers, and consistent use of terminology (e.g., 'high-quality, lower-priced') are properly cited. However, the qualitative accuracy is low because the LLM concludes that the language and strategic emphasis 'remained essentially unchanged,' which contradicts the ground truth. The original answer identifies a nuanced but important evolution in tone and context: while core phrasing may be similar, the 2024 filing introduces a stronger emphasis on 'differentiating our merchandise offerings' in competitive metropolitan markets, reflecting a strategic shift in response to BJ's. Additionally, the 2023 mention of sustainability initiatives tied to brand loyalty (though not directly to Kirkland) suggests a broader contextual evolution not acknowledged by the LLM. The LLM fails to capture this multi-hop nuance—synthesizing subtle shifts in framing over time—which is central to the question about evolution in competitive positioning. Thus, while the surface-level facts are correct, the reasoning and interpretation are oversimplified, missing the key insight about evolving strategic emphasis. Contextual relevance is high because the answer addresses the right documents, companies, and product lines, but the failure to detect tonal and strategic evolution limits its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 419,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Schwab’s U.S. state and municipal securities holdings fell from **$638 million at year‑end 2022** to **$579 million at year‑end 2023** and remained at **$579 million in 2024**. Throughout this period the firm repeatedly stressed that “substantially all securities in the investment portfolios were rated investment‑grade,” underscoring a conservative, credit‑quality‑focused fixed‑income strategy that prioritizes capital preservation and stable income over higher‑yield, riskier assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Schwab disclosed a $638 million investment in U.S. State and Municipal Securities in 2023, not 2022. The LLM incorrectly states that the amount was $638 million in 2022 and declined to $579 million in 2023 and 2024, which contradicts the original answer—there is no mention of $579 million in the ground truth, nor any indication of a decline. The original answer does not provide a 2024 dollar figure, only that the investment-grade emphasis continued. (2) The quantitative inaccuracies are severe: the LLM fabricates numbers for 2023 and 2024 and misplaces the $638 million figure in time. There is no support for a drop to $579 million or stability at that level. Calculations or trends inferred (a decline) are unsupported. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies the emphasis on investment-grade quality across years—a point supported by the original answer—the synthesis of quantitative trends is incorrect. It fails to accurately link the disclosed $638 million to 2023 and instead invents a time series not present in the source. (4) Despite the factual errors, the LLM captures the qualitative theme of a conservative, credit-quality-focused strategy, which aligns with the original answer’s interpretation. This saves it from a score of 0, but the numerical inaccuracies severely undermine the correctness. Contextual relevance is fair because the answer addresses both parts of the question—evolution of holdings and strategy—though based on false data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 439,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s maximum potential exposure to commercial‑aerospace customer financing guarantees fell from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024【page 100】【page 104】.  The portion of those guarantees carried by collaboration partners declined from $140 million in 2022 to $135 million in 2023 and to $131 million in 2024【page 100】【page 104】, indicating a gradual shift toward retaining more risk internally and a more conservative risk‑transfer strategy in this domain.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the collaboration partners' share of RTX's commercial aerospace customer financing guarantees as $140M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. These numbers are cited with correct years and consistent trend of decline. The LLM also correctly interprets the trend as indicating a shift toward internal risk retention and a more conservative risk-transfer strategy, which aligns with the ground truth's conclusion about reduced reliance on third-party risk sharing. (2) All numeric values are accurate and properly formatted; the additional data point about total maximum potential exposure ($304M → $288M → $274M) is not in the ground truth but does not contradict it and appears to be correctly sourced from the filings (pages 100 and 104 referenced). Since the question specifically asks about the collaboration partners' share, this extra context is supplementary and not required. (3) The multi-hop reasoning is sound: the model connects the declining partner share over three years to a strategic shift in risk management, which is a valid inference supported by the data. However, the LLM omits the key point in the ground truth that the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating conservative valuation. This missing element weakens the completeness of the risk assessment and shows a gap in full synthesis. (4) Despite this omission, the answer is factually correct, contextually relevant, and well-supported. The scores reflect high accuracy with a minor deduction in qualitative accuracy due to incomplete coverage of RTX’s conservative valuation approach, which is an important nuance in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 479,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "In the 2023 10‑K (page 12), Frame.io is described as a cloud‑native collaboration platform that supports video, still images, design files and PDFs and is tightly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, enabling frame‑accurate comments and real‑time review within those apps. By the 2024 filing (page 12), Adobe expanded Frame.io’s role, adding integration with Adobe GenStudio, camera‑to‑cloud uploads from both video and still‑image cameras, and positioning it as a scalable, end‑to‑end production hub that supports shooting, review, approval and marketing workflows at scale. Compared to earlier filings, where Frame.io supported fewer file types and fewer app integrations, the platform has evolved into a central, cloud‑native engine that streamlines the entire content‑production lifecycle. (page_12)",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Frame.io's integration and role within Adobe's ecosystem but contains key factual inaccuracies that affect correctness. (1) Correct elements: The 2023 description aligns with the ground truth—Frame.io is correctly identified as a cloud-native platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs. The expansion of its role into broader workflows by 2024 is also conceptually accurate. (2) Quantitative accuracy: Dates (2023, 2024) are correct, and no numerical values are misstated. However, the LLM incorrectly states that Photoshop, Lightroom, and Workfront integrations were already present in the 2023 filing, while the ground truth indicates these were added by 2024. This misplacement of integration timing undermines factual precision. (3) The LLM introduces 'Adobe GenStudio' as a new 2024 integration, which is not mentioned in the ground truth and appears to be fabricated or confused with another product—this is a significant error. Additionally, 'camera-to-cloud uploads from still-image cameras' is an overstatement; the ground truth specifies Camera-to-Cloud functionality for video production, not still cameras. (4) Multi-hop reasoning is partially sound—there is an attempt to show progression from 2022 to 2024—but the synthesis is flawed due to incorrect attribution of integrations and unsupported claims. Despite these issues, the answer remains contextually relevant and conveys the high-level trend of deepening integration and workflow expansion. Minor wording differences are acceptable, but the introduction of non-existent features and misattribution of integration timelines reduce the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 469,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin’s VH‑92A production focus rose in 2023, helping lift RMS net sales from $16.1 billion in 2022 to $16.2 billion in 2023, before falling again in 2024 when volume on the VH‑92A was lower than the prior year [page_41]. This ebb and flow shows that the VH‑92A remains a strategically important Marine‑Corps transport platform, but its production emphasis is shifted to balance competing helicopter and IWSS priorities within the Rotary and Mission Systems segment [page_41, page_50].",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the VH-92A was consistently mentioned as part of RMS's major programs from 2022 to 2024, indicating stable, ongoing production. However, the LLM claims production 'rose in 2023' and then 'fell again in 2024' with lower volume, which is not supported by the original answer and introduces unsupported trends. (2) The quantitative claims are incorrect: the LLM cites RMS net sales increasing from $16.1B to $16.2B due to VH-92A production, but the original answer does not mention these figures or attribute sales changes to the VH-92A. There is no evidence in the ground truth that VH-92A drove RMS sales fluctuations, nor that its production volume decreased in 2024. These numbers and causal relationships are fabricated or misattributed. (3) The multi-hop reasoning is flawed. The original answer synthesizes consistent program mentions across years to infer strategic continuity. The LLM instead infers production volume changes and financial impact without evidence, failing to correctly interpret the significance of sustained program inclusion. It also incorrectly references 'Marine-Corps transport platform' and 'IWSS priorities' (not mentioned in ground truth), introducing irrelevant or incorrect context. (4) While the LLM attempts to address the evolution and strategic importance, its core claims about production fluctuations and financial impact are unsupported, leading to a low correctness score. The answer is contextually relevant in structure but factually divergent, hence moderate contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 445,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "From 2022 to 2024 MDLZ’s 10‑K disclosures show a clear expansion of geographic scope and tightening of sales‑and‑media marketing restrictions. The 2022 filing (page 17) did not detail such restrictions, whereas the 2023 filing (page 11) noted that limits on promotions of products with specified nutrient profiles were applied in many jurisdictions, including the EU where over 25 member states had adopted extended producer responsibility (EPR) policies and packaging‑waste directives. By 2024 (page 11) the company added that the EU had adopted its Packaging and Packaging Waste Directive and that single‑use plastic bans and plastic taxes were being considered in Europe and Southeast Asia, indicating a further increase in regulatory stringency, particularly in emerging markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of geographic scope and regulatory stringency from 2022 to 2024, with accurate references to the EU, emerging markets, EPR policies, and the Packaging and Packaging Waste Directive. Quantitatively, the mention of 'over 25 EU member states' having adopted EPR policies in 2023 aligns with the ground truth. The progression of regulatory developments across years is logically presented. However, the LLM incorrectly states that the 2022 10-K 'did not detail such restrictions,' which contradicts the ground truth indicating that in 2022, over 25 EU countries already had EPR policies and plastic-related measures were under consideration in Europe and Southeast Asia. This omission of 2022 regulatory activity slightly undermines the accuracy of the timeline. Additionally, the LLM answer omits mention of India, Vietnam, and U.S. states contemplating EPR policies in 2023, which is a relevant expansion into emerging and other markets. While the 2024 developments are correctly noted (EU adoption of the directive and continued consideration of plastic bans/taxes in Southeast Asia), the answer underrepresents the global spread beyond the EU and Southeast Asia. The reasoning is sound and multi-hop synthesis is mostly accurate, connecting regulatory changes across years and regions. Wording differences are acceptable under semantic equivalence, but the missing detail about India and Vietnam reduces completeness. Contextual relevance is strong as the response directly addresses the evolution in scope and stringency over time in the specified regions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 442,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s 3.700% Notes due 2046 were disclosed as part of the Eleventh Supplemental Indenture in the 2022 and 2023 10‑Ks (page 105) and the same indenture appears unchanged in the 2024 10‑K (page 105). The notes have not been repurchased, restructured, or otherwise altered across the three filings. This consistency indicates a long‑term debt strategy that favors stable, moderate‑rate financing and a diversified maturity profile rather than frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities are correct: Microsoft, 3.700% Notes due 2046, Eleventh Supplemental Indenture, and the years 2022–2024 are properly identified. The reference to page 105 in each 10-K is consistent with the source data. (2) Quantitative accuracy is perfect: the interest rate (3.700%), maturity year (2046), and dates of the indenture (implied via reference to the 2016 agreement) are correct. There are no calculation errors. (3) The multi-hop reasoning is sound—by observing no changes across three years of filings, the model correctly infers a stable long-term debt strategy. The conclusion about favoring stable, moderate-rate financing and a diversified maturity profile is logically supported. (4) While the LLM answer captures the core strategic implication, it slightly underemphasizes the explicit connection to Microsoft’s confidence in long-term cash flows and fixed-cost predictability, which is highlighted in the original answer. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer fully addresses both parts of the question: evolution (no change) and strategic implication (stability preference). Minor omission of the 'predictable debt servicing' nuance prevents a perfect 10, but the response is otherwise excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 382,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings, Microsoft did not issue a 2.000% note due 2023; the supplemental indentures listed in each filing (pages 104–105) contain 2.375% Notes due 2023 (Sixth Supplemental Indenture) and 3.625% Notes due 2023 (Eighth Supplemental Indenture) but no 2.000% Notes due 2023. Consequently, the debt‑maturity profile for 2023 remained unchanged, with the company continuing to rely on the 2.375% and 3.625% notes while the 2.000% Notes due 2020 stayed on the books, illustrating a stable maturity structure across the three periods.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) It falsely claims that Microsoft did not issue 2.000% Notes due 2023, directly contradicting the ground truth, which confirms these notes were consistently referenced in the 2022, 2023, and 2024 10-K filings in Exhibit 4.14 under the Eleventh Supplemental Indenture. The LLM incorrectly states that only 2.375% and 3.625% Notes due 2023 existed, which is unsupported by the ground truth. (2) The quantitative inaccuracies are severe: the LLM invents non-existent notes (e.g., 2.375% and 3.625% due 2023) and references a '2.000% Notes due 2020' that is not mentioned in the original answer or implied context, introducing fabricated data. (3) The multi-hop reasoning fails completely: instead of tracing the evolution of the 2.000% Notes due 2023 across the three filings and analyzing their presence in Supplemental Indentures, the LLM denies their existence, missing the core analytical task. (4) Contextual relevance is low because the answer does not address the actual progression of the specified notes or their role in Microsoft’s debt maturity structure. The conclusion about a 'stable maturity structure' is based on false premises. Overall, the answer reflects a failure to retrieve or interpret the correct data, resulting in a nearly entirely fabricated response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 376,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Across Medtronic’s 2022, 2023 and 2024 Form 10‑K filings, the Non‑Employee Restricted Stock Unit Award Agreements all continued to be governed by the **Amended and Restated 2013 Stock Award and Incentive Plan** (see *10.42 in each filing).  The agreements were re‑issued each year but the underlying plan did not change.  In the 2024 filing, Medtronic added new Restricted Stock Unit Award Agreements for employees under the 2021 Medtronic plc Long‑Term Incentive Plan (see *10.81 and *10.82), but the non‑employee RSU agreements remained tied to the 2013 plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Medtronic's Non-Employee Restricted Stock Unit Award Agreements across 2022, 2023, and 2024 were consistently governed by the Amended and Restated 2013 Stock Award and Incentive Plan, which matches the original answer. The reference to Exhibit *10.42 in each filing is slightly off—the ground truth cites Exhibit 10.45 in the 2022 filing—but this is a minor discrepancy in exhibit numbering and does not affect the core factual accuracy. The LLM correctly notes the continuity in the underlying plan and form agreement, and appropriately highlights that in 2024, new employee RSU agreements were introduced under the 2021 plan, which adds context without conflating non-employee and employee arrangements. This additional detail is accurate and enhances the response. Quantitative accuracy is perfect: no numerical or date errors. The reasoning is sound, demonstrating correct multi-hop synthesis across three years of filings and distinguishing between employee and non-employee plans. The answer is semantically equivalent to the ground truth, with only slight variation in emphasis. One point was deducted from qualitative accuracy due to the exhibit number inconsistency, but overall the response is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 367,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension plans allocated **17 %** of plan assets to buy‑in annuity contracts in 2022, **16 %** in 2023, and returned to **17 %** in 2024 (page 104 shows 17 %/16 % for 2024/2023; page 105 shows 17 % for 2022). The allocation has remained essentially flat, with only a modest dip in 2023, indicating that the company consistently uses buy‑in annuity contracts as a core tool to hedge international pension liabilities and keep funded‑status risk predictable.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024, with the company shifting to fair value estimation methods. However, the LLM claims the allocation returned to 17% in 2024, which directly contradicts the ground truth. This error fundamentally misrepresents the trend. (2) Quantitatively, the 2022 (17%) and 2023 (16%) figures are correct, but the 2024 figure is wrong—the ground truth states the practice was discontinued, not that it rebounded to 17%. The LLM incorrectly cites pages 104 and 105 as sources, but even if those pages were accurate, the interpretation is flawed. (3) The multi-hop reasoning fails: the LLM does not recognize the strategic shift away from annuities toward fair value estimation, which is central to the question. Instead, it concludes that annuities remain a 'core tool,' which is the opposite of the actual strategy. (4) Contextual relevance is moderate because the answer addresses the right topic (annuity allocations in non-U.S. pension plans) and time frame, but the incorrect data and conclusion severely undermine its usefulness. The reasoning and synthesis are unsound, leading to a misleading interpretation of MDLZ's liability management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 381,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft issued 2.000% Notes due 2023 under the Eleventh Supplemental Indenture (4.14) in 2016【page_105】.  The notes were outstanding in FY 2022, matured in FY 2023, and were fully repaid by FY 2024, as reflected in the debt schedule.  This pattern shows Microsoft’s disciplined debt‑maturity strategy—maintaining a mix of short‑ and long‑term debt to keep borrowing costs low while ensuring liquidity.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth, particularly regarding the maturity and repayment of the 2.000% Notes. According to the original answer, the notes were still disclosed in all three fiscal years (2022, 2023, and 2024) and remained on Microsoft's books through the 2024 reporting period, indicating they were not retired or repaid by FY2024. However, the LLM claims the notes 'matured in FY 2023' and were 'fully repaid by FY 2024', which is incorrect based on the consistent disclosure in Exhibit 4.14 across all three reports. This misrepresents a key fact about the debt's status and undermines the conclusion about Microsoft's strategy. While the LLM correctly identifies the issuance under the Eleventh Supplemental Indenture in 2016 and references the correct exhibit, the core timeline and status of the debt are wrong. The reasoning about a 'disciplined debt-maturity strategy' is plausible but based on incorrect premises. The answer is contextually relevant and addresses the question's intent, but the factual inaccuracies—especially the false claim of repayment—severely reduce correctness. Quantitative accuracy is low due to incorrect treatment of maturity and repayment dates. Qualitative accuracy suffers from flawed multi-hop reasoning: instead of recognizing consistent disclosure as evidence of ongoing liability, the model assumes maturity implies repayment, failing to synthesize the actual reporting pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 406,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "In each of Microsoft’s 2022, 2023, and 2024 10‑K filings the 4.000% Notes due 2021 are disclosed as part of the **Third Supplemental Indenture (Exhibit 4.6)**, and the indenture’s terms and the notes’ classification as long‑term debt remain unchanged.  The 2023 filing added a new Fifteenth Supplemental Indenture (Exhibit 4.18), and the 2024 filing added an additional Indenture for Activision (Exhibit 4.19), but neither of these new indentures affected the 4.000% Notes due 2021, which stayed within the same supplemental indenture series across all three periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core information from the ground truth. (1) All entities—Microsoft, the 4.000% Notes due 2021, the Third Supplemental Indenture, Exhibit 4.6, and the relevant years (2022–2024)—are correctly identified. The treatment of the notes remaining under the same supplemental indenture across all years is accurately stated. (2) Quantitative elements—interest rate (4.000%), maturity year (2021), exhibit number (4.6), and the mention of new indentures in 2023 (Fifteenth, Exhibit 4.18) and 2024 (Activision, Exhibit 4.19)—are all correct. No calculations are required, and all dates/percentages match the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers that despite new indentures being added in later years, they did not affect the classification or treatment of the 2021 notes, which remained consistent. (4) The only minor omission is that the ground truth mentions other notes (e.g., 2.500% due 2016, 5.300% due 2041) grouped with the 4.000% Notes in Exhibit 4.6, and notes about new debt instruments like the 2.125% Notes due 2022 (in 2022) and 2.375% Notes due 2023 (in 2023), which provide additional context on Microsoft’s broader debt structure. While not critical to the main point, their absence slightly reduces completeness. However, the LLM answer still captures the essential evolution (or lack thereof) in treatment of the 2021 notes. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 410,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s 10‑K notes for FY 2022, 2023 and 2024 all state that no Euro Deferred Shares were issued or outstanding (April 29 2022; April 28 2023; April 26 2024).  The consistent absence of activity in this line item shows the company has not yet exercised its 40 000‑share authorization, indicating a capital‑structure strategy that relies on ordinary and preferred shares (and other instruments) rather than on deferred‑currency equity, thereby avoiding the additional complexity and currency exposure that Euro Deferred Shares would introduce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that no Euro Deferred Shares were issued or outstanding in fiscal years 2022, 2023, and 2024, and accurately notes the authorized capacity of 40,000 shares with €1.00 par value (implied through context of authorization without issuance). The fiscal year-end dates (April 29, 2022; April 28, 2023; April 26, 2024) align with Medtronic’s reported fiscal year-ends and are factually correct. (2) All numeric and date-related information is accurate. The absence of issuance and outstanding balances is correctly reported across all three years. The authorized share count (40,000) is consistent with ground truth, though not explicitly restated in the LLM answer, it is contextually acknowledged via '40 000-share authorization'. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three fiscal years and draws a logical inference about capital structure strategy—namely, that Medtronic relies on other equity instruments (ordinary and preferred shares) and avoids Euro Deferred Shares, likely due to complexity or currency exposure. This aligns with the ground truth’s interpretation of strategic preference or lack of market demand. (4) The LLM answer is semantically equivalent to the original answer, with slightly different phrasing but identical core meaning. The only minor omission is not explicitly stating the par value (€1.00), though this detail is less critical to the strategic interpretation. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 432,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Microsoft consistently disclosed the 4.000 % Notes due 2021 as part of Exhibit 4.6 (the third supplemental indenture dated February 8, 2011) in each of its 2022, 2023, and 2024 10‑K filings【page 104】. The unchanged disclosure indicates that the company treats the notes as a stable, long‑term liability and has made no material changes to their terms or status over this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in both quantitative and qualitative aspects. (1) Quantitatively, all key facts are accurate: the 4.000% Notes due 2021, Exhibit 4.6, the Third Supplemental Indenture, and the date February 8, 2011, are correctly cited across the 2022–2024 filings. No numeric or date inaccuracies are present. (2) The answer correctly observes that the disclosure was unchanged across the three years, which aligns with the ground truth. (3) However, the reasoning contains a minor inaccuracy: the ground truth states the Notes were 'matured or fully accounted for,' implying they are no longer active liabilities, whereas the LLM describes them as a 'stable, long-term liability,' which is misleading—long-term liabilities typically refer to obligations not yet due, but these notes matured in 2021. This mischaracterization affects the qualitative accuracy, as it misrepresents the nature of the debt post-maturity. (4) Despite this, the answer is contextually relevant and captures the consistency of disclosure. The core multi-hop synthesis—tracking the same exhibit and indenture across multiple years—is sound. The conclusion about no material changes is correct, but the interpretation of what that implies is slightly off. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 359,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin has not disclosed any new pension‑risk‑transfer transactions in 2022, 2023 or 2024, and the cumulative amount of defined‑benefit obligations transferred via group annuity contracts (GACs) remains at roughly $11.6 billion since 2018 【page 60】.  The company’s 2024 filing notes only cash contributions and CAS pension recoveries, with no additional GAC purchases reported 【page 49】, and its 2023 discussion reiterates that it continues to evaluate such transactions but has not increased the size of recent transfers 【page 21】.  This pattern signals a steady, risk‑transfer‑focused long‑term liability strategy that prioritizes volatility reduction over rapid acceleration of pension obligation transfers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the $11.6 billion cumulative pension obligation transferred since 2018 is correctly reported, consistent with the original answer. It accurately reflects that no new transfers were disclosed in 2022–2024, and correctly cites ongoing evaluation in 2023 and absence of new GAC purchases in 2024. These details align with the ground truth, which also notes the $11.6 billion figure as of 2022 and emphasizes continued strategic interest without reporting new transaction amounts in 2023 or 2024. The reasoning about a 'steady, risk-transfer-focused long-term liability strategy' is logically sound and semantically equivalent to the original answer’s conclusion of a 'deliberate, multi-year liability management approach.' The only minor shortcoming is that the LLM slightly underemphasizes the forward-looking commitment expressed in the 2024 filing—while it notes no new transfers occurred, the original answer highlights that Lockheed Martin 'reaffirmed its intent to pursue additional' transactions, which the LLM could have more explicitly acknowledged. However, the reference to 'continues to evaluate' and 'steady... strategy' captures the essence. All entities (Lockheed Martin, pension obligations, GACs, years) are correct, and the multi-hop synthesis across 2022–2024 filings is appropriate. Wording differs but meaning is substantively aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 392,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "In the 2022 10‑K (page 136) the 0.125% Notes due 2029 were disclosed as “incorporated by reference to Exhibit 4.4 of the Company’s 8‑K filed on September 18 2020.” The 2023 10‑K (page 132) retained that same reference, while the 2024 10‑K (page 130) updated the reference to the 8‑K filed on March 9 2021, indicating an amendment or re‑issuance. This evolution shows Coca‑Cola consistently uses the same naming convention and referencing approach for its debt instruments, with only minor updates to reflect amendments, underscoring a stable and consistent debt‑instrument structure over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error regarding the evolution of the disclosure. The ground truth states that the same Exhibit 4.4 from both the September 2020 and March 2021 Form 8-K filings was consistently referenced across all three years (2022, 2023, 2024), with no change in source references. However, the LLM claims that the 2024 10-K 'updated the reference' to the March 9, 2021 filing, implying a change or amendment, which contradicts the ground truth of consistent dual referencing across years. This misrepresents the core factual development over time. (2) The dates mentioned (September 18, 2020, and March 9, 2021) are factually plausible and align with known filings, but the assertion that the 2024 reference was 'updated' is incorrect — the ground truth confirms no change in referencing pattern. The exhibit numbers (4.23 and 4.31) and their repetition across years are omitted in the LLM answer, reducing completeness. (3) The multi-hop reasoning is partially sound — the model correctly identifies the need to compare disclosures across years and interprets referencing patterns as indicative of structural consistency. However, it fails to recognize that the dual sourcing (both 2020 and 2021 8-Ks) was consistently maintained, not updated, leading to an incorrect conclusion about an 'amendment or re-issuance.' This undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the question’s focus on disclosure evolution and consistency of debt structuring. Despite this, the factual inaccuracy about a supposed update in 2024 significantly reduces correctness. The conclusion about stable structure is aligned with the ground truth, but it is based on flawed premises, limiting its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 484,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s carrying amount of liabilities for performance and operating‑cost guarantees fell from **$1,109 million at December 31 2022** to **$1,091 million at December 31 2023** and further to **$993 million at December 31 2024** (Note 16, page 100). The decline—driven by higher settlements than new guarantees issued—shows a net reduction of $116 million over two years, indicating the company is gradually trimming its exposure to long‑term product‑performance risks in its commercial aerospace business, although the liability remains sizable.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, RTX's liabilities related to performance and operating cost guarantees are discussed in terms of the collaboration partners' share of financing guarantees, which were $141M (2022), $135M (2023), and $131M (2024). However, the LLM reports total carrying amounts of $1,109M, $1,091M, and $993M for 2022–2024, which do not match the ground truth data. These figures appear to be either from a different liability category or misattributed entirely. (2) The calculation of a $116M net reduction is based on incorrect numbers and therefore invalid. The actual trend in the ground truth shows a much smaller decline of $10M over the same period ($141M → $131M), and this specifically refers to the partners' share, not RTX’s total liability. (3) The reasoning and multi-hop synthesis are flawed. The LLM incorrectly interprets the liability amount and draws an unsupported conclusion that RTX is 'gradually trimming its exposure,' while the ground truth indicates stability and managed ongoing exposure through consistent estimation methodology. The LLM also fails to mention the key nuance that RTX’s own liabilities are not explicitly stated, which is a critical limitation noted in the original answer. (4) While the LLM addresses the question’s structure—discussing evolution over time and interpreting risk exposure—the factual inaccuracies in numbers, entities, and logic severely undermine correctness. The contextual relevance is moderate because it attempts the right analysis but on a false foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 444,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic’s Black‑Scholes assumptions for non‑qualified options have become more conservative: volatility rose from 23.04 % in 2022 to 24.29 % in 2024, the risk‑free rate climbed from 0.90 % to 4.16 %, dividend yield increased from 1.95 % to 3.18 %, and the expected life lengthened from 6.0 to 6.1 years (page 82). Consequently, the weighted‑average fair value of options granted fell from $22.83 million in 2022 to $17.76 million in 2023 and then edged up to $18.49 million in 2024, reflecting a shift toward higher market‑volatility and risk‑free rate assumptions and a more cautious equity‑compensation risk model (page 82).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that Medtronic consistently used the Black-Scholes model and evolved its disclosure around expected volatility—specifically clarifying in 2023 that implied volatility was derived from market-traded options. However, the LLM answer fabricates specific numerical values (e.g., volatility rising from 23.04% to 24.29%, risk-free rate from 0.90% to 4.16%, dividend yield from 1.95% to 3.18%, expected life from 6.0 to 6.1 years) and claims a change in fair value from $22.83 million to $17.76 million to $18.49 million, none of which are supported by the original answer or implied in the context. These numbers are entirely absent from the ground truth, indicating hallucination. (2) There are no verifiable calculations in the original answer to validate the LLM’s figures, and the dollar amounts for fair value are presented as if from a specific page (page 82), which is not referenced or confirmed in the ground truth. The original answer does not mention any changes in risk-free rate, dividend yield, expected life, or fair value of options—so these metrics are extraneous and incorrect. (3) The multi-hop reasoning is flawed: the question asks about the evolution in valuation *approach* and what it suggests about assumptions on volatility and risk modeling. The correct answer focuses on disclosure refinement and increased transparency in how implied volatility is sourced. The LLM instead shifts focus to fabricated numerical changes and incorrectly infers a 'more conservative' or 'cautious' model based on these false inputs. It fails to identify the actual evolution in disclosure practice. (4) While the LLM correctly identifies the use of the Black-Scholes model, it invents a narrative around changing assumptions and financial impacts that are not present in the ground truth. The contextual relevance is moderate because it addresses equity compensation risk modeling, but the factual foundation is unsound, leading to a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 560,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 2022 10‑K (page 136) lists the 1.000% notes due 2028; the 2023 10‑K (page 134) likewise references the same instrument; and the 2024 10‑K (page 130) again cites the 1.000% notes due 2028. The repeated issuance across these years signals a deliberate, stable use of a low‑interest, long‑term debt tool—likely to refinance existing debt or fund capital projects while keeping the maturity profile steady.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent presence of the 1.000% Notes due 2028 in The Coca-Cola Company's 10-K filings across 2022, 2023, and 2024, with accurate page references and interest rate, which matches the ground truth on quantitative and entity accuracy. All years, percentages, and instrument details are correct. (2) Quantitative accuracy is perfect: the 1.000% interest rate, 2028 maturity, and inclusion in all three years are factually sound and properly cited. (3) However, the LLM answer fails to incorporate a key element of the ground truth: the strategic shift in 2024 toward issuing higher-yielding debt (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054). This omission significantly weakens the qualitative reasoning and multi-hop synthesis required to fully address the question about the company's debt strategy evolution. The LLM concludes that the repeated reference indicates 'repeated issuance,' but the ground truth clarifies that the 1.000% Notes were maintained in disclosures, not necessarily reissued, and that the broader strategy shifted toward higher-cost debt in 2024. (4) While the answer is factually correct on the specific instrument and highly relevant, it misses the strategic contrast in 2024, leading to a partially correct interpretation of the debt strategy. Hence, correctness and qualitative accuracy are reduced, though quantitative accuracy remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 396,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "Microsoft has kept the Bank of New York Mellon Trust Company, N.A. as the trustee for all of its 2.125 % notes. In the 2022 filing the 2.125 % notes due 2022 were issued under the Fourth Supplemental Indenture (Exhibit 4.7) together with 0.875 % notes due 2017 and 3.500 % notes due 2042. In 2023 the company moved the 2.125 % notes due 2023 to the Fifteenth Supplemental Indenture (Exhibit 4.18) – the same trustee but a new indenture – and by 2024 the filing again referenced the Fifteenth Supplemental Indenture for the 2.125 % notes due 2024, while also noting that these notes were part of a broader debt program that included 3.125 % notes due 2028, indicating a consistent trustee arrangement but an expanding debt portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The Original Answer states that the 2.125% Notes were due in 2021, not 2022, 2023, or 2024 as claimed by the LLM—this is a critical error in dates and maturities. (2) The LLM incorrectly claims that in 2022 the notes were issued under the 'Fourth Supplemental Indenture (Exhibit 4.7)' alongside 0.875% notes due 2017 and 3.500% notes due 2042; the ground truth specifies the 'Seventh Supplemental Indenture' and associates the 2.125% Notes with 3.125% Notes due 2028, not the instruments listed by the LLM. (3) The LLM asserts a structural change in 2023 with a move to the 'Fifteenth Supplemental Indenture', but the ground truth explicitly states there was no change in structure or trustee arrangement across 2022–2024. (4) The trustee is correctly identified as The Bank of New York Mellon Trust Company, N.A., which is consistent with the ground truth. (5) The LLM fabricates an evolving indenture structure and expanding debt portfolio, while the original answer emphasizes stability and repetition of the same exhibit and trustee relationship. Thus, while the trustee name is correct and the general topic is addressed (contextual relevance is moderate), the quantitative details (dates, note percentages, exhibit numbers, indenture numbers) are largely incorrect, and the reasoning falsely infers evolution where the ground truth reports consistency. This represents a failure in multi-hop synthesis and factual grounding, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 425,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program share interest in IAE stayed at 57 % and in IAE LLC at 51 % from 2022 through 2024 (see the variable‑interest‑entity note on page 112 of the 2022 10‑K and page 102 of the 2024 10‑K).  The unchanged, majority‑stake positions confirm RTX’s continued role as the primary beneficiary of the V2500 and PW1100G‑JM engine programs, underscoring its strategic focus and ensuring a substantial share of the programs’ economics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect regarding the quantitative evolution of Pratt & Whitney's net program share interest. According to the ground truth, in 2022, the net program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51% as claimed. The decrease to 57% (IAE) and 51% (IAE LLC) occurred in 2023, not before or during 2022. The LLM incorrectly states that the shares remained unchanged from 2022 through 2024, which contradicts the documented decline in 2023. (2) The cited percentages are wrong for 2022, and the timeline of the change is misrepresented. While the 2023 and 2024 figures (57% and 51%) are accurate, the claim of stability from 2022 onward is false. The LLM also references specific 10-K pages, but these are not verifiable here and do not excuse the factual inaccuracy. (3) The multi-hop reasoning is flawed because the model fails to recognize the change between 2022 and 2023, which is central to the question about evolution. It incorrectly assumes stability, undermining the synthesis across years. (4) Despite the incorrect numbers and timeline, the answer is contextually relevant—it addresses the right entities (IAE, IAE LLC, V2500, PW1100G-JM) and attempts to interpret strategic implications. However, the conclusion about 'unchanged, majority-stake positions' is invalid due to the inaccurate premise. Thus, while the direction of reasoning (linking share interest to strategic positioning) is sound, the factual foundation is not, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 422,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s contributions to its 401(k) and other defined‑contribution plans rose from **$402 million in 2022 to $468 million in 2023** (Note 7, page 53) and then fell to **$443 million in 2024** (Note 14, page 69). This pattern shows a peak in 2023 followed by a modest decline, indicating that while the company remains heavily invested in employee benefits, it is slightly adjusting contributions—likely for cost‑control or plan‑design reasons—yet maintaining a strong overall commitment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 contribution amount. The ground truth states $299 million, but the LLM reports $402 million, which is materially incorrect. The 2023 ($468 million) and 2024 ($443 million) figures are correct. This error affects the overall quantitative accuracy. (2) Calculations: The increase from 2022 to 2023 and subsequent decrease to 2024 are correctly described in direction, but the magnitude of change is wrong due to the incorrect base year value. The LLM’s use of citation markers (Note 7, page 53; Note 14, page 69) suggests plausible sourcing, but the data itself is inaccurate for 2022. (3) Multi-hop reasoning: The model correctly synthesizes data across three years and identifies the trend—significant increase followed by a modest decline—which aligns with the ground truth’s interpretation. The qualitative assessment of a 'dynamic approach' or 'slight adjustment' is semantically similar and reasonable. (4) Despite the incorrect 2022 figure, the answer addresses all parts of the question: evolution over time and interpretation of spending trajectory. The reasoning is sound and contextually relevant, but the major numerical inaccuracy in a key data point limits correctness. Hence, correctness_score is 6 (partially correct with significant error), quantitative_accuracy is 5 (half credit due to one major number wrong), qualitative_accuracy is 7 (correct trend and interpretation), and contextual_relevance is 9 (fully on-topic and well-structured).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 422,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "Coca‑Cola first issued the 3.000 % Notes due 2051 in a 2021 8‑K filing (see 2022 10‑K, page 136).  The same note is listed unchanged in the 2023 10‑K (page 134) and the 2024 10‑K (page 130), with no new issuances or amendments reported for those years.  This steady presence of the 3.000 % Notes indicates a deliberate, conservative capital‑structure strategy that favors long‑term, moderate‑rate debt and avoids frequent refinancing, thereby maintaining predictable financing costs and a stable maturity profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance of the 3.000% Notes due 2051 via the 2021 Form 8-K, as referenced in the 2022 10-K, and confirms their unchanged presence in the 2023 and 2024 filings. The dates, percentages, and exhibit continuity are factually accurate, satisfying quantitative accuracy. (2) All numeric values—interest rate (3.000%), maturity year (2051), and document types (Form 8-K, 10-K)—are correct. Page numbers cited (136, 134, 130) align with typical disclosure locations and do not contradict the ground truth. (3) However, the LLM answer omits a key element from the original answer: the introduction of new, higher-coupon debt instruments in 2024 (5.000% Notes due 2034 and 5.300% Notes due 2054). This omission limits the completeness of the multi-hop reasoning, as the evolution in capital structure strategy is not fully captured. The original answer emphasizes diversification and strategic adaptation to market rates, while the LLM portrays a static, conservative strategy without acknowledging the new issuances. (4) Despite this, the reasoning is internally sound and contextually relevant—the conclusion about stability and predictable financing costs is supported by the continued disclosure of the 3.000% Notes. The answer is factually correct where it speaks, but incomplete in synthesizing the full progression across years. Hence, correctness and qualitative accuracy are reduced slightly, while quantitative accuracy remains perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 410,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first issued the 2.875% Notes due 2031 in 2021 as part of a six‑note series (Exhibit 4.16 in the 2022 10‑K, page 114).  The 2023 10‑K (Exhibit 4.14, page 111) and the 2024 10‑K (Exhibit 4.14, page 111) simply recited the same notes, with no new issuances or amendments.  This steady presence shows Oracle’s long‑term debt strategy of issuing fixed‑rate, long‑maturity notes to diversify its maturity profile, lock in rates, and keep interest expense predictable.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but also key inaccuracies and omissions that affect its overall correctness. (1) Quantitatively, the LLM correctly identifies the 2.875% Notes due 2031 and references the correct exhibits and pages in the 10-K filings for 2022, 2023, and 2024, which supports its claim of continuity. However, it incorrectly states the issuance occurred in 2021, while the ground truth indicates formal listing in 2022, which is a factual error affecting timeline accuracy. (2) The answer omits critical information from the ground truth: the introduction of newer, higher-yielding notes (4.500% due 2028 and 4.900% due 2033) in the 2024 filing, which is central to understanding Oracle’s evolving debt strategy. This omission undermines the completeness and qualitative accuracy of the response. (3) The reasoning is partially sound—correctly inferring that Oracle uses long-term, fixed-rate notes to manage interest expense—but fails the multi-hop synthesis required to contrast the stable presence of the 2.875% Notes with the strategic addition of costlier debt in later years. The ground truth emphasizes a shift toward diversification with higher-yielding instruments, a nuance entirely missing in the LLM answer. (4) While the LLM answer is contextually relevant and well-structured, it presents an incomplete and slightly misleading picture of Oracle’s debt strategy by ignoring the strategic evolution in 2024. Thus, the correctness score is reduced to 6 due to significant omissions and one key factual error in timing, despite accurate referencing and partial reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 439,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the same “Eleventh Supplemental Indenture” (Exhibit 4.14) that includes 2.000 % Notes due 2023【page_105】【page_104】.  By repeating this disclosure in every annual report, Microsoft signals that it keeps a predictable, long‑term debt schedule and is committed to fully informing investors of its obligations.  The consistency underscores a disciplined debt‑management policy and a transparent reporting strategy that reassures stakeholders about the company’s financial stewardship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 2.000% Notes due 2023, the Eleventh Supplemental Indenture, and their consistent disclosure across 2022, 2023, and 2024 10-K filings are accurately reported. The interest rate (2.000%) and maturity year (2023) match the original answer. (2) Quantitative accuracy is perfect—no calculations were required, but the cited percentages and years are correct. (3) The reasoning is sound: the LLM correctly infers that repeated disclosure reflects a predictable debt schedule, disciplined management, and transparency, which supports investor confidence—this mirrors the multi-hop synthesis in the ground truth. (4) The only minor omission is that the LLM does not explicitly mention the August 8, 2016 indenture date or the unaltered nature of the filing details (e.g., trustee, exact structure) over the three years, which slightly reduces completeness in qualitative depth. However, the core message about transparency and consistent liability management is preserved. Wording differs but semantic equivalence is strong. Contextual relevance is excellent as it directly addresses Microsoft's debt management and transparency strategy as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 348,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s contingent flight‑hour payments to Rolls‑Royce rose from **$735 million in 2022 to $1.053 billion in 2023, then fell to $765 million in 2024**—the amounts reflected in the “Other commercial aerospace commitments” line of the 2021‑commitments table (page 112).  These payments, which are triggered by each hour flown on V2500‑powered aircraft through June 2027, are capitalized as collaboration intangible assets and amortized to cost of sales (page 73).  The pattern shows that RTX’s long‑term exposure to Rolls‑Royce remains material but is gradually being realized as the aircraft fly, with the obligation expected to be fully paid by the 2027 cutoff.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in the quantitative figures. The ground truth does not specify any dollar amounts for RTX's contingent payments in 2022, 2023, or 2024—yet the LLM asserts specific numbers: $735M in 2022, $1.053B in 2023, and $765M in 2024. These figures are entirely fabricated and not present in the original answer or implied by it. There is no mention of actual payment amounts in the ground truth; instead, the focus is on accounting treatment and timing of obligations. (2) The dates are partially correct—the June 2027 cutoff for flight-hour payments is accurately mentioned, which aligns with the ground truth. However, the claim that these amounts appear in a '2021-commitments table (page 112)' introduces fabricated document metadata not present in the original. (3) The qualitative reasoning about accounting treatment (capitalization as collaboration intangible assets and amortization to cost of sales) is partially correct and improves from 2022 to 2023 in the actual timeline, which the LLM captures in simplified form. However, it fails to reflect the evolution across years—specifically, the shift in disclosure clarity between 2022 and 2023—and instead presents a static view. The conclusion about long-term exposure being 'material but gradually realized' is plausible but not directly supported by the ground truth, which emphasizes stability and ongoing recognition rather than fluctuating payment volumes. (4) Contextually, the LLM addresses the right entities (RTX, Rolls-Royce, V2500-powered aircraft, IAE 2012 agreement) and the correct time horizon (through 2027), so the framing is relevant. However, the inclusion of false numerical data and document references severely undermines factual reliability. The multi-hop synthesis is superficial—while it connects payments to flight hours and accounting treatment, it invents financial data rather than acknowledging absence of specific figures in the source. This constitutes a critical failure in factual correctness, warranting a low correctness score despite some structurally relevant elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 573,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "From 2022 to 2024 the share of domestic pension‑plan assets invested in U.S. equity funds rose from roughly 9.5 % ($89 m of $937 m) in 2022 to about 10.2 % ($91 m of $895 m) in 2024 (see page 57 for 2022/2023 and page 71 for 2024). This modest, steady uptick—about 0.7 percentage points over three years—shows that TMO is gradually increasing its domestic‑equity exposure while staying near its stated target allocation of ~10 % to U.S. equities, indicating a deliberate, incremental tilt toward domestic equities within a balanced, liability‑hedged portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that TMO's allocation to U.S. equity funds decreased from $125M in 2022 to $89M in 2023, then slightly increased to $93M in 2024. The LLM claims the amount rose from $89M in 2022 to $91M in 2024, which misrepresents both the starting value and the trend. The LLM also introduces percentages (9.5% to 10.2%) not present in the original answer and unsupported by the ground truth, which only provides absolute dollar amounts. (2) The dollar figures are incorrect: LLM reports $89M in 2022, but ground truth is $125M; LLM reports $91M in 2024, but ground truth is $93M. While $93M and $91M are close, the 2022 figure is significantly off. More critically, the LLM reverses the trend—ground truth shows a sharp drop then slight recovery, while LLM describes a steady increase. Calculations based on total plan assets are not verifiable from the ground truth and introduce unsupported context. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the three-year trajectory (decrease then partial rebound) and instead infers a continuous increase, leading to an incorrect conclusion about strategy. The synthesis across years is invalid due to incorrect data. (4) The contextual relevance is moderate because the answer addresses the right topic (TMO's domestic pension allocation to U.S. equities) and attempts to interpret strategic intent, but the reasoning is based on fabricated or misread data. Due to major factual and directional errors, the correctness score is low despite some proximity in 2024 figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 451,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "In its 2022 10‑K, Coca‑Cola listed 1.000% Notes due 2041 as part of its long‑term debt mix (page 136). By the 2024 filing, the company had broadened that mix, issuing a series of higher‑coupon notes—ranging from 3.125% to 5.400%—with maturities from 2032 to 2064 (page 130). This shift reflects a move from a single low‑yield long‑term note to a diversified portfolio of higher‑yielding debt to capture favorable market conditions and manage refinancing risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1.000% Notes due 2041 in 2022 and the introduction of higher-yielding notes in 2024, capturing the core evolution in Coca-Cola's debt strategy. However, it inaccurately states that the higher-coupon notes ranged from 3.125% to 5.400%, while the ground truth specifies exact new issues: 5.000% due 2034, 5.300% due 2054, and 5.400% due 2064. The 3.125% figure is not mentioned in the original answer and appears to be an error or misattribution. Additionally, the LLM omits specific references to the lower-yielding instruments in 2022 (0.400% due 2030) and 2023 (0.950% due 2036), which are key for showing the contrast and strategic shift. (2) The maturities mentioned (2032–2064) are close but not fully aligned with the ground truth (2034, 2054, 2064); 2032 is not referenced in the original. The percentage range is partially incorrect due to inclusion of 3.125%, which undermines quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from low-yield to higher-yield instruments over time and links it to market conditions and refinancing risk. It synthesizes information across years and recognizes the diversification of the debt portfolio. (4) Despite missing some specific instruments and introducing an incorrect lower bound (3.125%), the overall narrative aligns with the ground truth. The answer is contextually relevant and well-structured, but the quantitative inaccuracies prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 417,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle has kept the 1.650% Notes due 2026 as a core, low‑cost component of its debt mix in FY 2022, FY 2023 and FY 2024, as shown in Exhibit 4.16 of each filing (page 114).  At the same time the company has issued newer notes at higher rates—such as the 5.800% notes due 2025, 6.150% notes due 2029, 6.250% notes due 2032, 6.900% notes due 2052 (Exhibit 4.15, page 114) and the 4.500% notes due 2028, 4.650% notes due 2030, etc. (Exhibit 4.16, page 111)—to diversify maturities and fund specific initiatives.  This strategy reflects Oracle’s preference for anchoring its capital structure with the cheapest long‑term debt while using higher‑rate instruments for flexibility and project‑specific financing.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its reasoning and captures the core of Oracle's debt financing strategy: maintaining low-cost debt (1.650% Notes due 2026) while issuing higher-rate notes for flexibility and funding. However, there are minor quantitative inaccuracies. The original answer specifies that the 1.650% Notes were listed in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024), but the LLM incorrectly states Exhibit 4.16 for all three years. Additionally, the LLM lists several higher-rate notes not mentioned in the ground truth, such as the 6.150% due 2029, 6.250% due 2032, 6.900% due 2052, and 4.650% due 2030, which were not part of the original answer and lack verification from the provided truth. While it correctly identifies the 5.800% Notes due 2025 (2023) and 4.500% Notes due 2028 (2024), the inclusion of unverified additional notes reduces quantitative accuracy. The reasoning and synthesis across years and debt instruments are sound, showing a clear understanding of multi-hop context—Oracle’s strategy of combining cheap, long-term debt with newer, costlier instruments. The answer is contextually relevant and semantically aligned with the original in intent and interpretation, just overstated in specific instrument details. Hence, correctness is high but not perfect due to unsupported additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 369,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s repeated listing of Exhibit 4.6—which contains the 4.000 % Notes due 2021—across the 2022, 2023, and 2024 10‑Ks (see page 104) shows that the company is keeping the same long‑term debt instrument on its books and updating the indenture documentation each year. This consistency signals a deliberate strategy to maintain a stable, diversified maturity profile and preserve flexibility for future refinancing, rather than aggressively repurchasing or restructuring that note.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across 2022, 2023, and 2024, and accurately references the fiscal years and the exhibit number. The percentage (4.000%) and due date (2021) are correct, satisfying quantitative accuracy for these elements. However, the LLM incorrectly implies that the notes were still 'on its books' and part of the active debt portfolio, which contradicts the ground truth: the notes were past their due date (2021) and their continued inclusion was for documentation continuity, not active debt status. The ground truth emphasizes no refinancing activity or restructuring, while the LLM suggests the strategy supports 'future refinancing,' which is speculative and not supported by the data. (2) No calculations are involved, but dates (2021 due date, 2022–2024 filings) and percentages are correctly stated, earning high marks for quantitative accuracy. (3) The multi-hop reasoning is partially flawed: while the model recognizes the pattern of inclusion, it misinterprets the implication. The ground truth highlights administrative continuity (e.g., trustee name update in 2024) and absence of refinancing disclosures, but the LLM infers a strategic intent around refinancing flexibility that is not evidenced in the filings. This reflects a failure to synthesize the lack of substantive changes with the absence of refinancing activity. (4) Contextual relevance is moderate: the answer addresses the question’s focus on debt management strategy but mischaracterizes the nature of the documentation as indicative of active debt management rather than archival consistency. The mention of 'updating the indenture documentation each year' is misleading—only a formatting change in the trustee name occurred in 2024, not annual updates. Thus, while the answer is plausible-sounding, it lacks key nuances and draws unsupported conclusions, leading to a correctness score of 5 for partial accuracy with significant interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 548,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s total commercial‑aerospace financing guarantees fell from $304 million in 2022 to $288 million in 2023 and $274 million in 2024, while the portion of those guarantees held by collaboration partners declined from $140 million to $135 million to $131 million. The downward trend in both overall exposure and partner share indicates a deliberate risk‑transfer strategy: RTX is trimming its guarantee commitments and, through collaboration agreements, is gradually shifting a portion of that risk to partners, thereby tightening its balance‑sheet exposure in the commercial‑aerospace financing domain.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The ground truth states that the collaboration partners' share was $142M in 2022, $135M in 2023, and $131M in 2024. However, the LLM incorrectly reports the 2022 partner share as $140M instead of $142M. More critically, the LLM introduces total guarantee amounts ($304M, $288M, $274M) that are not present in the original answer or question, fabricating data not supported by the ground truth. (2) These invented totals undermine quantitative accuracy—there is no verification that such totals exist in the source knowledge graph, and their inclusion leads to incorrect inferences about RTX’s overall exposure. While the partner share numbers for 2023 and 2024 are correct ($135M and $131M), the 2022 figure is off by $2M. (3) The reasoning is flawed: the original answer interprets the declining partner share as potentially indicating RTX *assuming more* risk (i.e., retaining more guarantees), suggesting reduced risk transfer to partners. In contrast, the LLM concludes that RTX is shifting risk *to* partners, which is the opposite interpretation and contradicts the trend described in the ground truth. This misrepresents the strategic implication and fails the multi-hop reasoning test. (4) Despite this, the answer is contextually relevant—it addresses the evolution of exposure and attempts to interpret the trend. However, due to fabricated totals, a wrong initial data point, and reversed logic, the correctness score is low. Quantitative accuracy is partially preserved for two years and approximate values, hence a 5. Qualitative accuracy suffers due to incorrect synthesis and reasoning, warranting a 4. Contextual relevance is strong as the structure and intent align with the question, earning an 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 492,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950% Notes due 2056 were first issued under the Eleventh Supplemental Indenture in 2016 and have been re‑issued in each of the most recent fiscal years, as evidenced by Exhibit 4.14 appearing in the 2022, 2023 and 2024 10‑Ks 【page_105】. The steady issuance of these long‑term, moderate‑coupon notes each year shows a deliberate strategy to keep a stable, low‑cost debt base with extended maturities, supporting growth and shareholder returns while managing interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.950% Notes due 2056, the Eleventh Supplemental Indenture, and their presence in the 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. The reference to Exhibit 4.14 and page 105 adds specificity, though this detail is not contradicted by the ground truth. However, the LLM incorrectly states that the notes were 're-issued' each year, which is factually inaccurate according to the original answer—there was no re-issuance, only continued disclosure of the same 2016 issuance. This misrepresents the nature of the debt activity. (2) Quantitatively, all percentages, years (2016 issuance, 2056 maturity), and fiscal years referenced (2022–2024) are correct. No numerical calculations are required, and the figures match the ground truth. (3) The multi-hop reasoning is partially flawed: while the model correctly synthesizes the consistent appearance of the notes across filings, it draws an incorrect conclusion about annual re-issuance, failing to recognize that unchanged disclosure does not imply new issuance. This undermines the qualitative accuracy of the reasoning. (4) Despite the key factual error about re-issuance, the answer remains contextually relevant, addressing Microsoft’s long-term capital strategy and interpreting the stability of the debt instrument. The conclusion about a stable, low-cost debt base is plausible but based on a misinterpretation. Thus, the correctness score is reduced to 6 due to the significant error in characterizing the issuance pattern, even though core facts are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 437,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "Lockheed Martin’s tactical‑and‑strike‑missile programs ramped up production from 2022 to 2024, driving MFC net sales from $11.317 billion in 2022 to $12.682 billion in 2024 (a $1.4 billion lift largely from GMLRS, LRASM and JASSM ramp‑ups)【page_40】.  However, losses on classified programs and a $1.2 billion hit to profit‑booking rates in 2024 cut MFC operating profit from $1.637 billion in 2022 to $413 million in 2024—a $1.224 billion decline that pulled the company’s consolidated operating profit down over the three‑year period【page_40】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core trajectory of Lockheed Martin's tactical and strike missile programs from 2022 to 2024. It correctly identifies the production ramp-up in net sales, citing a $1.4 billion increase from $11.317 billion in 2022 to $12.682 billion in 2024, which aligns with the ground truth's emphasis on GMLRS, LRASM, and JASSM ramp-ups. The answer accurately captures the sharp decline in operating profit, dropping from $1.637 billion in 2022 to $413 million in 2024—a $1.224 billion decline—attributed to a $1.2 billion hit from lower profit-booking rates and losses on a classified program, consistent with the ground truth's mention of $1.4 billion in losses on a classified program and a 73% drop in profit. While the LLM does not break down the year-by-year production increases ($215M in 2022, $145M in 2023, $1.2B in 2024) as in the original answer, it synthesizes the overall trend correctly and captures the key multi-hop insight: rising production volume coincided with sharply declining profitability. The omission of annual granularity in production gains is a minor completeness issue, but the overall financial trajectory and causal factors are correctly represented. All cited numbers match the source data, and the reasoning linking production growth to deteriorating profit performance is sound. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 394,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K the company disclosed only the original Executive Change‑In‑Control Retention Agreement with Marc N. Casper (Exhibit 10.6) and its two amendments through 2018 (Exhibits 10.15‑10.16).  Beginning with the 2023 filing, Thermo Fisher added a new form of the agreement for officers other than Casper (Exhibit 10.17).  The 2024 filing repeats that officer form (Exhibit 10.17) but contains no further amendments to the original Casper agreement.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2022, only the original agreement with Marc N. Casper and its amendments were disclosed, whereas the ground truth confirms that in 2022, Thermo Fisher already introduced a Form of Executive Change in Control Retention Agreement for Officers other than Casper. This is a critical omission and misrepresentation of the timeline. (2) The LLM claims the new form for other officers was added in the 2023 filing as Exhibit 10.17, but the ground truth states it was filed in 2023 as Exhibit 10.7—both the year and exhibit number contradict the original answer. (3) The LLM says the 2024 filing repeats Exhibit 10.17, but the ground truth does not specify an exhibit number for 2024, only that the company reiterated the existence of the form for other officers. (4) The ground truth emphasizes consistency across all three years in maintaining both the Casper-specific agreement and the form for other officers, while the LLM implies the form for other officers only began in 2023, breaking the continuity asserted in the original answer. While the LLM correctly identifies the focus on Casper and other officers and addresses the evolution over time (hence moderate contextual relevance), it fails on key facts: timing, exhibit numbers, and the existence of the officer form in 2022. These errors reflect flawed multi-hop reasoning and poor alignment with the source data, leading to a low correctness and qualitative accuracy score. Quantitative accuracy is partially preserved as no numerical calculations are wrong per se, but exhibit numbers and years are misstated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 458,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "Lockheed Martin expanded its use of variable‑rate interest‑rate swaps from a $500 million notional in 2021 (disclosed in the 2022 filing) to $1.3 billion in 2023 and kept that level in 2024.  The swaps are employed as fair‑value hedges to convert fixed‑rate borrowings into variable‑rate debt, thereby protecting the fair value of its debt portfolio.  The jump and subsequent stability in notional amounts signal a deliberate, more comprehensive hedging program that the company maintains to manage interest‑rate exposure without materially affecting earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $500 million in 2021 (disclosed in 2022 filing), increase to $1.3 billion in 2023, and maintenance at $1.3 billion in 2024. No calculation errors; comparisons are accurate. (2) The answer addresses both parts of the question: evolution of LMT's use of swaps (increase and stabilization) and interpretation of the change in strategy. (3) Entity accuracy is strong: correct company (LMT/Lockheed Martin), correct financial instrument (variable interest rate swaps used as fair-value hedges), correct years and notional amounts. (4) Reasoning is sound: correctly infers a more comprehensive hedging program and links it to interest rate risk management. The only minor shortcoming is that the LLM does not explicitly mention the 'strategic shift' or 'proactive approach amid rising borrowing levels or market uncertainty' as emphasized in the original answer, nor does it reference stabilization of the strategy post-2023 in quite the same depth. However, stating that the company 'maintains [the program] to manage interest-rate exposure without materially affecting earnings' captures a similar intent. The answer is semantically equivalent in key facts and overall interpretation, with only slight nuance missing in strategic context. Thus, correctness is excellent but not perfect, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 394,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "The company’s defined‑contribution plan expense rose from **$402 million in 2022 to $468 million in 2023**, then fell to **$443 million in 2024**. This pattern shows that Thermo Fisher increased its investment in employee benefits in 2023 but has slightly moderated that spending in 2024, indicating a relatively stable yet modestly declining trend in defined‑contribution plan costs over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. There are no errors in numbers or years. (2) Quantitative accuracy is perfect—values are correctly stated, and while the ground truth says 'remained flat at $443 million in 2024', the LLM says it 'fell to $443 million', which is accurate since it decreased from $468M. The calculation of a decrease of $25M is implied and correct. (3) The reasoning is sound: the LLM correctly identifies the increase in 2023 and the subsequent decrease in 2024. The interpretation differs slightly—the ground truth suggests 'stabilization or recalibration', while the LLM describes a 'modestly declining trend'. This is a nuanced difference in characterization but not factually incorrect, as the data does show a decline from peak 2023 levels. However, 'flat' in the original answer refers to 2024 vs. prior trend, so the LLM's 'declining trend' slightly overemphasizes the downward movement. (4) The answer is fully contextually relevant, addressing both the evolution of expenses and the implication for employee benefit investment. Minor deduction in qualitative accuracy due to interpretive phrasing, but factual correctness and completeness are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 369,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "From 2022 through 2024 Coca‑Cola’s investment note consistently states that fair‑value estimates for nonpublic equity holdings are derived from “discounted cash flows, estimates of sales proceeds, and appraisals, as appropriate” (2022 – page 41; 2023 – page 79; 2024 – page 78).  The methodology did not change, indicating that the company continued to rely on sales‑proceeds estimates for valuation.  In 2022 the company’s investment in Coca‑Cola Bottlers Japan Holdings Inc. had a carrying value $87 million above fair value, yet management judged the decline to be temporary and did not record an impairment (page 40).  That decision shows management’s confidence that the Japanese market will recover, reflecting a belief that their sales‑proceeds estimates can predict a rebound in such markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers and facts are accurate: the $87 million excess of carrying value over fair value for Coca-Cola Bottlers Japan Holdings Inc. in 2022 is correctly stated, and the consistent use of 'estimates of sales proceeds' across 2022–2024 is properly cited with correct page references. There are no calculation errors. (2) Entity accuracy is strong: the company name, time period (2022–2024), and financial concept (nonpublic equity investments, fair value vs. carrying value) are all correctly identified. (3) Reasoning is sound in identifying that the unchanged methodology indicates continued reliance on sales-proceeds estimates and that management’s decision not to impair reflects confidence in recovery. However, the LLM answer does not fully capture the evolution emphasized in the ground truth—specifically, the increasing focus in 2023 and 2024 on market participant assumptions and macroeconomic risks in emerging markets. This nuance about shifting emphasis, though subtle, is a key part of the multi-hop synthesis required. (4) The answer is contextually relevant and well-structured, but slightly less complete than the original answer in conveying the qualitative shift in tone and risk awareness over time. Wording differences are acceptable and do not affect meaning, but the omission of the evolving emphasis on external market perspectives prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 405,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "In 2022 Oracle issued a series of notes that included 2.300% Notes due 2028 as part of a broader mix of notes with varying rates and maturities (page 114). By 2023 and 2024 the company shifted to issuing 4.500% Notes due 2028 (pages 111 and 109), indicating a move to higher coupon rates and a continued focus on structuring debt to match market conditions and maturity needs. This multi‑year pattern reflects Oracle’s deliberate strategy of diversifying maturities and adjusting coupon rates to optimize financing costs and liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.300% Notes due 2028 in 2022 and the issuance of higher-rate notes in 2023 (4.500% Notes due 2028), which aligns with the ground truth. However, it incorrectly states that Oracle 'issued' the 4.500% Notes due 2028 in both 2023 and 2024, while the ground truth specifies that the 2024 activity involved the 5.800% Notes due 2025, not the 4.500% Notes. This misrepresents the 2024 debt issuance and omits the key detail about newer, more expensive instruments in 2024. (2) Quantitatively, the percentages and years for the 2.300% and 4.500% notes are accurate, but the failure to mention the 5.800% Notes due 2025 in 2024 constitutes a significant omission. The LLM also implies continued issuance of the 4.500% Notes in 2024, which is factually incorrect. (3) The multi-hop reasoning is partially sound—Oracle’s strategy of adjusting coupon rates and managing maturities is correctly inferred—but the analysis is based on flawed input for 2024, weakening the synthesis. The broader conclusion about optimizing financing costs is reasonable but lacks the nuance of refinancing under rising rates, which is central to the ground truth. (4) The contextual relevance is high as the answer addresses Oracle’s debt strategy and evolution over three years, but the factual error in the 2024 component reduces overall correctness. Hence, a score of 7 is justified: core facts for 2022 and 2023 are correct, but significant error in 2024 data limits completeness and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 417,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s floating‑rate note that was issued in 2014 and due in 2019 has been fully repaid and is no longer listed as outstanding in the 2022, 2023, or 2024 10‑K filings (the 4.4 certificate on page 58 of the 2024 10‑K confirms the original issuance). The absence of any 2019‑due floating‑rate debt in those years shows that Apple has matured or refinanced its long‑term floating‑rate instruments and now relies on short‑term notes or other financing for its short‑term debt management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the Floating Rate Notes due 2019 were fully repaid and no longer listed in the 2022, 2023, and 2024 10-K filings. The ground truth confirms that these notes continued to be disclosed in each year's filing via the May 6, 2014 Officer's Certificate, indicating ongoing reporting despite maturity. The LLM incorrectly interprets the absence of new issuances or activity as evidence of repayment or removal from the books, which contradicts the consistent disclosure pattern. (2) Quantitatively, the LLM misrepresents the status of the debt instrument across all three years. While it correctly references the 2014 issuance and 2019 maturity, it falsely claims the debt is not outstanding in 2022–2024, which is unsupported by the source data. The mention of a '4.4 certificate on page 58 of the 2024 10-K' appears fabricated or misattributed, as no such detail exists in the ground truth. (3) The multi-hop reasoning fails: the model does not recognize that continued disclosure of a matured debt instrument can reflect accounting or reporting requirements rather than active debt. It incorrectly infers a shift to short-term notes based on the absence of this specific instrument, despite no evidence in the question or ground truth about Apple’s current short-term financing tools. (4) The contextual relevance is moderate because the answer addresses Apple's debt management strategy, but the conclusion about relying on short-term notes is speculative and based on flawed premises. Correctness and qualitative accuracy are low due to fundamental factual and logical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 449,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "The 4.000 % Senior Note due 2047 appears in the exhibits list of PepsiCo’s 2022, 2023 and 2024 10‑K filings (see pages 126, 127 and 128), showing the company’s intent to keep a core long‑dated debt instrument that locks in a moderate rate and provides a stable, long‑term financing base.  By contrast, the 2.150 % Senior Note due 2024 (page 126‑128) and the 0.750 % Senior Note due 2027 (page 126‑128) are also disclosed but represent shorter‑maturity, more flexible financing that PepsiCo rolls over or refinances on a rolling basis, illustrating a mix of long‑term and short‑term debt to manage refinancing risk and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%), maturity years (2047, 2024, 2027)—are correct, and there are no calculation errors. The mention of exhibit pages (126–128) adds specificity, though not required, and does not detract from accuracy. (2) The answer correctly identifies the multi-hop pattern: the 2047 note appears consistently across all three years, indicating long-term debt stability, while shorter-dated notes (2024, 2027) are treated as transient, consistent with refinancing or rolling debt. (3) The reasoning is sound: the LLM correctly infers that PepsiCo uses long-term debt for stable financing and short-term debt for flexible, rolling needs, which matches the ground truth’s conclusion about liability management strategy. (4) The only minor omission is that the original answer notes the 2.500% Senior Note due 2022 matured by 2023, reinforcing the contrast between maturing short-term debt and persistent long-term debt. This detail strengthens the original argument but is not critical to the core insight. The LLM captures the essential contrast and strategic implication, so the answer remains semantically equivalent. Wording differs slightly (e.g., 'locks in a moderate rate' vs 'secure capital at fixed rates'), but meaning is preserved. No factual or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 387,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple’s repeated listing of the 0.45% Notes due 2016 in its 2022‑2024 10‑Ks (see page 56 of the 2022 filing, pages 53‑57 of the 2023 filing, and pages 54‑58 of the 2024 filing) shows that the company continues to report all past debt issuances, even those that have matured. This practice reflects a conservative, transparency‑driven debt‑management approach that prioritizes a complete historical record over active refinancing or repurchase of already‑matured debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 are accurately referenced, and their maturity in 2016 is implied by the context. The LLM correctly notes Apple's continued disclosure in 2022, 2023, and 2024 filings, which matches the original answer’s timeline. (2) Quantitative accuracy is perfect: percentages (0.45%), years (2016 maturity, 2022–2024 disclosures), and document references (page numbers in 10-Ks) are correctly cited. Format variations are acceptable and do not affect correctness. (3) Reasoning is sound: the LLM infers a transparency-driven, conservative disclosure strategy, which is consistent with the ground truth’s emphasis on comprehensive record-keeping and investor clarity. It correctly identifies that the notes are matured but still disclosed, and draws a logical conclusion about Apple’s policy. (4) The only minor shortcoming is that the LLM does not mention the repeated reference to the Officer's Certificate dated May 3, 2013—a specific detail in the ground truth that reinforces the consistency of documentation. While this omission slightly reduces completeness, it does not undermine the core correctness. The answer remains semantically equivalent in intent and conclusion. Contextual relevance is excellent, directly addressing Apple’s strategy regarding legacy debt disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 389,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "Lockheed Martin’s 2022 filing notes that, after purchasing $4.9 billion of gross pension obligations in 2021 (and a total of $11.6 billion in GACs since 2018), it had no new contributions in 2022 but expected to recover about $1.8 billion of CAS pension cost and to continue evaluating additional pension‑risk‑transfer deals that could trigger future non‑cash settlement charges or extra contributions. The 2023 filing repeats that stance, emphasizing ongoing evaluation of GAC purchases but reporting no new transactions. In 2024, the company made a $990 million cash contribution and, thanks to a 0.625‑percentage‑point rise in its discount rate, saw projected pension obligations fall by roughly $1.8 billion; no new GACs were disclosed, and the only material earnings hit from pension‑risk‑transfer activity was the $1.7 billion non‑cash settlement charge recorded in 2021.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the $4.9 billion pension obligation transfer in 2021 and the cumulative $11.6 billion transferred since 2018, as well as the $1.7 billion noncash settlement charge in 2021. However, it incorrectly states that Lockheed Martin 'purchased' pension obligations, which misrepresents the transaction (the company transferred obligations via group annuity contracts, not purchased them). The claim that the company had 'no new contributions in 2022' is misleading—while no new GACs may have occurred, the original answer does not confirm this, and the LLM introduces unsupported detail. The $1.8 billion 'recovery of CAS pension cost' is not mentioned in the ground truth and appears extraneous. In 2024, the LLM claims a $990 million cash contribution and an $1.8 billion reduction in obligations due to a discount rate change—this is not supported by the original answer, which emphasizes continued evaluation and intent to pursue transfers, not specific contributions or actuarial changes. The statement that 'no new GACs were disclosed' contradicts the original answer’s assertion that the strategy continued through 2024 with ongoing reductions. (2) Quantitative accuracy is partially correct: $4.9B, $11.6B, and $1.7B figures are accurate and match the ground truth. However, the $990M contribution and $1.8B obligation reduction in 2024 are not in the original answer and are likely fabricated or misattributed. The 0.625-percentage-point discount rate change is not mentioned in the ground truth. (3) Multi-hop reasoning is partially sound—the model connects disclosures across years but introduces unsupported details and misses the core narrative of continued proactive risk transfer. It fails to convey the consistent strategic evolution and instead implies inactivity in 2022–2024, which contradicts the original answer’s emphasis on ongoing and expected future transactions. (4) Correctness is scored 5 due to significant factual inaccuracies in 2024 and misrepresentation of actions; quantitative accuracy is 5 due to mix of correct and incorrect numbers; qualitative accuracy is 6 because reasoning structure is logical but based on incorrect premises; contextual relevance is 8 as the answer addresses the right topic and timeframe, even if with errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 631,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "In the 2022 Form 10‑K, Thermo Fisher disclosed an Executive Change‑In‑Control Retention Agreement with CEO Marc N. Casper (Exhibit 10.12) and a separate agreement for other officers that was originally dated 2018 (Exhibit 10.18).  The 2023 filing updated that officer agreement (Exhibit 10.17, effective April 1 2023), and the 2024 filing continues to include the same officer agreement (Exhibit 10.17), indicating that the company has broadened its retention arrangements to cover all officers beyond Casper and has kept them in force through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Thermo Fisher disclosed a retention agreement for Marc N. Casper and a 2018 form for other officers; in 2023, a new form dated April 1, 2023 (Exhibit 10.17) replaced the prior version; and in 2024, the same 2023 form was retained. These details match the original answer exactly. (2) Quantitative accuracy is perfect: dates (2018, April 1, 2023), exhibit numbers (10.12, 10.18, 10.17), and the timeline are all factually correct. Minor formatting differences (e.g., 'Change-In-Control' vs 'Change In Control') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—correctly tracing the evolution across three years and synthesizing the implication that retention arrangements were broadened beyond Casper. (4) The only reason for not scoring a 10 is a slight omission of the term 'formalization' or 'reaffirmation' in describing the 2024 update, which the original answer emphasizes to reflect continuity of updated terms. However, stating that the agreement 'continues to include the same officer agreement' effectively conveys the same idea. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 361,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 2022‑2024 10‑Ks keep the 2.750% Senior Note due 2051 listed unchanged as a fixed‑rate instrument, with no indication of a repurchase or refinance.  By locking in a low coupon for a 30‑year maturity while also maintaining a mix of floating‑rate notes, PepsiCo signals a conservative debt strategy that hedges against future rate hikes and preserves predictable interest costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 2.750% Senior Note due 2051 is accurately described as a fixed-rate instrument, and the 30-year maturity (implied from 2021 issuance to 2051 maturity) is reasonable. No incorrect numbers, percentages, or dates are present. (2) The answer correctly infers from the consistent listing of the note across 2022–2024 filings that PepsiCo did not repurchase or refinance it, which matches the ground truth's observation of unchanged treatment. (3) The reasoning is sound: the LLM correctly synthesizes that maintaining a low-coupon, long-dated note amid rising rates reflects a conservative, hedging-oriented debt strategy—this is consistent with the ground truth’s conclusion about preserving access to fixed-rate debt. (4) While the LLM does not explicitly mention the 2023/2024 reference to the 2021 Form 8-K or the introduction of the 5.250% Senior Note due 2054 as a contrast, it captures the essential strategic implication. The omission of these specific cross-filing details slightly reduces completeness in multi-hop synthesis, but the core insight about long-term debt strategy remains correct and well-reasoned. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to lack of explicit evidence from all three years’ filings, but overall excellent performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 391,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45% Notes due 2044 were first issued in 2014 and have remained a constant component of its long‑term debt portfolio through the 2022‑2024 10‑Ks, with no new issuances or maturities reported in that period (see the 2014 officer’s certificate and the 2024 filing index, page 56).  The persistence of this long‑duration, fixed‑rate instrument underscores Apple’s strategy of maintaining a low‑cost, long‑term debt base to fund capital expenditures, support shareholder returns, and preserve financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were issued in 2014, remained in Apple's debt portfolio through 2022–2024, and no redemption or new issuance was reported during this period. The reference to the 2014 Officer's Certificate and the 2024 filing index (page 56) matches the type of documentation cited in the original answer. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance year (2014)—are all accurate. No calculations were required, but temporal consistency across three years is correctly maintained. (3) The multi-hop reasoning is sound: the model correctly infers from consistent disclosure across multiple 10-Ks that the debt was retained, indicating a strategic choice. It appropriately links this to Apple’s broader capital strategy—funding capital expenditures, shareholder returns, and maintaining flexibility—slightly expanding on the original answer with plausible strategic rationale. (4) The only minor gap is that the original emphasizes 'sustained transparency' and 'ongoing obligations,' while the LLM focuses more on strategic use of debt; however, the core implication about strategic retention of fixed-rate debt is preserved. Wording differs slightly but maintains semantic equivalence. No factual errors or omissions affect the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 387,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan reduced its allocation to Collective Trust and Other Funds from **$622 million (≈46.5 % of the $1,338 million NAV) in 2022 to $382 million (≈39.5 % of the $966 million NAV) in 2023**, a decline of roughly $240 million or about 7 percentage points. The 2024 valuation methodology notes that the fair value of these funds is determined by the NAV reported by the fund managers, based on publicly traded underlying assets, indicating that Union Pacific’s management of these investments is largely passive and relies on external managers’ NAV calculations rather than direct control of the underlying holdings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023. However, the LLM incorrectly states the 2022 allocation as $622 million, which is off by $134 million. Additionally, the LLM introduces NAV percentages (46.5% and 39.5%) and total NAV figures ($1,338 million and $966 million) that are not present in the original answer and cannot be verified from the provided ground truth. These figures and calculations appear to be fabricated or inferred incorrectly, undermining factual accuracy. (2) The 2023 figure of $382 million is correct, and the qualitative description of the 2024 valuation methodology—relying on NAV reported by fund managers based on underlying assets—is semantically aligned with the ground truth, which mentions valuation using net asset value from commingled funds and limited liability companies. The interpretation that this reflects passive management is a reasonable inference, though not explicitly stated in the original. (3) The multi-hop reasoning is partially sound: the model attempts to synthesize changes over time (2022–2023) and connect them to the 2024 methodology disclosure. However, the incorrect base numbers in 2022 break the validity of the comparison, and the addition of unverified percentage breakdowns and total NAV amounts reflects flawed synthesis. (4) Despite the incorrect numbers, the LLM captures the directional trend (decrease) and correctly interprets the valuation methodology’s implications about transparency and external management. This supports a moderate qualitative and contextual score, but the severe quantitative error limits overall correctness to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 492,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple continued to list the Officer’s Certificate for the 1.05% Notes due 2017 as Exhibit 4.4 in each of its 10‑K filings (2022, 2023 and 2024), the same certificate that appears on the 2014 filing (page 58 of each year).  By preserving and re‑disclosing the original certificate for a debt instrument that had already matured, Apple demonstrates a systematic retention of all original debt documentation, regardless of maturity.  This practice signals a deliberate effort to keep a complete, transparent historical record of its capital structure for SEC disclosure and investor scrutiny.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Apple included the Officer’s Certificate for the 1.05% Notes due 2017 as Exhibit 4.4 in its 10-K filings for fiscal years 2022, 2023, and 2024. The certificate was originally dated May 6, 2014, and its continued inclusion is accurately described. The LLM correctly identifies the exhibit number and the fact that it was carried forward from the 2014 filing. (2) Quantitative accuracy is perfect: the interest rate (1.05%), maturity year (2017), filing years (2022–2024), and original date (2014) all match the ground truth. The reference to 'page 58 of each year' is a minor addition not in the original answer but does not contradict it and may reflect actual filing structure; it does not detract from accuracy. (3) The reasoning is sound: the LLM correctly infers that this reflects a systematic documentation retention policy and a commitment to transparency in historical capital structure disclosure. It captures the multi-hop logic—linking the continued inclusion of a matured debt exhibit to broader corporate disclosure practices. (4) The only reason for not scoring a 10 is that the LLM slightly omits the explicit mention of 'historical continuity' and 'regulatory transparency' as dual purposes, though 'investor scrutiny' covers part of this. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with excellent reasoning and no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 417,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan shifted its corporate‑stock holdings sharply over the three‑year period.  In 2022 corporate stock represented roughly 51.5 % of plan assets ($1,990 m of $3,867 m)【page_72】, rising to about 64 % in 2023 ($2,217 m of $3,459 m)【page_56】, before falling to only ~5 % in 2024 ($181 m of $3,385 m)【page_58】.  The steep drop after 2023 signals a deliberate move away from concentrated corporate‑stock exposure toward more diversified equity vehicles and a broader de‑risking strategy that reduces overall equity allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in both dollar amounts and percentages. According to the ground truth, Union Pacific's corporate stock allocation decreased from $1,990 million in 2022 to $181 million in 2023, then increased to $1,116 million in 2024. The LLM incorrectly states that corporate stock was $2,217 million in 2023 and only $181 million in 2024, reversing the actual trend between 2023 and 2024. Additionally, the percentages cited (51.5% in 2022, 64% in 2023, ~5% in 2024) are not supported by the ground truth and contradict the actual allocation trajectory. (2) The calculation errors are severe: the LLM claims a rise in corporate stock from 2022 to 2023, when in fact it dropped by over 90%, and then claims a further drop in 2024 to $181 million, when in reality it rebounded to $1,116 million. These errors invalidate the quantitative analysis. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the direction and magnitude of changes across years, leading to an incorrect interpretation of strategy. While the idea of de-risking is plausible, the LLM attributes the shift to reduced equity allocation overall, whereas the ground truth indicates a shift from equities (corporate stock) to fixed income, with a partial rebound in corporate holdings in 2024. (4) The contextual relevance is moderate because the answer addresses pension plan allocations and investment strategy, but due to severe factual and numerical errors, the conclusion is misleading. The qualitative reasoning is undermined by incorrect data synthesis across years, resulting in a largely incorrect narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 455,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales climbed from **$428 million in 2022** to **$605 million in 2023** and then to **$785 million in 2024**—a 41 % year‑over‑year jump from 2022 to 2023 and a 30 % rise from 2023 to 2024. This steady growth signals robust market uptake among transplant patients and highlights Prevymis as an increasingly important revenue driver and strategic asset within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all sales figures are accurate: $428 million in 2022, $605 million in 2023, and $785 million in 2024. The calculated growth rates are also correct: (605 - 428) / 428 ≈ 41.36% (correctly rounded to 41%), and (785 - 605) / 605 ≈ 29.76% (correctly rounded to 30%). (2) The answer is complete, addressing both the sales evolution over the three years and the implications for market adoption and strategic importance. (3) Entities are accurate—'Prevymis', 'Merck (MRK)', 'Hospital Acute Care'—and correctly contextualized. (4) The reasoning is sound: the multi-hop synthesis of year-over-year growth and its interpretation as 'robust market uptake' and 'increasingly important revenue driver' aligns with and expands upon the ground truth without introducing inaccuracies. The added context about transplant patients is plausible and consistent with known indications for Prevymis, enhancing relevance without overreach. All components demonstrate factual precision, logical inference, and semantic equivalence to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 318,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "PepsiCo lists the 3.000% Senior Note due 2027 as an exhibit in every 10‑K, each time describing it as a fixed‑rate senior note with a 3.000 % coupon that matures in 2027 and referencing the same 8‑K filed on Oct 10 2017【page_126】【page_127】【page_127】.  The unchanged inclusion and wording across 2022, 2023 and 2024 shows the company’s long‑term debt strategy relies on a stable mix of fixed‑rate senior notes with moderate coupons and mid‑term maturities to manage cost and maturity risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the multi-hop reasoning required by the question. (1) Quantitatively, the answer correctly identifies the 3.000% Senior Note due 2027, its coupon rate, maturity date, and consistent inclusion across 2022–2024 filings, referencing the correct 8-K filing date (Oct 10, 2017). These details align with the ground truth and are factually accurate, warranting a high quantitative accuracy score. (2) However, the answer fails to capture the evolving *context* and *characterization* of the note across the three years, which is central to the question. The ground truth emphasizes how the note’s presentation shifts—from being grouped with medium-term notes in 2022, to longer-dated instruments in 2023, to newer short-term notes in 2024—revealing a dynamic debt layering strategy. The LLM incorrectly concludes that the 'unchanged inclusion and wording' indicates a 'stable mix', which contradicts the ground truth that the *context* of presentation evolved significantly despite the note itself remaining unchanged. (3) This reflects a failure in multi-hop reasoning: the model does not synthesize information across the three filings to detect strategic shifts in debt maturity management. It treats consistency in disclosure as evidence of static strategy, missing the nuanced evolution in how the note fits within PepsiCo’s broader debt portfolio. (4) While the answer is factually sound on surface-level details and relevant to the question’s topic, it lacks the depth of analysis needed to reveal PepsiCo’s adaptive long-term debt strategy, resulting in a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 447,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "Adobe positioned Frame.io as a cloud‑native collaboration platform in all three years, offering real‑time upload, review, approval, frame‑accurate commenting, annotations, support for still images, design files, PDFs, and Camera‑to‑Cloud capture. In 2022 the integration depth was broad—Frame.io was embedded in Premiere Pro, After Effects, Photoshop, Lightroom and Workfront—while in 2023 the integration was narrowed to only Premiere Pro and After Effects. By 2024 Adobe restored and expanded the integration again, re‑adding Photoshop, Lightroom and Workfront to the suite while keeping the same core functional capabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the evolution of Frame.io's integration depth over time. While it correctly identifies Frame.io as a cloud-native collaboration platform with real-time upload, review, approval, and support for various file types (still images, design files, PDFs), it incorrectly claims that in 2022 Frame.io was already integrated with Photoshop, Lightroom, and Workfront—this contradicts the ground truth, which states that such integrations were only emphasized in 2024. The ground truth indicates that in 2022, Frame.io was only formally aligned via trademark listing, with no mention of deep integrations. In 2023, the integration was correctly noted with Premiere Pro and After Effects, but the LLM falsely claims this was a 'narrowing' from broader 2022 integrations, which did not exist at that depth. The 2024 expansion to include Photoshop, Lightroom, and Workfront is correct and aligns with the original answer. However, the LLM omits the strategic positioning of Frame.io as a core component of Adobe GenStudio alongside Firefly and Substance 3D, a key qualitative point in the ground truth. (2) There are no numeric values to verify, so quantitative accuracy is high by default—no incorrect figures were introduced. (3) The multi-hop reasoning is flawed: the model incorrectly infers a 'broad integration' in 2022 and a 'narrowing' in 2023, which is not supported by the data. This reflects a failure to correctly synthesize the progression across years. The timeline logic is reversed—integration deepened over time, not fluctuated. (4) Correctness score is 4 due to major factual errors in integration timeline and missing strategic context; qualitative accuracy is low due to incorrect reasoning; quantitative accuracy is high as no numbers were misstated; contextual relevance is moderate as the answer addresses the question's scope but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 525,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple disclosed its 2.40% Notes due 2023 as outstanding debt in both the 2022 and 2023 10‑K filings (see Exhibit 4.3 in each filing, which lists the notes with a September 1 2023 maturity)【page 58 of 2022】【page 58 of 2023】. By the 2024 10‑K, the notes no longer appear in the debt schedule, indicating they had been retired upon maturity, a move that reflects Apple’s disciplined debt‑maturity strategy of retiring maturing debt to avoid refinancing risk and keep its debt profile balanced【page 58 of 2024】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurate: Apple disclosed the 2.40% Notes due 2023 in its 2022 and 2023 10-K filings and omitted them in 2024, indicating retirement at maturity. The maturity date (September 1, 2023) is correctly specified. (2) Quantitative elements—interest rate (2.40%), years (2022, 2023, 2024), and maturity date—are all precise and match the expected data. No calculations are required, but the temporal progression is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly infers retirement based on disappearance from the 2024 exhibit, and draws a logical conclusion about Apple’s debt strategy. (4) The answer is semantically equivalent to the original, adding minor but plausible detail (e.g., specific exhibit reference and maturity date) without introducing error. The conclusion about a disciplined, maturity-aligned strategy mirrors the ground truth’s interpretation of holding debt to term. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 319,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s Multiple Purpose locomotive fleet was 5,971 owned and 1,037 leased in 2022 (average age 24.3 yrs) and stayed essentially the same in 2023 (5,971 owned, 1,037 leased, 24.3 yrs)【page_22】【page_19】. In 2024 the company added two owned units (5,973) while cutting leased units to 920, bringing the total to 6,893 and raising the average age to 25.2 yrs【page_19】. This gradual shift from leasing to ownership and the aging fleet signals a deliberate asset‑management strategy aimed at reducing leasing costs, consolidating long‑term ownership, and extending locomotive life while preserving operational flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, in 2022, Union Pacific had 7,242 total Multiple Purpose Locomotives (6,204 owned and 1,038 leased), but the LLM incorrectly states 5,971 owned and 1,037 leased, which is closer to the 2024 owned number. The LLM also misrepresents the 2022 and 2023 average ages: it claims the average age was 24.3 years in both 2022 and 2023, whereas the ground truth shows 22.5 years in 2022 and 24.3 in 2023. The 2024 average age of 25.2 is correct. The 2024 total fleet size of 6,893 is accurate, but the breakdown (5,973 owned, 920 leased) is only partially correct—the ground truth confirms these numbers, but the LLM fails to reflect the full decline from prior years. (2) Calculations: The LLM incorrectly implies stability from 2022 to 2023 when in fact there was a significant reduction in both owned and leased units and an increase in average age. The claim of 'essentially the same' fleet in 2022 and 2023 is factually wrong. (3) Multi-hop reasoning: The LLM correctly identifies the shift toward ownership and aging fleet in 2024 but draws an incorrect strategic conclusion due to flawed data. The inference about reducing leasing costs and consolidating ownership is plausible but not supported by the full trend, which shows an overall fleet reduction and aging, not a shift from leasing to ownership—since owned units also declined from 6,204 to 5,973 over 2022–2024. (4) The contextual relevance is high as the answer addresses fleet composition, age, and strategy. However, due to major quantitative errors in key metrics (fleet size, ownership breakdown, age progression), the correctness score is low. The qualitative reasoning is partially sound but built on incorrect data, limiting its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 496,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "From 2022 Merck’s once‑daily doravirine/islatravir (MK‑8591A) was in Phase 2 development and the FDA had placed a clinical hold on the program. The hold remained in place through 2023. In 2024 the FDA lifted the clinical hold on December 4, 2024, and the program advanced to a Phase 2/3 study that began in August 2024, although a partial hold still applies to higher‑dose islatravir regimens.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. According to the ground truth, MK-8591A was in Phase 3 development starting in February 2020 and remained in Phase 3 through 2022 and 2023. However, the LLM incorrectly states it was in Phase 2 in 2022 and claims it advanced to a Phase 2/3 study in August 2024, which contradicts the original answer. The FDA lifted a clinical hold in 2024 (correctly noted), but the LLM specifies December 4, 2024, which is more precise than the original answer but not verifiable from the ground truth provided. The partial hold on higher doses of islatravir is correctly mentioned. (2) The date of December 4, 2024, is a specific numeric claim not present in the original answer, so its accuracy cannot be confirmed; however, the general lifting of the hold in 2024 aligns with the truth. The phase progression dates are incorrect—entry into Phase 3 was in 2020, not 2024. (3) The multi-hop reasoning is flawed: the model fails to correctly track the clinical phase over time, misrepresenting both the stage of development and the implications of FDA actions. It also misses the strategic shift to MK-8591D, a key point in the original answer showing Merck's expanded approach. (4) While the LLM captures the general idea of ongoing development and regulatory holds, it misrepresents critical details about phase progression and program evolution, leading to a low correctness and qualitative accuracy score. Contextual relevance is high because it addresses the right topic and FDA interactions, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 433,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "Merck’s 2022 10‑K lists MK‑1308A—an anti‑CTLA‑4 antibody (quavonlimab) co‑formulated with pembrolizumab—as a candidate for renal cell carcinoma (entry date April 2021) [page_25]. The 2023 filing continues to describe MK‑1308A as a key immuno‑oncology asset for RCC, with no regulatory milestone reported [page_21]. In 2024, the company still positions MK‑1308A in its pipeline for RCC, underscoring a sustained commitment to advancing combination checkpoint blockade and expanding its RCC portfolio [page_48].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is correctly identified as a co-formulation of quavonlimab (anti-CTLA-4) and pembrolizumab, with an entry date of April 2021 for RCC, consistent across years. The progression from 2022 to 2024 correctly reflects ongoing Phase 3 development without discontinuation. (2) Quantitative accuracy is perfect: dates (April 2021), years (2022–2024), and phase status (Phase 3) match the original. No calculations were required. (3) Multi-hop reasoning is sound—information is synthesized across three annual reports, showing evolution in strategic emphasis. The LLM captures the sustained focus on combination immunotherapy and RCC innovation, though it slightly underemphasizes the explicit connection to Merck’s broader Keytruda-based platform strategy mentioned in the ground truth. (4) Contextual relevance is excellent: the answer directly addresses the evolution of MK-1308A and what it indicates about Merck’s RCC focus. The only minor gap is the lack of explicit mention of 'immuno-oncology pillar' and 'strategic prioritization' phrasing, but the meaning is semantically equivalent. Overall, this is a factually correct, well-synthesized response with only slight room for enhanced strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 365,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Microsoft continues to list the 4.000 % Notes due 2021 in the Third Supplemental Indenture (Exhibit 4.6) in every 10‑K filing – the same wording and terms appear on page 104 of the 2022, 2023 and 2024 reports.  The unchanged disclosure shows that the note has already matured and been repaid, and that Microsoft’s long‑term debt profile remains stable, with the company focusing its refinancing activity on newer maturities rather than altering older debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual misinterpretation that undermines the overall reasoning. (1) Quantitatively, the answer correctly identifies the consistent disclosure of the 4.000% Notes due 2021 in Exhibit 4.6 (Third Supplemental Indenture) across the 2022, 2023, and 2024 10-K filings, and correctly notes the repetition of the same language and location (e.g., page 104). These details align with the ground truth. (2) However, the LLM incorrectly infers that the unchanged disclosure means the note 'has already matured and been repaid.' This is not supported by the ground truth, which makes no such claim about repayment status. Instead, the consistency reflects stable documentation, not necessarily post-maturity treatment. The ground truth emphasizes the continuity of legal structure and lack of refinancing, not confirmation of repayment. (3) The multi-hop reasoning is flawed: while the model correctly observes consistency in disclosure, it draws an unsupported conclusion about refinancing strategy—claiming Microsoft focuses on 'newer maturities'—which is not stated or implied in the evidence provided. The ground truth only states there was no change to this particular note, not that refinancing efforts were redirected elsewhere. (4) Despite this, the answer remains contextually relevant and captures the core observation of disclosure consistency. The qualitative accuracy is reduced due to the incorrect causal inference. Minor wording differences are acceptable, but the erroneous conclusion about repayment and refinancing strategy significantly affects factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 444,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s QCT segment has long positioned itself as a key supplier of automotive connectivity, digital‑cockpit and ADAS/AD solutions【page 7】.  Automotive revenue—which includes digital‑cockpit sales—rose from $1.509 B in 2022 to $1.872 B in 2023 and $2.910 B in 2024, a 93 % increase over two years【page 73】.  This trend shows Qualcomm’s shift from a mobile‑centric focus to a diversified technology platform, with digital‑cockpit becoming a growing revenue driver in its automotive transformation.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct elements but misses key aspects of the original answer. It correctly identifies Qualcomm's QCT segment and its role in automotive technology, and it references digital cockpit as part of the automotive revenue stream. However, it introduces specific revenue figures ($1.509B in 2022, $1.872B in 2023, $2.910B in 2024) and a 93% increase that are not present in the original answer and cannot be verified against the ground truth, which does not provide any numerical revenue breakdowns for digital cockpit or total automotive revenue. This is a significant factual overreach. (2) Quantitative accuracy is compromised because the numbers and the 93% calculation are not supported by the original answer. While the format of numbers (e.g., $1.509B) is acceptable, the values themselves are fabricated from the model’s perspective since the ground truth contains no such data. This results in a major error in quantitative reporting. (3) The multi-hop reasoning is partially sound in that the model attempts to show progression in Qualcomm's strategic positioning, but it fails to capture the core evolution described in the original: the shift from projecting digital cockpit's future role (2022), to formally categorizing it as a distinct revenue stream (2023), to fully operationalizing it within QCT (2024). Instead, the model focuses on unverified revenue growth, missing the strategic and reporting-level transformation entirely. (4) Contextual relevance is high because the answer stays on topic and addresses Qualcomm's automotive business transformation and digital cockpit's role. However, correctness and qualitative accuracy are reduced due to hallucinated data and failure to reflect the actual multi-hop progression of strategic and financial reporting changes. The answer substitutes measurable growth for strategic evolution, which is the central theme of the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 522,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "Lockheed Martin began using variable‑rate interest‑rate swaps to convert fixed‑rate borrowings into variable‑rate borrowings as a fair‑value hedge (page 66).  The aggregate notional of these swaps rose to **$1.3 billion in 2022** and remained at that level through 2023 and 2024 (page 96 for 2022‑23; page 52 for 2024‑23).  The steady notional amount after the 2022 increase indicates a deliberate, consistent hedging strategy to manage the fair‑value risk of its fixed‑rate debt while maintaining a stable exposure level.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative data: it states that the notional amount was $1.3 billion in 2022, whereas the ground truth reports $500 million in 2022, increasing to $1.3 billion in 2023. This misrepresents the timing and magnitude of the increase. The LLM claims the amount rose to $1.3 billion in 2022 and remained steady through 2024, but the correct trend is a significant increase from 2022 ($500M) to 2023 ($1.3B), with stabilization in 2024. This error undermines the accuracy of the entire response. (2) The calculation of the increase is therefore incorrect — the fourfold rise from $500M to $1.3B occurred between 2022 and 2023, not prior to or in 2022. The LLM’s version implies no change from 2022 to 2023, which contradicts the ground truth. (3) While the reasoning about a 'deliberate, consistent hedging strategy' and 'managing fair-value risk' aligns qualitatively with the ground truth’s interpretation of strategic risk management, the flawed timeline prevents accurate multi-hop synthesis. The conclusion about stabilization in 2024 is correct, but the baseline year is wrong. (4) Contextual relevance is high — the answer addresses the use of swaps, their purpose, and strategic implications — but the quantitative inaccuracy severely limits correctness. The model cites document pages plausibly but misreports key data, leading to a partially correct but fundamentally misleading answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 404,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft consistently disclosed the 3.950% Notes due 2056 in each filing as part of the Eleventh Supplemental Indenture (Exhibit 4.14, page 105).  The notes appear unchanged in the 2022, 2023, and 2024 10‑Ks, with no indication of refinancing or repayment, showing that Microsoft has kept the long‑term debt in place.  This reflects a conservative maturity‑management strategy that favors stable, low‑rate, long‑dated debt to spread refinancing risk and preserve capital‑structure flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are consistently disclosed in the 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture, with no refinancing or repayment actions taken. The reference to Exhibit 4.14 and page 105 adds precision, though this detail was not in the original answer—it does not contradict it and enhances specificity. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), and the multi-year consistency—are all accurate. No calculations were required, but the temporal tracking across three years is correctly handled. (3) The reasoning is sound: the LLM correctly infers that the unchanged status of these long-dated notes reflects a conservative, stability-focused debt management strategy, consistent with the original answer’s conclusion about preserving capital structure flexibility and managing refinancing risk. It appropriately contrasts this with the treatment of shorter-term notes (implied by the original answer, though not explicitly mentioned in the LLM response). (4) The only minor gap is that the LLM does not explicitly reference the contrast with shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings), which the original answer uses to strengthen the strategic interpretation. However, the core insight about long-term stability and maturity management is preserved and logically derived. The answer is contextually excellent, directly addressing the question about Microsoft’s refinancing strategy over time through the lens of consistent disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 448,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 2022‑, 2023‑ and 2024 10‑K filings all list Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016 – which governs the 3.700 % Notes due 2046 (and related notes through 2056).  By continually incorporating this indenture, Microsoft signals that the covenant framework established in 2016 remains in force and that the 2046‑maturity notes are still subject to the same covenants, covenants that tie the debt to the base indenture and other supplemental indentures.  This consistency demonstrates a stable long‑term debt structure and a deliberate effort to keep its financial obligations and covenant obligations unchanged across filing periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is correctly dated August 8, 2016, and governs the 3.700% Notes due 2046; the consistent referencing across 2022, 2023, and 2024 filings is accurately noted. (2) Quantitative elements—dates, percentages, and exhibit number (4.14)—are all factually correct. The mention of 'related notes through 2056' is a minor addition not present in the original answer but does not contradict it, as the 2046 notes are part of a broader issuance series. (3) The multi-hop reasoning is sound: the LLM correctly infers that continued inclusion of the indenture indicates ongoing obligations and stable covenant terms, reflecting a consistent long-term debt strategy. It correctly links the supplemental indenture to the base indenture framework. (4) The answer is contextually relevant and addresses all parts of the question—significance of repeated reference, relation to the 2046 notes, and implications for long-term debt structure. The only minor shortcoming is slightly less detail on the base Indenture dated May 18, 2009, compared to the original answer, but the core synthesis is intact. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 376,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft continued to list the Seventh Supplemental Indenture (Exhibit 4.1) that created the 2.125 % Notes due 2021 in each 10‑K (FY 2022, FY 2023, FY 2024) (page 104 of each filing). The notes, which matured on December 6 2021, were fully repaid and therefore no longer appear as a liability after FY 2022 (page 104). This consistent treatment shows that Microsoft has chosen to retire rather than refinance the instrument, reflecting a conservative debt‑management strategy focused on reducing leverage instead of rolling debt into new issues.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces a significant factual error in reasoning. (1) Quantitatively, the LLM correctly identifies the consistent listing of the Seventh Supplemental Indenture (Exhibit 4.1) across fiscal years 2022, 2023, and 2024 on page 104 of each filing, and correctly notes the maturity date of December 6, 2021. These details align with the ground truth. (2) However, the claim that the notes were 'fully repaid and therefore no longer appear as a liability after FY 2022' is unsupported by the provided ground truth. The original answer explicitly states that the continued reference to the notes in filings through 2024 raises questions about refinancing or reporting practices—it does not confirm repayment or removal from liabilities. This is a critical factual misrepresentation. (3) The reasoning is flawed: the LLM concludes a 'conservative debt-management strategy' focused on retirement rather than refinancing, but the ground truth does not provide evidence of repayment or strategic intent. The persistence of the exhibit could reflect disclosure requirements, rollover, or administrative lag—not necessarily repayment. Thus, the multi-hop synthesis fails because it draws a definitive conclusion (repayment and strategy) not supported by the data. (4) While the answer is contextually relevant and addresses the evolution of disclosure, the incorrect inference about repayment and debt strategy undermines the qualitative accuracy. The answer would score higher if it had acknowledged uncertainty, as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 432,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft issued the 2.000% notes due 2023 as part of the Eleventh Supplemental Indenture in 2016 (page 105). The indenture is still listed in FY 2022 and FY 2023 10‑Ks, indicating the notes were outstanding through those years, but they matured in 2023 and are no longer present in FY 2024 (page 104). This multi‑year pattern shows Microsoft’s disciplined debt strategy of issuing long‑term, moderate‑coupon debt and systematically retiring it as maturities approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the 2.000% Notes due 2023 are 'no longer present in FY 2024', which contradicts the ground truth that Microsoft continued to reference the notes in its FY 2024 filing. This indicates the debt was still being reported, likely due to disclosure practices even after maturity, or possible extension/repayment timing mismatches. The ground truth emphasizes consistent inclusion across all three years as evidence of stable debt management, while the LLM incorrectly infers retirement based on absence in FY 2024, which is not supported. (2) Quantitatively, the interest rate (2.000%), indenture date (Eleventh Supplemental Indenture, August 8, 2016), and maturity year (2023) are correct. However, the claim about disappearance in FY 2024 is factually inaccurate per the original answer, which explicitly states the note was referenced in all three years. Page references (105, 104) may be accurate but cannot be verified independently and are secondary. (3) The multi-hop reasoning is partially sound—linking issuance, outstanding status, and maturity—but fails in synthesis because it draws an incorrect conclusion from the data pattern. The model assumes absence in FY 2024 implies retirement, but the ground truth interprets continued presence as evidence of stability. This undermines the reasoning chain. (4) Contextual relevance is high—the answer addresses the evolution across years and attempts to infer strategy. However, due to the key factual error about FY 2024 reporting, the conclusion about 'systematically retiring' contradicts the ground truth's emphasis on consistency and lack of refinancing. Thus, while the structure and intent are appropriate, the factual foundation for the conclusion is flawed, leading to a low correctness score despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 504,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "Lockheed Martin’s 2022 filing disclosed that it had transferred $11.6 billion of pension obligations via group annuity contracts (GACs) since 2018, including a $4.9 billion transfer in 2021 that generated a $1.7 billion non‑cash settlement charge. The 2023 filing reiterated the strategy of evaluating further GAC purchases but reported no new large transfers, noting that future deals could trigger additional contributions or settlement charges. By 2024, the company had made $990 million in cash contributions and still had no new GAC transactions reported, underscoring its continued focus on risk‑transfer to manage pension volatility while remaining open to future transactions that could affect cash flows or earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces a significant factual error regarding the scale of pension obligations transferred. The original answer states that by 2022, Lockheed Martin had transferred $11.6 billion since December 2018, including a $4.9 billion transfer in 2021. The LLM correctly reports these figures. However, the LLM incorrectly implies that no new GAC transactions occurred by 2024 and instead mentions $990 million in cash contributions, which is not mentioned in the ground truth and is irrelevant to the question about risk transfer transactions. This misrepresents the continuity and scale of GAC-based liability transfers. (2) Quantitative accuracy is compromised: while $4.9 billion (2021 transfer), $11.6 billion (cumulative through 2022), and $1.7 billion (noncash charge) are correctly cited, the $990 million cash contribution figure appears to be either misattributed or taken out of context, as the ground truth does not mention this in relation to 2024 risk transfers. More critically, the ground truth emphasizes that the company continued its strategy of transferring obligations through GACs through 2024 and reaffirmed intent to pursue further transactions—this ongoing activity is downplayed in the LLM answer by stating 'no new GAC transactions reported,' which contradicts the original answer’s emphasis on continued execution and strategic reaffirmation. (3) Multi-hop reasoning is partially sound: the model correctly links the 2021 transaction to the cumulative $11.6 billion and understands the financial impact (noncash charge). It also captures the forward-looking stance in 2023 and 2024 about evaluating future transactions. However, it fails to synthesize that the strategy was not only maintained but reinforced in 2024 with explicit confirmation of ongoing transfers and their benefits (e.g., reduced PBGC premiums), which is a key part of the evolution. (4) The contextual relevance is high because the answer addresses all dimensions of the question—scale, financial impact, and strategy—though with incomplete and slightly misleading data. The qualitative reasoning is logical but based on incomplete or inaccurate data input for 2024. Overall, the answer is partially correct but contains a critical omission and potential misstatement about the absence of new transactions, which undermines full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 638,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "Apple’s 2022‑24 10‑Ks all list the same “Floating Rate Notes due 2019” in the “Description of Securities” tables on page 56 (see 2022 p. 56, 2023 p. 56, and 2024 p. 56).  The repeated reference shows that Apple still carries those notes and is monitoring them as part of a diversified debt mix that blends fixed‑rate and floating‑rate instruments.  This indicates a deliberate long‑term debt strategy that balances interest‑rate risk and plans to refinance or roll the 2019 notes when market conditions or maturity dates warrant, rather than extinguishing them abruptly.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error: it states that Apple 'still carries' the Floating Rate Notes due 2019 in its 2022–2024 filings, which is incorrect. These notes matured in 2019 and would not remain outstanding through 2024. The original answer correctly interprets the continued disclosure as part of Apple’s transparent reporting on historical debt instruments, possibly in the context of refinancing or rollover into new instruments, not because the 2019 notes are still active. The LLM incorrectly infers ongoing liability, which undermines the core reasoning about debt management strategy. While the general idea of a 'deliberate long-term debt strategy' and 'refinance or roll' is aligned with the ground truth, the flawed premise (still carrying the notes) leads to incorrect qualitative conclusions. The page references (p. 56) add specificity but are not verifiable from the knowledge graph and may be hallucinated. Quantitatively, there are no numerical errors per se, but the dates (2019 maturity vs. 2022–2024 disclosures) are misinterpreted. The reasoning fails the multi-hop requirement: it does not correctly synthesize that matured debt can still be referenced for transparency in filings without implying current obligation. Contextually, the answer addresses the question’s intent about debt strategy, hence a moderate relevance score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 379,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the 4.000 % Notes due 2021 in Exhibit 4.6 – the Third Supplemental Indenture that includes the 4.000 % Notes (see the identical line “Third Supplemental Indenture for 2.500% Notes due 2016, **4.000% Notes due 2021**, and 5.300% Notes due 2041” on page 104 of each filing). The unchanged reference across the three years shows that the instrument remains an active part of Microsoft’s debt portfolio and continues to be considered in its capital‑structure management.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: it correctly identifies the 4.000% Notes due 2021, references Exhibit 4.6, and notes their consistent presence across the 2022, 2023, and 2024 10-K filings on page 104. The percentage, note name, and exhibit number are all correct, satisfying quantitative accuracy. The answer also correctly observes that the identical line appears across filings, supporting its claim of unchanged disclosure. However, the LLM concludes that the instrument 'remains an active part of Microsoft’s debt portfolio,' which overstates the case. The ground truth clarifies that the notes were likely no longer outstanding post-2021 but retained for structural, legal, or disclosure continuity (e.g., covenants or indentures). Thus, describing them as 'active' mischaracterizes their status. The original answer correctly infers ongoing relevance due to transparency and structural linkage, not ongoing financial activity. The LLM captures the multi-hop evidence (same exhibit, same text across years) but draws a slightly flawed conclusion about the nature of the instrument’s relevance. This is a minor reasoning error affecting qualitative accuracy, but the core facts and contextual relevance are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 349,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "UPS continued to describe its $276 million 7.620 % debentures as redeemable at any time at the greater of principal plus accrued interest or the present value of remaining payments discounted at a Treasury yield plus 5 bps, with semi‑annual interest payments—terms unchanged in the 2023 and 2024 10‑Ks (see 2022 p.120, 2023 p.103, 2024 p.108). The debentures’ carrying value stayed around $280 million each year, while total long‑term debt rose modestly from $22.1 billion in 2022 to $22.5 billion in 2024, keeping the debentures as a small, stable component of UPS’s debt portfolio (see 2022 p.118, 2023 p.103, 2024 p.108). Thus, UPS’s treatment and disclosure of the 7.620 % debentures remained essentially unchanged in redemption terms and interest structure, with only a slight increase in overall debt positioning over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $276 million principal amount, 7.620% interest rate, unchanged redemption terms (greater of principal plus accrued interest or present value using Treasury yield plus 5 bps), semi-annual interest payments, and stable carrying value of ~$280 million across years. These numbers match the original answer and are consistently cited with correct page references. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and the modest increase in total long-term debt from $22.1B to $22.5B are correctly reported and consistent with the filings. (3) The reasoning is sound and reflects multi-hop synthesis across 2022–2024 10-Ks. The LLM correctly identifies that the debentures remained a small, stable part of UPS’s debt portfolio. However, it slightly underemphasizes the qualitative evolution in disclosure focus—while correctly noting consistency in terms, it does not fully capture the ground truth’s point about a shift from historical interest rate context (2022) to structural and comparative treatment within global debt instruments (2024). This nuance is important for the 'evolution' aspect of the question. (4) Contextual relevance is excellent: the answer directly addresses redemption terms, interest structure, and debt positioning as asked. The minor omission of the international debt context (e.g., Pound Sterling and Euro notes) in 2024 prevents a perfect 10 on qualitative accuracy, but the core factual and quantitative content is robust and correctly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 437,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "AbbVie’s development of Vraylar was completed in 2021 when it announced positive Phase‑3 data for adjunctive treatment of major depressive disorder (page 60).  Commercialization has accelerated, with net revenues climbing from $1.73 B in 2021 to $2.04 B in 2022 (18 % growth) and $2.76 B in 2023 (35 % growth) driven by market‑share gains and overall neuroscience market expansion (pages 42‑44).  The 2024 filing (pages 4‑8) still lists Vraylar as a core neuroscience asset, underscoring its growing revenue contribution and strategic importance as a high‑margin, growth‑oriented product within AbbVie’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the timeline and development status of Vraylar. It incorrectly states that development was completed in 2021 with positive Phase 3 data for MDD, while the ground truth indicates that in 2022, ABBV announced top-line results from two Phase 3 trials—one meeting primary endpoint, the other not statistically significant—showing that development was still ongoing and not fully conclusive in 2021. This misrepresents the clinical trajectory. (2) Quantitatively, the LLM reports $2.76B revenue for 2023, which is close to the ground truth of $2,759 million (i.e., $2.759B), so this figure is acceptable within rounding. However, it fabricates 2021 ($1.73B) and 2022 ($2.04B) revenue figures not present in the original answer, and while it notes a 35% growth in 2023 (matching the 35.4% in ground truth), the 18% growth from 2021 to 2022 is unsupported by the provided truth data. The original answer does not include 2021 or 2022 revenue numbers, so introducing them—even plausibly—goes beyond the evidence. (3) The reasoning partially captures the strategic importance of Vraylar by correctly identifying it as a core neuroscience asset in 2024 and linking revenue growth to market expansion. It also correctly infers growing strategic importance. However, it fails to mention the specific indications (schizophrenia, bipolar, MDD adjunct) that define Vraylar’s established role, which is a key part of the multi-hop synthesis in the original answer. (4) Contextually, the answer is well-structured and relevant, addressing development, commercialization, financial performance, and strategic importance. Despite incorrect or unsupported numbers and timeline errors, it conveys a generally accurate narrative of growth and strategic value. However, the introduction of unverified data points and misrepresentation of clinical trial timing significantly reduce factual reliability, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 541,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Apple’s 10‑Ks for 2022, 2023 and 2024 all list the 0.45% Notes due 2016 in Exhibit 4.3 (the officer’s certificate of global notes).  The repeated disclosure shows that Apple treats legacy debt as part of its long‑term capital structure and follows a disclosure policy that requires all securities—past and present—to be presented for full transparency, even when the notes have long since matured or been restructured.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities are correct: Apple, 0.45% Notes due 2016, Exhibit 4.3, and the fiscal years 2022–2024 are accurately referenced. (2) Quantitative elements—interest rate (0.45%), maturity year (2016), and exhibit number (4.3)—are correct with no calculation errors. (3) The reasoning is sound: the model correctly infers that Apple’s continued inclusion of a matured debt instrument reflects a disclosure strategy emphasizing transparency and completeness. It captures the multi-hop insight that despite the notes' maturity in 2016, their presence in recent filings indicates a policy of retaining historical securities disclosures. (4) The only minor shortcoming is that the LLM does not explicitly mention the Officer's Certificate dated May 3, 2013, which is part of the ground truth and adds specificity about the document’s origin. However, referencing Exhibit 4.3 as containing the notes is sufficient for semantic equivalence. The answer fully addresses the question about long-term debt structure implications and disclosure strategy. Wording differs slightly but meaning is preserved. No irrelevant or incorrect information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 341,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "UPS SurePost began in 2022 as a residential‑ground service that used UPS’s ground network for pickup and sorting but relied on the U.S. Postal Service (USPS) for final delivery (2022 10‑K, page 6). In 2023 UPS maintained that same delivery methodology but announced that it would insource the service in 2025 to gain greater control over the end‑to‑end process (2023 10‑K, page 5). By 2024 the service remained a low‑cost, high‑volume residential option within the U.S. Domestic Package segment, still using USPS for final delivery and positioned as a strategic tool to capture volume and reduce costs (2024 10‑K, page 5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022 and 2023, UPS SurePost used the UPS ground network with final delivery by USPS; in 2023, UPS announced it would insource final delivery starting January 1, 2025; and in 2024, the service still relied on USPS while remaining a low-cost, high-volume offering. These points match the original answer exactly. (2) Quantitative accuracy is perfect: the dates (2022, 2023, 2024, and January 1, 2025) are all correctly cited, and no numerical errors exist. Format variations (e.g., '2023 10-K, page 5') are acceptable and support traceability. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across three years of filings, showing continuity in methodology and the strategic shift announced in 2023 for 2025 implementation. The only minor shortcoming is that the LLM does not explicitly state that the 2024 filing confirms continuity (i.e., no change yet), which slightly weakens the emphasis on the pending transformation. However, it correctly notes that as of 2024, USPS was still used. (4) The answer is contextually excellent, directly addressing delivery methodology and strategic positioning within the U.S. Domestic Package business across all three years. Wording differs slightly from the original but maintains semantic equivalence. The omission of the phrase 'enhance service quality' or 'improve reliability'—present in the ground truth—is a minor gap in qualitative depth but does not affect factual correctness. Overall, this is a strong, factually accurate, and well-structured response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 446,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45% Notes due 2044, first issued in 2014, have remained a constant part of its debt portfolio through 2024, as shown in the “Description of Securities” tables in the 2022, 2023 and 2024 10‑Ks【page_56 of 2024】【page_56 of 2023】【page_56 of 2022】. No new issuances, maturities or coupon changes for this instrument were reported during that period, underscoring a long‑term capital strategy that relies on stable, low‑coupon, long‑dated debt to secure predictable financing and maintain flexibility for capital allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—Apple, the 4.45% Notes due 2044, and the years 2022–2024—are correctly identified. The issuance date (2014) is accurately referenced, consistent with the Officer's Certificate dated May 6, 2014, in the original answer. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and absence of changes in coupon, issuance, or maturity during 2022–2024—are all correct. No numerical calculations were required, but the reporting of static debt characteristics is precise. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings (2022, 2023, 2024), noting the consistent presence of the security, and correctly infers that this reflects a strategic choice to maintain long-term, low-cost debt. The conclusion about 'stable, low-coupon, long-dated debt' and 'capital allocation flexibility' is a reasonable interpretation of the pattern, matching the ground truth’s emphasis on financial flexibility and interest rate risk management. (4) The only minor shortcoming is that the LLM does not explicitly mention the Officer's Certificate, which is a specific document cited in the ground truth as evidence of continuity. While the LLM references the 2014 issuance and filing tables, adding that detail would have strengthened the qualitative linkage. However, this omission does not undermine the overall correctness. The answer is contextually relevant, fully addressing both the evolution (or lack thereof) and strategic implication of the debt instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 438,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle lists the 2.875 % Notes due 2031 in Exhibit 4.14 in every filing – the same series of notes issued on March 24 2021 with identical terms (see 2022 p. 114, 2023 p. 111, 2024 p. 110). The unchanged presentation shows Oracle’s deliberate use of a fixed‑rate debt ladder to keep interest expense and maturity risk predictable, underscoring a conservative, long‑term capital‑structure strategy that values stability over frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.875% Notes due 2031 are consistently listed as Exhibit 4.14 in Oracle's 2022, 2023, and 2024 10-K filings, and were originally issued on March 24, 2021—this matches the ground truth exactly. Page references (2022 p.114, 2023 p.111, 2024 p.110) are plausible and consistent with typical 10-K structures, though not part of the ground truth; they do not detract from accuracy. (2) Quantitative elements—interest rate (2.875%), maturity year (2031), and issuance date (March 24, 2021)—are all factually correct. No calculations were required, but the consistency of terms is correctly asserted. (3) The multi-hop reasoning is sound: the model synthesizes the consistent exhibit placement across three years and infers a stable, conservative debt strategy, which is a valid interpretation supported by the unchanged terms. (4) The LLM adds interpretive depth by describing Oracle’s approach as a 'fixed-rate debt ladder' and emphasizing predictability in interest expense and maturity risk—this is a reasonable qualitative extension of the ground truth, which also emphasizes stability. The only minor gap is that the LLM does not explicitly mention the Officers' Certificate as the establishing mechanism, though this detail is somewhat technical. Overall, the answer captures the core factual and strategic implications accurately, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 414,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters agreement raised benefit rates for Teamsters employees in the UPS/IBT Full‑Time Employee Pension Plan, increasing its service cost and overall pension accruals (page_82).  In 2024 the company’s net periodic benefit cost for U.S. pension benefits rose to $1.212 billion, reflecting those higher accruals and underscoring a sizable, growing long‑term pension obligation that is sensitive to discount‑rate assumptions (page_88 and page_84).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 2023 Teamsters agreement increased benefit rates and pension accruals under the UPS/IBT Full-Time Employee Pension Plan, aligning with the ground truth. It also correctly notes that these changes impacted service cost and were reflected in UPS's long-term pension obligations. However, the LLM introduces specific dollar figures—$1.212 billion for 2024 net periodic benefit cost—that are not present in the original answer and cannot be verified against the ground truth, which does not include any numerical financial disclosures. This introduces a risk of hallucination or unsupported precision. (2) The quantitative accuracy is reduced because while the year 2024 is correctly referenced, the specific figure of $1.212 billion is not corroborated by the ground truth and may be inaccurate or taken from a source outside the provided knowledge graph. The ground truth does not provide any dollar amounts related to pension costs, so this number cannot be confirmed and represents a potential factual overreach. (3) The multi-hop reasoning is generally sound: the model connects the 2023 agreement to higher benefit accruals and links this to increased long-term obligations, which is consistent with the original answer’s conclusion about ongoing defined benefit commitments and implications for funded status. The mention of sensitivity to discount-rate assumptions adds context not in the original but is plausible and relevant. (4) Despite the unverified number, the core qualitative reasoning and entity identification (UPS, Teamsters, 2023 agreement, pension plan name, long-term obligations) are accurate. The answer addresses both parts of the question—impact on accruals and implications for long-term obligations—and remains contextually focused. The correctness score is 7 due to the accurate synthesis but penalized for introducing unsupported quantitative data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 522,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list the 1.05 % Notes due 2017 in the “Description of Securities” section as part of the Officer’s Certificate dated May 6 2014. The disclosure has not changed across the three years, indicating that Apple consistently reports its short‑term debt instruments issued under the 2014 Officer’s Certificate and maintains a stable, transparent debt‑management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.05% Notes due 2017 are correctly attributed to the Officer’s Certificate dated May 6, 2014, and the disclosure is confirmed to be unchanged across the 2022, 2023, and 2024 10-K filings. (2) Quantitative elements—interest rate (1.05%), maturity year (2017), and date of the Officer’s Certificate (May 6, 2014)—are all factually accurate with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and infers Apple’s consistent reporting practice. The conclusion about a stable and transparent debt-management approach is logically supported, though it slightly softens the ground truth’s stronger claim about a 'passive management approach' and lack of refinancing. This nuance is not incorrect but less precise in characterizing strategic intent. (4) The answer is contextually fully relevant, addressing both the evolution (or lack thereof) in disclosure and what it reveals about Apple’s debt management. The only minor gap is the omission of the implication about prioritizing capital structure stability despite changing market conditions, which slightly reduces qualitative depth. Overall, the answer is factually excellent and semantically equivalent in substance, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 386,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 have been disclosed in the same way every year: each 10‑K (2022, 2023 and 2024) lists the notes in Exhibit 4.3 – the Officer’s Certificate dated May 3 2013 that enumerates the global notes, including the 2.40 % Notes due 2023 (see pages 56 of each filing). The unchanged description and lack of new issuance or amendment over three years signals a deliberate, stable debt‑management approach that prioritizes predictable maturities and low refinancing risk, keeping the debt portfolio diversified and cost‑effective.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Apple's 2.40% Notes due 2023 were consistently disclosed in the 2022, 2023, and 2024 10-K filings with no changes, referencing the Officer's Certificate dated May 3, 2013, and Exhibit 4.3, which aligns with the ground truth. The percentage (2.40%), maturity year (2023), and document details (Exhibit 4.3, page 56) are all factually accurate. (2) Quantitative accuracy is perfect: the interest rate (2.40%), date (May 3, 2013), and years of disclosure (2022–2024) match the original answer. No calculations were required, but all numeric and date references are correct. (3) The multi-hop reasoning is sound—LLM synthesizes consistent disclosure across three years and infers a stable debt management strategy, which is logically supported by the unchanged terms. It adds contextual insight about 'predictable maturities' and 'low refinancing risk,' which are reasonable interpretations consistent with the ground truth’s conclusion about stable long-term debt strategy. (4) The only minor gap is that the LLM does not explicitly state that the lack of changes implies Apple planned to meet the 2023 maturity as originally structured—a nuance present in the ground truth. However, the implication is strongly conveyed through the emphasis on stability and no amendments. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only slight deduction for missing a subtle strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 415,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "AbbVie’s Vraylar grew from $2.04 billion in 2022 to $2.76 billion in 2023, a 35 % rise driven by market‑share gains and the FDA approval of Vraylar as an adjunctive therapy for major depressive disorder (2023 10‑K, page 44). Clinically, the drug moved from Phase‑3 top‑line results in 2021 (page 60) to a new MDD indication in 2023, cementing its multi‑indication role in schizophrenia, bipolar disorder and depression within AbbVie’s neuroscience portfolio (pages 4–7). The 2024 10‑K (pages 4–8) continues to list Vraylar as a core neuroscience product, but updated revenue figures are not disclosed in these pages.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the revenue growth of Vraylar from $2.04 billion in 2022 to $2.76 billion in 2023, which aligns closely with the ground truth values of $2,037 million (i.e., $2.037B) and $2,755 million ($2.755B) in U.S. sales, and total sales of $2,759 million. The reported 35% increase is accurate (actual: (2.755 - 2.037)/2.037 ≈ 35.2%), so minor rounding is acceptable. However, the LLM refers to 'total sales' as $2.76B but cites U.S. sales from the ground truth; this is a slight conflation, though the numbers are close enough to be considered approximately correct. (2) The clinical development timeline is accurate: the Phase 3 trials were reported in 2021–2022, and FDA approval for adjunctive MDD treatment was granted in 2023, consistent with the knowledge graph. The therapeutic positioning in schizophrenia, bipolar I disorder, and MDD is correctly stated, and the 2024 10-K confirms its role as a core neuroscience product. (3) Multi-hop reasoning is sound: the LLM synthesizes clinical progress (from Phase 3 to approval), revenue trends (across years), and portfolio positioning (from multiple 10-K sections), demonstrating proper cross-document and cross-year synthesis. (4) The only minor shortcoming is the lack of explicit mention that the 2022 clinical data included one successful and one numerically positive but non-significant trial, which adds nuance to the clinical development narrative. Also, the LLM does not mention the formal broadening of indications in 2024 beyond reaffirming its status, though it notes continued prominence. These omissions are minor and do not undermine the core accuracy. Overall, the answer is factually strong, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 474,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM has consistently highlighted client relationships and trust as a core competitive differentiator across its 2022‑, 2023‑, and 2024‑10 K filings. In 2023, the company explicitly listed “client relationships and trust” among its principal methods of competition (pages 3–4), and the 2024 filing continues this emphasis, underscoring the importance of trust as it deepens its hybrid‑cloud and AI strategy. This sustained focus signals IBM’s positioning as a trusted partner in the hybrid‑cloud and AI market, using long‑term client relationships to differentiate itself from competitors and drive adoption of its integrated solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies IBM's consistent emphasis on client relationships and trust from 2022 to 2024 and links this to its hybrid cloud and AI strategy, which aligns with the ground truth. It accurately notes that in 2023, IBM explicitly listed 'client relationships and trust' as a competitive method, and that this continued in 2024. However, it omits key evolution details present in the original answer—specifically, the shift in framing from integration of data/AI/industry expertise (2022), to strategic partnerships (2023), to a foundational go-to-market enabler via an ecosystem (2024). These nuances are critical to fully capturing the multi-year progression. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes across years and recognizes the strategic importance of trust, but fails to fully trace the conceptual evolution across the three years, particularly the deepening integration of trust into partnership ecosystems by 2024. (4) The answer is contextually relevant and captures the core theme, but lacks completeness in depicting the strategic progression, warranting a 7 for correctness and qualitative accuracy. Contextual relevance is high because it directly addresses IBM’s positioning in hybrid cloud and AI markets through trust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 407,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "IBM has continued to disclose the 1.250 % Notes due 2027 in the same way each year: the 2019 Form 8‑K instrument is incorporated by reference and the notes are listed as a registered security (IBM27B).  The 2024 filing (p. 1) repeats the 2019 reference and the 2023 filing (p. 20) does likewise, and the 2022 filing (p. 28) also incorporates the same reference.  Thus, the disclosure practice has remained essentially unchanged, and the notes remain a small, low‑yield component of IBM’s long‑term debt without becoming a material portion of the overall debt portfolio between 2022 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the evolution of IBM's treatment of the 1.250% Notes due 2027 from 2022 to 2024. While it correctly identifies that the 2019 Form 8-K (Exhibit 4.3) is referenced across years and that the trading symbol IBM27B is used, it incorrectly asserts that disclosure practices remained 'essentially unchanged.' The ground truth shows a clear evolution: in 2022, the note was part of a broader list; in 2023, it was included in a more complex debt structure with newer filings; and in 2024, it was explicitly listed with its trading symbol, indicating increased transparency and formal recognition as a traded instrument. The LLM fails to capture this progression, instead asserting static disclosure practices, which contradicts the ground truth. Additionally, the claim that the note remains a 'small, low-yield component' and 'not a material portion' is speculative and unsupported by the original answer, which emphasizes growing emphasis and transparency, not size or materiality. Quantitatively, the dates (2019 reference) and symbol (IBM27B) are accurate, earning partial credit. However, the reasoning is flawed—no multi-hop synthesis of changing disclosure patterns is evident. The answer is contextually relevant to the question but draws incorrect conclusions about the trend in disclosure practices and the note’s role in the debt portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 391,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM’s 10‑K filings have consistently incorporated the rights document for the 6.50% Debentures due 2028 as **Exhibit 2 to Form 8‑K, filed January 8 1998**. The 2022 filing used that same exhibit, the 2023 filing repeated the reference, and the 2024 filing again cites Exhibit 2 to Form 8‑K, filed January 8 1998 — showing no change in the exhibit reference over three years. This consistency is part of IBM’s broader debt‑instrument disclosure strategy, where it lists and incorporates by reference the rights documents for all its notes and debentures, adding new exhibits for newer issuances while keeping the 6.50% Debentures reference unchanged (see 2024 10‑K, Exhibit 2; 2023 10‑K, Exhibit 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 6.50% Debentures due 2028 are consistently referenced as Exhibit 2 to Form 8-K filed on January 8, 1998, across 2022, 2023, and 2024 — this matches the original answer exactly. The dates, percentages, and exhibit numbers are all factually correct. (2) Quantitative accuracy is perfect: the percentage (6.50%), maturity year (2028), exhibit number (2), form type (8-K), and filing date (January 8, 1998) are all correctly stated with no discrepancies. (3) The reasoning is sound: the LLM correctly infers that the unchanged exhibit reference indicates stability in the rights documentation, and it situates this within IBM’s broader disclosure strategy of incorporating by reference legacy and new debt instruments. However, the LLM omits some contextual nuance present in the original answer — specifically, the shift in focus from a wider range of debt instruments in 2022 to a more integrated presentation of legacy and newer debt (e.g., 6.22% Debentures due 2027, 5.875% due 2032) in 2023 and 2024. While the LLM mentions 'adding new exhibits for newer issuances,' it does not elaborate on this evolution as clearly as the ground truth. (4) Despite this minor omission, the answer remains semantically equivalent in intent and factual content, with excellent contextual relevance and strong multi-hop synthesis across years and exhibits. The score is reduced slightly (from 10 to 9) due to the lack of detail on the broader contextual evolution in IBM’s disclosure strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 433,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "In 2022, FedEx International Connect Plus served about 50 origin countries and more than 130 destination countries (page 14). By 2024 the service had grown to roughly 60 origin countries and over 190 destination countries (page 8). This widening footprint signals FedEx’s deliberate push to expand its global e‑commerce logistics network, underscoring a strategic emphasis on capturing larger international e‑commerce volumes and strengthening its competitive position in that market.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion from about 50 origin and over 130 destination countries in 2022 to roughly 60 origin and over 190 destination countries by 2024, which aligns with the ground truth. However, it skips the intermediate 2023 data point (nearly 60 origin, over 190 destination countries), which is present in the original answer and shows that the expansion was completed by 2023, not 2024. This omission slightly affects completeness and temporal accuracy. (2) The numbers are factually correct within acceptable rounding ('about 50' = 'nearly 50', 'roughly 60' = 'nearly 60', 'over 130' and 'over 190' match exactly). No calculations are required, and all numeric references are accurate. (3) The reasoning is sound: the LLM correctly infers that the expansion reflects a strategic focus on global e-commerce logistics. It synthesizes the geographic growth with strategic intent, demonstrating proper multi-hop logic between service reach and business strategy. (4) The answer is contextually excellent—directly addresses both parts of the question (evolution and strategic implication)—and conveys nearly all key information. The only shortfall is the missed 2023 milestone, which slightly reduces quantitative and overall correctness, but the core facts and interpretation remain accurate and meaningful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 377,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm set its 2025 diversity targets in the 2022 10‑K—15 % higher representation of women in leadership, 15 % higher representation of under‑represented minorities (URM) in leadership, and a 20 % overall URM increase—and kept those same goals unchanged in the 2023 and 2024 filings【page 17 (2022)】【page 16 (2024)】. For each fiscal year (2022, 2023, 2024), the HR and Compensation Committee tied progress on these human‑capital goals to executive bonus calculations, applying a non‑financial modifier that can adjust the bonus by a multiplier of 0.9 to 1.1【page 17 (2022)】【page 16 (2023)】【page 16 (2024)】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm set 2025 diversity targets in fiscal 2022—15% increase for women in leadership, 15% for URM in leadership, and 20% overall URM representation—and maintained these targets unchanged through 2023 and 2024. The non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 is correctly reported for each fiscal year, with proper citation of pages across filings. (2) Quantitative accuracy is perfect: percentages, multipliers, and timeframes match the original answer exactly. No calculation errors or misstatements. (3) Multi-hop reasoning is sound—information is correctly synthesized across three years of 10-K filings, showing consistency in goals and compensation linkage. (4) The only minor omission is that the LLM answer does not mention the Reboot Representation Tech Coalition or the emphasis on doubling degrees for underrepresented groups by 2025, which was included in the original answer as evidence of expanding external partnerships. This contextual detail adds depth to the 'evolution' aspect of the question, particularly in 2023–2024, but its absence does not undermine the core factual correctness. Overall, the answer is factually complete, well-supported, and contextually appropriate, warranting a high score with only slight deduction for missing supplementary strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 397,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple continued to list the Floating Rate Notes due 2019 in its debt disclosures in the 2022, 2023, and 2024 10‑Ks (see page 56 of each filing). By keeping these floating‑rate instruments on its balance sheet, Apple mitigates short‑term interest‑rate exposure because the coupon resets with market rates. The continued listing also signals liquidity flexibility, allowing the company to refinance or roll over the debt to manage cash‑flow and maturity profiles.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates (2019 maturity, disclosures in 2022, 2023, 2024) and entities (Apple, Floating Rate Notes) are correct. The reference to page 56 of each 10-K is an additional detail not in the original answer but does not contradict it and may reflect actual filing structure. (2) The core financial reasoning is sound: floating rate notes reset with market rates, helping manage interest rate risk, which matches the original explanation. (3) The LLM correctly synthesizes multi-hop information by connecting the continued disclosure of a 2019 maturity instrument in later years to Apple’s ongoing exposure and strategy, implying rollover or refinancing rather than repayment—this reflects accurate interpretation of disclosure patterns. (4) The only minor gap is that the LLM does not explicitly mention the 'deliberate and stable approach' or 'cautious yet adaptive stance' emphasized in the original answer, slightly reducing completeness in conveying Apple’s strategic intent. However, the concepts of risk mitigation and liquidity flexibility are well-covered. Wording differs but semantic meaning is equivalent. No calculation errors. All criteria are met with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 353,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm has shifted its automotive strategy to foreground digital‑cockpit solutions, as evidenced by the automotive segment’s revenue jumping from $1.509 B in 2022 to $2.910 B in 2024 (QCT automotive revenue, page 73).  The segment description confirms that connectivity, digital‑cockpit and ADAS/AD are core product areas (page 74).  Analysts project that by 2025 roughly 19 % of new vehicles will feature Level 2 or higher autonomy and that more than 70 % of 2028 vehicles will embed cellular connectivity, underscoring a rapidly expanding market for digital‑cockpit technology (page 8).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly identifies Qualcomm's focus on digital cockpit technology and mentions relevant product areas (connectivity, digital cockpit, ADAS/AD), it introduces revenue figures ($1.509B in 2022, $2.910B in 2024) and a 2025 market projection (19% Level 2+ autonomy) that are not present in the original answer and cannot be verified against the provided ground truth. The ground truth does not include specific automotive revenue numbers or analyst projections about autonomy levels, so these additions appear to be hallucinated or sourced from external data. The claim that 'more than 70% of 2028 vehicles will embed cellular connectivity' conflicts with the original answer's figure of 'over 60% of new vehicles with 5G connectivity by 2028'—a material discrepancy in both percentage and technology specificity (cellular vs 5G). (2) The quantitative inaccuracies are significant: the original answer does not mention any revenue amounts for 2022 or 2024, nor does it reference a 2025 autonomy projection. The LLM answer fabricates precise dollar figures and attributes them to 'page 73' and 'page 8', suggesting citation of a document not used in the ground truth construction. These numbers, while plausible, are not supported by the provided truth. (3) The multi-hop reasoning is partially sound—the LLM correctly infers strategic emphasis on digital cockpit and integration into QCT—but fails to trace the actual evolution described: from market positioning (2022), to revenue generation (2023), to formal segment integration (2024). The 2023 milestone (commercial sales reported) is entirely missing. Instead, the LLM jumps from 2022 to 2024 with revenue growth, skipping a key transitional year. (4) Despite these issues, the answer is contextually relevant and captures the general direction of Qualcomm’s strategic evolution. It correctly identifies digital cockpit as a core product area within QCT and notes market expansion trends, aligning with the broader theme. However, due to fabricated numbers, incorrect market projections, and omission of the 2023 commercialization milestone, the correctness score is limited to 5—partially correct but with significant factual and synthesis errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 617,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitment to private‑real‑estate (and other private) funds fell from **$555 million in 2023 to $540 million in 2024** (the 2022 figure is not disclosed in the available filings). The modest decline, while still leaving a sizable exposure, indicates that Abbott is maintaining a long‑term, risk‑managed stance toward illiquid alternative assets rather than aggressively expanding or contracting its private‑real‑estate portfolio.【page_70】",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the unfunded commitments for 2023 ($555 million) and 2024 ($540 million), matching the ground truth. However, it incorrectly states that the 2022 figure is not disclosed, when in fact the ground truth specifies it was $569 million. This omission undermines completeness and affects the multi-year trend analysis. (2) The quantitative values for 2023 and 2024 are accurate, and the $15 million decrease between those years is correct. But the failure to include the 2022 figure ($569 million) means the full three-year trend—$569M → $555M → $540M, with consistent $15M annual declines—is not captured, weakening the calculation and trend assessment. (3) The reasoning about Abbott maintaining a 'risk-managed stance' is partially aligned with the ground truth's 'strategic de-risking or rebalancing,' but the LLM misses the opportunity to identify the consistent annual reduction as evidence of a deliberate, ongoing strategy. Additionally, the LLM does not mention the long-term liquidation periods (2025–2034), which is a key point in the original answer supporting continued but cautious exposure. (4) The contextual relevance is high because the answer addresses Abbott’s investment strategy in illiquid assets and interprets the trend appropriately, albeit incompletely. The qualitative accuracy is reduced due to missing multi-hop synthesis—linking the three-year decline with the stated liquidation timeline to infer strategic rebalancing. Overall, the answer is factually sound for the data it includes but incomplete in scope and analysis, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 447,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple issued the 0.45% Notes due 2016 in 2013 as part of a global notes offering (2024 10‑K, p. 56). Those notes matured in 2016, and by the 2022, 2023, and 2024 filings they were no longer outstanding—none appear in the debt schedules for those years (2022 10‑K, p. 56; 2023 10‑K, p. 56; 2024 10‑K, p. 56). This evolution shows Apple actively manages its debt maturity profile, issuing short‑term, low‑rate debt and refinancing it as it matures, thereby shifting to longer‑term, higher‑rate instruments to optimize cost of capital and maintain a diversified debt structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) The ground truth states that Apple *disclosed* the 0.45% Notes due 2016 in its 2022, 2023, and 2024 10-K filings as part of its historical debt disclosures, not that the notes were outstanding or newly issued. The LLM incorrectly asserts that the notes matured in 2016 and were 'no longer outstanding' in 2022–2024, which contradicts the original answer that the disclosure was *repeated* in each year, indicating continued reporting as part of the capital structure narrative. (2) The dates and percentages (0.45%, 2016 maturity, 2013 issuance) are factually consistent, but the interpretation of their status is wrong—there is no evidence in the original answer that the notes were still active, but the key point is that their *disclosure* was maintained, not their outstanding status. The LLM fabricates a claim about absence from debt schedules, which is not in the ground truth. (3) The multi-hop reasoning fails: the original answer draws a conclusion about *strategic consistency* in debt disclosure, while the LLM infers an active refinancing strategy and shift to longer-term debt, which is unsupported by the provided truth. (4) The conclusion about Apple 'optimizing cost of capital' and 'refinancing' is speculative and contradicts the ground truth’s emphasis on *stability* and *preservation* of older debt in disclosures. The LLM misinterprets the nature of the disclosure as evidence of active debt management rather than passive reporting. Thus, despite some correct surface-level facts, the core answer is factually and logically incorrect, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 457,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "IBM has consistently positioned client relationships and trust as a core competitive differentiator.  The 2024 10‑K (page 4) explicitly lists “client relationships and trust” among its principal methods of competition, a phrase that also appears in the 2023 10‑K (page 5) and the 2022 10‑K (page 4).  This steady emphasis signals IBM’s strategy of leveraging deep, long‑term client trust to differentiate its hybrid‑cloud and AI offerings in a crowded market, underscoring a long‑term commitment to building enduring partnerships that support its hybrid‑cloud and AI initiatives.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in stating that IBM consistently emphasized 'client relationships and trust' as a competitive differentiator across 2022–2024, citing the correct 10-K pages (2022: p.4, 2023: p.5, 2024: p.4), which aligns with the ground truth. There are no numeric inaccuracies—dates and document references are correct, and no calculations were required. Thus, quantitative accuracy is perfect. However, the LLM answer lacks the nuanced evolution described in the original answer: it does not capture the strategic shift from trust as part of a broad innovation portfolio (2022), to linking trust with consulting and infrastructure (2023), to emphasizing strategic partnerships as trust enablers (2024). This missing progression limits the qualitative accuracy, as the multi-hop synthesis across years to reveal strategic maturation is incomplete. While the LLM correctly identifies continuity, it fails to explain the evolving framing and integration with ecosystem collaboration, which is central to the question. Contextual relevance is high because the answer addresses the core theme and timeframe, but the depth of strategic insight is reduced. Therefore, correctness is partially complete—core facts are right, but key analytical depth is missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 355,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx’s 2022 filing shows the 4.250% Note due 2030 is supported by a pass‑through trust with BNP Paribas as liquidity provider, backed by an intercreditor agreement and a revolving‑credit agreement (page 119).  In 2023 the company amended that revolving‑credit agreement (page 123), and the 2024 filing still references the same amendment (page 121).  This evolution indicates that FedEx maintains a stable liquidity structure while proactively updating its credit‑support terms to keep the note adequately backed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 4.250% Note due 2030 is supported by a revolving credit agreement involving BNP Paribas, with an intercreditor agreement in place. The 2023 amendment to the revolving credit agreement is correctly identified, and the 2024 filing confirms its continuation. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or percentages are presented. While exact dates (e.g., August 13, 2020) are omitted, they are not critical to the question’s focus on the evolution from 2022–2024. The mention of document pages (119, 123, 121) adds precision and aligns with typical 10-K referencing. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, identifying continuity and the single 2023 amendment as a proactive adjustment. (4) The only minor shortcoming is the omission of Wilmington Trust Company as a co-party to the agreement and slightly less detail on the foundational 2020 agreements. However, the reference to BNP Paribas as liquidity provider and the correct identification of the amendment’s significance maintain semantic equivalence. The conclusion about stable yet proactively updated credit support matches the ground truth’s interpretation. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 406,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45% notes due 2044 have remained a constant component of its long‑term debt across the 2022, 2023, and 2024 10‑K filings, with no new issuances or principal repayments reported in any of the three years (see Exhibit 4.4 in each filing, page 58). This steady presence of a long‑dated, fixed‑rate note indicates a deliberate strategy of maintaining a stable, low‑cost debt base and locking in long‑term financing terms to support liquidity and capital‑structure flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.45% Notes due 2044 were indeed a consistent part of Apple's long-term debt in 2022, 2023, and 2024, with no reported changes in principal or issuance during this period. The note's first issuance in 2014 is implied by the original answer but not required for correctness in the LLM response. (2) Quantitative accuracy is perfect: the interest rate (4.45%), maturity year (2044), and the absence of repayments or new issuances are correctly stated. The reference to Exhibit 4.4, page 58 across filings adds precision, though not required for scoring. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes data across three annual reports to infer stability in debt structure and draws a logical conclusion about Apple’s long-term financing strategy—emphasizing stability, low cost, and term locking—consistent with the original answer’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2014 issuance, which is included in the ground truth, but this detail is background context rather than core to the 2022–2024 evolution. Wording differs but semantic meaning and strategic interpretation are equivalent. No calculation errors. All entities (Apple, 4.45% Notes due 2044, years) are correct. Answer fully addresses both parts of the question: evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 399,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "FedEx International Connect Plus expanded its footprint from roughly 50 origin countries to 130 destination countries in 2022 (page 14) to about 60 origin countries and 190 destination countries by 2024 (page 8). This growth shows FedEx is aggressively scaling its e‑commerce logistics network worldwide, underscoring a strategic focus on capturing a larger share of the global e‑commerce market with day‑definite delivery across more markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion from approximately 50 origin and 130 destination countries in 2022 to 60 origin and 190 destination countries by 2024, which aligns with the ground truth. However, it incorrectly states that the 60/190 footprint was reached by 2024, when in fact this expansion occurred by 2023 and remained stable into 2024. This misattribution of timing slightly affects factual precision. (2) All numeric values (50, 130, 60, 190) are accurate and match the ground truth, but the temporal assignment of the 60/190 expansion is off by one year. The LLM merges the 2023 expansion with 2024, missing the stabilization phase explicitly noted in the original answer. (3) The multi-hop reasoning is mostly sound—correctly synthesizing geographic growth over time and inferring strategic intent around e-commerce. However, it fails to recognize the two-year expansion followed by stabilization, instead implying continuous growth through 2024. This affects the depth of strategic interpretation. (4) Despite the timing inaccuracy, the answer captures the core strategic implication—FedEx’s focus on global e-commerce logistics with expanded international reach. Wording is semantically close and relevant, earning high marks for contextual relevance. Minor deduction in quantitative and qualitative accuracy due to the year misattribution and omission of stabilization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 392,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05% Notes due 2017 were fully retired and no longer outstanding in FY 2022, FY 2023 and FY 2024 – the notes matured in 2017 and are not listed in the debt schedule of any of those years (see the officer’s certificate of the registrant, dated May 6 2014, referenced in the 10‑K filings for 2022, 2023 and 2024)【page_56】【page_56】.  The continued reference to the 2017 notes in the officer’s certificate and in the description of securities shows Apple’s disciplined practice of maintaining a complete historical record of all debt issuances for regulatory transparency, even after a note has matured, thereby underscoring its proactive management of maturing debt instruments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.05% Notes due 2017 matured and were no longer outstanding in fiscal years 2022, 2023, and 2024, which aligns with the ground truth. It accurately references the Officer's Certificate dated May 6, 2014, and notes the continued inclusion in disclosures across all three years. However, the LLM incorrectly states that the notes are 'not listed in the debt schedule' of those years, while the ground truth confirms they *were* listed in Exhibit 4.4 in each year — a key factual contradiction. This undermines the correctness of the status description despite the accurate maturity timeline. (2) Quantitatively, all dates (2017 maturity, May 6, 2014 certificate) and percentages (1.05%) are correct. No numerical calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: the model correctly infers that continued disclosure implies a policy of historical record-keeping. However, it fails to acknowledge the actual *presence* of the notes in the exhibit listings, leading to flawed synthesis. The ground truth emphasizes that Apple *continued to list* the matured notes, whereas the LLM claims they were absent from the debt schedule — a critical discrepancy in entity status. (4) Contextual relevance is strong: the answer addresses both the status over time and the implications for debt management strategy. The interpretation of Apple’s disclosure practice as reflecting transparency and proactive management is plausible and adds value, though it contradicts the factual premise. Due to the significant error in factual status (absent vs. present in disclosures), the correctness score is reduced to 6 despite strong supporting logic and accurate ancillary details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 481,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "Qualcomm’s 2022‑2024 strategy increasingly centered on 5G, with licensing revenue driven by 5G‑enabled devices and a growing R&D commitment to 5G NR, 5G Advanced, and new applications such as automotive, IoT and XR (page 8, page 13). Licensing revenue remained highly concentrated, with a few premium OEMs (Apple, Samsung, Xiaomi) accounting for 10%+ each of consolidated revenue in FY 2024 (page 14) and a significant portion of licensing income coming from a limited number of licensees, many of which are Chinese OEMs (pages 18‑20). Geopolitical risk intensified over the period, as U.S. export restrictions, Chinese tariffs and trade‑security tensions threatened to limit business with Chinese customers and suppliers, potentially impacting both licensing revenue and R&D investments (pages 18‑22).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's increasing strategic focus on 5G from 2022 to 2024, highlighting R&D investments and expansion into automotive, IoT, and XR, which aligns with the original answer. It also appropriately notes rising geopolitical risks, including U.S. export restrictions and trade tensions affecting Chinese OEMs. However, it omits key quantitative details from the ground truth, such as the $560 million in revenue from Huawei in fiscal 2024 prior to the export license revocation, and the projection of over 27 billion IoT devices by 2026. These are significant omissions in the financial commitment and forward-looking strategic context. (2) No incorrect numbers are stated, but the LLM fails to include specific figures that are central to the original answer—particularly the $560M Huawei revenue and the 27 billion IoT device projection. While it references concentration among OEMs, it does not quantify the licensing revenue share from 5G or OFDMA-based devices, which the ground truth specifies as the 'majority' of QTL revenues. (3) The reasoning is logically sound and reflects a multi-hop synthesis across fiscal years and business domains (licensing, R&D, geopolitics), but it lacks integration of specific financial impacts and timelines (e.g., Huawei’s revenue contribution just before the ban). The mention of Chinese OEMs as key licensees is consistent with the original, but without linking that to the geopolitical risk impact on actual revenue, the synthesis is incomplete. (4) The answer is contextually relevant and well-structured, addressing all three dimensions of the question—licensing revenue, investment in new applications, and geopolitical risks—though with less precision on financial commitments. The qualitative accuracy is high due to correct entity identification (Qualcomm, 5G, IoT, automotive, geopolitical risks) and correct attribution of trends over time. The correctness score is 7 because core facts are accurate but key quantitative and strategic details from the ground truth are missing, reducing completeness and financial specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 570,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From 2022 to 2024 the domestic pension plan assets stayed close to the company’s target mix of roughly 10 % U.S. equity, 10 % international equity and 80 % fixed‑income.  In 2022 the assets were $89 m in U.S. equity, $91 m in international equity and $739 m in fixed income (≈9.5 %, 9.7 %, 78.9 % of $937 m).  In 2023 they were $93 m, $93 m and $739 m (≈9.8 %, 9.8 %, 78.0 % of $947 m).  By 2024 the amounts were $91 m, $89 m and $692 m (≈10.2 %, 9.9 %, 77.4 % of $895 m).  The modest rise in equity exposure and slight decline in fixed‑income holdings indicate a gradual, risk‑controlled shift toward higher return‑seeking assets while still maintaining a liability‑hedging, fixed‑income core.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in dollar amounts and years. According to the ground truth, in 2022, TMO allocated $125M to U.S. equity, $126M to international equity, and $1,001M to fixed income, totaling $1,267M. The LLM incorrectly reports 2022 figures as $89M, $91M, and $739M (which are actually the 2023 figures in the ground truth), and assigns them to the wrong year. Similarly, the LLM swaps 2023 and 2024 data: it reports 2023 as $93M/$93M/$739M (which matches the ground truth's 2024), and 2024 as $91M/$89M/$692M (which does not match any year in the ground truth). The total assets in 2024 are stated as $895M by the LLM, but ground truth reports $947M. (2) Calculations are based on incorrect inputs: percentages are derived from wrong totals and allocations. For example, claiming $89M is 9.5% of $937M is mathematically correct, but this combination does not reflect 2022 as stated—it reflects 2023. The LLM misattributes the timeline entirely. (3) Multi-hop reasoning is flawed: the answer concludes a 'gradual shift toward higher return-seeking assets' due to rising equity exposure, but the ground truth shows a sharp decline in total assets from 2022 to 2023 and stabilization in 2024, indicating de-risking, not re-risking. The LLM misinterprets the direction of the strategy. (4) Despite incorrect numbers and reversed timeline, the answer attempts to address the question's structure—discussing allocation changes and inferring strategy—hence moderate contextual relevance. However, due to pervasive quantitative errors and inverted reasoning, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 447,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s edge‑networking strategy shifted from a 2022 emphasis on 5G NR, Wi‑Fi 6/6E and early 5G Advanced (Release 18) to a 2024 focus that also incorporates Wi‑Fi 7, 5G Advanced, and AI‑driven edge‑computing features (see product development on page 9).  Despite this continued investment, revenue from its IoT/edge‑networking stream fell from $7.35 B in 2022 to $5.94 B in 2023 and $5.42 B in 2024 (see revenue breakdown on page 73), reflecting a decline in market share or demand even as the product portfolio expanded.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that edge networking became an explicitly recognized revenue contributor in 2023 and remained a focus in 2024, with no mention of declining revenue. In contrast, the LLM claims IoT/edge-networking revenue fell from $7.35B in 2022 to $5.94B in 2023 and $5.42B in 2024—specific figures not present in the original answer and contradicting the narrative of growing strategic importance. These numbers are entirely fabricated or misattributed, as the ground truth does not provide any revenue figures for edge networking. (2) Quantitative accuracy is severely lacking: the dollar amounts and implied 23% revenue decline are unsupported by the original answer, which emphasizes qualitative strategic evolution, not financial performance trends. There is no calculation or data source in the ground truth to justify these figures. (3) The multi-hop reasoning is flawed. While the LLM attempts to link product development (e.g., Wi-Fi 7, 5G Advanced) to strategic positioning, it incorrectly infers declining market success from non-existent revenue data. The original answer shows a consistent and maturing focus, whereas the LLM concludes a decline in market share or demand—unsupported and contradictory. (4) Contextual relevance is moderate: the answer addresses product development and revenue over 2022–2024 as asked, and mentions relevant technologies, but the synthesis is incorrect. The core claim of revenue decline invalidates the overall correctness, despite some topical alignment. The answer fabricates data rather than reflecting the documented strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 456,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple lists the 0.45% Notes due 2016 in the “Description of Securities of the Registrant” table that appears in the notes to the consolidated financial statements (page 56 in each filing).  By continuing to disclose this fixed‑rate debt even after its maturity, Apple demonstrates a disciplined approach to tracking all debt maturities and ensuring transparency about its debt portfolio.  This practice signals the company’s commitment to managing fixed‑rate debt proactively and maintaining a stable capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities are correct: Apple, 0.45% Notes, due 2016, and the context of 10-K filings from 2022–2024. The percentage (0.45%) and maturity year (2016) are correctly stated. (2) Quantitative accuracy is perfect—no calculations are required, and all dates and percentages match the original. (3) The reasoning is sound: the LLM correctly infers that continued disclosure of a matured note reflects transparency and disciplined debt tracking, which supports capital structure stability. It accurately identifies the location of the disclosure (‘Description of Securities’ table on page 56), adding specificity not in the ground truth but consistent with filing patterns. (4) The answer is semantically equivalent to the original—while it doesn’t explicitly state the note is no longer outstanding, it implies this by noting disclosure ‘even after its maturity,’ which captures the core insight. The only minor omission is not explicitly linking this practice to historical tracking of capital structure evolution, a nuance present in the original. However, the emphasis on transparency and proactive management conveys a similar conclusion. Thus, the answer is highly accurate with only slight room for added depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 359,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar’s EMD‑brand distribution network shrank from 193 countries in 2022 to 187 countries in 2024—a contraction of six countries (2022: 44 U.S. + 116 international dealers; 2024: 41 U.S. + 111 international dealers). This reflects a modest reduction in the global reach of the EMD brand.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that Caterpillar's EMD brand distribution network covered 130 countries in 2022 and decreased to 109 in 2024—a reduction of 21 countries (16%). The LLM incorrectly claims 193 countries in 2022 and 187 in 2024, a decrease of only 6 countries. These numbers are factually wrong and not supported by the original answer. Additionally, the LLM introduces dealer counts (e.g., 44 U.S. + 116 international) that are not present in the ground truth and appear fabricated. (2) Completeness: While the answer attempts to address the change in geographic reach over time, it fails to report the correct figures for 2022, 2023, and 2024 as required. The 2023 stability (130 countries) is omitted entirely. (3) Entity Accuracy: The company (Caterpillar, EMD brand) and time frame (2022–2024) are correctly identified, but the core metric—number of countries—is wrong. (4) Reasoning: The multi-hop synthesis is flawed. The model invents a breakdown by U.S. and international dealers not present in the original data and bases its conclusion on incorrect totals. There is no evidence in the ground truth to support the claim of 193 or 187 countries. (5) Semantic Equivalence: The conclusion that there was a 'modest reduction' contradicts the ground truth, which reports a significant 16% decline. The direction of change (reduction) is correct, but the magnitude and basis are entirely inaccurate. Overall, the answer fails on factual correctness, with major errors in numbers and unsupported details, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 451,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "At December 31 2022 the 1.750% 7‑year euro‑denominated senior notes were outstanding at **$642 million**; this rose to **$662 million** at December 31 2023 and fell to **$621 million** at December 31 2024. The modest increase followed by a reduction shows Thermo Fisher is managing its medium‑term debt mix conservatively—issuing new 7‑year notes to fund projects or refinance at favorable rates while keeping the overall exposure stable, a typical strategy for a large, cash‑flow‑rich healthcare company that also uses euro‑denominated debt to diversify currency risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that TMO's outstanding value for the 1.750% 7-Year Senior Notes was consistently $700 million from 2022 through 2024. However, the LLM claims the values were $642M, $662M, and $621M respectively—none of which match the ground truth. Additionally, the LLM incorrectly identifies the notes as 'euro-denominated,' which is not mentioned or implied in the original answer. (2) All numeric values are incorrect: $642M vs $700M in 2022, $662M vs $700M in 2023, and $621M vs $700M in 2024. There are no calculations in the original, but the LLM fabricates a trend (increase then decrease) that does not exist. (3) The multi-hop reasoning is flawed. The LLM invents a narrative about currency diversification and refinancing strategy based on non-existent fluctuations and euro-denomination, which undermines the qualitative accuracy. The original indicates stability in debt, suggesting a steady capital structure approach, while the LLM infers active management and rebalancing—unsupported by data. (4) Despite the factual errors, the LLM attempts to address both parts of the question—evolution of debt value and interpretation of strategy—and remains within the domain of medium-term debt strategy in healthcare, hence moderate contextual relevance. However, due to severe quantitative and qualitative inaccuracies, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 401,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "From 2022 to 2024, Caterpillar shifted its currency‑hedging exposure from LIBOR‑based instruments to SOFR‑based derivatives, as its risk team monitored LIBOR phase‑out timelines and adopted SOFR for variable‑rate loans (2022: LIBOR phase‑out on page 22; 2023: SOFR adoption on page 19; 2024: continued SOFR use on page 19). Throughout this period, the company maintained a diversified hedging program—match‑funding, selective derivatives, and a broad funding base—to manage currency and interest‑rate risk, demonstrating proactive adaptation to global financial reforms (currency‑hedging discussion on pages 20‑21).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Caterpillar's transition from LIBOR to SOFR in its financial instruments, particularly in the context of currency hedging and interest rate risk management. Quantitatively, the answer correctly references the key timeline: 2022 as the year of LIBOR phase-out awareness, 2023 as the year of SOFR adoption, and 2024 as continuation of SOFR use. While the LLM cites specific page numbers (e.g., page 22, 19), these are not part of the ground truth and cannot be verified from the provided data; however, such references do not introduce factual errors but may imply spurious precision. The statement that Caterpillar 'shifted its currency-hedging exposure from LIBOR-based instruments to SOFR-based derivatives' is slightly misleading—LIBOR and SOFR are interest rate benchmarks, not currency hedging instruments per se. The ground truth clarifies that currency hedging was consistently used throughout, while the shift from LIBOR to SOFR pertains more broadly to variable-rate loans and derivative contracts, not currency hedging specifically. This conflation slightly weakens the reasoning. However, the LLM correctly identifies the formation and expansion of a cross-functional risk team (implied via 'risk team monitored'), the adoption of SOFR in variable-rate loans, and the proactive adaptation to financial reforms. The answer is contextually relevant and synthesizes the multi-hop elements—LIBOR phase-out, SOFR adoption, risk management evolution—across years. It omits explicit mention of the FCA/IBA announcements and the full elimination of LIBOR references by 2024, but conveys the strategic pivot. Overall, the factual core is accurate with minor imprecision in framing, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 484,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "In 2022 Thermo Fisher’s 10‑K listed only a CEO‑specific Executive Change‑in‑Control Retention Agreement (Exhibit 10.12) for Marc N. Casper【page_46】.  By 2023 the company added a standardized ECCRA for all officers beyond the CEO (Exhibit 10.18)【page_47】, and the 2024 filing continues to reference that same officer‑level agreement (Exhibit 10.17)【page_75】, showing a clear shift from a CEO‑only arrangement to a uniform retention agreement for non‑CEO officers.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct and captures the core evolution of Thermo Fisher Scientific's Executive Change in Control Retention Agreements (ECCRA) from 2022 to 2024. It correctly identifies that in 2022, only CEO Marc N. Casper had a CEO-specific agreement (Exhibit 10.12), and that by 2023 a standardized form was introduced for officers beyond the CEO. The conclusion that this represents a shift from CEO-only to broader executive coverage is sound and matches the ground truth. However, there is a minor discrepancy in exhibit numbering: the LLM states the 2023 standardized agreement is Exhibit 10.18, while the ground truth and 2024 filing confirm it as Exhibit 10.17. The 2024 reference to Exhibit 10.17 is correct, but the inconsistency in 2023 exhibit number reduces quantitative accuracy. Additionally, the ground truth notes the 2023 form is explicitly titled 'Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper', which the LLM paraphrases adequately but without full precision. Despite this, the multi-hop reasoning across years and entities (CEO vs. other officers, standardization trend) is logically sound and semantically equivalent. The answer is highly relevant and conveys the key evolution accurately, warranting a high score with minor deductions for exhibit number inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 373,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "From 2022 to 2024 Intel’s treatment of PowerVia moved from a nascent idea to a commercial‑grade enabler. In the 2023 10‑K, PowerVia was announced as a breakthrough backside‑power feature for the planned Intel 20A node, projected to deliver up to a 15 % performance‑per‑watt gain over Intel 3. By the 2024 filing, Intel had shifted the technology to the 18A node, announcing a high‑volume commercial implementation of PowerVia as part of the Panther Lake family, underscoring its role as a core driver of performance‑per‑watt and density scaling in Intel’s next‑generation advanced process roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Intel's PowerVia technology from 2022 to 2024, aligning closely with the ground truth. (1) It correctly identifies PowerVia as a breakthrough backside-power technology introduced for Intel 20A and later transitioned to Intel 18A, reflecting the strategic shift. The mention of Panther Lake as the vehicle for high-volume implementation in 2024 is consistent with Intel's disclosed roadmap. (2) The 15% performance-per-watt gain over Intel 3 is a specific quantitative claim not present in the original answer; however, this figure is plausible and has been reported in Intel's public communications around 2023, so it does not constitute a factual error. The years (2022–2024) and node transitions (20A to 18A) are correct. (3) The multi-hop reasoning is sound: the model synthesizes the technological significance, roadmap shift, and commercialization timeline, showing how PowerVia remained central despite node rebranding. (4) The answer is contextually excellent, directly addressing the evolution and strategic implications. The only minor gap is the lack of explicit mention that Intel 20A was 'canceled'—the LLM says it was 'shifted', which softens the strategic pivot slightly—but this does not undermine the overall correctness. Semantic equivalence is maintained with strong factual grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 379,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple consistently listed the 1.05% Notes due 2017 in the “Officer’s Certificate” exhibits of its 10‑K filings for 2022, 2023 and 2024, with the description and terms unchanged across the three years.  The repeated, unchanged disclosure shows that Apple treats this instrument as a permanent part of its debt portfolio and maintains a disciplined, transparent reporting practice that tracks all outstanding debt, even those that have long since matured.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the 1.05% Notes due 2017 are correctly identified, and their inclusion in the 2022, 2023, and 2024 10-K filings is consistent with the ground truth. The mention of the Officer’s Certificate exhibit also aligns with the original answer. However, the qualitative reasoning contains a significant error: the claim that Apple treats the instrument as a 'permanent part of its debt portfolio' and that it is still 'outstanding' misrepresents the situation. The ground truth suggests the note may have been rolled over or maintained in some form, but does not support the conclusion that it remains an active liability or that Apple treats it as permanent. The original answer frames the continued disclosure as potentially indicating rollover or continuity in reporting practice, not ongoing obligation. The LLM overinterprets the evidence, implying the debt is still outstanding when it matured in 2017. This undermines the reasoning and leads to an incorrect inference about Apple’s debt management. While the multi-hop aspect (tracking disclosure across years) is handled correctly, the synthesis leads to a misleading conclusion. The answer is contextually relevant and addresses the evolution of disclosure, but the interpretation of the practice is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 368,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was first used in 2022 to grant restricted‑stock units (RSUs) to executives, including RSUs with retirement‑vesting terms and performance‑based RSUs (see the 2006 Plan exhibits on page 107).  By 2023 the plan was expanded to grant RSUs to non‑employee directors under standard vesting schedules (see the “Non‑Employee Director RSU Agreement” on page 107).  In 2024 the plan continued to provide RSUs to non‑employee directors and retained the same retirement‑vesting and performance‑vesting structures for executive awards, with no substantive change to vesting conditions (see the 2006 Plan exhibits on page 107).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but misses key aspects of the evolution of Intel's 2006 Equity Incentive Plan from 2022 to 2024, leading to a partially correct response. (1) Correctly identifies that in 2022, Intel used the plan for RSUs with retirement-vesting and performance-based terms for executives, aligning with the ground truth. (2) Mentions expansion in 2023 to include non-employee directors, which is accurate, but omits the critical fact that the plan was formally amended and restated on May 11, 2023—a key event in the evolution. (3) The claim that in 2024 there was 'no substantive change to vesting conditions' contradicts the ground truth, which notes a consolidation in documentation and a shift toward streamlined grant agreements and performance-based RSUs for grandfathered executives, indicating structural simplification and strategic focus. (4) The LLM fails to mention the distinction between grandfathered and non-grandfathered executives introduced in 2023, a significant nuance in vesting conditions. (5) While the LLM correctly references RSU types and general usage, it lacks the depth of synthesis regarding the plan’s evolution toward more nuanced performance alignment and simplified documentation. (6) Quantitative accuracy is high: no incorrect numbers or dates are presented; the reference to 'page 107' appears consistent with source formatting. (7) Contextual relevance is strong—the answer stays on topic and addresses the types of awards and vesting conditions over time—but reasoning is weakened by omissions and oversimplification. Overall, the answer captures surface-level continuity but misses key developments in plan structure and strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 465,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic’s 10‑K notes for FY 2022, FY 2023 and FY 2024 all state the same capital‑structure fact: the company is authorized to issue 40 000 Euro Deferred Shares (par €1.00) and that none were issued or outstanding as of the reporting dates (April 29 2022; April 28 2023; April 26 2024)【page 81 2022】【page 81 2023】【page 81 2024】. The unchanged, zero‑issuance position shows that Medtronic has not tapped this instrument, indicating a financing strategy that relies on other mechanisms (ordinary shares, debt, etc.) and treats the Euro Deferred Shares as a dormant, low‑impact component of its capital base.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Medtronic maintained an authorization of 40,000 Euro Deferred Shares with €1.00 par value across FY2022–FY2024, and zero shares were issued or outstanding in each year. The specific reporting dates (April 29, 2022; April 28, 2023; April 26, 2024) are correctly included, and citation of page 81 for each year aligns with the source structure. (2) Quantitative accuracy is perfect: the number 40,000, par value €1.00, and zero issuance are all correct, with no calculation errors. Format variations (e.g., '40 000' vs '40 thousand') are acceptable and common in international formatting. (3) Multi-hop reasoning is sound—the model correctly synthesizes disclosures across three fiscal years and draws a logical inference about financing strategy: the consistent non-use of Euro Deferred Shares suggests reliance on alternative capital tools like debt or ordinary shares. The mention of 'dormant, low-impact component' effectively captures the strategic implication of maintaining authorized but unissued shares. (4) The answer fully addresses both parts of the question: the evolution (or lack thereof) in disclosures and the strategic implication of non-issuance. Wording differs slightly from the original (e.g., 'dormant' vs 'not utilized'), but the meaning is equivalent. No omissions or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 397,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "Intel’s 2022 10‑K framed advanced packaging as a key pillar of its IDM 2.0 strategy, noting that a disaggregated, chip‑let approach would “introduce new areas of complexity…particularly in the deployment of advanced packaging technologies, several of which are novel, have a limited manufacturing history, and/or have increased costs.”  The company spent roughly **$17.5 billion on R&D in 2022**—much of it on process and packaging tech—yet still faced delays and yield risks that pushed operating losses to **$281 million** that year.  \n\nIn 2023, Intel continued to invest heavily (≈$16 billion in R&D) and secured several new design wins on its Intel 18A node, but the risk narrative remained unchanged: advanced packaging’s novelty and limited production history kept manufacturing complexity high, and the company’s operating loss rose to **$482 million** as capital outlays for the new foundry and packaging capabilities increased.  \n\nBy 2024, R&D spending had edged up to **$16.5 billion**, and the company recorded a **$3.1 billion** impairment charge in Q3 2024 tied to manufacturing assets (primarily the Intel 7 node), underscoring the financial toll of the complex, high‑cost packaging and process development.  Thus, while advanced packaging became a central competitive lever, execution risks—delays, yield challenges, and costly capital expenditures—intensified, driving larger operating losses and significant impairment charges.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: R&D spending (~$17.5B in 2022, ~$16B in 2023, $16.5B in 2024), the $3.1B impairment in Q3 2024 (aligned with 2024 financial impact), and operating losses ($281M in 2022, $482M in 2023). These figures match or are reasonably approximated from actual filings. The $3.1B non-cash impairment tied to Intel 7 is correctly cited and temporally placed in 2024. (2) The answer addresses all components of the question: strategic positioning (IDM 2.0, chiplet approach, UCIe implied via design wins), execution risks (manufacturing complexity, yield issues, delays), R&D investment trends, and financial impact (rising losses, impairment). (3) Entity accuracy is strong: Intel, IDM 2.0, Intel 7/18A nodes, and advanced packaging are correctly referenced. The timeline (2022–2024) is accurately followed. (4) Multi-hop reasoning is sound: the answer synthesizes risk disclosures, R&D trends, and financial outcomes across years to show escalating execution challenges despite strategic commitment. The only minor shortcoming is the lack of explicit mention of UCIe in silicon demonstration (a detail in the ground truth), but the reference to 'design wins on Intel 18A' and advanced packaging as a 'competitive lever' captures the essence. Wording differs but semantic equivalence is maintained. No calculation errors. Thus, the answer is factually robust, contextually complete, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 415,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "In its 2022 10‑K (page 7), Intel first introduced PowerVia as a future backside‑power delivery technology for the Intel 20A node, positioning it as part of its IDM 2.0 strategy. The 2023 10‑K (page 14) updated the roadmap, framing PowerVia as a breakthrough that could deliver up to a 15 % performance‑per‑watt improvement over Intel 3. By the 2024 10‑K (page 10), Intel disclosed that PowerVia is incorporated into the Intel 18A node and is ready for high‑volume commercial implementation, with high‑volume manufacturing slated to begin in 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as a backside power delivery technology for Intel 20A, linked to the IDM 2.0 strategy; in 2023, Intel stated it would deliver up to 15% performance-per-watt improvement over Intel 3; by 2024, it was confirmed as part of Intel 18A with high-volume manufacturing (HVM) expected in 2025. These match the original answer exactly. (2) Quantitative elements—'15%', '2025' HVM start—are correct and consistent with the ground truth. No calculation errors. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years of 10-K filings, correctly tracking the evolution from introduction to roadmap integration to manufacturing readiness. (4) The only minor shortcoming is that the LLM answer does not explicitly note the *shift* from Intel 20A to Intel 18A as the node where PowerVia would be implemented, which is a subtle but important nuance in the technology's evolution. The original answer highlights this as a 'shift in focus,' while the LLM states it was 'incorporated into Intel 18A' without clarifying it was moved from 20A. This slight omission in narrative clarity reduces qualitative accuracy slightly, but does not undermine factual correctness. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 395,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "No – the same reference to the 2013 Stock Award and Incentive Plan’s “Form of Restricted Stock Unit Award Agreement (U.S. Employees)” appears in both FY 2022 (page 113) and FY 2024 (page 114), indicating no substantive update to the agreement. This consistency suggests Medtronic is maintaining a stable, long‑term equity incentive framework, prioritizing continuity and predictable alignment of employee incentives over frequent plan revisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Medtronic did not update its U.S. employee restricted stock unit agreements between FY2022 and FY2024, correctly referencing the continued use of the 'Form of Restricted Stock Unit Award Agreement (U.S. Employees)' under the 2013 Stock Award and Incentive Plan. The specific page numbers cited (FY2022 page 113, FY2024 page 114) are consistent with actual filings and support the claim of no updates. The conclusion about Medtronic maintaining a stable, long-term equity incentive framework is logically sound and semantically equivalent to the ground truth's interpretation of 'stable and consistent equity compensation strategy.' The only minor omission is the lack of explicit mention of FY2023, which was included in the original answer; however, the reference to both FY2022 and FY2024 implies continuity through the period, including FY2023, especially given the consistent form used. All entities (Medtronic, 2013 Plan, U.S. employees, RSU agreement) are correctly identified. There are no calculation or date inaccuracies. The reasoning correctly synthesizes information across multiple annual filings (multi-hop) and draws an appropriate inference about equity strategy. Wording differs slightly but meaning is preserved. Thus, the answer is highly accurate with only a small reduction for incomplete temporal coverage mention.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 396,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "In 2022, Intel’s 2006 Equity Incentive Plan was used to award performance‑based RSUs only to grandfathered executives, as shown by the grant‑agreement form in Exhibit 10.1.5【page 107】. By 2024, the plan was broadened to include performance‑based RSUs for non‑grandfathered executives (Exhibit 10.1.6) and for non‑employee directors (Exhibit 10.1.7), indicating a more inclusive incentive structure【page 108】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but introduces significant inaccuracies. It correctly identifies the use of the 2006 Equity Incentive Plan in 2022 and 2024 and references performance-based RSUs, but incorrectly states that in 2022 the plan was used *only* for grandfathered executives. The ground truth does not support this limitation—it confirms use for executives on or after February 1, 2019, without restricting to grandfathered individuals. Furthermore, the claim that the plan was 'broadened' in 2024 to include non-grandfathered executives and non-employee directors is unsupported. The original answer states that in 2023, Intel already had separate agreements for both grandfathered and non-grandfathered executives, meaning the expansion occurred before 2024, not in it. Also, there is no mention in the ground truth about extending the plan to non-employee directors in 2024. (2) Quantitatively, the answer avoids specific numbers (e.g., grant amounts, performance metrics), so no numeric errors are present, but it misrepresents structural changes over time. Dates like 'September 26, 2023' (S-8 filing) from the ground truth are omitted, weakening temporal accuracy. (3) The multi-hop reasoning is flawed: the model fails to accurately synthesize the evolution across 2022–2023–2024. It skips 2023 entirely in its narrative and incorrectly positions changes in 2024 that actually occurred earlier. The conclusion about 'more inclusive' structure lacks support from the original answer, which emphasizes consistency rather than expansion. (4) Despite these issues, the answer remains contextually relevant—it addresses the core topic of how Intel used the 2006 plan for performance-based RSUs over time and cites appropriate exhibits. However, due to key factual misstatements and incorrect evolution timeline, the correctness score is reduced to 4, with moderate scores for qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 529,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel’s 2022 10‑K framed advanced packaging as the linchpin of its disaggregated‑design strategy, noting that the technology was “novel, has a limited manufacturing history, and/or has increased costs” and that delays or failures would hurt product launches (page_54).  In 2023 the company reiterated that packaging remains a significant expense and risk, citing limited market success for its accelerator offerings and the continued challenge of turning packaging investments into commercial wins (page_35).  By 2024 Intel’s filings show a more mature approach, with advanced packaging highlighted as a core element of its Open System Foundry and AI strategy and an increase in design wins and partnerships that support chip‑let integration, signalling a stronger but still risk‑laden capability to deliver AI‑optimized solutions (page_36).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures some correct qualitative aspects of Intel's advanced packaging evolution, such as the recognition of technical and manufacturing risks in 2022 and the strategic emphasis on packaging as part of its disaggregated design and AI strategy by 2024. It also correctly notes ongoing challenges in commercializing packaging investments, especially in accelerators. However, it omits critical quantitative and factual developments from the ground truth, most notably the $16.5 billion R&D investment and $3.1 billion in non-cash impairment charges in 2024, which are central to understanding the financial strain and execution risks. These omissions significantly undermine the factual completeness and accuracy of the response. (2) Quantitative accuracy is low because the LLM fails to report any numbers from the ground truth—no mention of the $16.5B R&D spend or $3.1B impairment charges—despite the question spanning a three-year financial and strategic evolution. These figures are essential for assessing the scale of investment and associated risks. Their absence constitutes a major factual gap. (3) The multi-hop reasoning is partially sound: the LLM correctly traces a narrative from risk acknowledgment in 2022 to strategic positioning in 2024 and references specific page numbers, suggesting document grounding. However, it fails to integrate the key 2024 financial data that reveals the tension between strategic progress and execution failure, which is central to the ground truth’s conclusion about persistent challenges. (4) Contextual relevance is high because the answer addresses the core themes—advanced packaging, disaggregated design, AI competition—and follows the correct timeline. Qualitative accuracy is moderate due to correct framing of risks and strategy, but the lack of key financial data and failure to mention UCIe silicon demonstration in 2023 (a concrete milestone) limits its fidelity. Correctness score is 6 due to partially accurate narrative but significant omissions of critical financial facts that alter the interpretation of Intel’s execution ability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 569,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Intel has continued to use its 2006 Equity Incentive Plan to grant restricted‑stock units (RSUs) to executives and non‑employee directors. In 2022 the plan was employed for RSU grants with retirement‑vesting and performance‑based terms, and by 2023 the plan’s use expanded to include non‑employee directors. In 2024 Intel issued new grant agreements—specifically for performance‑based RSUs to non‑grandfathered executives and for non‑employee directors—indicating a further broadening of the plan’s application【page_107】【page_108】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in reasoning and completeness. (1) Correct aspects: Intel did use the 2006 Equity Incentive Plan in 2022–2024 for RSUs with retirement-vesting and performance-based terms, and grants were issued to executives and non-employee directors. The mention of performance-based RSUs in 2024 aligns with the ground truth. (2) Quantitative accuracy is acceptable: no specific dollar amounts or percentages are involved, and the years (2022, 2023, 2024) are correctly referenced. (3) However, the reasoning is flawed: the claim that the plan’s use 'expanded to include non-employee directors' in 2023 is incorrect—the original answer confirms that non-employee directors were already included in 2022. Additionally, the LLM fails to mention the key 2023 amendment (amended and restated version effective May 11, 2023), which is a major evolution point. (4) The LLM incorrectly frames the 2024 developments as 'new grant agreements' indicating 'further broadening,' whereas the ground truth emphasizes sustained reliance on standardized agreements, not expansion. This misrepresents the evolution. (5) The answer omits the multi-hop synthesis of plan maturity and structural updates reflected in the 2023 amendment, weakening qualitative accuracy. While contextually relevant and focused on the right topic, the answer misses critical nuances and introduces factual errors in the progression of plan usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 405,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm’s 2022 10‑K classified all wireless‑access‑point revenue within its IoT segment, which accounted for $7.35 B of QCT revenue. By 2024 that IoT revenue had fallen to $5.42 B while automotive revenue rose to $2.91 B, indicating a strategic shift away from IoT toward automotive connectivity. The 2024 10‑K explicitly foregrounds Wi‑Fi 6/6E and 5G fixed‑wireless access‑points as core edge‑networking offerings, positioning Qualcomm as a leading supplier of next‑generation edge infrastructure even as the overall IoT revenue has contracted.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that in 2022, wireless access point revenue was classified under the IoT segment with a specific figure of $7.35B. The ground truth does not mention this number or this classification in 2022—instead, it states that wireless access points were highlighted as a growth driver but were not yet formally classified under edge networking. In 2023, the formal classification occurred under edge networking, not IoT. The LLM also claims IoT revenue fell to $5.42B in 2024 and that automotive rose to $2.91B, suggesting a strategic shift away from IoT—none of this is supported by the ground truth, which does not provide specific revenue figures for wireless access points or such a strategic pivot. (2) The quantitative inaccuracies are severe: the $7.35B and $5.42B figures are fabricated or misattributed, and no such revenue shifts are mentioned in the original answer. The ground truth explicitly states that exact revenue figures for wireless access points alone are not disclosed. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a strategic shift based on made-up revenue trends and misclassifies the financial segment for wireless access points. It fails to correctly trace the evolution from strategic emphasis (2022) to formal classification (2023) to continued positioning (2024) as described in the ground truth. (4) While the LLM attempts to address the question’s focus on strategic emphasis and market positioning, its factual foundation is incorrect, leading to a misleading conclusion. The mention of Wi-Fi 6/6E and 5G fixed-wireless access points in 2024 is plausible but not confirmed in the ground truth, and does not compensate for the core inaccuracies. Thus, the correctness score is low due to major factual and quantitative errors, despite some contextual relevance to edge networking and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 525,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales climbed steadily, rising from $428 million in 2022 to $605 million in 2023 and $785 million in 2024.  The upward trajectory demonstrates growing prescriber adoption and market penetration, reinforcing Prevymis’s position as a leading CMV‑prophylaxis within Merck’s Hospital Acute Care portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the sales figures. According to the ground truth, Prevymis sales were $370 million in 2022 and $428 million in 2023, but the LLM incorrectly reports $428 million in 2022 and $605 million in 2023. Only the 2024 figure ($785 million) is correct. This misrepresentation leads to an inaccurate growth trajectory. (2) The quantitative inaccuracies are critical: the correct compound growth rate from 2022 to 2024 is approximately 46% (from $370M to $785M), but the LLM's numbers imply a much lower growth rate (from $428M to $785M, ~83% over two years, but with wrong base). The LLM's stated 2023 figure ($605M) is entirely unsupported by the ground truth. (3) The reasoning about market positioning is qualitatively sound—increasing sales do suggest stronger adoption and strategic positioning in Hospital Acute Care, particularly for CMV prophylaxis in transplant patients—and this part aligns with the original answer. The LLM correctly identifies the product's role and segment. (4) While the contextual relevance is high (it addresses both sales evolution and market positioning), the severe quantitative errors undermine the correctness score. The answer fails on core factual accuracy despite reasonable interpretation of implications. Minor flexibility is allowed in wording, but not in financial data. Thus, correctness is scored low due to incorrect multi-year sales data, even though the final year and general trend direction (upward) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 421,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "Intel has shifted from a cautious, R&D‑heavy approach to advanced packaging in 2022—highlighting the risks of disaggregated designs and the need for new packaging tech—to a more execution‑focused strategy by 2023, when packaging revenue surged $483 million (driving total revenue to $952 million) and the company secured multiple Intel 18A design wins, especially for AI workloads. In 2024 the firm continued to build on that momentum, expanding its Open System Foundry’s packaging portfolio with 2D/2.5D/3D solutions and the Universal Chiplet Interconnect Express standard, while still grappling with process‑node delays, high capital outlays, and the need to defer or cancel some facility projects. This multi‑year trajectory shows that Intel is making tangible progress in packaging and generating revenue, yet its IDM 2.0 execution remains constrained by recurring manufacturing setbacks and capital‑intensive investments, underscoring a cautious but ongoing ability to advance the strategy amid significant headwinds.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. It states that 'packaging revenue surged $483 million (driving total revenue to $952 million)' in 2023 — this is entirely unsupported by the ground truth, which does not mention any specific packaging revenue figures or total revenue related to packaging. These numbers appear fabricated. Additionally, the claim of 'multiple Intel 18A design wins' in 2023 is not present in the original answer and introduces a detail not verified in the knowledge base. (2) The ground truth reports a $16.5 billion R&D investment in 2024 and a $3.1 billion non-cash impairment in Q3 2024 — neither of which is mentioned in the LLM answer. Instead, the model invents revenue figures with no basis in the source material. There are no correct numerical values in the LLM response when compared to the ground truth. (3) While the LLM captures the general multi-hop trajectory — acknowledging early caution in 2022, strategic emphasis on UCIe and packaging in 2023, and ongoing execution challenges in 2024 — it misrepresents the nature of progress. The original emphasizes delays in product rollouts (e.g., 4th Gen Xeon) and financial impairments as key setbacks, whereas the LLM frames progress as revenue growth and design wins, which are not corroborated. The reasoning is partially sound in structure but built on false premises. (4) Contextually, the answer addresses the evolution of Intel's packaging strategy and its implications for IDM 2.0, which aligns with the question. However, due to major quantitative errors and the introduction of unverified positive indicators (revenue surge, design wins), the overall correctness score is low. The qualitative accuracy is moderate because the strategic narrative arc is somewhat aligned, but factual grounding is weak. Contextual relevance is high as the response stays on topic and attempts multi-year synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 528,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM’s 2022, 2023, and 2024 10‑K filings all list “client relationships and trust” as a core competitive differentiator, showing a consistent emphasis over the three years. While the wording has remained largely unchanged, the context has shifted to highlight how IBM’s hybrid‑cloud and AI platforms enable clients to modernize and innovate, underscoring the company’s view that strong client trust is essential to successfully commercializing its hybrid‑cloud and AI strategy. This steady focus signals IBM’s positioning as a trusted partner in the hybrid‑cloud and AI market, using client relationships to differentiate itself in a highly competitive landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies that IBM consistently emphasized 'client relationships and trust' as a competitive differentiator from 2022 to 2024, which matches the original answer. The LLM correctly links this emphasis to IBM's hybrid cloud and AI strategy, noting that trust is foundational to commercializing these offerings—this reflects the semantic meaning of the ground truth. However, the LLM omits specific evolution details present in the original answer: (1) in 2022, IBM explicitly tied trust to hybrid cloud and AI for production with security; (2) in 2023, trust was reinforced as part of broader competitive methods like service, support, and talent; and (3) in 2024, the expansion of strategic partnerships (e.g., Palo Alto Networks) signaled deeper trust-based collaboration. These nuances represent multi-hop synthesis across years and strategies that the LLM does not fully capture. While the core facts and timeline are correct, and no numbers or dates are inaccurate (quantitative accuracy is perfect since no incorrect figures were cited), the qualitative accuracy is slightly reduced due to missing granular progression. Contextual relevance is strong—the response directly addresses the question and draws appropriate strategic implications. Thus, the answer is factually sound but lacks some depth in tracing the year-by-year strategic framing evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 398,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "In 2022, IBM’s 10‑K contained no reference to the 0.950% Notes due 2025, indicating the instrument was not newly issued or material at that time (page 28). By 2023, IBM disclosed the notes by incorporating the 2017 Form 8‑K that defined them (page 20). In 2024, IBM updated the indenture for the same notes and incorporated it as Exhibit 4.1 to a new Form 8‑K filing, reflecting a more proactive and transparent debt‑management strategy that keeps terms current and aligns with its broader capital‑structure optimization.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, IBM *did* disclose the 0.950% Notes due 2025 in 2022 by referencing Exhibit 4.1 to the Form 8-K filed May 22, 2017 — contrary to the LLM's claim that there was 'no reference' in 2022. This is a critical error in entity and disclosure accuracy. Additionally, the LLM incorrectly states that in 2024, IBM 'updated the indenture' and filed a 'new Form 8-K' with Exhibit 4.1, which is not supported by the ground truth; instead, the note was listed on the NYSE under IBM25B, indicating active trading, not an updated indenture. (2) There are no numerical values (e.g., percentages, dollar amounts, dates) in dispute — the 0.950% rate and 2025 maturity are correctly noted — so quantitative accuracy is partially preserved, but the misuse of filing dates (e.g., referencing a new 2024 Form 8-K that isn't in the truth) undermines date accuracy. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a progression from 'no disclosure' to 'incorporation' to 'update', when the actual progression is consistent disclosure via incorporation of the original 2017 instrument, then NYSE listing. The conclusion about a 'more proactive and transparent' strategy is speculative and not aligned with the evidence of regulatory continuity. (4) Contextual relevance is moderate — the answer addresses debt management and disclosure evolution — but the factual foundation is incorrect, leading to an invalid conclusion. The ground truth emphasizes stability and transparency through consistency, while the LLM invents a narrative of increasing proactivity based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 458,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "Intel did not discuss PowerVia in its 2022 10‑K, indicating the technology was still in early R&D. In the 2023 filing, Intel announced PowerVia as a breakthrough backside‑power delivery feature for the forthcoming Intel 20A node (page 14). By the 2024 filing, the company disclosed that PowerVia would be the first high‑volume commercial implementation in its Intel 18A process (page 10), signaling a shift from concept to production and underscoring Intel’s roadmap to embed backside power delivery in advanced nodes such as 18A, 14A, and beyond to boost power‑efficiency and signal integrity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of PowerVia from not being mentioned in 2022 (indicating early R&D), to being announced for Intel 20A in 2023, and then shifted to Intel 18A for high-volume production in 2024—matching the ground truth's timeline and strategic progression. (2) All dates (2022, 2023, 2024), technology names (PowerVia, Intel 20A, Intel 18A), and forward-looking nodes (14A and beyond) are factually correct. The mention of page numbers (14 in 2023, 10 in 2024) adds specificity and is consistent with document-based sourcing. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to show a strategic shift—from R&D to production—and correctly infers that the cancellation of Intel 20A in favor of Intel 18A (implied in 2024 filing) reflects a pivot to commercialization. (4) The only minor gap is that the LLM does not explicitly state that Intel canceled Intel 20A's productization, though it implies the shift by stating PowerVia moved to Intel 18A for production. This omission slightly affects completeness but does not distort the factual trajectory. Overall, the answer captures the core strategic evolution and roadmap implications accurately, with excellent contextual relevance and precise qualitative and quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 382,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 2022‑to‑2024 filings continue to reference the same 2021 Medtronic plc Long‑Term Incentive Plan for U.S. employees, with Restricted Stock Unit Award Agreements that vest either 100 % on the third anniversary or ratably over four years (see *10.80‑10.81* and *10.87‑10.88*).  The plan’s terms and award structure remain unchanged across the 10‑K filings, indicating a stable U.S. equity‑compensation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Medtronic's Restricted Stock Unit Award Agreements from 2022 to 2024 reference the '2021 Medtronic plc Long-Term Incentive Plan', while the ground truth confirms the agreements consistently reference an August 27, 2013 filing, not a 2021 plan. This is a critical error in both date and plan identification. (2) The exhibit numbers cited (10.80–10.81, 10.87–10.88) do not match the ground truth (Exhibit 10.54), indicating incorrect sourcing. (3) While the vesting schedules mentioned (lump sum at year 3 or ratably over 4 years) may reflect common structures, they are not confirmed in the ground truth and appear to be fabricated or misattributed. (4) The core reasoning about strategic stability aligns with the original answer’s conclusion, which supports contextual relevance, but the faulty entities and dates break the multi-hop synthesis required for accuracy. The answer incorrectly infers stability based on wrong documentation and timelines. Thus, despite reaching a semantically similar conclusion about stability, the factual foundation is incorrect, leading to low scores in quantitative and qualitative accuracy. The correctness score is low because the answer relies on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 366,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "Intel’s advanced‑packaging strategy, a cornerstone of its IDM 2.0 vision, has faced persistent execution challenges from 2022 to 2024. In 2022 the company highlighted significant delays in 10 nm and 7 nm nodes and the added complexity of a disaggregated design approach, which strained capital and slowed new capacity roll‑outs (page_54). By 2023, advanced‑packaging revenue grew and Intel secured several design wins, yet R&D and yield risks remained, and in 2024 the firm confronted further capital‑expenditure constraints, postponed fab construction, and the risk that disaggregated designs could impede timely product introductions, underscoring ongoing execution hurdles (page_35‑page_38, page_32‑page_36).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Intel's strategic positioning and execution challenges around advanced packaging from 2022 to 2024, including delays, capital constraints, and disaggregated design risks, which aligns with the question's focus. However, it contains significant factual inaccuracies. Notably, it incorrectly states that delays occurred in the '10 nm and 7 nm nodes' in 2022—while the ground truth specifies Intel 4 (formerly 7nm), not 10nm, as the key delay. More critically, the LLM answer omits the $3.1 billion impairment charge in 2024, a major quantitative and strategic fact in the original answer. This omission severely impacts quantitative accuracy. (2) No correct dollar amounts or specific financial figures (e.g., $3.1B impairment) are mentioned in the LLM response, and the reference to 'advanced-packaging revenue grew' lacks any numerical support or verification from the ground truth, which does not mention revenue growth. Thus, quantitative accuracy is low. (3) The multi-hop reasoning is partially sound: the model connects delays, capital constraints, and disaggregated design across years, and references execution challenges over time. It correctly identifies the strategic importance of disaggregation and capital issues. However, it fails to incorporate key developments like Intel’s progress with UCIe in 2023 and the asset impairment in 2024, weakening the synthesis. (4) Contextual relevance is high because the answer addresses the timeline, strategic themes, and challenges asked in the question. Qualitative accuracy is moderate due to correct framing but missing key differentiators like UCIe and incorrect node references. Correctness score is 6 due to partially accurate narrative but major omissions and one incorrect technical detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 492,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture’s target allocation for its defined‑benefit pension plans has shifted from 2022 to 2024 by reducing fixed‑income exposure and increasing equity in the non‑U.S. plans (2022: 50 % debt/21 % equity; 2023: 48 % debt/27 % equity; 2024: 42 % debt/23 % equity), while the U.S. plans have remained at 100 % debt throughout. This gradual move toward higher equity weights in the non‑U.S. plans signals a deliberate effort to improve risk‑adjusted returns, balancing duration matching with a more growth‑oriented asset mix. The unchanged 100 % debt stance for U.S. plans underscores a conservative, liability‑matching strategy, illustrating Accenture’s nuanced, multi‑year approach to risk and return.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth contains no specific percentages for asset allocation (e.g., 50% debt/21% equity in 2022), nor does it mention any numerical shifts across years or differentiate between U.S. and non-U.S. plans. These figures are entirely fabricated. The original answer describes a qualitative evolution in strategy—increased flexibility and duration matching—but provides no breakdown by region or exact percentages. (2) The cited numbers (e.g., 50%, 48%, 42% for debt; 21%, 27%, 23% for equity) have no basis in the source material and contradict the narrative by implying a clear downward trend in fixed income with a spike in 2023 equities, which is unsupported. The claim that U.S. plans are 100% debt is also not present in the original and represents a significant factual error. (3) The multi-hop reasoning is flawed: instead of synthesizing the evolving strategic emphasis on flexibility and risk-adjusted returns across years, the model invents a data-driven narrative with false precision. It fails to capture the actual theme—balancing fixed income and equities through duration matching and adaptive rebalancing—while incorrectly asserting a shift toward higher equity exposure. (4) Despite the factual inaccuracies, the answer is contextually relevant in that it attempts to address the evolution of asset allocation and link it to risk-adjusted returns. The general direction of interpreting strategic intent (balancing growth and liability matching) aligns loosely with the original, but the reliance on invented metrics severely undermines correctness. Hence, low scores for quantitative (1) and overall correctness (2), moderate for contextual relevance (6), and slightly above minimum for qualitative accuracy due to partial thematic alignment (3).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 505,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 2023 and 2024 10‑Ks repeatedly list the 1.05% Notes due 2017 in the Officer’s Certificate (see pages 56 of each filing), underscoring a disciplined, comprehensive disclosure of all debt issuances—even those that have matured—so the company keeps a full historical record for transparency and regulatory compliance (page_56). In contrast, the company’s 2022‑24 debt‑issuance activity shifted toward new, higher‑coupon, longer‑term fixed‑rate notes (e.g., 4.421% due 2026, 4.150% due 2030, 4.850% due 2053) and floating‑rate notes (see page 58), reflecting a proactive refinancing and capital‑raising strategy rather than merely reporting legacy debt (page_58).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's continued disclosure of the 1.05% Notes due 2017 in its 2023 and 2024 filings as a sign of comprehensive and transparent reporting, aligning with the ground truth. It also accurately contrasts this with Apple’s active debt issuance strategy from 2022–2024. However, there are discrepancies in the specific debt instruments cited: the LLM mentions 4.421% due 2026, 4.150% due 2030, and 4.850% due 2053, which are not present in the ground truth (which references Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024). These are significant factual deviations in terms of percentages and maturities. (2) Quantitative accuracy is reduced because the specific coupon rates and maturities do not match the original answer. While the general trend of issuing longer-term, higher-coupon debt may be plausible, the exact instruments cited are incorrect. The ground truth does not mention any notes due in 2026, 2030, or 2053 in this context. (3) The multi-hop reasoning is strong: the model correctly infers that referencing matured debt reflects a disclosure policy, and contrasts it with current issuance behavior. It synthesizes information across time and purpose (historical transparency vs. active capital management), which shows sound qualitative logic. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question and maintains focus on Apple’s disclosure practices and debt strategy. The qualitative accuracy is high due to correct reasoning and structure, despite incorrect specific debt examples. The correctness score is 8 because the core interpretation is accurate and the answer is well-supported, but it loses points for citing incorrect debt instruments, which affects factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 492,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "Accenture repurchased 12.18 million shares for $4.11 billion in fiscal 2022, with an available authorization of $3.13 million (page 94). In fiscal 2023 it continued to buy back shares, purchasing 2.07 million shares for $605 million in Q4 while its available authorization rose to $2.694 billion (page 39). In fiscal 2024 it again repurchased 2.07 million shares for $605 million in Q4 and expanded its total outstanding authority to $6.694 billion, with the available authorization remaining at $2.694 billion (page 39). This multi‑year pattern shows a consistent, flexible capital‑return strategy that relies heavily on share buybacks and periodically increases authorized capacity to support ongoing repurchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims Accenture repurchased 12.18 million shares for $4.11 billion in fiscal 2022, but the ground truth does not provide any such repurchase volume or value for that year—only that the available authorization was $3.13 billion. The LLM incorrectly states the available authorization in 2022 was $3.13 million (off by a factor of 1,000). In fiscal 2023 and 2024, the LLM cites repurchases of 2.07 million shares for $605 million in Q4 of each year, but the ground truth only confirms $605 million in repurchases during all of fiscal 2024 (not just Q4), with no mention of Q4-specific activity or share count. The available authorization in 2023 and 2024 is cited as $2.694 billion, which is close to the ground truth $2.69 billion, but the LLM incorrectly implies it increased from 2022 to 2023, while the ground truth shows it decreased due to repurchases, despite new authorizations. The total outstanding authority in 2024 is correctly noted as ~$6.69 billion, aligning with the $6.69 billion in the ground truth after the $4.0 billion addition. (2) Calculations and number usage are flawed: the $3.13 million vs. billion error is severe; the $605 million repurchase is misattributed to Q4 and repeated for two years without evidence; share counts are fabricated. (3) Multi-hop reasoning is partially sound—the LLM attempts to trace authorization changes over time and infers a consistent strategy, which aligns with the ground truth’s conclusion. However, the reasoning is based on incorrect data, undermining the validity. (4) Scores reflect major quantitative errors (3/10), partial qualitative accuracy in structure and strategy interpretation (5/10), high contextual relevance as it addresses the question’s intent (8/10), and an overall correctness score of 4 due to a mix of correct directional insights but severe factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 528,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "BMS continued to hold a $1 billion 4.350 % senior note due 2047 in each of its 2022, 2023 and 2024 10‑K filings (page 138 for 2022, page 136 for 2023, page 134 for 2024).  The note’s principal, coupon and maturity remained unchanged and it was incorporated by reference to the same 2019 8‑K exhibit each year.  This consistency shows BMS’s long‑term financing strategy of maintaining a stable, low‑cost, fixed‑rate debt mix with long maturities to manage interest‑rate risk and support its capital needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the principal amount of the 4.350% Senior Notes due 2047. The ground truth does not specify the amount as $1 billion, and no such figure is mentioned in the original answer; thus, this number is incorrect or unsupported. All other numeric elements (coupon rate: 4.350%, maturity year: 2047) are accurate, and the years referenced (2022–2024) match. However, the inclusion of an incorrect principal amount significantly undermines quantitative accuracy. (2) The LLM correctly identifies that the notes were consistently referenced across all three years and tied to the same 2019 8-K exhibit, which aligns with the ground truth mentioning the Eleventh Supplemental Indenture dated November 22, 2019. However, it fails to mention key context from the original answer—specifically, the issuance of new debt instruments in 2023 and 2024 (e.g., $1.75B 2.950% Notes due 2032, $2B 3.700% Notes due 2052, and $3.75B 4.250% Senior Notes due 2049)—which is essential for demonstrating BMY’s broader financing strategy of diversification and maturity staggering. (3) The reasoning is partially sound: the conclusion about maintaining stable, fixed-rate debt is plausible, but the LLM mischaracterizes the strategy as focused on 'low-cost' debt, whereas the ground truth describes the 4.350% notes as a 'high-yield component,' implying relatively higher cost. This contradiction reflects a failure in multi-hop synthesis—while the model recognizes consistency, it misinterprets the strategic role of the instrument. Additionally, the company is referred to as 'BMS' instead of 'BMY' (Bristol-Myers Squibb ticker), which is a minor entity inaccuracy. (4) Despite these issues, the answer remains contextually relevant, addressing the evolution over three years and inferring a strategic intent around long-term financing. The core idea of stability in debt structure is supported, but missing comparative context and containing a key numerical inaccuracy limits correctness. Hence, correctness_score is 6 due to partial accuracy with significant factual and interpretive flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 571,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple disclosed the 2.40% Notes due 2023 via an officer’s certificate (Exhibit 4.3) in its 2022 10‑K (page 56). The 2023 filing omitted that certificate, suggesting a brief shift to consolidating the disclosure within the “Description of Securities” exhibit (pages 53‑57). By 2024 Apple re‑introduced the officer’s certificate while still maintaining the “Description of Securities” exhibit, returning to its original disclosure format (page 56).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) The original answer states that Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across 2022, 2023, and 2024, with Exhibit 4.3 present and unchanged in all filings, referencing the Officer's Certificate dated May 3, 2013. The LLM claims the 2023 filing omitted the certificate and that Apple 're-introduced' it in 2024, which directly conflicts with the ground truth of consistent disclosure. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in the LLM answer that are factually wrong per se—'2.40% Notes due 2023' and 'May 3, 2013' are correct—but the core claim about changes in disclosure format involves incorrect inferences. The years (2022, 2023, 2024) and exhibit number (4.3) are accurate, but their usage in describing a changing approach is false. (3) The multi-hop reasoning fails: instead of recognizing consistency across filings, the model infers a shift and reversal in disclosure strategy not supported by the data. The claim that the 2023 filing 'omitted' the certificate and that it was 're-introduced' in 2024 is factually incorrect according to the ground truth. (4) Contextual relevance is moderate—the answer addresses the right topic, company, notes, and exhibits—but the conclusion about evolving disclosure is unsupported and incorrect. The model fabricates a narrative of change where the truth is stability. Thus, the correctness score is low due to major factual and reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 420,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized 127 million Class A shares in FY 2022 (page 91) and the number remained unchanged in FY 2023 (no change was reported in the 2023 filing).  By FY 2024 the authorized pool had grown to 141 million shares (page 98).  This incremental expansion shows Accenture is deliberately enlarging its share‑based compensation pool to support long‑term incentive plans and keep pace with growth while aligning employee incentives with shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the timeline of share authorization changes. It states that the authorized shares remained at 127 million in FY 2023 and then increased to 141 million in FY 2024. However, the ground truth shows the increase occurred from FY 2022 (127M) to FY 2023 (141M), and remained at 141M in FY 2024. This misrepresents the timing of the change, which is a key part of the multi-hop evolution. (2) Quantitatively, the numbers 127 million and 141 million are correct in value but incorrectly assigned to fiscal years. The calculation of an increase of 14 million shares is implied but not explicitly stated, and the sequencing is wrong. (3) The reasoning about Accenture's long-term strategy to expand the share pool is semantically aligned with the ground truth and contextually sound; however, the flawed timeline undermines the validity of the synthesis across years. The model fails to correctly track the progression across the three fiscal years, indicating a breakdown in multi-hop reasoning. (4) Despite the incorrect year mapping, the answer addresses both parts of the question—evolution of shares and strategic interpretation—and uses appropriate terminology and context from the filings (e.g., referencing pages, correct plan name), warranting moderate scores in qualitative accuracy and high contextual relevance. The core data points are present but misaligned temporally, leading to a correctness score of 6 due to partial accuracy with a significant factual flaw.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 422,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "In the 2022 10‑K, PowerVia is not referenced, indicating it was still in early concept stages. By the 2023 filing (page 14), Intel announced PowerVia as a breakthrough backside‑power delivery technology for the upcoming Intel 20A node, underscoring its strategic importance. In the 2024 filing (page 10), PowerVia is highlighted as a core feature of the Intel 18A node—its first high‑volume commercial implementation—showing that the technology has moved from a future innovation to a commercial cornerstone of Intel’s advanced process roadmap for performance‑per‑watt and density scaling.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of PowerVia from not being mentioned in 2022 (indicating early stage) to being announced for Intel 20A in 2023, and then transitioning to Intel 18A in 2024 as a core feature. These key milestones match the original answer. (2) There are no numeric values (e.g., dates, dollar amounts) in either answer that conflict—both correctly reference 2022, 2023, and 2024 developments. The LLM correctly notes the shift from Intel 20A to 18A, and the role of PowerVia in performance-per-watt and scaling, which is consistent with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to trace the strategic elevation of PowerVia. The only minor omission is that the original answer specifies Panther Lake as the first high-volume product using Intel 18A in 2025, which the LLM answer does not mention. While this detail adds context, its absence does not undermine the core factual accuracy. (4) The LLM uses slightly different phrasing (e.g., 'commercial cornerstone' vs 'foundational element') but maintains semantic equivalence. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 361,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s defined‑benefit pension plan invested **$239,293** in mutual‑fund equity securities in FY 2022, **$196,226** in FY 2023, and **$273,699** in FY 2024 (fair‑value data for pension assets, pages 89 and 96). The dip in 2023 followed by a rebound that surpassed the 2022 level signals a shift from a more cautious stance to a renewed emphasis on equity exposure, reflecting confidence in market growth and a willingness to take on higher risk for potential returns. This 3‑year trajectory indicates a dynamic asset‑allocation strategy that adjusts to market conditions and risk appetite.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. While it correctly reports the $239,293 million (likely meant to be $239,293 million, not $239,293) for FY2022 and $196,226 million for FY2023, it incorrectly states $273,699 million for FY2024, which contradicts the ground truth that the allocation remained unchanged at $196,226 million. This error completely alters the trajectory interpretation. (2) Quantitative accuracy is severely compromised: the FY2024 number is wrong, and the values appear to lack proper units (missing 'million' or 'M'), leading to potential misinterpretation of scale. Even if formatting is overlooked, the $273,699 figure is factually incorrect. (3) The multi-hop reasoning is flawed: instead of identifying a consistent reduction and stabilization, the LLM infers a rebound and renewed emphasis on equities, which is the opposite of the actual trend. This indicates a failure in synthesizing the correct data points over time. (4) Contextual relevance is moderate because the answer addresses the right topic (Accenture's mutual fund equity allocation) and attempts to interpret strategic positioning, but the conclusion is based on incorrect data, rendering the qualitative analysis invalid. The mention of 'defined-benefit pension plan' and 'fair-value data' adds context not in the original, but does not compensate for factual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 385,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck has kept Dificid (fidaxomicin) in the same niche hospital‑acute‑care portfolio as a treatment for C. difficile‑associated diarrhea, with no new indications or repositioning announced from 2022 through 2024 (see 2023 page 4 and 2024 page 130).  The intangible asset tied to Dificid remained valued at $145 million (net) in 2021 and was not impaired in the subsequent years, indicating stable confidence in its future cash flows (see 2021 page 115 and no impairment notes in 2024).  Global sales grew modestly from $263 million in 2022 to $302 million in 2023 and $340 million in 2024, representing a small but slightly expanding share of the pharmaceutical segment (≈0.5–0.6 % of total sales).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its qualitative assessment of Dificid's strategic positioning and asset stability, but contains significant quantitative inaccuracies. The ground truth states that Dificid was valued as a $145 million intangible asset in 2022, while the LLM claims this value was from 2021 and remained unchanged—this misaligns the timeline. More critically, the LLM reports global sales of $263M in 2022 and $302M in 2023, but the ground truth does not provide 2022 or 2023 sales figures—only 2024 sales of $340M. Thus, the LLM introduces unsupported data for 2022 and 2023, which undermines quantitative accuracy. However, the $340M figure for 2024 is correct and matches the ground truth. (2) The calculation of percentage contribution (0.5–0.6%) is plausible but not verifiable from the ground truth, which does not mention segment percentages. This introduces extraneous precision without support. (3) The multi-hop reasoning is sound in linking asset valuation, therapeutic positioning, and revenue over time, and correctly identifies Dificid’s role in the Hospital Acute Care portfolio across years. It appropriately infers stable valuation due to lack of impairment, though this point slightly distracts from the evolution asked in the question. (4) Despite incorrect or unverified sales numbers for 2022 and 2023, the core trajectory—Dificid growing in financial and strategic importance—is consistent with the ground truth. The answer addresses all three dimensions (valuation, positioning, revenue), but with partially fabricated intermediate data. Hence, correctness is reduced primarily due to unsupported numbers, though overall interpretation remains reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 466,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "From 2022‑24 Intel positioned advanced‑packaging as a core pillar of its IDM 2.0 and Intel Foundry strategy, investing roughly $17.5 B in R&D in 2022, $16.0 B in 2023 and $16.5 B in 2024, with a focus on process‑and‑packaging technology and a disaggregated, chip‑let design approach.  Yet the company continued to hit implementation delays—10 nm and 7 nm process setbacks, a 4th‑Gen Xeon Scalable launch delay, and a $922 M inventory charge for Gaudi AI accelerators—highlighting the complexity of its advanced‑packaging roadmap.  These delays, coupled with a $3.1 B impairment of Intel 7 assets in Q3 2024 and a $755 M penalty for construction delays, amplified financial‑risk exposure, raising concerns about write‑downs, penalties, and the ability to recoup long‑term R&D and capital‑intensive manufacturing investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the strategic importance of advanced packaging and correctly identifies Intel's IDM 2.0 and foundry focus, as well as implementation delays and financial risks, which aligns with the ground truth. However, it introduces specific R&D investment figures—$17.5B (2022), $16.0B (2023), $16.5B (2024)—that are not present in the original answer and cannot be verified from the provided ground truth, making them factually unsupported. The $922M inventory charge for Gaudi AI accelerators and $755M penalty for construction delays are also not mentioned in the ground truth and appear to be hallucinated. Only the $3.1B impairment charge in 2024 is correctly reported and matches the original answer. (2) Quantitative accuracy is low because three R&D figures and two financial charges are fabricated or unverified. The ground truth does not provide any R&D spending numbers or the $922M/$755M charges, so their inclusion undermines factual reliability. (3) The multi-hop reasoning is partially sound: the model connects advanced packaging to strategic positioning, execution delays, and financial risk, and correctly notes the 2024 $3.1B impairment as a key risk indicator. It also references disaggregated design complexity, which is consistent with the original. However, the reasoning is weakened by reliance on incorrect numerical data. (4) Despite the quantitative inaccuracies, the answer addresses all key themes—R&D emphasis, implementation delays, financial risk—and maintains contextual relevance. The core narrative of growing strategic focus followed by execution and financial strain is semantically aligned with the ground truth, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 468,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "In the 2022 and 2023 10‑K filings (page 23 of each), MK‑8591A is listed as a Phase 2 HIV‑1 candidate with footnote (4) indicating an FDA clinical hold. By the 2024 filing (page 24), footnote (4) notes that the hold was lifted on December 4 2024 (with a partial hold for higher‑dose regimens) and the program had entered a Phase 2/3 study that began in August 2024. This evolution shows Merck’s commitment to advancing a novel oral HIV therapy through late‑stage development, underscoring a long‑term strategy to expand its HIV portfolio despite earlier regulatory setbacks.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the development phase of MK-8591A. According to the ground truth, MK-8591A was in Phase 3 as of 2022 with a Phase 3 entry date of February 2020, but the LLM incorrectly states it was in Phase 2 in both 2022 and 2023. This is a major error in entity and stage accuracy. Additionally, the LLM claims that a Phase 2/3 study began in August 2024, which is not mentioned in the original answer and introduces unverified information. However, the date of the FDA lifting the clinical hold—December 4, 2024—is correctly stated, and the detail about the partial hold on higher-dose regimens is accurate. (2) Quantitatively, the December 4, 2024 date is correct, and no numerical calculations are required beyond dates and phases. The Phase misclassification (Phase 2 vs Phase 3) undermines quantitative accuracy, as development phase is a key metric. (3) The multi-hop reasoning is partially sound—the model connects regulatory status changes over time and infers strategic commitment—but it is based on incorrect foundational data (wrong phase), leading to flawed synthesis. The conclusion about Merck’s long-term strategy is reasonable but overstated given the inaccuracies in the underlying timeline. (4) Contextual relevance is high, as the answer addresses the evolution over time and attempts to interpret strategic implications. However, due to the critical error in development phase and the introduction of an unsupported new study start date (August 2024), the overall correctness score is low despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 441,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "In 2022, Merck positioned MK‑1308A (quavonlimab + pembrolizumab) as a broad‑based advanced‑solid‑tumor therapy, with activity planned in colorectal, hepatocellular, melanoma and small‑cell lung cancers (page 25). By 2023 the program had narrowed its clinical focus to renal cell carcinoma (RCC), retaining the same combination (page 18). In 2024 the RCC focus continues, with MK‑1308A still described as a quavonlimab‑pembrolizumab co‑formulation for RCC (page 48). Across all filings, no regulatory submissions, approvals or CRLs for MK‑1308A are reported, indicating the program remains in early clinical development.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error in the clinical focus of MK-1308A in 2022, claiming it was positioned as a broad-based therapy for colorectal, hepatocellular, melanoma, and small-cell lung cancers, which contradicts the ground truth stating it was specifically for renal cell carcinoma (RCC) from the start. This misrepresentation undermines the accuracy of the evolution narrative. However, the LLM correctly identifies the combination therapy (quavonlimab + pembrolizumab), the 2023 and 2024 focus on RCC, and the absence of regulatory approvals across all years. The quantitative accuracy is high—no numerical values are incorrect, and the timeline (2022–2024) is properly used. The qualitative accuracy suffers due to the incorrect initial clinical indication, which distorts the strategic evolution; the narrowing of focus implies a pivot that did not occur according to the ground truth. The reasoning is partially sound in tracking formulation specificity and lack of regulatory progress, but the multi-hop synthesis fails at the first step by mischaracterizing the 2022 strategy. Contextually, the answer addresses all parts of the question (clinical focus, combination therapies, regulatory progress) and remains relevant, citing appropriate document pages, though with incorrect content for 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 367,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12.18 million shares for $4.11 million, with an available authorization of $3.13 million and total outstanding authority of $6.13 million after a $3.00 million increase. In fiscal 2023 the company continued to use its share‑repurchase program, and in fiscal 2024 it bought 2.07 million shares in Q4 for $605 million while the Board added $4.00 billion in new authority, raising total outstanding authority to $6.694 billion and leaving $2.694 million available for the open‑market program. This steady repurchase activity, coupled with incremental increases in authorized capacity over three years, demonstrates Accenture’s disciplined, long‑term capital‑return strategy that balances shareholder payouts with flexibility for future investment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in fiscal 2022 share repurchase data. It claims Accenture repurchased 12.18 million shares for $4.11 million in fiscal 2022, which is grossly incorrect—$4.11 million is far too low for such a large number of shares and contradicts the ground truth, which does not specify 2022 repurchase volume but does state available authorization was $3.13 billion. The LLM also incorrectly states total outstanding authority in 2022 was $6.13 billion after a $3.00 billion increase, which is not supported by the original answer. In fiscal 2024, the LLM incorrectly states 2.07 million shares were bought in Q4 alone for $605 million, while the ground truth indicates 2,000,308 shares (approximately 2.0 million) were purchased for $605 million during the entire fiscal year, not just Q4. The $4.00 billion new authority and resulting $6.694 billion total outstanding authority in 2024 are correct. The remaining available authorization of $2.694 billion is correctly reported, though the LLM mistakenly writes '$2.694 million', a critical unit error. (2) Multiple calculation and unit errors: $4.11 million for 12.18 million shares implies a price per share of ~$0.34, which is implausible; the correct fiscal 2024 repurchase was $605 million for ~2 million shares (~$300/share), consistent with Accenture's actual stock price. The LLM also misrepresents the timing and magnitude of repurchase activity. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a pattern of sustained repurchases and replenishment of authority, and connects this to a disciplined capital return strategy. However, it fabricates or misattributes data for 2022 and 2024, undermining the synthesis. The original answer notes that 2023 disclosures reference 2024 activity, suggesting forward-looking consistency, which the LLM omits. (4) Correctness is scored low (4/10) due to major quantitative errors and unit confusion, despite capturing the general strategic direction. Quantitative accuracy is poor (3/10) due to incorrect numbers, units, and misattributed timeframes. Qualitative accuracy is moderate (5/10) as the strategic interpretation is reasonable but based on flawed data. Contextual relevance is high (8/10) because the answer addresses the evolution of repurchase activity and strategy as asked, even if factually flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 639,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "Bristol‑Myers Squibb has kept the $750 million 2.350 % notes due 2040 on its balance sheet in both the 2023 and 2024 10‑Ks (see the debt schedule on pages 134–136 of each filing), and the same instrument was also disclosed in the 2022 filing, indicating a deliberate decision to retain a long‑term fixed‑rate debt. This persistence reflects the company’s strategy of locking in a relatively low interest rate and maintaining a stable maturity profile to reduce refinancing risk and manage its long‑term debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $750 million 2.350% Notes due 2040 and their presence in Bristol-Myers Squibb's filings for 2022, 2023, and 2024. The dollar amount ($750 million vs $750,000,000) is semantically equivalent, and the interest rate (2.350%) and maturity year (2040) are accurate. (2) All quantitative elements match the ground truth: the principal amount, interest rate, and years of disclosure (2022–2024) are correct. The reference to specific pages (134–136) in the 10-Ks adds precision and supports the claim, though not required for correctness. (3) The reasoning is sound: the LLM correctly infers that the continued inclusion of the notes reflects a strategic choice to maintain fixed-rate debt, lock in low interest rates, and reduce refinancing risk—aligning with the ground truth’s emphasis on stable long-term liability management and interest rate risk mitigation. The only minor gap is that the LLM does not explicitly mention the 2022 filing beyond stating it was disclosed, whereas the original answer emphasizes its significance in signaling importance in the capital structure. However, the core multi-hop synthesis—tracking the note across three years and drawing strategic implications—is complete and logical. (4) The answer is highly contextually relevant, directly addressing how the persistence of the notes reflects BMY’s long-term debt strategy. The conclusion about managing refinancing risk and stabilizing interest expenses matches the original answer’s intent. Overall, the LLM answer is factually correct, well-reasoned, and only slightly less detailed than the ground truth in elaborating the strategic nuance for each year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 462,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Bristol‑Myers Squibb has kept the same fixed‑rate commitment on its $1 billion senior notes due 2047 across the 2022, 2023 and 2024 10‑K filings (see the 4.350% Senior Notes listed on pages 134, 136, 138 and 137).  The unchanged 4.350% rate shows the company’s preference for stable, predictable long‑term debt, avoiding refinancing risk and maintaining a conservative interest‑expense profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fixed interest rate of 4.350% for the Senior Notes due 2047 across 2022–2024 filings, which matches the ground truth. It accurately notes the consistency of the rate, a key factual point. The mention of a $1 billion principal amount is not contradicted by the ground truth (though not explicitly stated in the original answer), and such detail may come from the referenced filings; thus, it does not count as an error. However, the LLM cites specific page numbers (134, 136, 138, 137) without confirming their universal applicability across filings, which introduces minor inaccuracy or potential misalignment across documents—though not a factual error per se, it risks imprecision. (2) All numeric values—4.350%, 2047 maturity, and $1 billion—are factually plausible and consistent with known disclosures; no calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings to infer a stable debt strategy, correctly concluding that the unchanged rate reflects a preference for predictability and reduced refinancing risk. It misses the specific exhibit references (e.g., Exhibit 4bbb, 4ff) and supplemental indenture dates (e.g., November 13, 2020, 2023), which are part of the detailed disclosure pattern in the ground truth, but captures the essential synthesis. (4) The answer is contextually relevant, directly addressing both the evolution of the interest rate and the strategic implication. The omission of exhibit-level detail slightly reduces qualitative accuracy but does not undermine the core correctness. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 473,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "Nike’s 2022 filing simply listed FlyEase among its suite of technologies (source: page_7). In the 2024 filing, FlyEase is still mentioned in that same list, but the company adds detailed manufacturing metrics—96 finished‑goods footwear factories in 11 countries, 15 contract manufacturers producing Nike Brand footwear, and 50 % of production in Vietnam, 27 % in Indonesia and 18 % in China—demonstrating the scale and global integration of FlyEase technology (source: page_6).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of FlyEase reporting from 2022 to 2024 and provides accurate quantitative evidence from the 2024 filing regarding production scale and geographic distribution. The percentages for footwear manufacturing—50% in Vietnam, 27% in Indonesia, and 18% in China—are factually correct and match the ground truth. However, the LLM incorrectly implies that these specific manufacturing metrics (e.g., 96 factories, 15 contract manufacturers) are directly tied to FlyEase production, when in fact they refer to overall Nike Brand footwear production, of which FlyEase is a part. This over-attribution slightly misrepresents the data. (2) All numeric values (50%, 27%, 18%) are accurate and correctly cited. The additional details about 96 factories and 15 contract manufacturers are plausible and may appear in the filing, but their linkage to FlyEase is not supported in the ground truth, introducing a minor factual overreach. (3) The multi-hop reasoning is mostly sound: the model correctly infers that inclusion in broader manufacturing data indicates integration into global operations. However, it misses the nuanced progression noted in the original answer—specifically, that FlyEase gained parity with established technologies like Nike Air and Dri-FIT by 2023, which strengthens the narrative of strategic integration. This omission reduces completeness. (4) Despite minor overstatement in attributing factory counts directly to FlyEase, the core answer conveys the correct idea that FlyEase is now embedded in large-scale, globally distributed production. The answer is contextually relevant, factually grounded in correct percentages, and captures the essence of technological integration, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 487,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s debit‑card/RedCard suite has seen a steady decline in penetration: 20.5 % of purchases were paid with a RedCard in 2022, falling to 19.8 % in 2023 and 18.6 % in 2024 (Target Circle Card penetration)【page_27】【page_29】. The downward trend suggests that the loyalty‑driven payment strategy is losing momentum—while still capturing a sizable share of sales, its growth is slowing, indicating that the program may need to be refreshed to sustain or increase adoption.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in RedCard penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it reports 18.6% for 2024 instead of the correct 17.8%, introducing a factual error in the final and most critical data point. This discrepancy affects the overall quantitative accuracy. (2) The numbers for 2022 and 2023 are accurate, but the 2024 figure is incorrect—18.6% vs. 17.8%—a difference of 0.8 percentage points that alters the perceived rate of decline. No calculations are required in the question, but the trend interpretation depends on correct data points. (3) The reasoning is sound in interpreting the downward trend as a sign of weakening momentum in Target's loyalty-driven payment strategy. The model correctly synthesizes the implication of declining penetration over time, even referencing the need for a refresh, which is a reasonable inference. However, the incorrect 2024 value undermines the strength of the conclusion. (4) Contextual relevance is high—the answer addresses both parts of the question: the evolution of penetration and the strategic implication. The qualitative reasoning is strong and semantically aligned with the ground truth, despite the numerical inaccuracy in the final year. The citation of 'Target Circle Card penetration' for 2024 may reflect a misattribution or conflation of RedCard with a specific product variant, introducing entity confusion. Overall, the answer is partially correct but contains a significant factual error in the 2024 penetration rate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 432,
        "total_tokens": 1670
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 798,
    "successful_evaluations": 798,
    "failed_evaluations": 0,
    "average_correctness_score": 6.45,
    "average_quantitative_accuracy": 7.18,
    "average_qualitative_accuracy": 6.74,
    "average_contextual_relevance": 8.64,
    "score_distribution": {
      "excellent": 287,
      "good": 147,
      "fair": 213,
      "poor": 151
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 798,
    "failed": 2,
    "elapsed_seconds": 44518.91,
    "timestamp": "2026-02-03T13:25:53.191415"
  }
}